nct_id;nlm_download_date_description;study_first_submitted_date;results_first_submitted_date;disposition_first_submitted_date;last_update_submitted_date;study_first_submitted_qc_date;study_first_posted_date;study_first_posted_date_type;results_first_submitted_qc_date;results_first_posted_date;results_first_posted_date_type;disposition_first_submitted_qc_date;disposition_first_posted_date;disposition_first_posted_date_type;last_update_submitted_qc_date;last_update_posted_date;last_update_posted_date_type;start_month_year;start_date_type;start_date;verification_month_year;verification_date;completion_month_year;completion_date_type;completion_date;primary_completion_month_year;primary_completion_date_type;primary_completion_date;target_duration;study_type;acronym;baseline_population;brief_title;official_title;overall_status;last_known_status;phase;enrollment;enrollment_type;source;limitations_and_caveats;number_of_arms;number_of_groups;why_stopped;has_expanded_access;expanded_access_type_individual;expanded_access_type_intermediate;expanded_access_type_treatment;has_dmc;is_fda_regulated_drug;is_fda_regulated_device;is_unapproved_device;is_ppsd;is_us_export;biospec_retention;biospec_description;ipd_time_frame;ipd_access_criteria;ipd_url;plan_to_share_ipd;plan_to_share_ipd_description;created_at;updated_at;cities_lead;id.x;role;name;affiliation;intervention_names_comb;id.y;number_of_facilities;number_of_nsae_subjects;number_of_sae_subjects;registered_in_calendar_year;nlm_download_date;actual_duration;were_results_reported;months_to_report_results;has_us_facility;has_single_facility;minimum_age_num;maximum_age_num;minimum_age_unit;maximum_age_unit;number_of_primary_outcomes_to_measure;number_of_secondary_outcomes_to_measure;number_of_other_outcomes_to_measure
NCT04229069;ClinicalTrials.gov processed this data on May 29, 2020;2020-01-07;;;2020-01-21;2020-01-13;2020-01-14;Actual;;;;;;;2020-01-21;2020-01-22;Actual;January 3, 2013;Actual;2013-01-03;January 2020;2020-01-31;December 30, 2015;Actual;2015-12-30;December 30, 2014;Actual;2014-12-30;;Interventional;BASICA;;Acid-Base Balance, Metabolism and Minerals;Randomized, Double-blind, Placebo-controlled Intervention Study on Effects of Basica® on Acid-base Balance, Metabolism and Quality of Life in Elderly Healthy Volunteers.;Completed;;N/A;40;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;No;;2020-06-01T05:43:55Z;2020-06-01T05:43:55Z;Berlin;;;;;alkaline salt mixture | placebo;63460025;;;;2020;2020-05-29;24;FALSE;;;FALSE;60;70;Years;Years;1;;
NCT04209309;ClinicalTrials.gov processed this data on May 29, 2020;2019-12-17;;;2019-12-19;2019-12-19;2019-12-24;Actual;;;;;;;2019-12-19;2019-12-24;Actual;October 1, 2014;Actual;2014-10-01;December 2019;2019-12-31;July 1, 2016;Actual;2016-07-01;July 1, 2016;Actual;2016-07-01;;Interventional;;;Repetitive Transcranial Magnetic Stimulation as a Potential Tool to Reduce Sexual Arousal;Repetitive Transcranial Magnetic Stimulation as a Potential Tool to Reduce Sexual Arousal;Completed;;N/A;19;Actual;University of Regensburg;;3;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;No;Not allowed based on ethics vote.;2020-06-01T05:46:34Z;2020-06-01T05:46:34Z;Regensburg;;;;;repetitive transcranial magnetic stimulation;63461522;;;;2019;2020-05-29;21;FALSE;;;FALSE;18;50;Years;Years;1;;
NCT04157023;ClinicalTrials.gov processed this data on May 29, 2020;2019-11-01;;;2019-11-05;2019-11-05;2019-11-08;Actual;;;;;;;2019-11-05;2019-11-08;Actual;January 2017;Actual;2017-01-31;November 2019;2019-11-30;December 2017;Actual;2017-12-31;December 2017;Actual;2017-12-31;;Interventional;;;Simulator Training for Direct Ophthalmoscopy;Direct-Ophthalmoscopy-Simulator-Study;Completed;;N/A;78;Actual;University Hospital Tuebingen;;3;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;No;;2020-06-01T05:54:26Z;2020-06-01T05:54:26Z;Tübingen;;;;;Simulator-based Training of Direct Ophthalmoscopy;63465497;;;;2019;2020-05-29;11;FALSE;;;FALSE;18;;Years;;2;2;
NCT04152408;ClinicalTrials.gov processed this data on May 29, 2020;2018-10-22;;;2019-11-04;2019-11-04;2019-11-05;Actual;;;;;;;2019-11-04;2019-11-05;Actual;January 2017;Actual;2017-01-31;November 2019;2019-11-30;April 2017;Actual;2017-04-30;April 2017;Actual;2017-04-30;;Interventional;;;Clinical and Home Use Feasibility Study of a Percutaneous Optical Glucose Fiber Sensor;A Study to Investigate the Function, Safety and Tolerability of the FiberSense System in Diabetic Patients for a Period of Continuous Blood Glucose Monitoring up to 30 Days;Completed;;N/A;7;Actual;EyeSense GmbH;;1;;;FALSE;;;;TRUE;FALSE;FALSE;;;;;;;;;No;;2020-06-01T05:55:59Z;2020-06-01T05:55:59Z;Heidelberg;3437116;Principal Investigator;Christoph Hasslacher, Prof. Dr.;Diabetes Institut Heidelberg, Germany;FiberSense System;63465854;1;;;2018;2020-05-29;2;FALSE;;FALSE;TRUE;18;;Years;;3;9;
NCT04114201;ClinicalTrials.gov processed this data on May 29, 2020;2019-10-01;;;2019-10-02;2019-10-02;2019-10-03;Actual;;;;;;;2019-10-02;2019-10-03;Actual;August 2, 2012;Actual;2012-08-02;October 2019;2019-10-31;February 23, 2017;Actual;2017-02-23;February 23, 2017;Actual;2017-02-23;;Interventional;TKA PSI;;Clinical Outcome and OR Resource Use of Total Knee Arthroplasty Using Patient-Specific or Conventional Instrumentation;Evaluation of Zimmer® Patient Specific Instrumentation vs. Conventional Instrumentation in Total Knee Arthroplasty Procedures: Clinical and Economic Outcomes;Completed;;N/A;139;Actual;Technische Universität Dresden;;2;;;FALSE;;;;FALSE;FALSE;FALSE;;;FALSE;;;;;;No;;2020-06-01T06:02:22Z;2020-06-01T06:02:22Z;Dresden;;;;;PSI | Conventional;63468774;3;;;2019;2020-05-29;55;FALSE;;FALSE;FALSE;18;;Years;;1;6;
NCT03961906;ClinicalTrials.gov processed this data on May 29, 2020;2019-05-20;;;2019-05-22;2019-05-22;2019-05-23;Actual;;;;;;;2019-05-22;2019-05-23;Actual;January 1, 2015;Actual;2015-01-01;May 2019;2019-05-31;March 30, 2017;Actual;2017-03-30;March 30, 2017;Actual;2017-03-30;;Interventional;;;Physiotherapy in Hereditary Spastic Paraplegia;Design and Validation of a Modular Physiotherapy Concept for the Treatment of Hereditary Spastic Spinal Paralysis (HSP) - a Randomized Study;Completed;;Phase 2;53;Actual;University Hospital Tuebingen;;2;;;FALSE;;;;;FALSE;FALSE;;;;;;;;;No;Available upon request;2020-06-01T06:23:29Z;2020-06-01T06:23:29Z;Tübingen;;;;;physiotherapy;63480388;1;;;2019;2020-05-29;27;FALSE;;FALSE;TRUE;18;80;Years;Years;1;1;
NCT03868865;ClinicalTrials.gov processed this data on May 29, 2020;2019-02-27;;;2019-03-06;2019-03-06;2019-03-11;Actual;;;;;;;2019-03-06;2019-03-11;Actual;August 7, 2012;Actual;2012-08-07;March 2019;2019-03-31;April 7, 2015;Actual;2015-04-07;April 7, 2015;Actual;2015-04-07;;Interventional;;;Effects of an Integrative Day-care Clinic Program for Breast Cancer Patients During Chemotherapy;Effects of an Integrative Day-care Clinic Program for Breast Cancer Patients During Chemotherapy: an Observational Study;Completed;;N/A;57;Actual;Universität Duisburg-Essen;;1;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;Undecided;;2020-06-01T06:36:10Z;2020-06-01T06:36:10Z;Duisburg;;;;;Integrative mind-body-medicine group program;63487454;1;;;2019;2020-05-29;32;FALSE;;FALSE;TRUE;18;;Years;;6;;
NCT03860129;ClinicalTrials.gov processed this data on May 29, 2020;2018-09-24;;;2019-02-28;2019-02-28;2019-03-01;Actual;;;;;;;2019-02-28;2019-03-01;Actual;December 10, 2014;Actual;2014-12-10;February 2019;2019-02-28;May 31, 2017;Actual;2017-05-31;May 5, 2017;Actual;2017-05-05;;Interventional;;;Different Volatile Anaesthetics and the Depth of Long Term ICU Sedation;Depth of Long Term ICU Sedation Under 0,5 MAC Isoflurane, Sevoflurane or Desflurane Using MIRUS, an Automated Delivery System for Volatile Anaesthetics;Completed;;N/A;30;Actual;Ruhr University of Bochum;;3;;;FALSE;;;;TRUE;FALSE;FALSE;;;;;;;;;;;2020-06-01T06:37:19Z;2020-06-01T06:37:19Z;Bochum;3455552;Principal Investigator;Thomas Weber, PhD;Ruhr-University of Bochum, Germany;Isoflurane | Sevoflurane | Desflurane;63488132;;;;2018;2020-05-29;29;FALSE;;;FALSE;18;;Years;;1;;
NCT03854942;ClinicalTrials.gov processed this data on May 29, 2020;2019-02-18;;;2019-09-10;2019-02-25;2019-02-26;Actual;;;;;;;2019-09-10;2019-09-12;Actual;August 30, 2011;Actual;2011-08-30;September 2019;2019-09-30;December 13, 2017;Actual;2017-12-13;December 13, 2017;Actual;2017-12-13;;Interventional;;;Study of the Opioid Modulation of the Effect of Alcohol on the Dopaminergic Reward System;Opioid Modulation of the Effect of Alcohol on the Dopaminergic Reward System: a [18F]-Fallypride- and [18F]-Fluoro-DOPA-PET Study.;Terminated;;Phase 1;43;Actual;RWTH Aachen University;;3;;Recruitment rate could not be met in the study period, review group was dissolved before~   regular end of study. Recruitment was therefore terminated.;FALSE;;;;TRUE;FALSE;FALSE;;;;;;;;;No;;2020-06-01T06:37:56Z;2020-06-01T06:37:56Z;Aachen;;;;;Placebo | Naltrexone;63488518;1;;;2019;2020-05-29;76;FALSE;;FALSE;TRUE;21;45;Years;Years;2;4;7
NCT03829839;ClinicalTrials.gov processed this data on May 29, 2020;2019-02-01;;;2019-04-15;2019-02-01;2019-02-04;Actual;;;;;;;2019-04-15;2019-04-17;Actual;March 3, 2016;Actual;2016-03-03;April 2019;2019-04-30;August 16, 2017;Actual;2017-08-16;August 16, 2017;Actual;2017-08-16;;Interventional;;;Effects of Oxytocin and Lorazepam on Fear-related Intra-amygdalar Activity;Common and Dissociable Effects of Oxytocin and Lorazepam on the Neurocircuitry of Fear - an Ultra-high Field Imaging Study;Completed;;Phase 1;120;Actual;University Hospital, Bonn;;2;;;FALSE;;;;FALSE;FALSE;FALSE;;;FALSE;;;;;;No;;2020-06-01T06:41:40Z;2020-06-01T06:41:40Z;Bonn;;;;;Oxytocin | Lorazepam 1 mg | Placebo nasalspray | Placebo Oral Tablet;63490433;1;;;2019;2020-05-29;17;FALSE;;FALSE;TRUE;18;40;Years;Years;1;;
NCT03789448;ClinicalTrials.gov processed this data on May 29, 2020;2018-12-16;;;2019-01-03;2018-12-25;2018-12-28;Actual;;;;;;;2019-01-03;2019-01-04;Actual;September 1, 2014;Actual;2014-09-01;January 2019;2019-01-31;August 31, 2017;Actual;2017-08-31;August 31, 2017;Actual;2017-08-31;;Interventional;;;Early Access to ART for All in Swaziland: Effects on Economic Outcomes;MaxART: The Effect of Early Access to ART for All in Swaziland on Economic Outcomes;Completed;;N/A;3019;Actual;University Hospital Heidelberg;;2;;;FALSE;;;;;FALSE;FALSE;;;;;;;;;;;2020-06-01T06:47:13Z;2020-06-01T06:47:13Z;Heidelberg;;;;;Early Access to ART for All;63493494;;;;2018;2020-05-29;36;FALSE;;;FALSE;18;;Years;;2;3;
NCT03753841;ClinicalTrials.gov processed this data on May 29, 2020;2018-11-16;;;2018-11-22;2018-11-22;2018-11-27;Actual;;;;;;;2018-11-22;2018-11-27;Actual;January 14, 2014;Actual;2014-01-14;November 2018;2018-11-30;September 16, 2016;Actual;2016-09-16;September 3, 2016;Actual;2016-09-03;;Interventional;;;FEES to Determine Neurological Intensive Care Patients' Oral Diet;Flexible Endoscopic Evaluation of Swallowing (FEES) to Determine Neurological Patients' Oral Diet;Completed;;N/A;125;Actual;University of Giessen;;2;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;No;The authors declare that the data supporting the findings of this study will be available within the published article(s). The data that support the findings of this study will not be publically available due to local medical data protection policies.;2020-06-01T06:52:18Z;2020-06-01T06:52:18Z;Giessen;3462371;Principal Investigator;Tobias Braun, M.D.;University of Giessen;Adjustment of oral diet;63496231;1;;;2018;2020-05-29;32;FALSE;;FALSE;TRUE;;;;;2;2;
NCT03717493;ClinicalTrials.gov processed this data on May 29, 2020;2018-10-22;;;2018-10-25;2018-10-22;2018-10-24;Actual;;;;;;;2018-10-25;2018-10-29;Actual;December 17, 2012;Actual;2012-12-17;October 2018;2018-10-31;November 1, 2017;Actual;2017-11-01;May 1, 2017;Actual;2017-05-01;;Interventional;ER-BED;;Deficits in Emotion Regulation Skills as a Maintaining Factor in Binge Eating Disorder;Deficits in Emotion Regulation Skills as a Maintaining Factor in Binge Eating Disorder;Completed;;Phase 2/Phase 3;99;Actual;Friedrich-Alexander-Universität Erlange-Nürnberg;;2;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;From October 2018 to October 2028;Credible reason for request;;Yes;Deidentified IPD will be made available upon request;2020-06-01T06:57:11Z;2020-06-01T06:57:11Z;Erlangen;;;;;Affect Regulation Training;63498991;;;;2018;2020-05-29;53;FALSE;;;FALSE;18;69;Years;Years;1;;
NCT03667638;ClinicalTrials.gov processed this data on May 29, 2020;2018-09-09;;;2018-09-11;2018-09-11;2018-09-12;Actual;;;;;;;2018-09-11;2018-09-12;Actual;November 2016;Actual;2016-11-30;September 2018;2018-09-30;December 2017;Actual;2017-12-31;November 2017;Actual;2017-11-30;;Interventional;;;Influence of Platelet Concentrates on Wound Healing;The Influence of Autologous Platelet Concentrates on Human Keratinocyte Proliferation in Vitro and Wound Healing in Vivo;Completed;;N/A;5;Actual;Hannover Medical School;;1;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;Undecided;;2020-06-01T07:05:41Z;2020-06-01T07:05:41Z;Hannover;3467955;Principal Investigator;Peter Vogt, MD;Medical School Hannover;Platelet-Rich Plasma;63502789;1;;;2018;2020-05-29;12;FALSE;;FALSE;TRUE;18;80;Years;Years;1;3;
NCT03666338;ClinicalTrials.gov processed this data on May 29, 2020;2018-09-05;;;2018-09-11;2018-09-07;2018-09-11;Actual;;;;;;;2018-09-11;2018-09-13;Actual;July 11, 2011;Actual;2011-07-11;September 2018;2018-09-30;February 4, 2016;Actual;2016-02-04;November 4, 2015;Actual;2015-11-04;;Interventional;SOMS-GCS;;Influence of the Initial Level of Consciousness on Early, Goal-directed Mobilization;Influence of the Initial Level of Consciousness on Early, Goal-directed Mobilization;Completed;;N/A;200;Actual;Technische Universität München;;2;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;Undecided;On reasonable request from researchers after an agreement has been found.;2020-06-01T07:05:51Z;2020-06-01T07:05:51Z;Munich;;;;;Early, goal-directed mobilization;63502886;;;;2018;2020-05-29;52;FALSE;;;FALSE;18;;Years;;1;3;
NCT03663491;ClinicalTrials.gov processed this data on May 29, 2020;2018-06-21;;;2019-05-20;2018-09-05;2018-09-10;Actual;;;;;;;2019-05-20;2019-05-22;Actual;September 1, 2016;Actual;2016-09-01;May 2018;2018-05-31;March 31, 2017;Actual;2017-03-31;March 31, 2017;Actual;2017-03-31;;Interventional;;;Necessity of Transnasal Gastroscopy in Routine Diagnostics - a Patient Centered Requirement Analysis;Necessity of Transnasal Gastroscopy in Routine Diagnostics - a Patient Centered Requirement Analysis;Completed;;N/A;283;Actual;University of Leipzig;;3;;;FALSE;;;;FALSE;FALSE;FALSE;;;FALSE;;;All data will be available to other researchers on request. (Mail to juergen.feisthammel@medizin.uni-leipzig.de);All data will be available to other researchers on request. (Mail to juergen.feisthammel@medizin.uni-leipzig.de);;Yes;All data will be available to other researchers on request. (Mail to juergen.feisthammel@medizin.uni-leipzig.de);2020-06-01T07:06:14Z;2020-06-01T07:06:14Z;Leipzig;3468220;Study Chair;Albrecht Hoffmeister, Prof Dr;University of Leipzig;Nasal Gastroscopy | Oral Gastroscopy, unsedated | Oral Gastroscopy, sedated | Oral Gastroscopy with transnasal endoscope, sedated;63503106;1;;;2018;2020-05-29;7;FALSE;;FALSE;TRUE;18;;Years;;1;2;
NCT03657953;ClinicalTrials.gov processed this data on May 29, 2020;2018-08-14;;;2018-09-03;2018-09-03;2018-09-05;Actual;;;;;;;2018-09-03;2018-09-05;Actual;January 1, 2006;Actual;2006-01-01;September 2018;2018-09-30;September 30, 2015;Actual;2015-09-30;June 30, 2015;Actual;2015-06-30;;Interventional;;;Outcomes 8 Years After Minimal Invasive THA;Patient-relevant Outcomes 8 Years After Minimally Invasive Total Hip Replacement - a Randomized Prospective Study;Completed;;N/A;157;Actual;Technische Universität Dresden;;3;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;No;;2020-06-01T07:07:03Z;2020-06-01T07:07:03Z;Dresden;;;;;surgical approach;63503528;1;;;2018;2020-05-29;115;FALSE;;FALSE;TRUE;18;75;Years;Years;1;8;
NCT03636139;ClinicalTrials.gov processed this data on May 29, 2020;2018-08-10;;;2018-08-16;2018-08-15;2018-08-17;Actual;;;;;;;2018-08-16;2018-08-20;Actual;January 2016;Actual;2016-01-31;August 2018;2018-08-31;June 2017;Actual;2017-06-30;June 2017;Actual;2017-06-30;;Interventional;;;Cognitive Control of Negative Stimuli in BPD;Effects of Transcranial Direct Current Stimulation on the Cognitive Control of Negative Stimuli in Borderline Personality Disorder;Completed;;N/A;100;Actual;Freie Universität Berlin;;2;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;Undecided;;2020-06-01T07:10:45Z;2020-06-01T07:10:45Z;Berlin;;;;;transcranial DC stimulation : anodal | transcranial DC stimulation : sham;63505182;;;;2018;2020-05-29;17;FALSE;;;FALSE;18;;Years;;1;;
NCT03629665;ClinicalTrials.gov processed this data on May 29, 2020;2018-07-31;;;2018-08-12;2018-08-12;2018-08-14;Actual;;;;;;;2018-08-12;2018-08-14;Actual;January 2, 2012;Actual;2012-01-02;August 2018;2018-08-31;March 1, 2014;Actual;2014-03-01;March 1, 2014;Actual;2014-03-01;;Interventional;ILAT+rTMS;;Combining Language Therapy With rTMS in Aphasia;Combining Language Therapy With rTMS in Chronic Stage of Aphasia: A Randomized Controlled Trial;Completed;;N/A;17;Actual;University of Helsinki;;2;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;No;;2020-06-01T07:11:44Z;2020-06-01T07:11:44Z;Berlin;3470454;Study Chair;Friedemann Pulvermüller, Professor;Brain Language Laboratory, Department of Philosophy and Humanities, WE4, Freie Universität Berlin;Intensive Language-Action Therapy (ILAT) | Repetitive navigated Transcranial Magnetic Stimulation during naming training;63505671;;;;2018;2020-05-29;26;FALSE;;;FALSE;18;75;Years;Years;1;2;
NCT03587324;ClinicalTrials.gov processed this data on May 29, 2020;2018-07-02;;;2018-07-16;2018-07-02;2018-07-16;Actual;;;;;;;2018-07-16;2018-07-18;Actual;February 2013;Actual;2013-02-28;July 2018;2018-07-31;March 2015;Actual;2015-03-31;March 2015;Actual;2015-03-31;;Interventional;;;Perioperative Aspirin Response in Patients Undergoing Vascular Surgery;Perioperative Risk Factors for the Development of Aspirin Low Response in Patients Undergoing Vascular Surgery.;Completed;;N/A;176;Actual;St. Josef Hospital Bochum;;1;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T07:18:12Z;2020-06-01T07:18:12Z;Bochum;;;;;Whole blood aggregometry before and after vascular treatment (ASA/ Clopidogrel).;63508891;1;;;2018;2020-05-29;25;FALSE;;FALSE;TRUE;18;80;Years;Years;1;;
NCT03584451;ClinicalTrials.gov processed this data on May 29, 2020;2018-06-04;;;2018-08-16;2018-07-11;2018-07-12;Actual;;;;;;;2018-08-16;2018-08-17;Actual;February 2015;Actual;2015-02-28;August 2018;2018-08-31;December 2017;Actual;2017-12-31;July 2017;Actual;2017-07-31;;Interventional;;;Evaluation of the Effect of Rehabilitation Sport After Total Hip Arthroplasty (THA);Randomized, Clinical Survey for Evaluating the Effect of Rehabilitation Sport on Patients Who Underwent Total Hip Arthroplasty (THA);Completed;;N/A;160;Actual;Technische Universität Dresden;;2;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;No;no plan to share IPD;2020-06-01T07:18:52Z;2020-06-01T07:18:52Z;Dresden;;;;;rehabilitation sport;63509115;;;;2018;2020-05-29;29;FALSE;;;FALSE;18;75;Years;Years;1;11;
NCT03567278;ClinicalTrials.gov processed this data on May 29, 2020;2014-12-08;;;2018-06-15;2018-06-15;2018-06-25;Actual;;;;;;;2018-06-15;2018-06-25;Actual;November 2009;;2009-11-30;May 2018;2018-05-31;September 2015;Actual;2015-09-30;September 2010;Actual;2010-09-30;;Interventional;TA-FIM;;Feasibility Trial on ACURATE™ Transapical Implantation in Patients With Severe Symptomatic Aortic Stenosis (2009-01);Feasibility Trial on ACURATE™ Transapical Implantation in Patients With Severe Symptomatic Aortic Stenosis;Completed;;N/A;40;Actual;Boston Scientific Corporation;;1;;;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T07:21:33Z;2020-06-01T07:21:33Z;Leipzig;3474454;Principal Investigator;Friedrich Mohr, Professor;Herzzentrum Leipzig GmbH;ACURATE TA™;63510412;5;;;2014;2020-05-29;10;FALSE;;FALSE;FALSE;75;;Years;;1;5;
NCT03548974;ClinicalTrials.gov processed this data on May 29, 2020;2017-11-02;;;2018-05-24;2018-05-24;2018-06-07;Actual;;;;;;;2018-05-24;2018-06-07;Actual;January 2015;;2015-01-31;May 2018;2018-05-31;October 2015;Actual;2015-10-31;October 2015;Actual;2015-10-31;;Interventional;;;Internet-based MOTOmed Exercise to Reduce Spasticity and Improve Physical Function in Persons With Multiple Sclerosis;Internet-based Physical Activity Promotion Using the MOTOmed Movement Trainer to Reduce Spasticity and Improve Physical Function in Moderately to Severely Affected Persons With Multiple Sclerosis;Completed;;N/A;57;Actual;University of Erlangen-Nürnberg;;2;;;FALSE;;;;FALSE;;;;;;;;;;;Undecided;;2020-06-01T07:25:25Z;2020-06-01T07:25:25Z;Erlangen;;;;;Treatment group 1 | Treatment group 2;63511800;;;;2017;2020-05-29;9;FALSE;;;FALSE;18;;Years;;2;3;
NCT03531216;ClinicalTrials.gov processed this data on May 29, 2020;2018-05-09;;;2019-01-08;2018-05-09;2018-05-21;Actual;;;;;;;2019-01-08;2019-01-10;Actual;November 2, 2015;Actual;2015-11-02;May 2018;2018-05-31;March 21, 2016;Actual;2016-03-21;March 21, 2016;Actual;2016-03-21;;Interventional;;;Topical Rosemary Oil Application in Systemic Sclerosis;Psychophysiological Effect of Local Rosemary and Olive Oil Application Onto the Hands of Patients With Systemic Sclerosis - a Prospective Crossover, Open-label, Nonrandomized Trial;Completed;;N/A;12;Actual;ARCIM Institute Academic Research in Complementary and Integrative Medicine;;2;;;FALSE;;;;;FALSE;FALSE;;;;;;;;;;;2020-06-01T07:27:56Z;2020-06-01T07:27:56Z;Tübingen;3476787;Study Director;Jan Vagedes, Dr.;"ARCIM Institute; University of Tuebingen";Rosemary essential oil | Placebo;63513137;2;;;2018;2020-05-29;4;FALSE;;FALSE;FALSE;18;;Years;;1;5;
NCT03530839;ClinicalTrials.gov processed this data on May 29, 2020;2018-04-25;;;2018-05-08;2018-05-08;2018-05-21;Actual;;;;;;;2018-05-08;2018-05-21;Actual;January 2015;Actual;2015-01-31;May 2018;2018-05-31;May 2017;Actual;2017-05-31;May 2017;Actual;2017-05-31;;Interventional;;;Lesser Toe PIP Joint Arthrodesis Versus Resection Arthroplasty;Lesser Toe PIP Joint Arthrodesis Versus Resection Arthroplasty: A Randomized Controlled Study;Completed;;N/A;37;Actual;University Hospital Tuebingen;;2;;;FALSE;;;;;FALSE;FALSE;;;;;;;;;;;2020-06-01T07:27:59Z;2020-06-01T07:27:59Z;Tübingen;;;;;Arthrodesis | Resection arthroplasty;63513166;;;;2018;2020-05-29;28;FALSE;;;FALSE;30;75;Years;Years;2;1;
NCT03524755;ClinicalTrials.gov processed this data on May 29, 2020;2018-04-29;;;2018-05-12;2018-05-12;2018-05-15;Actual;;;;;;;2018-05-12;2018-05-15;Actual;July 10, 2013;Actual;2013-07-10;May 2018;2018-05-31;May 7, 2015;Actual;2015-05-07;May 7, 2015;Actual;2015-05-07;;Interventional;;;Physical Exercise for Patients Who Suffer From Weight Loss Due to Head and Neck Cancer Undergoing Medical Treatment;Effects of a Progressive Resistance Training in Cachectic Cancer Patients During Radiotherapy - a Randomized Controlled Pilot Trial;Completed;;N/A;20;Actual;Ludwig-Maximilians - University of Munich;;2;;;FALSE;;;;;FALSE;FALSE;;;;;;;;;No;My institution does not require data sharing and because of ethical concerns.;2020-06-01T07:29:09Z;2020-06-01T07:29:09Z;Munich;3477197;Principal Investigator;Claus Belka, Prof. Dr.;Klinikum der Universität München, Klinik und Poliklinik für Strahlentherapie und Radioonkologie;Exercise;63513627;;;;2018;2020-05-29;22;FALSE;;;FALSE;18;;Years;;1;1;
NCT03519698;ClinicalTrials.gov processed this data on May 29, 2020;2018-01-12;;;2018-05-08;2018-05-08;2018-05-09;Actual;;;;;;;2018-05-08;2018-05-09;Actual;December 15, 2015;Actual;2015-12-15;May 2018;2018-05-31;June 22, 2017;Actual;2017-06-22;June 22, 2017;Actual;2017-06-22;;Interventional;;;Footbaths With Ginger, Mustard & Warm Water Only in Female Adolescents With & Without Anorexia Nervosa;Efficacy of Footbaths With Ginger, Mustard & Warm Water Only on Psychophysiological Parameters in Female Adolescents With & Without Anorexia Nervosa - a Randomized, Controlled, Three-arm Study With Cross-over Design;Completed;;N/A;41;Actual;ARCIM Institute Academic Research in Complementary and Integrative Medicine;;3;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;;;2020-06-01T07:30:00Z;2020-06-01T07:30:00Z;Tübingen;3477544;Study Director;Jan Vagedes, Dr.;"ARCIM Institute; University of Tuebingen";Warm water | Mustard | Ginger;63514006;1;;;2018;2020-05-29;18;FALSE;;FALSE;TRUE;12;18;Years;Years;1;13;
NCT03505775;ClinicalTrials.gov processed this data on May 29, 2020;2018-04-12;;;2018-04-12;2018-04-12;2018-04-23;Actual;;;;;;;2018-04-12;2018-04-23;Actual;February 14, 2017;Actual;2017-02-14;April 2018;2018-04-30;October 31, 2017;Actual;2017-10-31;October 31, 2017;Actual;2017-10-31;;Interventional;;;Evaluation of the Muscular and Cutaneous Sodium Storage by 23Na MRI in Patients With Chronic Adrenal Insufficiency;Evaluation of the Muscular and Cutaneous Sodium Storage by 23Na Magnetic Resonance Imaging in Patients With Chronic Adrenal Insufficiency Compared to Healthy Subjects;Completed;;N/A;32;Actual;Wuerzburg University Hospital;;1;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;;;2020-06-01T07:32:20Z;2020-06-01T07:32:20Z;Würzburg;3478453;Principal Investigator;Stefanie Hahner, MD, Prof.;University Hospital Wuerzburg, Dept. of medicine I, Germany;23Na magnetic resonance imaging;63515067;1;;;2018;2020-05-29;8;FALSE;;FALSE;TRUE;18;;Years;;2;;
NCT03485716;ClinicalTrials.gov processed this data on May 29, 2020;2018-03-19;;;2018-03-30;2018-03-30;2018-04-02;Actual;;;;;;;2018-03-30;2018-04-02;Actual;August 1, 2016;Actual;2016-08-01;March 2018;2018-03-31;December 31, 2017;Actual;2017-12-31;March 31, 2017;Actual;2017-03-31;;Interventional;;;Metabolic Dynamics During Physical Activity;Metabolic Dynamics During Physical Activity Under Normobaric Normoxia or Moderate Hypoxia - a Pilot Study;Completed;;N/A;34;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;No;;2020-06-01T07:35:15Z;2020-06-01T07:35:15Z;Berlin;3479781;Principal Investigator;Michael Boschmann, Dr.;Charite University, Berlin, Germany;running on a treadmill under normoxia or hypoxia;63516596;1;;;2018;2020-05-29;8;FALSE;;FALSE;TRUE;18;55;Years;Years;1;;
NCT03467087;ClinicalTrials.gov processed this data on May 29, 2020;2018-02-27;;;2018-03-14;2018-03-14;2018-03-15;Actual;;;;;;;2018-03-14;2018-03-15;Actual;February 3, 2016;Actual;2016-02-03;March 2018;2018-03-31;March 16, 2017;Actual;2017-03-16;February 16, 2017;Actual;2017-02-16;;Interventional;;;Safety and Feasibility of Electrical Muscle Stimulation During Stem Cell Transplantation or Intensive Chemotherapy;Safety and Feasibility of Electrical Muscle Stimulation in Patients Undergoing Autologous and Allogeneic Stem Cell Transplantation or Chemotherapy Requiring Hospitalization;Completed;;N/A;45;Actual;University Hospital, Saarland;;1;;;FALSE;;;;FALSE;;FALSE;;;;;;;;;No;We do not plan to share individual participant data sets since we think there is no additional information to be gained from individual data sets in this very heterogenous group of patients;2020-06-01T07:38:29Z;2020-06-01T07:38:29Z;Homburg;3481036;Principal Investigator;Moritz Bewarder, M.D.;University Hospital, Saarland;Myopuls 2000D;63518004;;;;2018;2020-05-29;12;FALSE;;;FALSE;18;80;Years;Years;2;4;
NCT03425929;ClinicalTrials.gov processed this data on May 29, 2020;2018-01-28;;;2018-02-01;2018-02-01;2018-02-08;Actual;;;;;;;2018-02-01;2018-02-08;Actual;June 1, 2016;Actual;2016-06-01;February 2018;2018-02-28;March 18, 2017;Actual;2017-03-18;March 18, 2017;Actual;2017-03-18;;Interventional;;;Oxytocin, Trauma Disclosure and Intrusions;Effects of a Prolonged Oxytocin Treatment on Intrusions and Amygdala Reactivity in an Analogue Trauma Model;Completed;;Phase 1;70;Actual;University Hospital, Bonn;;3;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;No;;2020-06-01T07:44:47Z;2020-06-01T07:44:47Z;Bonn;3483706;Principal Investigator;René Hurlemann, MD, PhD;University of Bonn;Oxytocin | Placebo;63521133;1;;;2018;2020-05-29;9;FALSE;;FALSE;TRUE;18;40;Years;Years;6;6;
NCT03423576;ClinicalTrials.gov processed this data on May 29, 2020;2018-01-23;;;2018-02-15;2018-01-30;2018-02-06;Actual;;;;;;;2018-02-15;2018-02-19;Actual;August 1, 2011;Actual;2011-08-01;February 2018;2018-02-28;December 31, 2016;Actual;2016-12-31;February 28, 2016;Actual;2016-02-28;;Interventional;VEMSE-CF;;Effects of a Comprehensive Patient-centered Health Service in Cystic Fibrosis (VEMSE-CF);Effects of a Comprehensive Patient-centered Health Service With a Focus on Psychosocial Services for Patients With Rare Diseases Using Cystic Fibrosis as an Example (Evaluation Eines Ganzheitlichen Patientenzentrierten Versorgungsmodells für Patienten Mit Seltenen Erkrankungen Unter Besonderer Berücksichtigung Der Psychosozialen Versorgung am Beispiel Mukoviszidose);Completed;;N/A;318;Actual;Mukoviszidose Institut gGmbH;;2;;;FALSE;;;;;FALSE;FALSE;;;;;;;;;Undecided;;2020-06-01T07:45:05Z;2020-06-01T07:45:05Z;Ulm Würzburg;3483869;Principal Investigator;Lutz Goldbeck, Prof. Dr.;Ulm University Hospital;comprehensive patient-centered outpatient health service with multiple components;63521312;1;;;2018;2020-05-29;55;FALSE;;FALSE;TRUE;5;;Years;;1;6;6
NCT03404232;ClinicalTrials.gov processed this data on May 29, 2020;2018-01-05;;;2018-01-18;2018-01-18;2018-01-19;Actual;;;;;;;2018-01-18;2018-01-19;Actual;January 1, 2012;Actual;2012-01-01;January 2018;2018-01-31;December 31, 2017;Actual;2017-12-31;December 31, 2016;Actual;2016-12-31;;Interventional;;;Radiological and Clinical Efficacy of a Hybrid Spinal Implant (Topping Off): a Mono-center, Prospective Clinical Trial;The Use of the DTO Hybrid Dynamic Device: a Clinical Outcome- and Radiological-based Prospective Clinical Trial;Completed;;N/A;60;Actual;University Hospital, Aachen;;3;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;No;;2020-06-01T07:48:20Z;2020-06-01T07:48:20Z;Aachen;;;;;Dynesys DTO device (Zimmer Spine, Inc.);63522776;1;;;2018;2020-05-29;60;FALSE;;FALSE;TRUE;18;90;Years;Years;4;2;
NCT03402490;ClinicalTrials.gov processed this data on May 29, 2020;2017-12-22;;;2018-01-17;2018-01-17;2018-01-18;Actual;;;;;;;2018-01-17;2018-01-18;Actual;June 18, 2013;Actual;2013-06-18;January 2018;2018-01-31;December 8, 2015;Actual;2015-12-08;December 8, 2015;Actual;2015-12-08;;Interventional;Ex-DHFadd-on;;Enhancement of Physical Activity in Elderly Patients With Diastolic Heart Failure by a Motivational Intervention;Enhancement of Physical Activity in Elderly Patients With Diastolic Heart Failure by a Motivational Intervention - Pilot Data From an add-on Following the Ex-DHF Trial;Completed;;N/A;39;Actual;University of Göttingen;;2;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;;;2020-06-01T07:48:36Z;2020-06-01T07:48:36Z;Göttingen;;;;;Motivational interviewing;63522911;;;;2017;2020-05-29;30;FALSE;;;FALSE;18;;Years;;4;;2
NCT03378804;ClinicalTrials.gov processed this data on May 29, 2020;2017-10-06;;;2018-08-22;2017-12-14;2017-12-20;Actual;;;;;;;2018-08-22;2018-08-24;Actual;January 2017;;2017-01-31;August 2018;2018-08-31;November 2, 2017;Actual;2017-11-02;November 1, 2017;Actual;2017-11-01;;Interventional;PIEB;;PIEB-PCEA vs CEI-PCEA for Abdominal Oncological Surgery. A Randomized Prospective Clinical Trial;Randomized Comparison of Two Application Procedures: Programmed Intermittent Epidural Bolus in Patient-controlled Epidural Analgesia (PCEA) Versus Continous PCEA in Abdominal Oncological Surgery;Completed;;N/A;110;Actual;Philipps University Marburg Medical Center;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T07:52:11Z;2020-06-01T07:52:11Z;Marburg;;;;;Programmed intermittent epidural bolus application (PIEB) | Continous epidural analgesia;63524707;1;;;2017;2020-05-29;9;FALSE;;FALSE;TRUE;18;;Years;;1;1;5
NCT03358550;ClinicalTrials.gov processed this data on May 29, 2020;2017-11-26;;;2017-11-29;2017-11-29;2017-11-30;Actual;;;;;;;2017-11-29;2017-11-30;Actual;February 2, 2017;Actual;2017-02-02;November 2017;2017-11-30;March 23, 2017;Actual;2017-03-23;March 23, 2017;Actual;2017-03-23;;Interventional;;;Night Myopia and Dark Focus of Accommodation;Influence of an Imaginary Target on the State of Accommodation Under Scotopic Conditions;Completed;;N/A;39;Actual;University of Applied Sciences Jena;;1;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;No;;2020-06-01T07:55:37Z;2020-06-01T07:55:37Z;Jena;3488166;Principal Investigator;Philipp Hessler, M.Sc.;University of Applied Sciences Jena;Accommodation Measurement;63526240;1;;;2017;2020-05-29;1;FALSE;;FALSE;TRUE;22;39;Years;Years;1;3;
NCT03341741;ClinicalTrials.gov processed this data on May 29, 2020;2017-11-03;;;2017-11-08;2017-11-08;2017-11-14;Actual;;;;;;;2017-11-08;2017-11-14;Actual;March 11, 2014;Actual;2014-03-11;October 2017;2017-10-31;November 25, 2016;Actual;2016-11-25;December 19, 2015;Actual;2015-12-19;;Interventional;CotoCFII;;Combined Dry Powder Tobramycin and Nebulized Colistin Inhalation in CF Patients;Combined Dry Powder Tobramycin and Nebulized Colistin Inhalation in CF Patients;Completed;;Phase 3;26;Actual;University Hospital Tuebingen;;2;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;No;;2020-06-01T07:58:36Z;2020-06-01T07:58:36Z;Tübingen;;;;;Tobramycin Powder | Colistin;63527522;;;;2017;2020-05-29;21;FALSE;;;FALSE;12;;Years;;1;17;
NCT03332914;ClinicalTrials.gov processed this data on May 29, 2020;2017-11-02;;;2019-08-12;2017-11-02;2017-11-06;Actual;;;;;;;2019-08-12;2019-08-13;Actual;November 2, 2017;Actual;2017-11-02;August 2019;2019-08-31;December 27, 2017;Actual;2017-12-27;November 27, 2017;Actual;2017-11-27;;Interventional;;;A Crossover Designed Study to Evaluate Effects of Microcurrent Therapy on Knee Osteoarthritis;A Crossover Designed Study to Evaluate Effects of Microcurrent Therapy on Knee Osteoarthritis;Completed;;N/A;13;Actual;Ludwig-Maximilians - University of Munich;;2;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;No;;2020-06-01T07:59:57Z;2020-06-01T07:59:57Z;Munich;;;;;Microcurrent therapy;63528190;1;;;2017;2020-05-29;0;FALSE;;FALSE;TRUE;18;;Years;;1;6;
NCT03332446;ClinicalTrials.gov processed this data on May 29, 2020;2016-03-29;;;2017-11-14;2017-11-01;2017-11-06;Actual;;;;;;;2017-11-14;2017-11-17;Actual;August 2014;;2014-08-31;November 2017;2017-11-30;July 2017;Actual;2017-07-31;July 2017;Actual;2017-07-31;;Interventional;IceAge;;Influence of Cooling on the Effect of Strength Training;Influence of Cooling on the Effect of Strength Training;Completed;;N/A;11;Actual;Saarland University;;2;;;FALSE;;;;FALSE;;;;;;;;;;;Undecided;;2020-06-01T08:00:00Z;2020-06-01T08:00:00Z;Homburg;3489839;Principal Investigator;Tim Meyer, Prof.;Saarland University;cold water immersion;63528225;1;;;2016;2020-05-29;35;FALSE;;FALSE;TRUE;18;40;Years;Years;1;8;
NCT03331159;ClinicalTrials.gov processed this data on May 29, 2020;2017-10-29;;;2017-10-31;2017-10-31;2017-11-06;Actual;;;;;;;2017-10-31;2017-11-06;Actual;July 1, 2012;Actual;2012-07-01;October 2017;2017-10-31;October 31, 2015;Actual;2015-10-31;October 31, 2013;Actual;2013-10-31;;Interventional;;;Evaluation of Fusion After ALIF With an Osteoinductive Material or With Homologus Bone;Evaluation of Fusion After Anterior Lumbar Interbody Fusion With a New Osteoinductive Bone Substitute Material: a First Randomized Clinical Trial;Completed;;N/A;20;Actual;Johann Wolfgang Goethe University Hospital;;2;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;No;;2020-06-01T08:00:14Z;2020-06-01T08:00:14Z;Frankfurt;;;;;NanoBone | Homologous Bone;63528318;;;;2017;2020-05-29;16;FALSE;;;FALSE;18;;Years;;1;1;
NCT03330431;ClinicalTrials.gov processed this data on May 29, 2020;2017-09-27;;;2017-10-30;2017-10-30;2017-11-06;Actual;;;;;;;2017-10-30;2017-11-06;Actual;July 1, 2017;Actual;2017-07-01;October 2017;2017-10-31;November 15, 2017;Anticipated;2017-11-15;September 15, 2017;Actual;2017-09-15;;Interventional;;;Do Videos That Aim to Optimize Expectations Alter the Effectivess of PMR?;Effects of Videos Aiming to Optimize Expectations on Effectiveness of Progressive Muscle Relaxation (PMR);Unknown status;;N/A;66;Actual;Philipps University Marburg Medical Center;;3;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;;;2020-06-01T08:00:21Z;2020-06-01T08:00:21Z;Marburg;3489964;Principal Investigator;Winfried Rief, Professor;Philipps Universität Marburg;Progressive Muscle Relaxation (PMR);63528376;1;;;2017;2020-05-29;2;FALSE;;FALSE;TRUE;18;65;Years;Years;1;2;
NCT03323528;ClinicalTrials.gov processed this data on May 29, 2020;2017-10-24;;;2017-11-24;2017-10-24;2017-10-27;Actual;;;;;;;2017-11-24;2017-11-28;Actual;February 1, 2017;Actual;2017-02-01;October 2017;2017-10-31;November 15, 2017;Actual;2017-11-15;July 2, 2017;Actual;2017-07-02;;Interventional;DoriPha;;Safety and Efficacy of a Sore Throat Lozenge DORITHRICIN in Patients With Acute Pharyngitis;A Multi-centre, Randomized, Placebo-controlled, Double-blind, Parallel-group Study Investigating Safety and Efficacy of a Sore Throat Lozenge in the Symptomatic Treatment of Patients With Acute Pharyngitis;Completed;;Phase 4;321;Actual;Medice Arzneimittel Pütter GmbH & Co KG;;2;;;FALSE;;;;TRUE;FALSE;FALSE;;;;;;;;;No;study protocol, statistical analysis plan, informed consent form, clinical study report are shared with all 26 recruited centers of the DoriPha investigators;2020-06-01T08:01:33Z;2020-06-01T08:01:33Z;Münster;3490407;Study Director;R Ammer, MD, PhD;Universtiy hospital Muenster, MedD;Benzalkonium Chloride-Benzocaine Topical | Placebo Oral Tablet;63528905;1;;;2017;2020-05-29;5;FALSE;;FALSE;TRUE;18;99;Years;Years;1;3;
NCT03313336;ClinicalTrials.gov processed this data on May 29, 2020;2017-09-08;;;2017-11-13;2017-10-12;2017-10-18;Actual;;;;;;;2017-11-13;2017-11-14;Actual;October 30, 2017;Actual;2017-10-30;November 2017;2017-11-30;November 9, 2017;Actual;2017-11-09;November 9, 2017;Actual;2017-11-09;;Interventional;EMLA;;A Study to Assess Therapeutic Equivalence Between Test EMLA Patch With Marketed EMLA Patch in Healthy Subjects.;A Double-blind, Randomized, 2-period, Placebo-controlled, Single-center, Crossover Study to Assess the Therapeutic Equivalence of the EMLA Current Reference Patch and the EMLA Test Patch in Healthy Subjects.;Completed;;Phase 1;32;Actual;AstraZeneca;;3;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;No;;2020-06-01T08:03:20Z;2020-06-01T08:03:20Z;Berlin;3491022;Principal Investigator;Dr. med.Rainard Fuhr;PAREXEL Early Phase Clinical Unit Berlin;EMLA test patch | EMLA current reference patch | Placebo Patch;63529676;1;;;2017;2020-05-29;0;FALSE;;FALSE;TRUE;18;60;Years;Years;1;1;
NCT03312816;ClinicalTrials.gov processed this data on May 29, 2020;2017-10-12;;;2018-06-06;2017-10-12;2017-10-18;Actual;;;;;;;2018-06-06;2018-06-07;Actual;October 16, 2017;Actual;2017-10-16;June 2018;2018-06-30;December 8, 2017;Actual;2017-12-08;December 8, 2017;Actual;2017-12-08;;Interventional;;;Effect of Oxidized Plant Sterols on Serum Concentrations of Plant Sterol Oxidation Products (POP);The Effect of Oxidized Plant Sterol Intake on Serum Concentrations of Plant Sterol Oxidation Products (POP);Completed;;N/A;60;Actual;Unilever R&D;;4;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;;;2020-06-01T08:03:26Z;2020-06-01T08:03:26Z;Berlin;3491058;Principal Investigator;Christian Keicher, Dr;Charité Research Organisation GmbH;cookies enriched with POP;63529714;1;;;2017;2020-05-29;1;FALSE;;FALSE;TRUE;40;75;Years;Years;1;2;
NCT03312140;ClinicalTrials.gov processed this data on May 29, 2020;2017-10-04;;;2017-11-29;2017-10-16;2017-10-17;Actual;;;;;;;2017-11-29;2017-11-30;Actual;November 6, 2014;Actual;2014-11-06;October 2017;2017-10-31;February 8, 2017;Actual;2017-02-08;April 24, 2016;Actual;2016-04-24;;Interventional;;;Examination of the Lipid Metabolism of the Liver After Choline Substitution in Cystic Fibrosis;Examination of the Lipid Metabolism of the Liver After Choline Substitution in Cystic Fibrosis;Completed;;N/A;10;Actual;University Hospital Tuebingen;;1;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;;;2020-06-01T08:03:31Z;2020-06-01T08:03:31Z;Tübingen;3491108;Principal Investigator;Joachim Riethmüller, PD;Klinik für Kinder- und Jugendmedizin Tübingen;Choline Chloride;63529765;;;;2017;2020-05-29;17;FALSE;;;FALSE;18;;Years;;1;6;
NCT03299127;ClinicalTrials.gov processed this data on May 29, 2020;2017-09-27;;;2018-06-11;2017-09-27;2017-10-02;Actual;;;;;;;2018-06-11;2018-06-13;Actual;April 1, 2017;Actual;2017-04-01;June 2018;2018-06-30;December 15, 2017;Actual;2017-12-15;July 30, 2017;Actual;2017-07-30;;Interventional;;;Imagery Rescripting in Depression;A Self-help Manual of Imagery Rescripting Reduces Depressive Symptoms;Completed;;N/A;127;Actual;Universitätsklinikum Hamburg-Eppendorf;;2;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;Undecided;;2020-06-01T08:05:56Z;2020-06-01T08:05:56Z;Hamburg;3491955;Principal Investigator;Steffen Moritz, PhD;UKE Hamburg;imagery rescripting;63530746;1;;;2017;2020-05-29;4;FALSE;;FALSE;TRUE;18;;Years;;1;4;
NCT03281616;ClinicalTrials.gov processed this data on May 29, 2020;2017-09-11;;;2017-09-18;2017-09-11;2017-09-13;Actual;;;;;;;2017-09-18;2017-09-19;Actual;June 1, 2014;Actual;2014-06-01;September 2017;2017-09-30;September 30, 2015;Actual;2015-09-30;June 30, 2015;Actual;2015-06-30;;Interventional;;;Lifestyle in Turkish-Background Diabetics;Lifestyle Interventions in Turkish-background Patients With Metabolic Syndrome and Diabetes in Germany;Completed;;N/A;110;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;;FALSE;FALSE;;;;;;;;;No;;2020-06-01T08:08:48Z;2020-06-01T08:08:48Z;Berlin;;;;;Diet;63532083;;;;2017;2020-05-29;13;FALSE;;;FALSE;30;65;Years;Years;1;2;
NCT03273127;ClinicalTrials.gov processed this data on May 29, 2020;2017-09-04;;;2017-11-24;2017-09-04;2017-09-06;Actual;;;;;;;2017-11-24;2017-11-27;Actual;September 21, 2017;Actual;2017-09-21;November 2017;2017-11-30;November 9, 2017;Actual;2017-11-09;November 9, 2017;Actual;2017-11-09;;Interventional;;;To Assess the Pharmacokinetics, Safety and Tolerability of Abediterol Administered Once Daily for 9 Days, in Patients With Asthma on Inhaled Corticosteroids;A Phase 1, Randomized, Single-Blind, Placebo Controlled Study to Assess Pharmacokinetics, Safety and Tolerability of Abediterol Administered Once Daily for 9 Days, in Patients With Asthma on Inhaled Corticosteroids;Completed;;Phase 1;12;Actual;AstraZeneca;;2;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;;;2020-06-01T08:10:59Z;2020-06-01T08:10:59Z;Berlin;3493711;Principal Investigator;Dr.med. Rainard Fuhr;PAREXEL Early Phase Clinical Unit Berlin;Abediterol | Placebo;63532721;1;;;2017;2020-05-29;1;FALSE;;FALSE;TRUE;18;55;Years;Years;20;;8
NCT03272490;ClinicalTrials.gov processed this data on May 29, 2020;2017-08-31;;;2017-09-01;2017-09-01;2017-09-05;Actual;;;;;;;2017-09-01;2017-09-05;Actual;February 5, 2014;Actual;2014-02-05;September 2017;2017-09-30;July 1, 2017;Actual;2017-07-01;June 6, 2017;Actual;2017-06-06;;Interventional;;;Polyaxial Locking Plates in Treating Distal Humeral Fractures;Polyaxial Locking Plates in Treating Distal Humeral Fractures: a Comparative Randomized Trial for Clinical Outcome;Completed;;N/A;20;Actual;Technische Universität München;;2;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;No;;2020-06-01T08:11:04Z;2020-06-01T08:11:04Z;Munich;3493753;Study Director;Peter Bibethaler, Prof.;Department of Trauma Surgery Klinikum rechts der Isar Technical University of Munich, Germany Ismaninger Strasse 22 81675 Munich, Germany;Medartis | Synthes;63532748;;;;2017;2020-05-29;40;FALSE;;;FALSE;18;95;Years;Years;1;;
NCT03268720;ClinicalTrials.gov processed this data on May 29, 2020;2017-08-15;;;2017-08-29;2017-08-29;2017-08-31;Actual;;;;;;;2017-08-29;2017-08-31;Actual;April 2014;Actual;2014-04-30;August 2017;2017-08-31;December 2016;Actual;2016-12-31;December 2016;Actual;2016-12-31;;Interventional;NCGS;;Influence of the Immunosystem in Non-celiac Glutensensitivity;Influence of the Immunosystem in Non-celiac Glutensensitivity;Completed;;N/A;29;Actual;University of Erlangen-Nürnberg Medical School;;2;;;FALSE;;;;;FALSE;FALSE;;;;;;;;;No;;2020-06-01T08:11:37Z;2020-06-01T08:11:37Z;Erlangen;;;;;FODMAP low diet | gluten-free diet;63533056;1;;;2017;2020-05-29;32;FALSE;;FALSE;TRUE;18;;Years;;2;4;
NCT03265899;ClinicalTrials.gov processed this data on May 29, 2020;2017-08-18;;;2017-08-25;2017-08-25;2017-08-29;Actual;;;;;;;2017-08-25;2017-08-29;Actual;July 1, 2015;Actual;2015-07-01;August 2017;2017-08-31;November 30, 2016;Actual;2016-11-30;November 30, 2016;Actual;2016-11-30;;Interventional;;;Oxytocin and the Processing of Social Stress-Associated Chemosignals;Double-blind, Placebo-controlled, Randomized Study: Oxytocin Modulation of Stress-Associated Chemosignals Processing;Completed;;Phase 1;60;Actual;University Hospital, Bonn;;2;;;FALSE;;;;FALSE;FALSE;FALSE;;;FALSE;;;;;;No;;2020-06-01T08:12:08Z;2020-06-01T08:12:08Z;Bonn;3494191;Principal Investigator;Rene Hurlemann, MSc MD PhD;Department of Psychiatry, University of Bonn, Germany;Oxytocin | Placebo;63533272;;;;2017;2020-05-29;17;FALSE;;;FALSE;18;40;Years;Years;3;3;
NCT03252730;ClinicalTrials.gov processed this data on May 29, 2020;2017-07-18;;;2017-08-17;2017-08-16;2017-08-17;Actual;;;;;;;2017-08-17;2017-08-22;Actual;January 30, 2017;Actual;2017-01-30;August 2017;2017-08-31;February 27, 2017;Actual;2017-02-27;February 27, 2017;Actual;2017-02-27;;Interventional;;;In-Use Test With a Cosmetic Product;In-Use Test With a Cosmetic Product (WO 4260) for Topical Use on the Scalp;Completed;;N/A;34;Actual;Dr. August Wolff GmbH & Co. KG Arzneimittel;;1;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;No;;2020-06-01T08:14:34Z;2020-06-01T08:14:34Z;Hamburg;3495005;Study Director;Mona Mazinani, MD;SIT Skin Investigation and Technology Hamburg GmbH;WO 4260 Cosmetic Product for Topical Use;63534260;1;;;2017;2020-05-29;0;FALSE;;FALSE;TRUE;18;;Years;;1;3;
NCT03231839;ClinicalTrials.gov processed this data on May 29, 2020;2017-07-24;;;2017-07-24;2017-07-24;2017-07-27;Actual;;;;;;;2017-07-24;2017-07-27;Actual;February 1, 2009;Actual;2009-02-01;July 2017;2017-07-31;July 31, 2016;Actual;2016-07-31;June 30, 2012;Actual;2012-06-30;;Interventional;NUPREDM;;Nutritional Prevention of Diabetes Mellitus Type 2;Identification of Factors Predicting the Success of a Nutritional Intervention to Decrease the Risk of Type 2 Diabetes;Completed;;N/A;132;Actual;University Hospital Tuebingen;;3;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;No;Not allowed by ethics committee;2020-06-01T08:18:16Z;2020-06-01T08:18:16Z;Tübingen;;;;;Caloric restriction | no red meat | Increased fiber intake;63535839;1;;;2017;2020-05-29;41;FALSE;;FALSE;TRUE;18;75;Years;Years;1;4;
NCT03230422;ClinicalTrials.gov processed this data on May 29, 2020;2017-07-23;;;2017-09-28;2017-07-25;2017-07-26;Actual;;;;;;;2017-09-28;2017-10-02;Actual;July 24, 2017;Actual;2017-07-24;September 2017;2017-09-30;September 27, 2017;Actual;2017-09-27;July 31, 2017;Actual;2017-07-31;;Interventional;Kivi;;A Comparison of Video Laryngoscopes and the Direct Laryngoscope in Simulated Normal and Difficult Infant Airway.;A Comparison of the Novel King Vision Pediatric aBlade and the C-MAC Video Laryngoscope to the Direct Laryngoscope in Simulated Normal and Difficult Infant Airway. A Bicentric, Prospective, Randomized Manikin Study;Completed;;N/A;80;Actual;Johannes Gutenberg University Mainz;;2;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;No;;2020-06-01T08:18:35Z;2020-06-01T08:18:35Z;Mainz;3496492;Principal Investigator;Marc Kriege, MD;University Medical Centre Mainz;normal airway | difficult airway;63535946;1;;;2017;2020-05-29;0;FALSE;;FALSE;TRUE;;;;;1;4;
NCT03226587;ClinicalTrials.gov processed this data on May 29, 2020;2017-06-22;;;2017-11-08;2017-07-20;2017-07-24;Actual;;;;;;;2017-11-08;2017-11-09;Actual;August 2016;Actual;2016-08-31;November 2017;2017-11-30;August 2017;Actual;2017-08-31;August 2017;Actual;2017-08-31;;Interventional;;;Acute Effects of Whole Body Blue Light Exposure on Blood Pressure;Acute Effects of Whole Body Blue Light Exposure on Blood Pressure, Endothelial Function and Vascular Stiffness;Completed;;N/A;20;Actual;Heinrich-Heine University, Duesseldorf;;2;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;No;;2020-06-01T08:19:06Z;2020-06-01T08:19:06Z;Düsseldorf;3496751;Principal Investigator;Christian Heiß, MD;Division of Cardiology, Pulmonology and Vascular Medicine, University Hospital Dusseldorf;Blue light | control exposure;63536238;1;;;2017;2020-05-29;12;FALSE;;FALSE;TRUE;30;60;Years;Years;1;9;
NCT03206398;ClinicalTrials.gov processed this data on May 29, 2020;2017-06-30;;;2017-06-30;2017-06-30;2017-07-02;Actual;;;;;;;2017-06-30;2017-07-02;Actual;May 1, 2015;Actual;2015-05-01;June 2017;2017-06-30;February 1, 2016;Actual;2016-02-01;December 1, 2015;Actual;2015-12-01;;Interventional;;;Influence of an Anti-gravity Treadmill on Functional Outcome in Non-operatively Treated Pelvic Fractures - a Pilot Study;Influence of an Anti-gravity Treadmill on Functional Outcome in Non-operatively Treated Pelvic Fractures - a Pilot Study;Completed;;N/A;9;Actual;University of Leipzig;;1;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;Undecided;;2020-06-01T08:22:29Z;2020-06-01T08:22:29Z;Leipzig;;;;;anti-gravity treadmill;63537768;;;;2017;2020-05-29;7;FALSE;;;FALSE;;;;;1;2;
NCT03184285;ClinicalTrials.gov processed this data on May 29, 2020;2017-06-03;;;2017-06-09;2017-06-09;2017-06-12;Actual;;;;;;;2017-06-09;2017-06-12;Actual;June 1, 2015;Actual;2015-06-01;June 2017;2017-06-30;June 1, 2017;Actual;2017-06-01;June 1, 2017;Actual;2017-06-01;;Interventional;;;Continuous Non-invasive Assessment of Blood Pressure in Bariatric Surgery;Continuous Non-invasive Assessment of Blood Pressure in Comparison to the Invasive Gold-standard and to the Sphygmomanometer.;Completed;;N/A;50;Actual;University of Schleswig-Holstein;;1;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;No;;2020-06-01T08:25:59Z;2020-06-01T08:25:59Z;Kiel Lübeck;;;;;baseline alert 1 | Anti-Trendelenburg-position (ATB) | ATB in narcosis | baseline in narcosis 1 | passive leg raising | volume bolus substitution | baseline in narcosis 2 | start capnoperitoneum | ATB plus capnoperitoneum | ATB plus capnoperitoneum plus volume bolus substitution | ATB loss of capnoperitoneum | baseline | baseline alert 2 | torso position rising 30° at the beginning | torso position rising 30° at the end;63539441;1;;;2017;2020-05-29;24;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT03184272;ClinicalTrials.gov processed this data on May 29, 2020;2017-06-03;;;2017-06-09;2017-06-09;2017-06-12;Actual;;;;;;;2017-06-09;2017-06-12;Actual;June 1, 2015;Actual;2015-06-01;June 2017;2017-06-30;June 1, 2017;Actual;2017-06-01;June 1, 2017;Actual;2017-06-01;;Interventional;;;Non-invasive Assessment of Cardiac Output and Fluid Responsiveness in Bariatric Surgery;Accuracy of Non-invasive Assessment of Cardiac Output and Fluid Responsiveness in Patients Undergoing Bariatric Procedures.;Completed;;N/A;50;Actual;University of Schleswig-Holstein;;1;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;No;;2020-06-01T08:26:00Z;2020-06-01T08:26:00Z;Kiel Lübeck;;;;;baseline alert 1 | Anti-Trendelenburg-position (ATB) | ATB in narcosis | baseline in narcosis 1 | passive leg raising | volume bolus substitution | baseline in narcosis 2 | start capnoperitoneum | ATB plus capnoperitoneum | ATB plus capnoperitoneum plus volume bolus substitution | ATB loss of capnoperitoneum | baseline | baseline alert 2 | torso position rising 30° at the beginning | torso position rising 30° at the end;63539442;1;;;2017;2020-05-29;24;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT03157622;ClinicalTrials.gov processed this data on May 29, 2020;2015-11-10;;;2017-07-03;2017-05-16;2017-05-17;Actual;;;;;;;2017-07-03;2017-07-05;Actual;June 2015;Actual;2015-06-30;July 2017;2017-07-31;June 2017;Actual;2017-06-30;June 2017;Actual;2017-06-30;;Interventional;;;Single-Case Study on Therapeutic Change in Chronic Low Back Pain;Comparing Therapeutic Change During Exposure and Cognitive-Behavioral Therapy in the Context Chronic Low Back Pain;Completed;;N/A;12;Actual;Philipps University Marburg Medical Center;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T08:30:24Z;2020-06-01T08:30:24Z;Marburg;3501283;Principal Investigator;Julia Anna Glombiewski;Philipps-University Marburg, Departement of Clinical PSychology and Psychotherapy;Exposure in vivo | Cognitive Behavioural Psychotherapy;63541464;1;;;2015;2020-05-29;24;FALSE;;FALSE;TRUE;18;;Years;;1;9;
NCT03147131;ClinicalTrials.gov processed this data on May 29, 2020;2016-12-19;;;2017-05-14;2017-05-05;2017-05-10;Actual;;;;;;;2017-05-14;2017-05-16;Actual;August 1, 2010;Actual;2010-08-01;May 2017;2017-05-31;July 2017;Anticipated;2017-07-31;February 2012;Actual;2012-02-29;;Interventional;;;Periprosthetic Bone Mineral Density Changes After Implantation Of A Short Hip Stem Compared To A Straight Stem;Periprosthetic Bone Mineral Density Changes After Implantation Of A Short Hip Stem Compared To A Straight Stem: Five-Year Results Of A Prospective, Randomized DEXA-Analysis;Unknown status;;N/A;126;Anticipated;University Hospital Ulm;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;Individual participant data will not be shared.;2020-06-01T08:32:04Z;2020-06-01T08:32:04Z;Ulm;3501943;Principal Investigator;Ralf Bieger, PD Dr.;University Hospital Ulm - Department of Orthopedic Surgery;Total Hip Arthroplasty;63542262;;;;2016;2020-05-29;19;FALSE;;;FALSE;18;75;Years;Years;1;1;
NCT03146832;ClinicalTrials.gov processed this data on May 29, 2020;2017-04-18;;;2017-07-03;2017-05-09;2017-05-10;Actual;;;;;;;2017-07-03;2017-07-05;Actual;April 1, 2017;Actual;2017-04-01;July 2017;2017-07-31;June 15, 2017;Actual;2017-06-15;June 15, 2017;Actual;2017-06-15;;Interventional;;;Therapeutic Strategies During Exposure to Pain in an Experimental Design;Exposure Works, But How? Testing Different Therapeutic Strategies During Exposure to Pain in an Experimental Design;Completed;;N/A;139;Actual;Philipps University Marburg Medical Center;;3;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;No;;2020-06-01T08:32:06Z;2020-06-01T08:32:06Z;Marburg;;;;;Exposure therapy (according to habituation approach) | Exposure therapy (according to inhibitory learning approach);63542284;1;;;2017;2020-05-29;2;FALSE;;FALSE;TRUE;18;60;Years;Years;1;6;
NCT03141697;ClinicalTrials.gov processed this data on May 29, 2020;2017-04-26;;;2017-05-04;2017-05-04;2017-05-05;Actual;;;;;;;2017-05-04;2017-05-05;Actual;April 1, 2012;Actual;2012-04-01;May 2017;2017-05-31;August 31, 2014;Actual;2014-08-31;August 31, 2014;Actual;2014-08-31;;Interventional;;;The Use of CO2 in Routine-Colonoscopy;Is CO2 Insufflation an Amelioration of Routine Colonoscopy?;Completed;;N/A;150;Actual;University of Leipzig;;2;;;FALSE;;;;FALSE;FALSE;FALSE;;;FALSE;;;;;;Undecided;;2020-06-01T08:32:44Z;2020-06-01T08:32:44Z;Leipzig;;;;;Carbon Dioxide | Room air;63542676;1;;;2017;2020-05-29;29;FALSE;;FALSE;TRUE;18;;Years;;1;4;
NCT03141476;ClinicalTrials.gov processed this data on May 29, 2020;2017-03-21;;;2018-02-19;2017-05-02;2017-05-05;Actual;;;;;;;2018-02-19;2018-02-20;Actual;March 1, 2017;Actual;2017-03-01;February 2018;2018-02-28;December 12, 2017;Actual;2017-12-12;November 12, 2017;Actual;2017-11-12;;Interventional;;;Adequacy of Perioperative Cefuroxime Dosage According to the BMI;Perioperative Cefuroxime in Obese Patients: Dosage According to the BMI;Completed;;Phase 4;60;Actual;Universitätsklinikum Hamburg-Eppendorf;;3;;;FALSE;;;;FALSE;FALSE;FALSE;;;FALSE;;;;;;No;;2020-06-01T08:32:46Z;2020-06-01T08:32:46Z;Hamburg;;;;;Cefuroxime 1,5g | Cefuroxime 3g | Cefuroxime 4,5g;63542692;1;;;2017;2020-05-29;8;FALSE;;FALSE;TRUE;18;85;Years;Years;6;2;
NCT03140397;ClinicalTrials.gov processed this data on May 29, 2020;2017-05-02;;;2018-03-29;2017-05-03;2017-05-04;Actual;;;;;;;2018-03-29;2018-03-30;Actual;January 2016;;2016-01-31;March 2018;2018-03-31;December 31, 2017;Actual;2017-12-31;April 2017;Actual;2017-04-30;;Interventional;;;Oral Bioavailability and Bioactivity of Prenylflavonoids From Hops;Examination of the Bioavailability and Bioactivity of the Two Natural Food Ingredients 6-Prenylnaringenin and 8-Prenylnaringenin.;Completed;;Early Phase 1;16;Actual;University of Hohenheim;;3;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;No;;2020-06-01T08:32:55Z;2020-06-01T08:32:55Z;Tübingen;3502368;Principal Investigator;Sascha Venturelli, Dr. med. Dr. rer. nat.;Eberhard Karls University Tuebingen;Placebo | 6-prenylnaringenin | 8-prenylnaringenin;63542774;2;;;2017;2020-05-29;15;FALSE;;FALSE;FALSE;18;45;Years;Years;12;28;
NCT03134144;ClinicalTrials.gov processed this data on May 29, 2020;2017-04-25;;;2018-08-06;2017-04-25;2017-04-28;Actual;;;;;;;2018-08-06;2018-08-07;Actual;May 1, 2017;Actual;2017-05-01;August 2018;2018-08-31;October 15, 2017;Actual;2017-10-15;October 15, 2017;Actual;2017-10-15;;Interventional;;;Chairless Chair Exoskeleton. Work-physiological-biomechanical Analysis of the Lower Extremities;Chairless Chair Exoskeleton. Work-physiological-biomechanical Analysis of the Lower Extremities;Completed;;N/A;42;Actual;University Hospital Tuebingen;;;;;FALSE;;;;;FALSE;FALSE;;;;;;;;;;;2020-06-01T08:34:08Z;2020-06-01T08:34:08Z;Tübingen;;;;;Exoskeleton Chairless Chair;63543241;1;;;2017;2020-05-29;5;FALSE;;FALSE;TRUE;18;40;Years;Years;2;4;
NCT03126695;ClinicalTrials.gov processed this data on May 29, 2020;2017-04-20;;;2017-08-01;2017-04-20;2017-04-24;Actual;;;;;;;2017-08-01;2017-08-02;Actual;May 12, 2017;Actual;2017-05-12;July 2017;2017-07-31;July 24, 2017;Actual;2017-07-24;July 24, 2017;Actual;2017-07-24;;Interventional;;;A Study to Compare if the Uptake of Ticagrelor in the Body Differs When Different Tablets Are Administered;An Open-label, Randomized, 4-period, 4-treatment, Cross-over, Single-center, Single-dose Study to Assess the Relative Bioavailability of Ticagrelor in Different Formulations in Healthy Adult Subjects;Completed;;Phase 1;44;Actual;AstraZeneca;;4;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;;;2020-06-01T08:35:13Z;2020-06-01T08:35:13Z;Berlin;3503247;Principal Investigator;Rainard Fuhr, Dr. med.;PAREXEL Early Phase Clinical Unit Berlin;Ticagrelor granule | Ticagrelor pediatric tablets | Ticagrelor pediatric tablets suspended in water | Ticagrelor immediate release (IR) tablets (Commercial tablet);63543801;1;;;2017;2020-05-29;2;FALSE;;FALSE;TRUE;18;55;Years;Years;2;16;
NCT03120156;ClinicalTrials.gov processed this data on May 29, 2020;2017-03-30;;;2017-11-09;2017-04-18;2017-04-19;Actual;;;;;;;2017-11-09;2017-11-13;Actual;July 1, 2017;Actual;2017-07-01;November 2017;2017-11-30;October 27, 2017;Actual;2017-10-27;October 27, 2017;Actual;2017-10-27;;Interventional;;;Effects of Sensomotoric Insoles on Postural Control in Elderly People;Effects of Sensomotoric Insoles on Postural Control in Elderly People - a Prospective Randomized Controlled Trial;Completed;;N/A;17;Actual;Ludwig-Maximilians - University of Munich;;3;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;No;;2020-06-01T08:36:17Z;2020-06-01T08:36:17Z;Munich;;;;;sensomotoric insoles | normal standard insoles | No insoles;63544297;1;;;2017;2020-05-29;3;FALSE;;FALSE;TRUE;18;99;Years;Years;1;3;
NCT03118791;ClinicalTrials.gov processed this data on May 29, 2020;2017-04-07;;;2017-11-08;2017-04-12;2017-04-18;Actual;;;;;;;2017-11-08;2017-11-09;Actual;April 7, 2017;Actual;2017-04-07;November 2017;2017-11-30;October 31, 2017;Actual;2017-10-31;August 8, 2017;Actual;2017-08-08;;Interventional;;;Dose-Dependent Effects of Anthocyanins on Endothelial Function in Healthy Men;Investigation on Acute Dose-Dependent Effects of Anthocyanins on Endothelial Function;Completed;;N/A;10;Actual;Heinrich-Heine University, Duesseldorf;;6;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;;;2020-06-01T08:36:39Z;2020-06-01T08:36:39Z;Düsseldorf;;;;;anthocyanins;63544402;1;;;2017;2020-05-29;4;FALSE;;FALSE;TRUE;18;45;Years;Years;1;1;1
NCT03117088;ClinicalTrials.gov processed this data on May 29, 2020;2017-03-14;;;2018-01-08;2017-04-13;2017-04-17;Actual;;;;;;;2018-01-08;2018-01-09;Actual;June 1, 2017;Actual;2017-06-01;January 2018;2018-01-31;November 30, 2017;Actual;2017-11-30;November 30, 2017;Actual;2017-11-30;;Interventional;Safe-SCOPE;;Safe-SCOPE Pilot Study;Safe-SCOPE Pilot Study: Standardized Checklist Of Patient Information Exchange;Completed;;N/A;7;Actual;RWTH Aachen University;;2;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;No;;2020-06-01T08:36:55Z;2020-06-01T08:36:55Z;Aachen;3503863;Study Chair;Gernot Marx, Prof.;Uniklinik RWTH Aachen;Checklist ISBAR3 | Checklist VICUR;63544532;1;;;2017;2020-05-29;6;FALSE;;FALSE;TRUE;18;;Years;;1;9;
NCT03114306;ClinicalTrials.gov processed this data on May 29, 2020;2017-03-27;;;2019-07-23;2017-04-10;2017-04-14;Actual;;;;;;;2019-07-23;2019-07-24;Actual;April 5, 2017;Actual;2017-04-05;July 2019;2019-07-31;August 30, 2017;Actual;2017-08-30;August 30, 2017;Actual;2017-08-30;;Interventional;KneeOptOut;;Evaluation of a Fast-track Knee Arthroplasty Concept;Implementation of a Fast-track Knee Arthroplasty Concept: a Randomized, Controlled, Open Clinical Trial;Completed;;N/A;40;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;TRUE;FALSE;FALSE;;;;;;;;;No;Individual requests to analyse data are to be evaluated by local data safety authorities;2020-06-01T08:37:19Z;2020-06-01T08:37:19Z;Berlin;3504028;Principal Investigator;Sascha Treskatsch, Prof.;Charite University Berlin, Department of anaesthesia;local infiltration analgesia | regional-anaesthesiological catheter analgesia;63544741;1;;;2017;2020-05-29;4;FALSE;;FALSE;TRUE;18;;Years;;1;8;
NCT03114293;ClinicalTrials.gov processed this data on May 29, 2020;2017-03-31;;;2017-05-02;2017-04-13;2017-04-14;Actual;;;;;;;2017-05-02;2017-05-03;Actual;April 1, 2016;Actual;2016-04-01;May 2017;2017-05-31;May 30, 2017;Anticipated;2017-05-30;May 30, 2017;Anticipated;2017-05-30;;Interventional;PIA;;Evidence Based Patient Information and Smartphone Accelerometry to Enhance Physical Activity in MS;Evidence Based Patient Information and Smartphone Accelerometry to Enhance Physical Activity in MS;Unknown status;;N/A;40;Actual;Universitätsklinikum Hamburg-Eppendorf;;2;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;Undecided;;2020-06-01T08:37:19Z;2020-06-01T08:37:19Z;Hamburg;;;;;Smartphone App;63544742;;;;2017;2020-05-29;;FALSE;;;FALSE;18;65;Years;Years;1;6;
NCT03105024;ClinicalTrials.gov processed this data on May 29, 2020;2017-03-27;;;2018-04-10;2017-04-03;2017-04-07;Actual;;;;;;;2018-04-10;2018-04-11;Actual;March 22, 2017;Actual;2017-03-22;April 2018;2018-04-30;November 29, 2017;Actual;2017-11-29;November 29, 2017;Actual;2017-11-29;;Interventional;;;Self-efficacy Enhancement and Exposure Therapy;Enhancing Exposure: the Impact of Self-efficacy Enhancement on Treatment Outcome;Completed;;N/A;71;Actual;Ruhr University of Bochum;;3;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;No;;2020-06-01T08:38:47Z;2020-06-01T08:38:47Z;Bochum;3504645;Principal Investigator;Armin Zlomuzica, Dr.;Ruhr-University Bochum;Self-efficacy enhancement | Control intervention;63545443;1;;;2017;2020-05-29;8;FALSE;;FALSE;TRUE;18;38;Years;Years;3;4;9
NCT03098498;ClinicalTrials.gov processed this data on May 29, 2020;2017-03-27;;;2017-03-30;2017-03-30;2017-03-31;Actual;;;;;;;2017-03-30;2017-03-31;Actual;June 1, 2016;Actual;2016-06-01;March 2017;2017-03-31;December 1, 2017;Anticipated;2017-12-01;December 1, 2017;Anticipated;2017-12-01;;Interventional;ATTGAIN16;;Impact of Debridement Invasiveness on Attachment Gain After Antiinfective Periodontal Therapy;Impact of Debridement Invasiveness on Attachment Gain After Antiinfective Periodontal Therapy;Unknown status;;N/A;44;Anticipated;Wuerzburg University Hospital;;2;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;No;;2020-06-01T08:39:55Z;2020-06-01T08:39:55Z;Würzburg;3505075;Principal Investigator;Ulrich Schlagenhauf, Prof. Dr.;Chairman Dept. of Periodontology, University Hospital Wuerzburg, Germany;Subgingival Debridement;63545937;1;;;2017;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;4;
NCT03093584;ClinicalTrials.gov processed this data on May 29, 2020;2017-03-23;;;2017-03-27;2017-03-23;2017-03-28;Actual;;;;;;;2017-03-27;2017-03-29;Actual;April 2014;Actual;2014-04-30;March 2017;2017-03-31;July 2014;Actual;2014-07-31;July 2014;Actual;2014-07-31;;Interventional;AA_EW_Anxi;;Auricular Stimulation vs. Expressive Writing for Exam Anxiety;Auricular Acupuncture (AA) vs. Expressive Writing in Treatment of Pre-exam Anxiety - Randomised Crossover Study in Medical Students;Completed;;N/A;37;Actual;University Medicine Greifswald;;3;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;Undecided;;2020-06-01T08:40:45Z;2020-06-01T08:40:45Z;Greifswald;3505390;Principal Investigator;Taras Usichenko, MD. PhD;University Medicine of Greifswald;Auricular acupuncture | Expressive writing;63546313;;;;2017;2020-05-29;3;FALSE;;;FALSE;19;35;Years;Years;1;3;
NCT03093571;ClinicalTrials.gov processed this data on May 29, 2020;2017-03-23;;;2017-03-27;2017-03-23;2017-03-28;Actual;;;;;;;2017-03-27;2017-03-29;Actual;April 2015;Actual;2015-04-30;March 2017;2017-03-31;July 2015;Actual;2015-07-31;July 2015;Actual;2015-07-31;;Interventional;AAvsPMR;;Auricular Stimulation vs. Relaxation for Pre-exam Anxiety;Auricular Acupuncture vs. Progressive Muscle Relaxation in Treatment of Pre-exam Anxiety - Randomised Crossover Study in Medical Students;Completed;;N/A;47;Actual;University Medicine Greifswald;;3;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;Undecided;;2020-06-01T08:40:45Z;2020-06-01T08:40:45Z;Greifswald;3505391;Principal Investigator;Catharina Klausenitz, MD. PhD;University Medicine of Greifswald;Auricular stimulation | Relaxation;63546314;;;;2017;2020-05-29;3;FALSE;;;FALSE;19;35;Years;Years;1;3;
NCT03092388;ClinicalTrials.gov processed this data on May 29, 2020;2017-03-21;;;2017-03-30;2017-03-21;2017-03-27;Actual;;;;;;;2017-03-30;2017-04-04;Actual;February 2015;;2015-02-28;March 2017;2017-03-31;April 2016;Actual;2016-04-30;April 2016;Actual;2016-04-30;;Interventional;;;Leg Fluid Shift in Patients With Chronic Heart Failure and Obstructive or Central Sleep Apnea;Evaluation Eines Leg Fluid Shift Und Erörterung Der hämodynamischen Und Respiratorischen Auswirkungen Auf Patienten Mit Chronischer Herzinsuffizienz Und Obstruktiver Oder Zentraler Schlafapnoe;Completed;;N/A;40;Actual;Heart and Diabetes Center North-Rhine Westfalia;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T08:41:01Z;2020-06-01T08:41:01Z;Bochum;3505477;Study Director;Thomas Bitter, MD;Herz- und Diabeteszentrum NRW, Ruhr-Universitaet Bochum, Bad Oeynhausen, Germany;Multi Frequency Bioimpedance Analysis (mfBIA) | Polysomnography/Polygraphy (PSG/PG) | Capillary Blood Gas Analysis (CBGA) | Tilting Table with Hemodynamic Monitoring;63546406;1;;;2017;2020-05-29;14;FALSE;;FALSE;TRUE;18;;Years;;1;14;10
NCT03092206;ClinicalTrials.gov processed this data on May 29, 2020;2017-03-21;;;2017-08-16;2017-03-21;2017-03-27;Actual;;;;;;;2017-08-16;2017-08-21;Actual;April 18, 2017;Actual;2017-04-18;August 2017;2017-08-31;July 28, 2017;Actual;2017-07-28;July 28, 2017;Actual;2017-07-28;;Interventional;TAF-IR;;Changes in Insulin Sensitivity in Healthy Volunteers Taking Tenofovir Alafenamide (TAF)-Containing Antiretroviral Medication;Changes in Insulin Sensitivity in Healthy Volunteers Taking Tenofovir Alafenamide (TAF)-Containing Antiretroviral Medication: The TAF-IR Study;Completed;;Phase 1;30;Actual;Technische Universität München;;3;;;FALSE;;;;FALSE;FALSE;FALSE;;;FALSE;;;;;;No;;2020-06-01T08:41:03Z;2020-06-01T08:41:03Z;Munich;;;;;F/TAF | E/C/F/TAF | R/F/TAF;63546420;1;;;2017;2020-05-29;3;FALSE;;FALSE;TRUE;18;40;Years;Years;1;2;
NCT03085251;ClinicalTrials.gov processed this data on May 29, 2020;2017-03-15;;;2017-09-25;2017-03-15;2017-03-21;Actual;;;;;;;2017-09-25;2017-09-26;Actual;March 16, 2017;Actual;2017-03-16;September 2017;2017-09-30;June 1, 2017;Actual;2017-06-01;April 3, 2017;Actual;2017-04-03;;Interventional;;;Clinical System Accuracy Evaluation With OneTouch® Verio Flex Blood Glucose Monitoring System (BGMS);Clinical System Accuracy Evaluation With OneTouch® Verio Flex Blood Glucose Monitoring System (BGMS);Completed;;N/A;109;Actual;Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm;;1;;;FALSE;;;;;FALSE;FALSE;;;;;;;;;;;2020-06-01T08:42:21Z;2020-06-01T08:42:21Z;Ulm;;;;;Blood glucose monitoring systems for self-testing (BGMS);63546958;1;;;2017;2020-05-29;0;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT03081975;ClinicalTrials.gov processed this data on May 29, 2020;2017-03-04;;;2018-03-17;2017-03-16;2017-03-17;Actual;;;;;;;2018-03-17;2018-03-20;Actual;January 2015;;2015-01-31;March 2018;2018-03-31;December 2017;Actual;2017-12-31;December 2017;Actual;2017-12-31;;Interventional;;;Comparison of ADR Using NBI Versus HD White Light Colonoscopy in Screening and Surveillance Colonoscopies;Comparison of Adenoma Detection Rate Using Narrow Band Imaging Versus HD White Light Colonoscopy in Screening and Surveillance Colonoscopies;Completed;;N/A;500;Actual;Jena University Hospital;;2;;;FALSE;;;;;;;;;;;;;;;No;;2020-06-01T08:42:57Z;2020-06-01T08:42:57Z;Jena;3506214;Study Director;Carsten Schmidt, MD;University Clinic Jena;HD white light or NBI;63547211;1;;;2017;2020-05-29;35;FALSE;;FALSE;TRUE;55;;Years;;1;;
NCT03079518;ClinicalTrials.gov processed this data on May 29, 2020;2017-03-03;;;2017-12-05;2017-03-08;2017-03-14;Actual;;;;;;;2017-12-05;2017-12-06;Actual;March 10, 2017;Actual;2017-03-10;December 2017;2017-12-31;October 25, 2017;Actual;2017-10-25;October 25, 2017;Actual;2017-10-25;;Interventional;Iron Turtle;;Intravenous Iron in paTients With Heart failURe and Reduced Ejection fracTion (HFREF) pLus Iron dEficiency;Intravenous Iron in paTients With Heart failURe and Reduced Ejection fracTion (HFREF) pLus Iron dEficiency: Effects Upon Phosphate and FGF23 Metabolism;Completed;;Phase 2;23;Actual;RWTH Aachen University;;2;;;FALSE;;;;FALSE;FALSE;FALSE;;;FALSE;;;;;;No;IPD will not be shared due to publication afterwards;2020-06-01T08:43:15Z;2020-06-01T08:43:15Z;Aachen;;;;;Ferric Carboxymaltose | blood withdrawal;63547396;1;;;2017;2020-05-29;7;FALSE;;FALSE;TRUE;18;;Years;;2;4;
NCT03071796;ClinicalTrials.gov processed this data on May 29, 2020;2017-02-21;;;2017-06-22;2017-03-01;2017-03-07;Actual;;;;;;;2017-06-22;2017-06-23;Actual;March 7, 2017;Actual;2017-03-07;June 2017;2017-06-30;June 20, 2017;Actual;2017-06-20;June 15, 2017;Actual;2017-06-15;;Interventional;;;Influences of Multivitamin Supplementation on Health Parameters;Influence of Liquid Multivitamin Supplementation on Life Quality, Mood, Perception of Stress and Health-related Vital and Blood Parameters and the Immune System;Completed;;N/A;80;Actual;Martin-Luther-Universität Halle-Wittenberg;;2;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;No;;2020-06-01T08:44:30Z;2020-06-01T08:44:30Z;Halle;3506866;Principal Investigator;Kuno Hottenrott, Prof. Dr.;University of Halle-Wittenberg, Department of Sports;multivitamin supplement | Placebo;63547986;1;;;2017;2020-05-29;3;FALSE;;FALSE;TRUE;30;60;Years;Years;1;7;4
NCT03070821;ClinicalTrials.gov processed this data on May 29, 2020;2017-02-23;;;2017-02-28;2017-02-28;2017-03-06;Actual;;;;;;;2017-02-28;2017-03-06;Actual;January 30, 2013;Actual;2013-01-30;February 2017;2017-02-28;June 30, 2016;Actual;2016-06-30;June 30, 2016;Actual;2016-06-30;;Interventional;;;Therapy of Alzheimer's Disease With Neurofeedback;Neurofeedback and Follow-up With Real-time fMRI to Investigate Cognitive Function in Patients of Mild Cognitive Impairment (MCI) or Alzheimer's Disease (AD);Completed;;N/A;30;Actual;University Hospital, Aachen;;3;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;No;;2020-06-01T08:44:44Z;2020-06-01T08:44:44Z;Aachen;3506940;Principal Investigator;Kathrin Reetz, Prof. Dr.;University Hospital, Aachen;rtfMRI neurofeedback training | 3T MRI;63548060;;;;2017;2020-05-29;41;FALSE;;;FALSE;50;80;Years;Years;1;8;
NCT03065036;ClinicalTrials.gov processed this data on May 29, 2020;2012-02-29;;;2019-01-31;2017-02-22;2017-02-27;Actual;;;;;;;2019-01-31;2019-02-04;Actual;March 2010;Actual;2010-03-31;January 2019;2019-01-31;February 2014;Actual;2014-02-28;November 2013;Actual;2013-11-30;;Interventional;POAG;;Safety and Efficacy Study of the Hydrus Aqueous Implant in Subjects With POAG;A Prospective, Multi-Center Evaluation of the Hydrus Aqueous Implant (Standard and Low-Profile) for Lowering Intraocular Pressure (IOP) in Subjects With Mild to Advanced Primary Open Angle Glaucoma (POAG) With or Without a Cataract;Completed;;Phase 1/Phase 2;120;Actual;Ivantis, Inc.;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T08:45:52Z;2020-06-01T08:45:52Z;Berlin;3507357;Principal Investigator;Prof. Dr. Manfred Tetz, MD;Augentagesklinik Spreebogen Berlin;prestudy topical glaucoma medications;63548504;5;;;2012;2020-05-29;44;FALSE;;FALSE;FALSE;18;;Years;;1;1;
NCT03046940;ClinicalTrials.gov processed this data on May 29, 2020;2017-01-30;;;2017-06-08;2017-02-06;2017-02-08;Estimate;;;;;;;2017-06-08;2017-06-09;Actual;March 15, 2017;Actual;2017-03-15;June 2017;2017-06-30;June 8, 2017;Actual;2017-06-08;June 8, 2017;Actual;2017-06-08;;Interventional;;;The Influence of Doctor-patient Communication on Patients' Willingness to Take Medication;The Influence of Doctor-patient Communication on Patients' Willingness to Take Medication;Completed;;N/A;120;Actual;Philipps University Marburg Medical Center;;3;;;FALSE;;;;;FALSE;FALSE;;;;;;;;;;;2020-06-01T08:48:36Z;2020-06-01T08:48:36Z;Marburg;3508633;Principal Investigator;Winfried Rief, PhD, Prof;Philipps University Marburg Medical Center;Doctor-centered style of communication | Patient-centered style of communication;63549887;1;;;2017;2020-05-29;2;FALSE;;FALSE;TRUE;18;35;Years;Years;1;3;
NCT03042429;ClinicalTrials.gov processed this data on May 29, 2020;2017-02-01;;;2017-02-03;2017-02-01;2017-02-03;Estimate;;;;;;;2017-02-03;2017-02-06;Estimate;January 1, 2007;Actual;2007-01-01;February 2017;2017-02-28;December 31, 2016;Actual;2016-12-31;December 31, 2016;Actual;2016-12-31;;Interventional;NB2004-HR;;Combination Chemotherapy Followed by Stem Cell Transplant in High-risk Neuroblastoma Patients;Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-risk Neuroblastoma;Completed;;Phase 3;360;Actual;University of Cologne;;2;;;FALSE;;;;TRUE;FALSE;FALSE;;;;;;;;;No;;2020-06-01T08:49:25Z;2020-06-01T08:49:25Z;Köln;3508928;Study Chair;Frank Berthold, Prof.;University of Cologne;Cycles N8, N5 and N6 | Cycles N5 and N6;63550234;1;;;2017;2020-05-29;121;FALSE;;FALSE;TRUE;6;21;Months;Years;1;3;
NCT03039387;ClinicalTrials.gov processed this data on May 29, 2020;2016-10-28;;;2017-01-30;2017-01-30;2017-02-01;Estimate;;;;;;;2017-01-30;2017-02-01;Estimate;September 2016;;2016-09-30;August 2016;2016-08-31;April 2017;Anticipated;2017-04-30;April 2017;Anticipated;2017-04-30;;Interventional;;;Effects of tDCS on Cognitive Control and Emotion Regulation in Depressed Patients;The Effect of Transcranial Direct Current Stimulation (tDCS) on Cognitive Control and Emotion Regulation in Depressed Patients;Unknown status;;N/A;44;Anticipated;University Hospital Tuebingen;;2;;;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T08:49:53Z;2020-06-01T08:49:53Z;Tübingen;;;;;anodal transcranial direct current stimulation | transcranial direct current stimulation (sham);63550467;1;;;2016;2020-05-29;;FALSE;;FALSE;TRUE;18;65;Years;Years;4;;
NCT03035968;ClinicalTrials.gov processed this data on May 29, 2020;2017-01-24;;;2018-01-26;2017-01-25;2017-01-30;Estimate;;;;;;;2018-01-26;2018-01-29;Actual;December 2, 2015;Actual;2015-12-02;January 2018;2018-01-31;July 4, 2017;Actual;2017-07-04;April 14, 2017;Actual;2017-04-14;;Interventional;;;Vojta Therapy in Early Stroke Rehabilitation;Improvement of Postural Control and Motor Function by Vojta Therapy in Early Stroke Rehabilitation of Stroke Patients - a Pilot Study and New Approach in Stroke Rehabilitation;Completed;;N/A;40;Actual;Klinikum Frankfurt Höchst;;2;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;No;;2020-06-01T08:50:32Z;2020-06-01T08:50:32Z;Frankfurt;;;;;Vojta therapy | conventional physiotherapy;63550729;1;;;2017;2020-05-29;16;FALSE;;FALSE;TRUE;18;;Years;;1;8;
NCT03035669;ClinicalTrials.gov processed this data on May 29, 2020;2016-11-30;;;2017-01-25;2017-01-25;2017-01-30;Estimate;;;;;;;2017-01-25;2017-01-30;Estimate;November 2016;;2016-11-30;January 2017;2017-01-31;June 2017;Anticipated;2017-06-30;June 2017;Anticipated;2017-06-30;;Interventional;MFN&SOCCOG;;Effects of Mindfulness Training on Emotion Regulation and Social Cognition.;Effects of Mindfulness Training on Emotion Regulation and Social Cognition, a Psychophysiological and Neuroimaging Randomized Controled Study.;Unknown status;;N/A;60;Anticipated;Humboldt-Universität zu Berlin;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T08:50:36Z;2020-06-01T08:50:36Z;Berlin;;;;;Mindfulness group | Reading group;63550751;1;;;2016;2020-05-29;;FALSE;;FALSE;TRUE;18;55;Years;Years;2;10;
NCT03033849;ClinicalTrials.gov processed this data on May 29, 2020;2017-01-16;;;2017-09-11;2017-01-26;2017-01-27;Estimate;;;;;;;2017-09-11;2017-09-12;Actual;January 2017;;2017-01-31;September 2017;2017-09-30;March 2017;Actual;2017-03-31;March 2017;Actual;2017-03-31;;Interventional;;;User Performance Evaluation of Contour® Next One, Accu-Chek® Aviva Connect, FreeStyle Freedom Lite, OneTouch® Verio and GlucoMen® Areo Blood Glucose Monitoring Systems Following ISO 15197:2013;User Performance Evaluation of Contour® Next One, Accu-Chek® Aviva Connect, FreeStyle Freedom Lite, OneTouch® Verio and GlucoMen® Areo Blood Glucose Monitoring Systems Following ISO 15197:2013;Completed;;N/A;189;Actual;Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm;;1;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T08:50:57Z;2020-06-01T08:50:57Z;Ulm;;;;;Blood glucose monitoring system for self-testing Contour® Next One | Blood glucose monitoring system for self-testing Accu-Chek® Aviva Connect | Blood glucose monitoring system for self-testing FreeStyle Freedom Lite | Blood glucose monitoring system for self-testing OneTouch® Verio | Blood glucose monitoring system for self-testing GlucoMen® areo;63550892;1;;;2017;2020-05-29;1;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT03031002;ClinicalTrials.gov processed this data on May 29, 2020;2017-01-14;;;2017-01-24;2017-01-24;2017-01-25;Estimate;;;;;;;2017-01-24;2017-01-25;Estimate;February 2015;;2015-02-28;January 2017;2017-01-31;July 2016;Actual;2016-07-31;July 2016;Actual;2016-07-31;;Interventional;;;Extinction Generalization in Exposure Therapy;Extinction Generalization in Exposure Therapy for Spider Phobia;Completed;;N/A;77;Actual;Ruhr University of Bochum;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T08:51:26Z;2020-06-01T08:51:26Z;Bochum;3509710;Principal Investigator;Armin Zlomuzica, Dr.;Ruhr University of Bochum;Exposure treatment for spider fear;63551107;;;;2017;2020-05-29;17;FALSE;;;FALSE;18;65;Years;Years;1;5;3
NCT03022695;ClinicalTrials.gov processed this data on May 29, 2020;2015-07-01;;;2017-01-19;2017-01-11;2017-01-16;Estimate;;;;;;;2017-01-19;2017-01-20;Estimate;October 2013;;2013-10-31;June 2015;2015-06-30;December 2015;Actual;2015-12-31;November 2015;Actual;2015-11-30;;Interventional;HIFU;;Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU);Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU);Completed;;N/A;27;Actual;University Women's Hospital Tübingen;;1;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T08:52:51Z;2020-06-01T08:52:51Z;Tübingen;;;;;High Intensity Focused Ultrasound;63551737;1;;;2015;2020-05-29;25;FALSE;;FALSE;TRUE;18;;Years;;1;7;
NCT03019718;ClinicalTrials.gov processed this data on May 29, 2020;2017-01-06;;;2018-03-02;2017-01-10;2017-01-13;Estimate;;;;;;;2018-03-02;2018-03-05;Actual;July 2016;Actual;2016-07-31;March 2018;2018-03-31;October 31, 2017;Actual;2017-10-31;July 2017;Actual;2017-07-31;;Interventional;;;Implementation of the Internet-based Aftercare Program 'GSA-Online Plus';Implementation of the Online Aftercare Intervention 'GSA-Online Plus' (Healthy and Without Stress at the Workplace);Completed;;N/A;88;Actual;Johannes Gutenberg University Mainz;;1;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T08:53:29Z;2020-06-01T08:53:29Z;Mainz;3510537;Principal Investigator;Manfred E. Beutel, Prof. Dr.;University Medical Center, Department of Psychosomatic Medicine and Psychotherapy, Johannes Gutenberg University Mainz;GSA-Online plus;63551969;3;;;2017;2020-05-29;12;FALSE;;FALSE;FALSE;;;;;2;17;
NCT03011970;ClinicalTrials.gov processed this data on May 29, 2020;2016-12-12;;;2017-01-03;2017-01-03;2017-01-06;Estimate;;;;;;;2017-01-03;2017-01-06;Estimate;September 2014;;2014-09-30;January 2017;2017-01-31;February 2016;Actual;2016-02-29;December 2015;Actual;2015-12-31;;Interventional;;;Temporal Dynamics and Pharmacokinetics of Intranasally Administered Oxytocin;;Completed;;Phase 1;116;Actual;University Hospital, Bonn;;6;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T08:54:52Z;2020-06-01T08:54:52Z;Bonn;;;;;Oxytocin | Placebo;63552271;1;;;2016;2020-05-29;15;FALSE;;FALSE;TRUE;18;40;Years;Years;1;6;
NCT03013322;ClinicalTrials.gov processed this data on May 29, 2020;2017-01-01;;;2018-01-25;2017-01-04;2017-01-06;Estimate;;;;;;;2018-01-25;2018-01-29;Actual;January 28, 2015;Actual;2015-01-28;January 2018;2018-01-31;February 18, 2017;Actual;2017-02-18;February 18, 2017;Actual;2017-02-18;;Interventional;;;Anticholium® Per Se;Anticholium® Per Se a Randomized, Double-blind, Placebo-controlled, Monocentric Trial on the Adjunctive Use of Physostigmine Salicylate (Anticholium®) in Perioperative Sepsis and Septic Shock;Completed;;N/A;20;Actual;University Hospital Heidelberg;;2;;;FALSE;;;;FALSE;;;;;;;;;;;Undecided;;2020-06-01T08:54:39Z;2020-06-01T08:54:39Z;Heidelberg;3510966;Principal Investigator;Johannes B Zimmermann, MD, MSc;University Hospital Heidelberg;Physostigmine | Isotonic Saline;63552460;1;;;2017;2020-05-29;25;FALSE;;FALSE;TRUE;18;85;Years;Years;1;29;5
NCT03012750;ClinicalTrials.gov processed this data on May 29, 2020;2017-01-03;;;2017-01-04;2017-01-04;2017-01-06;Estimate;;;;;;;2017-01-04;2017-01-06;Estimate;February 2015;;2015-02-28;January 2017;2017-01-31;October 2016;Actual;2016-10-31;August 2016;Actual;2016-08-31;;Interventional;;;Angiosome Perfusion After Tibial Bypass;;Completed;;Phase 2;40;Actual;University Hospital Erlangen;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T08:54:44Z;2020-06-01T08:54:44Z;Erlangen;;;;;Indocyanine Green;63552503;;;;2017;2020-05-29;18;FALSE;;;FALSE;18;99;Years;Years;2;1;
NCT03011463;ClinicalTrials.gov processed this data on May 29, 2020;2017-01-02;;;2017-04-07;2017-01-02;2017-01-05;Estimate;;;;;;;2017-04-07;2017-04-10;Actual;November 2016;Actual;2016-11-30;April 2017;2017-04-30;March 2017;Actual;2017-03-31;March 2017;Actual;2017-03-31;;Interventional;;;Pharmacokinetic Interaction Between Trospium With an Inhibitor of OCT1 and of P-gp in Subjects Genotyped for OCT1;Pharmacokinetic Interaction Between Trospium Chloride After Intravenous (2 mg) and Oral Administration (30 mg) With Ranitidine (300 mg p.o.) as an Inhibitor of OCT1 and With Clarithromycin (500 mg p.o.) as an Inhibitor of P-glycoprotein in 24 Healthy Subjects Genotyped for OCT1;Completed;;Phase 1;24;Actual;Dr. R. Pfleger Chemische Fabrik GmbH;;6;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T08:54:55Z;2020-06-01T08:54:55Z;Greifswald;;;;;intravenous infusion of 2 mg trospium chloride | oral administration of 30 mg trospium chloride | oral administration of 300 mg ranitidine | oral administration of 500 mg clarithromycin;63552600;;;;2017;2020-05-29;4;FALSE;;;FALSE;18;45;Years;Years;1;4;
NCT03000361;ClinicalTrials.gov processed this data on May 29, 2020;2016-12-15;;;2017-07-28;2016-12-19;2016-12-22;Estimate;;;;;;;2017-07-28;2017-08-01;Actual;December 2016;;2016-12-31;July 2017;2017-07-31;February 1, 2017;Actual;2017-02-01;February 1, 2017;Actual;2017-02-01;;Interventional;MSCT;;Motorized Spiral Colonoscopy Trial: A First Feasibility Trial;Motorized Spiral Colonoscopy Trial (MSCT): A First Feasibility Trial;Completed;;N/A;30;Actual;Evangelisches Krankenhaus Düsseldorf;;1;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T08:56:34Z;2020-06-01T08:56:34Z;Düsseldorf;3511841;Principal Investigator;Horst Neuhaus, MD, PhD;Evangelisches Krankenhaus Duesseldorf, Germany;Motorized Spiral Colonoscopy;63553448;1;;;2016;2020-05-29;1;FALSE;;FALSE;TRUE;18;;Years;;1;10;
NCT02997137;ClinicalTrials.gov processed this data on May 29, 2020;2016-12-15;;;2016-12-15;2016-12-15;2016-12-19;Estimate;;;;;;;2016-12-15;2016-12-19;Estimate;October 2014;;2014-10-31;December 2016;2016-12-31;February 2016;Actual;2016-02-29;February 2016;Actual;2016-02-29;;Interventional;BOT-01;;Impact of an Amino Acid Composition With Micronutrients on Wellbeing of Patients With Chronic Exhaustion Conditions;Impact of a Specific Amino Acid Composition With Micronutrients on Wellbeing and Endocrine-cardiometabolic Situation of Patients With Chronic Exhaustion Conditions, Such as Burnout;Completed;;Phase 3;74;Actual;Kyberg Vital GmbH;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T08:57:14Z;2020-06-01T08:57:14Z;Bonn Köln;3512054;Principal Investigator;Christine Metzner, Professor MD;Bonn Education Association for Dietetics r.A., Cologne, Germany;BOT-01 | Placebo;63553695;1;;;2016;2020-05-29;16;FALSE;;FALSE;TRUE;18;65;Years;Years;2;3;5
NCT02993510;ClinicalTrials.gov processed this data on May 29, 2020;2016-12-02;;;2017-02-20;2016-12-12;2016-12-15;Estimate;;;;;;;2017-02-20;2017-02-23;Actual;December 2003;;2003-12-31;February 2017;2017-02-28;July 2016;Actual;2016-07-31;December 2015;Actual;2015-12-31;;Interventional;;;A Randomized Controlled Trial Comparing Chondro-Gide® to Microfracture Alone for Treatment of Knee Cartilage Defects.;Randomised Multi-Center Study: Microfracturing With Chondro-Gide® for the Treatment of Isolated Cartilage Defects in the Knee Project-Nr.: 10830-003;Completed;;Phase 3;67;Actual;Geistlich Pharma AG;;3;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T08:57:50Z;2020-06-01T08:57:50Z;Regensburg;3512297;Principal Investigator;Sven Anders, MD;University of Regensburg;Microfracture | Chondro-Gide sutured | Chondro-Gide glued;63553975;7;;;2016;2020-05-29;146;FALSE;;FALSE;FALSE;18;50;Years;Years;2;4;
NCT02992236;ClinicalTrials.gov processed this data on May 29, 2020;2016-12-07;;;2019-08-08;2016-12-09;2016-12-14;Estimate;;;;;;;2019-08-08;2019-08-09;Actual;August 2015;;2015-08-31;August 2019;2019-08-31;November 2016;Actual;2016-11-30;May 2016;Actual;2016-05-31;;Interventional;;;Effects of the NO-synthase Inhibitor VAS203 on Renal Function in Healthy Volunteers;Effects of the NO-synthase Inhibitor VAS203 on Renal Function in Healthy Volunteers;Completed;;Phase 1;16;Actual;Vasopharm GmbH;;2;;;FALSE;;;;FALSE;;;;;;;;;;;Undecided;;2020-06-01T08:58:04Z;2020-06-01T08:58:04Z;Erlangen;3512379;Principal Investigator;Roland E Schmieder, Prof. Dr.;Universitätsklinik Erlangen;VAS203 | Saline;63554072;1;12;0;2016;2020-05-29;9;TRUE;34;FALSE;TRUE;18;45;Years;Years;2;1;
NCT02990208;ClinicalTrials.gov processed this data on May 29, 2020;2016-12-05;;;2016-12-07;2016-12-07;2016-12-13;Estimate;;;;;;;2016-12-07;2016-12-13;Estimate;January 2014;;2014-01-31;December 2016;2016-12-31;October 2015;Actual;2015-10-31;October 2015;Actual;2015-10-31;;Interventional;;;Diaphragmatic Breathing During Virtual Reality Exposure Therapy for Aviophobia;Diaphragmatic Breathing During Virtual Reality Exposure Therapy for Aviophobia: Functional Coping Strategy or Avoidance Behavior? A Pilot Study;Completed;;N/A;30;Actual;University of Regensburg;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T08:58:36Z;2020-06-01T08:58:36Z;Regensburg;;;;;Diaphragmatic breathing | Virtual Reality Exposure Therapy;63554226;;;;2016;2020-05-29;21;FALSE;;;FALSE;20;65;Years;Years;1;4;
NCT02990039;ClinicalTrials.gov processed this data on May 29, 2020;2016-11-15;;;2019-03-08;2016-12-07;2016-12-12;Estimate;;;;;;;2019-03-08;2019-03-12;Actual;February 2015;;2015-02-28;March 2019;2019-03-31;September 2016;Actual;2016-09-30;September 2016;Actual;2016-09-30;;Interventional;;;A Tailored Feasibility Study to Increase Physical Activity and to Reduce Sedentary Time;A Tailored Feasibility Study to Increase Physical Activity and to Reduce Sedentary Time;Completed;;N/A;176;Actual;University Medicine Greifswald;;2;;;FALSE;;;;FALSE;;;;;;;;;;;Undecided;;2020-06-01T08:58:36Z;2020-06-01T08:58:36Z;Greifswald;3512526;Study Chair;Sabina Ulbricht, Dr.;Institute of Social Medicine and Prevention, University Medicine Greifswald, Greifswald, Germany;Counseling letter;63554239;;;;2016;2020-05-29;19;FALSE;;;FALSE;42;65;Years;Years;1;5;
NCT02976532;ClinicalTrials.gov processed this data on May 29, 2020;2016-11-15;;;2016-11-28;2016-11-28;2016-11-29;Estimate;;;;;;;2016-11-28;2016-11-29;Estimate;July 2013;;2013-07-31;November 2016;2016-11-30;October 2017;Anticipated;2017-10-31;July 2017;Anticipated;2017-07-31;;Interventional;;;Controlling Femoral Derotation Osteotomy With Electromagnetic Tracking;Controlling Femoral Derotation Osteotomy With Electromagnetic Tracking - an in Vivo Study;Unknown status;;N/A;20;Anticipated;Heidelberg University;;1;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:00:56Z;2020-06-01T09:00:56Z;Heidelberg;;;;;Electromagnetic tracking unit in femoral derotation surgery;63555266;1;;;2016;2020-05-29;;FALSE;;FALSE;TRUE;18;40;Years;Years;1;;
NCT02975154;ClinicalTrials.gov processed this data on May 29, 2020;2016-11-21;;;2017-10-11;2016-11-23;2016-11-29;Estimate;;;;;;;2017-10-11;2017-10-12;Actual;December 5, 2016;Actual;2016-12-05;October 2017;2017-10-31;September 4, 2017;Actual;2017-09-04;September 4, 2017;Actual;2017-09-04;;Interventional;;;Microcurrent Therapy in the Treatment of Osteoarthritis of the Knee;Microcurrent Therapy in the Treatment of Osteoarthritis of the Knee: a Randomized, Controlled Pilot Study;Completed;;N/A;56;Actual;Ludwig-Maximilians - University of Munich;;4;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:01:11Z;2020-06-01T09:01:11Z;Munich;3513572;Principal Investigator;Martin B Weigl;Department of Orthopedics, Physical Medicine and Rehabilitation, University Hospital Munich, Ludwig Maximilians University Munich;Microcurrent therapy;63555372;1;;;2016;2020-05-29;9;FALSE;;FALSE;TRUE;18;;Years;;1;6;
NCT02973919;ClinicalTrials.gov processed this data on May 29, 2020;2016-11-14;;;2016-11-21;2016-11-21;2016-11-28;Estimate;;;;;;;2016-11-21;2016-11-28;Estimate;July 2015;;2015-07-31;November 2016;2016-11-30;September 2016;Actual;2016-09-30;December 2015;Actual;2015-12-31;;Interventional;;;EMDR in Spider Phobia: Work Mechanisms and Treatment Outcome;EMDR in Spider Phobia: Work Mechanisms and Treatment Outcome;Completed;;N/A;53;Actual;University of Regensburg;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:01:29Z;2020-06-01T09:01:29Z;Regensburg;;;;;Eye Movement Desensitization and Reprocessing Therapy | Virtual Reality Exposure Therapy;63555467;;;;2016;2020-05-29;5;FALSE;;;FALSE;18;55;Years;Years;1;4;
NCT02971787;ClinicalTrials.gov processed this data on May 29, 2020;2016-11-18;;;2017-06-06;2016-11-21;2016-11-23;Estimate;;;;;;;2017-06-06;2017-06-07;Actual;November 2016;;2016-11-30;June 2017;2017-06-30;June 2017;Actual;2017-06-30;June 2017;Actual;2017-06-30;;Interventional;;;Salt Intake and Lactobacillus Abundance;Influence of Increased Salt Intake on Lactobacillus Abundance in Healthy Men;Completed;;N/A;8;Actual;Charite University, Berlin, Germany;;1;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:01:48Z;2020-06-01T09:01:48Z;Berlin;3513789;Principal Investigator;Anja Maehler, PhD;Charite University, Berlin, Germany;Probiotics | Salt;63555630;1;;;2016;2020-05-29;7;FALSE;;FALSE;TRUE;18;50;Years;Years;1;3;
NCT02971293;ClinicalTrials.gov processed this data on May 29, 2020;2016-10-28;;;2019-06-16;2016-11-18;2016-11-22;Estimate;;;;;;;2019-06-16;2019-06-18;Actual;December 15, 2016;Actual;2016-12-15;June 2019;2019-06-30;August 18, 2017;Actual;2017-08-18;August 18, 2017;Actual;2017-08-18;;Interventional;;;Efficacy, Pharmacokinetics (PK), Safety and Tolerability Study of Inhaled AZD8871;A Phase IIa, Randomised, Multi-Centre, Double-Blind, Placebo-Controlled, 3 Periods, Crossover Study to Investigate the Efficacy, Pharmacokinetics, Safety and Tolerability of Inhaled AZD8871 Administered Once Daily for 2 Weeks in Patients With Moderate to Severe COPD.;Completed;;Phase 2;42;Actual;AstraZeneca;;3;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;;;2020-06-01T09:01:53Z;2020-06-01T09:01:53Z;Berlin;3513819;Principal Investigator;Rainard Fuhr, Dr;PAREXEL International GmbH EPCU Berlin;AZD8871 100 µg | AZD8871 600 µg | Placebo;63555669;2;36;5;2016;2020-05-29;8;TRUE;11;FALSE;FALSE;40;80;Years;Years;1;26;
NCT02970838;ClinicalTrials.gov processed this data on May 29, 2020;2016-11-01;;;2016-11-18;2016-11-18;2016-11-22;Estimate;;;;;;;2016-11-18;2016-11-22;Estimate;November 2012;;2012-11-30;November 2016;2016-11-30;May 2014;Actual;2014-05-31;May 2014;Actual;2014-05-31;;Interventional;TADIA;;Therapy of Obesity and Diabetes Mellitus Type 2;Evaluation of a Structured Weight-loss Program for Therapy of Obesity and Diabetes Mellitus Type 2;Completed;;N/A;36;Actual;University Medicine Greifswald;;1;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:01:59Z;2020-06-01T09:01:59Z;Greifswald;3513850;Principal Investigator;Markus M Lerch, MD;Department of Medicine A, University Medicine Greifswald;Structured weight-loss program;63555702;1;;;2016;2020-05-29;18;FALSE;;FALSE;TRUE;18;70;Years;Years;1;28;
NCT02968914;ClinicalTrials.gov processed this data on May 29, 2020;2016-10-28;;;2019-07-03;2016-11-17;2016-11-21;Estimate;;;;;;;2019-07-03;2019-07-05;Actual;January 4, 2017;Actual;2017-01-04;June 2019;2019-06-30;July 13, 2017;Actual;2017-07-13;July 13, 2017;Actual;2017-07-13;;Interventional;;;Pharmacokinetic Comparability of Benralizumab Using Accessorized Pre-Filled Syringe or Autoinjector in Healthy Volunteers;A Multicenter, Randomized, Open-Label, Parallel Group Phase 1 Pharmacokinetic Comparability Study of Benralizumab Administrated Using Accessorized Pre-Filled Syringe (APFS) or Autoinjector (AI) in Healthy Volunteers.;Completed;;Phase 1;180;Actual;AstraZeneca;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T09:02:23Z;2020-06-01T09:02:23Z;Berlin;3513970;Principal Investigator;Dr. Rainard Fuhr, Medicine;PAREXEL Early Phase Clinical Unit Berlin;Benralizumab | Benralizumab;63555850;2;264;0;2016;2020-05-29;6;TRUE;17;FALSE;FALSE;18;55;Years;Years;3;6;
NCT02965534;ClinicalTrials.gov processed this data on May 29, 2020;2016-11-14;;;2018-10-16;2016-11-14;2016-11-16;Estimate;;;;;;;2018-10-16;2019-02-28;Actual;October 2015;;2015-10-31;October 2018;2018-10-31;March 2016;Actual;2016-03-31;February 2016;Actual;2016-02-29;;Interventional;;;Evaluation of a Night Spectacle Correction Concerning an Improvement of Mesopic Vision Quality;Evaluation of a Night Spectacle Correction Concerning an Improvement of Mesopic Vision Quality;Completed;;N/A;100;Actual;University of Applied Sciences Jena;;2;;;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T09:03:03Z;2020-06-01T09:03:03Z;Jena;3514226;Principal Investigator;Stephan Degle, Prof.;University of Applied Sciences Jena;Spectacle/Glasses;63556105;3;0;0;2016;2020-05-29;4;TRUE;8;FALSE;FALSE;18;40;Years;Years;1;5;
NCT02964520;ClinicalTrials.gov processed this data on May 29, 2020;2016-11-03;;;2017-01-04;2016-11-10;2016-11-16;Estimate;;;;;;;2017-01-04;2017-01-05;Estimate;July 2015;;2015-07-31;January 2017;2017-01-31;January 2017;Actual;2017-01-31;January 2017;Actual;2017-01-31;;Interventional;;;EEG Alpha/Theta Neurofeedback to Reduce Trait Anxiety;Alpha/Theta Neurofeedback Training as Treatment Method for Individuals With Moderate to Severe Trait Anxiety;Completed;;N/A;28;Actual;University of Hartford;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:03:14Z;2020-06-01T09:03:14Z;Tübingen;3514287;Study Chair;"Ute Strehl, Ph.D.; Dipl.-Psych.";University of Tuebingen, Institute for Medical Psychology and Behavioural Neurobiology, Germany;Neurofeedback training | Sham comparator: Sham neurofeedback training;63556183;1;;;2016;2020-05-29;18;FALSE;;TRUE;TRUE;18;;Years;;1;6;
NCT02963298;ClinicalTrials.gov processed this data on May 29, 2020;2016-10-11;;;2019-06-20;2016-11-10;2016-11-15;Estimate;;;;;;;2019-06-20;2019-06-21;Actual;October 2016;;2016-10-31;June 2019;2019-06-30;September 6, 2017;Actual;2017-09-06;September 6, 2017;Actual;2017-09-06;;Interventional;GCRRT;;CRRT for Glutamate Elimination After Cardiac Arrest;Pilot Trial Concerning Glutamate Elimination With CRRT for Neurological Outcome After Cardiac Arrest;Completed;;N/A;42;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T09:03:32Z;2020-06-01T09:03:32Z;Berlin;3514368;Principal Investigator;Christian Storm, MD;Charite University, Berlin, Germany;Continuous renal replacement therapy;63556275;1;;;2016;2020-05-29;10;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT02962518;ClinicalTrials.gov processed this data on May 29, 2020;2016-11-04;;;2016-11-08;2016-11-08;2016-11-11;Estimate;;;;;;;2016-11-08;2016-11-11;Estimate;July 2014;;2014-07-31;November 2016;2016-11-30;October 2016;Actual;2016-10-31;October 2016;Actual;2016-10-31;;Interventional;PRESSURE;;Pressure Device in the Treatment of Ear Keloids;PRESSURE: Prospektive, Randomisierte Und Kontrollierte Untersuchung Von Lokaler Druckapplikation im Rahmen Der Keloid-Therapie Der Ohrmuschel;Completed;;N/A;18;Actual;University of Ulm;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:03:42Z;2020-06-01T09:03:42Z;Ulm;3514429;Study Chair;Thomas K Hoffmann, Prof. Dr.;Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center Ulm, Germany;Pressure Device | Fillet Technique | Triamcinolone;63556336;1;;;2016;2020-05-29;27;FALSE;;FALSE;TRUE;18;;Years;;1;2;
NCT02957838;ClinicalTrials.gov processed this data on May 29, 2020;2016-10-24;;;2017-11-23;2016-11-03;2016-11-08;Estimate;;;;;;;2017-11-23;2017-11-27;Actual;November 2016;;2016-11-30;November 2017;2017-11-30;November 18, 2017;Actual;2017-11-18;October 6, 2017;Actual;2017-10-06;;Interventional;;;Mitochondrial Effects of C18:0 Supplementation in Humans;Mitochondrial Effects of C18:0 Supplementation in Type 2 Diabetics Versus Healthy Controls;Completed;;N/A;23;Actual;University Hospital Heidelberg;;2;;;FALSE;;;;FALSE;;;;;;;;;;;Yes;All relevant, collected data will be published.;2020-06-01T09:04:34Z;2020-06-01T09:04:34Z;Heidelberg;3515027;Study Director;Peter P Nawroth, MD;University Hospital Heidelberg;C18:0 | mock;63556694;1;;;2016;2020-05-29;10;FALSE;;FALSE;TRUE;18;;Years;;2;5;
NCT02951000;ClinicalTrials.gov processed this data on May 29, 2020;2016-10-28;;;2017-10-04;2016-10-31;2016-11-01;Estimate;;;;;;;2017-10-04;2017-10-06;Actual;February 2016;Actual;2016-02-29;October 2016;2016-10-31;June 2017;Actual;2017-06-30;November 2016;Actual;2016-11-30;;Interventional;Platysma;;Platysma Trial - Platysma Suturing Versus no Sutures for Wound Closure After Primary Thyroid Surgery;Platysma Trial - a Randomized Controlled Trial of Platysma Suturing Versus no Sutures for Wound Closure After Primary Thyroid Surgery;Completed;;N/A;80;Actual;University Hospital Tuebingen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;Undecided;;2020-06-01T09:06:38Z;2020-06-01T09:06:38Z;Tübingen;;;;;platysma suture | no platysma suture;63557217;1;;;2016;2020-05-29;9;FALSE;;FALSE;TRUE;18;99;Years;Years;1;5;
NCT02948907;ClinicalTrials.gov processed this data on May 29, 2020;2016-09-19;;;2016-10-28;2016-10-28;2016-10-31;Estimate;;;;;;;2016-10-28;2016-10-31;Estimate;September 2015;;2015-09-30;September 2016;2016-09-30;May 2017;Anticipated;2017-05-31;May 2017;Anticipated;2017-05-31;;Interventional;;;Elastography and Tissue Harmonic Imaging for Characterisation of Hilar and Mediastinal Lymph Nodes;Endobronchial Ultrasound Elastography and Tissue Harmonic Imaging for Characterisation of Hilar and Mediastinal Lymph Nodes;Unknown status;;N/A;100;Anticipated;Heidelberg University;;1;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T09:07:00Z;2020-06-01T09:07:00Z;Heidelberg;3515641;Principal Investigator;Felix Herth, MD;Thoraxklinik at University of Heidelberg;Procedure/Bronchoscopy;63557378;1;;;2016;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT02947542;ClinicalTrials.gov processed this data on May 29, 2020;2016-10-18;;;2017-05-14;2016-10-26;2016-10-28;Estimate;;;;;;;2017-05-14;2017-05-16;Actual;April 2016;;2016-04-30;May 2017;2017-05-31;December 2016;Actual;2016-12-31;November 2016;Actual;2016-11-30;;Interventional;UDDC;;Use of Different Diagnostic Coronary Catheters Over the Radial Access - the UDDC - Radial Trial;Use of Different Diagnostic Coronary Catheters Over the Radial Access - the UDDC - Radial Trial;Completed;;N/A;300;Actual;Charite University, Berlin, Germany;;3;;;FALSE;;;;FALSE;;;;;;;;;;;Undecided;;2020-06-01T09:07:11Z;2020-06-01T09:07:11Z;Berlin;3515727;Principal Investigator;David M Leistner, PD;Department of Cardiology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin;One-catheter concept | Standard catheter;63557482;1;;;2016;2020-05-29;7;FALSE;;FALSE;TRUE;18;95;Years;Years;1;5;
NCT02941432;ClinicalTrials.gov processed this data on May 29, 2020;2016-10-16;;;2017-11-03;2016-10-20;2016-10-21;Estimate;;;;;;;2017-11-03;2017-11-06;Actual;September 1, 2016;;2016-09-01;November 2017;2017-11-30;September 1, 2017;Actual;2017-09-01;September 1, 2017;Actual;2017-09-01;;Interventional;;;Black Tea Compresses for Facial Eczema and Perioral Dermatitis;Pilot Study of Effects and Tolerance of Black Tea Compress Treatment in Facial Eczema and Perioral Dermatitis;Completed;;N/A;26;Actual;University of Luebeck;;1;;;FALSE;;;;FALSE;;;;;;;;;;;Yes;It is planned to publish the study results, including anonymized clinical patient data and photographs in a scientific journal.;2020-06-01T09:08:14Z;2020-06-01T09:08:14Z;Lübeck;3516153;Principal Investigator;Iakov Shimanovich, MD;University of Lübeck;Black tea compress treatment;63557952;1;;;2016;2020-05-29;12;FALSE;;FALSE;TRUE;18;;Years;;6;1;
NCT02938221;ClinicalTrials.gov processed this data on May 29, 2020;2016-10-14;;;2017-01-11;2016-10-17;2016-10-19;Estimate;;;;;;;2017-01-11;2017-01-12;Estimate;October 2016;;2016-10-31;January 2017;2017-01-31;December 2016;Actual;2016-12-31;December 2016;Actual;2016-12-31;;Interventional;;;Telemedical Examination of a Three-Component Oculomotor Testing Battery;Feasibility and Safety of a Telemedically Performed Three-Component Oculomotor Testing Battery (HINTS) in Healthy Adults;Completed;;N/A;30;Actual;Munich Municipal Hospital;;1;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:08:57Z;2020-06-01T09:08:57Z;Munich;3516375;Principal Investigator;Gordian J Hubert, Dr. med.;Städtisches Klinikum München GmbH;Telemedical video-oculography system;63558198;1;;;2016;2020-05-29;2;FALSE;;FALSE;TRUE;18;;Years;;1;3;
NCT02935218;ClinicalTrials.gov processed this data on May 29, 2020;2016-08-30;;;2016-10-13;2016-10-13;2016-10-17;Estimate;;;;;;;2016-10-13;2016-10-17;Estimate;January 2015;;2015-01-31;September 2016;2016-09-30;October 2015;Actual;2015-10-31;April 2015;Actual;2015-04-30;;Interventional;;;Parenting Skills for Mothers With Borderline Personality Disorder: A Newly Developed Group Training Program;Parenting Skills for Mothers With Borderline Personality Disorder: A Newly Developed Group Training Program;Completed;;N/A;15;Actual;Freie Universität Berlin;;1;;;FALSE;;;;FALSE;;;;;;;;;;;No;qualitative data not suitable for sharing;2020-06-01T09:09:27Z;2020-06-01T09:09:27Z;Berlin;;;;;Parenting Skills for Mothers with BPD;63558426;;;;2016;2020-05-29;2;FALSE;;;FALSE;18;;Years;;1;;
NCT02930590;ClinicalTrials.gov processed this data on May 29, 2020;2016-09-26;;;2017-12-28;2016-10-10;2016-10-12;Estimate;;;;;;;2017-12-28;2018-10-23;Actual;September 2016;Actual;2016-09-30;December 2017;2017-12-31;March 2017;Actual;2017-03-31;March 2017;Actual;2017-03-31;;Interventional;;;Effects of Different Support Surfaces on the Properties Skin After Loading;Comparing the Effects of Three Different Support Surfaces on the Properties of Heel and Sacral Skin After Loading;Completed;;N/A;15;Actual;Charite University, Berlin, Germany;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T09:10:08Z;2020-06-01T09:10:08Z;Berlin;3516889;Study Director;Jan Kottner, PD Dr.;Charite University, Berlin, Germany;Alternating low pressure mattress with air loss function | Gel mattress | Basic foam;63558779;1;0;0;2016;2020-05-29;6;TRUE;5;FALSE;TRUE;60;80;Years;Years;6;88;
NCT02930525;ClinicalTrials.gov processed this data on May 29, 2020;2016-10-09;;;2018-07-20;2016-10-11;2016-10-12;Estimate;;;;;;;2018-07-20;2018-07-24;Actual;September 2016;Actual;2016-09-30;July 2018;2018-07-31;December 19, 2017;Actual;2017-12-19;December 2017;Actual;2017-12-31;;Interventional;HiFiPPS;;Effect of High Flow Nasal Cannula vs. Standard Care on Respiratory Stability in Pediatric Procedural Sedation;Effect of High Flow Nasal Cannula vs. Standard Care on Respiratory Stability in Pediatric Procedural Sedation: A Randomized Controlled Pilot Trial;Completed;;N/A;50;Actual;University of Freiburg;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:10:10Z;2020-06-01T09:10:10Z;Freiburg;3516891;Principal Investigator;Daniel Klotz, M.D.;Center for Pediatrics, Dep. of Pediatric Intensive Care, Medical Center - University of Freiburg, Freiburg, Germany;High Flow nasal cannula | Standard respiratory care;63558784;1;;;2016;2020-05-29;15;FALSE;;FALSE;TRUE;6;18;Years;Years;1;8;
NCT02928354;ClinicalTrials.gov processed this data on May 29, 2020;2016-10-07;;;2018-02-05;2016-10-07;2016-10-10;Estimate;;;;;;;2018-02-05;2018-02-06;Actual;November 25, 2016;Actual;2016-11-25;February 2018;2018-02-28;March 21, 2017;Actual;2017-03-21;March 21, 2017;Actual;2017-03-21;;Interventional;;;A Study to Assess the Effect of Particle Size of AZD7594 on Pharmacokinetics (PK) After a Single Inhaled Dose When Administered Using the Dry Powder Inhaler in Healthy Volunteers;A Randomized Open Label Three-Way Crossover Study in Healthy Male Volunteers to Investigate the Effect of Particle Size on Pharmacokinetics Following a Single Inhaled Dose of AZD7594 Via a Dry Powder Inhaler;Completed;;Phase 1;12;Actual;AstraZeneca;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T09:10:34Z;2020-06-01T09:10:34Z;Berlin;3517044;Principal Investigator;Dr. Thomas Körnicke;PAREXEL Early Phase Clinical Unit Berlin;Treatment A - AZD7594 | Treatment B - AZD7594 | Treatment C - AZD7594;63558953;1;;;2016;2020-05-29;3;FALSE;;FALSE;TRUE;18;55;Years;Years;3;12;
NCT02920840;ClinicalTrials.gov processed this data on May 29, 2020;2016-09-26;;;2016-09-28;2016-09-28;2016-09-30;Estimate;;;;;;;2016-09-28;2016-09-30;Estimate;September 2016;;2016-09-30;September 2016;2016-09-30;April 2017;Anticipated;2017-04-30;April 2017;Anticipated;2017-04-30;;Interventional;BOSSFRONT;;Brain-oscillation Synchronised Stimulation of the Prefrontal Cortex;Brain-oscillation Synchronised Stimulation of the Prefrontal Cortex: Development and Validation of a Personalized Closed-loop TMS Protocol for the Treatment of Major Depression;Unknown status;;N/A;18;Anticipated;University Hospital Tuebingen;;3;;;FALSE;;;;FALSE;;;;;;;;;;;Undecided;;2020-06-01T09:11:57Z;2020-06-01T09:11:57Z;Tübingen;3517624;Study Director;Brigitte Zrenner, MD;University Neurology Hospital Tübingen;Intermittent theta-burst stimulation | Negative-peak-triggered-TMS | Open-loop replay TMS;63559520;1;;;2016;2020-05-29;;FALSE;;FALSE;TRUE;18;65;Years;Years;1;2;1
NCT02919527;ClinicalTrials.gov processed this data on May 29, 2020;2016-09-27;;;2017-11-28;2016-09-28;2016-09-29;Estimate;;;;;;;2017-11-28;2017-11-30;Actual;September 2016;;2016-09-30;November 2017;2017-11-30;June 2017;Actual;2017-06-30;June 2017;Actual;2017-06-30;;Interventional;;;Acute Effects of Foam Rolling on Viscoelastic Tissue Properties and Fascial Sliding;Acute Effects of Foam Rolling on Viscoelastic Tissue Properties and Fascial Sliding: A Randomized, Controlled Crossover Trial;Completed;;N/A;16;Actual;Goethe University;;3;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T09:12:09Z;2020-06-01T09:12:09Z;Frankfurt;;;;;Self-Myofascial-Release | Stretching;63559618;1;;;2016;2020-05-29;9;FALSE;;FALSE;TRUE;20;40;Years;Years;2;2;
NCT02916576;ClinicalTrials.gov processed this data on May 29, 2020;2016-09-06;;;2017-02-13;2016-09-23;2016-09-27;Estimate;;;;;;;2017-02-13;2017-02-14;Actual;September 2016;;2016-09-30;February 2017;2017-02-28;February 2017;Actual;2017-02-28;December 2016;Actual;2016-12-31;;Interventional;;;"User Performance Evaluation of Contour® Plus One, Accu-Chek® Performa Connect, FreeStyle Optium Neo and OneTouch® Select Plus Blood Glucose Monitoring Systems Following ISO 15197:2013; EN ISO 15197:2015";"User Performance Evaluation of Contour® Plus One, Accu-Chek® Performa Connect, FreeStyle Optium Neo and OneTouch® Select Plus Blood Glucose Monitoring Systems Following ISO 15197:2013; EN ISO 15197:2015";Completed;;N/A;140;Anticipated;Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm;;1;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T09:12:42Z;2020-06-01T09:12:42Z;Ulm;;;;;Blood-Glucose Monitoring Systems for self-testing;63559846;1;;;2016;2020-05-29;3;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT02915250;ClinicalTrials.gov processed this data on May 29, 2020;2016-09-21;;;2017-06-28;2016-09-23;2016-09-26;Estimate;;;;;;;2017-06-28;2017-06-29;Actual;October 2016;Actual;2016-10-31;June 2017;2017-06-30;June 2017;Actual;2017-06-30;June 2017;Actual;2017-06-30;;Interventional;;;A Trial to Compare Post Prandial Blood Glucose Control of BioChaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes;A Randomised, Double-blind, Double-dummy, Three-period Cross-over Trial to Compare Post Prandial Blood Glucose Control of BioChaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes;Completed;;Phase 1;36;Actual;Adocia;;3;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:12:55Z;2020-06-01T09:12:55Z;Mainz;3518019;Principal Investigator;Leona Plum-Mörschel, MD;Profil Mainz GmbH & Co KG;BioChaperone® Combo | Humalog® Mix25 | Humalog® | Lantus® | Placebo;63559947;2;;;2016;2020-05-29;8;FALSE;;FALSE;FALSE;18;70;Years;Years;1;10;
NCT02618070;ClinicalTrials.gov processed this data on May 29, 2020;2015-11-24;;;2017-04-05;2015-11-26;2015-12-01;Estimate;;;;;;;2017-04-05;2017-04-06;Actual;March 2016;;2016-03-31;April 2017;2017-04-30;April 2017;Actual;2017-04-30;April 2017;Actual;2017-04-30;;Interventional;;;Cognitive Modulation of Dyspeptic Symptom During Food Ingestion in Functional Dyspepsia Patients Cognitive Modulation;;Completed;;N/A;30;Anticipated;University Hospital Tuebingen;;2;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T10:11:43Z;2020-06-01T10:11:43Z;Tübingen;3539032;Principal Investigator;Paul Enck, Prof.;Psychosomatic Medicine and Psychotherapy Department, University of Tübingen, Tübingen, Germany;Yogurt;63559994;1;;;2015;2020-05-29;13;FALSE;;FALSE;TRUE;18;65;Years;Years;2;;
NCT02912598;ClinicalTrials.gov processed this data on May 29, 2020;2016-09-16;;;2016-09-22;2016-09-22;2016-09-23;Estimate;;;;;;;2016-09-22;2016-09-23;Estimate;January 2015;;2015-01-31;September 2016;2016-09-30;November 2015;Actual;2015-11-30;November 2015;Actual;2015-11-30;;Interventional;;;Lung Isolation in Thoracic Surgery - a Randomized Trial Comparing the VivaSight™ EB Endobronchial Blocker With Established Devices;Lung Isolation in Thoracic Surgery - a Comparison of the VivaSight™ EB Endobronchial Blocker With Established Devices;Completed;;Phase 4;104;Actual;Otto-von-Guericke University Magdeburg;;4;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T09:13:35Z;2020-06-01T09:13:35Z;Magdeburg;3518209;Study Chair;Thomas Hachenberg, Prof. Dr. med.;Klinik für Anaesthesiologie und Intensivtherapie der Otto-von-Guericke-Universität / Medizinische Fakultät Universitätsklinikum Magdeburg A.ö.R.;Mallinckrodt™ Endobronchial Tube | Fuji Uniblocker™ | ETView VivaSight™-SL+EB | COOK© Arndt Endobronchial Blocker;63560150;;;;2016;2020-05-29;10;FALSE;;;FALSE;18;;Years;;1;5;
NCT02912377;ClinicalTrials.gov processed this data on May 29, 2020;2016-09-19;;;2017-05-17;2016-09-22;2016-09-23;Estimate;;;;;;;2017-05-17;2017-05-18;Actual;September 2016;;2016-09-30;May 2017;2017-05-31;May 2017;Actual;2017-05-31;May 2017;Actual;2017-05-31;;Interventional;;;Immunogenicity and Pharmacodynamic of B12019 and Neulasta® in Healthy Subjects;Multiple-doses, Randomised, Double-blind, Three-periods, Two-sequences Crossover Study to Assess the Immunogenicity and Pharmacodynamic Comparability of a Biosimilar Pegfilgrastim (B12019) and the Reference Product Neulasta® in Healthy Subjects;Completed;;Phase 1;96;Actual;Cinfa Biotech;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T09:13:44Z;2020-06-01T09:13:44Z;Ulm;3518220;Principal Investigator;Michael Lissy, MD;Nuvisan GmbH, 89231 Neu-Ulm;Neulasta, B12019;63560166;1;;;2016;2020-05-29;8;FALSE;;FALSE;TRUE;18;55;Years;Years;2;;
NCT02902861;ClinicalTrials.gov processed this data on May 29, 2020;2016-07-26;;;2016-09-15;2016-09-15;2016-09-16;Estimate;;;;;;;2016-09-15;2016-09-16;Estimate;February 2013;;2013-02-28;September 2016;2016-09-30;May 2015;Actual;2015-05-31;September 2014;Actual;2014-09-30;;Interventional;METOP;;Trial in Patients With Psoriasis Treated With Methotrexate Using an Optimized Treatment Schedule (METOP);An International Prospective, Double-blind, Placebo-controlled Phase III Randomised Controlled Trial (RCT) in Patients With Moderate to Severe Psoriasis Are Treated With Subcutaneous (s.c.) Methotrexate Using an Optimized Treatment Schedule.;Completed;;Phase 3;120;Actual;Sciderm GmbH;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:15:47Z;2020-06-01T09:15:47Z;Kiel;3518879;Principal Investigator;Ulrich Mrowietz, Professor;Psoriasis-Zentrum, Universitäts-Hautklinik Kiel;Methotrexate | Placebo ( for Methotrexate);63560893;1;;;2016;2020-05-29;19;FALSE;;FALSE;TRUE;18;;Years;;1;19;
NCT02896062;ClinicalTrials.gov processed this data on May 29, 2020;2016-08-31;;;2018-05-09;2016-09-06;2016-09-12;Estimate;;;;;;;2018-05-09;2018-05-15;Actual;October 2014;Actual;2014-10-31;May 2018;2018-05-31;November 2017;Actual;2017-11-30;October 2016;Actual;2016-10-31;;Interventional;;;Development and Evaluation of a Sleep-coaching Program;;Completed;;N/A;48;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;Undecided;;2020-06-01T09:16:43Z;2020-06-01T09:16:43Z;Berlin;;;;;sleep-coaching;63561407;1;;;2016;2020-05-29;24;FALSE;;FALSE;TRUE;18;65;Years;Years;1;1;
NCT02893800;ClinicalTrials.gov processed this data on May 29, 2020;2016-08-29;;;2017-08-29;2016-09-02;2016-09-09;Estimate;;;;;;;2017-08-29;2017-08-30;Actual;June 2016;Actual;2016-06-30;August 2017;2017-08-31;November 2016;Actual;2016-11-30;November 2016;Actual;2016-11-30;;Interventional;VODINO;;Validation and Optimization of the Individual Benefits of Locating Systems in Dementia Care;Assistive Technology for Dementia: Validation and Optimization of the Individual Benefits of Locating Systems in Dementia Care (VODINO);Completed;;N/A;40;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;Yes;Aim: develop better business model designs to promote the adoption of assistive technologies in the field of dementia.~In this context we share the qualitative data (transcripts of the interviews) with the department of business administration Prof.Dr.Wessel (Research Group Health-IT and Business Model Innovation) of the Free University of Berlin.;2020-06-01T09:17:21Z;2020-06-01T09:17:21Z;Berlin;3519448;Principal Investigator;Oliver Peters, MD;Charité CBF;Locating system watch with GPS-technology;63561582;1;;;2016;2020-05-29;5;FALSE;;FALSE;TRUE;;;;;1;4;
NCT02891863;ClinicalTrials.gov processed this data on May 29, 2020;2016-08-29;;;2017-04-18;2016-09-01;2016-09-08;Estimate;;;;;;;2017-04-18;2017-07-17;Actual;September 2015;;2015-09-30;August 2016;2016-08-31;March 2016;Actual;2016-03-31;March 2016;Actual;2016-03-31;;Interventional;LEVER;;Low Energy Therapy to Convert Ventricular Tachycardias;Low Energy Therapy Application to Convert Ventricular Tachycardias (LEVER);Terminated;;Early Phase 1;9;Actual;Boston Scientific Corporation;;1;;Futility;FALSE;;;;FALSE;;;;;;;;;;;No;Acute feasibility study of possible new product feature, confidential information;2020-06-01T09:17:35Z;2020-06-01T09:17:35Z;Leipzig;3519586;Principal Investigator;Andreas Bollmann, MD;Hertz Centrum, Leipzig;LEVER Acute Study System;63561730;1;4;6;2016;2020-05-29;6;TRUE;11;FALSE;TRUE;18;;Years;;2;;
NCT02888236;ClinicalTrials.gov processed this data on May 29, 2020;2016-08-30;;;2017-08-25;2016-08-30;2016-09-02;Estimate;;;;;;;2017-08-25;2017-08-28;Actual;September 2016;Actual;2016-09-30;August 2017;2017-08-31;July 6, 2017;Actual;2017-07-06;June 20, 2017;Actual;2017-06-20;;Interventional;;;LEO 32731 for the Treatment of Moderate to Severe Psoriasis Vulgaris;LEO 32731 for the Treatment of Moderate to Severe Psoriasis Vulgaris;Completed;;Phase 2;36;Actual;LEO Pharma;;2;;;FALSE;;;;FALSE;;;;;;;;;;;Undecided;;2020-06-01T09:18:06Z;2020-06-01T09:18:06Z;Berlin;3519820;Principal Investigator;Sandra Philipp, PhD;Charite University, Berlin, Germany;LEO 32731 | LEO 32731 Placebo;63562008;1;;;2016;2020-05-29;8;FALSE;;FALSE;TRUE;18;65;Years;Years;1;2;
NCT02888028;ClinicalTrials.gov processed this data on May 29, 2020;2014-07-03;;;2018-06-20;2016-08-29;2016-09-02;Estimate;;;;;;;2018-06-20;2018-06-21;Actual;May 2011;;2011-05-31;June 2018;2018-06-30;June 2014;Actual;2014-06-30;April 2014;Actual;2014-04-30;;Interventional;;;Quality of Life and Device Acceptance in Patients With ICD Undergoing Remote ICD FU;Quality of Life and Device Acceptance in Patients With Implantable Cardioverter-defibrillators Undergoing Remote ICD Follow-up;Completed;;N/A;182;Actual;Klinikum der Universitaet Muenchen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:18:09Z;2020-06-01T09:18:09Z;Munich;3519831;Principal Investigator;Johannes Siebermair, MD;Munich University Clinic, Campus Grosshadern, Munich, Germany;ICD remote monitoring | Control group;63562024;2;;;2014;2020-05-29;35;FALSE;;FALSE;FALSE;18;;Years;;1;2;
NCT02885103;ClinicalTrials.gov processed this data on May 29, 2020;2016-08-22;;;2018-03-25;2016-08-25;2016-08-31;Estimate;;;;;;;2018-03-25;2018-03-27;Actual;August 2016;;2016-08-31;March 2018;2018-03-31;November 2017;Actual;2017-11-30;November 2017;Actual;2017-11-30;;Interventional;AEROFLOW;;Combination of NHF and Nebulizer on Lung Function in COPD;Effect of Nasal Highflow in Combination With a Nebulizer on Reversibility in Lung Function in Patients With COPD;Completed;;N/A;20;Actual;University of Leipzig;;2;;;FALSE;;;;FALSE;;;;;;;;;;;Undecided;;2020-06-01T09:18:35Z;2020-06-01T09:18:35Z;Leipzig;3520041;Study Director;Hubert Wirtz, MD;University of Leipzig;Nasal high flow (NHF) | Nebulizer;63562243;1;;;2016;2020-05-29;15;FALSE;;FALSE;TRUE;;;;;2;;
NCT02883621;ClinicalTrials.gov processed this data on May 29, 2020;2016-08-21;;;2017-05-22;2016-08-24;2016-08-30;Estimate;;;;;;;2017-05-22;2017-05-23;Actual;September 2016;;2016-09-30;May 2017;2017-05-31;May 22, 2017;Actual;2017-05-22;April 2017;Actual;2017-04-30;;Interventional;Kappa-III;;The Diagnostic Yield of Cap Assisted Upper Endoscopy in Esophagus;Comparison Between Standard Endoscopy and Cap Assisted Endoscopy for Diagnostic Yield in Esophagus;Completed;;N/A;1000;Actual;Technische Universität München;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:18:45Z;2020-06-01T09:18:45Z;Munich;3520135;Principal Investigator;Mohamed Abdelhafez, MD;II Medizinische Klinik am Klinikum rechts der Isar der Technischen Universität München;cap assisted upper endoscopy | standard upper endoscopy;63562356;1;;;2016;2020-05-29;7;FALSE;;FALSE;TRUE;18;99;Years;Years;1;1;
NCT02883608;ClinicalTrials.gov processed this data on May 29, 2020;2016-08-21;;;2017-05-22;2016-08-24;2016-08-30;Estimate;;;;;;;2017-05-22;2017-05-23;Actual;August 2016;;2016-08-31;May 2017;2017-05-31;January 22, 2017;Actual;2017-01-22;October 2016;Actual;2016-10-31;;Interventional;KappaII;;Cap Assisted Forward-Viewing Endoscope vs Side-Viewing Endoscope for Examination of Major Duodenal Papilla;Cap Assisted Forward-Viewing Endoscope vs Side-Viewing Endoscope for Examination of Major Duodenal Papilla;Completed;;N/A;63;Actual;Technische Universität München;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:18:46Z;2020-06-01T09:18:46Z;Munich;;;;;cap assisted forward-viewing endoscope;63562357;1;;;2016;2020-05-29;2;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT02881216;ClinicalTrials.gov processed this data on May 29, 2020;2016-08-15;;;2016-08-25;2016-08-23;2016-08-26;Estimate;;;;;;;2016-08-25;2016-08-29;Estimate;January 2015;;2015-01-31;August 2016;2016-08-31;June 2016;Actual;2016-06-30;December 2015;Actual;2015-12-31;;Interventional;;;Procedural Advantages of a Novel Drug-Eluting Coronary Stent;Procedural Advantages of a Novel Drug-Eluting Coronary Stent With Ultra-Thin Struts and Bioabsorbable Abluminal Polymer Coating in an All-Comers Registry;Completed;;N/A;814;Actual;University Hospital Heidelberg;;2;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T09:19:03Z;2020-06-01T09:19:03Z;Heidelberg;;;;;Synergy Stent | Currently common drug-eluting stent (DES);63562537;;;;2016;2020-05-29;11;FALSE;;;FALSE;18;99;Years;Years;1;;
NCT02877797;ClinicalTrials.gov processed this data on May 29, 2020;2016-02-29;;;2016-08-19;2016-08-19;2016-08-24;Estimate;;;;;;;2016-08-19;2016-08-24;Estimate;February 2016;;2016-02-29;August 2016;2016-08-31;August 2016;Actual;2016-08-31;May 2016;Actual;2016-05-31;;Interventional;Kappa-I;;Cap Assisted Upper Endoscopy to Visualize the Major Duodenal Papilla;The Use of Cap Assisted Forward Viewing Esophagogastroduodenoscopy to Examine the Major Duodenal Papilla;Completed;;N/A;101;Actual;Technische Universität München;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T09:19:34Z;2020-06-01T09:19:34Z;Munich;3520548;Principal Investigator;Stefan von Delius;Technische Universität München;Cap;63562795;1;;;2016;2020-05-29;3;FALSE;;FALSE;TRUE;18;;Years;;1;3;
NCT02874911;ClinicalTrials.gov processed this data on May 29, 2020;2016-08-12;;;2016-08-17;2016-08-17;2016-08-22;Estimate;;;;;;;2016-08-17;2016-08-22;Estimate;September 2012;;2012-09-30;August 2016;2016-08-31;March 2016;Actual;2016-03-31;September 2014;Actual;2014-09-30;;Interventional;Move'n Fun;;Coordination Training With Complete Body Video Games in Children and Adults With Degenerative Ataxias;Coordination Training With Complete Body Video Games in Children and Adults With Degenerative Ataxias;Completed;;N/A;10;Actual;University Hospital Tuebingen;;1;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:20:02Z;2020-06-01T09:20:02Z;Tübingen;3520759;Principal Investigator;Synofzik Matthis, PD Dr.;University Hospital Tübingen;General training;63563015;;;;2016;2020-05-29;24;FALSE;;;FALSE;5;30;Years;Years;8;2;
NCT02870972;ClinicalTrials.gov processed this data on May 29, 2020;2016-08-10;;;2017-10-24;2016-08-17;2016-08-18;Estimate;;;;;;;2017-10-24;2017-10-26;Actual;August 2016;Actual;2016-08-31;October 2017;2017-10-31;August 2017;Actual;2017-08-31;August 2017;Actual;2017-08-31;;Interventional;APeX-1;;Efficacy and Safety of BCX7353 to Prevent Angioedema Attacks in Subjects With Hereditary Angioedema;A Randomized, Double-blind, Placebo-controlled, Dose-ranging, Parallel-group Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BCX7353 as a Preventative Treatment to Reduce the Frequency of Attacks in Subjects With Hereditary Angioedema;Completed;;Phase 2;75;Actual;BioCryst Pharmaceuticals;;5;;;FALSE;;;;TRUE;;;;;;;;;;;Yes;;2020-06-01T09:20:41Z;2020-06-01T09:20:41Z;Frankfurt;3521049;Principal Investigator;Emel Aygören-Pürsün, MD;University Hospital Frankfurt Goethe University;BCX7353 | Placebo;63563316;24;;;2016;2020-05-29;12;FALSE;;FALSE;FALSE;18;70;Years;Years;1;4;
NCT02868320;ClinicalTrials.gov processed this data on May 29, 2020;2016-08-09;;;2016-08-11;2016-08-11;2016-08-16;Estimate;;;;;;;2016-08-11;2016-08-16;Estimate;April 2014;;2014-04-30;August 2016;2016-08-31;July 2015;Actual;2015-07-31;June 2015;Actual;2015-06-30;;Interventional;;;SMS Technology for the Promotion of Diabetes Education and Self-Management in Egypt;SMS Technology for the Promotion of Diabetes Education and Self-Management;Completed;;N/A;73;Actual;Hannover Medical School;;2;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T09:21:01Z;2020-06-01T09:21:01Z;Hannover;3521212;Principal Investigator;Haitham Abaza;PLRI Institute for Medical Informatics, Hannover Medical School;SMS messages | Instruction booklet;63563524;1;;;2016;2020-05-29;14;FALSE;;FALSE;TRUE;;;;;1;7;
NCT02867969;ClinicalTrials.gov processed this data on May 29, 2020;2016-08-11;;;2016-08-11;2016-08-11;2016-08-16;Estimate;;;;;;;2016-08-11;2016-08-16;Estimate;August 2016;;2016-08-31;August 2016;2016-08-31;May 2017;Anticipated;2017-05-31;February 2017;Anticipated;2017-02-28;;Interventional;SlowSCA;;Slowing Down Disease Progression in Premanifest SCA: a Piloting Interventional Exergame Trial;Slowing Down Disease Progression in Premanifest SCA: a Piloting Interventional Exergame Trial;Unknown status;;N/A;26;Anticipated;University Hospital Tuebingen;;1;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:21:04Z;2020-06-01T09:21:04Z;Tübingen;;;;;Motor training;63563551;1;;;2016;2020-05-29;;FALSE;;FALSE;TRUE;18;80;Years;Years;1;5;
NCT02866825;ClinicalTrials.gov processed this data on May 29, 2020;2016-06-17;;;2017-02-14;2016-08-10;2016-08-15;Estimate;;;;;;;2017-02-14;2017-02-15;Actual;May 2016;;2016-05-31;February 2017;2017-02-28;January 2017;Actual;2017-01-31;December 2016;Actual;2016-12-31;;Interventional;CARDIAC;;Studying Complement Inhibition in Complex Cardiac Surgery;A Phase II Randomized, Placebo-controlled, Double-blind, Dose-escalation Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamic Dose Response Relationship of IFX-1 in Patients Undergoing Complex Cardiac Surgery;Completed;;Phase 2;116;Actual;InflaRx GmbH;;2;;;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T09:21:14Z;2020-06-01T09:21:14Z;Jena;3521311;Principal Investigator;Torsten Doenst, Prof. Dr.;University Hospital Jena;IFX-1 | Placebo;63563636;10;;;2016;2020-05-29;7;FALSE;;FALSE;FALSE;18;;Years;;1;13;
NCT02863549;ClinicalTrials.gov processed this data on May 29, 2020;2016-07-20;;;2016-08-06;2016-08-06;2016-08-11;Estimate;;;;;;;2016-08-06;2016-08-11;Estimate;July 2016;;2016-07-31;August 2016;2016-08-31;December 2017;Anticipated;2017-12-31;December 2017;Anticipated;2017-12-31;;Interventional;TVrepair;;MitraClip for Severe TR;Transcatheter Treatment of Severe Tricuspid Regurgitation Using the MitraClip System;Unknown status;;N/A;100;Anticipated;Klinikum der Universitaet Muenchen;;;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:21:44Z;2020-06-01T09:21:44Z;Munich;3521549;Principal Investigator;Daniel Braun, MD;Klinikum der Universität München;MitraClip in tricuspid valve;63563886;1;;;2016;2020-05-29;;FALSE;;FALSE;TRUE;18;99;Years;Years;2;4;
NCT02861001;ClinicalTrials.gov processed this data on May 29, 2020;2016-06-13;;;2017-03-22;2016-08-04;2016-08-10;Estimate;;;;;;;2017-03-22;2017-03-23;Actual;April 2016;;2016-04-30;March 2017;2017-03-31;January 13, 2017;Actual;2017-01-13;January 13, 2017;Actual;2017-01-13;;Interventional;VivaPDT;;VivaSight-SL™ Versus Bronchoscopy for Percutaneous Tracheotomy;Prospective, Randomized Study in Ventilated Critically Ill Patients Receiving Percutaneous Tracheotomy. A Comparison of Periinterventional Visualization of Conventional Bronchoscopy and an Endotracheal Tube Mounted Camera (VivaSight-SL™);Completed;;N/A;56;Actual;Universitätsklinikum Hamburg-Eppendorf;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:22:10Z;2020-06-01T09:22:10Z;Hamburg;;;;;conventional bronchoscopy | VivaSight-SL tube;63564078;1;;;2016;2020-05-29;8;FALSE;;FALSE;TRUE;18;;Years;;1;9;
NCT02858817;ClinicalTrials.gov processed this data on May 29, 2020;2016-07-28;;;2019-07-11;2016-08-05;2016-08-08;Estimate;;;;;;;2019-07-11;2019-07-15;Actual;November 28, 2016;Actual;2016-11-28;February 2018;2018-02-28;November 16, 2017;Actual;2017-11-16;November 16, 2017;Actual;2017-11-16;;Interventional;;;Safety and Protective Efficacy of IV Immunization With Cryopreserved PfSPZ Under A/P Chemoprophylaxis;Safety and Protective Efficacy of Intravenous Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Atovaquone/Proguanil Chemoprophylaxis;Completed;;Phase 1;30;Actual;University Hospital Tuebingen;;3;;;FALSE;;;;FALSE;;;;;;;;;;;Undecided;;2020-06-01T09:22:25Z;2020-06-01T09:22:25Z;Tübingen;3521854;Principal Investigator;Peter G Kremsner, Prof;University Hospital Tübingen, Tübingen, Germany;atovaquone/proguanil 250mg/100mg (A/P) | PfSPZ Challenge (NF54) | NaCl 0,9%;63564246;;;;2016;2020-05-29;11;FALSE;;;FALSE;18;45;Years;Years;1;2;2
NCT02857660;ClinicalTrials.gov processed this data on May 29, 2020;2016-07-28;;;2017-05-01;2016-08-02;2016-08-05;Estimate;;;;;;;2017-05-01;2017-05-02;Actual;August 2016;Actual;2016-08-31;May 2017;2017-05-31;April 2017;Actual;2017-04-30;February 2017;Actual;2017-02-28;;Interventional;FRANSO;;Effect of Whole Body Electromyostimulation and/or Protein Supplementation on Sarcopenic Obesity in 70+;Effect of Whole-body Electromyostimulation (WB-EMS) and/or Protein Supplementation on Sarcopenic Obesity in Community Dwelling Males 70+ With Sarcopenic Obesity;Completed;;Phase 3;100;Actual;University of Erlangen-Nürnberg Medical School;;3;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:22:42Z;2020-06-01T09:22:42Z;Erlangen;3521931;Study Chair;Cornel Sieber, MD;Institute of Biomedicine of Aging, University of Erlangen-Nürnberg;Whole body Electromyostimulation (exercise) | Protein;63564333;1;;;2016;2020-05-29;6;FALSE;;FALSE;TRUE;70;;Years;;2;5;
NCT02851108;ClinicalTrials.gov processed this data on May 29, 2020;2016-06-28;;;2020-03-11;2016-07-29;2016-08-01;Estimate;;;;;;;2020-03-11;2020-03-25;Actual;October 2016;Actual;2016-10-31;March 2020;2020-03-31;February 2017;Actual;2017-02-28;December 2016;Actual;2016-12-31;;Interventional;BlueACTn;;Methylene Blue Against Falciparum Malaria in Burkina Faso;Safety of Artesunate-amodiaquine Combined With Methylene Blue or Primaquine for Falciparum Malaria Treatment in African Children: A Randomised Controlled Trial;Completed;;Phase 2;100;Actual;Heidelberg University;;2;;;FALSE;;;;FALSE;;;;;;;;;;;Undecided;;2020-06-01T09:23:42Z;2020-06-01T09:23:42Z;Heidelberg;3522375;Principal Investigator;Olaf Müller, Prof. Dr.;Heidelberg University;Methylene Blue | Primaquine;63564831;1;128;4;2016;2020-05-29;2;TRUE;38;FALSE;TRUE;6;59;Months;Months;1;4;
NCT02848352;ClinicalTrials.gov processed this data on May 29, 2020;2016-06-29;;;2017-04-04;2016-07-25;2016-07-28;Estimate;;;;;;;2017-04-04;2017-04-06;Actual;June 2016;;2016-06-30;July 2016;2016-07-31;October 2016;Actual;2016-10-31;October 2016;Actual;2016-10-31;;Interventional;;;The Role of Expectations in Experimentally Induced Sadness;The Role of Expectations in Experimentally Induced Sadness;Completed;;N/A;128;Actual;Philipps University Marburg Medical Center;;4;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:24:13Z;2020-06-01T09:24:13Z;Marburg;3522571;Principal Investigator;Winfried Rief, Professor;Philipps University Marburg Medical Center;Placebo nasal spray | Film Sequence;63565044;1;;;2016;2020-05-29;4;FALSE;;FALSE;TRUE;18;40;Years;Years;1;;
NCT02848209;ClinicalTrials.gov processed this data on May 29, 2020;2016-07-25;;;2017-03-16;2016-07-25;2016-07-28;Estimate;;;;;;;2017-03-16;2017-03-20;Actual;July 2016;;2016-07-31;July 2016;2016-07-31;November 2016;Actual;2016-11-30;November 2016;Actual;2016-11-30;;Interventional;;;Histological Skin Changes of Different Peeling Agents in Surgically Subcutaneous Undermined Skin;Histological Evaluation of Peeling Induced Skin Changes of Different Peeling Agents in Surgically Subcutaneous Undermined Skin Flaps in Facelift Patients;Completed;;N/A;9;Actual;University Hospital Tuebingen;;4;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:24:15Z;2020-06-01T09:24:15Z;Tübingen;3522582;Principal Investigator;Phillipp Gonser, MD;BG Trauma Centre Tuebingen;TCA 20% Peeling | Phenol/croton oil Peeling | TCA 40% Peeling;63565054;1;;;2016;2020-05-29;4;FALSE;;FALSE;TRUE;40;80;Years;Years;1;1;
NCT02848014;ClinicalTrials.gov processed this data on May 29, 2020;2016-06-29;;;2017-04-04;2016-07-25;2016-07-28;Estimate;;;;;;;2017-04-04;2017-04-06;Actual;July 2016;Actual;2016-07-31;June 2016;2016-06-30;November 30, 2016;Actual;2016-11-30;November 2016;Actual;2016-11-30;;Interventional;;;The Effects of Interventions Aiming at Optimizing Expectations and Inducing Positive Emotions After an Acute Stressor;The Effects of Interventions Aiming at Optimizing Expectations and Inducing Positive Emotions After an Acute Stressor on Subjective and Objective Stress Paramaters;Completed;;N/A;74;Actual;Philipps University Marburg Medical Center;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T09:24:16Z;2020-06-01T09:24:16Z;Marburg;3522594;Principal Investigator;Winfried Rief, Professor;Philipps University Marburg Medical Center;Writing task;63565069;1;;;2016;2020-05-29;4;FALSE;;FALSE;TRUE;18;;Years;;1;4;
NCT02847260;ClinicalTrials.gov processed this data on May 29, 2020;2016-07-25;;;2017-09-13;2016-07-27;2016-07-28;Estimate;;;;;;;2017-09-13;2017-10-17;Actual;April 2012;;2012-04-30;September 2017;2017-09-30;March 2014;Actual;2014-03-31;March 2014;Actual;2014-03-31;;Interventional;RAPID;;Safety and Tolerability of Rapid Dose Titration of Subcutaneous Remodulin® Therapy in PAH Subjects (RAPID);A 16 Week, Open Label, Multi-centre, Study to Evaluate the Safety, Tolerability and Pharmacodynamic Effects of a Rapid Dose Titration Regimen of Subcutaneous Remodulin® Therapy in Subjects With Pulmonary Arterial Hypertension (PAH);Completed;;Phase 4;39;Actual;United Therapeutics;;1;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:24:25Z;2020-06-01T09:24:25Z;Dresden Duisburg Hamburg Heidelberg Köln Leipzig Munich Regensburg Homburg Würzburg;3522646;Principal Investigator;Grünig;Thoraxklinik am Universitätsklinikum, Heidelberg, Germany;Remodulin;63565129;;317;37;2016;2020-05-29;23;TRUE;40;;FALSE;18;;Years;;1;8;
NCT02843490;ClinicalTrials.gov processed this data on May 29, 2020;2016-07-21;;;2017-11-30;2016-07-22;2016-07-25;Estimate;;;;;;;2017-11-30;2017-12-02;Actual;August 5, 2016;Actual;2016-08-05;November 2017;2017-11-30;November 9, 2017;Actual;2017-11-09;August 17, 2017;Actual;2017-08-17;;Interventional;CAPTAIN;;Functional and Structural Outcomes in Neovascular Age-related Macular Degeneration;Correlation of Functional and Structural Outcomes With Serum Antibody Profiles in Patients With Neovascular Age-related Macular Degeneration Treated With Ranibizumab and Healthy Subjects: A Prospective, Controlled Monocenter Trial;Completed;;Phase 4;71;Actual;Johannes Gutenberg University Mainz;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:25:00Z;2020-06-01T09:25:00Z;Mainz;3522932;Principal Investigator;Christina Korb, MD;Johannes Gutenberg-University Mainz, Germany;Ranibizumab;63565417;1;;;2016;2020-05-29;12;FALSE;;FALSE;TRUE;50;;Years;;1;3;3
NCT02842892;ClinicalTrials.gov processed this data on May 29, 2020;2016-07-18;;;2018-02-27;2016-07-22;2016-07-25;Estimate;;;;;;;2018-02-27;2018-02-28;Actual;July 2016;;2016-07-31;February 2018;2018-02-28;April 2017;Actual;2017-04-30;April 2017;Actual;2017-04-30;;Interventional;;;Implication of Stiffness of the Hamstrings, Achilles Tendon and Calf Muscles for Jumping Performance;;Completed;;N/A;35;Anticipated;Goethe University;;3;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T09:25:04Z;2020-06-01T09:25:04Z;Frankfurt;;;;;Tissue stiffness;63565461;1;;;2016;2020-05-29;9;FALSE;;FALSE;TRUE;18;65;Years;Years;1;1;
NCT02836665;ClinicalTrials.gov processed this data on May 29, 2020;2016-07-12;;;2018-08-28;2016-07-14;2016-07-19;Estimate;;;;;;;2018-08-28;2018-08-31;Actual;August 2016;Actual;2016-08-31;August 2018;2018-08-31;December 31, 2017;Actual;2017-12-31;July 14, 2017;Actual;2017-07-14;;Interventional;Telederm;;Application of Telemedicine for Dermatological Emergency Patients;Application of Telemedicine for Dermatological Emergency Patients;Completed;;N/A;100;Actual;RWTH Aachen University;;2;;;FALSE;;;;FALSE;;;;;;;;;;;Undecided;;2020-06-01T09:26:28Z;2020-06-01T09:26:28Z;Aachen;3523365;Principal Investigator;Luigi Villa, Dr. med.;RWTH Aachen University;Telemedicine for dermatological emergency patients;63565931;1;;;2016;2020-05-29;10;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT02834377;ClinicalTrials.gov processed this data on May 29, 2020;2016-06-01;;;2019-01-25;2016-07-12;2016-07-15;Estimate;;;;;;;2019-01-25;2019-01-29;Actual;May 19, 2016;Actual;2016-05-19;January 2019;2019-01-31;October 1, 2017;Actual;2017-10-01;June 30, 2017;Actual;2017-06-30;;Interventional;TAPIR;;Personalized Hemodynamic Therapy in Patients Undergoing High-risk Surgery;Individualized Goal-directed Hemodynamic Therapy Targeting Preoperatively Assessed Personal Cardiac Output Values in Patients Undergoing High-risk Surgical Procedures: a Prospective and Randomized Clinical Trial;Completed;;N/A;188;Actual;Universitätsklinikum Hamburg-Eppendorf;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:26:48Z;2020-06-01T09:26:48Z;Hamburg;3523523;Study Chair;Bernd Saugel, MD;Universitätsklinikum Hamburg-Eppendorf;Treatment algorithm targeting individual cardiac output;63566107;1;;;2016;2020-05-29;13;FALSE;;FALSE;TRUE;18;;Years;;1;9;
NCT02834338;ClinicalTrials.gov processed this data on May 29, 2020;2016-06-15;;;2017-10-19;2016-07-12;2016-07-15;Estimate;;;;;;;2017-10-19;2017-10-20;Actual;July 26, 2016;Actual;2016-07-26;October 2017;2017-10-31;July 20, 2017;Actual;2017-07-20;July 20, 2017;Actual;2017-07-20;;Interventional;EPMIII;;Enhanced Perioperative Mobilization (EPM) Trial;Usage of Activity Tracking in Major Visceral Surgery - the Enhanced Perioperative Mobilization (EPM) Trial;Completed;;N/A;110;Actual;Technische Universität Dresden;;4;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:26:48Z;2020-06-01T09:26:48Z;Dresden;3523527;Principal Investigator;Thilo Welsch, MD, MBA;Department of Visceral, Thoracic and Vascular Surgery, University Hospital Carl Gustav Carus, Technical University of Dresden, Germany;activity tracking for autofeedback;63566110;1;;;2016;2020-05-29;11;FALSE;;FALSE;TRUE;18;75;Years;Years;1;12;
NCT02820519;ClinicalTrials.gov processed this data on May 29, 2020;2016-06-14;;;2017-08-25;2016-06-28;2016-07-01;Estimate;;;;;;;2017-08-25;2017-08-28;Actual;June 2016;;2016-06-30;August 2017;2017-08-31;July 21, 2017;Actual;2017-07-21;July 21, 2017;Actual;2017-07-21;;Interventional;LOX2015PILOT;;Tolerability and Analgesic Efficacy of Loxapine in Patients With Refractory, Chemotherapy-induced Neuropathic Pain;Tolerability and Analgesic Efficacy of Loxapine in Patients With Refractory, Chemotherapy-induced Neuropathic Pain;Terminated;;Phase 2;4;Actual;University of Witten/Herdecke;;1;;Intolerable high amount of adverse events;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:29:32Z;2020-06-01T09:29:32Z;Witten-Herdecke;3524477;Study Chair;Sven Schmiedl, MD;Witten/Herdecke University;Loxapine;63567154;1;;;2016;2020-05-29;12;FALSE;;FALSE;TRUE;18;;Years;;1;12;
NCT02818959;ClinicalTrials.gov processed this data on May 29, 2020;2016-06-24;;;2020-05-19;2016-06-27;2016-06-30;Estimate;;;;;;;2020-05-19;2020-05-21;Actual;December 2013;;2013-12-31;May 2020;2020-05-31;May 2015;Actual;2015-05-31;March 2014;Actual;2014-03-31;;Interventional;CP-0001;;First in Man Study of the JenaValve TAVI Plus System Transfemoral;First in Man Study of the JenaValve TAVI Plus System Transfemoral;Terminated;;N/A;7;Actual;JenaValve Technology, Inc.;;1;;Due to inability to recruit sufficient sample size in reasonable time frame.;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:29:50Z;2020-06-01T09:29:50Z;Hamburg;3524588;Principal Investigator;Hendrik Treede, MD;University of Hamburg Medical Center;JenaValve Pericardial TAVR System;63567272;2;;;2016;2020-05-29;3;FALSE;;FALSE;FALSE;75;;Years;;1;1;3
NCT02816268;ClinicalTrials.gov processed this data on May 29, 2020;2016-06-24;;;2016-06-27;2016-06-27;2016-06-28;Estimate;;;;;;;2016-06-27;2016-06-28;Estimate;September 2012;;2012-09-30;June 2016;2016-06-30;November 2015;Actual;2015-11-30;May 2014;Actual;2014-05-31;;Interventional;FULL CONTACT;;Contact Force Guided Ablation Versus Conventional Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation;Contact Force Guided Ablation Versus Conventional Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation;Completed;;N/A;120;Actual;Deutsches Herzzentrum Muenchen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;Yes;;2020-06-01T09:30:14Z;2020-06-01T09:30:14Z;Munich;;;;;Pulmonary vein isolation;63567477;1;;;2016;2020-05-29;20;FALSE;;FALSE;TRUE;;;;;1;3;
NCT02810535;ClinicalTrials.gov processed this data on May 29, 2020;2016-05-31;;;2017-11-29;2016-06-20;2016-06-23;Estimate;;;;;;;2017-11-29;2017-11-30;Actual;May 2016;;2016-05-31;November 2017;2017-11-30;September 19, 2017;Actual;2017-09-19;August 1, 2017;Actual;2017-08-01;;Interventional;LISA;;Local IgE in Subjects With Allergic or Non-allergic Rhinitis;Local IgE in Subjects With Allergic or Non-allergic Rhinitis;Completed;;N/A;150;Actual;Johann Wolfgang Goethe University Hospital;;3;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:31:01Z;2020-06-01T09:31:01Z;Frankfurt;;;;;Observation;63567913;1;;;2016;2020-05-29;14;FALSE;;FALSE;TRUE;18;45;Years;Years;1;3;
NCT02806583;ClinicalTrials.gov processed this data on May 29, 2020;2016-06-09;;;2017-10-06;2016-06-15;2016-06-20;Estimate;;;;;;;2017-10-06;2017-10-09;Actual;November 2015;;2015-11-30;October 2017;2017-10-31;May 2017;Actual;2017-05-31;March 13, 2017;Actual;2017-03-13;;Interventional;;;Talking Time: Telephone Support Groups for Informal Caregivers of People With Dementia;Talking Time: Telephone Support Groups for Informal Caregivers of People With Dementia: A Randomized Controlled Trial;Completed;;N/A;38;Actual;University of Leipzig;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:31:42Z;2020-06-01T09:31:42Z;Leipzig;3525399;Principal Investigator;Martin Berwig, Dr.;University of Leipzig;structured support groups;63568211;1;;;2016;2020-05-29;15;FALSE;;FALSE;TRUE;18;;Years;;1;4;3
NCT02802254;ClinicalTrials.gov processed this data on May 29, 2020;2016-06-12;;;2017-06-09;2016-06-12;2016-06-16;Estimate;;;;;;;2017-06-09;2017-06-12;Actual;August 2016;Actual;2016-08-31;June 2017;2017-06-30;June 2017;Actual;2017-06-30;June 2017;Actual;2017-06-30;;Interventional;RiskAct;;Increasing Risk Perception of Physical Activity Using Patient-targeted Feedback.;Increasing Risk Perception of Physical Activity Using Patient-targeted Feedback: Randomized Controlled Trial.;Completed;;Phase 2/Phase 3;121;Actual;Universitätsklinikum Hamburg-Eppendorf;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:32:16Z;2020-06-01T09:32:16Z;Hamburg;3525712;Study Director;Bernd Löwe, Prof. Dr.;Universitätsklinikum Hamburg-Eppendorf;Patient-targeted individual physical-activity-feedback | Pedometer;63568544;2;;;2016;2020-05-29;10;FALSE;;FALSE;FALSE;18;75;Years;Years;1;10;
NCT02801513;ClinicalTrials.gov processed this data on May 29, 2020;2016-06-11;;;2016-06-15;2016-06-15;2016-06-16;Estimate;;;;;;;2016-06-15;2016-06-16;Estimate;September 2013;;2013-09-30;June 2016;2016-06-30;March 2015;Actual;2015-03-31;March 2015;Actual;2015-03-31;;Interventional;GetWell;;Maintaining Mechanisms of Chronic Depression and Their Changeability;Maintaining Mechanisms of Chronic Depression and Their Changeability: the Role of Discrepancy-based Processing;Completed;;N/A;74;Actual;Freie Universität Berlin;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:32:27Z;2020-06-01T09:32:27Z;Berlin;3525767;Principal Investigator;Thorsten Barnhofer, PhD;Freie Universität Berlin;Brief Mindfulness Training | Resting Control Training;63568600;;;;2016;2020-05-29;18;FALSE;;;FALSE;18;65;Years;Years;3;4;
NCT02794298;ClinicalTrials.gov processed this data on May 29, 2020;2016-04-05;;;2017-01-05;2016-06-03;2016-06-09;Estimate;;;;;;;2017-01-05;2017-01-06;Estimate;April 2016;;2016-04-30;January 2017;2017-01-31;December 2016;Actual;2016-12-31;December 2016;Actual;2016-12-31;;Interventional;TRAINSTIM1;;tDCS Effects on GABA Concentration and Brain Functional Connectivity in Young Adults;Effects of Transcranial Direct Current Stimulation (tDCS) on GABA Concentration and Brain Functional Connectivity in Young Adults.;Completed;;N/A;32;Actual;Charite University, Berlin, Germany;;3;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T09:33:39Z;2020-06-01T09:33:39Z;Berlin;3526293;Principal Investigator;Agnes Flöel, Prof. Dr.;Charite University, Berlin, Germany;Transcranial direct current stimulation (tDCS) | sham-tDCS;63569148;1;;;2016;2020-05-29;8;FALSE;;FALSE;TRUE;18;30;Years;Years;1;3;
NCT02794272;ClinicalTrials.gov processed this data on May 29, 2020;2016-04-05;;;2017-01-05;2016-06-03;2016-06-09;Estimate;;;;;;;2017-01-05;2017-01-06;Estimate;April 2016;;2016-04-30;January 2017;2017-01-31;August 2016;Actual;2016-08-31;July 2016;Actual;2016-07-31;;Interventional;TRAINSTIM1;;tDCS Effects on GABA Concentration and Brain Functional Connectivity in Older Adults Of Working Age;Effects of Transcranial Direct Current Stimulation (tDCS) on GABA Concentration and Brain Functional Connectivity in Older Adults.;Completed;;N/A;24;Actual;Charite University, Berlin, Germany;;3;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T09:33:39Z;2020-06-01T09:33:39Z;Berlin;3526296;Principal Investigator;Agnes Flöel, Prof. Dr.;Charite University, Berlin, Germany;tDCS | sham-tDCS;63569150;1;;;2016;2020-05-29;3;FALSE;;FALSE;TRUE;50;65;Years;Years;1;3;
NCT02794259;ClinicalTrials.gov processed this data on May 29, 2020;2016-04-05;;;2017-01-05;2016-06-03;2016-06-09;Estimate;;;;;;;2017-01-05;2017-01-06;Estimate;April 2016;;2016-04-30;January 2017;2017-01-31;August 2016;Actual;2016-08-31;July 2016;Actual;2016-07-31;;Interventional;TRAINSTIM1;;tDCS Effects on GABA Concentration and Brain Functional Connectivity in Older Adults of Retirement Age;Effects of Transcranial Direct Current Stimulation (tDCS) on GABA Concentration and Brain Functional Connectivity in Older Adults;Completed;;N/A;24;Actual;Charite University, Berlin, Germany;;3;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T09:33:39Z;2020-06-01T09:33:39Z;Berlin;3526297;Principal Investigator;Agnes Flöel, Prof. Dr.;Charite University, Berlin, Germany;tDCS | sham-tDCS;63569151;1;;;2016;2020-05-29;3;FALSE;;FALSE;TRUE;66;;Years;;1;3;
NCT02793557;ClinicalTrials.gov processed this data on May 29, 2020;2016-05-16;;;2017-07-29;2016-06-03;2016-06-08;Estimate;;;;;;;2017-07-29;2017-08-01;Actual;January 2016;;2016-01-31;July 2017;2017-07-31;March 2017;Actual;2017-03-31;March 2017;Actual;2017-03-31;;Interventional;;;Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth;A Randomised, Double-blind, Placebo-controlled Trial of FOL-005 to Investigate Clinical Safety and Effect on Hair Growth in Healthy Volunteers;Completed;;Phase 1/Phase 2;44;Actual;Follicum AB;;5;;;FALSE;;;;FALSE;;;;;;;;;;;Undecided;;2020-06-01T09:33:45Z;2020-06-01T09:33:45Z;Berlin;3526361;Principal Investigator;Ulrike Blume-Peytavi, Professor;Klinik für Dermatologie, Venerologie und Allergologie, Charité-Universitätsmedizin Berlin Charitéplatz 1 - 10117 Berlin;Placebo | FOL-005;63569205;1;;;2016;2020-05-29;14;FALSE;;FALSE;TRUE;18;45;Years;Years;1;3;
NCT02790073;ClinicalTrials.gov processed this data on May 29, 2020;2016-05-25;;;2019-08-27;2016-05-30;2016-06-03;Estimate;;;;;;;2019-08-27;2019-08-28;Actual;May 2016;Actual;2016-05-31;August 2019;2019-08-31;November 15, 2017;Actual;2017-11-15;November 15, 2017;Actual;2017-11-15;;Interventional;;;Phase 2 Study With SNF472 in Calciphylaxis Patients;Phase 2 Open Label Single Arm Repeat Dose Study to Assess the Effect of SNF472 on Wound Healing in Uraemic Calciphylaxis Patients;Completed;;Phase 2;14;Actual;Sanifit Therapeutics S. A.;;1;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T09:34:28Z;2020-06-01T09:34:28Z;Aachen;3526587;Principal Investigator;Vincent Brandenburg;RWTH Aachen University;SNF472;63569470;3;60;22;2016;2020-05-29;17;TRUE;20;TRUE;FALSE;18;;Years;;1;2;
NCT02788448;ClinicalTrials.gov processed this data on May 29, 2020;2016-05-25;;;2018-01-30;2016-05-27;2016-06-02;Estimate;;;;;;;2018-01-30;2018-02-01;Actual;January 2016;Actual;2016-01-31;January 2018;2018-01-31;November 2017;Actual;2017-11-30;March 2017;Actual;2017-03-31;;Interventional;Frontier-III;;Safety and Performance Study of Large Hole Vascular Closure Device;Clinical Investigation Plan (CIP) for Safety and Performance Study of Large Hole Vascular Closure Device - FRONTIER III Study;Completed;;N/A;42;Actual;Vivasure Medical Limited;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T09:34:43Z;2020-06-01T09:34:43Z;Münster;3526698;Principal Investigator;Prof. Dr. med Giovanni Torsello, MD;St Fraziskus Hospital, Muenster, Germany;VIVASURE CLOSURE DEVICE;63569594;3;;;2016;2020-05-29;14;FALSE;;FALSE;FALSE;18;;Years;;1;2;
NCT02787122;ClinicalTrials.gov processed this data on May 29, 2020;2016-03-03;;;2020-03-03;2016-05-25;2016-06-01;Estimate;;;;;;;2020-03-03;2020-03-04;Actual;January 1, 2014;Actual;2014-01-01;March 2020;2020-03-31;December 31, 2017;Actual;2017-12-31;December 31, 2017;Actual;2017-12-31;;Interventional;CBT-E;;Pilot-trial of Emotion-focused Cognitive Behavior Therapy for Patients With Schizophrenia;Comparison of Emotion-focused Cognitive Behavior Therapy for Patients With Schizophrenia With Standard Treatment: Effects on Psychological Parameters and Rehospitalisation;Completed;;N/A;64;Actual;Philipps University Marburg Medical Center;;2;;;FALSE;;;;FALSE;;;;;;;;;;;Undecided;;2020-06-01T09:34:57Z;2020-06-01T09:34:57Z;Hamburg Marburg;3526781;Principal Investigator;Stephanie Mehl, Ph. D.;Philipps University Marburg Medical Center;CBT-E | Treatment as Usual;63569694;2;;;2016;2020-05-29;48;FALSE;;FALSE;FALSE;18;70;Years;Years;1;6;9
NCT02778269;ClinicalTrials.gov processed this data on May 29, 2020;2016-05-09;;;2017-04-06;2016-05-18;2016-05-19;Estimate;;;;;;;2017-04-06;2017-04-07;Actual;June 2016;Actual;2016-06-30;August 2016;2016-08-31;March 2017;Actual;2017-03-31;March 2017;Actual;2017-03-31;;Interventional;HypoArrhythmia;;Predicting Hypoglycaemia and Arrhythmias in the Patient With Diabetes and CKD - Validation Study;Predicting Hypoglycaemia and Arrhythmias in the Vulnerable Patient With Diabetes and Chronic Kidney Disease - Validation Study;Completed;;N/A;7;Actual;RWTH Aachen University;;1;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:36:53Z;2020-06-01T09:36:53Z;Aachen;3527432;Principal Investigator;Nikolaus Marx, Prof. Dr.;Uniklinik RWTH Aachen;12-lead ECG T-shirt | Dexcom G4-System;63570365;1;;;2016;2020-05-29;9;FALSE;;FALSE;TRUE;18;;Years;;4;1;
NCT02775175;ClinicalTrials.gov processed this data on May 29, 2020;2016-05-14;;;2018-04-30;2016-05-14;2016-05-17;Estimate;;;;;;;2018-04-30;2018-05-02;Actual;May 2016;;2016-05-31;April 2018;2018-04-30;October 2016;Actual;2016-10-31;July 2016;Actual;2016-07-31;;Interventional;Ramadan_16;;Influence of a Modified Ramadan Fasting on Health and Well-being in Healthy Muslims - a Randomised Controlled Trial;The Influence of a Modified Ramadan Fasting Regimen on Health and Well-being in Healthy Muslims - a Randomised Controlled Trial;Completed;;N/A;114;Actual;Universität Duisburg-Essen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;Undecided;;2020-06-01T09:37:43Z;2020-06-01T09:37:43Z;Duisburg;3527640;Study Director;Gustav Dobos, MD;Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen;Modified Ramadan Fasting;63570600;1;;;2016;2020-05-29;2;FALSE;;FALSE;TRUE;18;60;Years;Years;1;34;
NCT02775019;ClinicalTrials.gov processed this data on May 29, 2020;2016-05-13;;;2017-05-08;2016-05-13;2016-05-17;Estimate;;;;;;;2017-05-08;2017-05-09;Actual;May 2016;Actual;2016-05-31;May 2017;2017-05-31;August 2016;Actual;2016-08-31;August 2016;Actual;2016-08-31;;Interventional;NAVLAC16;;Health Impact of L.Reuteri Consumption in Crew Members of a Naval Ship at Sea;Impact of the Daily Consumption of L.Reuteri-containing Lozenges on Oral and General Health in Crew Members of a Naval Ship at Sea;Completed;;N/A;72;Actual;Wuerzburg University Hospital;;2;;;FALSE;;;;FALSE;;;;;;;;;;;Undecided;;2020-06-01T09:37:44Z;2020-06-01T09:37:44Z;Würzburg;3527649;Principal Investigator;Ulrich Schlagenhauf, Prof. Dr.;Chairman Dept. of Periodontology, University Hospital Wuerzburg, Germany;Lactobacillus reuteri | Placebo;63570612;1;;;2016;2020-05-29;3;FALSE;;FALSE;TRUE;18;65;Years;Years;1;6;
NCT02772146;ClinicalTrials.gov processed this data on May 29, 2020;2016-05-09;;;2017-03-13;2016-05-11;2016-05-13;Estimate;;;;;;;2017-03-13;2017-03-14;Actual;May 11, 2016;Actual;2016-05-11;February 2017;2017-02-28;January 23, 2017;Actual;2017-01-23;January 23, 2017;Actual;2017-01-23;;Interventional;;;A Clinical Study of the Safety and Efficacy of a Wearable Device (CLS UF) That Delivers Continuous Administration of Glucose to Recirculated Peritoneal Dialysis Fluid for the Purpose of Ultrafiltration in Patients With Congestive Heart Failure;A Clinical Study of the Safety and Efficacy of a Wearable Device (CLS UF) That Delivers Continuous Administration of Glucose to Recirculated Peritoneal Dialysis Fluid for the Purpose of Ultrafiltration in Patients With Congestive Heart Failure;Terminated;;N/A;2;Actual;Triomed AB;;1;;After 2 patients it was concluded that a large change in exclusion criteria and study design~   was needed to obtain the ojective for the study;FALSE;;;;FALSE;;;;;;;;;;;Undecided;The Sponsor may choose to publish or present data from this clinical investigation.;2020-06-01T09:38:15Z;2020-06-01T09:38:15Z;Heidelberg;3527828;Principal Investigator;Christian Morath, PD Dr. Med;Division of Nephrology, Heidelberg University Hospital, Germany;CLS UF;63570830;1;;;2016;2020-05-29;8;FALSE;;FALSE;TRUE;18;80;Years;Years;1;4;
NCT02771535;ClinicalTrials.gov processed this data on May 29, 2020;2016-04-05;;;2017-08-02;2016-05-12;2016-05-13;Estimate;;;;;;;2017-08-02;2017-08-03;Actual;March 2016;;2016-03-31;August 2017;2017-08-31;May 2017;Actual;2017-05-31;May 2017;Actual;2017-05-31;;Interventional;;;Long-term Efficacy of Metacognitive Training for Depression (D-MCT);Long-term Efficacy of Metacognitive Training for Depression (D-MCT): a 3-year Follow up;Completed;;N/A;84;Actual;Universitätsklinikum Hamburg-Eppendorf;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:38:21Z;2020-06-01T09:38:21Z;Hamburg;3527870;Principal Investigator;Lena Jelinek, PD Dr.;Universitätsklinikum Hamburg-Eppendorf;D-MCT | Health Training;63570877;1;;;2016;2020-05-29;14;FALSE;;FALSE;TRUE;18;65;Years;Years;1;7;
NCT02771015;ClinicalTrials.gov processed this data on May 29, 2020;2015-09-08;;;2016-05-10;2016-05-10;2016-05-12;Estimate;;;;;;;2016-05-10;2016-05-12;Estimate;August 2014;;2014-08-31;May 2016;2016-05-31;May 2016;Actual;2016-05-31;December 2015;Actual;2015-12-31;;Interventional;wounddressing;;Performance of Flexible Self-adherent Absorbent Dressing Coated With a Soft Silicone Layer After Hip -,Knee- Arthroplasty,Primary Spine Surgery in Comparison to a Standard Wound Dressing;A Mono-centre, Post CE-mark, Prospective-randomized Clinical Trial to Evaluate the Performance of a Flexible Self-adherent Absorbent Dressing Coated With a Soft Silicone Layer After Hip or Knee Arthroplasty or Primary Spine Surgery in Comparison to a Standard Wound Dressing (Cosmopor E®Steril, Fa. Hartmann);Completed;;N/A;200;Actual;University of Cologne;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T09:38:27Z;2020-06-01T09:38:27Z;Köln;3527905;Principal Investigator;Jan Bredow;University Hospital Cologne;Mepilex Border® | Cosmopor steril®;63570916;1;;;2015;2020-05-29;16;FALSE;;FALSE;TRUE;18;;Years;;1;4;
NCT02764749;ClinicalTrials.gov processed this data on May 29, 2020;2016-05-04;;;2016-11-24;2016-05-05;2016-05-06;Estimate;;;;;;;2016-11-24;2016-11-28;Estimate;June 2016;;2016-06-30;November 2016;2016-11-30;October 2016;Actual;2016-10-31;October 2016;Actual;2016-10-31;;Interventional;;;Cranberry (Poly)Phenol Consumption on Vascular Function;Sustained Effects of Cranberry (Poly)Phenol Consumption on Vascular Function in Healthy Individuals;Completed;;N/A;40;Actual;Heinrich-Heine University, Duesseldorf;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:39:34Z;2020-06-01T09:39:34Z;Düsseldorf;3528364;Principal Investigator;Ana Rodriguez-Mateo, PhD;Division of Cardiology, Pulmonology and Vascular Medicine, University Hospital Duesseldorf;cranberry (poly)phenol containing supplement | Placebo comparator: cranberry (poly)phenol deprived supplement;63571389;1;;;2016;2020-05-29;4;FALSE;;FALSE;TRUE;18;35;Years;Years;1;5;2
NCT02760680;ClinicalTrials.gov processed this data on May 29, 2020;2016-04-20;;;2017-03-15;2016-04-29;2016-05-04;Estimate;;;;;;;2017-03-15;2017-03-16;Actual;March 2015;;2015-03-31;March 2017;2017-03-31;July 2016;Actual;2016-07-31;June 2015;Actual;2015-06-30;;Interventional;;;Validation of the Peripheral Arterial Tone to Detect Sleep-disordered Breathing in Patients With Chronic Heart Failure;Validierung Der Peripher Arteriellen Tonometrie Zur Diagnostik Schlafbezogener Atmungsstörungen Bei Patienten Mit Systolischer Herzinsuffizienz;Completed;;N/A;30;Actual;Heart and Diabetes Center North-Rhine Westfalia;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:40:15Z;2020-06-01T09:40:15Z;Bochum;3528636;Study Director;Thomas Bitter, MD;Herz- und Diabeteszentrum NRW, Ruhr-Universitaet Bochum, Bad Oeynhausen, Germany;WatchPAT 200 (TM) | Polysomnography;63571700;1;;;2016;2020-05-29;3;FALSE;;FALSE;TRUE;18;;Years;;1;31;
NCT02760381;ClinicalTrials.gov processed this data on May 29, 2020;2016-04-23;;;2017-04-08;2016-04-29;2016-05-03;Estimate;;;;;;;2017-04-08;2017-04-11;Actual;May 2016;;2016-05-31;April 2017;2017-04-30;August 2017;Anticipated;2017-08-31;November 2016;Actual;2016-11-30;;Interventional;ATOMIC I;;Acetic Acid for Optical Characterization of Colonic Polyps;Acetic Acid for Optical Characterization of Colonic Polyps: A Feasibility Study;Unknown status;;N/A;55;Anticipated;Technische Universität München;;1;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:40:21Z;2020-06-01T09:40:21Z;Munich;;;;;NBI + Acetic Acid (AA);63571723;1;;;2016;2020-05-29;6;FALSE;;FALSE;TRUE;18;99;Years;Years;1;;
NCT02760316;ClinicalTrials.gov processed this data on May 29, 2020;2016-04-25;;;2017-10-16;2016-04-30;2016-05-03;Estimate;;;;;;;2017-10-16;2017-10-17;Actual;May 2, 2016;Actual;2016-05-02;October 2017;2017-10-31;September 11, 2017;Actual;2017-09-11;September 11, 2017;Actual;2017-09-11;;Interventional;;;A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of AZD9567.;A Phase I, Randomised, Single-blind Study to Asses the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of AZD9567 in Healthy Volunteers Using Prednisolone as Positive Control;Completed;;Phase 1;64;Anticipated;AstraZeneca;;9;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;;;2020-06-01T09:40:23Z;2020-06-01T09:40:23Z;Berlin;3528664;Principal Investigator;Rainard Fuhr, Dr. med.;PAREXEL Early Phase Clinical Unit, Berlin;AZD9567 10 mg | AZD9567 20 mg | AZD9567 40 mg | AZD9567 80 mg | Prednisolone 20 mg | AZD9567 125 mg | AZD9567 155 mg | Prednisolone 5 mg | Prednisolone 40 mg;63571728;2;;;2016;2020-05-29;16;FALSE;;FALSE;FALSE;18;55;Years;Years;5;18;
NCT02755246;ClinicalTrials.gov processed this data on May 29, 2020;2016-04-05;;;2016-12-21;2016-04-26;2016-04-28;Estimate;;;;;;;2016-12-21;2016-12-22;Estimate;April 2016;;2016-04-30;December 2016;2016-12-31;September 2016;Actual;2016-09-30;August 2016;Actual;2016-08-31;;Interventional;preSmartAge;;Polyamine-enriched Diet in Healthy Older Adults With Subjective Cognitive Decline;Effect of Polyamine-enriched Dietary Supplementation on Cognitive Function in Healthy Older Adults With Subjective Cognitive Decline;Completed;;Phase 2;30;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T09:41:20Z;2020-06-01T09:41:20Z;Berlin;3529050;Principal Investigator;Agnes Flöel, Prof. Dr.;Charite University, Berlin, Germany;Polyamine supplementation | Placebo supplementation;63572112;1;;;2016;2020-05-29;4;FALSE;;FALSE;TRUE;60;80;Years;Years;1;2;
NCT02754167;ClinicalTrials.gov processed this data on May 29, 2020;2016-04-14;;;2017-10-19;2016-04-27;2016-04-28;Estimate;;;;;;;2017-10-19;2017-10-20;Actual;June 6, 2016;Actual;2016-06-06;October 2017;2017-10-31;December 31, 2017;Anticipated;2017-12-31;February 6, 2017;Actual;2017-02-06;;Interventional;;;Phase Ib Study to Evaluate PRS-080 in Anemic Chronic Kidney Disease Patients;Phase Ib Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Hepcidin Antagonist PRS-080#022-DP in Anemic Chronic Kidney Disease Patients Undergoing Hemodialysis;Unknown status;;Phase 1/Phase 2;24;Actual;Pieris Pharmaceuticals GmbH;;2;;;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T09:41:30Z;2020-06-01T09:41:30Z;Munich;3529127;Principal Investigator;Lutz Renders, Prof. MD;Technical University, Munich;PRS-080#022-DP | PRS-080-Placebo#001;63572195;2;;;2016;2020-05-29;8;FALSE;;FALSE;FALSE;18;;Years;;1;6;
NCT02752802;ClinicalTrials.gov processed this data on May 29, 2020;2016-04-22;;;2017-01-09;2016-04-22;2016-04-27;Estimate;;;;;;;2017-01-09;2017-02-28;Actual;April 2016;;2016-04-30;January 2017;2017-01-31;May 2016;Actual;2016-05-31;May 2016;Actual;2016-05-31;;Interventional;;;DyeVert System RCT;Single Site Randomized Control Trial Evaluating the DyeVert System;Completed;;N/A;96;Actual;Osprey Medical, Inc;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:41:44Z;2020-06-01T09:41:44Z;Kiel Lübeck;3529212;Principal Investigator;Steffen Desch, MD;University Hospital of Schleswig-Holstein, Lubeck;Diagnostic Coronary Angiogram;63572300;1;10;12;2016;2020-05-29;1;TRUE;5;FALSE;TRUE;18;;Years;;1;2;
NCT02751229;ClinicalTrials.gov processed this data on May 29, 2020;2016-03-24;;;2017-05-08;2016-04-21;2016-04-26;Estimate;;;;;;;2017-05-08;2017-05-09;Actual;May 2016;;2016-05-31;March 2017;2017-03-31;May 2017;Actual;2017-05-31;May 2017;Actual;2017-05-31;;Interventional;;;Honest Open Proud for Adolescents With Mental Illness;Adaptation and Evaluation of the Honest Open Proud Program for Adolescents With Mental Illness;Completed;;Phase 2;100;Anticipated;University of Ulm;;2;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T09:42:04Z;2020-06-01T09:42:04Z;Ulm;3529320;Principal Investigator;Nicolas Rüsch, Professor;Department of Psychiatry II, Section Public Mental Health, Ulm University, Bezirkskrankenhaus Günzburg, Germany;Honest Open Proud (HOP);63572418;5;;;2016;2020-05-29;12;FALSE;;TRUE;FALSE;13;18;Years;Years;2;11;2
NCT02746692;ClinicalTrials.gov processed this data on May 29, 2020;2016-04-18;;;2017-11-28;2016-04-18;2016-04-21;Estimate;;;;;;;2017-11-28;2017-11-30;Actual;July 2016;;2016-07-31;November 2017;2017-11-30;August 2017;Actual;2017-08-31;August 2017;Actual;2017-08-31;;Interventional;Fit15;;Faster Back Home: Efficacy of a High-intensity Endurance Training;Faster Back Home: a Randomized Controlled Equivalence Study on the Efficacy of a High-intensity 15 Minute Aerobic Endurance Training;Completed;;N/A;40;Actual;Goethe University;;2;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T09:42:58Z;2020-06-01T09:42:58Z;Frankfurt;;;;;Fit15 | Endurance;63572767;1;;;2016;2020-05-29;13;FALSE;;FALSE;TRUE;18;65;Years;Years;2;6;
NCT02746198;ClinicalTrials.gov processed this data on May 29, 2020;2016-04-12;;;2016-11-16;2016-04-18;2016-04-21;Estimate;;;;;;;2016-11-16;2016-11-17;Estimate;January 2016;;2016-01-31;November 2016;2016-11-30;January 2017;Anticipated;2017-01-31;December 2016;Anticipated;2016-12-31;;Interventional;;;Clinical Pilot Trial on the Effect of a Probiotic Fermented Drink on Antibiotic-associated Diarrhea (AAD);A Randomized Double-blind Placebo-controlled Clinical Pilot Trial on the Effect of a Probiotic Fermented Drink on Antibiotic-associated Diarrhea (AAD) in Patients With Helicobacter Pylori Eradication Therapy;Unknown status;;N/A;125;Actual;Clinical Research Center Kiel GmbH;;2;;;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T09:43:04Z;2020-06-01T09:43:04Z;Kiel;;;;;probiotic dairy drink | acidified milk;63572807;1;;;2016;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;3;
NCT02745600;ClinicalTrials.gov processed this data on May 29, 2020;2016-03-23;;;2016-04-21;2016-04-16;2016-04-20;Estimate;;;;;;;2016-04-21;2016-04-22;Estimate;February 2016;;2016-02-29;April 2016;2016-04-30;March 2017;Anticipated;2017-03-31;February 2017;Anticipated;2017-02-28;;Interventional;ClinicIMPPACT;;Clinical Intervention Modelling, Planning and Proof for Ablation Cancer Treatment;Clinical Intervention Modelling, Planning and Proof for Ablation Cancer Treatment (ClinicIMPPACT);Unknown status;;N/A;60;Anticipated;University of Leipzig;;1;;;FALSE;;;;TRUE;;;;;;;;;;;Undecided;;2020-06-01T09:43:09Z;2020-06-01T09:43:09Z;Leipzig;3529707;Principal Investigator;Michael Moche, M.D.;Department of Diagnostic and Interventional Radiology, University Leipzig, Leipzig, Germany;RFA therapy simulator;63572850;4;;;2016;2020-05-29;;FALSE;;FALSE;FALSE;18;;Years;;2;3;
NCT02745340;ClinicalTrials.gov processed this data on May 29, 2020;2016-04-15;;;2016-05-03;2016-04-15;2016-04-20;Estimate;;;;;;;2016-05-03;2016-05-04;Estimate;May 2016;;2016-05-31;May 2016;2016-05-31;April 2017;Anticipated;2017-04-30;January 2017;Anticipated;2017-01-31;;Interventional;;;Substitution of Acetate by Citrate in the Bicarbonate Based Hemodialysis;Effect of an Acetate-free Dialysis (Citrate Based) on Parameters of Central Hemodynamics, Dialysis Adequacy, Quality of Life and Immunological Parameters in Chronic Hemodialysis;Unknown status;;N/A;100;Anticipated;Technische Universität München;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T09:43:11Z;2020-06-01T09:43:11Z;Munich;;;;;Acetate by Citrate substitution and vice versa;63572870;2;;;2016;2020-05-29;;FALSE;;FALSE;FALSE;18;;Years;;1;;
NCT02744638;ClinicalTrials.gov processed this data on May 29, 2020;2016-03-31;;;2016-11-16;2016-04-15;2016-04-20;Estimate;;;;;;;2016-11-16;2016-11-17;Estimate;February 2015;;2015-02-28;April 2016;2016-04-30;September 2016;Actual;2016-09-30;August 2016;Actual;2016-08-31;;Interventional;;;Effect of a Yoghurt Containing Four Probiotic Lactobacillus Strains on Bacterial Vaginosis;Double-blind, Randomized, Controlled Trial to Evaluate the Effect of a Yoghurt Containing Four Probiotic Lactobacillus Strains (L. Crispatus, L. Gasseri, L. Rhamnosus, L. Jensenii) on Bacterial Vaginosis (BV) in Adult Women;Completed;;N/A;36;Actual;Clinical Research Center Kiel GmbH;;2;;;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T09:43:21Z;2020-06-01T09:43:21Z;Kiel;3529769;Principal Investigator;Christiane Laue, Dr. med.;CRC Clinical Research Center Kiel;probiotic yoghurt | chemically acidified milk | Arilin;63572924;1;;;2016;2020-05-29;18;FALSE;;FALSE;TRUE;18;;Years;;1;2;
NCT02743988;ClinicalTrials.gov processed this data on May 29, 2020;2016-04-07;;;2016-04-14;2016-04-14;2016-04-19;Estimate;;;;;;;2016-04-14;2016-04-19;Estimate;May 2015;;2015-05-31;April 2016;2016-04-30;September 2017;Anticipated;2017-09-30;April 2017;Anticipated;2017-04-30;;Interventional;;;Influence of Oxygen Target Range on Intermittent Hypoxemia in Preterm Infants;Influence of Oxygen Target Range on Intermittent Hypoxemia in Preterm Infants;Unknown status;;N/A;36;Anticipated;University of Ulm;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:43:25Z;2020-06-01T09:43:25Z;Ulm;;;;;Oxygen;63572972;1;;;2016;2020-05-29;;FALSE;;FALSE;TRUE;;42;;Days;1;7;
NCT02743260;ClinicalTrials.gov processed this data on May 29, 2020;2016-04-11;;;2019-09-06;2016-04-13;2016-04-19;Estimate;;;;;;;2019-09-06;2019-09-10;Actual;April 2016;;2016-04-30;September 2019;2019-09-30;December 2017;Actual;2017-12-31;December 2017;Actual;2017-12-31;;Interventional;;;Drug Transporter Interaction Study PHENTRA_2015_KPUK;Single Centre in Vivo Cocktail Phenotyping Study on OATP1B1, OCT1/2, MATE1/2K, OAT1/3, and P-gp Drug Transporters in Healthy Volunteers;Completed;;Phase 4;24;Actual;University of Cologne;;6;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:43:36Z;2020-06-01T09:43:36Z;Köln;3529860;Principal Investigator;Uwe Fuhr, Prof. Dr.;Department of Pharmacology I, University Hospital Cologne Cologne, NRW, Germany, 50931;pitavastatin | Metformin | digoxin | Adefovir | sitagliptin;63573029;1;;;2016;2020-05-29;20;FALSE;;FALSE;TRUE;18;85;Years;Years;6;;
NCT02741973;ClinicalTrials.gov processed this data on May 29, 2020;2016-03-23;;;2018-02-16;2016-04-13;2016-04-18;Estimate;;;;;;;2018-02-16;2018-02-19;Actual;March 2016;Actual;2016-03-31;February 2018;2018-02-28;December 2016;Actual;2016-12-31;December 2016;Actual;2016-12-31;;Interventional;;;Yoga in School Sports - a Pilot Study in Germany;Yoga in School Sports - a Non-randomized Controlled Pilot Study in Germany;Completed;;N/A;102;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T09:43:51Z;2020-06-01T09:43:51Z;Berlin;;;;;Yoga | School sport;63573126;1;;;2016;2020-05-29;9;FALSE;;FALSE;TRUE;17;27;Years;Years;1;8;2
NCT02739685;ClinicalTrials.gov processed this data on May 29, 2020;2016-04-13;;;2019-09-24;2016-04-13;2016-04-15;Estimate;;;;;;;2019-09-24;2019-09-26;Actual;September 2016;;2016-09-30;September 2019;2019-09-30;January 2017;Actual;2017-01-31;January 2017;Actual;2017-01-31;;Interventional;SCORE-CTO;;Bioresorbable Vascular Scaffolds Versus Stents in Patients With Chronic Total Occlusion;Everolimus-eluting Bioresorbable Vascular Scaffolds Versus Everolimus-eluting Stents in Patients With Chronic Total Occlusion;Terminated;;N/A;17;Actual;University of Luebeck;;2;;Slow enrollment, access to devices;FALSE;;;;FALSE;;;;;;;;;;;Undecided;;2020-06-01T09:44:15Z;2020-06-01T09:44:15Z;Lübeck;;;;;Everolimus-eluting bioresorbable vascular scaffold | Everolimus-eluting stent;63573302;1;;;2016;2020-05-29;4;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT02735187;ClinicalTrials.gov processed this data on May 29, 2020;2016-03-16;;;2019-01-07;2016-04-11;2016-04-12;Estimate;;;;;;;2019-01-07;2019-01-08;Actual;March 2016;;2016-03-31;January 2019;2019-01-31;August 2016;Actual;2016-08-31;August 2016;Actual;2016-08-31;;Interventional;;;Efficacy and Safety of Blue Light (453 nm) Treatment for Mild Psoriasis Vulgaris Over Three Months Compared to Vitamin D.;Monocenter, Randomized, Blinded, Intraindividual Study Evaluating Efficacy and Safety of Blue Light (453 nm) Treatment for Mild Psoriasis Vulgaris Over Three Months Compared to Vitamin D;Completed;;N/A;51;Actual;Philips Electronics Nederland BV;;2;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T09:45:05Z;2020-06-01T09:45:05Z;Aachen;3530446;Principal Investigator;Verena von Felbert, PD Dr.;Universityclinic of the RWTH Aachen;Blue light treatment | Vitamin D;63573643;1;28;6;2016;2020-05-29;5;TRUE;12;FALSE;TRUE;18;74;Years;Years;1;5;5
NCT02734901;ClinicalTrials.gov processed this data on May 29, 2020;2016-03-09;;;2016-10-19;2016-04-11;2016-04-12;Estimate;;;;;;;2016-10-19;2016-10-20;Estimate;March 2016;;2016-03-31;October 2016;2016-10-31;September 2016;Actual;2016-09-30;September 2016;Actual;2016-09-30;;Interventional;;;Effects of Acute Red Raspberry Consumption on Vascular Function in Healthy Individuals;Effects of Acute Red Raspberry Consumption on Vascular Function in Healthy Individuals;Completed;;N/A;10;Actual;Heinrich-Heine University, Duesseldorf;;3;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:45:08Z;2020-06-01T09:45:08Z;Düsseldorf;3530472;Principal Investigator;Ana Rodriguez-Mateos, PhD;Division of Cardiology, Pulmonology and Vascular Medicine, University Hospital Duesseldorf;400 g frozen raspberries | 200 g frozen raspberries | Placebo;63573665;1;;;2016;2020-05-29;6;FALSE;;FALSE;TRUE;18;40;Years;Years;1;4;2
NCT02728466;ClinicalTrials.gov processed this data on May 29, 2020;2016-03-09;;;2016-06-21;2016-03-30;2016-04-05;Estimate;;;;;;;2016-06-21;2016-06-22;Estimate;October 2014;;2014-10-31;June 2016;2016-06-30;May 2016;Actual;2016-05-31;May 2016;Actual;2016-05-31;;Interventional;;;Effects of Cocoa Procyanidins on Vascular Function;Investigation on the Effects of Cocoa Procyanidins on Vascular Function in Healthy Individuals;Completed;;N/A;45;Actual;Heinrich-Heine University, Duesseldorf;;3;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:46:52Z;2020-06-01T09:46:52Z;Düsseldorf;3530912;Principal Investigator;Christian Heiß, MD;Division of Cardiology, Pulmonology and Vascular Medicine, University Hospital Duesseldorf;Flavanol and procyanidin supplement | Procyanidin-containing supplement | control supplement deprived of flavanols and procyanidins;63574157;1;;;2016;2020-05-29;19;FALSE;;FALSE;TRUE;18;35;Years;Years;1;3;6
NCT02728453;ClinicalTrials.gov processed this data on May 29, 2020;2016-03-24;;;2019-03-20;2016-03-30;2016-04-05;Estimate;;;;;;;2019-03-20;2019-03-22;Actual;April 27, 2016;Actual;2016-04-27;June 2018;2018-06-30;September 27, 2017;Actual;2017-09-27;September 25, 2017;Actual;2017-09-25;;Interventional;EMPATROPHY;;SGLT2 Inhibition and Left Ventricular Mass;SGLT2 Inhibition With Empagliflozin in Patients With Type 2 Diabetes Mellitus: Influences on Left Ventricular Mass, Function, and Cardiac Lipid Content;Terminated;;Phase 4;7;Actual;Hannover Medical School;;2;;Insufficient recruitment.;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:46:52Z;2020-06-01T09:46:52Z;Hannover;3530914;Principal Investigator;Jens Jordan, Prof. Dr.;Hannover Medical School;Empagliflozin | Glimepiride;63574158;1;;;2016;2020-05-29;17;FALSE;;FALSE;TRUE;40;79;Years;Years;1;12;5
NCT02727556;ClinicalTrials.gov processed this data on May 29, 2020;2016-03-21;;;2017-04-05;2016-04-01;2016-04-04;Estimate;;;;;;;2017-04-05;2017-04-06;Actual;March 2016;;2016-03-31;April 2017;2017-04-30;April 2017;Actual;2017-04-30;April 2017;Actual;2017-04-30;;Interventional;;;Physiological Response and Visual Attention to Visual Food Images in Healthy Subjects and in Functional Dyspepsia Patients;;Completed;;N/A;30;Anticipated;University Hospital Tuebingen;;2;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T09:47:02Z;2020-06-01T09:47:02Z;Tübingen;3530968;Principal Investigator;Paul Enck, Prof;Psychosomatic Medicine and Psychotherapy Department, University of Tübingen, Tübingen, Germany;visual images;63574227;1;;;2016;2020-05-29;13;FALSE;;FALSE;TRUE;18;65;Years;Years;4;5;
NCT02727452;ClinicalTrials.gov processed this data on May 29, 2020;2015-10-12;;;2016-03-29;2016-03-29;2016-04-04;Estimate;;;;;;;2016-03-29;2016-04-04;Estimate;March 2016;;2016-03-31;March 2016;2016-03-31;December 2017;Anticipated;2017-12-31;November 2017;Anticipated;2017-11-30;;Interventional;;;Immediate Bonding and Caesarean Section;Effects of Immediate Bonding (Skin-to-skin Contact) During Caesarean Section- Psychobiological and Somatic Outcomes of Mother and Child;Unknown status;;N/A;360;Anticipated;Johann Wolfgang Goethe University Hospital;;3;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T09:47:02Z;2020-06-01T09:47:02Z;Frankfurt;3530975;Study Director;Frank Louwen, Prof.;University Hospital Frankfurt-Dept. Obstetrics and Perinatal Medicine;Skin-to-skin contact;63574235;1;;;2015;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;6;
NCT02727140;ClinicalTrials.gov processed this data on May 29, 2020;2016-03-23;;;2017-05-02;2016-04-01;2016-04-04;Estimate;;;;;;;2017-05-02;2017-05-03;Actual;May 2016;Actual;2016-05-31;May 2017;2017-05-31;April 2017;Actual;2017-04-30;January 2017;Actual;2017-01-31;;Interventional;;;Yoga as a Supportive Therapy for Patients With Hypertension;Yoga as a Supportive Therapy for Patients With Hypertension: A Randomized Controlled Trial;Completed;;N/A;75;Actual;Universität Duisburg-Essen;;3;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:47:05Z;2020-06-01T09:47:05Z;Duisburg;;;;;Yoga with Asana (yoga postures) | Yoga without Asana (yoga postures);63574259;1;;;2016;2020-05-29;8;FALSE;;FALSE;TRUE;18;75;Years;Years;1;13;
NCT02726048;ClinicalTrials.gov processed this data on May 29, 2020;2016-03-29;;;2018-07-31;2016-03-29;2016-04-01;Estimate;;;;;;;2018-07-31;2018-08-02;Actual;April 2016;;2016-04-30;July 2018;2018-07-31;July 2017;Actual;2017-07-31;July 2017;Actual;2017-07-31;;Interventional;;;Simplus and Eson Non-Invasive Ventilation (NIV) Evaluation - Germany;Simplus and Eson Non-Invasive Ventilation (NIV) Evaluation - Germany;Terminated;;N/A;4;Actual;Fisher and Paykel Healthcare;;1;;Fisher & Paykel Healthcare placed an administrative hold on the Simplus and Eson Non-Invasive~   Ventilation Evaluation study being conducted at Charite, Berlin;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T09:47:14Z;2020-06-01T09:47:14Z;Berlin;3531076;Principal Investigator;Ingo Fietze, Professor;Charite University, Berlin, Germany;Simplus/Eson;63574340;1;;;2016;2020-05-29;15;FALSE;;FALSE;TRUE;18;;Years;;1;3;
NCT02724592;ClinicalTrials.gov processed this data on May 29, 2020;2016-03-07;;;2016-03-24;2016-03-24;2016-03-31;Estimate;;;;;;;2016-03-24;2016-03-31;Estimate;February 2013;;2013-02-28;March 2016;2016-03-31;October 2014;Actual;2014-10-31;April 2014;Actual;2014-04-30;;Interventional;;;Self Assembling Peptide P11-4 in Patients With Early Occlusal Carious Lesions;Effect of Self Assembling Peptide P11-4 in Patients With Early Occlusal Carious Lesions: A Mono-centre, Controlled, Single-blinded, Randomised Study;Completed;;Phase 2;70;Actual;University Medicine Greifswald;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:47:27Z;2020-06-01T09:47:27Z;Berlin Greifswald;3531183;Principal Investigator;Mohammad Alkilzy, Dr. PhD;Humboldt-Universität zu Berlin;self assembling peptide P11-4 (Curodont™ Repair) | fluoride varnish (Duraphat®);63574448;;;;2016;2020-05-29;14;FALSE;;;FALSE;5;;Years;;1;3;
NCT02722759;ClinicalTrials.gov processed this data on May 29, 2020;2016-03-10;;;2020-02-21;2016-03-23;2016-03-30;Estimate;;;;;;;2020-02-21;2020-02-25;Actual;March 2016;Actual;2016-03-31;February 2020;2020-02-29;October 2016;Actual;2016-10-31;September 2016;Actual;2016-09-30;;Interventional;;;Haemoglobin Measurement for Babies;Comparison of Alternative Non-invasive and Invasive Methods of Haemoglobin Measuring With the Gold Standard in Preterm and Term Neonates;Completed;;N/A;41;Actual;Johannes Gutenberg University Mainz;;1;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:47:46Z;2020-06-01T09:47:46Z;Mainz;;;;;hemoglobin measurement;63574589;1;;;2016;2020-05-29;6;FALSE;;FALSE;TRUE;;4;;Weeks;1;6;
NCT02721849;ClinicalTrials.gov processed this data on May 29, 2020;2016-03-17;;;2017-07-24;2016-03-22;2016-03-29;Estimate;;;;;;;2017-07-24;2017-07-26;Actual;April 2016;Actual;2016-04-30;July 2017;2017-07-31;July 2017;Actual;2017-07-31;March 2017;Actual;2017-03-31;;Interventional;;;Yoga for Chronic Headache in Adolescents;Randomisierte Kontrollierte Studie Zur Wirkung Von Yoga Bei Chronischen Kopfschmerzen im Jugendalter;Completed;;N/A;45;Actual;Universität Duisburg-Essen;;4;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:47:55Z;2020-06-01T09:47:55Z;Duisburg;;;;;Yoga for adolescents | Yoga for parents;63574659;2;;;2016;2020-05-29;11;FALSE;;FALSE;FALSE;12;16;Years;Years;1;29;
NCT02721836;ClinicalTrials.gov processed this data on May 29, 2020;2016-03-17;;;2017-05-23;2016-03-22;2016-03-29;Estimate;;;;;;;2017-05-23;2017-05-24;Actual;April 2016;;2016-04-30;May 2017;2017-05-31;May 2017;Actual;2017-05-31;December 2016;Actual;2016-12-31;;Interventional;;;Yoga for Patients With Irritable Bowel Syndrome;Randomized Controlled Trial on Yoga for Irritable Bowel Syndrome;Completed;;N/A;59;Actual;Universität Duisburg-Essen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:47:55Z;2020-06-01T09:47:55Z;Duisburg;;;;;Yoga | Nutrition Counselling;63574660;1;;;2016;2020-05-29;8;FALSE;;FALSE;TRUE;18;75;Years;Years;1;14;
NCT02720952;ClinicalTrials.gov processed this data on May 29, 2020;2016-03-16;;;2017-04-11;2016-03-25;2016-03-28;Estimate;;;;;;;2017-04-11;2017-05-19;Actual;March 2015;;2015-03-31;April 2017;2017-04-30;July 2016;Actual;2016-07-31;July 2016;Actual;2016-07-31;;Interventional;;;Treatment of Adrenal Insufficiency in Children;A Phase 3 Open-label Study of Infacort® in Neonates, Infants and Children Less Than 6 Years of Age With Adrenal Insufficiency;Completed;;Phase 3;24;Actual;Diurnal Limited;;1;;;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T09:48:02Z;2020-06-01T09:48:02Z;Berlin;3531418;Principal Investigator;Susanna Wiegand, MD;Charité-Universitätsmedizin Berlin, CVK;Infacort®;63574728;1;18;0;2016;2020-05-29;16;TRUE;7;FALSE;TRUE;;6;;Years;1;3;
NCT02716389;ClinicalTrials.gov processed this data on May 29, 2020;2016-03-04;;;2016-04-18;2016-03-17;2016-03-23;Estimate;;;;;;;2016-04-18;2016-04-19;Estimate;March 2016;;2016-03-31;April 2016;2016-04-30;April 2016;Actual;2016-04-30;April 2016;Actual;2016-04-30;;Interventional;;;Cervical Kinematics' Reliability: Zero Positioning Using a 3-D-bulls Eye Spirit Level;;Completed;;N/A;20;Actual;Goethe University;;2;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T09:49:00Z;2020-06-01T09:49:00Z;Frankfurt;;;;;Zebris CMS 70 | 3-D Bulls Eye Spirit Meter;63575071;1;;;2016;2020-05-29;1;FALSE;;FALSE;TRUE;18;65;Years;Years;1;2;
NCT02712372;ClinicalTrials.gov processed this data on May 29, 2020;2016-03-15;;;2017-01-05;2016-03-15;2016-03-18;Estimate;;;;;;;2017-01-05;2017-01-06;Estimate;June 2016;;2016-06-30;January 2017;2017-01-31;October 2016;Actual;2016-10-31;October 2016;Actual;2016-10-31;;Interventional;;;A Study to Assess the Safety and Tolerability of Single and Multiple Doses of AZD4831 in Healthy Male Subjects;A Phase I, Randomised, Single-Blind, Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD4831 After Single and Multiple Ascending Dose Administration to Healthy Male Subjects;Terminated;;Phase 1;104;Actual;AstraZeneca;;10;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T09:49:41Z;2020-06-01T09:49:41Z;Berlin;3532017;Principal Investigator;Rainard Fuhr, Dr. med.;PAREXEL Early Phase Clinical Unit Berlin, On the premises of Klinikum Westend, Haus 31, Spandauer Damm 130, 14050 Berlin, Germany;AZD4831 | AZD4831 placebo;63575378;;;;2016;2020-05-29;4;FALSE;;;FALSE;18;50;Years;Years;13;22;
NCT02710617;ClinicalTrials.gov processed this data on May 29, 2020;2016-03-11;;;2016-08-30;2016-03-11;2016-03-17;Estimate;;;;;;;2016-08-30;2016-08-31;Estimate;March 2016;;2016-03-31;August 2016;2016-08-31;May 2016;Actual;2016-05-31;April 2016;Actual;2016-04-30;;Interventional;;;System Accuracy Evaluation of 2 CE-marked Blood Glucose Monitoring System;;Completed;;N/A;109;Actual;Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm;;;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T09:50:03Z;2020-06-01T09:50:03Z;Ulm;;;;;Blood glucose monitoring systems for point-of-care-testing;63575511;1;;;2016;2020-05-29;1;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT02705456;ClinicalTrials.gov processed this data on May 29, 2020;2016-02-25;;;2017-05-08;2016-03-04;2016-03-10;Estimate;;;;;;;2017-05-08;2017-05-09;Actual;October 2014;;2014-10-31;May 2017;2017-05-31;December 2016;Actual;2016-12-31;August 2016;Actual;2016-08-31;;Interventional;ECOP;;Enamel Caries in Orthodontic Patients;Enamel Caries in Orthodontic Patients;Completed;;N/A;150;Actual;Wuerzburg University Hospital;;2;;;FALSE;;;;TRUE;;;;;;;;;;;Undecided;;2020-06-01T09:51:13Z;2020-06-01T09:51:13Z;Würzburg;3532477;Principal Investigator;Ulrich Schlagenhauf, Prof. Dr.;Wuerzburg University Hospital;Tooth Brushing HA | Tooth Brushing FL;63575904;1;;;2016;2020-05-29;22;FALSE;;FALSE;TRUE;12;25;Years;Years;1;3;
NCT02705027;ClinicalTrials.gov processed this data on May 29, 2020;2016-02-18;;;2016-03-05;2016-03-05;2016-03-10;Estimate;;;;;;;2016-03-05;2016-03-10;Estimate;August 2012;;2012-08-31;February 2016;2016-02-29;August 2016;Anticipated;2016-08-31;July 2016;Anticipated;2016-07-31;;Interventional;;;Comparison of Two Endoscopically Placed Nasojejunal Probes;Randomized, Controlled Comparison of Two Endoscopically Placed Nasojejunal Probes in Critically Ill Patients in Terms of Application Time and Technical Success;Unknown status;;N/A;64;Anticipated;Ruhr University of Bochum;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:51:16Z;2020-06-01T09:51:16Z;Bochum;;;;;Freka®-Trilumina versus Freka®-EasyIn;63575937;2;;;2016;2020-05-29;;FALSE;;FALSE;FALSE;18;90;Years;Years;1;;
NCT02703870;ClinicalTrials.gov processed this data on May 29, 2020;2015-09-18;;;2016-03-03;2016-03-03;2016-03-09;Estimate;;;;;;;2016-03-03;2016-03-09;Estimate;March 2013;;2013-03-31;March 2016;2016-03-31;December 2015;Actual;2015-12-31;December 2015;Actual;2015-12-31;;Interventional;;;Combined tDCS and Vision Restoration Training in Post-acute Stroke: an Exploratory Efficacy and Safety Study;Combined tDCS and Vision Restoration Training in Post-acute Stroke: an Exploratory Efficacy and Safety Study;Completed;;Phase 1/Phase 2;19;Actual;University of Magdeburg;;3;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:51:27Z;2020-06-01T09:51:27Z;Magdeburg;;;;;verum tDCS | sham tDCS | VRT;63576026;2;;;2015;2020-05-29;33;FALSE;;FALSE;FALSE;18;80;Years;Years;1;5;
NCT02703519;ClinicalTrials.gov processed this data on May 29, 2020;2016-03-06;;;2016-09-08;2016-03-06;2016-03-09;Estimate;;;;;;;2016-09-08;2016-09-09;Estimate;November 2014;;2014-11-30;September 2016;2016-09-30;August 2016;Actual;2016-08-31;August 2016;Actual;2016-08-31;;Interventional;OPSTAR;;Optimization of the Healing Process of the Uterine Scar Tissue After Re-cesarean Section;Optimierung Der Uterotomie-Wundheilung Nach Re-Sectio Caesarea;Completed;;N/A;116;Actual;Martin-Luther-Universität Halle-Wittenberg;;3;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:51:30Z;2020-06-01T09:51:30Z;Halle Magdeburg;3532645;Principal Investigator;Gregor Seliger, Dr. med.;Maternity Clinic/Perinatal Treatment Center, Halle University Hospital, Martin-Luther-Universität Halle-Wittenberg;resection of uterine scar tissue;63576053;2;;;2016;2020-05-29;21;FALSE;;FALSE;FALSE;18;;Years;;1;1;
NCT02701933;ClinicalTrials.gov processed this data on May 29, 2020;2016-02-17;;;2016-03-02;2016-03-02;2016-03-08;Estimate;;;;;;;2016-03-02;2016-03-08;Estimate;April 2014;;2014-04-30;March 2016;2016-03-31;December 2014;Actual;2014-12-31;December 2014;Actual;2014-12-31;;Interventional;;;Effects of Ketamine on Eye Movements, Perception and Brain Function;Effects of Ketamine on Eye Movements, Perception and Brain Function;Completed;;N/A;24;Actual;University of Bonn;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:51:48Z;2020-06-01T09:51:48Z;Bonn;3532766;Principal Investigator;Ulrich Ettinger, PhD;Department of Psychology, University of Bonn;Ketamine | Saline;63576173;1;;;2016;2020-05-29;8;FALSE;;FALSE;TRUE;18;45;Years;Years;1;18;
NCT02699034;ClinicalTrials.gov processed this data on May 29, 2020;2016-02-19;;;2018-02-05;2016-02-29;2016-03-04;Estimate;;;;;;;2018-02-05;2018-02-06;Actual;March 2016;;2016-03-31;February 2018;2018-02-28;October 5, 2016;Actual;2016-10-05;June 5, 2016;Actual;2016-06-05;;Interventional;;;Cardiovascular Magnetic Resonance-Guided Radiofrequency-Ablation for Atrial Flutter;Cardiovascular Magnetic Resonance-Guided Radiofrequency-Ablation for Atrial Flutter: Evaluation of a Tailored Interventional Guidance and Tracking System;Terminated;;N/A;5;Actual;University of Leipzig;;1;;Recommendation by BfArM after interim analysis;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:52:38Z;2020-06-01T09:52:38Z;Leipzig;3532977;Principal Investigator;Gerhard Hindricks, MD;Heart Center Leipzig;ablation for typical atrial flutter | Vision-MR ablation catheter;63576394;1;;;2016;2020-05-29;2;FALSE;;FALSE;TRUE;18;75;Years;Years;2;;
NCT02695940;ClinicalTrials.gov processed this data on May 29, 2020;2016-02-18;;;2018-11-14;2016-03-01;2016-03-02;Estimate;;;;;;;2018-11-14;2018-11-15;Actual;March 2016;;2016-03-31;May 2017;2017-05-31;September 2016;Actual;2016-09-30;September 2016;Actual;2016-09-30;;Interventional;;;Trial Twice Daily Application of LEO 124249 Ointment 30 mg/g in Treatment of Mild to Moderate Inverse Psoriasis;A Phase 2a, Proof of Concept Trial, Testing Twice Daily Application of LEO 124249 Ointment 30 mg/g in the Treatment of Mild to Moderate Inverse Psoriasis;Completed;;Phase 2;69;Actual;LEO Pharma;;2;;;FALSE;;;;FALSE;;;;;;;;;;;Undecided;;2020-06-01T09:53:18Z;2020-06-01T09:53:18Z;Münster;3533210;Principal Investigator;Thomas Luger, MD;Universitätsklinikum Münster, Klinik fur Hautkrankheiten;LEO 124249 ointment 30 mg/g | LEO 124249 ointment vehicle;63576630;1;;;2016;2020-05-29;6;FALSE;;FALSE;TRUE;18;75;Years;Years;1;14;
NCT02694926;ClinicalTrials.gov processed this data on May 29, 2020;2016-02-08;;;2018-01-18;2016-02-24;2016-03-01;Estimate;;;;;;;2018-01-18;2018-01-23;Actual;December 2014;;2014-12-31;December 2017;2017-12-31;December 2017;Actual;2017-12-31;November 2017;Actual;2017-11-30;;Interventional;;;National Education Programme for Patients With Chronic Adrenal Insufficiency;National (German-wide) Education Programme for Patients With Chronic Adrenal Insufficiency;Completed;;N/A;528;Actual;Wuerzburg University Hospital;;1;;;FALSE;;;;FALSE;;;;;;;;;;;Yes;publication of collected data in medical journals and specialist congresses;2020-06-01T09:53:51Z;2020-06-01T09:53:51Z;Würzburg;3533274;Principal Investigator;Stefanie Hahner, MD, Prof.;University Hospital Wuerzburg;Education;63576705;1;;;2016;2020-05-29;35;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT02694588;ClinicalTrials.gov processed this data on May 29, 2020;2015-12-04;;;2016-06-17;2016-02-23;2016-02-29;Estimate;;;;;;;2016-06-17;2016-06-20;Estimate;June 2014;;2014-06-30;June 2016;2016-06-30;December 2016;Anticipated;2016-12-31;October 2016;Anticipated;2016-10-31;;Interventional;Phen_IBD;;Clinical and Molecular Phenotyping in IBD;Systematic Profiling of Anti-inflammatory Drugs for the Detection of Drug- Specific Response Signatures in the Treatment of Chronic Inflammatory Disorders;Unknown status;;N/A;60;Anticipated;University of Schleswig-Holstein;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T09:53:55Z;2020-06-01T09:53:55Z;Kiel Lübeck;;;;;Infliximab | Vedolizumab;63576730;1;;;2015;2020-05-29;;FALSE;;FALSE;TRUE;18;80;Years;Years;1;;
NCT02690909;ClinicalTrials.gov processed this data on May 29, 2020;2016-02-19;;;2016-05-10;2016-02-19;2016-02-24;Estimate;;;;;;;2016-05-10;2016-05-11;Estimate;April 2016;;2016-04-30;May 2016;2016-05-31;August 2017;Anticipated;2017-08-31;April 2017;Anticipated;2017-04-30;;Interventional;;;A Study to Evaluate Safety and Efficacy of the Redy™ Renal Denervation System in the Treatment of Patients With Uncontrolled Hypertension;A Prospective, Post-marketing, Single-arm, Open Label, Multi-center Clinical Study to Evaluate the Safety and Efficacy of the ReDy™ Renal Denervation System in the Treatment of Patients With Uncontrolled Hypertension;Unknown status;;N/A;55;Anticipated;Renal Dynamics GmbH;;1;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:55:34Z;2020-06-01T09:55:34Z;Homburg;3533592;Principal Investigator;Felix Mahfoud, MD;Saarland University Medical Center Homburg, Germany;Redy™ Renal Denervation System;63577013;10;;;2016;2020-05-29;;FALSE;;FALSE;FALSE;18;75;Years;Years;1;6;
NCT02689960;ClinicalTrials.gov processed this data on May 29, 2020;2016-02-08;;;2017-06-19;2016-02-18;2016-02-24;Estimate;;;;;;;2017-06-19;2017-06-20;Actual;January 2017;Actual;2017-01-31;May 2017;2017-05-31;June 1, 2017;Actual;2017-06-01;April 2017;Actual;2017-04-30;;Interventional;Vapreda;;Vaginal Prednisone Administration for Prevention of Adrenal Crisis;Vaginal Prednisone Administration for Prevention of Adrenal Crisis - a Bioequivalence Study;Completed;;Phase 2;12;Actual;Wuerzburg University Hospital;;2;;;FALSE;;;;TRUE;;;;;;;;;;;Yes;;2020-06-01T09:55:46Z;2020-06-01T09:55:46Z;Würzburg;3533667;Principal Investigator;Stefanie Hahner, MD, Prof.;University Hospital Wuerzburg;100mg prednisone suppository;63577086;;;;2016;2020-05-29;2;FALSE;;;FALSE;18;;Years;;1;3;
NCT02685696;ClinicalTrials.gov processed this data on May 29, 2020;2016-02-08;;;2016-02-14;2016-02-14;2016-02-19;Estimate;;;;;;;2016-02-14;2016-02-19;Estimate;October 2013;;2013-10-31;February 2016;2016-02-29;February 2016;Actual;2016-02-29;February 2016;Actual;2016-02-29;;Interventional;;;Surgical Site Infection in Caesarean Section Using Alexis O Compared to Metal Retractors;To Investigate the Incidence of Surgical Site Infection in Low Risk Women Having a First Time Planned Caesarean Section Using the Alexis O Retractor and the Traditional Metal Retractor;Completed;;N/A;200;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:56:49Z;2020-06-01T09:56:49Z;Berlin;3533978;Principal Investigator;Larry Hinkson, MBBS,MRCOG;Charité University Hospital;Alexis O Retractor | Metal Retractor;63577407;;;;2016;2020-05-29;28;FALSE;;;FALSE;;;;;1;24;
NCT02684656;ClinicalTrials.gov processed this data on May 29, 2020;2016-02-09;;;2019-12-20;2016-02-12;2016-02-18;Estimate;;;;;;;2019-12-20;2019-12-24;Actual;February 2016;Actual;2016-02-29;December 2019;2019-12-31;September 2016;Actual;2016-09-30;September 2016;Actual;2016-09-30;;Interventional;;;Reduction of Oxalate and Inflammation by Hemodiafiltration vs. Hemodialysis;Pilot Study of Lowering Plasma Oxalate With Hemodiafiltration to Reduce Systemic Inflammation in Patients With End-Stage Renal Disease (ESRD);Completed;;N/A;14;Actual;University of Erlangen-Nürnberg Medical School;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:57:21Z;2020-06-01T09:57:21Z;Erlangen;3534055;Principal Investigator;Felix Knauf, MD;University Erlangen-Nuremberg, Germany;Hemodialysis | Hemodiafiltration;63577487;1;;;2016;2020-05-29;7;FALSE;;FALSE;TRUE;;;;;1;1;
NCT02682758;ClinicalTrials.gov processed this data on May 29, 2020;2016-02-04;;;2017-01-23;2016-02-10;2016-02-15;Estimate;;;;;;;2017-01-23;2017-01-24;Estimate;February 2016;;2016-02-29;January 2017;2017-01-31;March 2016;Actual;2016-03-31;March 2016;Actual;2016-03-31;;Interventional;;;Influence of Xenon Anaesthesia on Transpulmonary Pressure and Tidal Volume Distribution;Influence of Xenon Anaesthesia on Transpulmonary Pressure and Tidal Volume Distribution;Completed;;Phase 4;20;Actual;Heinrich-Heine University, Duesseldorf;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T09:57:49Z;2020-06-01T09:57:49Z;Düsseldorf;3534208;Principal Investigator;Peter Kienbaum, MD;Klinik für Anästhesiologie, Universitätsklinikum Düsseldorf, Germany;Xenon;63577632;1;;;2016;2020-05-29;1;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT02679833;ClinicalTrials.gov processed this data on May 29, 2020;2016-02-08;;;2018-05-07;2016-02-09;2016-02-10;Estimate;;;;;;;2018-05-07;2018-05-11;Actual;November 2014;;2014-11-30;May 2018;2018-05-31;December 2015;Actual;2015-12-31;December 2015;Actual;2015-12-31;;Interventional;;;Effect of Toothpaste Fortified With Cyanocobalamin on Vitamin B12 Status;Effect of Toothpaste Fortified With Cyanocobalamin on Vitamin B12 Status: A 3 Month Placebo Controlled Randomized Study;Completed;;N/A;180;Actual;Saarland University;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;Data sharing only between the two responsible study centers in a coded form, where participant ID is not shared.;2020-06-01T09:58:16Z;2020-06-01T09:58:16Z;Giessen Homburg;3534420;Study Chair;Markus Keller, PhD;Institute of Alternative and Sustainable Nutrition, Giessen, Germany;Placebo | Cyanocobalamin;63577844;2;;;2016;2020-05-29;13;FALSE;;FALSE;FALSE;18;75;Years;Years;4;;
NCT02679677;ClinicalTrials.gov processed this data on May 29, 2020;2016-01-18;;;2016-02-07;2016-02-07;2016-02-10;Estimate;;;;;;;2016-02-07;2016-02-10;Estimate;April 2015;;2015-04-30;February 2016;2016-02-29;July 2016;Anticipated;2016-07-31;July 2016;Anticipated;2016-07-31;;Interventional;;;Evaluation of the Effects of Whole Body Vibration on the Lung Function of Patients With Stable COPD;Evaluation of the Effects of Whole Body Vibration Training With the Galileo Training Device on the Lung Function of Patients With Stable COPD;Unknown status;;N/A;40;Anticipated;Heidelberg University;;2;;;FALSE;;;;FALSE;;;;;;;;;;;Yes;;2020-06-01T09:58:19Z;2020-06-01T09:58:19Z;Heidelberg;;;;;Whole Body Vibration;63577866;2;;;2016;2020-05-29;;FALSE;;FALSE;FALSE;18;;Years;;1;10;
NCT02677129;ClinicalTrials.gov processed this data on May 29, 2020;2016-02-02;;;2017-04-11;2016-02-04;2016-02-09;Estimate;;;;;;;2017-04-11;2017-04-12;Actual;August 2014;Actual;2014-08-31;April 2017;2017-04-30;November 2016;Actual;2016-11-30;September 2016;Actual;2016-09-30;;Interventional;;;Physical Function and Activities of Daily Living in Cancer Patients During Chemotherapy;Physical Function and Activities of Daily Living in Cancer Patients During Chemotherapy;Completed;;N/A;44;Actual;Goethe University;;2;;;FALSE;;;;TRUE;;;;;;;;;;;No;Only pseudonymised data without the plan to share;2020-06-01T09:58:55Z;2020-06-01T09:58:55Z;Frankfurt;3534593;Principal Investigator;Winfried Banzer, Prof.;Department of Sports Medicine, Goethe University Frankfurt;home-based exercise intervention;63578058;1;;;2016;2020-05-29;25;FALSE;;FALSE;TRUE;50;;Years;;1;16;
NCT02675816;ClinicalTrials.gov processed this data on May 29, 2020;2016-01-28;;;2016-08-10;2016-02-04;2016-02-05;Estimate;;;;;;;2016-08-10;2016-08-11;Estimate;August 2015;;2015-08-31;August 2016;2016-08-31;July 2016;Actual;2016-07-31;July 2016;Actual;2016-07-31;;Interventional;RCT;;Inspire® Upper Airway Stimulation System;Inspire® Upper Airway Stimulation System: Randomized Control Trial / European Post-Market Study;Terminated;;Phase 4;16;Actual;Inspire Medical Systems, Inc.;;1;;Study halted due to low recruitment. Reimbursement changes require a larger study with~   additional centers and therefore, a new study planned as replacement.;FALSE;;;;FALSE;;;;;;;;;;;Yes;;2020-06-01T09:59:17Z;2020-06-01T09:59:17Z;Mannheim Munich;3534685;Principal Investigator;Clemens Heiser, Dr. med.;Klinikum rechts der Isar der Technischen Universität München;Inspire® Upper Airway Stimulation (UAS) System;63578157;4;;;2016;2020-05-29;11;FALSE;;FALSE;FALSE;21;;Years;;1;4;
NCT02675660;ClinicalTrials.gov processed this data on May 29, 2020;2016-01-13;;;2016-09-06;2016-02-02;2016-02-05;Estimate;;;;;;;2016-09-06;2016-09-08;Estimate;April 2014;;2014-04-30;September 2016;2016-09-30;January 2016;Actual;2016-01-31;April 2015;Actual;2015-04-30;;Interventional;;;Single and Multiple Doses of an Oral Formulation of L-Homoarginine in Healthy Human Subjects;Study to Evaluate the Safety, Tolerability, Kinetics, and Dynamics of Single and Multiple Doses of an Oral Formulation of L-Homoarginine;Completed;;Phase 1;20;Actual;Universitätsklinikum Hamburg-Eppendorf;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T09:59:20Z;2020-06-01T09:59:20Z;Hamburg;;;;;L-Homoarginine | Placebo;63578169;;;;2016;2020-05-29;12;FALSE;;;FALSE;20;75;Years;Years;1;2;
NCT02672553;ClinicalTrials.gov processed this data on May 29, 2020;2015-11-06;;;2018-08-13;2016-01-29;2016-02-03;Estimate;;;;;;;2018-08-13;2019-01-28;Actual;May 2012;;2012-05-31;August 2018;2018-08-31;August 2015;Actual;2015-08-31;March 2015;Actual;2015-03-31;;Interventional;CADENCE-MIS;;EDWARDS INTUITY Valve System CADENCE-MIS Study;A Randomized Comparison of the EDWARDS INTUITY Valve System anD commErcially Available Aortic Bioprostheses in Subjects uNdergoing surgiCal Aortic Valve Replacement Using Minimally InvaSive Techniques;Completed;;N/A;100;Actual;Edwards Lifesciences;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;As of this date no IPD plan has been formulated.;2020-06-01T09:59:52Z;2020-06-01T09:59:52Z;Leipzig;3534916;Principal Investigator;Prof. Borger, MD;Leipzig Heart Center;EDWARDS INTUITY Valve System, Model 8300A | Stented Aortic Bioprostheses;63578405;1;152;190;2015;2020-05-29;34;TRUE;41;FALSE;TRUE;18;;Years;;2;26;
NCT02671929;ClinicalTrials.gov processed this data on May 29, 2020;2016-01-15;;;2017-10-27;2016-01-29;2016-02-02;Estimate;;;;;;;2017-10-27;2017-10-30;Actual;September 2015;;2015-09-30;October 2017;2017-10-31;July 2016;Actual;2016-07-31;May 2016;Actual;2016-05-31;;Interventional;KEN;;Translation and Development of an Online Self-help Intervention With Subsequent Feasibility Study;Translation and Development of an Online Self-help Intervention With Subsequent Feasibility Study as an After Care After Inpatient Psychosomatic Treatment;Completed;;Phase 2;83;Actual;Johannes Gutenberg University Mainz;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T10:00:02Z;2020-06-01T10:00:02Z;Mainz;3534961;Study Director;Manfred E Beutel, Prof. Dr.;Department for Psychosomatic Medicine and Psychotherapy at the University Medical Center of the Johannes Gutenberg-University Mainz;self-help program | therapeutic feedback;63578451;1;;;2016;2020-05-29;8;FALSE;;FALSE;TRUE;18;;Years;;1;12;
NCT02670265;ClinicalTrials.gov processed this data on May 29, 2020;2016-01-28;;;2016-01-28;2016-01-28;2016-02-01;Estimate;;;;;;;2016-01-28;2016-02-01;Estimate;June 2012;;2012-06-30;January 2016;2016-01-31;February 2014;Actual;2014-02-28;February 2014;Actual;2014-02-28;;Interventional;NUPAN;;Parenteral Nutrition in Patients With Biliopancreatic Mass Lesions;Early Parenteral Nutrition in Patients With Biliopancreatic Mass Lesions (NUPAN), a Prospective Randomized Interventional Trial;Completed;;N/A;100;Actual;University Medicine Greifswald;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T10:00:24Z;2020-06-01T10:00:24Z;Greifswald;3535079;Principal Investigator;Markus M Lerch, MD;Department of Medicine A, University Medicine Greifswald;Olimel Peri 2.5% ® | Isotonic fluid (E153);63578579;;;;2016;2020-05-29;20;FALSE;;;FALSE;18;;Years;;1;3;
NCT02667964;ClinicalTrials.gov processed this data on May 29, 2020;2015-11-24;;;2016-01-26;2016-01-26;2016-01-29;Estimate;;;;;;;2016-01-26;2016-01-29;Estimate;November 2015;;2015-11-30;January 2016;2016-01-31;June 2017;Anticipated;2017-06-30;November 2016;Anticipated;2016-11-30;;Interventional;;;FGF-21 and Exercise in Relation to Insulin Secretion;FGF-21 During Physical Exercise in Patients With Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus and Healthy Controls;Unknown status;;N/A;60;Anticipated;Charite University, Berlin, Germany;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:01:13Z;2020-06-01T10:01:13Z;Berlin;3535249;Principal Investigator;Thomas Bobbert, Dr;Charité;spiroergometry;63578753;1;;;2015;2020-05-29;;FALSE;;FALSE;TRUE;18;80;Years;Years;1;;
NCT02664805;ClinicalTrials.gov processed this data on May 29, 2020;2016-01-22;;;2018-03-20;2016-01-22;2016-01-27;Estimate;;;;;;;2018-03-20;2018-03-21;Actual;February 2016;;2016-02-29;March 2018;2018-03-31;October 2016;Actual;2016-10-31;July 2016;Actual;2016-07-31;;Interventional;;;Proof of Concept, Twice Daily Applications of LEO 124249 Ointment in the Treatment of Chronic Hand Eczema;A Phase 2a, Proof of Concept Trial, Testing Twice Daily Applications of LEO 124249 Ointment in the Treatment of Chronic Hand Eczema;Completed;;Phase 2;91;Actual;LEO Pharma;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:01:43Z;2020-06-01T10:01:43Z;Berlin;3535489;Principal Investigator;Margitta Worm, Prof Dr;Allergie-Centrum-Charité Klinik für Dermatologie, Venerologie und Allergologie;LEO 124249 ointment | LEO 124249 ointment vehicle;63578993;1;;;2016;2020-05-29;5;FALSE;;FALSE;TRUE;18;65;Years;Years;1;2;
NCT02661607;ClinicalTrials.gov processed this data on May 29, 2020;2015-06-17;;;2019-07-22;2016-01-21;2016-01-22;Estimate;;;;;;;2019-07-22;2019-07-23;Actual;October 2014;;2014-10-31;July 2019;2019-07-31;April 2016;Actual;2016-04-30;January 2016;Actual;2016-01-31;;Interventional;;;Point of Care Echocardiography Versus Chest Radiography for the Assessment of Central Venous Catheter Placement;A Prospective Study to Compare Point of Care Echocardiography Versus Chest Radiography for the Assessment of Central Venous Catheter Placement in Critical Care Environments;Completed;;N/A;100;Actual;University of Göttingen;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:02:20Z;2020-06-01T10:02:20Z;Göttingen;3535727;Principal Investigator;Peter Korsten, MD;University Medical Center Göttingen, Department of Nephrology and Rheumatology;Point of care echocardiography | Central venous catheter placement | Chest radiography;63579237;1;;;2015;2020-05-29;15;FALSE;;FALSE;TRUE;18;;Years;;1;4;
NCT02658370;ClinicalTrials.gov processed this data on May 29, 2020;2016-01-13;;;2016-01-15;2016-01-15;2016-01-18;Estimate;;;;;;;2016-01-15;2016-01-18;Estimate;August 2011;;2011-08-31;January 2016;2016-01-31;July 2014;Actual;2014-07-31;July 2014;Actual;2014-07-31;;Interventional;;;An Animated Home-based Physical Exercise Program as a Treatment Option for Patients With Rheumatoid Arthritis;A Prospective Pilot Study to Evaluate an Animated Home-based Physical Exercise Program as a Treatment Option for Patients With Rheumatoid Arthritis;Completed;;N/A;30;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T10:03:01Z;2020-06-01T10:03:01Z;Berlin;3535966;Principal Investigator;Eugen Feist, MD;Charité Berlin, Department of rheumatology and clinical immunology;animated home-based exercises (Wii-fit) | conventional home-based exercise program;63579483;;;;2016;2020-05-29;35;FALSE;;;FALSE;18;75;Years;Years;1;7;
NCT02656966;ClinicalTrials.gov processed this data on May 29, 2020;2016-01-12;;;2016-06-27;2016-01-13;2016-01-15;Estimate;;;;;;;2016-06-27;2016-06-28;Estimate;December 2015;;2015-12-31;June 2016;2016-06-30;May 2016;Actual;2016-05-31;May 2016;Actual;2016-05-31;;Interventional;AcuAnx;;Auricular Acupuncture for Treatment of Preoperative Anxiety;Auricular Acupuncture vs. Standard Therapy for Treatment of Preoperative Anxiety in Patients Scheduled for Ambulatory Gynaecological Surgery - a Pilot Non-randomized Controlled Trial;Completed;;Phase 2;42;Actual;University Medicine Greifswald;;2;;;FALSE;;;;FALSE;;;;;;;;;;;Undecided;;2020-06-01T10:03:15Z;2020-06-01T10:03:15Z;Greifswald;;;;;Auricular acupuncture;63579588;1;;;2016;2020-05-29;5;FALSE;;FALSE;TRUE;19;55;Years;Years;3;2;
NCT02655419;ClinicalTrials.gov processed this data on May 29, 2020;2015-12-01;;;2020-03-31;2016-01-12;2016-01-14;Estimate;;;;;;;2020-03-31;2020-04-02;Actual;May 19, 2016;Actual;2016-05-19;March 2020;2020-03-31;October 26, 2017;Actual;2017-10-26;October 26, 2017;Actual;2017-10-26;;Interventional;;;Determine the PK and Safety and Tolerability of ATM-AVI for the Treatment of cIAIs in Hospitalized Adults (REJUVENATE);A PHASE IIA PROSPECTIVE, OPEN-LABEL, MULTICENTER STUDY TO DETERMINE THE PHARMACOKINETICS (PK) AND SAFETY AND TOLERABILITY OF AZTREONAM-AVIBACTAM (ATM-AVI) FOR THE TREATMENT OF COMPLICATED INTRA-ABDOMINAL INFECTIONS (CIAIS) IN HOSPITALIZED ADULTS;Completed;;Phase 2;40;Actual;Pfizer;;1;;;FALSE;;;;FALSE;TRUE;FALSE;;;FALSE;;;;;https://www.pfizer.com/science/clinical_trials/trial_data_and_results/data_requests;Yes;Pfizer will provide access to individual de-identified participant data and related study documents (e.g. protocol, Statistical Analysis Plan (SAP), Clinical Study Report (CSR)) upon request from qualified researchers, and subject to certain criteria, conditions, and exceptions. Further details on Pfizer's data sharing criteria and process for requesting access can be found at: https://www.pfizer.com/science/clinical_trials/trial_data_and_results/data_requests.;2020-06-01T10:03:33Z;2020-06-01T10:03:33Z;Köln;3536193;Principal Investigator;Oliver Cornely;Clinical Trials Centre Cologne;ATM-AVI | Metronidazole;63579707;11;63;22;2015;2020-05-29;17;TRUE;12;FALSE;FALSE;18;90;Years;Years;54;6;
NCT02655276;ClinicalTrials.gov processed this data on May 29, 2020;2016-01-08;;;2017-12-04;2016-01-11;2016-01-14;Estimate;;;;;;;2017-12-04;2017-12-06;Actual;January 2016;;2016-01-31;December 2017;2017-12-31;May 2016;Actual;2016-05-31;May 2016;Actual;2016-05-31;;Interventional;;;Sublingual Glycine vs. Placebo on Attentional Difficulties and Hyperactivity in Prepuberal Children;Effects of Sublingual Microencapsulated Glycine on Attentional Difficulties and Hyperactivity in Prepuberal Children - A Placebo-controlled, Double-blind, Randomized, Cross-over Study;Completed;;N/A;30;Actual;University Hospital Freiburg;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T10:03:38Z;2020-06-01T10:03:38Z;Freiburg Tübingen;3536204;Study Director;Eberhard Schulz, Prof. Dr.;University Hospital Freiburg;microencapsulated Glycine | Placebo tablets;63579718;1;;;2016;2020-05-29;4;FALSE;;FALSE;TRUE;6;14;Years;Years;1;8;
NCT02654353;ClinicalTrials.gov processed this data on May 29, 2020;2016-01-09;;;2016-01-12;2016-01-12;2016-01-13;Estimate;;;;;;;2016-01-12;2016-01-13;Estimate;February 2012;;2012-02-29;January 2016;2016-01-31;December 2015;Actual;2015-12-31;December 2015;Actual;2015-12-31;;Interventional;;;A New Approach to Target the Substrates of Persistent Atrial Fibrillation: The Sequential Substrate Ablation Approach;A New Approach to Target the Substrates of Persistent Atrial Fibrillation: The Sequential Substrate Ablation Approach;Completed;;Phase 4;100;Actual;Johannes Gutenberg University Mainz;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:03:54Z;2020-06-01T10:03:54Z;Mainz;3536281;Principal Investigator;Thomas Rostock, MD;University Hospital Mainz, Department of Cardiology;Ablation;63579790;1;;;2016;2020-05-29;46;FALSE;;FALSE;TRUE;;;;;1;;
NCT02652585;ClinicalTrials.gov processed this data on May 29, 2020;2016-01-06;;;2017-09-26;2016-01-08;2016-01-12;Estimate;;;;;;;2017-09-26;2017-09-27;Actual;February 2016;Actual;2016-02-29;September 2017;2017-09-30;September 4, 2017;Actual;2017-09-04;August 25, 2017;Actual;2017-08-25;;Interventional;TEMANX;;Validation of a Test System for Development of Medications for Alcoholism;Validation of a Test System for Development of Medications for Alcoholism;Completed;;Phase 3;46;Actual;Technische Universität Dresden;;2;;;FALSE;;;;TRUE;;;;;;;;;;;Undecided;;2020-06-01T10:04:13Z;2020-06-01T10:04:13Z;Dresden;3536442;Study Director;Ulrich S Zimmermann, MD;Klinik und Poliklinik für Psychiatrie und Psychotherapie Unversitätsklinikum Carl Gustav Carus Dresden;Naltrexone | Placebo;63579920;1;;;2016;2020-05-29;18;FALSE;;FALSE;TRUE;25;55;Years;Years;1;18;
NCT02652338;ClinicalTrials.gov processed this data on May 29, 2020;2015-12-16;;;2016-01-07;2016-01-07;2016-01-11;Estimate;;;;;;;2016-01-07;2016-01-11;Estimate;April 2014;;2014-04-30;January 2016;2016-01-31;October 2015;Actual;2015-10-31;October 2015;Actual;2015-10-31;;Interventional;;;Dietary Supplement on Symptom Awareness and Heart Rhythm in Patients With Cardiac Arrhythmia;Influence of a Specific Micronutrient Combination on Symptom Awareness and Heart Rhythm in Patients With Cardiac Arrhythmia;Completed;;Phase 3;74;Actual;Trommsdorff GmbH & Co. KG;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:04:18Z;2020-06-01T10:04:18Z;Bonn;3536459;Study Chair;Christine Metzner, Prof. MD;Bonn Education Association for Dietetics r. A.;MNC-01 | Placebo;63579938;1;;;2015;2020-05-29;18;FALSE;;FALSE;TRUE;18;75;Years;Years;1;8;
NCT02647801;ClinicalTrials.gov processed this data on May 29, 2020;2015-12-15;;;2017-03-06;2016-01-04;2016-01-06;Estimate;;;;;;;2017-03-06;2017-03-07;Actual;September 2015;;2015-09-30;March 2017;2017-03-31;December 2016;Actual;2016-12-31;December 2016;Actual;2016-12-31;;Interventional;SMASH;;Self-control and Mindfulness Within Ambulatorily Assessed Network Systems Across Health Related Domains;The SMASH Study: Self-control and Mindfulness Within Ambulatorily Assessed Network Systems Across Health Related Domains;Completed;;N/A;137;Actual;Johannes Gutenberg University Mainz;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:05:09Z;2020-06-01T10:05:09Z;Mainz;3536813;Principal Investigator;Mario Wenzel, Dipl. Psych.;Department of Psychology, Johannes Gutenberg University Mainz;Mindfulness intervention;63580281;1;;;2015;2020-05-29;15;FALSE;;FALSE;TRUE;18;65;Years;Years;2;18;1
NCT02647489;ClinicalTrials.gov processed this data on May 29, 2020;2016-01-04;;;2018-06-22;2016-01-05;2016-01-06;Estimate;;;;;;;2018-06-22;2018-06-26;Actual;May 2016;;2016-05-31;October 2016;2016-10-31;November 10, 2017;Actual;2017-11-10;November 10, 2017;Actual;2017-11-10;;Interventional;PAMVAC;;Safety and Immunogenicity of the Placental Malaria Vaccine Candidate PAMVAC Variously Adjuvanted;Safety and Immunogenicity of the Placental Malaria Vaccine Candidate PAMVAC Adjuvanted With Alhydrogel, GLA-SE or GLA-LSQ in Healthy Malaria-Naïve Adults and Healthy, Lifelong Malaria-Exposed, Nulligravid Adult Women;Completed;;Phase 1;66;Actual;University Hospital Tuebingen;;11;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T10:05:12Z;2020-06-01T10:05:12Z;Tübingen;3536842;Principal Investigator;Benjamin G Mordmüller, MD;University Hospital Tübingen;PAMVAC | Alhydrogel | GLA-SE | GLA-LSQ | Placebo;63580305;1;;;2016;2020-05-29;17;FALSE;;FALSE;TRUE;18;45;Years;Years;1;1;
NCT02641782;ClinicalTrials.gov processed this data on May 29, 2020;2015-12-12;;;2017-02-01;2015-12-23;2015-12-29;Estimate;;;;;;;2017-02-01;2017-02-02;Estimate;November 2015;Actual;2015-11-30;February 2017;2017-02-28;January 30, 2017;Actual;2017-01-30;December 23, 2016;Actual;2016-12-23;;Interventional;NB2013-HR;;NB2013-HR German (GPOH) / Dutch (DCOG) Trial;Randomized Phase 2 Trial Comparing Experimental Immunotherapy in Recurrent High Risk Neuroblastoma Patients With Standard Immunotherapy in Patients With Recurrent and Newly Diagnosed High Risk Neuroblastoma;Terminated;;Phase 2;3;Actual;University of Cologne;;2;;Antibody supply was discontinued by United Therapeutics Corporation.;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T10:06:26Z;2020-06-01T10:06:26Z;Köln;3537278;Study Chair;Frank Berthold, Prof. Dr.;University of Cologne;antibody ch14.18 | GM-CSF | IL-2 i.v. | IL-2 s.c. | Retinoic acid;63580745;1;;;2015;2020-05-29;12;FALSE;;FALSE;TRUE;18;25;Months;Years;1;3;
NCT02640703;ClinicalTrials.gov processed this data on May 29, 2020;2015-12-12;;;2017-10-24;2015-12-22;2015-12-29;Estimate;;;;;;;2017-10-24;2017-10-25;Actual;March 2015;;2015-03-31;October 2017;2017-10-31;May 2017;Actual;2017-05-31;December 2016;Actual;2016-12-31;;Interventional;;;Effect of Morning vs. Evening Vaccination on Hypoxia and Bradycardia of Preterm Infants: a Randomised Controled Trial;Effect of Morning vs. Evening Vaccination on Hypoxia and Bradycardia of Preterm Infants: a Randomised Controled Trial;Completed;;Phase 3;16;Actual;University Hospital Tuebingen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T10:06:42Z;2020-06-01T10:06:42Z;Tübingen;3537382;Principal Investigator;Christian F. Poets, Prof.;Dept. of Neonatology, Tuebingen University Hospital;Infanrix + Prevenar 13;63580828;1;;;2015;2020-05-29;21;FALSE;;FALSE;TRUE;;6;;Months;1;1;
NCT02639520;ClinicalTrials.gov processed this data on May 29, 2020;2015-12-11;;;2017-07-26;2015-12-21;2015-12-24;Estimate;;;;;;;2017-07-26;2017-07-28;Actual;December 2015;;2015-12-31;July 2017;2017-07-31;June 29, 2017;Actual;2017-06-29;June 2017;Actual;2017-06-30;;Interventional;;;Efficacy of CLR Compared to Fosfomycin Trometamol in Acute Lower uUTIs;A Double-blind, Controlled, Parallel-group, Randomized, Multicenter Clinical Trial to Assess the Efficacy and Safety of a Herbal Drug Containing Centaury, Lovage Root and Rosemary Leaf (CLR) in Comparison to Fosfomycin Trometamol for the Treatment of Acute Lower Uncomplicated Urinary Tract Infections (uUTIs) in Women;Completed;;Phase 3;659;Actual;Bionorica SE;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:06:56Z;2020-06-01T10:06:56Z;Giessen Marburg;3537464;Principal Investigator;Florian Wagenlehner, Prof.;Universitätsklinikum Gießen und Marburg GmbH;Canephron® N | Fosfomycin trometamol | Canephron® N-placebo | Fosfomycin trometamol-placebo;63580921;1;;;2015;2020-05-29;18;FALSE;;FALSE;TRUE;18;70;Years;Years;1;;
NCT02637778;ClinicalTrials.gov processed this data on May 29, 2020;2015-12-15;;;2017-02-19;2015-12-17;2015-12-22;Estimate;;;;;;;2017-02-19;2017-02-23;Actual;February 2016;;2016-02-29;December 2015;2015-12-31;November 2016;Actual;2016-11-30;June 2016;Actual;2016-06-30;;Interventional;MoKaRi-Diet;;Modulation of Cardiovascular Risk Factors by the Diet;Intervention Study - Modulation of Cardiovascular Risk Factors by Personal Nutritional Counselling and Daily Menu Plans;Completed;;N/A;60;Actual;University of Jena;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:07:29Z;2020-06-01T10:07:29Z;Halle Jena Leipzig;3537579;Principal Investigator;Christine Dawczynski, PhD;"University oj Jena, Department of Nutritional Biochemistry and Physiology; Competence Cluster for Nutrition and Cardiovascular Health (nutriCARD), Halle-Jena-Leipzig, Germany";Cardioprotective diet | Cardioprotective diet + 3 g EPA + DHA/d;63581051;;;;2015;2020-05-29;4;FALSE;;;FALSE;20;80;Years;Years;1;14;8
NCT02637544;ClinicalTrials.gov processed this data on May 29, 2020;2015-10-01;;;2016-02-02;2015-12-21;2015-12-22;Estimate;;;;;;;2016-02-02;2016-02-03;Estimate;April 2014;;2014-04-30;February 2016;2016-02-29;August 2016;Anticipated;2016-08-31;April 2016;Anticipated;2016-04-30;;Interventional;;;Treatment Efficiency of Acupuncture in Non Chronified Pain Patients With TMDs;Wirksamkeit Von Akupunktur Auf Den Nicht Chronifizierten Schmerz Bei Craniomandibulärer Dysfunktion - Eine Randomisierte, Placebokontrollierte Klinische Studie;Unknown status;;N/A;40;Anticipated;University of Heidelberg Medical Center;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:07:37Z;2020-06-01T10:07:37Z;Heidelberg;3537598;Principal Investigator;Sinan Sen, Dr.med.dent.;Department of Orthodontics, University of Heidelberg;acupuncture;63581070;1;;;2015;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT02633228;ClinicalTrials.gov processed this data on May 29, 2020;2015-12-14;;;2017-06-28;2015-12-14;2015-12-17;Estimate;;;;;;;2017-06-28;2017-06-29;Actual;December 2014;;2014-12-31;June 2017;2017-06-30;June 2016;Actual;2016-06-30;February 2016;Actual;2016-02-29;;Interventional;;;Visual Acuity After the Combined Binocular Implantation of +2.0 Diopters and +3.0 Diopters Oculentis Multifocal Intraocular Lenses.;Evaluation of the Visual Acuity After the Implantation of an Oculentis +2.0 Diopters (Torical) Bifocal Intraocular Lens (MplusX (Toric) LU-313 MF20T/LS-313 MF20) in the Distance Dominant Eye, in Combination With a +3.0 Diopters Oculentis Bifocal Intraocular Lens (MplusX (Toric) LU-313 MF30T/LS-313 MF30) in the Fellow Eye.;Completed;;Phase 4;15;Anticipated;Charite University, Berlin, Germany;;;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T10:08:26Z;2020-06-01T10:08:26Z;Berlin;3537917;Principal Investigator;Eckart Bertelmann, MD, PhD;Charité - University Medicine Berlin, Department of Ophthalmology;Binocular cataract surgery with phacoemulsification and implantation of multifocal intraocular lenses;63581395;1;;;2015;2020-05-29;14;FALSE;;FALSE;TRUE;18;;Years;;6;1;
NCT02633072;ClinicalTrials.gov processed this data on May 29, 2020;2015-12-14;;;2017-06-28;2015-12-14;2015-12-17;Estimate;;;;;;;2017-06-28;2017-06-29;Actual;September 2014;;2014-09-30;June 2017;2017-06-30;December 2016;Actual;2016-12-31;December 2016;Actual;2016-12-31;;Interventional;;;Visual Acuity After the Combined Binocular Implantation of +2.75 Diopters and +3.25 Diopters Tecnis Multifocal Intraocular Lenses.;Evaluation of the Visual Acuity After the Implantation of a Tecnis +2.75 Diopters Bifocal Intraocular Lens (Tecnis ZKB00) in the Distance Dominant Eye, in Combination With a +3.25 Diopters Tecnis Bifocal Intraocular Lens (Tecnis ZLB00) in the Fellow Eye.;Completed;;Phase 4;15;Anticipated;Charite University, Berlin, Germany;;;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:08:27Z;2020-06-01T10:08:27Z;Berlin;3537930;Principal Investigator;Eckart Bertelmann, MD;Charité - University Medicine Berlin, Department of Ophthalmology;Binocular cataract surgery with phacoemulsification and implantation of multifocal intraocular lenses;63581407;1;;;2015;2020-05-29;27;FALSE;;FALSE;TRUE;18;;Years;;6;1;
NCT02632292;ClinicalTrials.gov processed this data on May 29, 2020;2015-12-03;;;2019-09-24;2015-12-11;2015-12-16;Estimate;;;;;;;2019-09-24;2019-09-26;Actual;January 2016;Actual;2016-01-31;September 2019;2019-09-30;January 3, 2017;Actual;2017-01-03;January 3, 2017;Actual;2017-01-03;;Interventional;SUGAR-EVE;;EverolimuS-ElUtinG BioresorbAble VasculaR Scaffolds vErsus EVerolimus-Eluting Stents in Patients With Diabetes Mellitus;EverolimuS-ElUtinG BioresorbAble VasculaR Scaffolds vErsus EVerolimus-Eluting Stents in Patients With Diabetes Mellitus;Terminated;;N/A;33;Actual;University of Luebeck;;2;;Slow enrollment;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:08:37Z;2020-06-01T10:08:37Z;Lübeck;;;;;Absorb GT1 | Promus;63581467;1;;;2015;2020-05-29;11;FALSE;;FALSE;TRUE;18;;Years;;1;15;
NCT02631798;ClinicalTrials.gov processed this data on May 29, 2020;2015-12-04;;;2016-02-17;2015-12-15;2015-12-16;Estimate;;;;;;;2016-02-17;2016-02-18;Estimate;December 2015;;2015-12-31;February 2016;2016-02-29;July 2016;Anticipated;2016-07-31;June 2016;Anticipated;2016-06-30;;Interventional;;;Chromocolonoscopy With Food-grade Dyes;Mucosal Staining After Oral Administration of Food Grade Dyes in Subjects Undergoing Outpatients Colonoscopy;Unknown status;;N/A;30;Anticipated;University of Schleswig-Holstein;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:08:46Z;2020-06-01T10:08:46Z;Kiel Lübeck;3538011;Principal Investigator;Mark Ellrichmann, MD;University Hospital Schleswig-Holstein, Campus Kiel;Food grade dye mucosal staining;63581503;1;;;2015;2020-05-29;;FALSE;;FALSE;TRUE;18;75;Years;Years;1;2;
NCT02620553;ClinicalTrials.gov processed this data on May 29, 2020;2015-06-08;;;2017-04-19;2015-11-30;2015-12-03;Estimate;;;;;;;2017-04-19;2017-04-20;Actual;September 2007;;2007-09-30;April 2017;2017-04-30;January 2014;Actual;2014-01-31;June 2013;Actual;2013-06-30;;Interventional;Pre-POINT;;Primary Intervention With Mucosal Insulin;Primary Intervention With Mucosal Insulin for Prevention of Type 1 Diabetes in Infants at High Genetic Risk to Develop Diabetes POINT (Primary Oral Insulin Trial) A Dose Finding and Safety Study ( Pre-POINT );Completed;;Phase 1/Phase 2;25;Actual;University of Colorado, Denver;;2;;;FALSE;;;;TRUE;;;;;;;;;;;Yes;;2020-06-01T10:11:20Z;2020-06-01T10:11:20Z;Dresden;3538840;Principal Investigator;Ezio Bonifacio, PhD;Medical Faculty Carl Gustav Carus, Dresden University of Technology;Human Insulin | Oral Placebo;63582359;1;;;2015;2020-05-29;70;FALSE;;TRUE;TRUE;2;7;Years;Years;3;2;
NCT02617095;ClinicalTrials.gov processed this data on May 29, 2020;2015-11-26;;;2017-03-06;2015-11-26;2015-11-30;Estimate;;;;;;;2017-03-06;2017-03-08;Actual;February 2015;;2015-02-28;March 2017;2017-03-31;October 2016;Actual;2016-10-31;June 2016;Actual;2016-06-30;;Interventional;;;Comparison of the Efficacy and Safety of T2762 Versus Optive® in the Treatment of Moderate to Severe Dry Eye Syndrome;Comparison of the Efficacy and Safety of T2762 Versus Optive® in the Treatment of Moderate to Severe Dry Eye Syndrome;Terminated;;N/A;64;Actual;Laboratoires Thea;;2;;recruitment rate too slow;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:11:52Z;2020-06-01T10:11:52Z;Erlangen;3539098;Principal Investigator;Friedrich KRUSE, Professor;Augenklinik mit Poliklinik - Swabachanlage 6 - 91054 Erlangen;Optive | T2762;63582624;1;;;2015;2020-05-29;16;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT02615860;ClinicalTrials.gov processed this data on May 29, 2020;2015-11-19;;;2015-11-23;2015-11-23;2015-11-26;Estimate;;;;;;;2015-11-23;2015-11-26;Estimate;November 2015;;2015-11-30;November 2015;2015-11-30;December 2017;Anticipated;2017-12-31;May 2017;Anticipated;2017-05-31;;Interventional;TECAIN;;Efficacy and Safety of TCA vs. ECA for the Treatment of AIN in HIV-positive Patients;Efficacy and Safety of Topical Trichloroacetic Acid vs. Electrocautery for the Treatment of Anal Intraepithelial Neoplasia in HIV-positive Patients (TECAIN) - a Randomized Controlled Trial;Unknown status;;N/A;560;Anticipated;University Hospital, Essen;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T10:12:04Z;2020-06-01T10:12:04Z;Duisburg;;;;;Topical 85% trichloroacetic acid (TCA) | Surgical electrocautery (ECA);63582720;1;;;2015;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;8;
NCT02613078;ClinicalTrials.gov processed this data on May 29, 2020;2015-10-23;;;2016-03-02;2015-11-19;2015-11-24;Estimate;;;;;;;2016-03-02;2016-03-03;Estimate;March 2016;;2016-03-31;February 2016;2016-02-29;October 2017;Anticipated;2017-10-31;April 2017;Anticipated;2017-04-30;;Interventional;;;Hypnotherapy vs. Probiotics in Children With IBS and Functional Abdominal Pain;Gut-Directed Hypnotherapy vs. Probiotics in Children and Adolescents With Irritable Bowel Syndrome and Functional Abdominal Pain - A Pilot Study;Unknown status;;N/A;60;Anticipated;University Hospital Tuebingen;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:12:38Z;2020-06-01T10:12:38Z;Tübingen;3539383;Principal Investigator;Marco D Gulewitsch, PhD;Eberhard Karls University, Tübingen, Germany;Gut-Directed Hypnotherapy | Nutritional Supplement | Self-Monitoring;63582929;1;;;2015;2020-05-29;;FALSE;;FALSE;TRUE;6;17;Years;Years;1;10;
NCT02612220;ClinicalTrials.gov processed this data on May 29, 2020;2015-11-13;;;2017-10-19;2015-11-20;2015-11-23;Estimate;;;;;;;2017-10-19;2017-10-20;Actual;December 3, 2015;Actual;2015-12-03;January 2017;2017-01-31;September 6, 2017;Actual;2017-09-06;September 6, 2017;Actual;2017-09-06;;Interventional;BioFoam;;Effectiveness of BioFoam® Surgical Matrix to Improve Hemostasis During Liver Resection;Effectiveness of BioFoam® Surgical Matrix to Improve Hemostasis During Liver Resection - A Randomized Controlled Trial;Completed;;N/A;101;Actual;Technische Universität Dresden;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:12:51Z;2020-06-01T10:12:51Z;Dresden;3539476;Principal Investigator;Christoph Reißfelder, MD;Department of Visceral, Thoracic and Vascular Surgery, University Hospital Carl Gustav Carus, TU Dresden, Germany;BioFoam® Surgical Matrix | Conservative hemostasis;63582996;1;;;2015;2020-05-29;21;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT02610764;ClinicalTrials.gov processed this data on May 29, 2020;2015-11-15;;;2017-04-12;2015-11-19;2015-11-20;Estimate;;;;;;;2017-04-12;2017-04-13;Actual;November 2015;;2015-11-30;April 2017;2017-04-30;December 2016;Actual;2016-12-31;December 2016;Actual;2016-12-31;;Interventional;ESO-CTC;;Pilot Sudy: Resectable Esophageal Adenocarcinoma and the Relevance of CTC;Resectable Esophageal Adenocarcinoma: The Influence of Multimodal Therapy on the Prevalence and Enumeration of Circulating Tumor Cells in Comparison With Conventional Response Evaluation in a Feasibility Study;Completed;;N/A;19;Actual;University Hospital Freiburg;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:13:07Z;2020-06-01T10:13:07Z;Freiburg;3539580;Principal Investigator;Birte Kulemann, Dr. med.;University Hospital Freiburg;Blood Test for CTC evaluation;63583106;1;;;2015;2020-05-29;13;FALSE;;FALSE;TRUE;18;;Years;;1;1;2
NCT02609412;ClinicalTrials.gov processed this data on May 29, 2020;2015-10-02;;;2016-05-10;2015-11-18;2015-11-20;Estimate;;;;;;;2016-05-10;2016-05-11;Estimate;May 2015;;2015-05-31;May 2016;2016-05-31;May 2016;Actual;2016-05-31;May 2016;Actual;2016-05-31;;Interventional;;;Immediate Effects of Self-myofascial Release on Latent Trigger Point Sensitivity;;Completed;;N/A;48;Actual;Goethe University;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:13:21Z;2020-06-01T10:13:21Z;Frankfurt;3539737;Principal Investigator;Winfried Banzer, MD, PhD;Department of Sports Medicine, Goethe University Frankfurt/Main;Static compression of LMTRP | Dynamic self-myofascial release of calf | Placebo laser acupuncture of LMTRP;63583207;1;;;2015;2020-05-29;12;FALSE;;FALSE;TRUE;18;65;Years;Years;1;;
NCT02606799;ClinicalTrials.gov processed this data on May 29, 2020;2015-10-01;;;2015-11-30;2015-11-16;2015-11-17;Estimate;;;;;;;2015-11-30;2015-12-02;Estimate;December 2015;;2015-12-31;November 2015;2015-11-30;September 2016;Anticipated;2016-09-30;July 2016;Anticipated;2016-07-31;;Interventional;EXCESS;;Extracorporeal Elimination of Cytokines Following Abdominal-thoracic Esophagectomy;Extracorporeal Elimination of Cytokines Following Abdominal-thoracic Esophagectomy - a Randomized Study (EXCESS);Unknown status;;Phase 2;24;Anticipated;Universitätsklinikum Hamburg-Eppendorf;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:14:03Z;2020-06-01T10:14:03Z;Hamburg;3539927;Principal Investigator;Axel Nierhaus, MD;University Medical Center Hamburg-Eppendorf, Dep. of Critical Care;CytoSorb cytokine elimination;63583406;1;;;2015;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;3;
NCT02602275;ClinicalTrials.gov processed this data on May 29, 2020;2015-10-28;;;2016-01-27;2015-11-09;2015-11-11;Estimate;;;;;;;2016-01-27;2016-01-28;Estimate;August 2015;;2015-08-31;January 2016;2016-01-31;December 2015;Actual;2015-12-31;December 2015;Actual;2015-12-31;;Interventional;NEURIM;;Neuronal Correlates of Neurexan® Action in Mildly to Moderately Stressed Probands;Neuronal Correlates of Neurexan® Action in Mildly to Moderately Stressed Probands - A Randomized, Placebo-controlled, Double-blind, Cross-over Trial of Mode of Action and Response Prediction by Functional Magnetic Resonance Imaging MRI;Completed;;Phase 2;53;Actual;Biologische Heilmittel Heel GmbH;;2;;;FALSE;;;;FALSE;;;;;;;;;;;Undecided;;2020-06-01T10:15:17Z;2020-06-01T10:15:17Z;Magdeburg;3540326;Principal Investigator;Martin Walter, PD Dr Med.;Clinical Affective Neuroimaging Laboratory, Univ. Magdeburg, Germany;Neurexan® | Placebo;63583748;1;;;2015;2020-05-29;4;FALSE;;FALSE;TRUE;31;59;Years;Years;6;4;
NCT02601963;ClinicalTrials.gov processed this data on May 29, 2020;2015-10-19;;;2017-02-14;2015-11-10;2015-11-11;Estimate;;;;;;;2017-02-14;2017-02-15;Actual;September 2015;;2015-09-30;February 2017;2017-02-28;August 2016;Actual;2016-08-31;August 2016;Actual;2016-08-31;;Interventional;EMIRA;;Safety and Efficacy Study of a Topical Minocycline Foam in Patients With Papulopustular Rosacea;A Randomized, Multicenter, Double-blind, Vehicle-controlled Study to Evaluate the Safety and Efficacy of Two Different Doses of a Topical Minocycline Foam Compared to Vehicle in the Treatment of Papulopustular Rosacea - Study FX2015-10;Completed;;Phase 2;233;Actual;Foamix Ltd.;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:15:21Z;2020-06-01T10:15:21Z;Kiel Lübeck;3540352;Principal Investigator;Ulrich Mrowietz, MD;University of Schleswig-Holstein;FMX-103 1.5% | FMX-103 3% | Vehicle foam (0%);63583773;20;;;2015;2020-05-29;11;FALSE;;FALSE;FALSE;18;;Years;;1;3;
NCT02599740;ClinicalTrials.gov processed this data on May 29, 2020;2015-11-03;;;2016-01-14;2015-11-06;2015-11-09;Estimate;;;;;;;2016-01-14;2016-01-15;Estimate;October 2015;;2015-10-31;January 2016;2016-01-31;December 2015;Actual;2015-12-31;December 2015;Actual;2015-12-31;;Interventional;;;Natural Fruit Extract Versus the Assumed Key Active Compound in Reducing the Post-prandial Blood Glucose Level;The Bioequivalence of a Natural Extract Versus the Assumed Key Active Compound in Reducing the Post-prandial Blood Glucose Levels;Completed;;N/A;84;Actual;Unilever R&D;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:15:49Z;2020-06-01T10:15:49Z;Berlin;3540502;Principal Investigator;Christian Keicher, Dr;Charité Research Organisation GmbH;Natural fruit extract | Assumed active | Placebo;63583944;1;;;2015;2020-05-29;2;FALSE;;FALSE;TRUE;18;50;Years;Years;1;7;
NCT02596594;ClinicalTrials.gov processed this data on May 29, 2020;2015-10-12;;;2018-01-24;2015-11-03;2015-11-04;Estimate;;;;;;;2018-01-24;2018-01-26;Actual;January 2010;;2010-01-31;January 2018;2018-01-31;April 2014;Actual;2014-04-30;April 2014;Actual;2014-04-30;;Interventional;port-IUGR;;Intraumbilical Amino Acids and Glucose Supplementation Via Port by Severe IUGR in Human Fetuses;Intraumbilical Amino Acids and Glucose Supplementation Via Subcutaneously Implanted Port System by Severe IUGR Human Fetuses;Completed;;N/A;14;Actual;Martin-Luther-Universität Halle-Wittenberg;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T10:16:31Z;2020-06-01T10:16:31Z;Halle;3540735;Principal Investigator;Michael Tchirikov, MD, PhD;Martin-Luther University Halle-Wittenberg;fetal nutrition port system;63584182;;;;2015;2020-05-29;51;FALSE;;;FALSE;18;;Years;;1;3;
NCT02595840;ClinicalTrials.gov processed this data on May 29, 2020;2015-10-23;;;2019-04-18;2015-11-02;2015-11-04;Estimate;;;;;;;2019-04-18;2019-04-19;Actual;November 25, 2015;Actual;2015-11-25;April 2019;2019-04-30;November 20, 2017;Actual;2017-11-20;November 20, 2017;Actual;2017-11-20;;Interventional;Trans-MARBLE;;Biomarker Study Accompanying the AIO-TRK-0114 Study (MARBLE);Biomarker Study Accompanying the AIO-TRK-0114 Study (MARBLE);Terminated;;Phase 2;4;Actual;Universität Duisburg-Essen;;2;;Futility;FALSE;;;;TRUE;FALSE;FALSE;;;FALSE;;;;;;;;2020-06-01T10:16:45Z;2020-06-01T10:16:45Z;Duisburg;;;;;Afatinib | Pemetrexed;63584240;;;;2015;2020-05-29;24;FALSE;;;FALSE;18;;Years;;1;2;
NCT02595645;ClinicalTrials.gov processed this data on May 29, 2020;2015-10-29;;;2016-11-02;2015-11-02;2015-11-03;Estimate;;;;;;;2016-11-02;2016-11-03;Estimate;August 2015;;2015-08-31;November 2016;2016-11-30;October 2016;Actual;2016-10-31;August 2016;Actual;2016-08-31;;Interventional;GENESIS;;GENESIS: Genetic Biopsy for Prediction of Surveillance Intervals After Endoscopic Resection of Colonic Polyps;GENESIS: Genetic Biopsy for Prediction of Surveillance Intervals After Endoscopic Resection of Colonic Polyps;Completed;;N/A;101;Actual;University of Ulm;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:16:48Z;2020-06-01T10:16:48Z;Ulm;3540820;Principal Investigator;Alexander G. Meining, Prof. Dr.;University Ulm, Internal Medicine I, Interventional and experimental endoscopy (InExEn);Polypectomy and NGS;63584256;4;;;2015;2020-05-29;12;FALSE;;FALSE;FALSE;18;;Years;;1;;
NCT02594930;ClinicalTrials.gov processed this data on May 29, 2020;2015-10-31;;;2016-10-17;2015-11-02;2015-11-03;Estimate;;;;;;;2016-10-17;2016-10-19;Estimate;September 2015;;2015-09-30;October 2016;2016-10-31;November 2017;Anticipated;2017-11-30;September 2017;Anticipated;2017-09-30;;Interventional;COSPI;;Comparison of Two Different Techniques of Synovial Biopsy and Resistances of Cutaneous Smears in Suspected PPI;Comparison of Directed Versus Undirected Synovial Biopsy in Culture-negative Periprosthetic Joint Infections (With Preoperative Smears From the Skin) of the Knee and Evaluation of Outcome After Revision Joint Arthroplasty;Unknown status;;N/A;30;Anticipated;Technische Universität München;;1;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T10:16:58Z;2020-06-01T10:16:58Z;Munich;3540874;Study Chair;Ruediger Eisenhart-Rothe, Prof.;Klinikum rechts der Isar, TU Munich;synovial biopsy of total knee arthroplasty;63584310;1;;;2015;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT02594345;ClinicalTrials.gov processed this data on May 29, 2020;2015-10-30;;;2016-02-22;2015-10-30;2015-11-03;Estimate;;;;;;;2016-02-22;2016-02-23;Estimate;October 2015;;2015-10-31;February 2016;2016-02-29;December 2015;Actual;2015-12-31;December 2015;Actual;2015-12-31;;Interventional;;;Effect of Exosomes Derived From Red Blood Cell Units on Platelet Function and Blood Coagulation;In Vitro Study of the Effect of Exosomes Derived From Red Blood Cell Units on Platelet Function and Blood Coagulation in Healthy Volunteers' Blood;Completed;;N/A;18;Actual;Johann Wolfgang Goethe University Hospital;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:17:02Z;2020-06-01T10:17:02Z;Frankfurt;3540915;Principal Investigator;Dania P Fischer, M.D.;University Hospital, Frankfurt;in vitro study;63584355;1;;;2015;2020-05-29;2;FALSE;;FALSE;TRUE;18;80;Years;Years;1;4;
NCT02594332;ClinicalTrials.gov processed this data on May 29, 2020;2015-08-31;;;2017-07-11;2015-11-02;2015-11-03;Estimate;;;;;;;2017-07-11;2017-07-13;Actual;November 17, 2015;Actual;2015-11-17;July 2017;2017-07-31;May 22, 2017;Actual;2017-05-22;May 22, 2017;Actual;2017-05-22;;Interventional;MEMORY;;Effects of Mepolizumab Compared to Placebo on Airway Physiology in Patients With Eosinophilic Asthma: MEMORY Study;A Randomized, Double-blind, Placebo-controlled, Mono-center Study to Evaluate the Effects of Mepolizumab on Airway Physiology in Patients With Eosinophilic Asthma: the MEMORY Study;Terminated;;Phase 3;29;Actual;Johannes Gutenberg University Mainz;;2;;recruitment problems;FALSE;;;;FALSE;;;;;;;;;;;Undecided;;2020-06-01T10:17:02Z;2020-06-01T10:17:02Z;Mainz;3540916;Principal Investigator;Stephanie Korn, MD;Johannes Gutenberg University Mainz;Mepolizumab | Placebo;63584356;1;;;2015;2020-05-29;18;FALSE;;FALSE;TRUE;18;;Years;;7;33;
NCT02591524;ClinicalTrials.gov processed this data on May 29, 2020;2015-10-27;;;2015-10-28;2015-10-28;2015-10-29;Estimate;;;;;;;2015-10-28;2015-10-29;Estimate;November 2015;;2015-11-30;October 2015;2015-10-31;April 2016;Anticipated;2016-04-30;January 2016;Anticipated;2016-01-31;;Interventional;;;Upper and Lower Airway Colonization in Cystic Fibrosis Patients After Lung Transplantation;Upper and Lower Airway Colonization in Cystic Fibrosis Patients After Lung Transplantation;Unknown status;;N/A;100;Anticipated;Hannover Medical School;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:17:35Z;2020-06-01T10:17:35Z;Hannover;;;;;Bronchoalveolar and Nasal Lavage;63584572;1;;;2015;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;3;
NCT02590575;ClinicalTrials.gov processed this data on May 29, 2020;2015-10-23;;;2017-05-11;2015-10-28;2015-10-29;Estimate;;;;;;;2017-05-11;2017-05-12;Actual;October 2015;;2015-10-31;May 2017;2017-05-31;April 2017;Actual;2017-04-30;December 2016;Actual;2016-12-31;;Interventional;Prismalung;;Low Flow CO2 Removal on RRT;Low Flow CO2 Removal Via a Membrane Gas Exchange Device (Prismalung®) on a Renal Replacement Platform (Prismaflex®) in Hypercapnic, Ventilated Patients Requiring Renal Replacement;Completed;;N/A;20;Actual;University of Erlangen-Nürnberg Medical School;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:17:43Z;2020-06-01T10:17:43Z;Erlangen;3541199;Principal Investigator;Stefan John, MD;University of Erlangen-Nuernberg;Extracorporeal CO2 removal with the Prismalung(R) gas exchanger on the Prismaflex(R) renal replacement platform;63584646;1;;;2015;2020-05-29;14;FALSE;;FALSE;TRUE;18;;Years;;2;11;
NCT02588794;ClinicalTrials.gov processed this data on May 29, 2020;2015-10-27;;;2015-10-27;2015-10-27;2015-10-28;Estimate;;;;;;;2015-10-27;2015-10-28;Estimate;October 2015;;2015-10-31;October 2015;2015-10-31;December 2017;Anticipated;2017-12-31;August 2017;Anticipated;2017-08-31;;Interventional;CASAKI;;Cytokine Adsorption in Sepsis and Acute Kidney Injury;Cytokine Adsorption in Sepsis and Acute Kidney Injury;Unknown status;;N/A;124;Anticipated;Technische Universität München;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:18:02Z;2020-06-01T10:18:02Z;Munich;;;;;CytoSorb 300 ml device (3804606CE01);63584783;1;;;2015;2020-05-29;;FALSE;;FALSE;TRUE;18;80;Years;Years;1;4;
NCT02588300;ClinicalTrials.gov processed this data on May 29, 2020;2015-10-25;;;2016-04-21;2015-10-25;2015-10-27;Estimate;;;;;;;2016-04-21;2016-04-22;Estimate;July 2013;;2013-07-31;April 2016;2016-04-30;October 2015;Actual;2015-10-31;October 2015;Actual;2015-10-31;;Interventional;;;Upper Airway Collapse in Patients With Obstructive Sleep Apnea Syndrome by Drug Induced Sleep Endoscopy;Evaluation of the Upper Airway Collapse in Patients With Obstructive Sleep Apnea Syndrome by Drug Induced Sleep Endoscopy According to the Munich Sleep Video Protocol;Completed;;N/A;43;Actual;Technische Universität München;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:18:06Z;2020-06-01T10:18:06Z;Munich;;;;;Drug induced sleep endoscopy;63584821;1;;;2015;2020-05-29;27;FALSE;;FALSE;TRUE;18;75;Years;Years;1;;
NCT02588144;ClinicalTrials.gov processed this data on May 29, 2020;2015-10-24;;;2017-06-16;2015-10-24;2015-10-27;Estimate;;;;;;;2017-06-16;2017-06-20;Actual;October 2015;;2015-10-31;June 2017;2017-06-30;September 2017;Anticipated;2017-09-30;September 2017;Anticipated;2017-09-30;;Interventional;STN+SNr;;Combined Stimulation of STN and SNr for Resistant Freezing of Gait in Parkinson's Disease;Combined Stimulation of Subthalamic Nucleus and Substantia Nigra Pars Reticulata for Resistant Freezing of Gait in Parkinson's Disease: A Randomized Controlled Multicenter Trial;Unknown status;;N/A;54;Anticipated;University Hospital Tuebingen;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T10:18:08Z;2020-06-01T10:18:08Z;Tübingen;3541361;Principal Investigator;Daniel Weiss, MD;Department for Neurodegenerative Diseases, Centre for Neurology, Tübingen, Germany, and Hertie-Institute for Clinical Brain Research;[standard STN] | [STN+SNr];63584833;10;;;2015;2020-05-29;;FALSE;;FALSE;FALSE;18;80;Years;Years;1;12;
NCT02587533;ClinicalTrials.gov processed this data on May 29, 2020;2015-10-13;;;2018-01-08;2015-10-23;2015-10-27;Estimate;;;;;;;2018-01-08;2018-01-09;Actual;November 2015;;2015-11-30;January 2018;2018-01-31;December 2017;Actual;2017-12-31;December 2017;Actual;2017-12-31;;Interventional;ChemoBar;;Peripheral Chemoreflex/Arterial Baroreflex Interaction in Patients With Electrical Carotid Sinus Stimulation;Peripheral Chemoreflex/Arterial Baroreflex Interaction in Patients With Electrical Carotid Sinus Stimulation;Completed;;N/A;11;Actual;Hannover Medical School;;4;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T10:18:16Z;2020-06-01T10:18:16Z;Hannover;3541409;Principal Investigator;Jens Tank, MD;Hannover Medical School;Hypoxia without dopamine | Hypoxia with dopamine | Hyperoxia without dopamine | Hyperoxia with dopamine;63584879;1;;;2015;2020-05-29;25;FALSE;;FALSE;TRUE;18;;Years;;1;1;7
NCT02587338;ClinicalTrials.gov processed this data on May 29, 2020;2015-06-16;;;2018-04-09;2015-10-26;2015-10-27;Estimate;;;;;;;2018-04-09;2018-04-10;Actual;May 2015;Actual;2015-05-31;April 2018;2018-04-30;December 2017;Actual;2017-12-31;April 2017;Actual;2017-04-30;;Interventional;CATS;;Cognitive Ability Training in Seniors;Verbesserung Kognitiver Fähigkeiten im Alter;Completed;;N/A;50;Actual;Wuerzburg University Hospital;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:18:19Z;2020-06-01T10:18:19Z;Würzburg;3541423;Principal Investigator;Martin J. Herrmann, PD Dr;University of Würzburg;Verum tDCS | Sham tDCS;63584895;1;;;2015;2020-05-29;23;FALSE;;FALSE;TRUE;60;70;Years;Years;1;1;
NCT02585882;ClinicalTrials.gov processed this data on May 29, 2020;2015-10-22;;;2015-10-23;2015-10-22;2015-10-23;Estimate;;;;;;;2015-10-23;2015-10-26;Estimate;March 2012;;2012-03-31;October 2015;2015-10-31;October 2015;Actual;2015-10-31;August 2013;Actual;2013-08-31;;Interventional;;;Preventive Effect of Salt Fluoridation;Caries Preventive Effect of Salt Fluoridation in Preschool Children in The Gambia;Completed;;N/A;441;Actual;University of Witten/Herdecke;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:18:40Z;2020-06-01T10:18:40Z;Witten-Herdecke;;;;;Fluoride table salt;63585006;;;;2015;2020-05-29;17;FALSE;;;FALSE;;;;;1;;
NCT02585752;ClinicalTrials.gov processed this data on May 29, 2020;2015-10-20;;;2018-04-19;2015-10-22;2015-10-23;Estimate;;;;;;;2018-04-19;2018-04-23;Actual;October 1, 2015;Actual;2015-10-01;April 2018;2018-04-30;November 24, 2017;Actual;2017-11-24;September 30, 2017;Actual;2017-09-30;;Interventional;ComfortCOPD;;A Study of Expiratory Pressure Modulation in Moderate to Severe COPD Patients - Phase 1b;A Study of Expiratory Pressure Modulation in Moderate to Severe COPD Patients - Phase 1b;Terminated;;N/A;20;Actual;ResMed;;1;;Low recruitment;FALSE;;;;FALSE;;FALSE;;;;;;;;;;;2020-06-01T10:18:43Z;2020-06-01T10:18:43Z;Aachen;3541527;Principal Investigator;Michael Dreher, MD;Universitätsklinikum Aachen;Noninvasive ventilation;63585016;1;;;2015;2020-05-29;24;FALSE;;FALSE;TRUE;18;100;Years;Years;1;5;
NCT02575612;ClinicalTrials.gov processed this data on May 29, 2020;2015-10-12;;;2019-09-28;2015-10-13;2015-10-14;Estimate;;;;;;;2019-09-28;2019-10-01;Actual;July 2014;;2014-07-31;September 2019;2019-09-30;February 2015;Actual;2015-02-28;February 2015;Actual;2015-02-28;;Interventional;;;Diagnosis of Pathological Complete Response by Minimal Invasive Biopsy After Neoadjuvant Chemotherapy in Breast Cancer;Can a Pathological Complete Response in the Breast be Diagnosed by Vacuum-assisted, Ultrasound Guided Minimal Invasive Biopsy After Neoadjuvant Chemotherapy in Breast Cancer Patients? A Proof of Concept From a Prospective Cohort Study;Completed;;N/A;50;Actual;Heidelberg University;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:20:59Z;2020-06-01T10:20:59Z;Heidelberg;3542223;Study Chair;Joerg Heil, Prof. Dr.;University of Heidelberg, Department of Gynecology, Breast Unit;vacuum-assisted biopsy;63585791;1;;;2015;2020-05-29;7;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT02569619;ClinicalTrials.gov processed this data on May 29, 2020;2015-10-02;;;2016-03-09;2015-10-05;2015-10-07;Estimate;;;;;;;2016-03-09;2016-03-10;Estimate;April 2014;;2014-04-30;March 2016;2016-03-31;March 2016;Actual;2016-03-31;March 2016;Actual;2016-03-31;;Interventional;GAF;;Evaluation of an Intervention to Promote Physical Activity in Outpatients With Mental Disorders;Evaluation of an Intervention to Promote Physical Activity in Outpatients With Mental Disorders: Motivational Determinants of Adherence, Effect on Cognitive Determinants of Physical Activity, Physical Activity, Sitting Time and Clinical Symptoms;Completed;;Phase 2;86;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:22:24Z;2020-06-01T10:22:24Z;Berlin;3542690;Study Director;Andreas Ströhle, Prof.;Charité Universitätsmedizin Berlin - Departement of Psychiatry and Psychotherapy;Activity Intervention | Healthy Diet Intervention;63586247;1;;;2015;2020-05-29;23;FALSE;;FALSE;TRUE;18;;Years;;2;10;
NCT02566369;ClinicalTrials.gov processed this data on May 29, 2020;2015-10-01;;;2019-10-28;2015-10-01;2015-10-02;Estimate;;;;;;;2019-10-28;2019-11-12;Actual;November 30, 2015;Actual;2015-11-30;July 2018;2018-07-31;November 14, 2017;Actual;2017-11-14;November 14, 2017;Actual;2017-11-14;;Interventional;;;Efficacy and Safety of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream in Acne Vulgaris;A Multi-Center, Randomized, Double-Blind, Parallel-Group Vehicle Controlled Study To Compare The Efficacy And Safety Of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream In Subjects With Acne Vulgaris;Completed;;Phase 3;1208;Actual;Galderma R&D;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T10:23:04Z;2020-06-01T10:23:04Z;Berlin;3542952;Principal Investigator;Ulrike Blume-Peytavi, MD;Charité Universitätsmedizin;CD5789 (trifarotene) 50μg/g cream | Placebo cream;63586495;124;502;13;2015;2020-05-29;23;TRUE;17;TRUE;FALSE;9;;Years;;1;;
NCT02564081;ClinicalTrials.gov processed this data on May 29, 2020;2015-09-29;;;2016-02-01;2015-09-29;2015-09-30;Estimate;;;;;;;2016-02-01;2016-02-02;Estimate;August 2015;;2015-08-31;February 2016;2016-02-29;December 2015;Actual;2015-12-31;November 2015;Actual;2015-11-30;;Interventional;;;Remote Effects of Lower Limb Stretching;;Completed;;N/A;63;Actual;Goethe University;;3;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T10:23:33Z;2020-06-01T10:23:33Z;Frankfurt;;;;;Static Stretching lower limb | Static stretching Cervical;63586664;1;;;2015;2020-05-29;3;FALSE;;FALSE;TRUE;18;50;Years;Years;1;2;
NCT02560948;ClinicalTrials.gov processed this data on May 29, 2020;2015-09-23;;;2018-10-10;2015-09-24;2015-09-25;Estimate;;;;;;;2018-10-10;2018-10-11;Actual;December 2015;;2015-12-31;September 2015;2015-09-30;August 2016;Actual;2016-08-31;August 2016;Actual;2016-08-31;;Interventional;;;Clinical Efficacy and Safety of a Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis;A Multicenter, International, Randomised, Double-blind, Placebo Controlled Study to Demonstrate the Clinical Efficacy and Safety of a Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis;Completed;;Phase 3;554;Actual;BioTech Tools S.A.;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T10:24:31Z;2020-06-01T10:24:31Z;Aachen;3543350;Principal Investigator;Ralph Mösges, Professor;Private practice, Aachen, Germany;Placebo solution | gpASIT+TM;63586904;3;;;2015;2020-05-29;8;FALSE;;FALSE;FALSE;18;64;Years;Years;1;15;6
NCT02560220;ClinicalTrials.gov processed this data on May 29, 2020;2015-08-06;;;2018-07-23;2015-09-24;2015-09-25;Estimate;;;;;;;2018-07-23;2018-07-26;Actual;August 5, 2015;Actual;2015-08-05;July 2018;2018-07-31;April 18, 2017;Actual;2017-04-18;April 18, 2017;Actual;2017-04-18;;Interventional;TOL-1;;MIC Cell Therapy for Individualized Immunosuppression in Living Donor Kidney Transplant Recipients;A Single-arm Phase-I Trial for the Determination of Safety and Feasibility of the Intravenous Administration of Mitomycin C-treated Donor Peripheral Blood Mononuclear Cells (MICs) for Individualized Immunosuppression in Living Donor Kidney Transplant Recipients (TOL-1 Study);Completed;;Phase 1;14;Actual;Heidelberg University;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T10:24:37Z;2020-06-01T10:24:37Z;Heidelberg;3543440;Principal Investigator;Martin Zeier, MD;Heidelberg University;Mitomycin C-induced peripheral blood mononuclear cells (MICs);63586961;1;;;2015;2020-05-29;20;FALSE;;FALSE;TRUE;18;;Years;;1;10;
NCT02559141;ClinicalTrials.gov processed this data on May 29, 2020;2015-09-23;;;2015-10-27;2015-09-23;2015-09-24;Estimate;;;;;;;2015-10-27;2015-10-29;Estimate;March 2014;;2014-03-31;October 2015;2015-10-31;October 2015;Actual;2015-10-31;October 2015;Actual;2015-10-31;;Interventional;;;Non-invasive Early Goal Directed Therapy in Colorectal Surgery: a Feasibility Study;;Completed;;N/A;80;Actual;University of Schleswig-Holstein;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:24:53Z;2020-06-01T10:24:53Z;Kiel Lübeck;;;;;Dobutamine;63587043;1;;;2015;2020-05-29;19;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT02557698;ClinicalTrials.gov processed this data on May 29, 2020;2015-09-21;;;2017-03-07;2015-09-22;2015-09-23;Estimate;;;;;;;2017-03-07;2017-04-05;Actual;November 2014;;2014-11-30;March 2017;2017-03-31;September 2015;Actual;2015-09-30;April 2015;Actual;2015-04-30;;Interventional;;;Effectiveness of Using an Oil Bath Additive;Prospective, Randomized Study on the Skin Functional Parameters to Assess Skin Barrier Improvement After the Use of a Commercially Available Oil Bath Containing 84.75% Soybean Oil Compared to no Bath Additive;Completed;;N/A;60;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:25:07Z;2020-06-01T10:25:07Z;Berlin;;;;;Balneum oil bath;63587149;1;0;0;2015;2020-05-29;5;TRUE;20;FALSE;TRUE;6;85;Months;Years;1;29;
NCT02554318;ClinicalTrials.gov processed this data on May 29, 2020;2015-09-14;;;2015-09-17;2015-09-17;2015-09-18;Estimate;;;;;;;2015-09-17;2015-09-18;Estimate;October 2013;;2013-10-31;September 2015;2015-09-30;February 2015;Actual;2015-02-28;February 2015;Actual;2015-02-28;;Interventional;FSS;;Fermented Soybean Supplementation Among Active Pulmonary Tuberculosis Patients With Standard Therapy in Indonesia;The Effect of Fermented Soybean Supplementation on the Body Weight and Physical Function of Tuberculosis Patients With Standard Therapy in Indonesia;Completed;;N/A;129;Actual;University of Giessen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:25:58Z;2020-06-01T10:25:58Z;Giessen;3543845;Study Director;Michael B Krawinkel, Prof. Dr.;University of Giessen;Rifampicin | Isoniazid | Pyrazinamide | Ethambutol | Fermented soybean;63587404;;;;2015;2020-05-29;16;FALSE;;;FALSE;18;55;Years;Years;1;3;2
NCT02553668;ClinicalTrials.gov processed this data on May 29, 2020;2015-07-09;;;2015-09-16;2015-09-16;2015-09-17;Estimate;;;;;;;2015-09-16;2015-09-17;Estimate;October 2015;;2015-10-31;September 2015;2015-09-30;December 2016;Anticipated;2016-12-31;October 2016;Anticipated;2016-10-31;;Interventional;;;Proteomics for Identification of Hyperoxia-induced Changes in Protein Expression;Proteomics for Identification of Hyperoxia-induced Changes in Protein Expression;Unknown status;;N/A;40;Anticipated;University Hospital of Cologne;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:26:05Z;2020-06-01T10:26:05Z;Köln;3543893;Principal Investigator;Stefan Braunecker, M.D.;Universityhospital of Cologne;Oxygen (FiO2 1,0) | Facemask;63587454;;;;2015;2020-05-29;;FALSE;;;FALSE;18;50;Years;Years;1;8;
NCT02552875;ClinicalTrials.gov processed this data on May 29, 2020;2014-07-29;;;2015-09-16;2015-09-16;2015-09-17;Estimate;;;;;;;2015-09-16;2015-09-17;Estimate;September 2014;;2014-09-30;September 2015;2015-09-30;September 2015;Actual;2015-09-30;September 2015;Actual;2015-09-30;;Interventional;STSTS;;Shortening of the Twitch Stabilization Period by Tetanic Stimulation in Acceleromyography in Children and Young Adults;Shortening of the Twitch Stabilization Period by Tetanic Stimulation in Acceleromyography in Children and Young Adults;Completed;;Phase 4;80;Actual;University of Regensburg;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T10:26:17Z;2020-06-01T10:26:17Z;Regensburg;3543947;Principal Investigator;Christoph Unterbuchner, MD;University Medical Center Regensburg, Germany;Tetanic stimulation | Staircase Stimulation;63587515;1;;;2014;2020-05-29;12;FALSE;;FALSE;TRUE;1;21;Month;Years;1;1;
NCT02552654;ClinicalTrials.gov processed this data on May 29, 2020;2015-09-16;;;2016-09-30;2015-09-16;2015-09-17;Estimate;;;;;;;2016-09-30;2016-10-03;Estimate;September 2015;;2015-09-30;September 2016;2016-09-30;January 2016;Actual;2016-01-31;November 2015;Actual;2015-11-30;;Interventional;;;Cortisol and the Formation of Intrusive Memories;Cortisol and the Formation of Intrusive Memories: An Experimental Approach With a Trauma Film Paradigm;Completed;;N/A;60;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:26:18Z;2020-06-01T10:26:18Z;Berlin;3543967;Study Director;Stefan Roepke;Charite University, Berlin, Germany;Stress Film | Hydrocortisone | Placebo;63587532;;;;2015;2020-05-29;2;FALSE;;;FALSE;18;34;Years;Years;1;2;
NCT02552589;ClinicalTrials.gov processed this data on May 29, 2020;2015-09-03;;;2016-02-05;2015-09-16;2015-09-17;Estimate;;;;;;;2016-02-05;2016-02-08;Estimate;September 2015;;2015-09-30;February 2016;2016-02-29;February 2016;Actual;2016-02-29;February 2016;Actual;2016-02-29;;Interventional;;;Effect of Toothpaste on the Reduction of Plaque and Inflammation;Clinical Evaluation of the Effect of an Experimental Toothpaste on the Reduction of Dental Plaque and Gingival Inflammation;Completed;;N/A;241;Actual;Technische Universität Dresden;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T10:26:19Z;2020-06-01T10:26:19Z;Dresden;;;;;Amine fluoride | Placebo;63587537;1;;;2015;2020-05-29;5;FALSE;;FALSE;TRUE;18;65;Years;Years;1;9;
NCT02551978;ClinicalTrials.gov processed this data on May 29, 2020;2015-09-11;;;2015-11-26;2015-09-15;2015-09-16;Estimate;;;;;;;2015-11-26;2015-11-30;Estimate;September 2015;;2015-09-30;September 2015;2015-09-30;November 2015;Actual;2015-11-30;October 2015;Actual;2015-10-31;;Interventional;KOP;;Kids Obesity Prevention Program - Study (KOP);Kids Obesity Prevention Program - Study (KOP). A Serious Game to Address Barriers to Prevention and Treatment of Obesity in Primary School Children;Completed;;N/A;60;Anticipated;University Hospital Tuebingen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:26:28Z;2020-06-01T10:26:28Z;Tübingen;3544012;Principal Investigator;Stephan Zipfel, Prof. Dr.;University Hospital Tuebingen, Germany;The serious game KOP;63587582;;;;2015;2020-05-29;1;FALSE;;;FALSE;9;12;Years;Years;1;5;
NCT02551302;ClinicalTrials.gov processed this data on May 29, 2020;2015-09-15;;;2015-09-15;2015-09-15;2015-09-16;Estimate;;;;;;;2015-09-15;2015-09-16;Estimate;October 2015;;2015-10-31;September 2015;2015-09-30;December 2017;Anticipated;2017-12-31;December 2017;Anticipated;2017-12-31;;Interventional;BalanC;;Efficacy of Hybrid Systems (Topping Off) Versus Rigid Spinal Fusion in Lumbar Fusion Surgery: A Dual-center, Prospective, Randomized Pilot Study (CD Horizon BalanC);;Unknown status;;N/A;60;Anticipated;University of Cologne;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:26:35Z;2020-06-01T10:26:35Z;Köln;3544052;Principal Investigator;Jan Siewe, Dr.med.;University Hospital Cologne;Solera™ Medtronic | CD HORIZON BalanC™ Medtronic;63587634;;;;2015;2020-05-29;;FALSE;;;FALSE;30;;Years;;1;1;
NCT02550600;ClinicalTrials.gov processed this data on May 29, 2020;2015-07-24;;;2015-09-11;2015-09-11;2015-09-15;Estimate;;;;;;;2015-09-11;2015-09-15;Estimate;November 2015;;2015-11-30;September 2015;2015-09-30;December 2017;Anticipated;2017-12-31;July 2017;Anticipated;2017-07-31;;Interventional;EXODUS;;Extracorporeal Lung Assist Device in Acute Lung Impairment;EXODUS: Extracorporeal Lung Assist Device in Acute Lung Impairment: A Randomized Controlled Study;Unknown status;;N/A;300;Anticipated;Technische Universität München;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T10:26:45Z;2020-06-01T10:26:45Z;Munich;3544104;Principal Investigator;Wolfgang Huber, MD;"II. Medizinische Klinik; Klinikum rechts der Isar; Ismaningerstrasse 22; D-81675 München; Germany";iLA activve treatment | Control group;63587688;8;;;2015;2020-05-29;;FALSE;;FALSE;FALSE;18;;Years;;1;12;
NCT02550418;ClinicalTrials.gov processed this data on May 29, 2020;2015-09-14;;;2017-07-25;2015-09-14;2015-09-15;Estimate;;;;;;;2017-07-25;2017-07-26;Actual;October 2015;;2015-10-31;July 2017;2017-07-31;March 2017;Actual;2017-03-31;March 2017;Actual;2017-03-31;;Interventional;TOPICAL-1;;Budesonide 9 mg Capsules in Active UC;Open-label, Multi-centre, Proof of Concept Phase IIa Clinical Trial on the Efficacy and Tolerability of an 8 Week Oral Treatment With Once Daily 9 mg Budesonide in Patients With Active Ulcerative Colitis;Completed;;Phase 2;60;Actual;Dr. Falk Pharma GmbH;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:26:47Z;2020-06-01T10:26:47Z;Kiel Lübeck;3544113;Principal Investigator;Klaus Fellermann, MD;University of Schleswig-Holstein;Budesonide;63587699;1;;;2015;2020-05-29;17;FALSE;;FALSE;TRUE;18;75;Years;Years;1;2;
NCT02548585;ClinicalTrials.gov processed this data on May 29, 2020;2015-09-04;;;2019-01-08;2015-09-10;2015-09-14;Estimate;;;;;;;2019-01-08;2019-04-05;Actual;December 9, 2015;Actual;2015-12-09;January 2019;2019-01-31;February 24, 2017;Actual;2017-02-24;February 24, 2017;Actual;2017-02-24;;Interventional;;;A Multiple-ascending-dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of MEDI0382 in Overweight and Obese Participants With Type 2 Diabetes Mellitus;A Phase 1/2, Randomized, Double-blind, Placebo-controlled, Multiple-ascending-dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MEDI0382 in Overweight and Obese Subjects With a History of Type 2 Diabetes Mellitus;Completed;;Phase 1/Phase 2;113;Actual;MedImmune LLC;;7;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;;;2020-06-01T10:27:08Z;2020-06-01T10:27:08Z;Leipzig;3544289;Principal Investigator;Michael Stumvoll;Universitätsklinikum Leipzig;MEDI0382 | Placebo;63587835;11;501;4;2015;2020-05-29;14;TRUE;15;FALSE;FALSE;18;65;Years;Years;2;24;
NCT02547519;ClinicalTrials.gov processed this data on May 29, 2020;2015-08-29;;;2018-02-12;2015-09-09;2015-09-11;Estimate;;;;;;;2018-02-12;2018-02-13;Actual;August 2015;;2015-08-31;February 2018;2018-02-28;December 2017;Actual;2017-12-31;December 2017;Actual;2017-12-31;;Interventional;;;Pre-POINT-Early Study;Pilot Study Using Oral Insulin at Early Age for Immune Efficacy in Primary Prevention of Type 1 Diabetes;Completed;;Phase 2;44;Actual;Technische Universität München;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T10:27:31Z;2020-06-01T10:27:31Z;Dresden Munich;3544358;Principal Investigator;Anette-G. Ziegler, Prof. Dr., MD;Forschergruppe Diabetes, Klinikum rechts der Isar, Technische Universität München, Lehrstuhl für Diabetes und Gestationsdiabetes, der Technischen Universität München;Oral Insulin | Placebo;63587915;1;;;2015;2020-05-29;28;FALSE;;FALSE;TRUE;6;2;Months;Years;2;5;1
NCT02545296;ClinicalTrials.gov processed this data on May 29, 2020;2015-07-08;;;2018-03-06;2015-09-07;2015-09-09;Estimate;;;;;;;2018-03-06;2018-03-07;Actual;July 2015;;2015-07-31;March 2018;2018-03-31;August 2017;Actual;2017-08-31;October 2016;Actual;2016-10-31;;Interventional;BABY;;HIV Point-of-Care Test Evaluation in Infants;HIV Point-of-Care Tests in Babies Study (BABY) - Operational Evaluation of HIV Point-of-Care Tests for Very Early Infant HIV Diagnostics in Infants Born to HIV Infected Mothers in Mbeya, Tanzania;Completed;;N/A;604;Actual;Ludwig-Maximilians - University of Munich;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T10:27:57Z;2020-06-01T10:27:57Z;Munich;3544521;Study Director;Michael Hoelscher, Prof Dr;Medical Centre of the University of Munich;In-vitro Diagnostics;63588087;1;;;2015;2020-05-29;15;FALSE;;FALSE;TRUE;;48;;Hours;2;;
NCT02542033;ClinicalTrials.gov processed this data on May 29, 2020;2015-09-03;;;2016-10-19;2015-09-03;2015-09-04;Estimate;;;;;;;2016-10-19;2016-10-20;Estimate;May 2015;;2015-05-31;September 2015;2015-09-30;November 2015;Actual;2015-11-30;August 2015;Actual;2015-08-31;;Interventional;;;Glycemic Response to Low Sugar Apple Juice;Double-blind, Randomized, Controlled, Cross-over Trial on Glycemic Response to Low Sugar Apple Juice;Completed;;N/A;30;Actual;Clinical Research Center Kiel GmbH;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:28:41Z;2020-06-01T10:28:41Z;Kiel;;;;;treated apple juice with low sugar content | un-treated apple juice with normal sugar content;63588332;1;;;2015;2020-05-29;3;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT02541357;ClinicalTrials.gov processed this data on May 29, 2020;2015-09-01;;;2017-05-23;2015-09-03;2015-09-04;Estimate;;;;;;;2017-05-23;2017-05-25;Actual;September 2015;Actual;2015-09-30;May 2017;2017-05-31;October 2016;Actual;2016-10-31;October 2016;Actual;2016-10-31;;Interventional;MBM_Colo;;Preoperative Relaxation and Intensified Patient Surgery Education in Patients Undergoing Colorectal Surgery;Effects of Preoperative Relaxation and Intensified Surgery Education on Preoperative Wellbeing and Postoperative Complaints in Patients Undergoing Colorectal Surgery - a Randomized Controlled Trial;Terminated;;N/A;4;Actual;Universität Duisburg-Essen;;4;;Recruitment insufficient;FALSE;;;;TRUE;;;;;;;;;;;No;Study has been terminated;2020-06-01T10:28:51Z;2020-06-01T10:28:51Z;Duisburg;3544822;Principal Investigator;Gustav Dobos, Prof, MD;Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, University of Duisburg-Essen;relaxation program | surgery education;63588387;1;;;2015;2020-05-29;13;FALSE;;FALSE;TRUE;18;;Years;;2;15;
NCT02541071;ClinicalTrials.gov processed this data on May 29, 2020;2015-08-06;;;2015-09-03;2015-09-03;2015-09-04;Estimate;;;;;;;2015-09-03;2015-09-04;Estimate;November 2013;;2013-11-30;September 2015;2015-09-30;October 2014;Actual;2014-10-31;October 2014;Actual;2014-10-31;;Interventional;;;Influence of the Noradrenergic System on the Formation of Intrusive Memories;Influence of the Noradrenergic System on the Formation of Intrusive Memories: An Experimental Approach With a Trauma Film Paradigm;Completed;;N/A;118;Actual;Charite University, Berlin, Germany;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:28:53Z;2020-06-01T10:28:53Z;Berlin;3544839;Study Director;Stefan Roepke, Dr.;Charite University, Berlin, Germany;Stress Film | Yohimbine | Clonidine | placebo;63588409;1;;;2015;2020-05-29;11;FALSE;;FALSE;TRUE;18;44;Years;Years;1;2;
NCT02539680;ClinicalTrials.gov processed this data on May 29, 2020;2015-08-25;;;2017-11-22;2015-08-31;2015-09-03;Estimate;;;;;;;2017-11-22;2017-11-24;Actual;September 2015;Actual;2015-09-30;April 2017;2017-04-30;November 2017;Actual;2017-11-30;October 2017;Actual;2017-10-31;;Interventional;PeTRA;;Intestinal Phosphate Transporter Expression in CKD Patients;Joint Study on Intestinal Phosphate-TRAnsporter Expression in CKD Patients;Terminated;;N/A;18;Actual;RWTH Aachen University;;3;;insufficiant recruitment;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T10:29:09Z;2020-06-01T10:29:09Z;Aachen;;;;;endoscopy;63588511;1;;;2015;2020-05-29;25;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT02535741;ClinicalTrials.gov processed this data on May 29, 2020;2015-08-21;;;2018-03-29;2015-08-26;2015-08-31;Estimate;;;;;;;2018-03-29;2018-06-26;Actual;October 2006;;2006-10-31;February 2018;2018-02-28;May 2016;Actual;2016-05-31;May 2013;Actual;2013-05-31;;Interventional;TriathlonCR;;Clinical Outcome Study for the Triathlon Cruciate Retaining (CR) Total Knee;Clinical Outcome Study for the Triathlon CR Total Knee;Completed;;N/A;168;Actual;Stryker European Operations BV;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:30:08Z;2020-06-01T10:30:08Z;Hannover;3545219;Principal Investigator;Christina Stukenborg-Colsman, Prof.;Medizinische Universität Hannover;Triathlon CR Total Knee System;63588809;6;0;61;2015;2020-05-29;80;TRUE;28;FALSE;FALSE;21;80;Years;Years;1;4;
NCT02534285;ClinicalTrials.gov processed this data on May 29, 2020;2015-08-25;;;2016-12-20;2015-08-26;2015-08-27;Estimate;;;;;;;2016-12-20;2016-12-21;Estimate;August 2015;;2015-08-31;December 2016;2016-12-31;November 2016;Actual;2016-11-30;November 2016;Actual;2016-11-30;;Interventional;;;Study to Investigate the Impact of Noise on Requirements of Anesthetics During General Anesthesia;;Completed;;N/A;100;Actual;Technische Universität Dresden;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:30:27Z;2020-06-01T10:30:27Z;Dresden;3545311;Principal Investigator;Matthias Hübler, MD;"Consultant Dept. of Anesthesia; University Hospital Dresden; Technische Universität Dresden";hearing protection;63588920;1;;;2015;2020-05-29;15;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT02532881;ClinicalTrials.gov processed this data on May 29, 2020;2015-07-30;;;2016-11-11;2015-08-25;2015-08-26;Estimate;;;;;;;2016-11-11;2016-11-15;Estimate;August 2015;;2015-08-31;November 2016;2016-11-30;October 2016;Actual;2016-10-31;August 2016;Actual;2016-08-31;;Interventional;Reh@:Info;;Evaluation of a Video-based Internet Intervention as Preparation for Inpatient Psychosomatic Rehabilitation;Evaluation of a Video-based Internet Intervention as Preparation for Inpatient Psychosomatic Rehabilitation: A Randomized Controlled Trial;Completed;;Phase 2;492;Actual;Johannes Gutenberg University Mainz;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:30:48Z;2020-06-01T10:30:48Z;Mainz;3545405;Principal Investigator;Rüdiger Zwerenz, Dr.;University Medical Center, Department of Psychosomatic Medicine and Psychotherapy, Johannes Gutenberg University Mainz;Videos | Treatment as usual;63589031;5;;;2015;2020-05-29;12;FALSE;;FALSE;FALSE;18;;Years;;1;13;
NCT02532166;ClinicalTrials.gov processed this data on May 29, 2020;2015-08-17;;;2015-08-24;2015-08-24;2015-08-25;Estimate;;;;;;;2015-08-24;2015-08-25;Estimate;January 2012;;2012-01-31;August 2015;2015-08-31;December 2016;Anticipated;2016-12-31;December 2015;Anticipated;2015-12-31;;Interventional;;;Incidence of Esophageal Lichen Planus in Patients With Known Oral Lichen Planus;Incidence of Esophageal Lichen Planus in Patients With Known Oral Lichen Planus. Diagnostic Value of White Light Endoscopy, Narrow Band Imaging and Chromoendoscopy for Detection of Esophageal Manifestation in Patients With Oral Lichen.;Unknown status;;N/A;50;Anticipated;Ruhr University of Bochum;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:31:06Z;2020-06-01T10:31:06Z;Bochum;;;;;Esophageal lichen planus;63589085;2;;;2015;2020-05-29;;FALSE;;FALSE;FALSE;18;;Years;;1;1;
NCT02531386;ClinicalTrials.gov processed this data on May 29, 2020;2015-08-07;;;2015-11-06;2015-08-20;2015-08-24;Estimate;;;;;;;2015-11-06;2015-11-09;Estimate;August 2015;;2015-08-31;September 2015;2015-09-30;November 2015;Actual;2015-11-30;September 2015;Actual;2015-09-30;;Interventional;;;System Accuracy Evaluation of 6 CE-marked Blood Glucose Monitoring System Following ISO 15197:2013;System Accuracy Evaluation of Accu-Chek Aviva Nano (Roche Diagnostics), Accu-Chek Performa Nano (Roche Diagnostics), FreeStyle Lite (Abbott Diabetes Care), OneTouch Verio IQ (LifeScan), Contour Next Link 2.4 (Bayer Consumer Care), One Additional CE-marked Blood Glucose Monitoring System Following ISO 15197:2013;Completed;;N/A;120;Anticipated;Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm;;;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T10:31:45Z;2020-06-01T10:31:45Z;Ulm;;;;;6 blood glucose monitoring systems for self-testing (blood glucose meters);63589145;1;;;2015;2020-05-29;1;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT02527707;ClinicalTrials.gov processed this data on May 29, 2020;2015-08-13;;;2018-02-06;2015-08-17;2015-08-19;Estimate;;;;;;;2018-02-06;2018-02-09;Actual;September 2015;;2015-09-30;February 2018;2018-02-28;August 2016;Actual;2016-08-31;August 2016;Actual;2016-08-31;;Interventional;LOWR 4;;Titrating-Dose of Lonafarnib in Combination With Ritonavir;A Phase 2, Open-Label Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Activity of a Titrating-Dose Lonafarnib in Combination With Ritonavir in Patients Chronically Infected With Hepatitis Delta Virus;Completed;;Phase 2;15;Actual;Eiger BioPharmaceuticals;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T10:32:53Z;2020-06-01T10:32:53Z;Hannover;3545762;Principal Investigator;Heiner Wedemeyer, MD, PhD;Hannover Medical School;lonafarnib | Ritonavir;63589421;;;;2015;2020-05-29;11;FALSE;;;FALSE;18;65;Years;Years;1;1;
NCT02526732;ClinicalTrials.gov processed this data on May 29, 2020;2015-08-17;;;2018-09-01;2015-08-17;2015-08-18;Estimate;;;;;;;2018-09-01;2018-09-05;Actual;September 2015;;2015-09-30;September 2018;2018-09-30;December 20, 2017;Actual;2017-12-20;December 20, 2017;Actual;2017-12-20;;Interventional;HELP;;Hepatic Inflammation and Physical Performance in Patients With NASH;Influence of Hepatic Inflammation and Hepatocellular Apoptosis on Physical Performance and Training Effect in Patients With Non - Alcoholic Steatohepatitis;Completed;;N/A;44;Actual;Johannes Gutenberg University Mainz;;1;;;FALSE;;;;FALSE;;;;;;;;;;;Yes;Publication in scientific journals and conferences;2020-06-01T10:33:02Z;2020-06-01T10:33:02Z;Mainz;3545835;Study Director;Peter R Galle, MD;I. Medizinische Klinik und Poliklinik, Universitätsmedizin Mainz;individual training program;63589494;1;;;2015;2020-05-29;27;FALSE;;FALSE;TRUE;18;70;Years;Years;1;1;
NCT02526342;ClinicalTrials.gov processed this data on May 29, 2020;2015-08-02;;;2016-05-15;2015-08-15;2015-08-18;Estimate;;;;;;;2016-05-15;2016-05-17;Estimate;August 2015;;2015-08-31;May 2016;2016-05-31;September 2016;Anticipated;2016-09-30;August 2016;Anticipated;2016-08-31;;Interventional;;;Impact of Negative Pressure Wound Therapy on Free Muscle Flaps;Impact of Negative Pressure Wound Therapy on Free Muscle Flaps;Unknown status;;N/A;30;Anticipated;Klinik Bogenhausen;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T10:33:06Z;2020-06-01T10:33:06Z;Munich;3545864;Principal Investigator;Ulf Dornseifer, M.D.;Bogenhausen Academic Hospital, Technische Universität München, Munich, Germany;V.A.C. UltraTM (KCI®,San Antonio, Texas, USA);63589524;1;;;2015;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT02523859;ClinicalTrials.gov processed this data on May 29, 2020;2015-08-11;;;2017-08-01;2015-08-13;2015-08-14;Estimate;;;;;;;2017-08-01;2017-08-02;Actual;July 2015;;2015-07-31;August 2017;2017-08-31;March 2016;Actual;2016-03-31;March 2016;Actual;2016-03-31;;Interventional;;;Study of the Efficacy and Safety of Remimazolam in General Anesthesia in Adults Undergoing Cardiac Surgery;A Randomized, Single-blind, Propofol-controlled Phase III Study Evaluating the Efficacy and Safety of Remimazolam in General Anesthesia in Adult Patients Undergoing Cardiac Surgery, Including Follow-up Sedation in the Post-anesthesia Care Unit/Intensive Care Unit;Terminated;;Phase 3;25;Actual;Paion UK Ltd.;;2;;Poor recruitment;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:33:34Z;2020-06-01T10:33:34Z;Leipzig;3546050;Principal Investigator;Stefan Probst, MD;Herzzentrum Leipzig GmbH;Remimazolam | Propofol;63589715;1;;;2015;2020-05-29;8;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT02520830;ClinicalTrials.gov processed this data on May 29, 2020;2015-07-08;;;2015-11-02;2015-08-07;2015-08-13;Estimate;;;;;;;2015-11-02;2015-11-03;Estimate;March 2014;;2014-03-31;November 2015;2015-11-30;September 2015;Actual;2015-09-30;September 2015;Actual;2015-09-30;;Interventional;;;Effects of Blueberry-polyphenols on Endothelial Function, Absorption and Metabolism;Sustained Effects of Blueberry Polyphenols on Vascular Function in Healthy Individuals;Completed;;N/A;45;Actual;Heinrich-Heine University, Duesseldorf;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:34:04Z;2020-06-01T10:34:04Z;Düsseldorf;3546284;Principal Investigator;Ana Rodriguez-Mateos, PhD;Division of Cardiology, Pulmonology and Vascular Medicine, University Hospital Duesseldorf;Blueberry Group | Placebo Group;63589948;1;;;2015;2020-05-29;18;FALSE;;FALSE;TRUE;18;70;Years;Years;1;3;2
NCT02519101;ClinicalTrials.gov processed this data on May 29, 2020;2015-08-01;;;2017-08-29;2015-08-07;2015-08-10;Estimate;;;;;;;2017-08-29;2017-08-30;Actual;June 2015;;2015-06-30;August 2017;2017-08-31;May 2016;Actual;2016-05-31;May 2016;Actual;2016-05-31;;Interventional;ANIKOB;;Effects of Continuous Noninvasive Arterial Pressure Measurement on Anaesthesia;Impact of Continuous Noninvasive Arterial Blood Pressure Monitoring on Blood Pressure Stability During General Anaesthesia in Orthopedic Patients;Completed;;N/A;160;Actual;Ludwig-Maximilians - University of Munich;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:34:24Z;2020-06-01T10:34:24Z;Munich;;;;;continuous noninvasive blood pressure monitoring ClearSight-Device;63590080;1;;;2015;2020-05-29;11;FALSE;;FALSE;TRUE;18;;Years;;2;1;1
NCT02517801;ClinicalTrials.gov processed this data on May 29, 2020;2015-07-08;;;2015-11-02;2015-08-06;2015-08-07;Estimate;;;;;;;2015-11-02;2015-11-03;Estimate;January 2015;;2015-01-31;November 2015;2015-11-30;September 2015;Actual;2015-09-30;September 2015;Actual;2015-09-30;;Interventional;Anthocyanins;;Investigation on the Sustained Effect of Anthocyanins on Endothelial Function in Postmenopausal Women;Investigation on the Sustained Effect of Anthocyanins on Endothelial Function in Postmenopausal Women;Completed;;N/A;20;Actual;Heinrich-Heine University, Duesseldorf;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:34:40Z;2020-06-01T10:34:40Z;Düsseldorf;3546506;Principal Investigator;Ana Rodriguez-Mateos, PhD;Division of Cardiology, Pulmonary Disease and Vascular Medicine, University Hospital Duesseldorf;Anthocyanin capsules | placebo capsules;63590178;1;;;2015;2020-05-29;8;FALSE;;FALSE;TRUE;50;;Years;;1;4;2
NCT02517775;ClinicalTrials.gov processed this data on May 29, 2020;2015-07-08;;;2015-11-02;2015-08-04;2015-08-07;Estimate;;;;;;;2015-11-02;2015-11-03;Estimate;October 2014;;2014-10-31;November 2015;2015-11-30;September 2015;Actual;2015-09-30;September 2015;Actual;2015-09-30;;Interventional;Cranberry;;Effects of Cranberry Consumption in Vascular Function in Healthy Individuals;Intake and Time-dependent Effects of Cranberry (Poly)Phenol Consumption in Vascular Function in Healthy Individuals;Completed;;N/A;10;Actual;Heinrich-Heine University, Duesseldorf;;6;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:34:40Z;2020-06-01T10:34:40Z;Düsseldorf;;;;;Cranberry 320 | Cranberry 640 | Cranberry 960 | Cranberry 1280 | Cranberry 1600 | Cranberry deprived supplement;63590180;1;;;2015;2020-05-29;11;FALSE;;FALSE;TRUE;18;40;Years;Years;1;4;2
NCT02515526;ClinicalTrials.gov processed this data on May 29, 2020;2015-08-01;;;2019-09-06;2015-08-03;2015-08-04;Estimate;;;;;;;2019-09-06;2019-09-09;Actual;June 2015;;2015-06-30;September 2019;2019-09-30;August 27, 2015;Actual;2015-08-27;August 27, 2015;Actual;2015-08-27;;Interventional;;;Effect of Acute Ethanol Consumption on The Activity of Major Cytochrome P450 Enzymes, NAT2 and P-glycoprotein;Effect of Acute Ethanol Consumption on The Activity of Major Cytochrome P450 Enzymes, NAT2 and P-glycoprotein;Completed;;N/A;16;Actual;University of Cologne;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T10:35:08Z;2020-06-01T10:35:08Z;Köln;3546668;Principal Investigator;Uwe Fuhr;Department of Pharmacology,University Hospital Cologne;caffeine, tolbutamide, omeprazole, dextromethorphan, digoxin, midazolam single doses | ethanol multiple doses plus caffeine, tolbutamide, omeprazole, dextromethorphan, digoxin, midazolam single doses;63590350;1;;;2015;2020-05-29;1;FALSE;;FALSE;TRUE;18;55;Years;Years;9;7;
NCT02512575;ClinicalTrials.gov processed this data on May 29, 2020;2015-07-06;;;2018-09-27;2015-07-29;2015-07-31;Estimate;;;;;;;2018-09-27;2018-10-04;Actual;November 18, 2015;Actual;2015-11-18;September 2018;2018-09-30;September 26, 2016;Actual;2016-09-26;September 26, 2016;Actual;2016-09-26;;Interventional;;;A Single Ascending Dose Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of AZD9567.;A Phase I, Randomized, Single-Blind, Placebo-Controlled Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Single Ascending Oral Doses Of AZD9567 In Healthy Subjects.;Completed;;Phase 1;72;Actual;AstraZeneca;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:35:45Z;2020-06-01T10:35:45Z;Berlin;3546886;Principal Investigator;Rainhard Fuhr, Dr. med.;PAREXEL International GmbH, Berlin;AZD9567 Monohydrat | Placebo oral suspension/ Placebo capsule | Prednisolone;63590574;1;16;0;2015;2020-05-29;10;TRUE;12;FALSE;TRUE;18;55;Years;Years;6;3;
NCT02512328;ClinicalTrials.gov processed this data on May 29, 2020;2015-02-24;;;2015-07-27;2015-07-27;2015-07-30;Estimate;;;;;;;2015-07-27;2015-07-30;Estimate;March 2015;;2015-03-31;July 2015;2015-07-31;October 2015;Anticipated;2015-10-31;October 2015;Anticipated;2015-10-31;;Interventional;PERICLESAPPI;;Improvement of Colonoscopy Preparation by New Media (APP);"First Experiences With an Offline App (SPA; Smartphone Application) for Colonoscopy Preparation- PERICLES-I APP; Prospective Evaluations of Improvement of Colonocopy Preparation by Optimized Visualization (PERICLES)";Unknown status;;Phase 1;25;Anticipated;Technische Universität München;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:35:50Z;2020-06-01T10:35:50Z;Munich;;;;;APP supported colonoscopy preparation;63590594;1;;;2015;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;2;
NCT02509962;ClinicalTrials.gov processed this data on May 29, 2020;2015-07-24;;;2017-07-18;2015-07-24;2015-07-28;Estimate;;;;;;;2017-07-18;2017-07-19;Actual;July 2015;;2015-07-31;July 2017;2017-07-31;July 2017;Actual;2017-07-31;June 2016;Actual;2016-06-30;;Interventional;BSALT;;Increased Salt Intake in Healthy Men;Effects of Increased Salt Intake on Metabolic, Cardiovascular and Immunoregulatory Functions in Healthy Men;Completed;;N/A;14;Actual;Charite University, Berlin, Germany;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:36:13Z;2020-06-01T10:36:13Z;Berlin;3547047;Principal Investigator;Michael Boschmann, Dr.;Charite University, Berlin, Germany;Slow sodium tablets;63590771;1;;;2015;2020-05-29;11;FALSE;;FALSE;TRUE;20;50;Years;Years;1;;
NCT02509728;ClinicalTrials.gov processed this data on May 29, 2020;2015-07-22;;;2018-05-09;2015-07-27;2015-07-28;Estimate;;;;;;;2018-05-09;2018-05-15;Actual;July 2015;Actual;2015-07-31;May 2018;2018-05-31;December 31, 2017;Actual;2017-12-31;October 31, 2017;Actual;2017-10-31;;Interventional;;;Metabolic Effects of Choline and Docosahexaenoic Acid Supplementation in Preterm Infants;Nahrungsergänzung Mit Cholin- Und Docosahexaensäure Bei Sehr Unreifen Frühgeborenen;Completed;;N/A;24;Actual;University Hospital Tuebingen;;4;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:36:15Z;2020-06-01T10:36:15Z;Tübingen;3547064;Principal Investigator;Axel Franz, MD;University Hospital Tuebingen;choline supplementation | DHA supplementation | standard nutrition;63590788;1;;;2015;2020-05-29;27;FALSE;;FALSE;TRUE;;2;;Months;1;7;
NCT02509559;ClinicalTrials.gov processed this data on May 29, 2020;2015-06-30;;;2015-07-23;2015-07-23;2015-07-28;Estimate;;;;;;;2015-07-23;2015-07-28;Estimate;October 2013;;2013-10-31;July 2015;2015-07-31;January 2015;Actual;2015-01-31;February 2014;Actual;2014-02-28;;Interventional;BBEmoMem_G;;Effects of Propranolol (vs. Placebo) on Information Processing During Presentation of Emotionally Arousing Pictures;Effects of Propranolol (vs. Placebo) on Information Processing During Presentation of Emotionally Arousing Pictures After Single Dose (80 mg) Administration and Relationships Between ß1- and ß2-adrenoreceptors Genotype and Both the Information Processing and the Propranolol Effects in 64 Healthy Male Subjects;Completed;;Phase 1;8;Actual;University Medicine Greifswald;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T10:36:16Z;2020-06-01T10:36:16Z;Greifswald;;;;;propranololhydrochloride | placebo | Net Station® System and compatible Geodesic Sensor Nets® | VITAPORT | ergoselect II 100/200 | SpiroScout | Mobil-O-Graph® PWA | Saliva collection;63590800;1;;;2015;2020-05-29;4;FALSE;;FALSE;TRUE;18;35;Years;Years;4;8;4
NCT02508220;ClinicalTrials.gov processed this data on May 29, 2020;2015-03-18;;;2015-11-30;2015-07-23;2015-07-24;Estimate;;;;;;;2015-11-30;2015-12-02;Estimate;July 2015;;2015-07-31;July 2015;2015-07-31;November 2015;Actual;2015-11-30;November 2015;Actual;2015-11-30;;Interventional;;;Short-term Effects of Oxytocin Nasal Spray on Chronic Tinnitus;Short-term Effects of Oxytocin Nasal Spray on Chronic Tinnitus;Completed;;N/A;15;Actual;University of Regensburg;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:36:32Z;2020-06-01T10:36:32Z;Regensburg;;;;;Syntocinon | Placebo;63590903;;;;2015;2020-05-29;4;FALSE;;;FALSE;18;;Years;;2;3;
NCT02507167;ClinicalTrials.gov processed this data on May 29, 2020;2015-07-22;;;2015-07-22;2015-07-22;2015-07-23;Estimate;;;;;;;2015-07-22;2015-07-23;Estimate;November 2012;;2012-11-30;July 2015;2015-07-31;December 2014;Actual;2014-12-31;July 2013;Actual;2013-07-31;;Interventional;;;Impact of Two Genetic Variants of OATP1B3 or MRP2 or Rifampin on Systemic Disposition and Biological Efficacy of CCK-8;Impact of Two Genetic Variants of OATP 1B3 or MRP 2 or Rifampin Mediated Transporter Inhibition on Systemic Disposition and Biological Efficacy of CCK-8 in 36 Healthy Male Individuals;Completed;;Phase 1;19;Actual;University Medicine Greifswald;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T10:36:48Z;2020-06-01T10:36:48Z;Greifswald;;;;;mixed meal | Rifampin;63590982;1;;;2015;2020-05-29;8;FALSE;;FALSE;TRUE;18;45;Years;Years;1;7;5
NCT02503293;ClinicalTrials.gov processed this data on May 29, 2020;2015-07-01;;;2019-04-05;2015-07-17;2015-07-20;Estimate;;;;;;;2019-04-05;2019-04-09;Actual;July 29, 2015;Actual;2015-07-29;April 2019;2019-04-30;December 11, 2017;Actual;2017-12-11;December 11, 2017;Actual;2017-12-11;;Interventional;;;A Study to Compare Quality of Life and Satisfaction in Primary Immunodeficient Patients Treated With Subcutaneous Injections of Gammanorm® 165 mg/mL Administered With Two Different Delivery Devices: Injections Using Pump or Rapid Push;A Randomised, Cross-over Study to Compare Quality of Life and Satisfaction in Primary Immunodeficient Patients Treated With Subcutaneous Injections of Gammanorm® 165 mg/mL Administered With Two Different Delivery Devices: Injections Using Pump or Rapid Push;Completed;;Phase 4;30;Actual;Octapharma;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:37:44Z;2020-06-01T10:37:44Z;Freiburg;3547515;Principal Investigator;Klaus Warnatz, MD;Centre of Chronic Immunodeficiency, University Medical Centre Freiburg, Breisacher;Chrono Super PID then Generic Syringe-Gammanorm | Generic Syringe then Chrono Super PID-Gammanorm;63591277;12;;;2015;2020-05-29;28;FALSE;;FALSE;FALSE;18;;Years;;1;1;
NCT02501837;ClinicalTrials.gov processed this data on May 29, 2020;2015-07-15;;;2015-07-15;2015-07-15;2015-07-17;Estimate;;;;;;;2015-07-15;2015-07-17;Estimate;July 2014;;2014-07-31;July 2015;2015-07-31;June 2015;Actual;2015-06-30;June 2015;Actual;2015-06-30;;Interventional;;;The Influence of Oxytocin on Pair-bonding and Emotion Regulation;The Influence of Oxytocin on Pair-bonding and Emotion Regulation;Completed;;Early Phase 1;40;Actual;University Hospital, Bonn;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:38:00Z;2020-06-01T10:38:00Z;Bonn;;;;;Syntocinon-Spray;63591388;1;;;2015;2020-05-29;11;FALSE;;FALSE;TRUE;18;45;Years;Years;2;3;
NCT02501577;ClinicalTrials.gov processed this data on May 29, 2020;2015-07-09;;;2015-07-16;2015-07-16;2015-07-17;Estimate;;;;;;;2015-07-16;2015-07-17;Estimate;March 2015;;2015-03-31;July 2015;2015-07-31;October 2015;Anticipated;2015-10-31;October 2015;Anticipated;2015-10-31;;Interventional;supraview;;Comparison of Various Supraglottic Airway Devices for Fiberoptical Guided Tracheal Intubation;Comparison of Various Supraglottic Airway Devices for Fiberoptical Guided Tracheal Intubation;Unknown status;;N/A;30;Anticipated;University of Regensburg;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:38:03Z;2020-06-01T10:38:03Z;Regensburg;3547687;Study Chair;Thomas Metterlein, MD;Uni Regensburg;SAD 1 | SAD 2;63591409;1;;;2015;2020-05-29;;FALSE;;FALSE;TRUE;18;80;Years;Years;1;;
NCT02500394;ClinicalTrials.gov processed this data on May 29, 2020;2015-07-07;;;2017-05-04;2015-07-14;2015-07-16;Estimate;;;;;;;2017-05-04;2017-05-05;Actual;June 2015;;2015-06-30;May 2017;2017-05-31;January 2017;Actual;2017-01-31;December 2016;Actual;2016-12-31;;Interventional;BigpAK;;Biomarker Guided Intervention for Prevention of Acute Kidney Injury;Biomarker Guided Intervention to Prevent Development of Acute Kidney Injury in High-risk Surgical Patients;Completed;;N/A;135;Actual;University Hospital Regensburg;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T10:38:24Z;2020-06-01T10:38:24Z;Regensburg;;;;;Ionosteril;63591498;1;;;2015;2020-05-29;18;FALSE;;FALSE;TRUE;18;;Years;;1;6;
NCT02494830;ClinicalTrials.gov processed this data on May 29, 2020;2015-07-07;;;2015-07-09;2015-07-09;2015-07-10;Estimate;;;;;;;2015-07-09;2015-07-10;Estimate;August 2014;;2014-08-31;July 2015;2015-07-31;October 2014;Actual;2014-10-31;September 2014;Actual;2014-09-30;;Interventional;;;Single Dose Administration of Ketamine 10, 20, 40 and 80 mg and 5 mg Solution for Infusion in 15 Healthy Subjects;Comparative Bioavailability Study of Ketamine and Norketamine After Single Dose Administration of Ketamine 10, 20, 40 and 80 mg Prolonged Release Tablets in Fasting State and 5 mg Ketamine Solution for Infusion in 15 Healthy Subjects in Serum, Urine and Feces;Completed;;Phase 1;15;Actual;University Medicine Greifswald;;5;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T10:39:25Z;2020-06-01T10:39:25Z;Greifswald;;;;;Ketamine;63591924;1;;;2015;2020-05-29;1;FALSE;;FALSE;TRUE;18;45;Years;Years;1;10;2
NCT02493283;ClinicalTrials.gov processed this data on May 29, 2020;2015-06-30;;;2015-07-06;2015-07-06;2015-07-09;Estimate;;;;;;;2015-07-06;2015-07-09;Estimate;September 2011;;2011-09-30;July 2015;2015-07-31;March 2015;Actual;2015-03-31;June 2012;Actual;2012-06-30;;Interventional;;;Pharmacokinetics and Distribution of Dapsone in Leucocytes After Single-dose and Multiple-dose Administration;Pharmacokinetics and Distribution of Dapsone (DDS) in Leucocytes After Single-dose and Multiple-dose Administration in Healthy Subjects Genotyped for CYP2C9 and NAT2 and in Patients With Autoimmune Bullous Dermatoses;Completed;;Phase 1;23;Actual;University Medicine Greifswald;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T10:39:47Z;2020-06-01T10:39:47Z;Greifswald;;;;;Dapsone single dose | Dapsone multiple dose | leucocytes | Met-Hb;63592043;1;;;2015;2020-05-29;9;FALSE;;FALSE;TRUE;18;45;Years;Years;1;14;
NCT02488694;ClinicalTrials.gov processed this data on May 29, 2020;2015-06-30;;;2018-01-08;2015-07-01;2015-07-02;Estimate;;;;;;;2018-01-08;2018-01-09;Actual;November 2015;;2015-11-30;January 2018;2018-01-31;December 2017;Actual;2017-12-31;December 2017;Actual;2017-12-31;;Interventional;MARBLE;;Maintaining ERBB Blockade in EGFR-mutated Lung Cancer;A Randomized, Open-label, Phase II Study of Maintaining Pan-ERBB Blockade Following Platinum-based Induction Chemotherapy in Patients With EGFR Mutated, Metastatic Non-small-cell Lung Cancer Progressing After Treatment With Afatinib as First EGFR-targeting Agent;Terminated;;Phase 2;4;Actual;AIO-Studien-gGmbH;;2;;unsufficient recruitment;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T10:41:04Z;2020-06-01T10:41:04Z;Duisburg;3548609;Principal Investigator;Martin Schuler, Prof. Dr.;Westdeutsches Tumorzentrum, Universitätsklinikum Essen;Afatinib | Pemetrexed;63592385;1;;;2015;2020-05-29;25;FALSE;;FALSE;TRUE;18;;Years;;1;4;
NCT02487680;ClinicalTrials.gov processed this data on May 29, 2020;2015-06-29;;;2017-05-11;2015-06-30;2015-07-01;Estimate;;;;;;;2017-05-11;2017-05-12;Actual;June 2015;Actual;2015-06-30;May 2017;2017-05-31;November 2015;Actual;2015-11-30;September 2015;Actual;2015-09-30;;Interventional;;;Effects of an Amino Acid and Chromium-picolinate Containing Drink on Glucose Metabolism on Healthy Subjects;Effect of a Table Water Enriched With Amino Acids and Chromium on Blood Glucose and Insulin Levels After a Meal;Completed;;N/A;20;Actual;DoubleGood AB;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:41:14Z;2020-06-01T10:41:14Z;Heidelberg Mannheim;3548695;Principal Investigator;Per Humpert, MD, Prof;Stoffwechselzentrum Rhein Pfalts, Mannheim, Germany and Department of internal medicine, University of Heidelberg, Germany;Amino Acids and chromium-picolinate containing drink | Placebo drink;63592463;;;;2015;2020-05-29;3;FALSE;;;FALSE;18;;Years;;1;1;
NCT02487381;ClinicalTrials.gov processed this data on May 29, 2020;2015-06-29;;;2015-08-13;2015-06-30;2015-07-01;Estimate;;;;;;;2015-08-13;2015-08-17;Estimate;April 2015;;2015-04-30;August 2015;2015-08-31;August 2015;Actual;2015-08-31;July 2015;Actual;2015-07-31;;Interventional;;;Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids;Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids on the Endocannabinoid System, Cognition and Neuronal Oscillations;Completed;;Phase 1;60;Anticipated;Central Institute of Mental Health, Mannheim;;4;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:41:18Z;2020-06-01T10:41:18Z;Mannheim;;;;;delta-9-tetrahydrocannabinol | Cannabidiol | Placebo;63592486;1;;;2015;2020-05-29;3;FALSE;;FALSE;TRUE;18;45;Years;Years;1;7;1
NCT02484339;ClinicalTrials.gov processed this data on May 29, 2020;2015-05-13;;;2016-04-26;2015-06-24;2015-06-29;Estimate;;;;;;;2016-04-26;2016-04-27;Estimate;December 2014;;2014-12-31;April 2016;2016-04-30;December 2017;Anticipated;2017-12-31;December 2016;Anticipated;2016-12-31;;Interventional;α-RT;;Treatment of Advanced Castration Resistant Prostate Carcinoma With Limited Bone Metastases (α-RT);Phase II Open-label Study to Evaluate the Efficacy and Safety of Radium in Combination With External Beam Radiotherapy (EBRT) vs. EBRT Alone in the Treatment of Castration Resistant Prostate Carcinoma With Limited Bone Metastases;Unknown status;;Phase 2;274;Anticipated;University Hospital Freiburg;;2;;;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T10:41:56Z;2020-06-01T10:41:56Z;Freiburg;3548923;Principal Investigator;Ursula Nestle;University Hospital Freiburg, Germany;Radium-223 dichloride | Conventional or high dose radiotherapy;63592721;6;;;2015;2020-05-29;;FALSE;;FALSE;FALSE;18;85;Years;Years;1;8;
NCT02483221;ClinicalTrials.gov processed this data on May 29, 2020;2015-06-24;;;2017-07-26;2015-06-25;2015-06-26;Estimate;;;;;;;2017-07-26;2017-07-31;Actual;April 2015;;2015-04-30;July 2017;2017-07-31;December 1, 2016;Actual;2016-12-01;December 1, 2016;Actual;2016-12-01;;Interventional;;;Postoperative Pain Therapy With Hydromorphone TCI-PCA vs. Morphine PCA;Phase 4 Study of Postoperative Pain Therapy With Hydromorphone Using Patient-Controlled Target-Controlled Infusion (TCI-PCA) vs. Patient-Controlled Analgesia (PCA) With Morphine After Elective Cardiac Surgery;Completed;;Phase 4;50;Actual;University of Erlangen-Nürnberg Medical School;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T10:42:08Z;2020-06-01T10:42:08Z;Erlangen;3548996;Principal Investigator;Christian Jeleazcov, MD, MS;Department of Anesthesiology, University Hospital Erlangen;Hydromorphone | Morphine;63592806;1;;;2015;2020-05-29;19;FALSE;;FALSE;TRUE;40;85;Years;Years;1;3;
NCT02481271;ClinicalTrials.gov processed this data on May 29, 2020;2015-06-22;;;2017-05-23;2015-06-22;2015-06-25;Estimate;;;;;;;2017-05-23;2017-05-25;Actual;December 2015;;2015-12-31;May 2017;2017-05-31;June 2017;Anticipated;2017-06-30;June 2017;Anticipated;2017-06-30;;Interventional;MBM_Galle;;Preoperative Relaxation and Intensified Patient Surgery Education in Patients Undergoing Cholecystectomy;Effects of Preoperative Relaxation and Intensified Surgery Education on Preoperative Wellbeing and Postoperative Complaints in Patients Undergoing Cholcystectomy - a Randomized Controlled Trial;Unknown status;;N/A;108;Anticipated;Universität Duisburg-Essen;;4;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:42:29Z;2020-06-01T10:42:29Z;Duisburg;3549145;Principal Investigator;Gustav Dobos, Prof, MD;Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, University of Duisburg-Essen;relaxation program | surgery education;63592952;1;;;2015;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;2;15;1
NCT02481128;ClinicalTrials.gov processed this data on May 29, 2020;2015-06-05;;;2017-01-31;2015-06-22;2015-06-25;Estimate;;;;;;;2017-01-31;2017-02-01;Estimate;May 2014;;2014-05-31;January 2017;2017-01-31;January 2017;Actual;2017-01-31;December 2016;Actual;2016-12-31;;Interventional;;;Surgical Trial to Evaluate the Impact of a Lymphoscintigraphy Prior to Sentinel Node Biopsy in Early Breast Cancer;"Randomized Controlled Multicenter Surgical Trial to Evaluate the Impact of a Lymphoscintigraphy Prior to Sentinel Node Biopsy in Early Breast Cancer; SenSzi (GBG80)";Completed;;N/A;1198;Actual;Kliniken Essen-Mitte;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T10:42:31Z;2020-06-01T10:42:31Z;Duisburg;3549155;Principal Investigator;Sherko Kümmel, MD;Kliniken Essen-Mitte;without preoperative access to lymphoscintigraphy findings;63592963;23;;;2015;2020-05-29;31;FALSE;;FALSE;FALSE;18;;Years;;1;3;
NCT02479412;ClinicalTrials.gov processed this data on May 29, 2020;2015-06-17;;;2017-08-28;2015-06-19;2015-06-24;Estimate;;;;;;;2017-08-28;2018-02-15;Actual;June 25, 2015;Actual;2015-06-25;August 2017;2017-08-31;February 8, 2016;Actual;2016-02-08;February 8, 2016;Actual;2016-02-08;;Interventional;;;A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of Three Dose Levels of AZD7594, Given Once Daily by Inhalation, in Patients With Mild to Moderate Asthma;A RANDOMIZED, DOUBLE BLIND, MULTIPLE DOSING (14 DAYS), PLACEBO-CONTROLLED, INCOMPLETE BLOCK CROSSOVER, MULTI CENTER STUDY TO ASSESS EFFICACY AND SAFETY OF THREE DOSE LEVELS OF AZD7594, GIVEN ONCE DAILY BY INHALATION, IN PATIENTS WITH MILD TO MODERATE ASTHMA;Completed;;Phase 2;54;Actual;AstraZeneca;;9;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:42:51Z;2020-06-01T10:42:51Z;Berlin Bonn Frankfurt Hamburg Lübeck;3549288;Principal Investigator;Rainard Fuhr, Dr. med.;PAREXEL International GmbH, Berlin, Germany;800 μg AZD7594 once daily | 250 µg AZD7594 once daily | 58 µg AZD7594 once daily | Placebo once daily | Salbutamol;63593095;10;119;0;2015;2020-05-29;7;TRUE;11;FALSE;FALSE;18;75;Years;Years;1;25;
NCT02478957;ClinicalTrials.gov processed this data on May 29, 2020;2015-06-19;;;2016-09-27;2015-06-22;2015-06-23;Estimate;;;;;;;2016-09-27;2016-09-29;Estimate;June 2015;;2015-06-30;September 2016;2016-09-30;June 2016;Actual;2016-06-30;March 2016;Actual;2016-03-31;;Interventional;;;Treatment of Indolent Systemic Mastocytosis With PA101;Randomized, Double-blind, Placebo-controlled, Crossover Design, Efficacy and Safety Study With PA101 in Patients With Indolent Systemic Mastocytosis;Completed;;Phase 2;41;Actual;Patara Pharma;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:42:57Z;2020-06-01T10:42:57Z;Berlin;3549342;Principal Investigator;Frank Siebenhaar, MD;Charite University, Berlin, Germany;PA101 | Placebo;63593130;8;;;2015;2020-05-29;9;FALSE;;FALSE;FALSE;18;75;Years;Years;1;2;
NCT02478944;ClinicalTrials.gov processed this data on May 29, 2020;2014-11-05;;;2016-06-29;2015-06-18;2015-06-23;Estimate;;;;;;;2016-06-29;2016-06-30;Estimate;October 2014;;2014-10-31;June 2016;2016-06-30;January 2017;Anticipated;2017-01-31;December 2016;Anticipated;2016-12-31;;Interventional;EMSIBD;;Esophageal Motility Disease Screening in Patient With Suspicion or Diagnosis of IBD;Esophageal Motility Disease Screening in Patient With Suspicion or Diagnosis of IBD;Unknown status;;N/A;40;Anticipated;University Hospital Erlangen;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:42:57Z;2020-06-01T10:42:57Z;Erlangen;3549343;Study Director;Heinz Albrecht, MD;UK Erlangen;Manometry;63593131;1;;;2014;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;2;1;
NCT02478034;ClinicalTrials.gov processed this data on May 29, 2020;2015-06-11;;;2016-03-04;2015-06-18;2015-06-23;Estimate;;;;;;;2016-03-04;2016-03-07;Estimate;May 2015;;2015-05-31;March 2016;2016-03-31;March 2016;Actual;2016-03-31;March 2016;Actual;2016-03-31;;Interventional;MR-STIM;;Effects of Mineralocorticoid Receptor Stimulation on Cognition;Effekte Von Fludrocortison Auf Soziale Kognition Und Gedächtnis Unter Berücksichtigung Von Geschlechtereffekten;Completed;;N/A;80;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:43:12Z;2020-06-01T10:43:12Z;Berlin;3549406;Principal Investigator;Katja Wingenfeld, PhD;Charité University;Fludrocortisone;63593200;1;;;2015;2020-05-29;10;FALSE;;FALSE;TRUE;18;30;Years;Years;1;2;
NCT02478021;ClinicalTrials.gov processed this data on May 29, 2020;2015-06-11;;;2015-06-18;2015-06-18;2015-06-23;Estimate;;;;;;;2015-06-18;2015-06-23;Estimate;September 2014;;2014-09-30;June 2015;2015-06-30;May 2015;Actual;2015-05-31;May 2015;Actual;2015-05-31;;Interventional;CORT-COG;;Effects of Hydrocortisone on Social Cognition and Memory;Effekte Von Hydrocortison Auf Soziale Kognition Und Gedächtnis Unter Berücksichtigung Von Geschlechtereffekten;Completed;;N/A;80;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:43:12Z;2020-06-01T10:43:12Z;Berlin;3549407;Principal Investigator;Katja Wingenfeld;Charite University;Hydrocortisone;63593201;1;;;2015;2020-05-29;8;FALSE;;FALSE;TRUE;18;30;Years;Years;1;2;
NCT02476500;ClinicalTrials.gov processed this data on May 29, 2020;2015-05-03;;;2015-11-28;2015-06-16;2015-06-19;Estimate;;;;;;;2015-11-28;2015-12-02;Estimate;May 2015;;2015-05-31;November 2015;2015-11-30;November 2015;Actual;2015-11-30;November 2015;Actual;2015-11-30;;Interventional;LLETZ-1;;Construct Validity of a Large Loop Excision of the Transformation Zone (LLETZ) Training Model;Prospective Case-control Study to Assess the Construct Validity of a Large Loop Excision of the Transformation Zone (LLETZ) Training Model;Completed;;N/A;150;Anticipated;Ruhr University of Bochum;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:43:33Z;2020-06-01T10:43:33Z;Bochum;3549533;Principal Investigator;Guenther A Rezniczek, PhD;Ruhr University Bochum;LLETZ on a training model;63593319;1;;;2015;2020-05-29;6;FALSE;;FALSE;TRUE;18;80;Years;Years;1;3;
NCT02476370;ClinicalTrials.gov processed this data on May 29, 2020;2015-06-16;;;2017-05-23;2015-06-18;2015-06-19;Estimate;;;;;;;2017-05-23;2017-05-25;Actual;June 2015;;2015-06-30;May 2017;2017-05-31;June 2017;Anticipated;2017-06-30;June 2017;Anticipated;2017-06-30;;Interventional;MBM_Hernio;;Effects of Preoperative Relaxation and Intensified Surgery Education in Patients Undergoing Herniotomy;Effects of Preoperative Relaxation and Intensified Surgery Education on Preoperative Wellbeing and Postoperative Complaints in Patients Undergoing Herniotomy - a Randomized Controlled Trial;Unknown status;;N/A;108;Anticipated;Universität Duisburg-Essen;;4;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:43:34Z;2020-06-01T10:43:34Z;Duisburg;3549545;Principal Investigator;Gustav Dobos, Prof, MD;Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, University of Duisburg-Essen;relaxation program | surgery education;63593328;1;;;2015;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;2;15;1
NCT02475603;ClinicalTrials.gov processed this data on May 29, 2020;2015-06-10;;;2015-06-15;2015-06-15;2015-06-19;Estimate;;;;;;;2015-06-15;2015-06-19;Estimate;September 2012;;2012-09-30;September 2012;2012-09-30;January 2016;Anticipated;2016-01-31;June 2015;Actual;2015-06-30;;Interventional;;;Clinical, Biochemical and Neurophysiological Consequences of Intraoperative Tourniquet During Total Knee Arthroplasty;Clinical, Biochemical and Neurophysiological Consequences of Intraoperative;Unknown status;;N/A;100;Anticipated;Universitätsmedizin Mannheim;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:43:44Z;2020-06-01T10:43:44Z;Mannheim;;;;;Total knee arthroplasty;63593387;1;;;2015;2020-05-29;33;FALSE;;FALSE;TRUE;55;85;Years;Years;1;5;
NCT02475252;ClinicalTrials.gov processed this data on May 29, 2020;2015-05-03;;;2016-01-19;2015-06-16;2015-06-18;Estimate;;;;;;;2016-01-19;2016-01-21;Estimate;April 2015;;2015-04-30;January 2016;2016-01-31;January 2016;Actual;2016-01-31;January 2016;Actual;2016-01-31;;Interventional;HSK-2;;Construct Validity of a Diagnostic Hysteroscopy Training Model;Prospective Case-control Study to Assess the Construct Validity of a Diagnostic Hysteroscopy in a Pelvic Training Model Using an Objective Structured Assessment of Technical Skills (OSATS) Assessment;Terminated;;N/A;15;Actual;Ruhr University of Bochum;;2;;"Recruitment too slow; study completion not possible within frame";FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:43:49Z;2020-06-01T10:43:49Z;Bochum;3549625;Principal Investigator;Clemens B Tempfer, MD;Ruhr University Bochum;hysteroscopy on a training model;63593415;1;;;2015;2020-05-29;9;FALSE;;FALSE;TRUE;18;80;Years;Years;1;2;
NCT02471963;ClinicalTrials.gov processed this data on May 29, 2020;2015-06-05;;;2018-05-09;2015-06-10;2015-06-15;Estimate;;;;;;;2018-05-09;2018-05-15;Actual;December 2014;;2014-12-31;May 2018;2018-05-31;June 2016;Actual;2016-06-30;November 2015;Actual;2015-11-30;;Interventional;;;Effect of Empagliflozin on Macrovascular and Microvascular Circulation and on Endothelium Function;Randomized, Double-blind, Placebo Controlled, Crossover Clinical Study to Analyse the Effect of Empagliflozin on Macrovascular and Microvascular Circulation and on Endothelium Function;Completed;;Phase 3;74;Actual;University of Erlangen-Nürnberg Medical School;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T10:44:42Z;2020-06-01T10:44:42Z;Erlangen;3549869;Principal Investigator;Roland E Schmieder, Prof.;Department of Medicine 4, University of Erlangen-Nuernberg;Empagliflozin | Placebo;63593664;1;;;2015;2020-05-29;11;FALSE;;FALSE;TRUE;18;75;Years;Years;1;3;
NCT02469012;ClinicalTrials.gov processed this data on May 29, 2020;2015-05-05;;;2015-06-08;2015-06-08;2015-06-11;Estimate;;;;;;;2015-06-08;2015-06-11;Estimate;October 2014;;2014-10-31;June 2015;2015-06-30;April 2017;Anticipated;2017-04-30;October 2016;Anticipated;2016-10-31;;Interventional;IFNfreeCOG;;Neurocognitive Performance and Emotional State in HCV Patients With IFN-free Antiviral Therapy;Evaluation of Quality of Life, Neurocognitive Performance, Fatigue, and Emotional State in HCV Patients Before, During, and in the (Long-term) Follow-up of an IFN-free Antiviral Therapy;Unknown status;;N/A;30;Anticipated;University of Wuerzburg;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:45:21Z;2020-06-01T10:45:21Z;Würzburg;;;;;Combination #1 | Combination #2 | Combination #3 | Combination #4 | Combination #5;63593889;1;;;2015;2020-05-29;;FALSE;;FALSE;TRUE;18;75;Years;Years;1;3;
NCT02468999;ClinicalTrials.gov processed this data on May 29, 2020;2015-03-24;;;2016-01-07;2015-06-08;2015-06-11;Estimate;;;;;;;2016-01-07;2016-01-08;Estimate;January 2015;;2015-01-31;January 2016;2016-01-31;December 2015;Actual;2015-12-31;December 2015;Actual;2015-12-31;;Interventional;;;Influence of Central Nervous Insulin Action on Insulin Sensitivity of Peripheral Organs in Lean Versus Overweight Humans;;Completed;;N/A;21;Actual;University Hospital Tuebingen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:45:21Z;2020-06-01T10:45:21Z;Tübingen;3550088;Principal Investigator;Andreas Fritsche, Prof. Dr.;University Hospital Tuebingen;human insulin;63593890;1;;;2015;2020-05-29;11;FALSE;;FALSE;TRUE;18;40;Years;Years;3;2;
NCT02468427;ClinicalTrials.gov processed this data on May 29, 2020;2015-05-03;;;2015-10-06;2015-06-09;2015-06-10;Estimate;;;;;;;2015-10-06;2015-10-07;Estimate;March 2015;;2015-03-31;October 2015;2015-10-31;October 2015;Actual;2015-10-31;October 2015;Actual;2015-10-31;;Interventional;VAC-OSATS;;Objective Structured Assessment of Technical Skills (OSATS) Evaluation of Delivery by Vacuum Extraction;Objective Structured Assessment of Technical Skills (OSATS) Evaluation of Operative-Vaginal Delivery by Vacuum Extraction on a Pelvic Training Model;Completed;;N/A;137;Actual;Ruhr University of Bochum;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:45:29Z;2020-06-01T10:45:29Z;Bochum;3550124;Principal Investigator;Clemens B Tempfer, MD;Ruhr University Bochum;hands-on teaching | Frontal teaching;63593933;1;;;2015;2020-05-29;7;FALSE;;FALSE;TRUE;18;80;Years;Years;1;2;
NCT02466594;ClinicalTrials.gov processed this data on May 29, 2020;2015-05-25;;;2015-07-05;2015-06-04;2015-06-09;Estimate;;;;;;;2015-07-05;2015-07-07;Estimate;November 2013;;2013-11-30;July 2015;2015-07-31;April 2015;Actual;2015-04-30;April 2014;Actual;2014-04-30;;Interventional;;;Impact of Active Thermoregulation on the Microcirculation of Free Flaps;Impact of Active Thermoregulation on the Microcirculation of Free Flaps;Completed;;N/A;25;Actual;Klinik Bogenhausen;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T10:45:48Z;2020-06-01T10:45:48Z;Munich;3550283;Principal Investigator;Ulf Dornseifer, MD;Department of Plastic, Reconstructive, Hand and Burn Surgery, Bogenhausen Academic Hospital, Munich 81925, Germany;Hilotherm Clinic®;63594077;1;;;2015;2020-05-29;5;FALSE;;FALSE;TRUE;18;50;Years;Years;1;;
NCT02460861;ClinicalTrials.gov processed this data on May 29, 2020;2015-05-28;;;2015-05-29;2015-05-29;2015-06-03;Estimate;;;;;;;2015-05-29;2015-06-03;Estimate;November 2011;;2011-11-30;May 2015;2015-05-31;December 2015;Anticipated;2015-12-31;October 2013;Actual;2013-10-31;;Interventional;iPROLOGX;;Intraoperational Prostate Loge Biopsies (iPROLOGX) After Radical Prostatovesiculectomy;Intraoperational Prostate Loge Biopsies (iPROLOGX) After Radical Prostatovesiculectomy (RPVE) in Prostate Cancer (PCA) Patients for Molecular Tumor Marker Analysis;Unknown status;;N/A;279;Actual;University of Magdeburg;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:47:01Z;2020-06-01T10:47:01Z;Magdeburg;3550716;Study Chair;Martin Schostak, Prof.Dr.med.;University of Magdeburg;biopsies of the prostatic fossa in Magdeburg | RPVE | ETRARP | CE | biopsies of the prostatic fossa in gronau;63594513;2;;;2015;2020-05-29;23;FALSE;;FALSE;FALSE;;;;;2;;
NCT02454634;ClinicalTrials.gov processed this data on May 29, 2020;2015-05-12;;;2018-11-06;2015-05-26;2015-05-27;Estimate;;;;;;;2018-11-06;2018-11-07;Actual;June 2015;Actual;2015-06-30;September 2017;2017-09-30;September 19, 2017;Actual;2017-09-19;September 19, 2017;Actual;2017-09-19;;Interventional;NOA-16;;Phase I Trial of IDH1 Peptide Vaccine in IDH1R132H-mutated Grade III-IV Gliomas;Targeting IDH1R132H in WHO Grade III-IV IDH1R132H-mutated Gliomas by a Peptide Vaccine - a Phase I Safety, Tolerability and Immunogenicity Multicenter Trial (NOA-16);Completed;;Phase 1;39;Actual;National Center for Tumor Diseases, Heidelberg;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T10:48:12Z;2020-06-01T10:48:12Z;Heidelberg;3551194;Principal Investigator;Michael Platten, MD;"University Hospital Heidelberg, Neurology Clinic; Neurooncology Program at the NCT";IDH1 peptide vaccine;63594988;8;;;2015;2020-05-29;27;FALSE;;FALSE;FALSE;18;;Years;;2;4;
NCT02453906;ClinicalTrials.gov processed this data on May 29, 2020;2015-04-29;;;2016-07-26;2015-05-21;2015-05-27;Estimate;;;;;;;2016-07-26;2016-07-27;Estimate;May 2015;;2015-05-31;July 2016;2016-07-31;September 2015;Actual;2015-09-30;September 2015;Actual;2015-09-30;;Interventional;;;XNKQ Acupuncture Compared to Control Interventions Measured With EEG and fMRI;Cerebral Response of Healthy Subjects to a Somatosensory Stimulation With XNKQ Acupuncture Compared to Control Interventions Measured With EEG and fMRI;Completed;;N/A;29;Actual;Charite University, Berlin, Germany;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:48:24Z;2020-06-01T10:48:24Z;Berlin;3551239;Principal Investigator;Claudia M. Witt, MD;Charite University, Berlin, Germany;XNKQ | Control 1 | Control 2 | Control 3;63595041;1;;;2015;2020-05-29;4;FALSE;;FALSE;TRUE;18;40;Years;Years;2;;
NCT02453451;ClinicalTrials.gov processed this data on May 29, 2020;2015-05-13;;;2016-04-05;2015-05-20;2015-05-25;Estimate;;;;;;;2016-04-05;2016-04-06;Estimate;July 2015;;2015-07-31;April 2016;2016-04-30;April 2017;Anticipated;2017-04-30;January 2017;Anticipated;2017-01-31;;Interventional;MitraClipASD;;The Effect of the Hole in the Cardiac Septum Developed by the MitraClip Procedure on the Blood Flow Mechanics;The Effect of the Iatrogenic Atrial Septal Defect After MitraClip Procedure on the Hemodynamic Outcome;Unknown status;;N/A;40;Anticipated;RWTH Aachen University;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T10:48:32Z;2020-06-01T10:48:32Z;Aachen;;;;;2D-/3D-TTE | 3D-TEE | Walking Test | MitraClip procedure;63595076;1;;;2015;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;3;
NCT02452307;ClinicalTrials.gov processed this data on May 29, 2020;2015-04-14;;;2017-08-14;2015-05-19;2015-05-22;Estimate;;;;;;;2017-08-14;2017-08-17;Actual;April 2004;;2004-04-30;August 2017;2017-08-31;October 2017;Anticipated;2017-10-31;October 2017;Anticipated;2017-10-31;;Interventional;;;Peptide-specific Vaccination in HLA-A*02 Positive Patients With Biochemical Recurrence After Radical Prostatectomy;Prospective Randomized Trial of Peptide-specific Vaccination in HLA-A*02 Positive Prostate Carcinoma Patients With Biochemical Recurrence After Radical Prostatectomy;Unknown status;;Phase 1/Phase 2;36;Actual;University Hospital Tuebingen;;5;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:49:01Z;2020-06-01T10:49:01Z;Tübingen;3551359;Principal Investigator;Arnulf Stenzl, Prof.;Department of Urology, University of Tuebingen;Peptide vaccine | Montanide ISA-51 | Granulocyte macrophage colony stimulating factor (GM-CSF) | Imiquimod | mRNA | Protamin | local hyperthermia;63595162;;;;2015;2020-05-29;;FALSE;;;FALSE;45;80;Years;Years;1;2;
NCT02451163;ClinicalTrials.gov processed this data on May 29, 2020;2015-05-19;;;2016-04-11;2015-05-19;2015-05-21;Estimate;;;;;;;2016-04-11;2016-04-12;Estimate;September 2014;;2014-09-30;April 2016;2016-04-30;March 2016;Actual;2016-03-31;December 2015;Actual;2015-12-31;;Interventional;Fib-CC-2014;;DBRCT on the Effect of Wheat Polysaccharides on Common Cold Infections in Elderly;A Randomized, Controlled Clinical Study on the Effect of Polysaccharides From Wheat on Common Cold Infections in Elderly;Completed;;Phase 2;247;Actual;Clinical Research Center Kiel GmbH;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:49:17Z;2020-06-01T10:49:17Z;Kiel;3551435;Principal Investigator;Christiane Laue, MD;Clinical Research Center Kiel GmbH;wheat polysaccharides | maltodextrin;63595250;1;;;2015;2020-05-29;15;FALSE;;FALSE;TRUE;50;;Years;;1;1;
NCT02450578;ClinicalTrials.gov processed this data on May 29, 2020;2015-03-16;;;2017-07-10;2015-05-18;2015-05-21;Estimate;;;;;;;2017-07-10;2017-07-13;Actual;October 2015;Actual;2015-10-31;July 2017;2017-07-31;April 2016;Actual;2016-04-30;April 2016;Actual;2016-04-30;;Interventional;;;DSM265 Chemoprophylaxis of Plasmodium Falciparum Malaria;Evaluation of the Prophylactic Antimalarial Activity of a Single Dose of DSM265 in Non-immune Healthy Adult Volunteers by Controlled Human Malaria Infection With PfSPZ Challenge;Completed;;Phase 1;22;Actual;Medicines for Malaria Venture;;4;;;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T10:49:25Z;2020-06-01T10:49:25Z;Tübingen;3551482;Principal Investigator;Benjamin Mordmüller, Dr. med;Institut für Tropenmedizin, Uni. of Tübingen;DSM265 400mg | Placebo to DSM265 400 mg | Plasmodium falciparum sporozoite challenge | Malarone;63595294;1;;;2015;2020-05-29;6;FALSE;;FALSE;TRUE;18;45;Years;Years;1;6;
NCT02446171;ClinicalTrials.gov processed this data on May 29, 2020;2015-04-29;;;2017-01-30;2015-05-15;2015-05-18;Estimate;;;;;;;2017-01-30;2017-03-10;Actual;May 2015;;2015-05-31;January 2017;2017-01-31;July 2015;Actual;2015-07-31;July 2015;Actual;2015-07-31;;Interventional;;;A Bioavailability Study With Alternate Methods of Administration of Naloxegol Tablets, and Solution;An Open-Label, Randomized, 4-Period, 4-Treatment, Crossover, Single-Center, Single-Dose Bioavailability Study With Alternate Methods of Administration of Crushed Naloxegol Tablets, 25 mg and of a Naloxegol Solution Formulation, 25 mg, Compared to Whole Naloxegol Tablets, 25 mg, in Healthy Subjects;Completed;;Phase 1;44;Actual;AstraZeneca;;4;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:50:33Z;2020-06-01T10:50:33Z;Berlin;3551786;Principal Investigator;Rainard Fuhr, Dr. med.;PAREXEL International GmbH, Berlin;Naloxegol 25 mg tablet, crushed, suspended in water, given orally | Naloxegol 25mg tablet crushed, suspended in water, given via nasogastric tube | Naloxegol 25 mg (10 mL oral solution) | Naloxegol 25 mg tablet, given orally;63595629;1;49;0;2015;2020-05-29;2;TRUE;9;FALSE;TRUE;18;55;Years;Years;3;14;
NCT02441621;ClinicalTrials.gov processed this data on May 29, 2020;2015-04-28;;;2015-05-07;2015-05-07;2015-05-12;Estimate;;;;;;;2015-05-07;2015-05-12;Estimate;June 2015;;2015-06-30;May 2015;2015-05-31;June 2016;Anticipated;2016-06-30;May 2016;Anticipated;2016-05-31;;Interventional;;;Prediction of Volume Responsiveness in Presence of Left Ventricular Diastolic Dysfunction;Prediction of Fluid Responsiveness in Presence of Diastolic Dysfunction;Unknown status;;N/A;50;Anticipated;University of Schleswig-Holstein;;7;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T10:51:29Z;2020-06-01T10:51:29Z;Kiel Lübeck;;;;;passive leg raising | premedication | intubation and mechanical ventilation | central venous catheter | arterial catheter | transesophageal echocardiography | transpulmonary thermodilution catheter;63595974;1;;;2015;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT02438228;ClinicalTrials.gov processed this data on May 29, 2020;2015-04-29;;;2016-02-10;2015-05-05;2015-05-08;Estimate;;;;;;;2016-02-10;2016-02-11;Estimate;November 2014;;2014-11-30;February 2016;2016-02-29;November 2015;Actual;2015-11-30;November 2015;Actual;2015-11-30;;Interventional;;;Cardiac Output by Nine Different Pulse Contour Algorithms;Estimation of Cardiac Output by Nine Different Pulse Contour Algorithms Compared With Transpulmonary Thermodilution;Completed;;N/A;30;Actual;University of Schleswig-Holstein;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T10:52:09Z;2020-06-01T10:52:09Z;Kiel Lübeck;;;;;Cardiac output measurement;63596234;1;;;2015;2020-05-29;12;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT02437357;ClinicalTrials.gov processed this data on May 29, 2020;2015-03-23;;;2016-09-26;2015-05-04;2015-05-07;Estimate;;;;;;;2016-09-26;2016-09-27;Estimate;March 2015;;2015-03-31;September 2016;2016-09-30;June 2016;Actual;2016-06-30;June 2016;Actual;2016-06-30;;Interventional;;;A Trial on Metacognitive Training for Depression (D-MCT);A Randomized-Controlled Trial on Metacognitive Training for Depression (D-MCT) - an New Group Intervention for Depressed Patients;Completed;;N/A;60;Actual;Universitätsklinikum Hamburg-Eppendorf;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:52:22Z;2020-06-01T10:52:22Z;Hamburg;3552449;Principal Investigator;Marit Hauschildt, Ph.D.;Universitätsklinikum Hamburg-Eppendorf;Metacognitive Training | Positivity Training;63596301;1;;;2015;2020-05-29;15;FALSE;;FALSE;TRUE;18;70;Years;Years;1;7;
NCT02436083;ClinicalTrials.gov processed this data on May 29, 2020;2015-03-09;;;2015-05-05;2015-05-05;2015-05-06;Estimate;;;;;;;2015-05-05;2015-05-06;Estimate;July 2007;;2007-07-31;May 2015;2015-05-31;December 2014;Actual;2014-12-31;June 2012;Actual;2012-06-30;;Interventional;;;Antibiotics in Free Flaps Reconstructions;The Value of Perioperative Antibiotics on the Success of Oral Free Flap Reconstructions;Completed;;Phase 4;350;Actual;Technische Universität München;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:52:38Z;2020-06-01T10:52:38Z;Munich;;;;;antibiotic (use of penicilline, unacid, cefuroxime);63596399;;;;2015;2020-05-29;59;FALSE;;;FALSE;18;90;Years;Years;1;;
NCT02434692;ClinicalTrials.gov processed this data on May 29, 2020;2014-09-02;;;2017-08-16;2015-04-30;2015-05-05;Estimate;;;;;;;2017-08-16;2017-08-21;Actual;May 2014;;2014-05-31;August 2017;2017-08-31;April 11, 2017;Actual;2017-04-11;April 11, 2017;Actual;2017-04-11;;Interventional;;;Safety and Performance Study of the ARGOS-IO (Intraocular) System in Patients With Primary Open Angle Glaucoma (POAG);A Prospective, Open-label, Multicenter Clinical Investigation to Assess the Safety and Performance of the ARGOS-IO System in Patients With Primary Open Angle Glaucoma (POAG);Completed;;N/A;22;Actual;Implandata Ophthalmic Products GmbH;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T10:53:01Z;2020-06-01T10:53:01Z;Magdeburg;3552652;Principal Investigator;Hagen Thieme, Prof.;University Eye Clinic Magdeburg, Germany;ARGOS-IO system;63596505;11;;;2014;2020-05-29;34;FALSE;;FALSE;FALSE;40;85;Years;Years;1;3;
NCT02432833;ClinicalTrials.gov processed this data on May 29, 2020;2015-04-29;;;2018-04-12;2015-05-01;2015-05-04;Estimate;;;;;;;2018-04-12;2018-04-13;Actual;May 2015;;2015-05-31;April 2018;2018-04-30;January 24, 2017;Actual;2017-01-24;January 24, 2017;Actual;2017-01-24;;Interventional;STEADY;;Multicentre, Open Label, Randomized, Two-arm, Parallel-group Study to Assess Efficacy and Safety of ENVARSUS® Compared With Tacrolimus Used as Per Current Clinical Practice in the Initial Maintenance Setting in de Novo Kidney Transplant Patients;Multicentre, Open Label, Randomized, Two-arm, Parallel-group Study to Assess Efficacy and Safety of ENVARSUS® Compared With Tacrolimus Used as Per Current Clinical Practice in the Initial Maintenance Setting in de Novo Kidney Transplant Patients;Completed;;Phase 4;428;Actual;Chiesi Farmaceutici S.p.A.;;2;;;FALSE;;;;FALSE;;;;;;;;;;;Undecided;;2020-06-01T10:53:34Z;2020-06-01T10:53:34Z;Berlin;3552775;Principal Investigator;Klemens Budde, MD;Berlin, Germany;ENVARSUS® | PROGRAF® | ADVAGRAF®;63596648;1;;;2015;2020-05-29;20;FALSE;;FALSE;TRUE;18;;Years;;1;7;
NCT02429960;ClinicalTrials.gov processed this data on May 29, 2020;2015-04-08;;;2019-09-24;2015-04-28;2015-04-29;Estimate;;;;;;;2019-09-24;2019-09-26;Actual;April 2015;;2015-04-30;September 2019;2019-09-30;September 2015;Actual;2015-09-30;September 2015;Actual;2015-09-30;;Interventional;AMUPS;;Comparison of Different Analgesia-Monitors in Tracing Unconscious Pain Sensations;Investigation of the Clinical Use of Different Analgesia-Monitors for Tracing Unconscious Pain Sensations During General Anesthesia;Completed;;N/A;30;Actual;Universitätsklinikum Hamburg-Eppendorf;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:54:12Z;2020-06-01T10:54:12Z;Hamburg;3552991;Study Director;Christian Zoellner, Professor;"Department of Anesthesiology; Center of Anesthesiology and Intensive Care Medicine, Hamburg Eppendorf University Medical Center";Analgesia monitor (PhysioDoloris®) | Analgesia monitor (SPI®) | Analgesia monitor (AlgiScan®) | Remifentanil;63596863;1;;;2015;2020-05-29;5;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT02429219;ClinicalTrials.gov processed this data on May 29, 2020;2015-02-19;;;2015-04-28;2015-04-28;2015-04-29;Estimate;;;;;;;2015-04-28;2015-04-29;Estimate;November 2013;;2013-11-30;April 2015;2015-04-30;February 2015;Actual;2015-02-28;February 2015;Actual;2015-02-28;;Interventional;SATURN-P;;Saline With Alcohol in TransUrethral Resection aNd Photoselective Vaporisation of the Prostate;Prospective Study of Monitoring the Alcohol Concentration in Breathing Air During Transurethral Prostate Resection of Benign Prostate Hyperplasia (BPH) Assessing the Uptake of Irrigation Fluids;Completed;;N/A;60;Actual;University of Magdeburg;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:54:22Z;2020-06-01T10:54:22Z;Magdeburg;3553041;Principal Investigator;Markus Porsch, MD;Urologic Faculty University Magdeburg;Saline Irrigation with Ethanol | transurethral resection of the prostate | photoselective vaporisation of the prostate;63596918;1;;;2015;2020-05-29;15;FALSE;;FALSE;TRUE;;;;;1;1;
NCT02425163;ClinicalTrials.gov processed this data on May 29, 2020;2015-02-10;;;2015-04-20;2015-04-20;2015-04-23;Estimate;;;;;;;2015-04-20;2015-04-23;Estimate;March 2012;;2012-03-31;April 2015;2015-04-30;January 2015;Actual;2015-01-31;March 2013;Actual;2013-03-31;;Interventional;ElaProC;;Shear Wave Elastography of Prostate Cancer;Shear Wave Elastography of Prostate Cancer;Completed;;Phase 2;73;Actual;University of Magdeburg;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:55:00Z;2020-06-01T10:55:00Z;Magdeburg;3553353;Principal Investigator;Martin Schostak, Prof. Dr.;Urologische Klinik, Otto-von-Guericke University Magdeburg;Transrectal shear wave elastography of the prostate | Transrectal random biopsy of the prostate;63597227;1;;;2015;2020-05-29;12;FALSE;;FALSE;TRUE;;;;;1;4;
NCT02424552;ClinicalTrials.gov processed this data on May 29, 2020;2015-04-14;;;2017-04-28;2015-04-20;2015-04-23;Estimate;;;;;;;2017-04-28;2017-05-01;Actual;June 26, 2015;Actual;2015-06-26;April 2017;2017-04-30;March 9, 2017;Actual;2017-03-09;February 9, 2017;Actual;2017-02-09;;Interventional;EVITA;;Effect of Vitamin D as add-on Therapy for Vitamin D Insufficient Patients With Severe Asthma;EVITA Trial: Effect of VItamin D as add-on Therapy for Vitamin D Insufficient Patients With Severe Asthma: a Randomized, Double-blind, Placebo-controlled Trial;Terminated;;Phase 4;54;Actual;Johannes Gutenberg University Mainz;;2;;recruitment problems;FALSE;;;;TRUE;;;;;;;;;;;Undecided;;2020-06-01T10:55:10Z;2020-06-01T10:55:10Z;Mainz;3553397;Principal Investigator;Stephanie Korn, MD;Johannes Gutenberg University Mainz;Placebo | Vitamin D3;63597273;9;;;2015;2020-05-29;19;FALSE;;FALSE;FALSE;18;;Years;;1;8;
NCT02421172;ClinicalTrials.gov processed this data on May 29, 2020;2015-03-18;;;2019-04-29;2015-04-15;2015-04-20;Estimate;;;;;;;2019-04-29;2019-05-23;Actual;April 13, 2015;Actual;2015-04-13;April 2019;2019-04-30;November 23, 2016;Actual;2016-11-23;November 23, 2016;Actual;2016-11-23;;Interventional;;;Efficacy, Safety, and Pharmacokinetics Study of CJM112 in Hidradenitis Suppurativa Patients;A Randomized, Double-blind, Placebo Controlled, Multiple Dose Study to Evaluate the Clinical Efficacy, Safety, Tolerability, Dose Relation, Pharmacokinetics and Pharmacodynamics of CJM112 in Moderate to Severe Chronic Hidradenitis Suppurativa Patients;Completed;;Phase 2;66;Actual;Novartis;;5;;;FALSE;;;;FALSE;TRUE;FALSE;;;;;;;;;Undecided;Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.~This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com;2020-06-01T10:55:51Z;2020-06-01T10:55:51Z;Berlin Bochum;3553651;Principal Investigator;Sylke Schneider-Burrus;Psoriasis Research and Treatment Center, Charité hospital, Berlin, Germany;CJM112 | Placebo;63597527;16;305;4;2015;2020-05-29;19;TRUE;12;TRUE;FALSE;;;;;1;5;
NCT02421016;ClinicalTrials.gov processed this data on May 29, 2020;2015-04-09;;;2015-06-01;2015-04-15;2015-04-20;Estimate;;;;;;;2015-06-01;2015-06-02;Estimate;May 2015;;2015-05-31;April 2015;2015-04-30;April 2017;Anticipated;2017-04-30;December 2016;Anticipated;2016-12-31;;Interventional;;;Test Efficacy With Bioresorbable Polymer Coating Versus Bioresorbable Polymer Backbone (ISAR-RESORB);A Prospective, Randomized Trial of SYNERGY Bioresorbable Polymer Coated Stents Versus ABSORB Bioresorbable Backbone Stents in Patients Undergoing Coronary Stenting (ISAR-RESORB);Unknown status;;N/A;230;Anticipated;Deutsches Herzzentrum Muenchen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:55:54Z;2020-06-01T10:55:54Z;Munich;3553666;Principal Investigator;Robert Byrne, MB BCh PhD;Deutsches Herzzentrum München;SYNERGY EES | ABSORB [BVS];63597540;1;;;2015;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;4;
NCT02420145;ClinicalTrials.gov processed this data on May 29, 2020;2015-04-09;;;2015-09-22;2015-04-14;2015-04-17;Estimate;;;;;;;2015-09-22;2015-09-23;Estimate;April 2015;;2015-04-30;September 2015;2015-09-30;August 2015;Actual;2015-08-31;August 2015;Actual;2015-08-31;;Interventional;;;Yoga for Abdominal Obesity;Randomized-controlled Trial of Yoga for Women With Abdominal Obesity;Completed;;N/A;60;Actual;Universität Duisburg-Essen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:56:05Z;2020-06-01T10:56:05Z;Duisburg;;;;;Yoga;63597607;1;;;2015;2020-05-29;4;FALSE;;FALSE;TRUE;18;64;Years;Years;1;17;
NCT02417103;ClinicalTrials.gov processed this data on May 29, 2020;2015-04-10;;;2017-08-02;2015-04-14;2015-04-15;Estimate;;;;;;;2017-08-02;2017-08-03;Actual;December 2011;;2011-12-31;August 2017;2017-08-31;December 2016;Actual;2016-12-31;September 2016;Actual;2016-09-30;;Interventional;;;Pretreatment of Patients Expecting Bariatric Surgery With the GLP-1 Analogon Liraglutid;Pretreatment of Patients Expecting Bariatric Surgery With the GLP-1 Analogon;Terminated;;Phase 3;2;Actual;Universitätsklinikum Hamburg-Eppendorf;;2;;Recruiting failure;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:56:40Z;2020-06-01T10:56:40Z;Hamburg;3553948;Principal Investigator;Jens Aberle, MD;Universitätsklinikum Hamburg-Eppendorf;GLP-1 (Liraglutide) | Placebo;63597835;1;;;2015;2020-05-29;57;FALSE;;FALSE;TRUE;18;77;Years;Years;1;1;
NCT02415491;ClinicalTrials.gov processed this data on May 29, 2020;2015-04-01;;;2016-02-17;2015-04-08;2015-04-14;Estimate;;;;;;;2016-02-17;2016-02-18;Estimate;May 2015;;2015-05-31;February 2016;2016-02-29;November 2016;Anticipated;2016-11-30;November 2016;Anticipated;2016-11-30;;Interventional;ASO;;Cardiovascular MRI and Cardiopulmonary Exercise Capacity After Neonatal ASO) in Young Adults;Cardiovascular Magnetic Resonance at Rest and Stress in Relation to Cardiopulmonary Exercise Capacity in Young Adults After Arterial Switch Operation (ASO) for Transposition of the Great Arteries (TGA);Unknown status;;N/A;100;Anticipated;RWTH Aachen University;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:57:01Z;2020-06-01T10:57:01Z;Aachen;3554067;Principal Investigator;Hedwig Hoevels-Guerich, Prof MD;Department od Pediatric Cardiology, University Hospital Aachen;Correlation Heart Magnetic Resonance Imaging at rest and stress with Cardiopulmonary stress test;63597958;1;;;2015;2020-05-29;;FALSE;;FALSE;TRUE;18;28;Years;Years;4;3;
NCT02413957;ClinicalTrials.gov processed this data on May 29, 2020;2015-01-12;;;2017-01-10;2015-04-09;2015-04-10;Estimate;;;;;;;2017-01-10;2017-01-11;Estimate;January 2015;;2015-01-31;January 2017;2017-01-31;January 2016;Actual;2016-01-31;January 2016;Actual;2016-01-31;;Interventional;;;Medication Reconciliation in Comparison to an Extensive Medication Safety Check;Pilot Project to Investigate the Influence of Medication Reconciliation and an Extensive Medication Safety Check on the Number of Adverse Drug Events in the Elderly;Completed;;N/A;220;Actual;RWTH Aachen University;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:57:27Z;2020-06-01T10:57:27Z;Aachen;;;;;Medication Reconciliation | Pharmaceutical Care;63598070;1;;;2015;2020-05-29;12;FALSE;;FALSE;TRUE;65;;Years;;1;5;
NCT02410096;ClinicalTrials.gov processed this data on May 29, 2020;2015-03-18;;;2016-09-02;2015-04-01;2015-04-07;Estimate;;;;;;;2016-09-02;2016-09-05;Estimate;April 2015;;2015-04-30;September 2016;2016-09-30;July 2016;Actual;2016-07-31;February 2016;Actual;2016-02-29;;Interventional;;;Bronchial Inflammation and Hyperresponsiveness After Oil Supplementation;Examination of Bronchial Inflammation and Hyperresponsiveness After Oil Supplementation With Middle-chain and Polyunsaturated Fatty Acids in an Exercise-induced Asthma Provocation Model;Completed;;N/A;73;Actual;Johann Wolfgang Goethe University Hospital;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:58:28Z;2020-06-01T10:58:28Z;Frankfurt;3554493;Principal Investigator;Johannes Schulze, MD;Johann Wolfgang Goethe University Hospital;Exercise challenge in a cold chamber | Methacholine challenge | Oil supplementation verum | Oil supplementation placebo;63598365;1;;;2015;2020-05-29;10;FALSE;;FALSE;TRUE;12;44;Years;Years;1;2;1
NCT02409771;ClinicalTrials.gov processed this data on May 29, 2020;2015-03-12;;;2017-04-03;2015-04-06;2015-04-07;Estimate;;;;;;;2017-04-03;2017-04-04;Actual;June 2015;Actual;2015-06-30;April 2017;2017-04-30;January 17, 2017;Actual;2017-01-17;January 17, 2017;Actual;2017-01-17;;Interventional;;;Clinical Trial With PRECIZON Presbyopic;Prospective Multicenter Clinical Trial With the PRECIZON Presbyopic Multifocal Intraocular Lens;Completed;;N/A;70;Actual;Ophtec BV;;1;;;FALSE;;;;FALSE;;;;;;;;;;;Undecided;;2020-06-01T10:58:32Z;2020-06-01T10:58:32Z;Heidelberg;3554512;Principal Investigator;Mike P. Holzer, Prof. Dr.;Heidelberg University;PRECIZON Presbyopic;63598389;6;;;2015;2020-05-29;18;FALSE;;FALSE;FALSE;45;;Years;;3;8;
NCT02408575;ClinicalTrials.gov processed this data on May 29, 2020;2015-03-18;;;2016-10-25;2015-04-02;2015-04-03;Estimate;;;;;;;2016-10-25;2016-10-26;Estimate;February 2015;;2015-02-28;October 2016;2016-10-31;June 2016;Actual;2016-06-30;June 2016;Actual;2016-06-30;;Interventional;NoA-Tin;;Hearing Aids With Notched Amplification for the Treatment of Chronic Tinnitus;Hearing Aids With Notched Amplification for the Treatment of Chronic Tinnitus - A Controlled Randomized Pilot Study on Safety, Tolerability and Clinical Performance;Completed;;N/A;44;Actual;University of Regensburg;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T10:58:45Z;2020-06-01T10:58:45Z;Regensburg;3554604;Principal Investigator;Berthold Langguth, M.D., Ph.D.;University of Regensburg;Notched filtering (verum) | No filtering (placebo);63598481;1;;;2015;2020-05-29;16;FALSE;;FALSE;TRUE;18;85;Years;Years;1;36;
NCT02406014;ClinicalTrials.gov processed this data on May 29, 2020;2015-03-27;;;2017-05-08;2015-03-31;2015-04-01;Estimate;;;;;;;2017-05-08;2017-05-09;Actual;April 2015;;2015-04-30;May 2017;2017-05-31;June 2016;Actual;2016-06-30;June 2016;Actual;2016-06-30;;Interventional;;;Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp;Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp;Completed;;Phase 4;502;Actual;LEO Pharma;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:59:21Z;2020-06-01T10:59:21Z;Bochum;3554827;Principal Investigator;Eggert Stockfleth, Prof.Dr.med.;St. Josef-Hospital im Katholischen Klinikum Bochum;Ingenol Mebutate Gel, 0.015% | Diclofenac sodium gel 3%;63598672;1;;;2015;2020-05-29;14;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT02404844;ClinicalTrials.gov processed this data on May 29, 2020;2015-02-20;;;2018-04-19;2015-03-26;2015-04-01;Estimate;;;;;;;2018-04-19;2018-04-20;Actual;December 2014;;2014-12-31;April 2018;2018-04-30;October 19, 2017;Actual;2017-10-19;September 19, 2017;Actual;2017-09-19;;Interventional;PIKTAM;;Trial of BKM120/Tamoxifen-combination in Patients With HR-pos, HER2-neg Breast Cancer;Molecularly Stratified Parallel Cohort, Single Arm Phase II Trial of the Phosphoinositide 3-kinase (PI3K) Inhibitor Buparlisib (BKM120) in Combination With Tamoxifen in Patients With Hormone Receptor-positive, HER2-negative Inoperable (Locally Advanced or Metastatic) Breast Cancer With Prior Exposure to Antihormonal Therapy;Completed;;Phase 2;48;Actual;University Hospital, Essen;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:59:33Z;2020-06-01T10:59:33Z;Duisburg;3554923;Principal Investigator;Anja Welt, MD;University Hospital, Essen;BKM120 | Tamoxifen;63598764;1;;;2015;2020-05-29;33;FALSE;;FALSE;TRUE;18;;Years;;1;9;2
NCT02403986;ClinicalTrials.gov processed this data on May 29, 2020;2015-03-26;;;2019-09-03;2015-03-30;2015-03-31;Estimate;;;;;;;2019-09-03;2019-09-06;Actual;April 2015;;2015-04-30;September 2019;2019-09-30;March 30, 2017;Actual;2017-03-30;March 30, 2017;Actual;2017-03-30;;Interventional;;;An Efficacy and Safety Study Evaluating Treatment Sessions of Restylane Skinboosters Vital Lidocaine in the Face;A Randomised, Multi-centre, Parallel-group, Efficacy and Safety Study Evaluating Two and Three Initial Treatment Sessions of Restylane Skinboosters Vital Lidocaine in the Face;Completed;;Phase 4;53;Actual;Q-Med AB;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T10:59:49Z;2020-06-01T10:59:49Z;Hamburg;3554980;Principal Investigator;Martina Kerscher, MD;University of Hamburg;Restylane Vital Skinboosters Lidocaine;63598829;1;55;6;2015;2020-05-29;23;TRUE;27;FALSE;TRUE;35;45;Years;Years;2;;
NCT02400333;ClinicalTrials.gov processed this data on May 29, 2020;2015-03-09;;;2016-08-16;2015-03-23;2015-03-27;Estimate;;;;;;;2016-08-16;2016-09-29;Estimate;June 2015;;2015-06-30;August 2016;2016-08-31;July 2015;Actual;2015-07-31;July 2015;Actual;2015-07-31;;Interventional;;;Study to Assess the Bioavailability of Ticagrelor OD Tablet vs. IR Tablet;An Open-label, Randomised, Four-period, Four-treatment, Crossover, Single-centre, Single-dose Study to Assess the Bioavailability of Ticagrelor Orodispersible Tablets, Compared to Ticagrelor Immediate-release Tablets in Healthy Subjects;Completed;;Phase 1;100;Actual;AstraZeneca;;4;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:00:37Z;2020-06-01T11:00:37Z;Berlin;3555243;Principal Investigator;Rainard Fuhr, Dr. med.;PAREXEL International GmbH, Berlin;Ticagrelor OD tablet (90 mg single dose) administered with 200 ml of water | Ticagrelor OD tablet (90 mg single dose) administered without water | Ticagrelor OD tablet (90 mg single dose) suspended in water administered via nasogastric tube | Brilique®, Ticagrelor IR tablet (90 mg) administered with 200mL of water;63599107;1;29;0;2015;2020-05-29;1;TRUE;9;FALSE;TRUE;18;55;Years;Years;3;10;
NCT02398877;ClinicalTrials.gov processed this data on May 29, 2020;2015-03-09;;;2016-03-04;2015-03-25;2015-03-26;Estimate;;;;;;;2016-03-04;2016-03-07;Estimate;February 2013;;2013-02-28;March 2016;2016-03-31;February 2016;Actual;2016-02-29;February 2016;Actual;2016-02-29;;Interventional;Cort-Metab;;HPA Axis Activity Due To Early Traumatic Stress and Metabolic Symptoms;Altered Hypothalamic-Pituitary-Adrenal Axis (HPA-Axis) Activity Due To Early Traumatic Stress and Its Relevance for Metabolic Symptoms;Completed;;N/A;140;Actual;Charite University, Berlin, Germany;;4;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:00:52Z;2020-06-01T11:00:52Z;Berlin;3555363;Principal Investigator;Katja Wingenfeld, PhD;Charite University;stress;63599221;1;;;2015;2020-05-29;36;FALSE;;FALSE;TRUE;18;60;Years;Years;4;;
NCT02398864;ClinicalTrials.gov processed this data on May 29, 2020;2015-03-13;;;2015-03-20;2015-03-20;2015-03-26;Estimate;;;;;;;2015-03-20;2015-03-26;Estimate;March 2015;;2015-03-31;March 2015;2015-03-31;June 2017;Anticipated;2017-06-30;March 2017;Anticipated;2017-03-31;;Interventional;EBUS-nonM;;Accuracy and Safety of Endobronchial Ultrasound (EBUS) in Suspected Non-malignant Mediastinal Lymphadenopathy;Accuracy and Safety of Endobronchial Ultrasound (EBUS) in Suspected Non-malignant Mediastinal Lymphadenopathy;Unknown status;;N/A;120;Anticipated;Hannover Medical School;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:00:52Z;2020-06-01T11:00:52Z;Hannover;3555364;Principal Investigator;Thomas Fuehner, MD;Hannover Medical School;EBUS with TBNA;63599223;;;;2015;2020-05-29;;FALSE;;;FALSE;18;;Years;;1;2;
NCT02396706;ClinicalTrials.gov processed this data on May 29, 2020;2015-03-18;;;2015-09-02;2015-03-23;2015-03-24;Estimate;;;;;;;2015-09-02;2015-09-03;Estimate;January 2015;;2015-01-31;September 2015;2015-09-30;June 2015;Actual;2015-06-30;June 2015;Actual;2015-06-30;;Interventional;;;RCT to Evaluate the Efficacy and Safety of Ivy Leaves Cough Liquid vs. Placebo in the Treatment of Acute Cough;Randomized, Controlled, Double-blind, Multi-center Trial to Evaluate the Efficacy and Safety of a Liquid Containing Ivy Leaves Dry Extract vs. Placebo in the Treatment of Acute Cough;Completed;;Phase 2;181;Actual;Engelhard Arzneimittel GmbH & Co.KG;;2;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T11:01:14Z;2020-06-01T11:01:14Z;Duisburg;3555517;Principal Investigator;Axel Schaefer;Medizentrum Essen-Borbeck;Ivy Leaves Cough Liquid | Placebo;63599390;1;;;2015;2020-05-29;5;FALSE;;FALSE;TRUE;18;75;Years;Years;1;;
NCT02395159;ClinicalTrials.gov processed this data on May 29, 2020;2015-03-16;;;2017-10-26;2015-03-19;2015-03-20;Estimate;;;;;;;2017-10-26;2017-10-27;Actual;July 2015;Actual;2015-07-31;October 2017;2017-10-31;October 10, 2017;Actual;2017-10-10;July 2017;Actual;2017-07-31;;Interventional;IMS;;Reduction of Groin Wound Infections After Vascular Surgery by Using an Incision Management System (IMS);Reduction of Groin Wound Infections After Vascular Surgery in Patients With Risk Factors by the Use a Negative Pressure Wound Incision Management System (KCI Prevena);Completed;;N/A;204;Actual;RWTH Aachen University;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:01:34Z;2020-06-01T11:01:34Z;Aachen;3555636;Principal Investigator;Jochen Grommes;University Hospital, Aachen;Prevena™ IMS | sterile plaster dressings;63599508;2;;;2015;2020-05-29;24;FALSE;;FALSE;FALSE;18;;Years;;1;5;
NCT02394002;ClinicalTrials.gov processed this data on May 29, 2020;2015-03-16;;;2015-03-19;2015-03-19;2015-03-20;Estimate;;;;;;;2015-03-19;2015-03-20;Estimate;March 2015;;2015-03-31;March 2015;2015-03-31;March 2017;Anticipated;2017-03-31;March 2016;Anticipated;2016-03-31;;Interventional;SEPinBSP;;SEP Changes During Deep Anesthesia;The Effect of Burst-suppression-pattern in EEG on Generating Somatosensory Evoked Potentials;Unknown status;;N/A;60;Anticipated;Heinrich-Heine University, Duesseldorf;;3;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T11:01:50Z;2020-06-01T11:01:50Z;Düsseldorf;3555721;Principal Investigator;Andrea Szelényi, Prof.;Neurosurgical Clinic, Heinrich Heine University;Propofol;63599596;1;;;2015;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT02393950;ClinicalTrials.gov processed this data on May 29, 2020;2015-03-06;;;2016-10-28;2015-03-13;2015-03-20;Estimate;;;;;;;2016-10-28;2016-12-23;Estimate;March 2015;;2015-03-31;March 2016;2016-03-31;March 2016;Actual;2016-03-31;October 2015;Actual;2015-10-31;;Interventional;FIMPAM;;Safety, Tolerability,Pharmacokinetics and Pharmacodynamics of ODM-106 in Healthy Volunteers;Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of Single Escalating Doses of ODM-106: A Randomised, Double-blind, Placebo-controlled Single Centre Study in Healthy Males;Completed;;Phase 1;16;Actual;Orion Corporation, Orion Pharma;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T11:01:50Z;2020-06-01T11:01:50Z;Berlin;3555723;Principal Investigator;Rainard Fuhr, MD;Parexel International GmbH, Berlin, Germany;ODM-106 | Placebo;63599600;1;56;0;2015;2020-05-29;7;TRUE;12;FALSE;TRUE;18;45;Years;Years;1;9;
NCT02384850;ClinicalTrials.gov processed this data on May 29, 2020;2015-03-02;;;2018-02-13;2015-03-04;2015-03-10;Estimate;;;;;;;2018-02-13;2018-02-14;Actual;March 2015;;2015-03-31;February 2018;2018-02-28;March 9, 2017;Actual;2017-03-09;March 9, 2017;Actual;2017-03-09;;Interventional;SENTINEL;;Phase 1 Trial To Evaluate mFOLFOX6 With Selinexor In Patients With Metastatic Colorectal Cancer;An Investigator Initiated Phase 1 Trial To Evaluate mFOLFOX6 With Selinexor (KPT-330), An Oral Selective Inhibitor Of Nuclear Export (SINE), In Patients With Metastatic Colorectal Cancer;Completed;;Phase 1;10;Actual;GSO Global Clinical Research BV;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:03:59Z;2020-06-01T11:03:59Z;Hamburg;3556414;Principal Investigator;Carsten Bokemeyer, Prof. Dr.;University Hospital Hamburg;Selinexor | Oxaliplatin | 5-FU | Folinic Acid;63600306;2;;;2015;2020-05-29;23;FALSE;;FALSE;FALSE;18;;Years;;1;4;
NCT02383238;ClinicalTrials.gov processed this data on May 29, 2020;2014-07-24;;;2018-05-09;2015-03-02;2015-03-09;Estimate;;;;;;;2018-05-09;2018-05-11;Actual;March 2014;;2014-03-31;May 2018;2018-05-31;October 2015;Actual;2015-10-31;October 2015;Actual;2015-10-31;;Interventional;Dapa;;Effect of Dapagliflozin on Microvascular and Macrovascular Circulation and Total Body Sodium Content;Randomized, Placebo Controlled, Crossover Clinical Study to Analyse the Effect of Dapagliflozin on Microvascular and Macrovascular Circulation and Total Body Sodium Content;Completed;;Phase 3;59;Actual;University of Erlangen-Nürnberg Medical School;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T11:04:21Z;2020-06-01T11:04:21Z;Erlangen;3556537;Principal Investigator;Roland Schmieder, Prof.;Department of Medicine 4, University of Erlangen-Nuernberg;Dapagliflozin | Placebo;63600433;1;;;2014;2020-05-29;19;FALSE;;FALSE;TRUE;18;75;Years;Years;1;1;
NCT02382926;ClinicalTrials.gov processed this data on May 29, 2020;2015-03-03;;;2015-03-12;2015-03-06;2015-03-09;Estimate;;;;;;;2015-03-12;2015-03-13;Estimate;October 2014;;2014-10-31;March 2015;2015-03-31;November 2014;Actual;2014-11-30;November 2014;Actual;2014-11-30;;Interventional;RehaDrivecECG;;Reha Drive: Capacitive Electrocardiography in Car Seat in Cardiological Patients;Capacitive Electrocardiography in the Driver`s Seat and Elevation of Vital Signs Via Camera During Cardiac Rehabilitation;Completed;;N/A;10;Actual;RWTH Aachen University;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:04:26Z;2020-06-01T11:04:26Z;Aachen;3556553;Principal Investigator;Sebastian Reith, MD;University Hospital Aachen, Clinic of Cardiology, Angiology, Pneumology and Intensive Care Medicine;Capacitive ECG and contactless heart and breathing rate measurements via camera;63600456;2;;;2015;2020-05-29;1;FALSE;;FALSE;FALSE;18;;Years;;1;1;1
NCT02382445;ClinicalTrials.gov processed this data on May 29, 2020;2014-08-11;;;2017-05-08;2015-03-05;2015-03-06;Estimate;;;;;;;2017-05-08;2017-05-09;Actual;January 2014;;2014-01-31;May 2017;2017-05-31;May 8, 2017;Actual;2017-05-08;May 8, 2017;Actual;2017-05-08;;Interventional;BIS & Dementia;;Anesthesia Depth Increases the Degree of Postoperative Dementia, Delirium, and Cognitive Dysfunction;Anesthesia Depth Increases the Degree of Postoperative Dementia, Delirium, and Cognitive Dysfunction by a Higher Load of Neurotrophic Drugs;Completed;;N/A;138;Actual;Universitätsmedizin Mannheim;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:04:31Z;2020-06-01T11:04:31Z;Mannheim;3556599;Study Director;Thomas Frietsch, Prof, MD;Universitätsmedizin Mannheim;Anesthesia depth monitor | Sham control | propofol and sevoflurane;63600493;1;;;2014;2020-05-29;39;FALSE;;FALSE;TRUE;18;110;Years;Years;1;1;
NCT02380937;ClinicalTrials.gov processed this data on May 29, 2020;2015-02-16;;;2018-02-05;2015-03-04;2015-03-05;Estimate;;;;;;;2018-02-05;2018-02-06;Actual;January 2015;;2015-01-31;November 2015;2015-11-30;August 2015;Actual;2015-08-31;August 2015;Actual;2015-08-31;;Interventional;;;Radio Frequency Ablation for Atrial Flutter With Magnetic Resonance Guidance and Tracking;Radio Frequency Ablation for Atrial Flutter With Magnetic Resonance Guidance and Tracking: Pilot Study Using a Combination Imricor and Philips Interventional System;Terminated;;N/A;8;Actual;University of Leipzig;;1;;The study was terminated prematurely on 05May 2015 because of the unavailability of study~   devices.;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:05:00Z;2020-06-01T11:05:00Z;Leipzig;3556727;Principal Investigator;Gerhard Hindricks, Professor;Heart Center Leipzig;ablation for typical atrial flutter | Vision Ablation Catheter;63600608;1;;;2015;2020-05-29;7;FALSE;;FALSE;TRUE;18;75;Years;Years;1;1;
NCT02377154;ClinicalTrials.gov processed this data on May 29, 2020;2015-02-13;;;2017-12-11;2015-02-24;2015-03-03;Estimate;;;;;;;2017-12-11;2017-12-13;Actual;February 2015;;2015-02-28;December 2017;2017-12-31;May 2016;Actual;2016-05-31;May 2015;Actual;2015-05-31;;Interventional;;;Comparability of Keratometry of VERION Image Guided System With Established Measuring Devices;Comparability of Keratometry and Intraocular Lens (IOL) Calculation of VERION Image Guided System With Established Measuring Devices in Ophthalmologically Healthy Individuals;Completed;;N/A;150;Actual;Heidelberg University;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:05:59Z;2020-06-01T11:05:59Z;Heidelberg;3557021;Principal Investigator;Mike P Holzer, MD, FEBO;Department of opthalmology, University of Heidelberg;Slit lamp | Autorefractor | IOLMaster 500 | Pentacam HR | LenStar LS900 | VERION Image Guided System;63600898;1;;;2015;2020-05-29;3;FALSE;;FALSE;TRUE;18;;Years;;1;5;
NCT02376075;ClinicalTrials.gov processed this data on May 29, 2020;2015-02-11;;;2015-02-25;2015-02-25;2015-03-03;Estimate;;;;;;;2015-02-25;2015-03-03;Estimate;January 2013;;2013-01-31;February 2015;2015-02-28;September 2014;Actual;2014-09-30;September 2014;Actual;2014-09-30;;Interventional;;;Effects of Linagliptin on Endothelial- , Renal-, and Retinal Function in Patients With Hypertension and Albuminuria;Effects of Linagliptin on Endothelial- , Renal-, and Retinal Function in Comparison to Placebo in Patients With Hypertension and Albuminuria;Completed;;Phase 3;43;Actual;ikfe-CRO GmbH;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:06:14Z;2020-06-01T11:06:14Z;Mainz;3557095;Principal Investigator;Thomas Forst, MD, PhD;Profil GmbH Mainz;Linagliptin | Placebo;63600981;1;;;2015;2020-05-29;20;FALSE;;FALSE;TRUE;45;80;Years;Years;1;12;
NCT02374567;ClinicalTrials.gov processed this data on May 29, 2020;2015-01-05;;;2018-02-27;2015-02-24;2015-03-02;Estimate;;;;;;;2018-02-27;2018-02-28;Actual;January 2015;Actual;2015-01-31;February 2018;2018-02-28;June 28, 2017;Actual;2017-06-28;June 28, 2017;Actual;2017-06-28;;Interventional;GAP;;Pharmacovigilance in Gerontopsychiatric Patients;Pharmacovigilance in Gerontopsychiatric Patients;Terminated;;Phase 3;407;Actual;Hannover Medical School;;1;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T11:06:29Z;2020-06-01T11:06:29Z;Hannover;3557205;Principal Investigator;Helge Frieling, Prof., MD;Hannover Medical School;Phenobarbital | Phenytoin | Carbamazepine | Oxcarbazepine | Valproic Acid | Lamotrigine | Topiramate | Gabapentin | Levetiracetam | Pregabalin | Lacosamide | Clonazepam | Biperiden | Levomepromazine | Fluphenazine | Perphenazine | Perazine | Thioridazine | Haloperidol | Melperone | Pipamperone | Bromperidol | Benperidol | Sertindole | Ziprasidone | Flupentixol | Chlorprothixene | Zuclopenthixol | Fluspirilene | Pimozide | Clozapine | Olanzapine | Quetiapine | Sulpiride | Tiapride | Amisulpride | Prothipendyl | Risperidone | Aripiprazole | Paliperidone | Diazepam | Oxazepam | Lorazepam | Bromazepam | Clobazam | Alprazolam | Hydroxyzine | Buspirone | Chloral Hydrate | Flurazepam | Nitrazepam | Triazolam | Lormetazepam | Temazepam | Midazolam | Brotizolam | Zopiclone | Zolpidem | Zaleplon | Melatonin | Clomethiazole | Diphenhydramine | Promethazine | Imipramine | Clomipramine | Opipramol | Trimipramine | Amitriptyline | Nortriptyline | Doxepin | Maprotiline | Amitriptyline oxide | Fluoxetine | Citalopram | Paroxetine | Sertraline | Fluvoxamine | Escitalopram | Tranylcypromine | Moclobemide | Mianserin | Trazodone | Mirtazapine | Bupropion | Venlafaxine | Reboxetine | Duloxetine | Agomelatine | Pyritinol | Piracetam | Donepezil | Rivastigmine | Galantamine | Memantine | Nicergoline | Acamprosate | Lithium;63601095;5;;;2015;2020-05-29;29;FALSE;;FALSE;FALSE;65;;Years;;1;6;
NCT02372318;ClinicalTrials.gov processed this data on May 29, 2020;2015-02-06;;;2017-06-28;2015-02-19;2015-02-26;Estimate;;;;;;;2017-06-28;2017-07-02;Actual;April 2015;;2015-04-30;January 2016;2016-01-31;May 2016;Actual;2016-05-31;May 2016;Actual;2016-05-31;;Interventional;NALCUE;;Single-dose of Nalmefene to Modulate Neural Alcohol Cue Reactivity;Nalmefene Challenge to Modulate Neural Reactivity to Alcohol-related and Emotional Cues in Non-treatment Seeking Alcohol Dependent Participants;Terminated;;Early Phase 1;23;Actual;Central Institute of Mental Health, Mannheim;;2;;Anticipated nr of 25 probands was not reached in terms of full data sets (missing data, low~   fMRI data quality), but time frame for recruitment ended.;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:07:03Z;2020-06-01T11:07:03Z;Mannheim;3557362;Principal Investigator;Sabine Vollstädt-Klein, Prof. Dr.;Central Institute of Mental Health, Mannheim;Nalmefene | Placebo;63601264;1;;;2015;2020-05-29;13;FALSE;;FALSE;TRUE;18;65;Years;Years;1;;
NCT02371434;ClinicalTrials.gov processed this data on May 29, 2020;2015-02-18;;;2020-02-03;2015-02-19;2015-02-25;Estimate;;;;;;;2020-02-03;2020-02-05;Actual;February 2015;;2015-02-28;February 2020;2020-02-29;November 1, 2017;Actual;2017-11-01;November 1, 2017;Actual;2017-11-01;;Interventional;ONEnTreg13;;The ONE Study nTreg Trial (ONEnTreg13);The ONE Study: A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation - nTregs Trial;Completed;;Phase 1/Phase 2;17;Actual;Charite University, Berlin, Germany;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T11:07:17Z;2020-06-01T11:07:17Z;Berlin;;;;;autologous CD4+CD25+FoxP3+ natural regulat. T cells (nTregs);63601330;1;;;2015;2020-05-29;32;FALSE;;FALSE;TRUE;18;65;Years;Years;7;5;
NCT02369848;ClinicalTrials.gov processed this data on May 29, 2020;2015-02-09;;;2018-03-19;2015-02-17;2015-02-24;Estimate;;;;;;;2018-03-19;2018-04-18;Actual;June 2015;Actual;2015-06-30;March 2018;2018-03-31;December 2016;Actual;2016-12-31;December 2015;Actual;2015-12-31;;Interventional;;;Shockwave Lithoplasty DISRUPT Trial for PAD (DISRUPT PAD 2);Shockwave Lithoplasty DISRUPT Trial for PAD (DISRUPT PAD 2);Completed;;N/A;60;Actual;Shockwave Medical, Inc.;;1;;;FALSE;;;;FALSE;FALSE;TRUE;;;TRUE;;;;;;;;2020-06-01T11:07:42Z;2020-06-01T11:07:42Z;Freiburg;3557553;Principal Investigator;Thomas Zeller, MD;Universitäts-Herzzentrum Freiburg & Bad Krozingen;Shockwave Lithoplasty System;63601450;8;117;84;2015;2020-05-29;6;TRUE;21;FALSE;FALSE;18;;Years;;2;9;
NCT02368158;ClinicalTrials.gov processed this data on May 29, 2020;2015-02-04;;;2015-09-15;2015-02-19;2015-02-20;Estimate;;;;;;;2015-09-15;2015-09-16;Estimate;October 2013;;2013-10-31;September 2015;2015-09-30;December 2015;Anticipated;2015-12-31;December 2015;Anticipated;2015-12-31;;Interventional;RehaDrive;;Reha Drive: Predictors of Fitness to Drive a Car for Cardiologic Patients and Determination of Vital Signs;Reha Drive: Predictors of Fitness to Drive a Car for Cardiologic Patients in Rehabilitation and Acute Clinic and Contactless Determination of Vital Signs Via Camera;Unknown status;;N/A;40;Anticipated;RWTH Aachen University;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:08:01Z;2020-06-01T11:08:01Z;Aachen;3557680;Principal Investigator;Sebastian Reith, MD;Department of Cardiology, Angiology, Pneumology and Intensive Medicine, RWTH Aachen University Hospital;Driving simulation with elevation of medical data in comparison to Lane Change Test plus automotive monitoring via contactless sensors;63601574;2;;;2015;2020-05-29;;FALSE;;FALSE;FALSE;18;;Years;;7;2;
NCT02367495;ClinicalTrials.gov processed this data on May 29, 2020;2015-02-13;;;2019-01-07;2015-02-13;2015-02-20;Estimate;;;;;;;2019-01-07;2019-01-08;Actual;January 2015;;2015-01-31;January 2019;2019-01-31;October 25, 2017;Actual;2017-10-25;October 25, 2017;Actual;2017-10-25;;Interventional;ISAR-DESIRE 3A;;Trial of a Novel Paclitaxel-coated Balloon With Citrate Excipient for Restenosis in -Limus Analogue DES;Trial of a Novel Paclitaxel-coated Balloon With Citrate Excipient for Restenosis in -Limus Analogue Drug-eluting Coronary Stents;Completed;;N/A;125;Actual;Deutsches Herzzentrum Muenchen;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:08:15Z;2020-06-01T11:08:15Z;Munich;3557730;Principal Investigator;Robert Byrne, MB BCh PhD;Deutsches Herzzentrum Muenchen;PCB;63601625;1;;;2015;2020-05-29;33;FALSE;;FALSE;TRUE;18;;Years;;1;3;
NCT02366052;ClinicalTrials.gov processed this data on May 29, 2020;2013-11-01;;;2017-05-15;2015-02-11;2015-02-19;Estimate;;;;;;;2017-05-15;2017-05-16;Actual;February 1, 2015;Actual;2015-02-01;May 2017;2017-05-31;May 10, 2017;Actual;2017-05-10;May 10, 2017;Actual;2017-05-10;;Interventional;NucesNASH;;Nutritional Counseling vs. Nutritional Supplements for NASH - a Randomized Prospective, Open Label Pilot Study;Nutritional Counseling Versus Nutritional Supplements for the Treatment of NASH - a Randomized Prospective, Open Label Pilot Study (Nuces NASH);Completed;;Phase 2;42;Actual;Johannes Gutenberg University Mainz;;3;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T11:08:37Z;2020-06-01T11:08:37Z;Jena Mainz;3557836;Principal Investigator;Jörn M Schattenberg, MD;Johannes Gutenberg Universität;Nutritional Counseling | Lactobacillus casei shirota (LCS) | Nutritional Counseling and LCS;63601733;2;;;2013;2020-05-29;27;FALSE;;FALSE;FALSE;18;75;Years;Years;1;3;1
NCT02365350;ClinicalTrials.gov processed this data on May 29, 2020;2015-02-06;;;2016-11-17;2015-02-10;2015-02-18;Estimate;;;;;;;2016-11-17;2016-11-18;Estimate;January 2015;;2015-01-31;November 2016;2016-11-30;August 2016;Actual;2016-08-31;August 2016;Actual;2016-08-31;;Interventional;;;Randomized Clinical Trial on Follicular Flushing in IVF;A Randomized, Controlled, Open Trial Comparing a 17 G Single Lumen Aspiration Needle With a Modified Double Lumen Needle System (STEINER-TAN Needle®) for Follicular Flushing During Oocyte Pick-up in IVF Patients With Poor Ovarian Response;Completed;;N/A;80;Actual;University of Luebeck;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:08:44Z;2020-06-01T11:08:44Z;Lübeck;3557885;Principal Investigator;Georg Griesinger, MD MSc PhD;University of Luebeck;STEINER-TAN Needle® | 17 G single lumen needle;63601786;1;;;2015;2020-05-29;19;FALSE;;FALSE;TRUE;18;45;Years;Years;1;5;
NCT02364986;ClinicalTrials.gov processed this data on May 29, 2020;2014-12-10;;;2016-06-02;2015-02-10;2015-02-18;Estimate;;;;;;;2016-06-02;2016-06-03;Estimate;January 2015;;2015-01-31;June 2016;2016-06-30;January 2017;Anticipated;2017-01-31;January 2017;Anticipated;2017-01-31;;Interventional;RESI;;Immune- and miRNA-response to Recombinant Interferon Beta in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis;Immune- and miRNA-response to Recombinant Interferon Beta in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis;Unknown status;;Phase 1;50;Anticipated;University Hospital, Bonn;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:08:48Z;2020-06-01T11:08:48Z;Bonn;3557913;Principal Investigator;Marcus Müller, PD Dr.;Department of Neurology University Hospital Bonn;Rebif® | Avonex;63601814;2;;;2014;2020-05-29;;FALSE;;FALSE;FALSE;18;65;Years;Years;1;11;
NCT02364219;ClinicalTrials.gov processed this data on May 29, 2020;2015-01-20;;;2015-02-19;2015-02-16;2015-02-18;Estimate;;;;;;;2015-02-19;2015-02-20;Estimate;February 2015;;2015-02-28;February 2015;2015-02-28;May 2016;Anticipated;2016-05-31;February 2016;Anticipated;2016-02-29;;Interventional;PREWARM;;Impact of Prewarming on Perioperative Body Core Temperature and the Outcomes of Cytoreductive- and Major Open Abdominal Surgery: A Randomised Trial;Impact of Prewarming on Perioperative Body Core Temperature and the Outcomes of Cytoreductive- and Major Open Abdominal Surgery: A Randomised Trial (PREWARM);Unknown status;;N/A;48;Anticipated;Charite University, Berlin, Germany;;4;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:08:58Z;2020-06-01T11:08:58Z;Berlin;3557974;Principal Investigator;Michael Sander;Department of Anesthesiology and Intensive Care Medicine Campus Charité Mitte / Campus Virchow-Klinikum Berlin;Prewarming | Microdialysis;63601873;1;;;2015;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;1;2
NCT02364167;ClinicalTrials.gov processed this data on May 29, 2020;2015-02-09;;;2016-06-27;2015-02-13;2015-02-16;Estimate;;;;;;;2016-06-27;2016-06-28;Estimate;January 2015;;2015-01-31;June 2016;2016-06-30;May 2017;Anticipated;2017-05-31;May 2017;Anticipated;2017-05-31;;Interventional;ACUSEC;;Acupuncture for Pain Control After Elective Caesarean Section;Acupuncture vs. Placebo Acupuncture and vs. Standard Therapy for Pain Control After Elective Caesarean Section - a Randomized Controlled Trial;Unknown status;;Phase 2/Phase 3;180;Anticipated;University Medicine Greifswald;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:08:59Z;2020-06-01T11:08:59Z;Greifswald;3557978;Study Director;Taras I Usichenko, MD, PhD;University Medicine of Greifswald;Standard therapy | Verum acupuncture | Placebo acupuncture;63601877;1;;;2015;2020-05-29;;FALSE;;FALSE;TRUE;19;45;Years;Years;1;2;
NCT02362802;ClinicalTrials.gov processed this data on May 29, 2020;2015-02-01;;;2017-10-27;2015-02-12;2015-02-13;Estimate;;;;;;;2017-10-27;2017-10-30;Actual;September 2014;Actual;2014-09-30;October 2017;2017-10-31;December 2017;Anticipated;2017-12-31;May 31, 2017;Actual;2017-05-31;;Interventional;MyDate;;Myocardial Minimal Damage After Rapid Ventricular Pacing;Myocardial Minimal Damage After Rapid Ventricular Pacing;Unknown status;;N/A;149;Actual;Deutsches Herzzentrum Muenchen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:09:13Z;2020-06-01T11:09:13Z;Munich;3558099;Principal Investigator;Christof Kolb, MD;Deutsches Herzzentrum München;Implantable Cardioverter Defibrillator;63601980;1;;;2015;2020-05-29;32;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT02362789;ClinicalTrials.gov processed this data on May 29, 2020;2015-02-09;;;2018-06-25;2015-02-09;2015-02-13;Estimate;;;;;;;2018-06-25;2018-12-28;Actual;January 4, 2015;Actual;2015-01-04;June 2018;2018-06-30;July 15, 2016;Actual;2016-07-15;July 15, 2016;Actual;2016-07-15;;Interventional;PSORITUS;;Secukinumab Study in PSOriasis Exploring pruRITUS Intensity and Lesional Biomarkers;Exploratory Study on the Kinetics of Psoriasis Symptoms, Pruritus Intensity and Lesional Biomarkers in Patients With Moderate to Severe Plaque-type Psoriasis Treated With Subcutaneous Secukinumab (300 mg) During a 16 Week Open-label run-in Phase Followed by a 16 Week Randomized, Double-blind, Placebo-controlled Withdrawal Phase;Completed;;Phase 3;132;Actual;Novartis;;2;;;FALSE;;;;FALSE;;;;;;;;;;;Undecided;Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.~This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com;2020-06-01T11:09:13Z;2020-06-01T11:09:13Z;Münster;3558100;Principal Investigator;Study Lead;Muenster;Secukinumab | Placebo;63601981;19;169;19;2015;2020-05-29;18;TRUE;12;FALSE;FALSE;18;;Years;;1;;
NCT02361697;ClinicalTrials.gov processed this data on May 29, 2020;2015-01-19;;;2016-05-18;2015-02-06;2015-02-12;Estimate;;;;;;;2016-05-18;2016-05-19;Estimate;December 2014;;2014-12-31;May 2016;2016-05-31;December 2017;Anticipated;2017-12-31;December 2016;Anticipated;2016-12-31;;Interventional;;;DTI in Children With Multiple Sclerosis;Monitoring of Neurodegenerative Processes in Children With Multiple Sclerosis by Diffusion-weighed Magnetic Resonance Imaging (DTI);Unknown status;;N/A;15;Anticipated;University Hospital Muenster;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:09:29Z;2020-06-01T11:09:29Z;Münster;3558192;Principal Investigator;Christiane Elpers, MD;University Hospital Muenster;DTI-MRI;63602062;1;;;2015;2020-05-29;;FALSE;;FALSE;TRUE;5;18;Years;Years;2;8;
NCT02360033;ClinicalTrials.gov processed this data on May 29, 2020;2015-01-21;;;2019-10-16;2015-02-04;2015-02-10;Estimate;;;;;;;2019-10-16;2019-10-18;Actual;January 2015;;2015-01-31;October 2019;2019-10-31;September 2017;Actual;2017-09-30;January 2017;Actual;2017-01-31;;Interventional;;;Systemic Therapy and Cognitive Behavioral Therapy for Social Anxiety Disorders;Systemic Therapy and Cognitive Behavioral Therapy for Social Anxiety Disorders With Adults: Manual Development and Randomized-Controled Feasibility Study;Completed;;N/A;38;Actual;Heidelberg University;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:09:49Z;2020-06-01T11:09:49Z;Heidelberg;3558313;Study Director;Christina Hunger, Dr.;Institute of Medical Psychology, University Hospital Heidelberg/Germany;Systemic Therapy for Social Anxiety Disorder | Cognitive Behavioral Therapy for Social Anxiety Disorder;63602189;1;;;2015;2020-05-29;24;FALSE;;FALSE;TRUE;18;65;Years;Years;3;10;
NCT02359045;ClinicalTrials.gov processed this data on May 29, 2020;2015-02-04;;;2017-03-21;2015-02-04;2015-02-09;Estimate;;;;;;;2017-03-21;2017-05-01;Actual;February 12, 2015;Actual;2015-02-12;March 2017;2017-03-31;July 27, 2015;Actual;2015-07-27;July 27, 2015;Actual;2015-07-27;;Interventional;;;Study in Healthy Subjects to Compare the Concentrations of the Omega-3 Fatty Acids EPA and DHA in Blood When Delivered as Three New Capsules in Relation to the Epanova® Capsule Under Fasting and Fed Conditions;A Randomized, Open-label, Single-center, Cross-over Study in Healthy Subjects to Assess the Relative Bioavailability of EPA and DHA Delivered by Three New Capsule Formulation Prototypes in Relation to the Current Epanova® Capsule Under Fasting (Part 1) and Fed (Part 2) Conditions;Completed;;Phase 1;137;Actual;AstraZeneca;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:09:59Z;2020-06-01T11:09:59Z;Hannover;3558409;Principal Investigator;Ronald Goldwater, Dr.;PAREXEL Early Phase Clinical Unit Baltimore, 3001 S. Hanover St., Baltimore, MD 21225, United States of America;D1400147 | D14000136 | D14000137 | Epanova®;63602265;1;79;0;2015;2020-05-29;5;TRUE;12;TRUE;TRUE;18;55;Years;Years;9;23;
NCT02358720;ClinicalTrials.gov processed this data on May 29, 2020;2015-01-27;;;2015-02-06;2015-02-06;2015-02-09;Estimate;;;;;;;2015-02-06;2015-02-09;Estimate;December 2014;;2014-12-31;February 2015;2015-02-28;December 2016;Anticipated;2016-12-31;December 2015;Anticipated;2015-12-31;;Interventional;SMART;;Single-fraction IMRT Versus External Beam Radiotherapy for Patients With Spine Bone Metastases;Single-fraction IMRT Versus External Beam Radiotherapy for Patients With Spine Bone Metastases;Unknown status;;Phase 1/Phase 2;60;Anticipated;Heidelberg University;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:10:04Z;2020-06-01T11:10:04Z;Heidelberg;3558434;Principal Investigator;Harald Rief, MD, PhD;University Hospital Heidelberg;Arm A | Arm B;63602290;1;;;2015;2020-05-29;;FALSE;;FALSE;TRUE;18;80;Years;Years;1;1;
NCT02358408;ClinicalTrials.gov processed this data on May 29, 2020;2015-01-26;;;2016-01-27;2015-02-03;2015-02-09;Estimate;;;;;;;2016-01-27;2016-01-28;Estimate;January 2015;;2015-01-31;January 2016;2016-01-31;April 2015;Actual;2015-04-30;February 2015;Actual;2015-02-28;;Interventional;;;System Accuracy Evaluation of Karajishi Contour and Karajishi TS Blood Glucose Monitoring Systems Following ISO 15197:2013;System Accuracy Evaluation of Karajishi Contour and Karajishi TS Blood Glucose Monitoring Systems Following ISO 15197:2013;Completed;;N/A;136;Actual;Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm;;;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T11:10:08Z;2020-06-01T11:10:08Z;Ulm;;;;;Blood glucose monitoring systems for self-testing;63602316;1;;;2015;2020-05-29;0;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT02357706;ClinicalTrials.gov processed this data on May 29, 2020;2015-01-27;;;2020-04-08;2015-02-03;2015-02-06;Estimate;;;;;;;2020-04-08;2020-04-20;Actual;January 2015;;2015-01-31;April 2020;2020-04-30;December 2015;Actual;2015-12-31;June 2015;Actual;2015-06-30;;Interventional;;;Comparison of Auto-Adjusting Positive Airway Pressure Devices;Comparison of Auto-Adjusting Positive Airway Pressure Devices;Completed;;N/A;20;Actual;ResMed;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:10:24Z;2020-06-01T11:10:24Z;Berlin;3558510;Principal Investigator;Ingo Fietz, Prof;Charite Center of Sleep Medicine;APAP B (Apex iCH Auto) | APAP A (ResMed AirSense AutoSet);63602369;1;0;0;2015;2020-05-29;5;TRUE;21;FALSE;TRUE;18;;Years;;2;7;
NCT02356016;ClinicalTrials.gov processed this data on May 29, 2020;2015-01-21;;;2016-05-20;2015-02-04;2015-02-05;Estimate;;;;;;;2016-05-20;2016-05-23;Estimate;August 2013;;2013-08-31;May 2016;2016-05-31;May 2016;Actual;2016-05-31;May 2016;Actual;2016-05-31;;Interventional;;;Effects of Whole-body Electromyostimulation and Dietary Supplements on Sarcopenic Obesity;Effects of Whole-body Electromyostimulation and Dietary Supplements on Sarcopenic Obesity in Elderly Females Living in the Community;Completed;;Phase 2/Phase 3;75;Actual;University of Erlangen-Nürnberg Medical School;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:10:43Z;2020-06-01T11:10:43Z;Erlangen;3558635;Study Chair;Cornel Sieber, MD;Institute of Biomedicine of Age, University of Erlangen-Nuremberg;WB-EMS Intervention | WB-EMS-Intervention and dietary supplementation | control (dietary counseling);63602498;;;;2015;2020-05-29;33;FALSE;;;FALSE;70;;Years;;3;5;3
NCT02353858;ClinicalTrials.gov processed this data on May 29, 2020;2014-12-02;;;2018-02-12;2015-02-02;2015-02-03;Estimate;;;;;;;2018-02-12;2018-02-13;Actual;August 2012;;2012-08-31;February 2018;2018-02-28;December 2017;Actual;2017-12-31;December 2017;Actual;2017-12-31;;Interventional;HT01;;Preoperative Radiochemotherapy With Hyperthermia for Locally Advanced Rectal Cancer;Preoperative Radiochemotherapy With Concurrent Deep Regional Hyperthermia for Locally Advanced Rectal Cancer. A Prospective Phase II Trial;Completed;;Phase 2;78;Actual;University Hospital Tuebingen;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:11:12Z;2020-06-01T11:11:12Z;Tübingen;;;;;Deep regional hyperthermia | Radiotherapy | Chemotherapy (5-Fluorouracil);63602663;1;;;2014;2020-05-29;64;FALSE;;FALSE;TRUE;18;80;Years;Years;1;7;
NCT02353793;ClinicalTrials.gov processed this data on May 29, 2020;2014-12-15;;;2016-11-26;2015-02-02;2015-02-03;Estimate;;;;;;;2016-11-26;2016-11-29;Estimate;April 2015;;2015-04-30;November 2016;2016-11-30;September 2016;Actual;2016-09-30;September 2016;Actual;2016-09-30;;Interventional;;;Trauma Patients and Hypothermia in the Emergency Room: ReadyHeat® Versus Cotton Wool Blanket;Trauma Patients and Hypothermia in the Emergency Room: a Trial Between Self-warming ReadyHeat® Blanket and Traditional Cotton Wool Blanket;Completed;;N/A;60;Actual;University of Schleswig-Holstein;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:11:13Z;2020-06-01T11:11:13Z;Kiel Lübeck;3558802;Study Director;Jan Höcker, M.D.;Klinik für Anästhesiologie und Operative Intensivmedizin, Arnold-Heller-Str. 3, Haus 12, 24105 Kiel;ReadyHeat® blanket | Cotton wool blanket;63602669;1;;;2014;2020-05-29;17;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT02353533;ClinicalTrials.gov processed this data on May 29, 2020;2015-01-23;;;2016-11-18;2015-01-28;2015-02-02;Estimate;;;;;;;2016-11-18;2016-11-21;Estimate;January 2015;;2015-01-31;November 2016;2016-11-30;December 2017;Anticipated;2017-12-31;October 2017;Anticipated;2017-10-31;;Interventional;FiRE;;Endoscopic Full-thickness REsection of Residual Colorectal Lesions - The FiRE Study;;Unknown status;;N/A;40;Anticipated;Technische Universität München;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:11:16Z;2020-06-01T11:11:16Z;Munich;3558823;Study Director;Stefan von Delius, MD;II. Medizinische Klinik, Klinikum rechts der Isar der Technischen Universität München, Germany;over- the- scope full- thickness resection device (FTRD) | EMR;63602688;1;;;2015;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT02350946;ClinicalTrials.gov processed this data on May 29, 2020;2015-01-20;;;2015-01-26;2015-01-26;2015-01-30;Estimate;;;;;;;2015-01-26;2015-01-30;Estimate;January 2015;;2015-01-31;January 2015;2015-01-31;January 2017;Anticipated;2017-01-31;January 2017;Anticipated;2017-01-31;;Interventional;;;Effects of Oxytocin on Emotion Recognition and Response Inhibition;Effects of Oxytocin on Emotion Recognition and Response Inhibition;Unknown status;;Phase 2;40;Anticipated;RWTH Aachen University;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:11:54Z;2020-06-01T11:11:54Z;Aachen;;;;;Oxytocin | Placebo;63602888;1;;;2015;2020-05-29;;FALSE;;FALSE;TRUE;18;45;Years;Years;2;7;
NCT02349880;ClinicalTrials.gov processed this data on May 29, 2020;2015-01-23;;;2018-04-24;2015-01-23;2015-01-29;Estimate;;;;;;;2018-04-24;2018-04-25;Actual;October 2011;;2011-10-31;April 2018;2018-04-30;March 2015;Actual;2015-03-31;December 2014;Actual;2014-12-31;;Interventional;;;A Shared Decision-making Training for Inpatients With Schizophrenia;A Shared Decision-making Training for Inpatients With Schizophrenia;Completed;;N/A;264;Actual;Technische Universität München;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:12:07Z;2020-06-01T11:12:07Z;Munich;;;;;shared decision making training;63602972;;;;2015;2020-05-29;38;FALSE;;;FALSE;18;65;Years;Years;1;;
NCT02348736;ClinicalTrials.gov processed this data on May 29, 2020;2015-01-12;;;2018-01-17;2015-01-22;2015-01-28;Estimate;;;;;;;2018-01-17;2018-01-19;Actual;January 2015;;2015-01-31;January 2018;2018-01-31;April 2015;Actual;2015-04-30;April 2015;Actual;2015-04-30;;Interventional;SensaScope;;Comparison of SensaScope Intuboscope and McGrath Series 5 for Endotracheal Intubation;Comparative Study Between SensaScope Intuboscope and McGrath Series 5 Videolaryngoscope to Tracheal Intubation: a Prospective Randomised Study;Completed;;N/A;76;Actual;Johannes Gutenberg University Mainz;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:12:27Z;2020-06-01T11:12:27Z;Mainz;3559191;Principal Investigator;Marc Kriege, MD;University JG, Mainz;Time for tracheal intubation;63603061;1;;;2015;2020-05-29;2;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT02345447;ClinicalTrials.gov processed this data on May 29, 2020;2015-01-19;;;2018-05-09;2015-01-23;2015-01-26;Estimate;;;;;;;2018-05-09;2018-05-11;Actual;October 2013;Actual;2013-10-31;May 2018;2018-05-31;October 2017;Actual;2017-10-31;October 2015;Actual;2015-10-31;;Interventional;OTV_PRE_01;;Herbal-Based Medication vs. Placebo in Preventing Acute Otitis Media in Children at High Risk of Recurrence;Efficacy and Safety of an Herbal-Based Medication vs. Placebo in Preventing Acute Otitis Media in Children at High Risk of Recurrence: A Placebo Controlled, Randomized, Double-blinded Parallel-Group Comparison for Superiority;Completed;;Phase 3;296;Anticipated;University Hospital Tuebingen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:13:21Z;2020-06-01T11:13:21Z;Tübingen;3559431;Principal Investigator;Axel Franz, MD;University Hospital Tuebingen;Herbal-based medication | Placebo;63603316;1;;;2015;2020-05-29;24;FALSE;;FALSE;TRUE;12;59;Months;Months;1;11;
NCT02345278;ClinicalTrials.gov processed this data on May 29, 2020;2015-01-19;;;2015-12-01;2015-01-23;2015-01-26;Estimate;;;;;;;2015-12-01;2015-12-02;Estimate;May 2015;;2015-05-31;December 2015;2015-12-31;November 2015;Actual;2015-11-30;November 2015;Actual;2015-11-30;;Interventional;DTS;;SUBLIVAC FIX Mite Mixture Dose Tolerability Study;A Randomized, Double-blind, Placebo-controlled Study to Determine Tolerability and Safety of Different Dosages of SUBLIVAC FIX Mite Mixture in Patients With Allergic Rhinitis / Rhinoconjunctivitis Caused by House Dust Mites;Completed;;Phase 1/Phase 2;81;Actual;HAL Allergy;;5;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T11:13:24Z;2020-06-01T11:13:24Z;Berlin;3559444;Study Chair;Margitta Worm, Prof.Dr.med.;Allergie-Centrum-Charité;SUBLIVAC FIX Mite mixture | Placebo;63603330;10;;;2015;2020-05-29;6;FALSE;;FALSE;FALSE;18;60;Years;Years;1;4;
NCT02345200;ClinicalTrials.gov processed this data on May 29, 2020;2015-01-19;;;2015-01-22;2015-01-22;2015-01-26;Estimate;;;;;;;2015-01-22;2015-01-26;Estimate;April 2013;;2013-04-30;January 2015;2015-01-31;April 2014;Actual;2014-04-30;April 2014;Actual;2014-04-30;;Interventional;;;Body Composition and Hormonal Status in Ataxia Telangiectasia;Body Composition, Muscle Strength and Hormonal Status in Patients With Ataxia Telangiectasia Compared to Healthy Controls;Completed;;N/A;52;Actual;Johann Wolfgang Goethe University Hospital;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:13:29Z;2020-06-01T11:13:29Z;Frankfurt;3559450;Principal Investigator;Stefan Zielen, Prof. Dr.;University Childrens´ Hospital Frankfurt;bioelectrical impedance analysis | blood draw;63603334;;;;2015;2020-05-29;12;FALSE;;;FALSE;2;45;Years;Years;1;;
NCT02345135;ClinicalTrials.gov processed this data on May 29, 2020;2015-01-19;;;2017-11-29;2015-01-22;2015-01-26;Estimate;;;;;;;2017-11-29;2017-11-30;Actual;September 2012;;2012-09-30;November 2017;2017-11-30;July 31, 2016;Actual;2016-07-31;January 31, 2016;Actual;2016-01-31;;Interventional;;;Susceptibility to Infections in Ataxia Telangiectasia;Susceptibility to Infections in Patients With Ataxia Telangiectasia : A Prospective Follow-up Study;Completed;;N/A;41;Actual;Johann Wolfgang Goethe University Hospital;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:13:32Z;2020-06-01T11:13:32Z;Frankfurt;3559456;Principal Investigator;Stefan Zielen, Prof. Dr.;Johann Wolfgang Goethe University, Childrens Hospital;Blood collection | Lung function measurement | Symptom diary;63603339;;;;2015;2020-05-29;40;FALSE;;;FALSE;2;45;Years;Years;1;4;
NCT02344030;ClinicalTrials.gov processed this data on May 29, 2020;2015-01-13;;;2018-08-01;2015-01-21;2015-01-22;Estimate;;;;;;;2018-08-01;2018-08-03;Actual;January 2015;;2015-01-31;August 2018;2018-08-31;February 2015;Actual;2015-02-28;February 2015;Actual;2015-02-28;;Interventional;KingVision;;Comparsion of King Vision® Standard Blade and King Vision® Channeled Blade in Patients Scheduled for Tracheal Intubation;Comparative Study of King Vision® Standard Blade and King Vision® Channeled for Tracheal Intubation: a Prospective Randomised Study;Completed;;N/A;44;Actual;Johannes Gutenberg University Mainz;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:13:48Z;2020-06-01T11:13:48Z;Mainz;3559550;Principal Investigator;Marc Kriege, MD;University JG, Mainz;channeled blade | standard blade;63603422;1;;;2015;2020-05-29;0;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT02343029;ClinicalTrials.gov processed this data on May 29, 2020;2015-01-12;;;2015-08-31;2015-01-20;2015-01-21;Estimate;;;;;;;2015-08-31;2015-09-02;Estimate;June 2014;;2014-06-30;August 2015;2015-08-31;August 2015;Actual;2015-08-31;August 2015;Actual;2015-08-31;;Interventional;SMART;;Physical Activity and Cerebral Metabolism in the Elderly: a Randomised Controlled Trial;Physical Activity and Cerebral Metabolism in the Elderly: a Randomised Controlled Trial;Completed;;N/A;60;Actual;Goethe University;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:14:08Z;2020-06-01T11:14:08Z;Frankfurt;3559631;Principal Investigator;Johannes Pantel, Prof.;Institute of General Practice, Goethe University, Frankfurt/Main, Germany;Individualised aerobic exercise training | Waiting Control;63603497;2;;;2015;2020-05-29;14;FALSE;;FALSE;FALSE;65;;Years;;1;15;
NCT02342509;ClinicalTrials.gov processed this data on May 29, 2020;2015-01-06;;;2015-01-14;2015-01-14;2015-01-21;Estimate;;;;;;;2015-01-14;2015-01-21;Estimate;September 2014;;2014-09-30;January 2015;2015-01-31;December 2014;Actual;2014-12-31;December 2014;Actual;2014-12-31;;Interventional;MIRCONTROL;;Automated Control of End-tidal Volatile Anesthetic Concentration;Automated Control of End-tidal Volatile Anesthetic Concentration Using the MIRUS System: A Comparison of Isoflurane, Sevoflurane and Desflurane in Anesthesia.;Completed;;N/A;63;Actual;Ruhr University of Bochum;;3;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T11:14:16Z;2020-06-01T11:14:16Z;Bochum;3559672;Principal Investigator;Thomas Weber, PhD;Ruhr-Universtiy of Bochum, Germany;Desflurane | Sevoflurane | Isoflurane;63603539;;;;2015;2020-05-29;3;FALSE;;;FALSE;18;;Years;;1;1;
NCT02341898;ClinicalTrials.gov processed this data on May 29, 2020;2014-12-16;;;2017-05-02;2015-01-16;2015-01-19;Estimate;;;;;;;2017-05-02;2017-05-03;Actual;March 2015;;2015-03-31;May 2017;2017-05-31;March 2017;Actual;2017-03-31;March 2017;Actual;2017-03-31;;Interventional;IMPRINT;;Implementation of a Multicomponent Intervention to Prevent Physical Restraints in Nursing Home Residents (IMPRINT);Implementation of a Multicomponent Intervention to Prevent Physical Restraints in Nursing Home Residents: a Cluster-randomized Controlled Trial;Completed;;N/A;10800;Actual;University of Luebeck;;3;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T11:14:25Z;2020-06-01T11:14:25Z;Lübeck;3559714;Principal Investigator;Sascha Köpke, Prof. Dr.;University of Lübeck;Educational programme for all nurses | Training and structured support for nominated key nurses | Facultative train-the-trainer module for key nurses | Printed study material | Supportive material (poster, mugs etc.);63603585;4;;;2014;2020-05-29;24;FALSE;;FALSE;FALSE;18;;Years;;1;3;1
NCT02340299;ClinicalTrials.gov processed this data on May 29, 2020;2015-01-10;;;2018-01-30;2015-01-13;2015-01-16;Estimate;;;;;;;2018-01-30;2018-01-31;Actual;January 1, 2015;Actual;2015-01-01;January 2018;2018-01-31;December 31, 2017;Actual;2017-12-31;December 31, 2017;Actual;2017-12-31;;Interventional;;;Nasal HFOV Versus Nasal CPAP to Reduce Post-extubation pCO2;Nasal High Frequency Oscillation Ventilation Versus Nasal Continuous Positive Airway Pressure to Reduce Post-extubation pCO2 in Very Low Birth Weight Infants: a Randomized Controlled Trial;Terminated;;N/A;6;Actual;Charite University, Berlin, Germany;;2;;Slow recruitment;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T11:14:52Z;2020-06-01T11:14:52Z;Berlin;3559882;Principal Investigator;Christoph Czernik, MD PhD;Charite University, Berlin, Germany;nHFOV | nCPAP;63603710;1;;;2015;2020-05-29;36;FALSE;;FALSE;TRUE;;28;;Days;1;13;5
NCT02339597;ClinicalTrials.gov processed this data on May 29, 2020;2014-01-27;;;2015-01-12;2015-01-12;2015-01-15;Estimate;;;;;;;2015-01-12;2015-01-15;Estimate;January 2014;;2014-01-31;January 2015;2015-01-31;November 2015;Anticipated;2015-11-30;November 2015;Anticipated;2015-11-30;;Interventional;;;Therapy Adherence of APAP Therapy Initiation in Sleep-lab Versus at Home;Therapy Adherence in Different Settings of Automatic Positive Airway Pressure (APAP) Therapy Initiation in Patients With Obstructive Sleep Apnea (OSA): Comparison Between in Sleep-lab vs. at Home Environment.;Unknown status;;N/A;224;Anticipated;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:15:03Z;2020-06-01T11:15:03Z;Berlin;;;;;Automatic Positive Airway Pressure (APAP) initiation;63603766;1;;;2014;2020-05-29;;FALSE;;FALSE;TRUE;18;80;Years;Years;1;1;1
NCT02338388;ClinicalTrials.gov processed this data on May 29, 2020;2015-01-12;;;2015-01-13;2015-01-12;2015-01-14;Estimate;;;;;;;2015-01-13;2015-01-15;Estimate;January 2012;;2012-01-31;January 2015;2015-01-31;August 2014;Actual;2014-08-31;April 2014;Actual;2014-04-30;;Interventional;;;Cesarean-scar Thickness and Closure Technique;Longitudinal Transvaginal Ultrasound Evaluation of Cesarean-scar Thickness in the First Two Years After Single- or Double-layer Uterotomy Closure: a Prospective Randomized Study;Completed;;N/A;435;Actual;Charite University, Berlin, Germany;;3;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T11:15:22Z;2020-06-01T11:15:22Z;Berlin;;;;;cesarean section technique;63603855;;;;2015;2020-05-29;27;FALSE;;;FALSE;;;;;1;;
NCT02337400;ClinicalTrials.gov processed this data on May 29, 2020;2015-01-09;;;2016-08-29;2015-01-09;2015-01-13;Estimate;;;;;;;2016-08-29;2016-08-31;Estimate;January 2015;;2015-01-31;August 2016;2016-08-31;April 2016;Actual;2016-04-30;February 2016;Actual;2016-02-29;;Interventional;;;Evaluation of a Cognitive Behavioral Smoking Reduction Program;Das Verhaltenstherapeutische Therapiemanual Smoke_less Zur Reduktion Des Tabakkonsums: Eine Evaluationsstudie Mit Ambulanten Patienten;Completed;;N/A;155;Actual;Ludwig-Maximilians - University of Munich;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:15:41Z;2020-06-01T11:15:41Z;Munich;;;;;Cognitive behavioral smoking reduction program Smoke_less | 15 minute counseling interview;63603932;1;;;2015;2020-05-29;13;FALSE;;FALSE;TRUE;18;70;Years;Years;2;9;
NCT02337062;ClinicalTrials.gov processed this data on May 29, 2020;2015-01-09;;;2019-03-07;2015-01-12;2015-01-13;Estimate;;;;;;;2019-03-07;2019-03-20;Actual;February 2015;;2015-02-28;March 2019;2019-03-31;September 2015;Actual;2015-09-30;September 2015;Actual;2015-09-30;;Interventional;;;Phase IIIb Study of APD421 in Combination as PONV Prophylaxis;Randomised, Double-blind, Placebo-controlled Phase III Study of APD421 (Amisulpride for IV Injection) as Combination Prophylaxis Against Post-operative Nausea and Vomiting in High-risk Patients;Completed;;Phase 3;1147;Actual;Acacia Pharma Ltd;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T11:15:44Z;2020-06-01T11:15:44Z;Würzburg;3560126;Principal Investigator;Peter Kranke, MD;Würzburg University Hospitals;APD421 | Placebo;63603958;25;474;57;2015;2020-05-29;7;TRUE;21;TRUE;FALSE;18;;Years;;1;5;
NCT02336334;ClinicalTrials.gov processed this data on May 29, 2020;2014-12-08;;;2016-07-18;2015-01-12;2015-01-13;Estimate;;;;;;;2016-07-18;2016-07-19;Estimate;October 2014;;2014-10-31;July 2016;2016-07-31;July 2016;Actual;2016-07-31;April 2016;Actual;2016-04-30;;Interventional;;;Evaluation of Posturing-Adherence in Patients After Intraocular Surgery;Measurement and Logging of Posturing Adherence of Patients After Intraocular Surgery With Gasendotamponades Using a Sensorsystem With Different Feedback-Methods;Completed;;N/A;48;Actual;University Hospital Tuebingen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:15:56Z;2020-06-01T11:15:56Z;Tübingen;;;;;Positioning measurement | Patient feedback | Usefulness of a sketch | Closure rate of macular holes;63604012;1;;;2014;2020-05-29;18;FALSE;;FALSE;TRUE;18;;Years;;1;4;
NCT02336321;ClinicalTrials.gov processed this data on May 29, 2020;2014-12-19;;;2015-05-13;2015-01-07;2015-01-12;Estimate;;;;;;;2015-05-13;2015-05-14;Estimate;April 2014;;2014-04-30;March 2014;2014-03-31;May 2015;Actual;2015-05-31;October 2014;Actual;2014-10-31;;Interventional;;;Daily-life Brain Control Of A Hand Exoskeleton After Cervical Spinal Cord Injury;Restoration of Daily-life Hand Function Using a Brain/Neural-Computer Interaction (BNCI) System in Paralysis After Cervical Spinal Cord Injury;Completed;;Phase 1;6;Actual;University Hospital Tuebingen;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T11:15:56Z;2020-06-01T11:15:56Z;Tübingen;;;;;BNCI controlled hand exoskeleton;63604013;1;;;2014;2020-05-29;6;FALSE;;FALSE;TRUE;15;65;Years;Years;1;;
NCT02334813;ClinicalTrials.gov processed this data on May 29, 2020;2015-01-06;;;2017-05-04;2015-01-07;2015-01-08;Estimate;;;;;;;2017-05-04;2017-06-09;Actual;July 2002;;2002-07-31;May 2017;2017-05-31;January 2015;Actual;2015-01-31;January 2015;Actual;2015-01-31;;Interventional;EIS2002;;Daily Prednisone Versus Pulsed Dexamethasone in Treatment-naïve Adult Patients With Immune Thrombocytopenia;A Randomized Trial of Daily Prednisone Versus Pulsed Dexamethasone in Treatment-naïve Adult Patients With Immune Thrombocytopenia;Completed;;Phase 3;26;Actual;University Hospital, Essen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T11:16:14Z;2020-06-01T11:16:14Z;Duisburg;3560279;Principal Investigator;Ulrich Dührsen, MD;University Hospital, Essen;Prednisone | Dexamethasone;63604127;;12;0;2015;2020-05-29;152;TRUE;27;;FALSE;18;;Years;;1;;
NCT02330471;ClinicalTrials.gov processed this data on May 29, 2020;2014-12-27;;;2015-04-16;2014-12-31;2015-01-05;Estimate;;;;;;;2015-04-16;2015-04-17;Estimate;January 2014;;2014-01-31;April 2015;2015-04-30;March 2015;Actual;2015-03-31;March 2015;Actual;2015-03-31;;Interventional;CONE-1;;Forced Versus Spray Coagulation in Women Undergoing LLETZ-conization for Cervical Dysplasia: a Randomized Trial;Forced Versus Spray Coagulation in Women Undergoing LLETZ-conization for Cervical Dysplasia: a Randomized Trial;Completed;;Phase 3;160;Actual;Ruhr University of Bochum;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:17:08Z;2020-06-01T11:17:08Z;Bochum;3560605;Principal Investigator;Clemens B Tempfer, MD;Ruhr University Bochum;Spray | Forced;63604460;1;;;2014;2020-05-29;14;FALSE;;FALSE;TRUE;18;80;Years;Years;1;3;
NCT02329912;ClinicalTrials.gov processed this data on May 29, 2020;2014-12-01;;;2015-12-01;2014-12-31;2015-01-01;Estimate;;;;;;;2015-12-01;2015-12-02;Estimate;December 2014;;2014-12-31;December 2015;2015-12-31;December 2016;Anticipated;2016-12-31;March 2016;Anticipated;2016-03-31;;Interventional;PIDuSA;;Postoperative Ileus: Duration and Severity Assessment With the SmartPill®;The SmartPill® as an Objective Parameter to Evaluate Severity and Duration of Postoperative Ileus;Unknown status;;N/A;55;Anticipated;University Hospital, Bonn;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:17:14Z;2020-06-01T11:17:14Z;Bonn;3560643;Study Director;Tim O. Vilz, MD;Department of Surgery, University of Bonn;SmartPill;63604502;1;;;2014;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;6;
NCT02329067;ClinicalTrials.gov processed this data on May 29, 2020;2014-12-29;;;2017-08-28;2014-12-29;2014-12-31;Estimate;;;;;;;2017-08-28;2017-08-29;Actual;December 2014;;2014-12-31;August 2017;2017-08-31;July 2017;Actual;2017-07-31;July 2016;Actual;2016-07-31;;Interventional;WALDI;;The Metabolic Effect of Walnuts in Healthy Subjects;The Metabolic Effect of Walnut Consumption in Healthy Men and Healthy Postmenopausal Women Substituting Walnuts for Different Food Components;Completed;;N/A;180;Actual;Ludwig-Maximilians - University of Munich;;4;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:17:22Z;2020-06-01T11:17:22Z;Munich;3560707;Principal Investigator;Klaus G Parhofer, MD;Ludwig-Maximilians - University of Munich;walnuts;63604566;1;;;2014;2020-05-29;19;FALSE;;FALSE;TRUE;50;;Years;;1;9;
NCT02325440;ClinicalTrials.gov processed this data on May 29, 2020;2014-09-04;;;2014-12-19;2014-12-19;2014-12-25;Estimate;;;;;;;2014-12-19;2014-12-25;Estimate;March 2014;;2014-03-31;December 2014;2014-12-31;April 2016;Anticipated;2016-04-30;April 2016;Anticipated;2016-04-30;;Interventional;ToFingo2;;Study to Assess Immune Function and MRI Disease Activity in RRMS Patients When Switching From Natalizumab to Gilenya;A 32-week, Monocentric, Exploratory, Single Arm Study to Assess Immune Function and MRI Disease Activity in Patients With RRMS Transferred From Previous Treatment With Natalizumab to Gilenya® (Fingolimod);Unknown status;;Phase 4;15;Anticipated;University Hospital Muenster;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:18:22Z;2020-06-01T11:18:22Z;Münster;3560974;Principal Investigator;Luisa Klotz, PD. Dr. med.;Universitätsklinikum Muenster, Germany;Fingolimod | Natalizumab;63604844;1;;;2014;2020-05-29;;FALSE;;FALSE;TRUE;18;65;Years;Years;2;2;
NCT02322502;ClinicalTrials.gov processed this data on May 29, 2020;2014-12-12;;;2016-10-05;2014-12-22;2014-12-23;Estimate;;;;;;;2016-10-05;2016-10-06;Estimate;February 2015;;2015-02-28;October 2016;2016-10-31;February 2016;Actual;2016-02-29;February 2016;Actual;2016-02-29;;Interventional;;;Emergence Times and Airway Reactions in General Laryngeal Mask Airway Anesthesia;Emergence Times and Airway Reactions in General Laryngeal Mask Airway Anesthesia: a Randomized Multicenter Controlled Trial (ACC Baxter);Completed;;Phase 3;352;Actual;RWTH Aachen University;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:19:08Z;2020-06-01T11:19:08Z;Aachen;3561213;Principal Investigator;Mark Coburn, Prof.;University Hospital, Aachen;Desflurane | Sevoflurane | propofol;63605070;4;;;2014;2020-05-29;12;FALSE;;FALSE;FALSE;18;75;Years;Years;1;2;
NCT02321813;ClinicalTrials.gov processed this data on May 29, 2020;2014-12-11;;;2017-09-21;2014-12-16;2014-12-22;Estimate;;;;;;;2017-09-21;2017-09-25;Actual;January 2014;;2014-01-31;September 2017;2017-09-30;June 2017;Actual;2017-06-30;November 2016;Actual;2016-11-30;;Interventional;DIQOL;;Direct Improvement of Quality of Life Using a Tailored Pathway With Quality of Life Diagnosis and Therapy: Randomised Trial in Colorectal Cancer Patients;Direct Improvement of Quality of Life Using a Tailored Pathway With Quality of Life Diagnosis and Therapy: Protocol of a Randomised Clinical Trial in Colorectal Cancer Patients;Completed;;N/A;220;Actual;Tumor Center Regensburg;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T11:19:20Z;2020-06-01T11:19:20Z;Regensburg;3561258;Study Chair;Monika Klinkhammer-Schalke, MD, Ass. Prof.;Tumor Center Regensburg e.V., An-Institute of the University of Regensburg, Germany;quality of life pathway | placebo control;63605123;1;;;2014;2020-05-29;34;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT02320851;ClinicalTrials.gov processed this data on May 29, 2020;2014-12-16;;;2014-12-18;2014-12-18;2014-12-19;Estimate;;;;;;;2014-12-18;2014-12-19;Estimate;January 2015;;2015-01-31;December 2014;2014-12-31;October 2017;Anticipated;2017-10-31;July 2017;Anticipated;2017-07-31;;Interventional;;;Tailored Care for Somatoform Vertigo/Dizziness;Tailored Care for Somatoform Vertigo/Dizziness - From Diagnostics to Therapy;Unknown status;;N/A;216;Anticipated;Technische Universität München;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T11:19:30Z;2020-06-01T11:19:30Z;Munich;3561345;Principal Investigator;Claas Lahmann, PD Dr. med.;Department of Psychosomatic Medicine and Psychotherapy, Klinikum rechts der Isar, Technische Universitaet, Munich;SVD-tailored Integrative Psychotherapy (IPT) | Self-help group (SHG);63605144;;;;2014;2020-05-29;;FALSE;;;FALSE;18;;Years;;1;6;1
NCT02318810;ClinicalTrials.gov processed this data on May 29, 2020;2014-12-12;;;2016-05-02;2014-12-12;2014-12-17;Estimate;;;;;;;2016-05-02;2016-05-03;Estimate;March 2015;;2015-03-31;May 2016;2016-05-31;May 2016;Actual;2016-05-31;May 2016;Actual;2016-05-31;;Interventional;;;Influence of the Neuromuscular Blockade on Mask Ventilation;"The Influence of the Neuromuscular Blockade on Mask Ventilation; a Placebo Controlled, Randomized Trial With Three Different Dosages of Rocuronium (0.3 mg/kg, 0.6 mg/kg and 0.9 mg/kg)";Completed;;N/A;300;Actual;University of Rostock;;4;;;FALSE;;;;TRUE;;;;;;;;;;;Undecided;;2020-06-01T11:19:58Z;2020-06-01T11:19:58Z;Rostock;3561511;Principal Investigator;Thomas Mencke, Prof.;University of Rostock;Rocuronium 0.3 mg/kg | Rocuronium 0.6 mg/kg | Rocuronium 0.9 mg/kg | Placebo;63605328;1;;;2014;2020-05-29;14;FALSE;;FALSE;TRUE;18;80;Years;Years;1;;
NCT02316132;ClinicalTrials.gov processed this data on May 29, 2020;2014-12-05;;;2015-12-04;2014-12-09;2014-12-12;Estimate;;;;;;;2015-12-04;2015-12-07;Estimate;December 2014;;2014-12-31;December 2015;2015-12-31;June 2016;Anticipated;2016-06-30;June 2016;Anticipated;2016-06-30;;Interventional;;;Confocal Laser Endomicroscopy, IBS and Stress;Confocal Endomicroscopy for the Detection of Food Intolerances in Patients With IBS: Add on Control Group: Does Stress Cause Similar Mucosal Changes to Food Antigens?;Unknown status;;N/A;30;Anticipated;University of Schleswig-Holstein;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:20:41Z;2020-06-01T11:20:41Z;Kiel Lübeck;3561720;Principal Investigator;Annette Fritscher-Ravens, MD, PhD;University of Schleswig-Holstein;Stress | Control;63605541;1;;;2014;2020-05-29;;FALSE;;FALSE;TRUE;18;80;Years;Years;1;;
NCT02315300;ClinicalTrials.gov processed this data on May 29, 2020;2014-12-01;;;2016-06-14;2014-12-08;2014-12-11;Estimate;;;;;;;2016-06-14;2016-06-15;Estimate;November 2014;;2014-11-30;May 2016;2016-05-31;May 2016;Actual;2016-05-31;May 2016;Actual;2016-05-31;;Interventional;HypoArrhyth;;Predicting Hypoglycaemia and Arrhythmias in the Vulnerable Patient With Diabetes and Chronic Kidney Disease;Predicting Hypoglycaemia and Arrhythmias in the Vulnerable Patient With Diabetes and Chronic Kidney Disease;Completed;;N/A;62;Actual;RWTH Aachen University;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:20:51Z;2020-06-01T11:20:51Z;Aachen;3561781;Principal Investigator;Nikolaus Marx, Prof.;Uniklinik RWTH Aachen;medilog® DARWIN FD12 | Continuous Glucose Monitoring;63605618;1;;;2014;2020-05-29;18;FALSE;;FALSE;TRUE;18;;Years;;10;1;
NCT02314572;ClinicalTrials.gov processed this data on May 29, 2020;2014-12-08;;;2015-12-15;2014-12-09;2014-12-11;Estimate;;;;;;;2015-12-15;2015-12-16;Estimate;March 2013;;2013-03-31;December 2015;2015-12-31;June 2015;Actual;2015-06-30;December 2014;Actual;2014-12-31;;Interventional;;;Visual Acuity After the Combined Binocular Implantation of +2.5 Diopters and +3.0 Diopters ReSTOR Multifocal Intraocular Lenses.;Evaluation of the Visual Acuity After the Implantation of a ReSTOR +2.5 Diopters Intraocular Lens (ReSTOR SV25T0) in the Distance Dominant Eye, in Combination With a +3.0 Diopters ReSTOR Intraocular Lens (ReSTOR SN6AD1) in the Fellow Eye.;Completed;;Phase 4;15;Actual;Charite University, Berlin, Germany;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:21:02Z;2020-06-01T11:21:02Z;Berlin;;;;;Binocular cataract surgery with phacoemulsification and implantation of multifocal intraocular lenses;63605674;1;;;2014;2020-05-29;21;FALSE;;FALSE;TRUE;18;;Years;;6;1;
NCT02313493;ClinicalTrials.gov processed this data on May 29, 2020;2014-12-07;;;2014-12-09;2014-12-07;2014-12-10;Estimate;;;;;;;2014-12-09;2014-12-11;Estimate;September 2012;;2012-09-30;December 2014;2014-12-31;November 2015;Anticipated;2015-11-30;July 2015;Anticipated;2015-07-31;;Interventional;;;Efficacy and Feasibility of Baby Triple P - a Pilot Study;Improving Mental Health in First Time Parents - A Randomized Controlled Pilot Study;Unknown status;;N/A;78;Anticipated;Ruhr University of Bochum;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:21:24Z;2020-06-01T11:21:24Z;Bochum;;;;;Baby Triple P;63605754;;;;2014;2020-05-29;;FALSE;;;FALSE;;;;;2;2;
NCT02312674;ClinicalTrials.gov processed this data on May 29, 2020;2014-11-07;;;2014-12-08;2014-12-08;2014-12-09;Estimate;;;;;;;2014-12-08;2014-12-09;Estimate;January 2015;;2015-01-31;November 2014;2014-11-30;January 2016;Anticipated;2016-01-31;January 2016;Anticipated;2016-01-31;;Interventional;;;Prevention of Cancer-associated Malnutrition Through Oral Nutritional Supplements;Prevention of Malnutrition Through Oral Nutritional Supplements in Cancer Patients Receiving Palliative Therapy;Unknown status;;N/A;80;Anticipated;University of Hohenheim;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:21:37Z;2020-06-01T11:21:37Z;Tübingen;3561981;Study Director;"Michael Bitzer, MD; Prof.";Department of Hepatology, Gastroenterology, Infectious Diseases, University Hospital Tübingen;Oral nutritional supplement;63605816;;;;2014;2020-05-29;;FALSE;;;FALSE;18;80;Years;Years;2;5;4
NCT02312505;ClinicalTrials.gov processed this data on May 29, 2020;2012-12-03;;;2016-10-24;2014-12-06;2014-12-09;Estimate;;;;;;;2016-10-24;2016-10-25;Estimate;March 2012;;2012-03-31;October 2016;2016-10-31;December 2014;Actual;2014-12-31;November 2014;Actual;2014-11-30;;Interventional;;;Comparison of a New Semi-invasive Monitoring System With Transpulmonary Thermodilution in Cardiac Surgery Patients;Estimation of Cardiac Output by a New Semi-invasive Monitoring System: Accuracy and Limitations;Completed;;N/A;65;Actual;University of Schleswig-Holstein;;1;;;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T11:21:39Z;2020-06-01T11:21:39Z;Kiel Lübeck;3561993;Study Director;Berthold Bein, Professor;University Schleswig-Holstein, Campus Kiel, Germany;COPFX;63605829;1;;;2012;2020-05-29;32;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT02312479;ClinicalTrials.gov processed this data on May 29, 2020;2014-12-04;;;2016-09-26;2014-12-04;2014-12-09;Estimate;;;;;;;2016-09-26;2016-09-27;Estimate;December 2014;;2014-12-31;September 2016;2016-09-30;April 2016;Actual;2016-04-30;November 2015;Actual;2015-11-30;;Interventional;;;Safety and Performance Study of the Nyxoah SAT System for Treating OSA;Safety and Performance Study of the Use of the Nyxoah SAT System for the Treatment of Obstructive Sleep Apnea;Terminated;;N/A;6;Actual;Nyxoah S.A.;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T11:21:39Z;2020-06-01T11:21:39Z;Mannheim;3561995;Principal Investigator;Joachim T Maurer, OA Dr. med.;Universitäts-HNO-Klinik Mannheim;Nyxoah SAT system;63605831;2;;;2014;2020-05-29;11;FALSE;;FALSE;FALSE;21;70;Years;Years;2;;
NCT02309918;ClinicalTrials.gov processed this data on May 29, 2020;2014-11-04;;;2017-08-25;2014-12-04;2014-12-05;Estimate;;;;;;;2017-08-25;2017-08-28;Actual;November 2014;;2014-11-30;August 2017;2017-08-31;August 2016;Actual;2016-08-31;August 2016;Actual;2016-08-31;;Interventional;;;HepNet Acute HCV IV - LDV/SOF FDC in Acute Genotype 1 Hepatitis C Virus Infection;Interferon-free Treatment of Acute Genotype 1 Hepatitis C Virus Infection With Ledipasvir/Sofosbuvir Fixed-Dose Combination - The HepNet Acute HCV IV Study;Completed;;Phase 2;20;Actual;HepNet Study House, German Liverfoundation;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:22:25Z;2020-06-01T11:22:25Z;Hannover;3562190;Principal Investigator;Michael P. Manns, Prof. Dr.;MHH, Klinik für Gastroenterologie, Hepatologie und Endokrinologie, Carl-Neuberg-Str. 1, 30625 Hannover, Germany;LDV/SOF FDC;63606027;20;;;2014;2020-05-29;21;FALSE;;FALSE;FALSE;18;;Years;;2;3;3
NCT02308813;ClinicalTrials.gov processed this data on May 29, 2020;2014-10-27;;;2016-02-01;2014-12-01;2014-12-04;Estimate;;;;;;;2016-02-01;2016-02-02;Estimate;October 2014;;2014-10-31;November 2014;2014-11-30;June 2015;Actual;2015-06-30;May 2015;Actual;2015-05-31;;Interventional;;;Predictability of the Ability to Perform an Emergency Stop With Disorders of the Hip;Predictability of Braking Performance in Patients With Degenerative Disease of the Hip Joint or With Total Hip Arthroplasty;Completed;;N/A;100;Actual;University Hospital Tuebingen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:22:37Z;2020-06-01T11:22:37Z;Tübingen;3562255;Principal Investigator;Ulf K Hofmann, MD;University Hospital Tuebingen;Braking and functionality;63606111;1;;;2014;2020-05-29;7;FALSE;;FALSE;TRUE;18;85;Years;Years;1;;
NCT02307396;ClinicalTrials.gov processed this data on May 29, 2020;2014-11-24;;;2018-10-10;2014-12-01;2014-12-04;Estimate;;;;;;;2018-10-10;2018-10-11;Actual;February 1, 2015;Actual;2015-02-01;October 2018;2018-10-31;June 22, 2016;Actual;2016-06-22;June 22, 2016;Actual;2016-06-22;;Interventional;;;Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients;Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics for the Prevention of Relapse in Long-term Stabilized Schizophrenic Patients: a Randomized, Single-blind, Longitudinal Trial;Completed;;Phase 4;21;Actual;Technische Universität München;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T11:23:19Z;2020-06-01T11:23:19Z;Munich;;;;;Perphenazine | Sulpiride | bromperidol | Zuclopenthixol | Thioridazine | Paliperidone | Ziprasidone | Benperidol | Fluspirilene | Pimozide | Perazine | Fluphenazine | Flupentixole | Sertindole | Olanzapine | Amisulpride | Risperidone | Haloperidol | Quetiapine;63606219;1;;;2014;2020-05-29;16;FALSE;;FALSE;TRUE;18;65;Years;Years;1;11;
NCT02306447;ClinicalTrials.gov processed this data on May 29, 2020;2014-12-01;;;2016-05-12;2014-12-01;2014-12-03;Estimate;;;;;;;2016-05-12;2016-05-13;Estimate;August 2014;;2014-08-31;May 2016;2016-05-31;April 2016;Actual;2016-04-30;April 2016;Actual;2016-04-30;;Interventional;rpms-tinn;;Combined Transcranial and Peripheral Muscle Magnetic Stimulation in Chronic Tinnitus;Combined Transcranial and Peripheral Muscle Magnetic Stimulation in Chronic Tinnitus;Completed;;N/A;54;Actual;University of Regensburg;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:23:29Z;2020-06-01T11:23:29Z;Regensburg;3562467;Principal Investigator;Berthold Langguth, MD, PhD;Department of Psychiatry, University of Regensburg, Germany;rPMS and rTMS;63606294;1;;;2014;2020-05-29;20;FALSE;;FALSE;TRUE;18;80;Years;Years;1;5;
NCT02304965;ClinicalTrials.gov processed this data on May 29, 2020;2014-11-21;;;2015-09-02;2014-12-01;2014-12-02;Estimate;;;;;;;2015-09-02;2015-09-03;Estimate;November 2014;;2014-11-30;June 2015;2015-06-30;September 2015;Actual;2015-09-30;June 2015;Actual;2015-06-30;;Interventional;;;Activity at Pulse Pressure Above an Individual Threshold in Patients With LVAD;Daily Physical Activity at Pulse Pressure Above an Individual Threshold in Patients With Continuous Flow Left Ventricular Assist Devices - a Feasibility Study;Completed;;N/A;7;Actual;Hannover Medical School;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:23:46Z;2020-06-01T11:23:46Z;Hannover;3562577;Principal Investigator;Sven Haufe, Dr.;Hannover Medical School;Daily physical activity;63606407;1;;;2014;2020-05-29;7;FALSE;;FALSE;TRUE;45;65;Years;Years;1;4;
NCT02304081;ClinicalTrials.gov processed this data on May 29, 2020;2014-11-11;;;2018-06-18;2014-11-25;2014-12-01;Estimate;;;;;;;2018-06-18;2018-06-20;Actual;January 2015;;2015-01-31;June 2018;2018-06-30;August 2016;Actual;2016-08-31;August 2016;Actual;2016-08-31;;Interventional;;;Saxagliptin in Combination With Dapagliflozin - Effects on Islet Cell Function;Effect of Saxagliptin in Addition to Dapagliflozin and Metformin on Insulin Resistance, Islet Cell Dysfunction, and Metabolic Control in Subjects With Type 2 Diabetes Mellitus on Previous Metformin Treatment;Completed;;Phase 4;64;Actual;Profil Mainz GmbH & Co KG;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:23:59Z;2020-06-01T11:23:59Z;Mainz;3562665;Principal Investigator;Thomas Forst, Prof. Dr.;Profil Mainz GmbH & Co KG, Rheinstraße 4c, 55116 Mainz;Saxagliptin | Placebo for Saxagliptin;63606474;1;;;2014;2020-05-29;19;FALSE;;FALSE;TRUE;30;75;Years;Years;1;18;
NCT02300337;ClinicalTrials.gov processed this data on May 29, 2020;2014-11-20;;;2015-01-16;2014-11-24;2014-11-25;Estimate;;;;;;;2015-01-16;2015-01-19;Estimate;November 2014;;2014-11-30;January 2015;2015-01-31;January 2015;Actual;2015-01-31;January 2015;Actual;2015-01-31;;Interventional;LTS;;Comparison of Reduced Cuff-pressure of the Laryngeal Tube Under General Anesthesia;Comparative Study of the Tightness of the Laryngeal Tube Under Mechanical Ventilation Before and After Reduction of Cuff Pressure on 60cmH₂O, 50cmH₂O, 40cmH₂O or 30cmH₂O;Completed;;N/A;60;Actual;Johannes Gutenberg University Mainz;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:24:46Z;2020-06-01T11:24:46Z;Mainz;3562957;Principal Investigator;Rüdiger Noppens, MD;University JG, Mainz;Reduce Cuff pressure;63606760;1;;;2014;2020-05-29;2;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT02299089;ClinicalTrials.gov processed this data on May 29, 2020;2014-11-17;;;2017-05-16;2014-11-21;2014-11-24;Estimate;;;;;;;2017-05-16;2017-12-15;Actual;January 2015;;2015-01-31;May 2017;2017-05-31;June 2016;Actual;2016-06-30;May 2016;Actual;2016-05-31;;Interventional;;;Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs);A Phase II, Open-label, Multicentre, Randomised Study of the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of CAM2029 in Patients With Acromegaly and Neuroendocrine Tumours (NETs) Previously Treated With Sandostatin® LAR®;Completed;;Phase 2;12;Actual;Camurus AB;;4;;;FALSE;;;;FALSE;;;;;;;;;;;No;No plan to share IPD;2020-06-01T11:25:05Z;2020-06-01T11:25:05Z;Berlin;3563039;Principal Investigator;Marianne Pavel, Professor;Charité Campus Virchow Klinikum, Berlin, Germany;octreotide FluidCrystal® injection depot;63606855;10;50;2;2014;2020-05-29;16;TRUE;8;FALSE;FALSE;18;;Years;;6;3;1
NCT02297334;ClinicalTrials.gov processed this data on May 29, 2020;2014-10-08;;;2017-08-28;2014-11-18;2014-11-21;Estimate;;;;;;;2017-08-28;2017-08-29;Actual;September 2013;;2013-09-30;August 2017;2017-08-31;August 2017;Actual;2017-08-31;October 2015;Actual;2015-10-31;;Interventional;;;Removal of Cytokines During Extracorporeal Circulation in Cardiac Surgery;Reduction of Inflammation Reaction to Extracorporeal Circulation in Cardiac Surgery by Interleukin Dialysis;Completed;;N/A;40;Actual;Universitätsklinikum Hamburg-Eppendorf;;2;;;FALSE;;;;FALSE;;;;;;;;;;;Undecided;;2020-06-01T11:25:32Z;2020-06-01T11:25:32Z;Hamburg;3563184;Study Director;Jens C. Kubitz, MD PhD;Department of Anaesthesiology Center of Anaesthesiology and Intensive Care Medicine University Medical Center Hamburg-Eppendorf University of Hamburg;CytoSorb device;63606991;1;;;2014;2020-05-29;25;FALSE;;FALSE;TRUE;18;;Years;;1;3;6
NCT02296814;ClinicalTrials.gov processed this data on May 29, 2020;2014-11-07;;;2015-07-16;2014-11-19;2014-11-20;Estimate;;;;;;;2015-07-16;2015-07-17;Estimate;November 2014;;2014-11-30;July 2015;2015-07-31;April 2015;Actual;2015-04-30;April 2015;Actual;2015-04-30;;Interventional;CESAR;;Efficacy and Safety of Sinusitis Hevert SL Tablets Compared to Placebo in Adult Patients With Acute, Uncomplicated Rhinosinusitis;Efficacy and Safety of Sinusitis Hevert SL Tablets Compared to Placebo in Adult Patients With Acute, Uncomplicated Rhinosinusitis. A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Phase IV Study (Sinusitis Study);Completed;;Phase 4;314;Actual;Hevert-Arzneimittel GmbH & Co. KG;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:25:37Z;2020-06-01T11:25:37Z;Berlin;3563225;Principal Investigator;Andreas Michalsen, Prof Dr;Immanuel Krankenhaus Berlin;Sinusitis Hevert SL Tablet | Placebo for Sinusitis Hevert SL Tablet;63607031;20;;;2014;2020-05-29;5;FALSE;;FALSE;FALSE;18;75;Years;Years;2;13;
NCT02296372;ClinicalTrials.gov processed this data on May 29, 2020;2014-11-04;;;2017-02-07;2014-11-18;2014-11-20;Estimate;;;;;;;2017-02-07;2017-02-10;Actual;November 2014;;2014-11-30;February 2017;2017-02-28;June 2016;Actual;2016-06-30;April 2016;Actual;2016-04-30;;Interventional;;;Accuracy, Feasibility and Acceptance of Continuous Glucose Monitoring in Critically Ill Patients;Pilot Observation of Continuous Glucose Monitoring in Critically Ill Patients Under Consideration of Accuracy, Feasibility and Acceptance by Ward Staff;Completed;;N/A;20;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T11:25:43Z;2020-06-01T11:25:43Z;Berlin;3563251;Principal Investigator;Steffen Weber-Carstens, MD;Charite University, Berlin, Germany;Continuous glucose monitoring;63607063;1;;;2014;2020-05-29;17;FALSE;;FALSE;TRUE;18;;Years;;1;2;1
NCT02295462;ClinicalTrials.gov processed this data on May 29, 2020;2014-11-12;;;2017-05-02;2014-11-17;2014-11-20;Estimate;;;;;;;2017-05-02;2017-05-03;Actual;December 2014;;2014-12-31;May 2017;2017-05-31;February 2017;Actual;2017-02-28;February 2017;Actual;2017-02-28;;Interventional;EPCentCare;;Effect of Person-Centred-Care on Antipsychotic Drug Use in Nursing Homes: a Cluster-randomised Trial;Effect of Person-Centred-Care on Antipsychotic Drug Use in Nursing Homes: a Cluster-randomised Trial;Completed;;N/A;1158;Actual;Martin-Luther-Universität Halle-Wittenberg;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T11:26:06Z;2020-06-01T11:26:06Z;Halle;3563315;Principal Investigator;Gabriele Meyer, Prof. Dr.;Martin-Luther-Universität Halle-Wittenberg;Person-centered Care | Optimised Treatment;63607132;3;;;2014;2020-05-29;26;FALSE;;FALSE;FALSE;18;;Years;;1;6;1
NCT02293746;ClinicalTrials.gov processed this data on May 29, 2020;2014-11-12;;;2017-03-06;2014-11-14;2014-11-18;Estimate;;;;;;;2017-03-06;2017-03-07;Actual;June 2014;Actual;2014-06-30;March 2017;2017-03-31;January 9, 2017;Actual;2017-01-09;December 11, 2016;Actual;2016-12-11;;Interventional;;;Inspire® Upper Airway Stimulation (UAS) System German Post-Market Study;Inspire® Upper Airway Stimulation (UAS) System German Post-Market Study: CE Certificate Number 562872;Completed;;Phase 4;60;Actual;Inspire Medical Systems, Inc.;;1;;;FALSE;;;;FALSE;;;;;;;;;;;Yes;;2020-06-01T11:26:42Z;2020-06-01T11:26:42Z;Mannheim Munich;3563443;Principal Investigator;Clemens Heiser, Dr. med.;Klinikum rechts der Isar der Technischen Universität München;Inspire® Upper Airway Stimulation (UAS) System;63607264;3;;;2014;2020-05-29;29;FALSE;;FALSE;FALSE;21;;Years;;1;1;
NCT02291562;ClinicalTrials.gov processed this data on May 29, 2020;2014-11-11;;;2015-01-15;2014-11-13;2014-11-14;Estimate;;;;;;;2015-01-15;2015-01-16;Estimate;July 2014;;2014-07-31;November 2014;2014-11-30;December 2014;Actual;2014-12-31;December 2014;Actual;2014-12-31;;Interventional;;;Effects of THC and CBD on Human Episodic Memory Function;Effects of D-9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD) on Human Episodic Memory Function;Completed;;N/A;20;Actual;Central Institute of Mental Health, Mannheim;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:27:17Z;2020-06-01T11:27:17Z;Mannheim;;;;;Tetrahydrocannabinol | Cannabidiol | placebo;63607431;1;;;2014;2020-05-29;5;FALSE;;FALSE;TRUE;18;50;Years;Years;1;1;
NCT02291536;ClinicalTrials.gov processed this data on May 29, 2020;2014-11-11;;;2015-01-15;2014-11-13;2014-11-14;Estimate;;;;;;;2015-01-15;2015-01-16;Estimate;February 2014;;2014-02-28;November 2014;2014-11-30;December 2014;Actual;2014-12-31;December 2014;Actual;2014-12-31;;Interventional;AB_THC_CBD;;Processing of Salient Emotional Stimuli as a Function of Tetrahydrocannabinol (THC) and Cannabidiol (CBD);Processing of Salient Emotional Stimuli as a Function of Tetrahydrocannabinol (THC) and Cannabidiol (CBD);Completed;;N/A;20;Actual;Central Institute of Mental Health, Mannheim;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:27:18Z;2020-06-01T11:27:18Z;Mannheim;3563605;Principal Investigator;Oliver Grimm, MD;Central Institute of Mental Health, Mannheim;tetrahydrocannabinol | cannabidiol | placebo;63607433;1;;;2014;2020-05-29;10;FALSE;;FALSE;TRUE;18;65;Years;Years;1;1;
NCT02290613;ClinicalTrials.gov processed this data on May 29, 2020;2014-10-31;;;2020-04-17;2014-11-10;2014-11-14;Estimate;;;;;;;2020-04-17;2020-04-30;Actual;July 1, 2014;Actual;2014-07-01;April 2020;2020-04-30;December 31, 2017;Actual;2017-12-31;November 27, 2017;Actual;2017-11-27;;Interventional;EDITA;;Early Treatment of Borderline Pulmonary Arterial Hypertension Associated With Systemic Sclerosis (SSc-APAH);Early Treatment of Borderline Pulmonary Arterial Hypertension Associated With Systemic Sclerosis (SSc-APAH) A Randomized, Controlled, Double-blind, Parallel Group, Proof-of-concept Trial EDITA;Completed;;Phase 2;38;Actual;Heidelberg University;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:27:34Z;2020-06-01T11:27:34Z;Heidelberg;3563687;Principal Investigator;Ekkehard Grünig, MD;Thoraxclinic at the University of Heidelberg;Ambrisentan | Placebo;63607504;1;91;12;2014;2020-05-29;41;TRUE;25;FALSE;TRUE;18;;Years;;1;21;
NCT02290067;ClinicalTrials.gov processed this data on May 29, 2020;2014-10-22;;;2014-12-19;2014-11-12;2014-11-13;Estimate;;;;;;;2014-12-19;2014-12-23;Estimate;October 2014;;2014-10-31;December 2014;2014-12-31;November 2014;Actual;2014-11-30;November 2014;Actual;2014-11-30;;Interventional;;;System Accuracy and User Performance of Blood Glucose Monitoring Systems for Self-Testing in Managing Diabetes Mellitus;EVALUATING SYSTEM ACCURACY AND USER PERFORMANCE OF BLOOD GLUCOSE MONITORING SYSTEMS FOR SELF-TESTING IN MANAGING DIABETES MELLITUS;Completed;;N/A;130;Anticipated;B. Braun Melsungen AG;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:27:42Z;2020-06-01T11:27:42Z;Ulm;3563723;Principal Investigator;Nina Jendrike, Dr. med.;Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm;Blood glucose monitoring system (Omnitest 3) | Blood glucose monitoring system (Omnitest 5) | Blood glucose monitoring system (Omnitest 5D);63607545;1;;;2014;2020-05-29;1;FALSE;;FALSE;TRUE;18;;Years;;2;;
NCT02284256;ClinicalTrials.gov processed this data on May 29, 2020;2014-11-03;;;2017-08-14;2014-11-03;2014-11-05;Estimate;;;;;;;2017-08-14;2017-08-16;Actual;November 2014;;2014-11-30;August 2017;2017-08-31;August 2015;Actual;2015-08-31;August 2015;Actual;2015-08-31;;Interventional;;;A Safety and Efficacy Study Comparing Fibrocaps and Tachosil in Hepatic Surgery;A Phase 3b, Randomized, Single-Blind, Controlled, Comparative Efficacy and Safety Study of Topical FibrocapsTM (RaplixaTM) and Tachosil® in Surgical Hemostasis During Hepatic Resection;Completed;;Phase 3;150;Actual;Mallinckrodt;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:29:05Z;2020-06-01T11:29:05Z;Frankfurt;3564170;Principal Investigator;Wolf Bechstein, MD;J.W.Goethe-Universität;Fibrocaps | TachoSil;63607990;15;;;2014;2020-05-29;9;FALSE;;FALSE;FALSE;18;;Years;;1;;
NCT02283099;ClinicalTrials.gov processed this data on May 29, 2020;2014-10-31;;;2017-05-24;2014-11-04;2014-11-05;Estimate;;;;;;;2017-05-24;2017-05-30;Actual;November 2014;;2014-11-30;May 2017;2017-05-31;November 2015;Actual;2015-11-30;November 2015;Actual;2015-11-30;;Interventional;;;Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (rVSVΔG-ZEBOV-GP);An Open Label, Single Center, Dose Escalation Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Single Ascending Dose of the Ebola Virus Vaccine rVSVΔG-ZEBOV-GP (BPSC1001);Completed;;Phase 1;30;Actual;Universitätsklinikum Hamburg-Eppendorf;;1;;;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T11:29:20Z;2020-06-01T11:29:20Z;Hamburg;3564255;Study Director;Marylyn M. Addo, MD;Universitätsklinikum Hamburg-Eppendorf;rVSVΔ-ZEBOV-GP;63608077;1;;;2014;2020-05-29;12;FALSE;;FALSE;TRUE;18;55;Years;Years;1;2;
NCT02280226;ClinicalTrials.gov processed this data on May 29, 2020;2014-10-29;;;2018-02-05;2014-10-30;2014-10-31;Estimate;;;;;;;2018-02-05;2018-02-07;Actual;April 2014;;2014-04-30;February 2018;2018-02-28;July 2016;Actual;2016-07-31;July 2016;Actual;2016-07-31;;Interventional;;;Evaluating the Influence of Apnea on Cardiac Function Using Cardiac Magnetic Resonance Imaging.;Evaluating the Influence of Apnea on Heart Function With Strain Analysis and Measurement of Fibrosis Derived From T1-mapping Using Cardiac Magnetic Resonance Imaging (MRI).;Completed;;N/A;17;Actual;University Hospital, Bonn;;1;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T11:29:55Z;2020-06-01T11:29:55Z;Bonn;;;;;magnetic resonance imaging (MRI);63608301;;0;0;2014;2020-05-29;27;TRUE;15;;FALSE;16;;Years;;2;;
NCT02277977;ClinicalTrials.gov processed this data on May 29, 2020;2014-10-27;;;2014-10-27;2014-10-27;2014-10-29;Estimate;;;;;;;2014-10-27;2014-10-29;Estimate;November 2014;;2014-11-30;October 2014;2014-10-31;December 2015;Anticipated;2015-12-31;November 2015;Anticipated;2015-11-30;;Interventional;;;Evaluation of Impaired Microcirculation During Septic Shock With Contrast Enhanced Ultrasound;Messung Von Mikrozirkulationsstörungen im Septischen Schock Mit Kontrastmittel- verstärkter Sonographie Evaluation of Impaired Microcirculation During Septic Shock With Contrast Enhanced Ultrasound;Unknown status;;N/A;24;Anticipated;University Hospital Freiburg;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:30:28Z;2020-06-01T11:30:28Z;Freiburg;3564724;Study Director;Daniel Duerschmied, MD, PHD;University of Freiburg;Contrast enhanced ultrasound;63608469;;;;2014;2020-05-29;;FALSE;;;FALSE;;;;;1;;
NCT02276469;ClinicalTrials.gov processed this data on May 29, 2020;2014-10-09;;;2015-01-01;2014-10-24;2014-10-28;Estimate;;;;;;;2015-01-01;2015-01-05;Estimate;July 2011;;2011-07-31;January 2015;2015-01-31;December 2014;Actual;2014-12-31;November 2014;Actual;2014-11-30;;Interventional;PEER;;Peer Support for Severe Mental Disorders;Randomized Controlled Trial of Peer to Peer Support for People With Severe Mental Disorders: Schizophrenia, Affective Disorders and Personality Disorders in Comparison to Standard Care;Completed;;N/A;200;Actual;Universitätsklinikum Hamburg-Eppendorf;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T11:30:47Z;2020-06-01T11:30:47Z;Hamburg;3564845;Principal Investigator;Thomas Bock, Prof. Dr.;University Medical Center Hamburg-Eppendorf (UKE);peer support;63608588;;;;2014;2020-05-29;40;FALSE;;;FALSE;17;;Years;;1;9;
NCT02275884;ClinicalTrials.gov processed this data on May 29, 2020;2014-10-17;;;2014-10-23;2014-10-23;2014-10-27;Estimate;;;;;;;2014-10-23;2014-10-27;Estimate;June 2013;;2013-06-30;October 2014;2014-10-31;June 2015;Anticipated;2015-06-30;April 2015;Anticipated;2015-04-30;;Interventional;Choc-PD;;Pharmacologically Active Constituents of Chocolate and Their Symptomatic Effects in Patients With Idiopathic Parkinson's Disease;Evaluation of Plasma Concentrations of Pharmacologically Active Constituents of Chocolate and Their Symptomatic Effects in Patients With Idiopathic Parkinson's Disease;Unknown status;;N/A;30;Anticipated;Technische Universität Dresden;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:30:55Z;2020-06-01T11:30:55Z;Dresden;3564881;Principal Investigator;Matthias Löhle, MD;Department of Neurology, Dresden University of Technology;Dark chocolate (85% cocoa) | White chocolate (0% cocoa);63608634;1;;;2014;2020-05-29;;FALSE;;FALSE;TRUE;40;;Years;;2;3;
NCT02273141;ClinicalTrials.gov processed this data on May 29, 2020;2014-10-16;;;2018-04-12;2014-10-22;2014-10-23;Estimate;;;;;;;2018-04-12;2018-05-15;Actual;November 2014;;2014-11-30;April 2018;2018-04-30;August 2015;Actual;2015-08-31;August 2015;Actual;2015-08-31;;Interventional;;;Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus a Sodium Picosulfate and Magnesium Salt Solution Using Day Before-Only Dosing Regimen in Adults.;A Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 (a Low Volume Bowel Cleansing Solution) Versus Sodium Picosulfate and Magnesium Salt (SP+MS) Solution Using Day Before-Only Dosing Regimen in Adults.;Completed;;Phase 3;515;Actual;Norgine;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:31:31Z;2020-06-01T11:31:31Z;Kiel Lübeck;3565076;Principal Investigator;Stefan Schreiber;University of Schleswig-Holstein;NER1006, Day Before-Only Dosing | SP+MS, Day Before-Only Dosing;63608840;19;82;2;2014;2020-05-29;9;TRUE;11;FALSE;FALSE;18;85;Years;Years;2;4;
NCT02272036;ClinicalTrials.gov processed this data on May 29, 2020;2014-10-20;;;2017-04-19;2014-10-21;2014-10-22;Estimate;;;;;;;2017-04-19;2017-04-21;Actual;December 2015;;2015-12-31;April 2017;2017-04-30;April 2017;Actual;2017-04-30;February 2017;Actual;2017-02-28;;Interventional;PERICLES-II;;Short Message Service in Colonoscopy Preparation (PERICLES-II-SMS);Improvement of Colonoscopy Preparation by New Media (SMS) (PERICLES-II-Study);Completed;;N/A;500;Actual;Technische Universität München;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:31:50Z;2020-06-01T11:31:50Z;Munich;;;;;Colonoscopy | mobile phone;63608926;4;;;2014;2020-05-29;14;FALSE;;FALSE;FALSE;18;;Years;;1;2;
NCT02270853;ClinicalTrials.gov processed this data on May 29, 2020;2014-10-14;;;2016-02-17;2014-10-20;2014-10-21;Estimate;;;;;;;2016-02-17;2016-02-18;Estimate;April 2014;;2014-04-30;February 2016;2016-02-29;December 2016;Anticipated;2016-12-31;December 2016;Anticipated;2016-12-31;;Interventional;SAS CA;;SAS in Patients With Bronchial Carcinoma;Incidence of Sleep Apnea Syndrome (SAS) in Patients With Bronchial Carcinoma;Unknown status;;N/A;100;Anticipated;RWTH Aachen University;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:32:14Z;2020-06-01T11:32:14Z;Aachen;3565248;Principal Investigator;Michael Dreher, Univ.-Prof.;RWTH Aachen University Hospital;sleep apnea screening with ApneaLinkTM;63609017;3;;;2014;2020-05-29;;FALSE;;FALSE;FALSE;18;;Years;;1;;
NCT02262949;ClinicalTrials.gov processed this data on May 29, 2020;2014-09-25;;;2016-12-06;2014-10-08;2014-10-13;Estimate;;;;;;;2016-12-06;2016-12-07;Estimate;September 2014;;2014-09-30;December 2016;2016-12-31;July 2016;Actual;2016-07-31;July 2015;Actual;2015-07-31;;Interventional;REALITY2;;A Prospective Study of the Bard® LifeStent® Solo Vascular Stent System;A Prospective Study of the Bard® LifeStent® Solo Vascular Stent System (REALITY2);Completed;;N/A;31;Actual;C. R. Bard;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:34:01Z;2020-06-01T11:34:01Z;Freiburg;3565862;Principal Investigator;Thomas Zeller, Prof. Dr.;University Heart Centre Freiburg, Bad Krozingen;LifeStent Vascular Stent;63609616;4;;;2014;2020-05-29;10;FALSE;;FALSE;FALSE;21;;Years;;2;3;
NCT02262442;ClinicalTrials.gov processed this data on May 29, 2020;2014-10-07;;;2016-02-17;2014-10-10;2014-10-13;Estimate;;;;;;;2016-02-17;2016-02-18;Estimate;October 2014;;2014-10-31;February 2016;2016-02-29;August 2016;Anticipated;2016-08-31;August 2016;Anticipated;2016-08-31;;Interventional;EnkAtomizerII;;Effect of the Topical Application of Anaesthetics With EnkFiberoptic Atomizer During the Bronchoscopy;Effect of the Topical Application of Anaesthetics With EnkFiberoptic Atomizer on Usage of Anaesthetics and Sedatives During the Bronchoscopy;Unknown status;;Phase 4;60;Anticipated;RWTH Aachen University;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:34:07Z;2020-06-01T11:34:07Z;Aachen;3565891;Principal Investigator;Tobias Müller, Dr. med.;Department of Cardiology, Pneumology, Vascular Medicine and Intensive Care Medicine, RWTH Aachen University Hospital;Enk Fiberoptic Atomizer | bronchoscope;63609655;1;;;2014;2020-05-29;;FALSE;;FALSE;TRUE;18;85;Years;Years;1;1;
NCT02261779;ClinicalTrials.gov processed this data on May 29, 2020;2014-09-23;;;2015-07-06;2014-10-09;2014-10-10;Estimate;;;;;;;2015-07-06;2015-07-07;Estimate;September 2014;;2014-09-30;July 2015;2015-07-31;September 2017;Anticipated;2017-09-30;September 2017;Anticipated;2017-09-30;;Interventional;TCP-AML;;Phase I/II Trial of ATRA and TCP in Patients With Relapsed or Refractory AML and no Intensive Treatment is Possible;Phase I/II Pilot Trial of ATRA (Tretinoin) and TCP (Tranylcypromine) in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) and no Intensive Treatment is Possible;Unknown status;;Phase 1/Phase 2;16;Anticipated;Martin-Luther-Universität Halle-Wittenberg;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T11:34:14Z;2020-06-01T11:34:14Z;Halle;3565945;Principal Investigator;Carsten Mueller-Tidow, Prof.;Martin-Luther-Universität Halle-Wittenberg;Tranylcypromine | Tretinoin;63609707;1;;;2014;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;3;
NCT02260115;ClinicalTrials.gov processed this data on May 29, 2020;2014-10-01;;;2018-02-22;2014-10-08;2014-10-09;Estimate;;;;;;;2018-02-22;2018-02-23;Actual;November 2013;Actual;2013-11-30;February 2018;2018-02-28;July 2016;Actual;2016-07-31;June 2014;Actual;2014-06-30;;Interventional;LABS-1;;A Randomized Multi-centre Study to Assess the Safety and Manageability of a Laparoscopic Adhesion Barrier in Women Undergoing Gynecologic Laparoscopic Surgery Followed by Second Look Laparoscopy;A Randomized, Controlled, Subject and Reviewer-Blinded, Multi-Centre Study To Assess The Safety and Manageability Of LABS™ In Women Undergoing Gynaecologic Laparoscopic Surgery Followed By Second Look Laparoscopy;Completed;;Phase 1;78;Actual;Actamax Surgical Materials LLC;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T11:34:39Z;2020-06-01T11:34:39Z;Tübingen;3566080;Principal Investigator;Sara Y Brucker, MD, PhD;Deputy Head of Department of Gynecology and Obstetrics, University of Tubingen Women's Hospital;LABS™ | Surgical Control;63609833;4;;;2014;2020-05-29;7;FALSE;;FALSE;FALSE;18;46;Years;Years;1;1;3
NCT02258815;ClinicalTrials.gov processed this data on May 29, 2020;2013-08-07;;;2014-10-02;2014-10-02;2014-10-07;Estimate;;;;;;;2014-10-02;2014-10-07;Estimate;August 2010;;2010-08-31;October 2014;2014-10-31;December 2015;Anticipated;2015-12-31;December 2014;Anticipated;2014-12-31;;Interventional;;;CH14.18 1021 Antibody and IL2 After Haplo SCT in Children With Relapsed Neuroblastoma;Phase II Feasability Study Using ch14.18/CHO Antibody and Subcutaneous Interleukin 2 After Haploidentical Stem Cell Transplantation in Children With Relapsed Neuroblastoma;Unknown status;;Phase 2;35;Anticipated;University Children’s Hospital Tuebingen;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T11:34:52Z;2020-06-01T11:34:52Z;Tübingen;3566149;Principal Investigator;Peter Lang, MD, PhD;University Hospital Tuebingen;ch14.18/CHO;63609933;4;;;2013;2020-05-29;;FALSE;;FALSE;FALSE;1;21;Year;Years;1;3;
NCT02253771;ClinicalTrials.gov processed this data on May 29, 2020;2014-08-31;;;2015-06-04;2014-09-28;2014-10-01;Estimate;;;;;;;2015-06-04;2015-06-08;Estimate;August 2014;;2014-08-31;June 2015;2015-06-30;December 2015;Anticipated;2015-12-31;December 2015;Anticipated;2015-12-31;;Interventional;;;Shockwave Therapy for Acute Low Back Pain;Shockwave Therapy for Acute Low Back Pain: a Randomized Placebo-controlled Clinical Trial;Unknown status;;N/A;60;Anticipated;University Hospital Muenster;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:35:58Z;2020-06-01T11:35:58Z;Münster;3566528;Principal Investigator;Niklas Deventer, Dr. med.;Universitätsklinikum Münster, Klinik für Allgemeine Orthopädie und Tumororthopädie;shockwave therapy;63610319;1;;;2014;2020-05-29;;FALSE;;FALSE;TRUE;18;65;Years;Years;1;4;
NCT02253563;ClinicalTrials.gov processed this data on May 29, 2020;2014-09-24;;;2016-05-10;2014-09-26;2014-10-01;Estimate;;;;;;;2016-05-10;2016-05-12;Estimate;June 2011;;2011-06-30;May 2016;2016-05-31;February 2014;Actual;2014-02-28;February 2014;Actual;2014-02-28;;Interventional;;;Resistance Versus Balance Training in Parkinson's Disease;Resistance Training Versus Balance Training to Improve Postural Control in Patients With Parkinson's Disease - a Randomized Controlled Rater Blinded Trial;Completed;;N/A;40;Actual;University of Kiel;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:36:01Z;2020-06-01T11:36:01Z;Kiel;;;;;Resistance Training | Balance Training;63610335;;;;2014;2020-05-29;32;FALSE;;;FALSE;40;100;Years;Years;1;;
NCT02253056;ClinicalTrials.gov processed this data on May 29, 2020;2014-09-19;;;2015-03-30;2014-09-26;2014-10-01;Estimate;;;;;;;2015-03-30;2015-03-31;Estimate;September 2014;;2014-09-30;March 2015;2015-03-31;March 2015;Actual;2015-03-31;March 2015;Actual;2015-03-31;;Interventional;MIFT;;Monday is Fasting Day - Non-Randomized Trial on Intermittent Fasting;Montag Ist Fasten-Tag (German) - MIFT [Monday is Fasting Day];Completed;;N/A;36;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T11:36:08Z;2020-06-01T11:36:08Z;Berlin;3566581;Principal Investigator;Andreas Michalsen, MD;Charité Medical University;Fasting / Caloric Restriction | Healthy Diet;63610371;1;;;2014;2020-05-29;6;FALSE;;FALSE;TRUE;18;65;Years;Years;1;9;
NCT02252575;ClinicalTrials.gov processed this data on May 29, 2020;2014-09-26;;;2018-02-01;2014-09-26;2014-09-30;Estimate;;;;;;;2018-02-01;2018-02-05;Actual;September 2014;Actual;2014-09-30;February 2018;2018-02-28;October 2017;Actual;2017-10-31;April 2015;Actual;2015-04-30;;Interventional;;;Assessment of Electromagnetic Interference Between E-transportation and Cardiac Implantable Electronic Devices;Assessment of Electromagnetic Interference Between E-transportation and Cardiac Implantable Electronic Devices;Completed;;N/A;107;Actual;Deutsches Herzzentrum Muenchen;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:36:13Z;2020-06-01T11:36:13Z;Munich;3566616;Study Chair;Christof Kolb, MD;Deutsches Herzzentrum München;Electromagnetic field;63610407;1;;;2014;2020-05-29;7;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT02251535;ClinicalTrials.gov processed this data on May 29, 2020;2014-09-23;;;2014-09-25;2014-09-25;2014-09-29;Estimate;;;;;;;2014-09-25;2014-09-29;Estimate;July 2014;;2014-07-31;September 2014;2014-09-30;September 2015;Anticipated;2015-09-30;April 2015;Anticipated;2015-04-30;;Interventional;DePuyAttune;;In-vivo Comparison of Different Levels of Femoral Rollback in a Primary Total Knee Arthroplasty;Retrospective Non-randomized In-vivo Comparison of Different Levels of Femoral Rollback in the ATTUNE Total Knee Arthroplasiy System on the Basis of Fluoroscopic and Marker-based Motion Capture Evaluation.;Unknown status;;N/A;30;Anticipated;Charite University, Berlin, Germany;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:36:30Z;2020-06-01T11:36:30Z;Berlin;;;;;ATTUNE® Knee System | PFC® SIGMA® Knee System;63610486;1;;;2014;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;4;
NCT02251470;ClinicalTrials.gov processed this data on May 29, 2020;2014-09-25;;;2015-12-01;2014-09-26;2014-09-29;Estimate;;;;;;;2015-12-01;2015-12-02;Estimate;October 2014;;2014-10-31;December 2015;2015-12-31;August 2015;Actual;2015-08-31;June 2015;Actual;2015-06-30;;Interventional;WiiMobil;;Home-based Balance Training Using Wii Fit After Stroke: A Feasibility Study;The Application of a Video-game System (Nintendo Wii®) as an Independent Exercise Program to Improve Mobility After Stroke - a Randomized Phase II Trial;Completed;;Phase 1/Phase 2;14;Actual;Martin-Luther-Universität Halle-Wittenberg;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:36:30Z;2020-06-01T11:36:30Z;Halle;;;;;HBE Wii (EG) | HBE Control (CG);63610492;2;;;2014;2020-05-29;8;FALSE;;FALSE;FALSE;60;;Years;;1;1;
NCT02248922;ClinicalTrials.gov processed this data on May 29, 2020;2014-09-22;;;2018-01-02;2014-09-22;2014-09-25;Estimate;;;;;;;2018-01-02;2018-10-09;Actual;January 27, 2015;Actual;2015-01-27;January 2018;2018-01-31;April 10, 2017;Actual;2017-04-10;April 10, 2017;Actual;2017-04-10;;Interventional;ELIXIR;;Evaluation of Lung Clearance Index in Cystic Fibrosis (CF) Patients, Infected With P.Aeruginosa;An 8 Week Open-label Interventional Multicenter Study to Evaluate the Lung Clearance Index as Endpoint for Clinical Trials in Cystic Fibrosis Patients ≥ 6 Years of Age, Chronically Infected With Pseudomonas Aeruginosa;Terminated;;Phase 4;17;Actual;Novartis;;1;;Reason for termination was challenge with enrollment and recruitment. A significant decrease in~   the eligible patient population was main driver.;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;Undecided;Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.~This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com;2020-06-01T11:37:01Z;2020-06-01T11:37:01Z;Erlangen;3566910;Study Director;Jörg Ziegler, PhD;Novartis Pharma GmbH, Nürnberg, Germany;TIS or TIP;63610689;6;11;0;2014;2020-05-29;26;TRUE;5;FALSE;FALSE;6;;Years;;1;6;
NCT02247778;ClinicalTrials.gov processed this data on May 29, 2020;2014-09-21;;;2014-09-28;2014-09-21;2014-09-25;Estimate;;;;;;;2014-09-28;2014-09-30;Estimate;April 2014;;2014-04-30;September 2014;2014-09-30;September 2015;Anticipated;2015-09-30;September 2014;Actual;2014-09-30;;Interventional;ClavFrac;;Surgical Innovations in Treatment of Clavicle Fractures;Outcome of Mini-incision-technique for Treatment of Midshaft Fractures of the Clavicle;Unknown status;;N/A;40;Anticipated;Technische Universität München;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:37:16Z;2020-06-01T11:37:16Z;Munich;3566992;Principal Investigator;Chlodwig Kirchhoff, MD;Klinik und Poliklinik für Unfallchirurgie, Klinikum rechts der Isar, Technische Universität München;conventional plate osteosynthesis | mini-incision-type osteosynthesis;63610780;1;;;2014;2020-05-29;5;FALSE;;FALSE;TRUE;18;75;Years;Years;1;2;
NCT02247180;ClinicalTrials.gov processed this data on May 29, 2020;2014-09-16;;;2014-09-18;2014-09-18;2014-09-23;Estimate;;;;;;;2014-09-18;2014-09-23;Estimate;September 2014;;2014-09-30;September 2014;2014-09-30;December 2015;Anticipated;2015-12-31;May 2015;Anticipated;2015-05-31;;Interventional;;;Cognitive Rehabilitation in Alzheimer`s Disease;Cognitive Rehabilitation in Alzheimer`s Disease (AD);Unknown status;;N/A;14;Anticipated;University of Rostock;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:37:26Z;2020-06-01T11:37:26Z;Rostock;3567044;Principal Investigator;Stefan Teipel, Prof.;Department of Psychosomatic Medicine, University of Rostock, Rostock, Germany;cognitive rehabilitation | standardized cognitive training;63610823;1;;;2014;2020-05-29;;FALSE;;FALSE;TRUE;;;;;3;3;
NCT02246595;ClinicalTrials.gov processed this data on May 29, 2020;2014-09-18;;;2016-04-22;2014-09-22;2014-09-23;Estimate;;;;;;;2016-04-22;2016-04-25;Estimate;April 2014;;2014-04-30;April 2016;2016-04-30;December 2015;Actual;2015-12-31;December 2015;Actual;2015-12-31;;Interventional;SCIENS;;Studying Complement Inhibition in Early, Newly Developing Septic Organ Dysfunction;A Phase II Randomized, Placebo-controlled, Double-blind, Dose Controlled Trial in Patients Suffering From Early, Newly Developing Abdominal or Pulmonary Derived Septic Organ Dysfunction to Evaluate Safety, Pharmacokinetics, Pharmacodynamics and to Estimate Efficacy of the New Humanized Monoclonal i.v. Administered Antibody CaCP29;Completed;;Phase 2;72;Actual;InflaRx GmbH;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T11:37:36Z;2020-06-01T11:37:36Z;Jena;3567091;Principal Investigator;Michael Bauer, Prof. Dr.;University Hospital Jena;CaCP29 | Placebo;63610870;11;;;2014;2020-05-29;20;FALSE;;FALSE;FALSE;18;;Years;;3;7;
NCT02241642;ClinicalTrials.gov processed this data on May 29, 2020;2014-09-11;;;2018-01-30;2014-09-15;2014-09-16;Estimate;;;;;;;2018-01-30;2018-02-01;Actual;October 2013;Actual;2013-10-31;January 2018;2018-01-31;November 2017;Actual;2017-11-30;November 2016;Actual;2016-11-30;;Interventional;FRONTIER-II;;Safety and Performance Study of Large Hole Vascular Closure Device;Safety and Performance Study of Large Hole Vascular Closure Device - FRONTIER II Study;Completed;;N/A;65;Actual;Vivasure Medical Limited;;1;;;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T11:38:43Z;2020-06-01T11:38:43Z;Münster;3567433;Principal Investigator;Prof. Dr. med Giovanni Torsello, MD;St Fraziskus Hospital, Muenster, Germany;VIVASURE CLOSURE DEVICE™;63611244;9;;;2014;2020-05-29;37;FALSE;;FALSE;FALSE;18;;Years;;1;1;1
NCT02238392;ClinicalTrials.gov processed this data on May 29, 2020;2014-09-09;;;2014-09-10;2014-09-10;2014-09-12;Estimate;;;;;;;2014-09-10;2014-09-12;Estimate;January 2012;;2012-01-31;September 2014;2014-09-30;June 2014;Actual;2014-06-30;June 2014;Actual;2014-06-30;;Interventional;;;Adenosine vs AF Termination for Paroxysmal AF Ablation;Arrhythmia Inducibility Versus Elimination of Dormant PV Conduction as a Procedural Endpoint of Catheter Ablation for Paroxysmal Atrial Fibrillation: a Prospective Randomized Trial;Completed;;N/A;150;Actual;Johannes Gutenberg University Mainz;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:39:25Z;2020-06-01T11:39:25Z;Mainz;3567750;Principal Investigator;Thomas Rostock, MD;University Hospital Mainz, Dept. of Cardiology;Adenosine test | Termination of AF;63611492;1;;;2014;2020-05-29;29;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT02235220;ClinicalTrials.gov processed this data on May 29, 2020;2014-09-04;;;2014-09-25;2014-09-08;2014-09-09;Estimate;;;;;;;2014-09-25;2014-09-26;Estimate;September 2014;;2014-09-30;September 2014;2014-09-30;December 2015;Anticipated;2015-12-31;September 2015;Anticipated;2015-09-30;;Interventional;;;Reduction of Masticatory Muscle Activity by Restoring Canine Guidance;Reduction of Masticatory Muscle Activity by Restoring Canine Guidance With Composite Resin Fillings in Patients With Bruxism.;Unknown status;;N/A;30;Anticipated;University of Kiel;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:39:55Z;2020-06-01T11:39:55Z;Kiel;3567986;Study Director;Matthias Kern, DDS, PhD;University of Kiel;Composite resin restoration;63611734;;;;2014;2020-05-29;;FALSE;;;FALSE;;;;;1;;
NCT02228486;ClinicalTrials.gov processed this data on May 29, 2020;2014-08-15;;;2014-08-26;2014-08-26;2014-08-29;Estimate;;;;;;;2014-08-26;2014-08-29;Estimate;August 2014;;2014-08-31;August 2014;2014-08-31;August 2016;Anticipated;2016-08-31;August 2016;Anticipated;2016-08-31;;Interventional;;;Relapse Prevention in Alcohol Dependency by Transcranial Direct Current Stimulation Supported Cue Exposure Therapy;Alcohol Cue-Reactivity in Patients With Alcohol Dependency and Effects of Transcranial Direct Current Stimulation (tDCS) on Cue-exposure Therapy;Unknown status;;N/A;48;Anticipated;University Hospital Tuebingen;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:41:28Z;2020-06-01T11:41:28Z;Tübingen;3568526;Principal Investigator;Ann-Christine Ehlis, PhD;University Hospital Tuebingen;tDCS | Cue Exposure Therapy;63612247;1;;;2014;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;2;3
NCT02227641;ClinicalTrials.gov processed this data on May 29, 2020;2014-08-26;;;2016-06-23;2014-08-27;2014-08-28;Estimate;;;;;;;2016-06-23;2016-06-24;Estimate;October 2014;;2014-10-31;June 2016;2016-06-30;March 2017;Anticipated;2017-03-31;October 2016;Anticipated;2016-10-31;;Interventional;;;Preventative/Preemptive Adoptive Transfer of Peptide Stimulated CMV/EBV Specific T-cells in Patients After Allogeneic Stem Cell Transplantation;Prospective, Open, Randomized, Two-arm, Controlled, Multicenter Clinical Phase I/IIa Trial to Evaluate the Safety and Efficacy of Adoptive Immunotherapy With Allogeneic CMV/EBV Specific, Peptide Stimulated T-cells (CD3+) for Prevention or Preemptive Therapy of Reactivation of CMV and/or EBV in Patients After Allogeneic, HLA Identical Stem Cell Transplantation;Unknown status;;Phase 1/Phase 2;50;Anticipated;University of Erlangen-Nürnberg Medical School;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T11:41:40Z;2020-06-01T11:41:40Z;Berlin Erlangen;3568595;Study Director;Armin H Gerbitz, MD, PhD;Charite University, Berlin, Germany;CMV/EBV specific T-cell;63612313;6;;;2014;2020-05-29;;FALSE;;FALSE;FALSE;18;75;Years;Years;1;4;
NCT02227550;ClinicalTrials.gov processed this data on May 29, 2020;2014-06-27;;;2017-10-19;2014-08-27;2014-08-28;Estimate;;;;;;;2017-10-19;2017-10-20;Actual;December 2014;;2014-12-31;October 2017;2017-10-31;September 2017;Actual;2017-09-30;April 2017;Actual;2017-04-30;;Interventional;AXAFA;;Apixaban During Atrial Fibrillation Catheter Ablation: Comparison to Vitamin K Antagonist Therapy;An Investigator-driven, Prospective, Parallel-group, Randomised, Open, Blinded Outcome Assessment (PROBE), Multi-centre Trial to Determine the Optimal Anticoagulation Therapy for Patients Untergoing Catheter Ablation of Atrial Fibrillation;Completed;;Phase 4;676;Actual;Atrial Fibrillation Network;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T11:41:41Z;2020-06-01T11:41:41Z;Münster;3568606;Principal Investigator;Paulus Kirchhof, Professor;University of Birmingham Centre for Cardiovascular Scienes, UK and University Hospital Muenster, Germany;Vitamin K antagonist | Apixaban;63612320;13;;;2014;2020-05-29;28;FALSE;;TRUE;FALSE;18;;Years;;1;17;
NCT02226770;ClinicalTrials.gov processed this data on May 29, 2020;2014-04-17;;;2014-08-26;2014-08-26;2014-08-27;Estimate;;;;;;;2014-08-26;2014-08-27;Estimate;July 2010;;2010-07-31;August 2014;2014-08-31;October 2016;Anticipated;2016-10-31;October 2014;Anticipated;2014-10-31;;Interventional;Anxiety-CHF;;Heart-focused Anxiety in Patients With Heart Failure and ICD;Heart-focused Anxiety in Patients With Implantable Cardioverter Defibrillator (ICD) and/or Mechanical Cardiovascular Assist Device (AD) (Anxiety-CHF);Unknown status;;N/A;100;Anticipated;University Hospital, Saarland;;1;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T11:41:52Z;2020-06-01T11:41:52Z;Homburg;3568675;Principal Investigator;Ingrid Kindermann, PD Dr. med.;Saarland University Hospital;Implantable Cardioverter Defibrillator (ICD);63612378;1;;;2014;2020-05-29;;FALSE;;FALSE;TRUE;;;;;4;12;
NCT02223767;ClinicalTrials.gov processed this data on May 29, 2020;2014-08-20;;;2016-01-11;2014-08-21;2014-08-22;Estimate;;;;;;;2016-01-11;2016-01-12;Estimate;August 2014;;2014-08-31;January 2016;2016-01-31;October 2015;Actual;2015-10-31;April 2015;Actual;2015-04-30;;Interventional;BEAT;;TMS Augmented Exposure Therapy;Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment of Height Phobics;Completed;;N/A;47;Actual;Wuerzburg University Hospital;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:42:34Z;2020-06-01T11:42:34Z;Würzburg;3568945;Principal Investigator;Martin J. Herrmann, PhD;University of Würzburg;Experimental: Verum TMS | Experimental: Sham TMS;63612609;1;;;2014;2020-05-29;8;FALSE;;FALSE;TRUE;18;65;Years;Years;2;1;
NCT02223091;ClinicalTrials.gov processed this data on May 29, 2020;2014-07-02;;;2015-08-03;2014-08-21;2014-08-22;Estimate;;;;;;;2015-08-03;2015-08-04;Estimate;September 2014;;2014-09-30;August 2015;2015-08-31;March 2015;Actual;2015-03-31;February 2015;Actual;2015-02-28;;Interventional;KOKON-AS;;KOKON Consultation on Complementary Medicine in Oncology - a Pilot Study;Prospective, Multi-center, Cluster-randomized, Pragmatic, Mixed-method Pilot Study Evaluating a Consultation Training Program for Physicians Within the Framework of KOKON (Competence Network Complementary Medicine in Oncology);Completed;;N/A;137;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:42:44Z;2020-06-01T11:42:44Z;Berlin;3569001;Principal Investigator;Claudia M Witt, MD, MBA;Charite University, Berlin, Germany;Consultation by a trained physician | Consultation by an untrained physician;63612660;8;;;2014;2020-05-29;5;FALSE;;FALSE;FALSE;18;;Years;;1;8;
NCT02222675;ClinicalTrials.gov processed this data on May 29, 2020;2014-08-20;;;2017-04-12;2014-08-20;2014-08-21;Estimate;;;;;;;2017-04-12;2017-04-14;Actual;April 2009;;2009-04-30;August 2014;2014-08-31;May 2015;Actual;2015-05-31;April 2015;Actual;2015-04-30;;Interventional;MAC-001;;Conserving Breast Surgery - Comparison of Conventional With Sonography;Comparison of Sonographically Assisted With Conventionally Breast Surgery - Prospective, Randomised, Multicenter, Parallel Group Study With Two Study Arms;Completed;;N/A;46;Actual;University Women's Hospital Tübingen;;2;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T11:42:48Z;2020-06-01T11:42:48Z;Tübingen;;;;;Sonography assisted breast surgery | Conventional breast surgery;63612692;1;;;2014;2020-05-29;73;FALSE;;FALSE;TRUE;18;70;Years;Years;1;;
NCT02222051;ClinicalTrials.gov processed this data on May 29, 2020;2014-08-18;;;2018-04-30;2014-08-20;2014-08-21;Estimate;;;;;;;2018-04-30;2018-05-02;Actual;August 2014;;2014-08-31;April 2018;2018-04-30;April 2015;Actual;2015-04-30;December 2014;Actual;2014-12-31;;Interventional;TaiChiNe;;Tai Chi for Chronic Non-specific Neck Pain;Tai Chi for Chronic Non-specific Neck Pain: A Randomized Controlled Trial;Completed;;N/A;114;Actual;Universität Duisburg-Essen;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:42:57Z;2020-06-01T11:42:57Z;Duisburg;3569078;Principal Investigator;Gustav Dobos, Prof.;Department of Internal and Integrative Medicine, Kliniken Essen-Mitte;Tai Chi | Neck exercises;63612740;1;;;2014;2020-05-29;4;FALSE;;FALSE;TRUE;18;;Years;;1;13;1
NCT02220517;ClinicalTrials.gov processed this data on May 29, 2020;2014-07-07;;;2015-03-23;2014-08-18;2014-08-20;Estimate;;;;;;;2015-03-23;2015-03-24;Estimate;November 2011;;2011-11-30;March 2015;2015-03-31;October 2014;Actual;2014-10-31;August 2014;Actual;2014-08-31;;Interventional;;;Randomized Study Comparing MR-guided in Bore Versus MRI/US Fusion-guided Prostate Biopsy;A Prospective Randomized Study Comparing the Diagnostic Efficacy of MR-guided in Bore Prostate Biopsy Versus MRI/US Fusion-guided Prostate Biopsy in Men With at Least One Negative Prostate Biopsy;Completed;;N/A;480;Actual;Heinrich-Heine University, Duesseldorf;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:43:18Z;2020-06-01T11:43:18Z;Düsseldorf;3569190;Principal Investigator;Christian Arsov, MD;Department of Urology, University of Düsseldorf;MR-guided in-bore prostate biopsy | MRI/US fusion-guided prostate biopsy;63612856;1;;;2014;2020-05-29;33;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT02217657;ClinicalTrials.gov processed this data on May 29, 2020;2014-08-14;;;2016-05-30;2014-08-14;2014-08-15;Estimate;;;;;;;2016-05-30;2016-06-01;Estimate;August 2013;;2013-08-31;May 2016;2016-05-31;July 2016;Anticipated;2016-07-31;June 2016;Anticipated;2016-06-30;;Interventional;;;SmartTouch Catheter for Left Anterior Line - SmarT Line Study;Bidirectional Conduction Block of Left Atrial Anterior Line in Patients With Left Atrial Ablation - Reduction of RF Applications Using the Thermocool SmartTouch Contact Force Sensing Catheter;Unknown status;;Phase 4;75;Anticipated;Klinikum der Universitaet Muenchen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T11:43:53Z;2020-06-01T11:43:53Z;Munich;3569409;Principal Investigator;Heidi Estner, MD;Munich University Clinic, Campus Großhadern;Thermocool Smart Touch Catheter;63613079;1;;;2014;2020-05-29;;FALSE;;FALSE;TRUE;18;80;Years;Years;1;1;
NCT02216526;ClinicalTrials.gov processed this data on May 29, 2020;2014-08-11;;;2018-04-09;2014-08-13;2014-08-15;Estimate;;;;;;;2018-04-09;2018-04-13;Actual;September 2014;;2014-09-30;April 2018;2018-04-30;April 2015;Actual;2015-04-30;April 2015;Actual;2015-04-30;;Interventional;;;Skin Health and Effectiveness of Standardized Skin Care Regimens in Nursing Home Residents;A Prevalence and Multi-center Randomized Parallel-group Pragmatic Trial to Compare the Effectiveness of Standardized Skin Care Regimens on Skin Health in Nursing Home Residents;Completed;;N/A;133;Actual;Charite University, Berlin, Germany;;3;;;FALSE;;;;FALSE;;;;;;;;;;;Undecided;;2020-06-01T11:44:05Z;2020-06-01T11:44:05Z;Berlin;3569491;Principal Investigator;Ulrike Blume-Peytavi, Prof. Dr.;Charite University, Berlin, Germany;Cetaphil® Restoraderm | Excipial;63613164;1;8;0;2014;2020-05-29;7;TRUE;24;FALSE;TRUE;65;;Years;;1;34;
NCT02214784;ClinicalTrials.gov processed this data on May 29, 2020;2013-09-04;;;2018-02-01;2014-08-11;2014-08-12;Estimate;;;;;;;2018-02-01;2018-02-05;Actual;December 2012;;2012-12-31;February 2018;2018-02-28;January 2015;Actual;2015-01-31;January 2015;Actual;2015-01-31;;Interventional;;;Neurotech Vital Device For The Treatment Of Stress Urinary Incontinence;A Randomised Controlled Double-Blind Clinical Study To Evaluate The Safety And Performance Of Neuromuscular Electrical Stimulation (NMES) With The Neurotech Vital Device For The Treatment Of Stress Urinary Incontinence;Completed;;N/A;50;Actual;Atlantic Therapeutics;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:44:27Z;2020-06-01T11:44:27Z;Berlin;3569633;Principal Investigator;R Tunn, Professor;St Hedwig Krankenhaus, Berlin;Active Neurotech Vital | Modified Neurotech Vital Device;63613298;3;;;2013;2020-05-29;25;FALSE;;FALSE;FALSE;18;;Years;;2;14;5
NCT02213406;ClinicalTrials.gov processed this data on May 29, 2020;2014-08-05;;;2017-07-04;2014-08-08;2014-08-11;Estimate;;;;;;;2017-07-04;2017-07-06;Actual;;;;July 2017;2017-07-31;July 2017;Actual;2017-07-31;June 2017;Actual;2017-06-30;;Interventional;;;Neuronal and Sensory Perception of Fat;Fat and the Brain-Neuronal and Sensory Fat Perception;Completed;;N/A;;;University Hospital Tuebingen;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:44:43Z;2020-06-01T11:44:43Z;Tübingen;;;;;yogurt;63613406;1;;;2014;2020-05-29;;FALSE;;FALSE;TRUE;18;50;Years;Years;1;1;
NCT02213367;ClinicalTrials.gov processed this data on May 29, 2020;2014-08-08;;;2016-08-25;2014-08-08;2014-08-11;Estimate;;;;;;;2016-08-25;2016-08-26;Estimate;July 2014;;2014-07-31;August 2016;2016-08-31;March 2016;Actual;2016-03-31;March 2016;Actual;2016-03-31;;Interventional;;;Bilastine Updosing in Chronic Spontaneous Urticaria;Phase 3 Study, Exploratory, Disease Activity Controlled Dose Escalating Study to Assess the Efficacy, and Safety of Treatment With Bilastine 20 mg, 40 mg and 80 mg in Chronic Spontaneous Urticaria.;Completed;;Phase 3;30;Actual;Charite University, Berlin, Germany;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:44:43Z;2020-06-01T11:44:43Z;Berlin;3569788;Principal Investigator;Karsten Weller, MD;Dpt. of Dermatology and Allergy , Charité;Bilastine | Bilastine | Bilastin;63613409;1;;;2014;2020-05-29;20;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT02207582;ClinicalTrials.gov processed this data on May 29, 2020;2014-07-31;;;2018-06-14;2014-08-01;2014-08-04;Estimate;;;;;;;2018-06-14;2018-06-18;Actual;July 2014;;2014-07-31;June 2018;2018-06-30;December 6, 2016;Actual;2016-12-06;October 14, 2016;Actual;2016-10-14;;Interventional;tRNS-depr;;Prefrontal Transcranial Random Noise Stimulation in Patients With Depression;Prefrontal Transcranial Random Noise Stimulation in Patients With Depression;Terminated;;N/A;44;Actual;University of Regensburg;;2;;no efficacy;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T11:46:06Z;2020-06-01T11:46:06Z;Regensburg;3570257;Principal Investigator;Berthold Langguth;University of Regensburg;Verum Prefrontal tRNS | Placebo Prefrontal tRNS;63613851;1;;;2014;2020-05-29;26;FALSE;;FALSE;TRUE;18;70;Years;Years;1;5;
NCT02207309;ClinicalTrials.gov processed this data on May 29, 2020;2014-07-31;;;2017-11-08;2014-07-31;2014-08-04;Estimate;;;;;;;2017-11-08;2017-11-13;Actual;June 22, 2015;Actual;2015-06-22;November 2017;2017-11-30;July 29, 2016;Actual;2016-07-29;July 29, 2016;Actual;2016-07-29;;Interventional;;;Pazopanib Maintenance Phase II;A Randomized, Double Blind, Phase II Trial of Pazopanib Versus Placebo as Maintenance Therapy in Patients With Retroperitoneal and Visceral High-risk Soft Tissue Sarcomas Following Prior Neo- and/or Adjuvant Doxorubicin / Ifosfamide Chemotherapy With Regional Hyperthermia;Terminated;;Phase 2;1;Actual;Ludwig-Maximilians - University of Munich;;2;;poor recruitment;FALSE;;;;;;;;;;;;;;;;;2020-06-01T11:46:15Z;2020-06-01T11:46:15Z;Munich;3570282;Principal Investigator;Lars Lindner, MD, PhD;Ludwig-Maximilians - University of Munich;Pazopanib | Placebo (for Pazopanib);63613873;1;;;2014;2020-05-29;13;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT02206854;ClinicalTrials.gov processed this data on May 29, 2020;2014-07-31;;;2015-09-10;2014-07-31;2014-08-01;Estimate;;;;;;;2015-09-10;2015-09-11;Estimate;June 2014;;2014-06-30;September 2015;2015-09-30;September 2014;Actual;2014-09-30;September 2014;Actual;2014-09-30;;Interventional;;;Bioavailability, Pharmacokinetics and Tissue Distribution of R-flurbiprofen Capsules in Healthy Subjects;Bioavailability, Pharmacokinetics and Tissue Distribution of R-flurbiprofen Capsules in Healthy Subjects;Completed;;Phase 1;16;Actual;Goethe University;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:46:21Z;2020-06-01T11:46:21Z;Frankfurt;3570316;Principal Investigator;Gerd Geisslinger, Prof MD;Goethe University;R-flurbiprofen;63613908;1;;;2014;2020-05-29;3;FALSE;;FALSE;TRUE;18;65;Years;Years;4;2;
NCT02203461;ClinicalTrials.gov processed this data on May 29, 2020;2014-07-28;;;2014-11-04;2014-07-28;2014-07-30;Estimate;;;;;;;2014-11-04;2014-11-05;Estimate;July 2014;;2014-07-31;November 2014;2014-11-30;October 2014;Actual;2014-10-31;October 2014;Actual;2014-10-31;;Interventional;;;Changes in Insulin Resistance in Healthy Volunteers on STRIBILD® Medication;Changes in Insulin Resistance in Healthy Volunteers on STRIBILD® Medication - A Controlled, Mono Center, Three-arm, Randomized Phase I Study.;Completed;;Phase 1;30;Actual;Technische Universität München;;3;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T11:47:08Z;2020-06-01T11:47:08Z;Munich;3570610;Principal Investigator;Christoph D Spinner, MD;University Hospital Klinikum rechts der Isar, Technische Universitaet Muenchen;Tenofovir disaproxil fumarate/emtricitabine/elvitegravir/cobicistat | Tenofovir disaproxil fumarate/emtricitabine + Lopinavir/ritonavir | Tenofovir disaproxil fumarate/emtricitabine + ritonavir-boosted darunavir;63614164;1;;;2014;2020-05-29;3;FALSE;;FALSE;TRUE;18;40;Years;Years;1;1;
NCT02198482;ClinicalTrials.gov processed this data on May 29, 2020;2014-07-22;;;2018-02-27;2014-07-22;2014-07-23;Estimate;;;;;;;2018-02-27;2018-02-28;Actual;February 2016;;2016-02-29;February 2018;2018-02-28;November 2016;Actual;2016-11-30;November 2016;Actual;2016-11-30;;Interventional;;;Trial of Intensive Chemotherapy With or Without Volasertib in Patients With Newly Diagnosed High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML);Dose Finding Safety Run-in Phase Followed by a Randomized Phase II Trial of Intensive Chemotherapy With or Without Volasertib (BI 6727) Administered Prior or After Chemotherapy in Patients With Newly Diagnosed High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML);Terminated;;Phase 2;6;Actual;University of Ulm;;3;;development program of study drug volasertib was stopped by Boehringer Ingelheim due to~   manufacturing problems;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T11:48:34Z;2020-06-01T11:48:34Z;Ulm;3570982;Study Chair;Peter Paschka, MD;University Hospital Ulm;Volasertib | Cytarabine | Daunorubicin | Mitoxantrone;63614542;45;;;2014;2020-05-29;9;FALSE;;FALSE;FALSE;18;;Years;;1;6;
NCT02196896;ClinicalTrials.gov processed this data on May 29, 2020;2014-07-16;;;2017-03-16;2014-07-21;2014-07-22;Estimate;;;;;;;2017-03-16;2017-03-17;Actual;June 2014;;2014-06-30;March 2017;2017-03-31;November 2016;Actual;2016-11-30;November 2016;Actual;2016-11-30;;Interventional;;;Enhancing Inpatient Psychotherapeutic Treatment With Online Self-help : Acceptance and Efficacy;Enhancing Inpatient Psychotherapeutic Treatment With Online Self Help in a Randomised Controlled Trial: Acceptance and Efficacy;Completed;;N/A;229;Actual;Johannes Gutenberg University Mainz;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T11:48:53Z;2020-06-01T11:48:53Z;Mainz;3571147;Principal Investigator;Manfred E Beutel, Prof. Dr.;University Medical Center, Department of Psychosomatic Medicine and Psychotherapy, Johannes Gutenberg University Mainz;deprexis® | Information;63614663;2;;;2014;2020-05-29;29;FALSE;;FALSE;FALSE;18;65;Years;Years;1;17;
NCT02196324;ClinicalTrials.gov processed this data on May 29, 2020;2014-07-14;;;2018-02-27;2014-07-21;2014-07-22;Estimate;;;;;;;2018-02-27;2018-03-01;Actual;July 9, 2014;Actual;2014-07-09;February 2018;2018-02-28;June 10, 2016;Actual;2016-06-10;May 27, 2016;Actual;2016-05-27;;Interventional;;;A Randomized Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prurigo Nodularis (PN);A Randomized, Double-Blind, Placebo-Controlled, Study of Neurokinin-1 Receptor Antagonist Serlopitant in Subjects With Prurigo Nodularis;Completed;;Phase 2;128;Actual;Menlo Therapeutics Inc.;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T11:49:05Z;2020-06-01T11:49:05Z;Münster;3571191;Principal Investigator;Sonja Staender, MD;University of Muenster, Germany;serlopitant | Placebo;63614708;15;;;2014;2020-05-29;22;FALSE;;FALSE;FALSE;18;80;Years;Years;1;1;
NCT02190383;ClinicalTrials.gov processed this data on May 29, 2020;2014-04-14;;;2017-03-14;2014-07-12;2014-07-15;Estimate;;;;;;;2017-03-14;2017-03-15;Actual;November 2013;;2013-11-30;March 2017;2017-03-31;August 2017;Anticipated;2017-08-31;August 2017;Anticipated;2017-08-31;;Interventional;;;Efficacy of a Habit Reversal Treatment on Tic-symptoms;Within Subject Design on the Efficacy of Habit Reversal Treatment Programme in Children and Adolescents With Tics;Unknown status;;N/A;50;Anticipated;University of Cologne;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:50:42Z;2020-06-01T11:50:42Z;Köln;;;;;Habit Reversal Training;63615161;1;;;2014;2020-05-29;;FALSE;;FALSE;TRUE;8;18;Years;Years;1;8;
NCT02190370;ClinicalTrials.gov processed this data on May 29, 2020;2014-04-14;;;2017-03-14;2014-07-12;2014-07-15;Estimate;;;;;;;2017-03-14;2017-03-15;Actual;November 2013;;2013-11-30;March 2017;2017-03-31;August 2017;Anticipated;2017-08-31;June 2017;Anticipated;2017-06-30;;Interventional;;;Efficacy of a Resources Activation Treatment on Tic-symptoms;Within Subject Design on the Efficacy of a Resources Activation Treatment Programme in Children and Adolescents With Tics;Unknown status;;N/A;50;Anticipated;University of Cologne;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:50:43Z;2020-06-01T11:50:43Z;Köln;;;;;Resources activation;63615162;1;;;2014;2020-05-29;;FALSE;;FALSE;TRUE;8;18;Years;Years;2;7;
NCT02189473;ClinicalTrials.gov processed this data on May 29, 2020;2014-07-07;;;2020-02-18;2014-07-10;2014-07-14;Estimate;;;;;;;2020-02-18;2020-03-05;Actual;July 2010;;2010-07-31;February 2020;2020-02-29;July 2015;Actual;2015-07-31;July 2015;Actual;2015-07-31;;Interventional;SCORE-2;;Radiotherapy of Motor Deficits From Metastatic Epidural Spinal Cord Compression;Radiotherapy of Motor Deficits From Metastatic Epidural Spinal Cord Compression (10 x 3 Gy Versus 5 x 4 Gy);Completed;;N/A;203;Actual;University of Schleswig-Holstein;;2;;;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T11:50:53Z;2020-06-01T11:50:53Z;Kiel Lübeck;3571770;Study Chair;Dirk Rades, MD;Department of Radiation Oncology, University of Lübeck, Germany;radiotherapy;63615231;15;124;159;2014;2020-05-29;60;TRUE;44;TRUE;FALSE;18;89;Years;Years;1;7;
NCT02188589;ClinicalTrials.gov processed this data on May 29, 2020;2014-07-04;;;2019-03-14;2014-07-10;2014-07-11;Estimate;;;;;;;2019-03-14;2019-03-26;Actual;April 2014;Actual;2014-04-30;November 2018;2018-11-30;June 2017;Actual;2017-06-30;December 2015;Actual;2015-12-31;;Interventional;;;Evaluation of an Absorbable Implant for the Treatment of Nasal Valve Collapse;Evaluation of an Absorbable Implant for the Treatment of Nasal Valve Collapse;Completed;;N/A;30;Actual;Spirox, Inc.;;1;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T11:51:01Z;2020-06-01T11:51:01Z;Munich;3571856;Principal Investigator;Alexander Berghaus, MD;Ludwig-Maximilians - University of Munich;INEX nasal implant;63615299;1;22;10;2014;2020-05-29;20;TRUE;5;FALSE;TRUE;18;;Years;;1;2;
NCT02185703;ClinicalTrials.gov processed this data on May 29, 2020;2014-07-04;;;2015-08-03;2014-07-04;2014-07-09;Estimate;;;;;;;2015-08-03;2015-08-05;Estimate;July 2014;;2014-07-31;August 2015;2015-08-31;July 2015;Actual;2015-07-31;July 2015;Actual;2015-07-31;;Interventional;Amici;;Chordate System S020 Acute Migraine Clinical Investigation;A Randomized, Placebo-controlled, Double-blind, Multi-center Clinical Investigation to Evaluate the Performance and Safety of the Chordate System When Used in the Treatment of Acute Migraine Attacks of Moderate to Severe Intensity;Terminated;;N/A;51;Actual;Chordate Medical;;2;;Too slow recruitment rate;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:51:43Z;2020-06-01T11:51:43Z;Duisburg;3572092;Principal Investigator;Hans-Christoph Diener, Prof. Dr.;Universitätsklinikum Essen;Chordate System S020 in treatment mode | Chordate System S020 in placebo mode;63615521;9;;;2014;2020-05-29;12;FALSE;;FALSE;FALSE;18;65;Years;Years;1;9;
NCT02185534;ClinicalTrials.gov processed this data on May 29, 2020;2014-07-04;;;2016-05-18;2014-07-04;2014-07-09;Estimate;;;;;;;2016-05-18;2016-06-22;Estimate;August 2014;;2014-08-31;May 2016;2016-05-31;October 2014;Actual;2014-10-31;October 2014;Actual;2014-10-31;;Interventional;;;Clopidogrel Bioequivalence Study in Healthy Subjects;An Open-label, Randomised, Three-way Crossover Study in Healthy Subjects to Assess the Bioequivalence of European Source Generic Clopidogrel Tablets and US and Japanese Source Branded Clopidogrel (Plavix®) Tablets.;Completed;;Phase 1;144;Actual;AstraZeneca;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:51:44Z;2020-06-01T11:51:44Z;Berlin;3572106;Principal Investigator;Rainard Fuhr, Dr. med.;PAREXEL International GmbH, Berlin;Clopidogrel;63615533;1;223;0;2014;2020-05-29;2;TRUE;10;FALSE;TRUE;18;55;Years;Years;2;1;
NCT02181140;ClinicalTrials.gov processed this data on May 29, 2020;2013-07-08;;;2019-06-05;2014-07-02;2014-07-03;Estimate;;;;;;;2019-06-05;2019-06-18;Actual;August 2011;;2011-08-31;April 2019;2019-04-30;October 2014;Actual;2014-10-31;October 2014;Actual;2014-10-31;;Interventional;COS;;Core Biopsy Endo Sonography Study Evaluation of the Significance of the Pro-core® Needle;Prospective Evaluation of the Significance of the Pro-core® Needle in Differential Diagnosis of Tumorous and Inflammatory Processes;Completed;;N/A;56;Actual;Universitätsklinikum Hamburg-Eppendorf;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T11:52:37Z;2020-06-01T11:52:37Z;Hamburg;3572333;Principal Investigator;Thomas Rösch, Prof. Dr.;University Hospital Eppendorf, Hamburg;EUS guided FNA and fine needle punction;63615868;1;0;0;2013;2020-05-29;38;TRUE;6;FALSE;TRUE;18;;Years;;1;2;
NCT02180464;ClinicalTrials.gov processed this data on May 29, 2020;2014-07-01;;;2015-06-09;2014-07-01;2014-07-02;Estimate;;;;;;;2015-06-09;2015-06-10;Estimate;June 2014;;2014-06-30;June 2015;2015-06-30;December 2014;Actual;2014-12-31;December 2014;Actual;2014-12-31;;Interventional;Left/Right;;A Intra-individual Comparison to Investigate the Efficacy and the Safety of LAS41004 Formulation in Mild to Moderate Psoriasis;A Phase IIa, 28-day Treatment, Multi-center, Randomized, Comparator-controlled, Observer-blind Trial With Intra-individual Left/Right Comparison to Investigate the Anti-psoriatic Efficacy and the Safety of an LAS41004 Formulation in Comparison to an Active Reference in Patients With Mild to Moderate Plaque Psoriasis;Completed;;Phase 2;40;Actual;Almirall, S.A.;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:52:45Z;2020-06-01T11:52:45Z;Hamburg;3572381;Principal Investigator;Walter Wigger-Alberti, Dr med;bioskin, Hamburg;LAS41004 | control;63615920;1;;;2014;2020-05-29;6;FALSE;;FALSE;TRUE;18;;Years;;1;3;
NCT02178631;ClinicalTrials.gov processed this data on May 29, 2020;2014-06-25;;;2015-05-26;2014-06-27;2014-07-01;Estimate;;;;;;;2015-05-26;2015-05-27;Estimate;February 2013;;2013-02-28;May 2015;2015-05-31;May 2014;Actual;2014-05-31;May 2014;Actual;2014-05-31;;Interventional;;;Effectiveness of Internet-based Depression Treatment (EVIDENT) in Severe Depression;;Completed;;N/A;163;Actual;University of Luebeck;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:53:13Z;2020-06-01T11:53:13Z;Lübeck;;;;;Deprexis | CAU;63616058;4;;;2014;2020-05-29;15;FALSE;;FALSE;FALSE;18;65;Years;Years;1;4;
NCT02175953;ClinicalTrials.gov processed this data on May 29, 2020;2014-06-24;;;2016-10-25;2014-06-25;2014-06-26;Estimate;;;;;;;2016-10-25;2016-10-26;Estimate;June 2014;;2014-06-30;October 2016;2016-10-31;May 2016;Actual;2016-05-31;November 2015;Actual;2015-11-30;;Interventional;;;Short-term Caregiver Psychotherapy;Psychotherapeutical Short-term Intervention for Caregivers of Persons With Dementia;Completed;;Phase 2;13;Actual;University of Rostock;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:53:57Z;2020-06-01T11:53:57Z;Rostock;;;;;Psychotherapy;63616259;1;;;2014;2020-05-29;17;FALSE;;FALSE;TRUE;18;100;Years;Years;1;1;
NCT02175160;ClinicalTrials.gov processed this data on May 29, 2020;2014-06-11;;;2016-02-01;2014-06-23;2014-06-26;Estimate;;;;;;;2016-02-01;2016-02-02;Estimate;July 2014;;2014-07-31;June 2014;2014-06-30;June 2015;Actual;2015-06-30;May 2015;Actual;2015-05-31;;Interventional;;;Predictability of the Ability to Perform an Emergency Stop;Predictability of the Ability to Perform an Emergency Stop in Knee Osteoarthritis and Patients With Total Knee Arthroplasty;Completed;;N/A;60;Actual;University Hospital Tuebingen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:54:10Z;2020-06-01T11:54:10Z;Tübingen;3572811;Principal Investigator;Ulf K Hofmann, MD;University Hospital Tuebingen;Braking and functionality;63616322;1;;;2014;2020-05-29;10;FALSE;;FALSE;TRUE;18;85;Years;Years;1;;
NCT02169115;ClinicalTrials.gov processed this data on May 29, 2020;2014-06-12;;;2016-11-02;2014-06-18;2014-06-20;Estimate;;;;;;;2016-11-02;2016-12-20;Estimate;December 2012;;2012-12-31;November 2016;2016-11-30;December 2014;Actual;2014-12-31;December 2014;Actual;2014-12-31;;Interventional;UFO;;Urticaria Facticia Treatment With Omalizumab (UFO);Double-blind, Placebo-controlled 12-week, Parallel-group Study With a 6 Weeks Follow up Period to Demonstrate Efficacy and Safety of Subcutaneous Omalizumab in Patients With Urticaria Factitia Refractory to Standard Treatment;Completed;;Phase 2;61;Actual;Charite University, Berlin, Germany;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:55:36Z;2020-06-01T11:55:36Z;Berlin;3573168;Principal Investigator;Martin Metz, MD;Charité University;Omalizumab | Omalizumab | Placebo;63616784;2;102;6;2014;2020-05-29;24;TRUE;10;FALSE;FALSE;18;;Years;;1;6;
NCT02163863;ClinicalTrials.gov processed this data on May 29, 2020;2014-06-09;;;2019-11-12;2014-06-13;2014-06-16;Estimate;;;;;;;2019-11-12;2019-11-14;Actual;February 2010;;2010-02-28;November 2019;2019-11-30;July 2014;Actual;2014-07-31;October 2012;Actual;2012-10-31;;Interventional;Mimics;;BioMimics 3D Stent Clinical Investigation: The Mimics Study;BioMimics 3D Stent Clinical Investigation: The Mimics Study;Completed;;N/A;86;Actual;Veryan Medical Ltd.;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T11:57:02Z;2020-06-01T11:57:02Z;Berlin Frankfurt Freiburg Hamburg Leipzig Münster;3573587;Principal Investigator;Thomas Zeller, M.D.;Universitäts-Herzzentrum Freiburg Bad Krozingen;Femoropopliteal stenting;63617183;1;;;2014;2020-05-29;32;FALSE;;FALSE;TRUE;18;;Years;;2;5;
NCT02159170;ClinicalTrials.gov processed this data on May 29, 2020;2014-06-03;;;2015-01-15;2014-06-05;2014-06-09;Estimate;;;;;;;2015-01-15;2015-01-16;Estimate;March 2014;;2014-03-31;January 2015;2015-01-31;December 2014;Actual;2014-12-31;December 2014;Actual;2014-12-31;;Interventional;LOGIN_NGF;;Cortical Representation of Hyperalgesia Induced by Nerve Growth Factor;Cortical Representation of NGF-induced Hyperalgesia;Completed;;N/A;20;Actual;Central Institute of Mental Health, Mannheim;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:58:08Z;2020-06-01T11:58:08Z;Heidelberg Mannheim;3574019;Principal Investigator;Herta Flor, PhD;Medical Faculty Mannheim, Heidelberg University;NGF injection;63617542;1;;;2014;2020-05-29;9;FALSE;;FALSE;TRUE;18;60;Years;Years;1;1;
NCT02158468;ClinicalTrials.gov processed this data on May 29, 2020;2014-05-26;;;2018-06-22;2014-06-04;2014-06-06;Estimate;;;;;;;2018-06-22;2018-06-26;Actual;October 2011;;2011-10-31;December 2014;2014-12-31;September 2014;Actual;2014-09-30;August 2014;Actual;2014-08-31;;Interventional;LIPSIA-COND;;Effect of Conditioning on Myocardial Damage in STEMI;Effect of Conditioning on Myocardial Damage in ST-elevation Myocardial Infarction - Comparison of Combined Intrahospital Preconditioning Plus Postconditioning Versus Postconditioning Versus Control.;Completed;;N/A;600;Actual;University of Leipzig;;3;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T11:58:24Z;2020-06-01T11:58:24Z;Leipzig;3574070;Principal Investigator;Ingo Eitel, MD;University Leipzig- Heart Center;Combined intrahospital pre- and postconditioning | Postconditioning;63617596;1;;;2014;2020-05-29;34;FALSE;;FALSE;TRUE;18;;Years;;1;1;2
NCT02157454;ClinicalTrials.gov processed this data on May 29, 2020;2014-05-27;;;2015-11-09;2014-06-04;2014-06-06;Estimate;;;;;;;2015-11-09;2015-11-10;Estimate;June 2014;;2014-06-30;November 2015;2015-11-30;November 2015;Actual;2015-11-30;September 2015;Actual;2015-09-30;;Interventional;DIPExRCT;;Effect of a Website Offering Individual Patients' Experiences for Cancer Patients;Randomized Controlled Trial to Evaluate the Effect of a Website Offering Individual Patient's Experiences on Patient Competence of Colorectal Cancer Patients;Completed;;N/A;212;Actual;Berlin School of Public Health;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:58:37Z;2020-06-01T11:58:37Z;Berlin;;;;;Website access;63617673;1;;;2014;2020-05-29;15;FALSE;;FALSE;TRUE;18;;Years;;1;4;
NCT02157389;ClinicalTrials.gov processed this data on May 29, 2020;2014-06-03;;;2015-01-15;2014-06-05;2014-06-06;Estimate;;;;;;;2015-01-15;2015-01-16;Estimate;July 2012;;2012-07-31;January 2015;2015-01-31;December 2014;Actual;2014-12-31;December 2014;Actual;2014-12-31;;Interventional;;;Psychobiological Mechanisms of Placebo and Nocebo Effects in the Treatment of Chronic Back Pain;Psychobiological Mechanisms of Placebo and Nocebo Effects in the Treatment of Chronic Back Pain;Completed;;N/A;80;Actual;Central Institute of Mental Health, Mannheim;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:58:37Z;2020-06-01T11:58:37Z;Heidelberg Mannheim;3574148;Principal Investigator;Herta Flor, PhD;Medical Faculty Mannheim, Heidelberg University;Administration of a pharmacological placebo;63617678;1;;;2014;2020-05-29;29;FALSE;;FALSE;TRUE;18;75;Years;Years;1;2;
NCT02157363;ClinicalTrials.gov processed this data on May 29, 2020;2014-05-12;;;2017-10-19;2014-06-02;2014-06-06;Estimate;;;;;;;2017-10-19;2017-10-20;Actual;June 16, 2014;Actual;2014-06-16;October 2017;2017-10-31;February 28, 2017;Actual;2017-02-28;February 28, 2017;Actual;2017-02-28;;Interventional;POETRI;;POsitioning for Esophageal Cancer Resection;POsitioning for Esophageal Cancer Resection - a Randomized Controlled TRIal (POETRI);Terminated;;N/A;47;Actual;Technische Universität Dresden;;2;;poor recruitment due to change of surgical technique;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T11:58:38Z;2020-06-01T11:58:38Z;Dresden;3574150;Principal Investigator;Thilo Welsch, MD;Department of Surgery, University Hospital Dresden;Repositioning | Single positioning;63617680;1;;;2014;2020-05-29;32;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT02157129;ClinicalTrials.gov processed this data on May 29, 2020;2014-05-27;;;2017-08-16;2014-06-03;2014-06-05;Estimate;;;;;;;2017-08-16;2017-08-21;Actual;May 2014;;2014-05-31;August 2017;2017-08-31;April 2017;Actual;2017-04-30;April 2017;Actual;2017-04-30;;Interventional;;;LipoAerosol© Inhalation After Tracheostomy;LipoAerosol© Inhalation to Maintain the Functional Integrity of the Tracheo-bronchial System in Patients After Tracheostomy;Completed;;N/A;100;Actual;Technische Universität München;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T11:58:41Z;2020-06-01T11:58:41Z;Munich;3574170;Principal Investigator;Andreas Knopf, PD Dr.;HNO, Klinikum rechts der Isar, TU München;LipoAerosol© inhalation | Physiologic saline inhalation;63617698;1;;;2014;2020-05-29;35;FALSE;;FALSE;TRUE;;;;;1;1;2
NCT02156661;ClinicalTrials.gov processed this data on May 29, 2020;2014-06-03;;;2017-05-05;2014-06-04;2014-06-05;Estimate;;;;;;;2017-05-05;2017-05-09;Actual;May 2013;;2013-05-31;May 2017;2017-05-31;June 2014;Actual;2014-06-30;June 2014;Actual;2014-06-30;;Interventional;;;Oxytocin and Emotion Processing;;Completed;;Phase 1;97;Actual;University Hospital, Bonn;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T11:58:46Z;2020-06-01T11:58:46Z;Bonn;;;;;Oxytocin;63617734;;;;2014;2020-05-29;13;FALSE;;;FALSE;20;40;Years;Years;1;1;
NCT02153372;ClinicalTrials.gov processed this data on May 29, 2020;2014-02-13;;;2016-05-11;2014-05-29;2014-06-03;Estimate;;;;;;;2016-05-11;2016-05-12;Estimate;July 2013;;2013-07-31;May 2016;2016-05-31;September 2014;Actual;2014-09-30;September 2014;Actual;2014-09-30;;Interventional;BMC2012;;Cell Therapy by Bone Marrow-derived Mononuclear Cells (BMC) for Large Bone Defect Repair: Phase-I Clinical Trial;Cell Based Therapy by Implanted Bone Marrow-derived Mononuclear Cells (BMC) for Bone Augmentation of Plate-stabilized Proximal Humeral Fractures;Completed;;Phase 1;10;Actual;Goethe University;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T11:59:38Z;2020-06-01T11:59:38Z;Frankfurt;3574465;Principal Investigator;Ingo Marzi, MD Prof.;Department of Trauma-, hand- and reconstructive surgery, Goethe University, Frankfurt;BMC2012;63617986;1;;;2014;2020-05-29;14;FALSE;;FALSE;TRUE;50;90;Years;Years;5;5;10
NCT02153294;ClinicalTrials.gov processed this data on May 29, 2020;2014-05-23;;;2018-03-23;2014-06-02;2014-06-03;Estimate;;;;;;;2018-03-23;2018-03-26;Actual;August 2014;;2014-08-31;March 2018;2018-03-31;November 18, 2017;Actual;2017-11-18;September 20, 2017;Actual;2017-09-20;;Interventional;PReVENT-NL;;PRotective VENTilation in Patients Without ARDS;PRotective VENTilation in Patients Without ARDS at Start of Ventilation - PReVENT, a Randomized Controlled Trial;Completed;;N/A;952;Actual;Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA);;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T11:59:39Z;2020-06-01T11:59:39Z;Dresden;3574473;Study Chair;Marcelo Gama de Abreu, MD, PhD;Department of Anesthesiology and Intensive Care Medicine, University Hospital Carl Gustav Carus, Technical University Dresden, Germany;low tidal volume | high tidal volume;63617992;1;;;2014;2020-05-29;37;FALSE;;FALSE;TRUE;18;100;Years;Years;1;7;
NCT02150473;ClinicalTrials.gov processed this data on May 29, 2020;2014-02-27;;;2017-10-17;2014-05-28;2014-05-29;Estimate;;;;;;;2017-10-17;2017-10-18;Actual;October 2014;;2014-10-31;October 2017;2017-10-31;September 14, 2017;Actual;2017-09-14;September 14, 2017;Actual;2017-09-14;;Interventional;;;The Effect of Adalimumab Plus Methotrexate (MTX) Versus Placebo Plus MTX on Cartilage in (RA) Patients;Delayed Gadolinium-enhanced Magnetic Resonance (MR) Imaging of Cartilage - A Pilot Study to Measure the Effect of Adalimumab Plus MTX Versus Placebo Plus MTX on Cartilage in Early RA Patients;Terminated;;Phase 3;21;Actual;Heinrich-Heine University, Duesseldorf;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:00:28Z;2020-06-01T12:00:28Z;Düsseldorf;;;;;Adalimumab | Placebo;63618208;1;;;2014;2020-05-29;34;FALSE;;FALSE;TRUE;18;80;Years;Years;1;;
NCT02149927;ClinicalTrials.gov processed this data on May 29, 2020;2014-04-22;;;2014-05-23;2014-05-23;2014-05-29;Estimate;;;;;;;2014-05-23;2014-05-29;Estimate;June 2013;;2013-06-30;May 2014;2014-05-31;January 2014;Actual;2014-01-31;December 2013;Actual;2013-12-31;;Interventional;;;Neural Mechanisms of Sevoflurane Induced Anesthesia: an EEG fMRI Study in Healthy Volunteers;;Completed;;Early Phase 1;20;Actual;Technische Universität München;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:00:34Z;2020-06-01T12:00:34Z;Munich;3574802;Study Chair;Eberhard F Kochs, MD;Klinikum rechts der Isar, Technische Universität München, Munich, Germany;Sevoflurane;63618251;1;;;2014;2020-05-29;6;FALSE;;FALSE;TRUE;18;35;Years;Years;1;1;
NCT02149238;ClinicalTrials.gov processed this data on May 29, 2020;2014-05-22;;;2014-12-19;2014-05-26;2014-05-29;Estimate;;;;;;;2014-12-19;2014-12-23;Estimate;February 2011;;2011-02-28;December 2014;2014-12-31;December 2014;Actual;2014-12-31;December 2014;Actual;2014-12-31;;Interventional;New Drink;;Interaction of Cocoa Methylxanthines With Cocoa Flavanol Related Vascular Effects;Acute Study to Investigate the Interaction of Cocoa Methylxanthines With Cocoa Flavanol Related Vascular Effects;Completed;;N/A;36;Anticipated;Heinrich-Heine University, Duesseldorf;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:00:41Z;2020-06-01T12:00:41Z;Düsseldorf;;;;;flavanol | methylxanthine | flavanol + methylxanthine;63618301;1;;;2014;2020-05-29;46;FALSE;;FALSE;TRUE;18;60;Years;Years;2;3;
NCT02148835;ClinicalTrials.gov processed this data on May 29, 2020;2014-05-23;;;2017-11-29;2014-05-23;2014-05-28;Estimate;;;;;;;2017-11-29;2018-09-24;Actual;May 2014;;2014-05-31;November 2017;2017-11-30;December 2014;Actual;2014-12-31;December 2014;Actual;2014-12-31;;Interventional;;;Influence of Dietary Omega-3 Fatty Acids in Various triOMEG Sausages on the HS-Omega-3 Index in Healthy Individuals;Influence of Dietary Omega-3 Fatty Acids in Various triOMEG Sausages on the HS-Omega-3 Index in Healthy Individuals;Completed;;N/A;44;Actual;Ludwig-Maximilians - University of Munich;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:00:49Z;2020-06-01T12:00:49Z;Munich;3574898;Principal Investigator;Anton Köhler, MD;Ludwig-Maximilians - University of Munich;Sausage: Triomeg | Sausage: Control;63618331;1;12;0;2014;2020-05-29;7;TRUE;30;FALSE;TRUE;20;60;Years;Years;1;1;
NCT02148770;ClinicalTrials.gov processed this data on May 29, 2020;2014-05-14;;;2016-05-27;2014-05-27;2014-05-28;Estimate;;;;;;;2016-05-27;2016-05-30;Estimate;November 2014;;2014-11-30;June 2015;2015-06-30;May 2017;Anticipated;2017-05-31;May 2017;Anticipated;2017-05-31;;Interventional;;;The Effect of Neurofeedback on Eating Behaviour;Modulating Functional Connectivity Between Eating-related Brain Areas by Neurofeedback;Unknown status;;N/A;50;Anticipated;University Hospital Tuebingen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;Yes;We will share the data inside the EU-consortium;2020-06-01T12:00:49Z;2020-06-01T12:00:49Z;Tübingen;3574905;Principal Investigator;Manfred Hallschmid, PhD;University Tuebingen;Neurofeedback;63618337;1;;;2014;2020-05-29;;FALSE;;FALSE;TRUE;18;65;Years;Years;1;3;
NCT02147223;ClinicalTrials.gov processed this data on May 29, 2020;2014-05-22;;;2015-04-15;2014-05-22;2014-05-26;Estimate;;;;;;;2015-04-15;2015-04-16;Estimate;November 2013;;2013-11-30;April 2015;2015-04-30;November 2014;Actual;2014-11-30;November 2014;Actual;2014-11-30;;Interventional;;;Sex-dependent Effects of Flavanols on Vascular Status;Sex-dependent Effects of Flavanol Metabolism and Absorption on Vascular Status;Completed;;N/A;24;Actual;Heinrich-Heine University, Duesseldorf;;4;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:01:14Z;2020-06-01T12:01:14Z;Düsseldorf;;;;;Flavanol rich intervention | Flavanol free intervention;63618455;1;;;2014;2020-05-29;12;FALSE;;FALSE;TRUE;50;;Years;;1;5;
NCT02144948;ClinicalTrials.gov processed this data on May 29, 2020;2014-05-20;;;2017-02-13;2014-05-20;2014-05-22;Estimate;;;;;;;2017-02-13;2017-02-14;Actual;August 2014;;2014-08-31;August 2015;2015-08-31;January 2016;Actual;2016-01-31;January 2016;Actual;2016-01-31;;Interventional;PUNiDIA;;Investigation of the Effect of E.-Coli-Nissle as Supporting Therapy to Standard Care of Diabetes Mellitus Type II;Pilot Study to Investigate the Effect of E-coli-nissle as Probiotic Adjuvant to Antidiabetic Standard Care in Patients With Diabetes Mellitus Type II;Completed;;Phase 3;10;Actual;GWT-TUD GmbH;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:01:49Z;2020-06-01T12:01:49Z;Dresden;3575230;Principal Investigator;Antje Bergmann, Prof.Dr.med.;Carus Hausarztpraxis on behalf of GWT-TUD GmbH;e.-coli-nissle;63618631;1;;;2014;2020-05-29;17;FALSE;;FALSE;TRUE;45;80;Years;Years;1;4;
NCT02144870;ClinicalTrials.gov processed this data on May 29, 2020;2014-04-14;;;2017-03-14;2014-05-19;2014-05-22;Estimate;;;;;;;2017-03-14;2017-03-16;Actual;November 2013;;2013-11-30;March 2017;2017-03-31;September 2017;Anticipated;2017-09-30;July 2017;Anticipated;2017-07-31;;Interventional;;;Efficacy of Psychotherapy Treatment of Children With Tics;Randomized Control Trial on the Efficacy of Habit Reversal Treatment Programme in Children and Adolescents - a Comparison With Resource Activation Treatment;Unknown status;;N/A;100;Anticipated;University of Cologne;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:01:50Z;2020-06-01T12:01:50Z;Köln;;;;;Habit Reversal Training | Resources activation;63618637;1;;;2014;2020-05-29;;FALSE;;FALSE;TRUE;8;18;Years;Years;2;8;
NCT02143427;ClinicalTrials.gov processed this data on May 29, 2020;2014-05-18;;;2017-03-14;2014-05-20;2014-05-21;Estimate;;;;;;;2017-03-14;2017-03-16;Actual;May 2014;;2014-05-31;February 2017;2017-02-28;September 2017;Anticipated;2017-09-30;July 2017;Anticipated;2017-07-31;;Interventional;;;Treatment of Children With Peer Related Aggressive Behavior (ScouT);Treatment of Children With Peer Related Aggressive Behavior With the Computer Based Treatment Program ScouT - a Randomized Controlled Trial;Unknown status;;N/A;140;Anticipated;University of Cologne;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:02:10Z;2020-06-01T12:02:10Z;Köln;3575353;Principal Investigator;Anja Goertz-Dorten, PhD;Department of Child and Adolescent Psychiatry Univ. Cologne;Social Skills Training | Treatment Program with techniques to activate resources;63618747;1;;;2014;2020-05-29;;FALSE;;FALSE;TRUE;6;12;Years;Years;1;14;
NCT02142231;ClinicalTrials.gov processed this data on May 29, 2020;2014-04-24;;;2015-01-06;2014-05-19;2014-05-20;Estimate;;;;;;;2015-01-06;2015-01-07;Estimate;April 2014;;2014-04-30;January 2015;2015-01-31;June 2014;Actual;2014-06-30;June 2014;Actual;2014-06-30;;Interventional;AcuTA;;AcuTA: Acupuncture in Test Anxiety;Acupuncture Randomized Trial for Preventing Test Anxiety;Completed;;N/A;25;Actual;Goethe University;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:02:26Z;2020-06-01T12:02:26Z;Frankfurt Munich;;;;;Acupuncture | Laser Acupuncture;63618840;1;;;2014;2020-05-29;2;FALSE;;FALSE;TRUE;18;;Years;;1;5;
NCT02140138;ClinicalTrials.gov processed this data on May 29, 2020;2014-04-07;;;2016-06-10;2014-05-15;2014-05-16;Estimate;;;;;;;2016-06-10;2016-06-13;Estimate;June 2014;;2014-06-30;June 2016;2016-06-30;April 2016;Actual;2016-04-30;April 2016;Actual;2016-04-30;;Interventional;;;An Open Label Randomised Trial of RNActive® Cancer Vaccine in High Risk and Intermediate Risk Patients With Prostate Cancer;An Open Label Randomised Phase II Trial of RNActive® Cancer Vaccine (CV9104) in High Risk and Intermediate Risk Patients With Prostate Cancer;Terminated;;Phase 2;35;Actual;CureVac AG;;3;;Recruitment was terminated after enrolment of 35 instead of 36 evaluable patients for~   administrative reasons.;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:02:57Z;2020-06-01T12:02:57Z;Tübingen;3575626;Principal Investigator;Arnulf Stenzl, Prof. Dr. med.;Klinik für Urologie, Universitätsklinikum Tübingen;CV9104 | needle free injection device (Tropis®);63619003;3;;;2014;2020-05-29;22;FALSE;;FALSE;FALSE;18;;Years;;1;4;2
NCT02139098;ClinicalTrials.gov processed this data on May 29, 2020;2014-04-24;;;2018-03-07;2014-05-13;2014-05-15;Estimate;;;;;;;2018-03-07;2018-03-09;Actual;May 2014;;2014-05-31;March 2018;2018-03-31;November 2017;Actual;2017-11-30;November 2017;Actual;2017-11-30;;Interventional;ALPHASOM;;Alternative Dosing Regimens in the Pharmacotherapy of Insomnia;Phase III Study on Alternative Dosing Regimens in the Pharmacotherapy of Mild to Moderate Insomnia;Terminated;;Phase 3;23;Actual;Philipps University Marburg Medical Center;;5;;Recruiting problems because of the time expenditure required for participating and the strict~   criteria of inclusion and exclusion;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:03:11Z;2020-06-01T12:03:11Z;Marburg;3575706;Principal Investigator;Winfried Rief, Prof. Dr.;Clinical Psychology and Psychotherapy, Department of Psychology, Philipps University Marburg;Amitriptyline | Zolpidem | Amitriptyline | Placebo;63619082;1;;;2014;2020-05-29;42;FALSE;;FALSE;TRUE;18;69;Years;Years;4;7;
NCT02138552;ClinicalTrials.gov processed this data on May 29, 2020;2013-11-11;;;2014-05-12;2014-05-12;2014-05-14;Estimate;;;;;;;2014-05-12;2014-05-14;Estimate;October 2013;;2013-10-31;May 2014;2014-05-31;April 2014;Actual;2014-04-30;April 2014;Actual;2014-04-30;;Interventional;OML0113;;Dose Finding Study to Assess Octenidine Mouthwash Concentrations in Comparison to Placebo;Phase II Study to Assess Bacterial Count Reduction of Three Octenidine Mouthwash Concentrations in Comparison to a Placebo in Patients With Mild Gingivitis;Completed;;Phase 2;90;Actual;Schülke & Mayr GmbH;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:03:25Z;2020-06-01T12:03:25Z;Dresden;3575746;Study Director;Katrin Lorenz, Dr.;Poliklinik für Parodontologie Med. Fakultät C. G. Carus der TU Dresden;Octenidine dihydrochloride | Placebo;63619124;2;;;2013;2020-05-29;6;FALSE;;FALSE;FALSE;18;;Years;;1;4;
NCT02137798;ClinicalTrials.gov processed this data on May 29, 2020;2014-05-02;;;2014-10-07;2014-05-13;2014-05-14;Estimate;;;;;;;2014-10-07;2014-10-09;Estimate;March 2014;;2014-03-31;October 2014;2014-10-31;September 2014;Actual;2014-09-30;September 2014;Actual;2014-09-30;;Interventional;AF-FII;;Reduction of Fluoroscopy Exposure During Atrial Fibrillation Ablation;Atrial Fibrillation Ablation Facilitated by Fluoroscopy Image Integrated 3-dimentional Electroanatomical Mapping System;Completed;;N/A;80;Actual;Technische Universität Dresden;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:03:36Z;2020-06-01T12:03:36Z;Dresden;3575805;Principal Investigator;Christopher Piorkowski, M.D.;Department of Electrophysiology, University of Dresden - Heart Center;Radio-frequency catheter ablation;63619182;1;;;2014;2020-05-29;6;FALSE;;FALSE;TRUE;18;75;Years;Years;2;3;
NCT02135926;ClinicalTrials.gov processed this data on May 29, 2020;2014-04-30;;;2018-06-05;2014-05-06;2014-05-12;Estimate;;;;;;;2018-06-05;2018-06-07;Actual;March 2014;;2014-03-31;June 2018;2018-06-30;February 1, 2017;Actual;2017-02-01;February 1, 2017;Actual;2017-02-01;;Interventional;THRILL;;Thrombectomy in Patients Ineligible for iv tPA;Comparison of Thrombectomy and Standard Care for Ischemic Stroke in Patients Ineligibility for Tissue Plasminogen Activator Treatment;Terminated;;N/A;4;Actual;University Hospital Heidelberg;;2;;Results from other RCT made randomization unethical.;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:04:03Z;2020-06-01T12:04:03Z;Heidelberg;3575964;Principal Investigator;Martin Bendszus, MD;University Hospital Heidelberg;Thrombectomy | Best medical care;63619321;19;;;2014;2020-05-29;34;FALSE;;FALSE;FALSE;18;80;Years;Years;1;4;1
NCT02134769;ClinicalTrials.gov processed this data on May 29, 2020;2014-04-09;;;2016-11-11;2014-05-07;2014-05-09;Estimate;;;;;;;2016-11-11;2016-11-15;Estimate;August 2014;;2014-08-31;July 2015;2015-07-31;December 2015;Actual;2015-12-31;November 2015;Actual;2015-11-30;;Interventional;Bionect;;Influence of Bionecteurs on Catheter-associated Infection;Incidence of Catheter-related Bloodstream Infections Using Bionecteur Device;Completed;;N/A;221;Actual;University Hospital Tuebingen;;2;;;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T12:04:29Z;2020-06-01T12:04:29Z;Tübingen;3576057;Principal Investigator;Helene A Haeberle, MD;University Hospital Tuebingen, Germany;Bionecteur;63619408;1;;;2014;2020-05-29;15;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT02134470;ClinicalTrials.gov processed this data on May 29, 2020;2014-05-06;;;2015-04-28;2014-05-08;2014-05-09;Estimate;;;;;;;2015-04-28;2015-04-29;Estimate;April 2014;;2014-04-30;April 2015;2015-04-30;December 2015;Anticipated;2015-12-31;December 2015;Anticipated;2015-12-31;;Interventional;;;Diagnostic Relevance of Salivary Testosterone Concentrations in Doping Control.;Diagnostic Relevance of Salivary Testosterone Concentrations After Exogene Low-dose Hormone Application as a Screening Method for in Doping Control.;Unknown status;;N/A;12;Anticipated;Paracelsus Medical University;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:04:31Z;2020-06-01T12:04:31Z;Dresden Munich;3576081;Principal Investigator;Hande Hofmann, Dr.;Technische Universität München, GER;Testosterone supplementation;63619431;1;;;2014;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;2;1
NCT02134457;ClinicalTrials.gov processed this data on May 29, 2020;2014-04-26;;;2017-03-08;2014-05-06;2014-05-09;Estimate;;;;;;;2017-03-08;2017-03-09;Actual;August 2014;;2014-08-31;March 2017;2017-03-31;January 2017;Actual;2017-01-31;January 2017;Actual;2017-01-31;;Interventional;CARE-ROP;;Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity;Multicenter Randomized Double Masked Parallel Design Exploratory Study to Assess Safety and Efficacy of Two Different Doses of Intravitreal Anti-VEGF Treatment With Ranibizumab (0.12 mg vs. 0.20 mg) in Infants With Retinopathy of Prematurity (ROP);Completed;;Phase 2;19;Actual;University Hospital Freiburg;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:04:31Z;2020-06-01T12:04:31Z;Freiburg;3576083;Principal Investigator;Andreas Stahl, MD;University Eye Hospital Freiburg, Germany;ranibizumab;63619432;9;;;2014;2020-05-29;29;FALSE;;FALSE;FALSE;;;;;1;8;6
NCT02130128;ClinicalTrials.gov processed this data on May 29, 2020;2014-04-28;;;2015-06-03;2014-05-02;2014-05-05;Estimate;;;;;;;2015-06-03;2015-06-08;Estimate;April 2014;;2014-04-30;June 2015;2015-06-30;December 2014;Actual;2014-12-31;December 2014;Actual;2014-12-31;;Interventional;;;Continuing Evaluation of the LungPoint ATV System;Continuing Evaluation of the LungPoint ATV System;Terminated;;N/A;6;Actual;Broncus Medical Inc;;1;;Sufficient clinical evidence was gathered;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:05:40Z;2020-06-01T12:05:40Z;Heidelberg;3576439;Principal Investigator;Felix Herth, MD;Heidelberg University;LungPoint ATV System;63619762;1;;;2014;2020-05-29;8;FALSE;;FALSE;TRUE;21;75;Years;Years;1;1;
NCT02129439;ClinicalTrials.gov processed this data on May 29, 2020;2014-04-30;;;2018-03-08;2014-05-01;2014-05-02;Estimate;;;;;;;2018-03-08;2018-03-09;Actual;April 2014;;2014-04-30;July 2017;2017-07-31;June 22, 2017;Actual;2017-06-22;June 22, 2017;Actual;2017-06-22;;Interventional;SECURE;;Efficacy, Pharmacokinetics, Tolerability, Safety of SB012 Intrarectally Applied in Active Ulcerative Colitis Patients;SB012 for Treatment of Active Ulcerative Colitis: Prospective Multi-centre Randomised Double-blind Placebo-controlled Phase IIa Clinical Trial to Evaluate Efficacy, Pharmacokinetics, Tolerability and Safety of SB012 Enema Administered OD;Completed;;Phase 1/Phase 2;20;Actual;Sterna Biologicals GmbH & Co. KG;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:05:53Z;2020-06-01T12:05:53Z;Erlangen;3576492;Principal Investigator;Markus F. Neurath, Prof. Dr.;Department of Medicine 1 - Gastroenterology, Pneumology and Endocrinology, University Clinic Erlangen, Germany;SB012 | Placebo;63619814;3;;;2014;2020-05-29;38;FALSE;;FALSE;FALSE;18;75;Years;Years;1;4;4
NCT02129400;ClinicalTrials.gov processed this data on May 29, 2020;2014-04-15;;;2015-03-30;2014-04-30;2014-05-02;Estimate;;;;;;;2015-03-30;2015-03-31;Estimate;May 2014;;2014-05-31;March 2015;2015-03-31;January 2015;Actual;2015-01-31;January 2015;Actual;2015-01-31;;Interventional;XEPO;;Influence on Erythropoetin-level by Xenon;Xenon-inhalation: Elimination of Xenon and Its Effect on Erythropoetin Levels in Blood of Healthy Volunteers;Terminated;;Phase 3;36;Actual;RWTH Aachen University;;16;;The analysis of the blood samples was much expensive than calculated. The recruitment had to be~   stopped after 36 study participants.;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:05:53Z;2020-06-01T12:05:53Z;Aachen;3576495;Principal Investigator;Rolf Rossaint, Prof. M.D.;University Hospital RWTH Aachen, Department for Anesthesia;Xenon pro Anaesthesia 100 % (V/V) | Aer medicinalis Linde 100%;63619817;1;;;2014;2020-05-29;8;FALSE;;FALSE;TRUE;18;65;Years;Years;1;1;3
NCT02128698;ClinicalTrials.gov processed this data on May 29, 2020;2014-04-29;;;2016-10-25;2014-04-29;2014-05-01;Estimate;;;;;;;2016-10-25;2016-10-26;Estimate;March 2014;;2014-03-31;October 2016;2016-10-31;November 2015;Actual;2015-11-30;November 2015;Actual;2015-11-30;;Interventional;PAPAB;;Physical Activity and Protein Supplementation After Bariatric Surgery (PAPAB);Physical Activity and Protein Supplementation After Bariatric Surgery;Completed;;N/A;50;Actual;University of Hohenheim;;4;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:06:09Z;2020-06-01T12:06:09Z;Tübingen;3576562;Study Director;Alfred Königsrainer, Professor;Department of General, Visceral, and Transplant Surgery, University Hospital of Tübingen, Tübingen, Germany;Protein | Placebo | Computer-assisted exercise | Usual exercise;63619871;1;;;2014;2020-05-29;20;FALSE;;FALSE;TRUE;18;65;Years;Years;1;4;8
NCT02127736;ClinicalTrials.gov processed this data on May 29, 2020;2014-04-29;;;2014-09-01;2014-04-29;2014-05-01;Estimate;;;;;;;2014-09-01;2014-09-03;Estimate;;;;September 2014;2014-09-30;September 2014;Actual;2014-09-30;September 2014;Actual;2014-09-30;;Interventional;;;Pharmacological Conditioning of Sleep Patterns in Healthy Participants Using Amitriptylin;Pharmacological Conditioning of Sleep Patterns in Healthy Participants Using Amitriptylin;Completed;;N/A;;;Philipps University Marburg Medical Center;;2;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T12:06:26Z;2020-06-01T12:06:26Z;Marburg;;;;;Amitriptyline | Placebo;63619947;1;;;2014;2020-05-29;;FALSE;;FALSE;TRUE;18;69;Years;Years;2;;
NCT02126852;ClinicalTrials.gov processed this data on May 29, 2020;2014-04-28;;;2016-04-27;2014-04-28;2014-04-30;Estimate;;;;;;;2016-04-27;2016-04-28;Estimate;April 2014;;2014-04-30;April 2016;2016-04-30;April 2016;Actual;2016-04-30;April 2016;Actual;2016-04-30;;Interventional;CAMEM;;Comparison of AMG and EMG to Avoid Residual Paralysis After General Anesthesia;Comparison of AMG (Acceleromyography) and EMG (Electromyography) to Avoid Postoperative Residual Paralysis After General Anesthesia;Completed;;N/A;214;Actual;Technische Universität München;;2;;;FALSE;;;;FALSE;;;;;;;;;;;Undecided;;2020-06-01T12:06:41Z;2020-06-01T12:06:41Z;Munich;3576706;Principal Investigator;Manfred Blobner, M.D.;Klinik für Anaesthesiologie, Klinikum rechts der Isar der Technischen Universität München, Ismaninger Str. 22, 81675 München, Germany;Acceleromyography (AMG, one-dimensionally) | Acceleromyography (AMG, three-dimensionally) | Electromyography (EMG);63620013;2;;;2014;2020-05-29;24;FALSE;;FALSE;FALSE;18;;Years;;1;1;
NCT02126085;ClinicalTrials.gov processed this data on May 29, 2020;2014-04-23;;;2016-05-22;2014-04-28;2014-04-29;Estimate;;;;;;;2016-05-22;2016-05-24;Estimate;April 2014;;2014-04-30;May 2016;2016-05-31;May 2016;Actual;2016-05-31;February 2016;Actual;2016-02-29;;Interventional;SIESTA;;Sedation vs. Intubation for Endovascular Stroke TreAtment;Sedation vs. Intubation for Endovascular Stroke TreAtment;Completed;;N/A;150;Actual;University Hospital Heidelberg;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:06:49Z;2020-06-01T12:06:49Z;Heidelberg;3576773;Principal Investigator;Julian Bösel, PD;Department of Neurology, University Hospital Heidelberg;Endovascular recanalisation;63620075;1;;;2014;2020-05-29;22;FALSE;;FALSE;TRUE;18;;Years;;1;3;3
NCT02125903;ClinicalTrials.gov processed this data on May 29, 2020;2014-02-05;;;2015-01-23;2014-04-28;2014-04-29;Estimate;;;;;;;2015-01-23;2015-01-26;Estimate;May 2013;;2013-05-31;January 2015;2015-01-31;November 2014;Actual;2014-11-30;May 2014;Actual;2014-05-31;;Interventional;;;Comparison of Continuous Femoral Nerve Block and Adductor Canal Block After Total Knee Replacement Therapy;Randomized Controlled Study: Comparison of Continuous Femoral Nerve Block and Adductor Canal Block After Total Knee Replacement Therapy Relating to Early Mobilization and Analgesia;Completed;;N/A;44;Actual;Philipps University Marburg Medical Center;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:06:50Z;2020-06-01T12:06:50Z;Marburg;3576793;Study Director;Karolin Piechowiak, Dr;Dept. of Anesthesia And Intensiv Care Medicine University of Marburg;Ropivacaine;63620088;1;;;2014;2020-05-29;12;FALSE;;FALSE;TRUE;50;80;Years;Years;1;6;
NCT02125344;ClinicalTrials.gov processed this data on May 29, 2020;2014-04-22;;;2017-07-10;2014-04-25;2014-04-29;Estimate;;;;;;;2017-07-10;2017-07-13;Actual;December 2014;Actual;2014-12-31;July 2017;2017-07-31;January 30, 2017;Actual;2017-01-30;November 2016;Actual;2016-11-30;;Interventional;;;A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto);A Randomized Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto);Completed;;Phase 3;961;Actual;German Breast Group;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:06:58Z;2020-06-01T12:06:58Z;Heidelberg;3576845;Principal Investigator;Andreas Schneeweiss, MD, Prof.;NTC Heidelberg;non-pegylated liposomal doxorubicin | Carboplatin | Paclitaxel | Epirubicin | Cyclophosphamide | Pertuzumab | Trastuzumab | Ferric carboxymaltose;63620132;1;;;2014;2020-05-29;23;FALSE;;FALSE;TRUE;18;;Years;;2;20;
NCT02121704;ClinicalTrials.gov processed this data on May 29, 2020;2014-04-15;;;2015-11-05;2014-04-22;2014-04-23;Estimate;;;;;;;2015-11-05;2015-11-06;Estimate;May 2014;;2014-05-31;November 2015;2015-11-30;November 2015;Actual;2015-11-30;August 2015;Actual;2015-08-31;;Interventional;MEXICO;;Magnetic Endoscope Imaging in Colonoscopy: Influence on Propofol Dosage;;Completed;;N/A;334;Actual;Technische Universität München;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:07:53Z;2020-06-01T12:07:53Z;Munich;3577148;Principal Investigator;Peter Klare, MD;II. Medizinische Klinik, Klinikum rechts der Isar der Technischen Universität München, Germany;Magnetic Endoscope Imaging (Scope Guide);63620403;1;;;2014;2020-05-29;15;FALSE;;FALSE;TRUE;18;90;Years;Years;1;2;
NCT02120859;ClinicalTrials.gov processed this data on May 29, 2020;2014-04-19;;;2014-04-20;2014-04-20;2014-04-23;Estimate;;;;;;;2014-04-20;2014-04-23;Estimate;October 2012;;2012-10-31;April 2014;2014-04-30;April 2014;Actual;2014-04-30;December 2013;Actual;2013-12-31;;Interventional;OCTOPUS-2;;Optical Coherence Tomography to Investigate FFR-Guided DEB-only Elective Coronary Angioplasty;Fractional Flow Reserve - Guided Elective Coronary Angioplasty Using Paclitaxel - Eluting Balloons With Provisional Stent Implantation: A Phase 4 Feasibility Study With 6-Month Follow-up by Optical Coherence Tomography;Completed;;Phase 4;50;Actual;University of Jena;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:08:06Z;2020-06-01T12:08:06Z;Jena;3577218;Study Director;Tudor C Poerner, MD;University Hospital of Jena, Heart Center, Cardiology Division;Provisional bare metal stenting | FFR - guided DEB angioplasty;63620466;1;;;2014;2020-05-29;14;FALSE;;FALSE;TRUE;18;;Years;;1;3;1
NCT02120313;ClinicalTrials.gov processed this data on May 29, 2020;2014-04-17;;;2017-05-19;2014-04-17;2014-04-22;Estimate;;;;;;;2017-05-19;2017-05-23;Actual;April 2014;;2014-04-30;May 2017;2017-05-31;June 2016;Actual;2016-06-30;March 2016;Actual;2016-03-31;;Interventional;;;Inpatient Versus Outpatient Rehabilitation After TKA;Inpatient Versus Outpatient Rehabilitation Following Total Knee Arthroplasty;Completed;;N/A;42;Actual;University of Rostock;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:08:17Z;2020-06-01T12:08:17Z;Rostock;3577267;Study Chair;Philipp Bergschmidt, MD;Department of Orthopedics, University Medicine Rostock;inpatient rehabilitation | outpatient rehabilitation;63620508;1;;;2014;2020-05-29;23;FALSE;;FALSE;TRUE;50;80;Years;Years;1;8;
NCT02118779;ClinicalTrials.gov processed this data on May 29, 2020;2014-04-11;;;2017-07-13;2014-04-18;2014-04-21;Estimate;;;;;;;2017-07-13;2017-07-18;Actual;April 2, 2014;Actual;2014-04-02;July 2017;2017-07-31;October 17, 2016;Actual;2016-10-17;March 29, 2016;Actual;2016-03-29;;Interventional;OPTIMISTIC;;Observational Prolonged Trial in Myotonic Dystrophy Type 1;Observational Prolonged Trial in Myotonic Dystrophy Type 1 to Improve Quality of Life Standards, a Target Identification Collaboration;Completed;;N/A;255;Actual;Radboud University;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:08:52Z;2020-06-01T12:08:52Z;Munich;3577428;Principal Investigator;Benedikt Schoser, Prof;Munich University, Germany;Behavioural change intervention;63620626;4;;;2014;2020-05-29;24;FALSE;;FALSE;FALSE;18;;Years;;1;9;1
NCT02116088;ClinicalTrials.gov processed this data on May 29, 2020;2014-04-14;;;2017-03-14;2014-04-14;2014-04-16;Estimate;;;;;;;2017-03-14;2017-03-15;Actual;October 2012;;2012-10-31;March 2017;2017-03-31;April 2017;Anticipated;2017-04-30;March 2017;Anticipated;2017-03-31;;Interventional;;;Prevention and Intervention of Externalizing Problem Behavior in School: Development and Evaluation of a Teacher Coaching.;Prevention and Intervention of Externalizing Problem Behavior in School: Development and Evaluation of a Teacher Coaching.;Unknown status;;N/A;53;Anticipated;University of Cologne;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:09:33Z;2020-06-01T12:09:33Z;Köln;3577677;Study Director;Manfred Döpfner, Univ. Prof. Dr.;University Clinic of Cologne;Teacher Coaching;63620832;1;;;2014;2020-05-29;;FALSE;;FALSE;TRUE;6;11;Years;Years;1;9;
NCT02115880;ClinicalTrials.gov processed this data on May 29, 2020;2014-04-07;;;2014-05-27;2014-04-14;2014-04-16;Estimate;;;;;;;2014-05-27;2014-05-28;Estimate;May 2014;;2014-05-31;May 2014;2014-05-31;October 2016;Anticipated;2016-10-31;August 2016;Anticipated;2016-08-31;;Interventional;PRODO;;PRimary Prevention Of Depression in Offspring of Depressed Parents;PRimary Prevention Of Depression in Offspring of Depressed Parents;Unknown status;;N/A;100;Anticipated;Ludwig-Maximilians - University of Munich;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:09:35Z;2020-06-01T12:09:35Z;Munich;3577695;Principal Investigator;Gerd Schulte-Körne, MD;Ludwig-Maximilians - University of Munich;Prevention programme;63620848;1;;;2014;2020-05-29;;FALSE;;FALSE;TRUE;8;17;Years;Years;1;2;
NCT02115516;ClinicalTrials.gov processed this data on May 29, 2020;2014-04-11;;;2017-05-12;2014-04-14;2014-04-16;Estimate;;;;;;;2017-05-12;2017-05-15;Actual;April 2014;;2014-04-30;February 2016;2016-02-29;April 2016;Actual;2016-04-30;December 2015;Actual;2015-12-31;;Interventional;;;Safety and Protective Efficacy of Intravenous Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chemoprophylaxis;Safety and Protective Efficacy of Intravenous Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chemoprophylaxis;Completed;;Phase 1;67;Actual;Sanaria Inc.;;12;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:09:42Z;2020-06-01T12:09:42Z;Tübingen;3577740;Principal Investigator;Benjamin Mordmüller, MD;Institute of Tropical Medicine, University of Tuebingen;PfSPZ Challenge | 0.9% Sodium Chloride (Placebo);63620876;1;;;2014;2020-05-29;20;FALSE;;FALSE;TRUE;18;45;Years;Years;2;2;2
NCT02110524;ClinicalTrials.gov processed this data on May 29, 2020;2014-04-04;;;2015-02-25;2014-04-08;2014-04-10;Estimate;;;;;;;2015-02-25;2015-02-26;Estimate;December 2011;;2011-12-31;February 2015;2015-02-28;December 2014;Actual;2014-12-31;September 2012;Actual;2012-09-30;;Interventional;;;CVI Drug Coated Balloon First In Human Trial;Prospective, Controlled, Multi-Center, Open, Single Arm Study for the Treatment of Subjects Presenting De Novo Occluded/Stenotic or Re-occluded/Restenotic Lesions of the Superficial Femoral or Popliteal Arteries Using a Paclitaxel-Coated Percutaneous Angioplasty Catheter;Completed;;N/A;80;Actual;Spectranetics Corporation;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:10:53Z;2020-06-01T12:10:53Z;Berlin;3578199;Principal Investigator;Henrik Schröder, MD;Jewish Hospital Berlin;Percutaneous Transluminal Angioplasty;63621255;1;;;2014;2020-05-29;9;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT02110459;ClinicalTrials.gov processed this data on May 29, 2020;2014-04-08;;;2016-06-16;2014-04-08;2014-04-10;Estimate;;;;;;;2016-06-16;2016-06-17;Estimate;April 2013;;2013-04-30;June 2016;2016-06-30;July 2015;Actual;2015-07-31;July 2015;Actual;2015-07-31;;Interventional;;;Pharmacokinetics and Safety of POL7080 in Patients With Renal Impairment;An Open-label, Non-randomized, Monocenter, Single-dose, Phase I Study to Evaluate Pharmacokinetics and Safety of POL7080 Administered as Single Intravenous Infusion to Subjects With Renal Impairment;Completed;;Phase 1;48;Actual;Polyphor Ltd.;;6;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:10:54Z;2020-06-01T12:10:54Z;Kiel;3578204;Principal Investigator;Atef Halabi, MD;CRS Clinical Research Services Kiel GmbH;POL7080;63621260;1;;;2014;2020-05-29;27;FALSE;;FALSE;TRUE;18;79;Years;Years;1;2;
NCT02110407;ClinicalTrials.gov processed this data on May 29, 2020;2014-02-13;;;2017-07-26;2014-04-08;2014-04-10;Estimate;;;;;;;2017-07-26;2017-07-27;Actual;March 2014;Actual;2014-03-31;July 2017;2017-07-31;May 2017;Actual;2017-05-31;January 2017;Actual;2017-01-31;;Interventional;;;Modulation of Visual-Spatial Learning in Healthy Young Adults by tDCS;Modulation of Visual-Spatial Learning in Healthy Young Adults by Transcranial Direct Current Stimulation - Proof of Principle and Mechanisms;Completed;;N/A;24;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:10:55Z;2020-06-01T12:10:55Z;Berlin;3578208;Principal Investigator;Agnes Flöel, Prof. Dr.;Charite University, Berlin, Germany;tDCS | training;63621264;1;;;2014;2020-05-29;34;FALSE;;FALSE;TRUE;18;35;Years;Years;1;6;
NCT02110056;ClinicalTrials.gov processed this data on May 29, 2020;2014-02-13;;;2018-01-29;2014-04-08;2014-04-10;Estimate;;;;;;;2018-01-29;2018-01-30;Actual;March 2014;;2014-03-31;January 2018;2018-01-31;November 2015;Actual;2015-11-30;November 2015;Actual;2015-11-30;;Interventional;;;Modulation of Visual-Spatial Learning in Healthy Older Adults by tDCS;Modulation of Visual-Spatial Learning in Healthy Older Adults by Transcranial Direct Current Stimulation - Proof of Principle and Mechanisms;Completed;;N/A;32;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:11:00Z;2020-06-01T12:11:00Z;Berlin;3578232;Principal Investigator;Agnes Flöel, Prof. Dr.;Charite University, Berlin, Germany;tDCS | training;63621288;1;;;2014;2020-05-29;20;FALSE;;FALSE;TRUE;50;90;Years;Years;1;7;
NCT02110043;ClinicalTrials.gov processed this data on May 29, 2020;2014-02-13;;;2017-07-26;2014-04-08;2014-04-10;Estimate;;;;;;;2017-07-26;2017-07-27;Actual;March 2014;;2014-03-31;July 2017;2017-07-31;October 2017;Anticipated;2017-10-31;August 2017;Anticipated;2017-08-31;;Interventional;;;Modulation of Visual-Spatial Learning in Patients With Mild Cognitive Impairment (MCI) by tDCS;Modulation of Visual-Spatial Learning in Patients With Mild Cognitive Impairment (MCI) by Transcranial Direct Current Stimulation - Proof of Principle and Mechanisms;Unknown status;;N/A;21;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:11:00Z;2020-06-01T12:11:00Z;Berlin;3578233;Principal Investigator;Agnes Flöel, Prof. Dr.;Charite University, Berlin, Germany;tDCS | training;63621289;1;;;2014;2020-05-29;;FALSE;;FALSE;TRUE;50;90;Years;Years;1;7;
NCT02108353;ClinicalTrials.gov processed this data on May 29, 2020;2013-11-04;;;2017-05-24;2014-04-05;2014-04-09;Estimate;;;;;;;2017-05-24;2017-05-25;Actual;January 2015;;2015-01-31;May 2017;2017-05-31;March 29, 2017;Actual;2017-03-29;March 29, 2017;Actual;2017-03-29;;Interventional;;;Circadian Phase Adjustment and Improvement of Metabolic Control in Night Shift Workers;Multicenter, Randomized, Double-blind, Placebo Controlled Trial of 2 mg Melatonin for Circadian Phase Adjustment and Improvement of Metabolic Control in Night Shift Workers;Completed;;Phase 3;46;Actual;Universitätsklinikum Hamburg-Eppendorf;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:11:20Z;2020-06-01T12:11:20Z;Hamburg;3578376;Study Chair;Rainer H Boeger, MD;Universitätsklinikum Hamburg-Eppendorf;Melatonin 2mg | Placebo;63621421;3;;;2013;2020-05-29;26;FALSE;;FALSE;FALSE;18;;Years;;1;11;
NCT02107534;ClinicalTrials.gov processed this data on May 29, 2020;2014-04-03;;;2014-04-03;2014-04-03;2014-04-08;Estimate;;;;;;;2014-04-03;2014-04-08;Estimate;January 2012;;2012-01-31;April 2014;2014-04-30;October 2014;Anticipated;2014-10-31;September 2014;Anticipated;2014-09-30;;Interventional;;;Group-based Training for Parents of Children With Dyslexia;Evaluation of a Group-based Training for Parents of Children With Dyslexia;Unknown status;;N/A;42;Anticipated;University of Heidelberg Medical Center;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:11:36Z;2020-06-01T12:11:36Z;Heidelberg;3578436;Principal Investigator;Joachim Pietz, Prof. Dr.;University Heidelberg Medical Centre;parent training (dyslexia);63621480;1;;;2014;2020-05-29;;FALSE;;FALSE;TRUE;;;;;1;1;
NCT02104882;ClinicalTrials.gov processed this data on May 29, 2020;2014-03-26;;;2016-10-14;2014-03-31;2014-04-07;Estimate;;;;;;;2016-10-14;2016-10-17;Estimate;March 2014;;2014-03-31;October 2016;2016-10-31;September 2016;Actual;2016-09-30;September 2016;Actual;2016-09-30;;Interventional;;;INTRAGO-Intraoperative Radiotherapy for Glioblastoma - a Phase I/II Study;INTRAGO-Intraoperative Radiotherapy for Glioblastoma - a Phase I/II Study;Completed;;Phase 1/Phase 2;12;Actual;Universitätsmedizin Mannheim;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:12:23Z;2020-06-01T12:12:23Z;Heidelberg Mannheim;3578652;Study Chair;Frederik Wenz, MD;Department of Radiation Oncology, Universitätsmedizin Mannheim, University of Heidelberg;Intraoperative Radiotherapy (Applicator Surface Dose: 20-40 Gy);63621679;1;;;2014;2020-05-29;30;FALSE;;FALSE;TRUE;50;;Years;;1;2;
NCT02102919;ClinicalTrials.gov processed this data on May 29, 2020;2014-03-31;;;2016-07-14;2014-03-31;2014-04-03;Estimate;;;;;;;2016-07-14;2016-07-15;Estimate;January 2013;;2013-01-31;July 2016;2016-07-31;February 2015;Actual;2015-02-28;January 2015;Actual;2015-01-31;;Interventional;;;Innovative Training Program for Elderly in Need of Care Individuals;Skilling-up Exercise for Elderly in Need of Care;Completed;;Phase 4;30;Actual;Bern University of Applied Sciences;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:12:48Z;2020-06-01T12:12:48Z;Frankfurt;3578875;Study Director;Dietmar Schmidtbleicher, Prof;Goethe University;SR-WBV | Virtual Games (VG) | SR-WBV | Aktiv Tramp (Swiss Frei AG, Switzerland);63621829;1;;;2014;2020-05-29;24;FALSE;;FALSE;TRUE;65;;Years;;1;3;
NCT02099968;ClinicalTrials.gov processed this data on May 29, 2020;2014-03-26;;;2019-07-08;2014-03-26;2014-03-31;Estimate;;;;;;;2019-07-08;2019-07-10;Actual;April 2014;;2014-04-30;July 2019;2019-07-31;December 2015;Actual;2015-12-31;March 2015;Actual;2015-03-31;;Interventional;;;Comprehensive Lifestyle Modification for Patients With Hypertension and Metabolic Syndrome: a Multicenter Randomized Controlled Trial;Intensivierte Ernährungs- Und Lebensstilmodifikation Bei Patienten Mit Bluthochdruck Und Kardiometabolischer Risikokonstellation. Eine Zweizentrische Randomisiert-kontrollierte Interventionsstudie über 6 Monate;Completed;;N/A;145;Actual;Universität Duisburg-Essen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:13:33Z;2020-06-01T12:13:33Z;Duisburg;;;;;Comprehensive Lifestyle Modification | Standard Lifestyle Modification / modified DASH;63622055;2;;;2014;2020-05-29;11;FALSE;;FALSE;FALSE;25;75;Years;Years;2;37;
NCT02099292;ClinicalTrials.gov processed this data on May 29, 2020;2014-03-21;;;2014-03-25;2014-03-25;2014-03-28;Estimate;;;;;;;2014-03-25;2014-03-28;Estimate;May 2001;;2001-05-31;March 2014;2014-03-31;March 2014;Actual;2014-03-31;May 2005;Actual;2005-05-31;;Interventional;Mz-135;;Rituximab and DexaBEAM as Salvage Therapy for Relapsed Lymphoma;Eine Phase II Studie Zur Beurteilung Der Wirksamkeit Von Rituximab in Der Salvage- Und Hochdosistherapie Mit Autologer Stammzelltransplantation Bei Patienten Mit B-Zell-Non-Hodgkin-Lymphom;Completed;;Phase 2;103;Actual;Johannes Gutenberg University Mainz;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:13:41Z;2020-06-01T12:13:41Z;Mainz;3579194;Principal Investigator;Georg Hess, MD;Johannes Gutenberg University Mainz;Rituximab and DexaBEAM;63622105;;;;2014;2020-05-29;48;FALSE;;;FALSE;18;65;Years;Years;1;1;1
NCT02096913;ClinicalTrials.gov processed this data on May 29, 2020;2014-03-24;;;2017-10-26;2014-03-24;2014-03-26;Estimate;;;;;;;2017-10-26;2017-10-30;Actual;June 2013;Actual;2013-06-30;October 2017;2017-10-31;September 2017;Actual;2017-09-30;September 2017;Actual;2017-09-30;;Interventional;;;Safety Study of Ibuprofen to Treat Acute Traumatic Spinal Cord Injury;The Rho-Inhibitor Ibuprofen for the Treatment of Acute Spinal Cord Injury: Investigation of Safety, Feasibility and Pharmacokinetics;Completed;;Phase 1;12;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:14:17Z;2020-06-01T12:14:17Z;Berlin;3579401;Principal Investigator;Andreas Niedeggen, MD;Unfallkrankenhaus Berlin, Treatment Centre for Spinal Cord Injuries, Germany;Dolormin® extra (Ibuprofen) | Dolormin® extra (Ibuprofen);63622288;1;;;2014;2020-05-29;51;FALSE;;FALSE;TRUE;18;65;Years;Years;1;8;1
NCT02096562;ClinicalTrials.gov processed this data on May 29, 2020;2013-11-11;;;2016-05-23;2014-03-23;2014-03-26;Estimate;;;;;;;2016-05-23;2016-05-24;Estimate;July 2013;;2013-07-31;May 2016;2016-05-31;March 2015;Actual;2015-03-31;March 2015;Actual;2015-03-31;;Interventional;;;Knee Swelling Under Use of Compression Stockings After Outpatient Surgery;Prospective Randomized Assessment of Postsurgical Swelling Applying Compression Stockings vs. Conventional Wrapping After Outpatient Surgery;Completed;;N/A;27;Actual;University of Rostock;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:14:23Z;2020-06-01T12:14:23Z;Rostock;3579424;Study Director;Thomas Tischer, Prof. Dr.;OUK Rostock;Patients use compression stockings for 10 days after surgery | normal therapy - no compression stockings;63622314;1;;;2013;2020-05-29;20;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT02095392;ClinicalTrials.gov processed this data on May 29, 2020;2014-03-17;;;2015-11-30;2014-03-20;2014-03-24;Estimate;;;;;;;2015-11-30;2015-12-02;Estimate;April 2014;;2014-04-30;November 2015;2015-11-30;July 2014;Actual;2014-07-31;July 2014;Actual;2014-07-31;;Interventional;;;Effects of Soluble Phosphate in Humans;The Effect of Soluble Phosphate in Combination With Different Calcium Doses on Calcium and Phosphorus Metabolism in Healthy Adults;Completed;;N/A;62;Actual;University of Jena;;4;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:14:37Z;2020-06-01T12:14:37Z;Jena;3579521;Principal Investigator;Michael Glei, Prof. Dr.;Friedrich-Schiller-University Jena, Institute of Nutrition, Department of Nutritional Toxicology;P1000/Ca0 | P1000/Ca500 | P1000/Ca1000 | Placebo;63622403;1;;;2014;2020-05-29;3;FALSE;;FALSE;TRUE;18;60;Years;Years;1;1;
NCT02094287;ClinicalTrials.gov processed this data on May 29, 2020;2014-03-17;;;2015-09-17;2014-03-20;2014-03-21;Estimate;;;;;;;2015-09-17;2015-09-18;Estimate;September 2010;;2010-09-30;September 2015;2015-09-30;February 2015;Actual;2015-02-28;November 2013;Actual;2013-11-30;;Interventional;;;Placebo Effect in the Treatment of Atopic Dermatitis;Placebo Effect in Atopic Dermatitis - Increase the Pharmacological Effect of Itching Caused by Classical Conditioning and Expectancy Processes: A Randomized Controlled Trial;Completed;;N/A;166;Actual;Charite University, Berlin, Germany;;4;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:14:54Z;2020-06-01T12:14:54Z;Berlin;3579602;Principal Investigator;Margitta Worm, Prof. Dr.;Charite University, Berlin, Germany;dimetindene | instruction | conditioning;63622490;2;;;2014;2020-05-29;38;FALSE;;FALSE;FALSE;18;65;Years;Years;1;3;
NCT02092974;ClinicalTrials.gov processed this data on May 29, 2020;2014-03-19;;;2017-07-04;2014-03-19;2014-03-20;Estimate;;;;;;;2017-07-04;2017-07-06;Actual;April 2014;;2014-04-30;July 2017;2017-07-31;December 2014;Actual;2014-12-31;December 2014;Actual;2014-12-31;;Interventional;LESO;;Mechanism of tDCS-induced Learning Enhancement - the Role of Serotonin;Mechanism of tDCS-induced Learning Enhancement - the Role of Serotonin;Completed;;Phase 1;40;Actual;Charite University, Berlin, Germany;;4;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:15:12Z;2020-06-01T12:15:12Z;Berlin;3579705;Principal Investigator;Agnes Flöel, Prof. Dr.;Charite University, Berlin, Germany;tDCS | Citalopram | sham-tDCS + placebo;63622591;1;;;2014;2020-05-29;8;FALSE;;FALSE;TRUE;18;80;Years;Years;1;4;
NCT02092753;ClinicalTrials.gov processed this data on May 29, 2020;2014-02-26;;;2016-02-25;2014-03-18;2014-03-20;Estimate;;;;;;;2016-02-25;2016-02-26;Estimate;March 2014;;2014-03-31;February 2016;2016-02-29;January 2016;Actual;2016-01-31;January 2016;Actual;2016-01-31;;Interventional;KOLIBRI;;Ketogenic Or LOGI Diet In a Breast Cancer Rehabilitation Intervention (KOLIBRI);Ketogenic Or LOGI Diet In a Breast Cancer Rehabilitation Intervention (KOLIBRI);Completed;;N/A;150;Actual;Universitätsmedizin Mannheim;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:15:16Z;2020-06-01T12:15:16Z;Heidelberg Mannheim;3579718;Study Chair;Marc Sütterlin, MD, Prof.;Department of Obstetrics and Gynecology, University Hospital Mannheim, University of Heidelberg, Mannheim, Germany;Standard diet (SD) | Experimental 1: Ketogenic diet (KD). | Experimental 2: Low glycämic and insulinemic diet (LOGI);63622607;1;;;2014;2020-05-29;22;FALSE;;FALSE;TRUE;18;70;Years;Years;1;2;
NCT02090686;ClinicalTrials.gov processed this data on May 29, 2020;2014-03-17;;;2018-02-19;2014-03-17;2014-03-18;Estimate;;;;;;;2018-02-19;2018-02-20;Actual;March 2014;;2014-03-31;February 2018;2018-02-28;February 28, 2015;Actual;2015-02-28;October 2014;Actual;2014-10-31;;Interventional;Cupping-LBP;;Pulsatile Cupping in Low Back Pain;Efficacy of Pulsatile Cupping in Patients With Chronic Low Back Pain - a Randomized Controlled Study.;Completed;;N/A;110;Actual;Charite University, Berlin, Germany;;3;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T12:15:48Z;2020-06-01T12:15:48Z;Berlin;3579891;Principal Investigator;Benno Brinkhaus, Professor;Charite University, Berlin, Germany;Pulsatile Cupping | Minimal Cupping;63622765;1;;;2014;2020-05-29;7;FALSE;;FALSE;TRUE;18;65;Years;Years;1;6;
NCT02089009;ClinicalTrials.gov processed this data on May 29, 2020;2014-03-11;;;2016-07-17;2014-03-13;2014-03-17;Estimate;;;;;;;2016-07-17;2016-07-19;Estimate;December 2013;;2013-12-31;July 2016;2016-07-31;February 2016;Actual;2016-02-29;February 2016;Actual;2016-02-29;;Interventional;;;Comparison of Non-mydriatic Camera Systems in a Female Health Hospital;Comparison of Non-mydriatic Camera Systems for Screening and Follow-up Examinations -Focused on the Retinal Vessel Situation- in the Population of a Female Health Hospital;Completed;;N/A;214;Actual;University Hospital Tuebingen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:16:05Z;2020-06-01T12:16:05Z;Tübingen;3580024;Principal Investigator;Martin A Leitritz, M.D.;University Hospital Tuebingen;Retinal imaging | Vessel measurements | Change in vessel diameters;63622892;2;;;2014;2020-05-29;26;FALSE;;FALSE;FALSE;18;;Years;;1;2;
NCT02084381;ClinicalTrials.gov processed this data on May 29, 2020;2014-02-07;;;2017-04-04;2014-03-07;2014-03-12;Estimate;;;;;;;2017-04-04;2017-04-05;Actual;February 2014;;2014-02-28;April 2017;2017-04-30;February 2015;Actual;2015-02-28;July 2014;Actual;2014-07-31;;Interventional;PERCI-MCO;;PERCI- Medium Cut Off (MCO);Permeability Enhancement to Reduce Chronic Inflammation _ Medium Cut Off (MCO) (Study no 1502);Completed;;N/A;50;Actual;Baxter Healthcare Corporation;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:17:06Z;2020-06-01T12:17:06Z;Halle;3580435;Principal Investigator;Matthias Girndt, Prof. Dr.;Martin-Luther-Universität Halle-Wittenberg;MCO-Ci 400 | Revaclear 400;63623242;2;;;2014;2020-05-29;5;FALSE;;FALSE;FALSE;18;99;Years;Years;1;1;1
NCT02081053;ClinicalTrials.gov processed this data on May 29, 2020;2014-03-04;;;2017-01-18;2014-03-06;2014-03-07;Estimate;;;;;;;2017-01-18;2017-01-20;Estimate;January 2014;;2014-01-31;January 2017;2017-01-31;November 2016;Actual;2016-11-30;November 2016;Actual;2016-11-30;;Interventional;EU-STAR;;Evaluating Clinical Outcomes of Targeted Radiofrequency Ablation and Kyphoplasty (Also Known as Vertebral Augmentation) to Treat Painful Metastatic Vertebral Body Tumors;A Prospective, Multicenter Clinical Study to Evaluate the Clinical Outcomes of Targeted Radiofrequency Ablation and Vertebral Augmentation to Treat Painful Metastatic Vertebral Body Tumor(s);Terminated;;N/A;30;Actual;Merit Medical Systems, Inc.;;1;;Difficulty Enrolling;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:17:55Z;2020-06-01T12:17:55Z;Frankfurt;3580718;Principal Investigator;Thomas Vogl, MD;Goethe-Universität Frankfurt am Main;STAR™ Tumor Ablation System and StabiliT® Vertebral Augmentation System;63623497;8;;;2014;2020-05-29;34;FALSE;;FALSE;FALSE;18;;Years;;1;3;
NCT02080299;ClinicalTrials.gov processed this data on May 29, 2020;2014-03-01;;;2016-11-01;2014-03-04;2014-03-06;Estimate;;;;;;;2016-11-01;2016-11-02;Estimate;September 2013;;2013-09-30;November 2016;2016-11-30;August 2017;Anticipated;2017-08-31;August 2017;Anticipated;2017-08-31;;Interventional;;;Protection by Remote Ischemic Preconditioning During Transcatheter Aortic Valve Implantation;Protection of Heart, Brain and Kidney by Remote Ischemic Preconditioning in Patients Undergoing Transcatheter Aortic Valve Implantation - a Randomized, Single-blind Study;Unknown status;;Phase 2;100;Actual;University Hospital, Essen;;2;;;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T12:18:06Z;2020-06-01T12:18:06Z;Duisburg;3580779;Principal Investigator;Philipp Kahlert, MD;Department of Cardiology, West-German Heart Center Essen, University Duisburg-Essen;Remote ischemic preconditioning (RIPC) | Placebo;63623555;1;;;2014;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;13;
NCT02079688;ClinicalTrials.gov processed this data on May 29, 2020;2014-03-04;;;2017-01-12;2014-03-04;2014-03-06;Estimate;;;;;;;2017-01-12;2017-01-13;Estimate;February 2014;;2014-02-28;January 2017;2017-01-31;January 2017;Actual;2017-01-31;November 2016;Actual;2016-11-30;;Interventional;;;Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of the Topical Formulation SB011 Applied to Lesional Skin in Patients With Atopic Eczema;A Phase IIa, Single-centre, Randomised, Vehicle Controlled, Double-blind Trial for Assessment of Efficacy, Safety and Tolerability of the Topical Formulation SB011 Containing a Human GATA-3 Specific DNAzyme and of Systemic Absorption of hgd40 Following Application to Lesional Skin in Patients With Atopic Eczema;Completed;;Phase 2;25;Actual;Sterna Biologicals GmbH & Co. KG;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:18:13Z;2020-06-01T12:18:13Z;Hannover;3580829;Principal Investigator;Thomas Werfel, Prof. Dr.;Division for Immunodermatology and Allergy Research Clinic for Dermatology, Allergy and Venereology Hannover Medical School;SB011, 2 % (Water/Oil/Water) emulsion of hgd40 | Multiple W/O/W formulation, active ingredient-free vehicle;63623603;1;;;2014;2020-05-29;33;FALSE;;FALSE;TRUE;18;69;Years;Years;1;11;
NCT02079311;ClinicalTrials.gov processed this data on May 29, 2020;2014-02-18;;;2015-10-14;2014-03-04;2014-03-05;Estimate;;;;;;;2015-10-14;2015-11-13;Estimate;January 2014;;2014-01-31;June 2014;2014-06-30;April 2014;Actual;2014-04-30;April 2014;Actual;2014-04-30;;Interventional;;;Evaluation of Core Body Temperature When Using Forced Air Warming or an Active Blanket to Prevent Perioperative Hypothermia;Evaluation of Perioperative Core Body Temperature When Using Forced Air Warming or BARRIER® EasyWarm to Prevent Inadvertent Perioperative Hypothermia: An Open-label, Randomized Non-inferiority Comparison;Completed;;N/A;55;Actual;Molnlycke Health Care AB;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:18:17Z;2020-06-01T12:18:17Z;Giessen Marburg;3580859;Principal Investigator;Alexander Torossian, Prof. MD;Universitätsklinikum Gießen und Marburg GmbH;Active self warming blanket | Forced air warming device;63623632;3;28;0;2014;2020-05-29;2;TRUE;16;FALSE;FALSE;18;;Years;;1;;
NCT02078986;ClinicalTrials.gov processed this data on May 29, 2020;2014-03-03;;;2015-05-27;2014-03-04;2014-03-05;Estimate;;;;;;;2015-05-27;2015-05-28;Estimate;February 2014;;2014-02-28;May 2015;2015-05-31;March 2015;Actual;2015-03-31;February 2015;Actual;2015-02-28;;Interventional;EMSvsHIT;;Effectiveness of WB-EMS Versus HIT-Resistance Training (RT);Comparison of the Effect of Whole-Body Electromyostimulation Versus High Intensity Resistance Exercise Training on Body Composition and Strength in Middle Aged Males;Terminated;;Phase 3;50;Actual;University of Erlangen-Nürnberg Medical School;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:18:22Z;2020-06-01T12:18:22Z;Erlangen;3580889;Study Chair;Wolfgang K Kemmler, PhD;Institute of Medical Physics, University of Erlangen-Nuremberg;Whole Body Electromyostimulation | High Intensity Resistance Exercise Training;63623657;1;;;2014;2020-05-29;12;FALSE;;FALSE;TRUE;25;55;Years;Years;1;1;1
NCT02077309;ClinicalTrials.gov processed this data on May 29, 2020;2014-02-28;;;2017-04-10;2014-03-03;2014-03-04;Estimate;;;;;;;2017-04-10;2017-04-12;Actual;August 2014;;2014-08-31;December 2015;2015-12-31;November 2015;Actual;2015-11-30;September 2015;Actual;2015-09-30;;Interventional;Lina-Plaque;;Effect of Linagliptin on Vascular Inflammation in Patients With Type 2 Diabetes Mellitus;Linagliptin as a Modulator of Vascular Inflammation in Patients With Type 2 Diabetes Mellitus;Terminated;;Phase 3;4;Actual;RWTH Aachen University;;2;;bad recruitment of suitable participants, just 4 patients in one year;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:18:51Z;2020-06-01T12:18:51Z;Aachen;3581021;Principal Investigator;Nikolaus Marx, Univ.-Prof.;Department of Internal Medicine I, RWTH Aachen University Hospital;Linagliptin | Placebo;63623784;2;;;2014;2020-05-29;13;FALSE;;FALSE;FALSE;50;;Years;;1;3;
NCT02077205;ClinicalTrials.gov processed this data on May 29, 2020;2014-02-04;;;2014-02-28;2014-02-28;2014-03-04;Estimate;;;;;;;2014-02-28;2014-03-04;Estimate;January 2012;;2012-01-31;February 2014;2014-02-28;December 2015;Anticipated;2015-12-31;June 2014;Anticipated;2014-06-30;;Interventional;;;Manualised Cognitive Behavioral Therapy of Anxiety Disorders in Children and Adolescents in Routine Care Setting;;Unknown status;;N/A;200;Anticipated;Ruhr University of Bochum;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:18:52Z;2020-06-01T12:18:52Z;Bochum;;;;;Manualised Cognitive Behavioral Therapy;63623792;1;;;2014;2020-05-29;;FALSE;;FALSE;TRUE;4;18;Years;Years;4;2;
NCT02076646;ClinicalTrials.gov processed this data on May 29, 2020;2014-02-24;;;2016-10-27;2014-02-26;2014-03-03;Estimate;;;;;;;2016-10-27;2016-10-31;Estimate;October 2013;;2013-10-31;October 2016;2016-10-31;June 2017;Anticipated;2017-06-30;April 2017;Anticipated;2017-04-30;;Interventional;;;A Phase I/II Dose Escalation Study of the Tumor-targeting Human L19-IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Dacarbazine for Patients With Metastatic Melanoma;A Phase I/II Dose Escalation Study of the Tumor-targeting Human L19-IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Dacarbazine for Patients With Metastatic Melanoma;Unknown status;;Phase 1/Phase 2;96;Anticipated;Philogen S.p.A.;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:18:59Z;2020-06-01T12:18:59Z;Tübingen;3581079;Principal Investigator;Claus Garbe, Prof. M.D.;University Hospital Tuebingen (Germany);L19IL2 - Ph I | L19IL2 at RD - Ph II | DTIC;63623834;2;;;2014;2020-05-29;;FALSE;;FALSE;FALSE;18;70;Years;Years;2;10;
NCT02071849;ClinicalTrials.gov processed this data on May 29, 2020;2014-02-17;;;2017-03-20;2014-02-25;2014-02-26;Estimate;;;;;;;2017-03-20;2017-04-17;Actual;September 2013;;2013-09-30;March 2017;2017-03-31;August 2016;Actual;2016-08-31;April 2015;Actual;2015-04-30;;Interventional;;;HAART 200 Aortic Valve Annuloplasty Trial;HAART 200 Aortic Valve Annuloplasty During Bicuspid Aortic Valve Reconstruction Trial;Completed;;N/A;20;Actual;Biostable Science & Engineering;;1;;;FALSE;;;;TRUE;;;;;;;;;;;Undecided;;2020-06-01T12:20:20Z;2020-06-01T12:20:20Z;Munich;3581522;Principal Investigator;Dominico Mazzitelli, MD;München Heart Center;HAART 200 Aortic Valve Annuloplasty Device;63624203;4;41;17;2014;2020-05-29;19;TRUE;21;FALSE;FALSE;18;;Years;;2;27;
NCT02071615;ClinicalTrials.gov processed this data on May 29, 2020;2014-02-15;;;2014-04-16;2014-02-22;2014-02-26;Estimate;;;;;;;2014-04-16;2014-04-17;Estimate;August 2013;;2013-08-31;April 2014;2014-04-30;March 2014;Actual;2014-03-31;March 2014;Actual;2014-03-31;;Interventional;MKM;;Effects of Modafinil, Caffeine and Methylphenidate in Healthy Volunteers;Effects of Modafinil, Caffeine and Methylphenidate on Functional Brain Activity and Cognitive Performance in Healthy Volunteers: a Randomized, Placebo-controlled, Double-blind fMRI Study;Completed;;N/A;48;Actual;Charite University, Berlin, Germany;;3;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T12:20:23Z;2020-06-01T12:20:23Z;Berlin;3581535;Principal Investigator;Dimitris Repantis, MD;Department of Psychiatry and Psychotherapy, Charité - University;Methylphenidate 20 mg tablet given once by mouth | modafinil 200mg tablet given once by mouth | caffein 200mg tablet given once by mouth | placebo;63624222;1;;;2014;2020-05-29;7;FALSE;;FALSE;TRUE;18;35;Years;Years;1;2;
NCT02071511;ClinicalTrials.gov processed this data on May 29, 2020;2014-02-10;;;2019-04-28;2014-02-21;2014-02-26;Estimate;;;;;;;2019-04-28;2019-05-01;Actual;January 2014;;2014-01-31;April 2019;2019-04-30;August 2016;Actual;2016-08-31;January 2016;Actual;2016-01-31;;Interventional;ARDEVAT;;Renal Denervation In Patient Undergoing VT Ablation:Combined Renal Denervation and VT Ablation vs. Simply VT Ablation;Renal Denervation In Patient Undergoing VT Ablation:Combined Renal Denervation and VT Ablation vs. Simply VT Ablation;Terminated;;N/A;50;Actual;Universitätsklinikum Hamburg-Eppendorf;;2;;results of the SYMPLICITY HTN 3 trial;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T12:20:23Z;2020-06-01T12:20:23Z;Hamburg;3581541;Principal Investigator;Stephan Willems, MD;University Heart Center Hamburg;Ablation of ventricular arrhythmias + renal denervation | Ablation of ventricular arrhythmias;63624230;1;;;2014;2020-05-29;24;FALSE;;FALSE;TRUE;18;;Years;;1;2;
NCT02066246;ClinicalTrials.gov processed this data on May 29, 2020;2014-01-22;;;2014-10-08;2014-02-18;2014-02-19;Estimate;;;;;;;2014-10-08;2014-10-09;Estimate;August 2013;;2013-08-31;October 2014;2014-10-31;September 2014;Actual;2014-09-30;September 2014;Actual;2014-09-30;;Interventional;;;Lung Function After Robot-assisted Radical Prostate Ectomy;Investigation of the Possible Advantages of the AirSeal-system Compared to Conventional CO2 Insufflation Systems in Terms of Lung Function and Hemodynamics in Robot-assisted Laparoscopic Radical Prostate Ectomy;Completed;;N/A;192;Actual;Universitätsklinikum Hamburg-Eppendorf;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:21:25Z;2020-06-01T12:21:25Z;Hamburg;3581996;Study Director;Daniel A Reuter, PhD MD;Department of Anaesthesiology Center of Anaesthesiology and Intensive Care Medicine University Medical Center Hamburg-Eppendorf University of Hamburg;AirSeal | Olympus UHI-3;63624633;2;;;2014;2020-05-29;13;FALSE;;FALSE;FALSE;18;;Years;;2;3;
NCT02062138;ClinicalTrials.gov processed this data on May 29, 2020;2014-02-06;;;2017-05-19;2014-02-10;2014-02-13;Estimate;;;;;;;2017-05-19;2017-05-22;Actual;January 2014;Actual;2014-01-31;May 2017;2017-05-31;April 2016;Actual;2016-04-30;January 2016;Actual;2016-01-31;;Interventional;;;Effectiveness of Passive and Active ROM Exercises Following TKA;Effectiveness of New Interventional Approaches to Improve Physical Function Following Total Knee Arthroplasty;Completed;;N/A;60;Actual;University of Rostock;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:22:41Z;2020-06-01T12:22:41Z;Rostock;3582337;Study Chair;Rainer Bader, MD;Department of Orthopedics, University Medicine Rostock;continuous passive motion (CPM) | controlled active motion (CAM I) | controlled active motion (CAM II);63624946;1;;;2014;2020-05-29;24;FALSE;;FALSE;TRUE;50;80;Years;Years;1;9;
NCT02061722;ClinicalTrials.gov processed this data on May 29, 2020;2014-02-03;;;2016-05-31;2014-02-11;2014-02-13;Estimate;;;;;;;2016-05-31;2016-06-01;Estimate;January 2013;;2013-01-31;March 2016;2016-03-31;May 2016;Actual;2016-05-31;May 2016;Actual;2016-05-31;;Interventional;PEARL-HD;;[PETDE10] Imaging of PDE10A Enzyme Levels in Huntington's Disease Gene Expansion Carriers and Healthy Controls With PET.;[PETDE10] Imaging of Phosphodiesterase 10 A (PDE10A) Enzyme Levels in the Living Human Brain of Huntington´s Disease Gene Expansion Carriers and Healthy Controls With Positron Emission Tomography;Completed;;Early Phase 1;90;Actual;CHDI Foundation, Inc.;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:22:47Z;2020-06-01T12:22:47Z;Ulm;3582370;Principal Investigator;Bernhard Landwehrmeyer, MD, PhD;Ulm University Hospital;PET Imaging with [18F]MNI-659;63624980;8;;;2014;2020-05-29;40;FALSE;;FALSE;FALSE;18;70;Years;Years;1;;
NCT02059369;ClinicalTrials.gov processed this data on May 29, 2020;2013-05-23;;;2017-04-10;2014-02-07;2014-02-11;Estimate;;;;;;;2017-04-10;2017-04-11;Actual;August 2012;;2012-08-31;April 2017;2017-04-30;December 2014;Actual;2014-12-31;July 2014;Actual;2014-07-31;;Interventional;ADLINE;;Ablation of Complex Fractionated Electrograms With or Without Additional Linear Lesions for Persistent Atrial Fibrillation;Ablation of Complex Fractionated Electrograms With or Without Additional Linear Lesions for Persistent Atrial Fibrillation;Completed;;N/A;90;Anticipated;Deutsches Herzzentrum Muenchen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:23:14Z;2020-06-01T12:23:14Z;Munich;;;;;PVI+CFAE+DCC | PVI, CFAE, anterior and roof line, DCC;63625162;1;;;2013;2020-05-29;23;FALSE;;FALSE;TRUE;18;80;Years;Years;1;2;
NCT02058810;ClinicalTrials.gov processed this data on May 29, 2020;2014-02-06;;;2019-09-24;2014-02-07;2014-02-10;Estimate;;;;;;;2019-09-24;2019-09-26;Actual;September 2010;;2010-09-30;September 2019;2019-09-30;May 2014;Actual;2014-05-31;May 2014;Actual;2014-05-31;;Interventional;;;Nasal High Flow at Acute Hart Failure;Does the Use of Optiflow High Flow Oxygen on Patients With Acute Cardial Decompensation (NYHA Classification Stage III-IV) Allow for Quicker Improvement of the Organ Dysfunction Than Conventional Standard-Oxygen-Insufflation-Therapy?;Terminated;;N/A;46;Actual;University Hospital Regensburg;;2;;Lack of patients, PI left;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:23:31Z;2020-06-01T12:23:31Z;Regensburg;;;;;Nasal high flow | Conventional nasal oxygen;63625207;1;;;2014;2020-05-29;44;FALSE;;FALSE;TRUE;18;;Years;;1;1;1
NCT02054468;ClinicalTrials.gov processed this data on May 29, 2020;2014-01-30;;;2014-05-07;2014-02-03;2014-02-04;Estimate;;;;;;;2014-05-07;2014-05-08;Estimate;March 2012;;2012-03-31;May 2014;2014-05-31;February 2014;Actual;2014-02-28;February 2014;Actual;2014-02-28;;Interventional;ROSANNA;;Rocuronium Dose Finding Study After Single-shot or Steady-state Propofol Anesthesia;Rocuronium Dose Finding Study After Single-shot or Steady-state Propofol;Completed;;N/A;82;Actual;Technische Universität München;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:24:57Z;2020-06-01T12:24:57Z;Munich;3582980;Principal Investigator;Manfred Blobner, M.D.;Klinik für Anaesthesiologie, Klinikum rechts der Isar der Technischen Universität München, Ismaninger Str. 22, 81675 München, Germany;Single-Shot Propofol | 30min infusion Propofol | Remifentanil infusion | Rocuronium (0.07mg/kg/body mass) | Rocuronium (0.1mg/kg/body mass) | Rocuronium (0.15mg/kg/body mass) | Rocuronium (0.2mg/kg/body mass) | Rocuronium (0.3mg/kg/body mass) | Rocuronium (0.45mg/kg/body mass);63625535;1;;;2014;2020-05-29;23;FALSE;;FALSE;TRUE;18;;Years;;2;1;
NCT02054351;ClinicalTrials.gov processed this data on May 29, 2020;2014-01-29;;;2017-06-30;2014-02-03;2014-02-04;Estimate;;;;;;;2017-06-30;2017-07-02;Actual;December 2013;;2013-12-31;June 2017;2017-06-30;March 21, 2017;Actual;2017-03-21;March 2017;Actual;2017-03-31;;Interventional;OVAR;;Phase 1 Trial of IMAB027 in Patients With Recurrent Advanced Ovarian Cancer (OVAR);A First-in-human Dose Escalation and Dose Finding Phase 1 Trial of IMAB027 in Patients With Recurrent Advanced Ovarian Cancer (OVAR);Completed;;Phase 1;72;Actual;Astellas Pharma Inc;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:24:59Z;2020-06-01T12:24:59Z;Heidelberg;3582985;Principal Investigator;Dirk Jaeger, Prof. Dr.;Nationales Zentrum für Tumorerkrankungen, Heidelberg;IMAB027;63625544;9;;;2014;2020-05-29;39;FALSE;;FALSE;FALSE;18;;Years;;1;3;
NCT02054299;ClinicalTrials.gov processed this data on May 29, 2020;2014-01-30;;;2016-05-11;2014-02-03;2014-02-04;Estimate;;;;;;;2016-05-11;2016-05-12;Estimate;April 2013;;2013-04-30;May 2016;2016-05-31;February 2016;Actual;2016-02-29;February 2016;Actual;2016-02-29;;Interventional;PG-OCT;;Open Label Pharmacokinetic-Pharmacogenetic Study on Polymorphisms in the Organic Cation Transporter OCT1;Effects of Genetic Polymorphisms in the Organic Cation Transporter OCT1 on Cellular Uptake and Metabolism of Antidepressants and Other Organic Cationic Drugs;Completed;;Phase 1;48;Actual;University Medical Center Goettingen;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:25:01Z;2020-06-01T12:25:01Z;Göttingen;3582989;Study Director;Juergen Brockmoeller, Prof.;University Medical Center Goettingen;Drug application Amitriptyline | Drug application Desvenlafaxine | Drug application Sumatriptan | Drug application Proguanil | Drug application Fenoterol | Drug application Thiamine;63625548;1;;;2014;2020-05-29;34;FALSE;;FALSE;TRUE;18;50;Years;Years;1;5;
NCT02052960;ClinicalTrials.gov processed this data on May 29, 2020;2014-01-27;;;2017-07-25;2014-01-31;2014-02-03;Estimate;;;;;;;2017-07-25;2017-07-27;Actual;January 2014;;2014-01-31;July 2017;2017-07-31;December 15, 2017;Anticipated;2017-12-15;September 30, 2017;Anticipated;2017-09-30;;Interventional;RESGEX;;CetuGEX™ in Comparison to Cetuximab for the Treatment of Patients With Head and Neck Cancer;Randomized, Controlled, Open Label, Multicenter, Phase II Study to Evaluate the Efficacy and Safety of CetuGEX™ Plus CT in Comparison to Cetuximab Plus CT in Patients With Stage III/IV Recurrent and/or Metastatic SCCHN;Unknown status;;Phase 2;240;Actual;Glycotope GmbH;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:25:19Z;2020-06-01T12:25:19Z;Berlin;3583102;Principal Investigator;Ulrich Keilholz, Prof;Charite University, Berlin, Germany;Tomuzotuximab | Cetuximab | Chemotherapy;63625649;35;;;2014;2020-05-29;;FALSE;;FALSE;FALSE;18;;Years;;1;;
NCT02052193;ClinicalTrials.gov processed this data on May 29, 2020;2014-01-28;;;2017-05-02;2014-01-30;2014-01-31;Estimate;;;;;;;2017-05-02;2017-05-05;Actual;January 2014;Actual;2014-01-31;July 2015;2015-07-31;December 2017;Anticipated;2017-12-31;January 2017;Actual;2017-01-31;;Interventional;;;Evaluation of Photosensitivity in Dabrafenib or Vemurafenib Treated Metastatic Melanoma Patients - a Phase IIa/IIb Study;Evaluation of Photosensitivity in Dabrafenib or Vemurafenib Treated Metastatic Melanoma Patients - a Phase IIa/IIb Study;Terminated;;Phase 2;8;Actual;University Hospital Tuebingen;;2;;Second cohort not opened because Simon-Two_Step model failed;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:25:28Z;2020-06-01T12:25:28Z;Tübingen;3583152;Principal Investigator;Claus Garbe, M.D.;Dept. of Dermatology, University Hopsital Tuebingen, Germany;Dabrafenib | Vemurafenib;63625707;1;;;2014;2020-05-29;36;FALSE;;FALSE;TRUE;18;;Years;;2;2;
NCT02051660;ClinicalTrials.gov processed this data on May 29, 2020;2014-01-29;;;2019-05-23;2014-01-29;2014-01-31;Estimate;;;;;;;2019-05-23;2019-05-24;Actual;March 2013;Actual;2013-03-31;May 2019;2019-05-31;December 2017;Actual;2017-12-31;June 2017;Actual;2017-06-30;;Interventional;;;German Evaluation of the Effectiveness of the Psychological Intervention Managing Cancer and Living Meaningfully (CALM);German Randomized Controlled Trial of the Psychotherapeutic Intervention for Advanced Cancer Patients: Managing Cancer and Living Meaningfully (CALM);Completed;;N/A;206;Actual;University of Leipzig;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:25:33Z;2020-06-01T12:25:33Z;Hamburg Leipzig;3583200;Principal Investigator;Anja Mehnert, Prof Dr;University Medical Center of Leipzig;Manualized CALM intervention | Non-manualized supportive intervention.;63625745;2;;;2014;2020-05-29;51;FALSE;;FALSE;FALSE;18;;Years;;2;;
NCT02051621;ClinicalTrials.gov processed this data on May 29, 2020;2013-12-03;;;2014-01-30;2014-01-30;2014-01-31;Estimate;;;;;;;2014-01-30;2014-01-31;Estimate;August 2010;;2010-08-31;January 2014;2014-01-31;August 2017;Anticipated;2017-08-31;August 2015;Anticipated;2015-08-31;;Interventional;TripleA;;Therapy of Atrial Flutter by Afib Ablation;Isolated Atrial Fibrillation Ablation in Patients With Isolated Atrial Flutter;Unknown status;;N/A;100;Anticipated;University of Rostock;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:25:33Z;2020-06-01T12:25:33Z;Rostock;3583204;Principal Investigator;Dietmar Baensch, PhD, MD;University Medical Centre Rostock;Antiarrhythmic drug | Cavo-tricuspid-isthmus-ablation | Pulmonary vein isolation;63625748;1;;;2013;2020-05-29;;FALSE;;FALSE;TRUE;21;;Years;;1;1;
NCT02051387;ClinicalTrials.gov processed this data on May 29, 2020;2013-09-18;;;2018-03-07;2014-01-30;2014-01-31;Estimate;;;;;;;2018-03-07;2018-03-08;Actual;January 2013;;2013-01-31;March 2018;2018-03-31;August 2017;Actual;2017-08-31;August 2017;Actual;2017-08-31;;Interventional;CBD-IS;;Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study;Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study With Approved Antipsychotics in Vivo;Completed;;Phase 1;74;Actual;Central Institute of Mental Health, Mannheim;;7;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:25:35Z;2020-06-01T12:25:35Z;Mannheim;;;;;Cannabidiol CR | Cannabidiol | Amisulpride | Olanzapine | Quetiapine | Risperidone | Placebo;63625766;2;;;2013;2020-05-29;55;FALSE;;FALSE;FALSE;18;45;Years;Years;1;2;
NCT02049853;ClinicalTrials.gov processed this data on May 29, 2020;2014-01-28;;;2015-05-19;2014-01-28;2014-01-30;Estimate;;;;;;;2015-05-19;2015-05-20;Estimate;June 2013;;2013-06-30;May 2015;2015-05-31;May 2015;Actual;2015-05-31;April 2015;Actual;2015-04-30;;Interventional;;;The Triple A Initiative Study (Aktionsbündnis Akute Atemnot);A Prospective Randomized Study of Coordinated Diagnostic Pathways and Treatment Algorithms for Patients With Acute Dyspnea Including Point-of-care Testing of a Cardiac Biomarker by the Emergency Medical Service Team;Terminated;;N/A;67;Actual;Klinikum Nürnberg;;2;;recruitment numbers lower than expected;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:25:54Z;2020-06-01T12:25:54Z;Erlangen;3583360;Principal Investigator;Michael Christ, Prof.;Klinikum Nürnberg;NTproBNP measurement with point of care device Cobash232 in the POCT group;63625886;6;;;2014;2020-05-29;22;FALSE;;FALSE;FALSE;18;;Years;;1;10;
NCT02046915;ClinicalTrials.gov processed this data on May 29, 2020;2014-01-22;;;2017-10-27;2014-01-24;2014-01-28;Estimate;;;;;;;2017-10-27;2017-10-30;Actual;April 2014;;2014-04-30;October 2016;2016-10-31;August 17, 2017;Actual;2017-08-17;August 17, 2016;Actual;2016-08-17;;Interventional;PERSPECTIVE;;Phase II Multicenter, Open-label, Single Arm Clinical Study of Pomalidomide and dexamethasonE and Cyclophosphamide;Phase II Multicenter, Open-label, Single Arm Clinical Study of Pomalidomide and dexamethasonE in RelapSed Myeloma Plus rEsponse Adapted Cyclophosphamide as a Tailored InnoVativE Strategy;Completed;;Phase 2;60;Actual;University Hospital Tuebingen;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:26:31Z;2020-06-01T12:26:31Z;Tübingen;;;;;Imnovid (pomalidomide) | Dexamethasone | Endoxan (Cyclophosphamide);63626111;1;;;2014;2020-05-29;28;FALSE;;FALSE;TRUE;18;99;Years;Years;1;1;
NCT02045550;ClinicalTrials.gov processed this data on May 29, 2020;2014-01-13;;;2014-01-23;2014-01-23;2014-01-27;Estimate;;;;;;;2014-01-23;2014-01-27;Estimate;January 2014;;2014-01-31;January 2014;2014-01-31;August 2015;Anticipated;2015-08-31;August 2015;Anticipated;2015-08-31;;Interventional;;;Tolerance and Effect of a Prophylactical Treatment With Ivy Leaves Dry Extract in Recurrent Wheezy Bronchitis;Tolerance and Effect of a Prophylactical Treatment With a Cough Medicine Con-taining Ivy Leaves Dry Extract in Children With Recurrent Wheezy Bronchitis;Unknown status;;Phase 2;60;Anticipated;Technische Universität Dresden;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:27:04Z;2020-06-01T12:27:04Z;Dresden;3583746;Principal Investigator;Christian Vogelberg, MD PhD;Technische Universität Dresden;Prospan Syrup;63626215;1;;;2014;2020-05-29;;FALSE;;FALSE;TRUE;1;3;Year;Years;1;2;
NCT02044913;ClinicalTrials.gov processed this data on May 29, 2020;2014-01-22;;;2015-07-14;2014-01-22;2014-01-24;Estimate;;;;;;;2015-07-14;2015-07-15;Estimate;March 2012;;2012-03-31;July 2015;2015-07-31;June 2015;Actual;2015-06-30;June 2015;Actual;2015-06-30;;Interventional;;;Randomized-controlled Trial of Aftercare-Coordination by Phone for Depression and Anxiety;Randomized-controlled Trial of Aftercare-Coordination by Phone for Patients With Depression and Anxiety Subsequent to an Inpatient Treatment.;Completed;;N/A;218;Actual;Universitätsklinikum Hamburg-Eppendorf;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:27:12Z;2020-06-01T12:27:12Z;Hamburg;3583807;Principal Investigator;Dr. phil. Hanne Melchior;University Medical Center Hamburg-Eppendorf, Centre of Psychosocial Medicine, Department of Medical Psychology;Phone-based Aftercare-Coordination;63626265;1;;;2014;2020-05-29;39;FALSE;;FALSE;TRUE;18;;Years;;1;3;
NCT02043600;ClinicalTrials.gov processed this data on May 29, 2020;2014-01-21;;;2015-09-22;2014-01-21;2014-01-23;Estimate;;;;;;;2015-09-22;2015-09-23;Estimate;February 2014;;2014-02-28;September 2015;2015-09-30;August 2015;Actual;2015-08-31;May 2015;Actual;2015-05-31;;Interventional;;;Randomized-controlled Trial of Yoga for Ulcerative Colitis;Randomized-controlled Trial of Yoga for Ulcerative Colitis;Completed;;N/A;77;Actual;Universität Duisburg-Essen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:27:32Z;2020-06-01T12:27:32Z;Duisburg;3583952;Principal Investigator;Holger Cramer, PhD;Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany;Yoga | Self-care;63626365;1;;;2014;2020-05-29;15;FALSE;;FALSE;TRUE;18;70;Years;Years;1;37;1
NCT02039167;ClinicalTrials.gov processed this data on May 29, 2020;2014-01-15;;;2018-11-19;2014-01-15;2014-01-17;Estimate;;;;;;;2018-11-19;2018-11-21;Actual;January 2014;;2014-01-31;November 2018;2018-11-30;April 12, 2017;Actual;2017-04-12;March 21, 2017;Actual;2017-03-21;;Interventional;WatchAFIB;;Left Atrial Appendage Occlusion vs. Usual Care in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease;WATCH Bleeding Episodes After Left Atrial Appendage Occlusion Versus Usual Care in Patients With Atrial FIBrillatIon and Severe to eNd-stage Chronic Kidney Disease (WatchAFIB in CKD);Terminated;;N/A;14;Actual;University of Magdeburg;;2;;The recruitment rate was very poor. The study was stopped by amendment on 2015-08-28.;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:28:53Z;2020-06-01T12:28:53Z;Magdeburg;3584356;Principal Investigator;Rüdiger C Braun-Dullaeus, Prof;Otto-von-Guericke University Magdeburg Faculty of Medicine;Left atrial appendage occlusion;63626706;4;;;2014;2020-05-29;38;FALSE;;FALSE;FALSE;18;80;Years;Years;1;1;1
NCT02038244;ClinicalTrials.gov processed this data on May 29, 2020;2014-01-09;;;2015-09-22;2014-01-14;2014-01-16;Estimate;;;;;;;2015-09-22;2015-09-23;Estimate;February 2014;;2014-02-28;May 2015;2015-05-31;March 2015;Actual;2015-03-31;September 2014;Actual;2014-09-30;;Interventional;POSITIVE;;Integrative Medicine for Chronic Pain;Integrative Medicine for Chronic Pain - Process-Outcome-Study in the Context of an Internal Medicine Ward for Integrative Medicine;Completed;;N/A;300;Actual;Universität Duisburg-Essen;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:29:16Z;2020-06-01T12:29:16Z;Duisburg;;;;;Multimodal integrative medicine inpatient treatment program;63626776;1;;;2014;2020-05-29;7;FALSE;;FALSE;TRUE;18;75;Years;Years;1;12;6
NCT02037581;ClinicalTrials.gov processed this data on May 29, 2020;2014-01-14;;;2017-08-07;2014-01-14;2014-01-16;Estimate;;;;;;;2017-08-07;2017-08-08;Actual;June 2011;;2011-06-30;August 2017;2017-08-31;April 2015;Actual;2015-04-30;December 2014;Actual;2014-12-31;;Interventional;ICEP;;Integrated Care Including Assertive Community Treatment in Early Psychosis;Integrated Care in Early Psychosis (ICEP Study): a 12-month Quasi Experimental Study With Historic Control Group;Completed;;N/A;120;Actual;Universitätsklinikum Hamburg-Eppendorf;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:29:29Z;2020-06-01T12:29:29Z;Hamburg;3584484;Study Director;Martin Lambert, Prof.;UHH Hamburg-Eppendorf;Early detection and Integrated Care | Standard Care;63626828;1;;;2014;2020-05-29;42;FALSE;;FALSE;TRUE;12;29;Years;Years;1;;
NCT02035709;ClinicalTrials.gov processed this data on May 29, 2020;2013-12-04;;;2015-07-02;2014-01-13;2014-01-14;Estimate;;;;;;;2015-07-02;2015-07-03;Estimate;December 2013;;2013-12-31;July 2015;2015-07-31;April 2015;Actual;2015-04-30;April 2015;Actual;2015-04-30;;Interventional;TCI-PCA;;Postoperative Pain Therapy With Hydromorphone Using TCI-PCA;Phase 4 Study of Postoperative Pain Therapy With Hydromorphone Using Patient-Controlled Target-Controlled Infusion (TCI-PCA) vs. Patient-Controlled Analgesia (PCA) After Elective Cardiac Surgery;Completed;;Phase 4;50;Actual;University of Erlangen-Nürnberg Medical School;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:29:56Z;2020-06-01T12:29:56Z;Erlangen;3584638;Principal Investigator;Christian Jeleazcov, MD, Associate Professor;Department of Anesthesiology, University Hospital Erlangen;Hydromorphone;63626972;2;;;2013;2020-05-29;16;FALSE;;FALSE;FALSE;40;85;Years;Years;1;1;1
NCT02034539;ClinicalTrials.gov processed this data on May 29, 2020;2014-01-10;;;2014-01-10;2014-01-10;2014-01-13;Estimate;;;;;;;2014-01-10;2014-01-13;Estimate;October 2013;;2013-10-31;January 2014;2014-01-31;November 2014;Anticipated;2014-11-30;October 2014;Anticipated;2014-10-31;;Interventional;;;VADOplex Critical Limb Ischemia Study;Prospektive, Randomisierte Und Kontrollierte Studie Zum Einfluss Des VADOplex-Systems Auf Die Lebensqualität im Rahmen Der Behandlung Der Chronisch-kritischen Extremitätenischämie im Stadium IV Nach Fontaine;Unknown status;;Phase 2/Phase 3;38;Anticipated;Asklepios Kliniken Hamburg GmbH;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:30:13Z;2020-06-01T12:30:13Z;Hamburg;;;;;VADOplex system;63627060;1;;;2014;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;2;5;
NCT02034279;ClinicalTrials.gov processed this data on May 29, 2020;2014-01-07;;;2017-05-17;2014-01-10;2014-01-13;Estimate;;;;;;;2017-05-17;2017-05-18;Actual;May 2014;Actual;2014-05-31;May 2017;2017-05-31;February 10, 2017;Actual;2017-02-10;December 31, 2016;Actual;2016-12-31;;Interventional;INFECIR2;;The INFECIR-2 Albumin Prevention Study;Albumin Administration in the Prevention of Hepatorenal Syndrome and Death in Patients With Cirrhosis, Bacterial Infections Other Than Spontaneous Bacterial Peritonitis and High Risk of Hospital Mortality;Terminated;;Phase 4;136;Actual;EASL - CLIF Consortium;;2;;Low recruitment rate and expiration of the study drug;FALSE;;;;TRUE;;;;;;;;;;;Undecided;Undecided yet;2020-06-01T12:30:16Z;2020-06-01T12:30:16Z;Bonn Frankfurt Heidelberg Munich Tübingen Ulm;3584778;Principal Investigator;Matthias Dollinger;University of Ulm, Heidelberg and Tübingen, Germany;Albumin;63627080;1;;;2014;2020-05-29;31;FALSE;;FALSE;TRUE;18;;Years;;1;5;
NCT02029131;ClinicalTrials.gov processed this data on May 29, 2020;2014-01-03;;;2017-02-22;2014-01-06;2014-01-07;Estimate;;;;;;;2017-02-22;2017-02-23;Actual;January 2014;;2014-01-31;February 2017;2017-02-28;February 2017;Actual;2017-02-28;September 2014;Actual;2014-09-30;;Interventional;;;Exercise and Low Back Pain;Effects of a Home-based Exercise Program on Low Back Pain in Employees;Completed;;N/A;226;Actual;Hannover Medical School;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:31:45Z;2020-06-01T12:31:45Z;Hannover;;;;;Exercise;63627477;1;;;2014;2020-05-29;8;FALSE;;FALSE;TRUE;18;67;Years;Years;1;8;
NCT02027805;ClinicalTrials.gov processed this data on May 29, 2020;2014-01-03;;;2017-06-03;2014-01-03;2014-01-06;Estimate;;;;;;;2017-06-03;2017-06-06;Actual;March 5, 2014;Actual;2014-03-05;June 2017;2017-06-30;November 3, 2016;Actual;2016-11-03;September 7, 2016;Actual;2016-09-07;;Interventional;;;Safety and Efficacy Study of T-Guard to Treat Steroid-resistant Acute GVHD;A Phase I/II Multicentric Study to Determine the Safety and Efficacy of a Combination of Anti-CD3 & Anti-CD7 Ricin A Immunotoxins (T-Guard) for the Treatment of Steroid-resistant Acute Graft-versus-Host Disease.;Completed;;Phase 1/Phase 2;20;Actual;Xenikos;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:32:04Z;2020-06-01T12:32:04Z;Münster;3585326;Principal Investigator;Matthias Stelljes, MD, PhD;Unversity Hospital Münster, Münster (Germany);T-Guard;63627578;2;;;2014;2020-05-29;30;FALSE;;FALSE;FALSE;18;;Years;;1;8;5
NCT02027792;ClinicalTrials.gov processed this data on May 29, 2020;2014-01-03;;;2018-04-30;2014-01-03;2014-01-06;Estimate;;;;;;;2018-04-30;2018-05-02;Actual;January 2014;;2014-01-31;April 2018;2018-04-30;August 2014;Actual;2014-08-31;August 2014;Actual;2014-08-31;;Interventional;KoGon;;Cabbage Leaf Wraps in Osteoarthritis of the Knee;Randomised Controlled Trial on the Efficacy of Cabbage Leaf Wraps in Symptomatic Primary Osteoarthritis of the Knee;Completed;;N/A;81;Actual;Universität Duisburg-Essen;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:32:04Z;2020-06-01T12:32:04Z;Duisburg;;;;;Cabbage leave wraps | Diclofenac Gel;63627579;1;;;2014;2020-05-29;7;FALSE;;FALSE;TRUE;18;;Years;;1;13;2
NCT02027662;ClinicalTrials.gov processed this data on May 29, 2020;2013-12-20;;;2015-06-09;2014-01-02;2014-01-06;Estimate;;;;;;;2015-06-09;2015-06-10;Estimate;January 2014;;2014-01-31;June 2015;2015-06-30;June 2015;Actual;2015-06-30;April 2015;Actual;2015-04-30;;Interventional;OsvaRenNEW;;Therapeutic Equivalence of OsvaRen® Tablets and OsvaRen® Granules;Study to Investigate Efficacy and Safety Equivalence of OsvaRen® Tablets and OsvaRen® Granules;Completed;;Phase 2/Phase 3;61;Actual;Fresenius Medical Care Deutschland GmbH;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:32:07Z;2020-06-01T12:32:07Z;Aachen;3585335;Principal Investigator;Jürgen Floege, MD;University Aachen;Osvaren Granules | Osvaren film-coated tablets;63627588;11;;;2013;2020-05-29;15;FALSE;;FALSE;FALSE;18;80;Years;Years;1;1;
NCT02026492;ClinicalTrials.gov processed this data on May 29, 2020;2013-12-19;;;2015-03-16;2014-01-01;2014-01-03;Estimate;;;;;;;2015-03-16;2015-03-17;Estimate;June 2013;;2013-06-30;March 2015;2015-03-31;July 2014;Actual;2014-07-31;July 2014;Actual;2014-07-31;;Interventional;;;Exercise Challenge in a Cold Chamber;Exercise-induced Bronchoconstriction in a Cold Chamber Compared to Methacholine Challenge;Completed;;N/A;79;Actual;Johann Wolfgang Goethe University Hospital;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:32:19Z;2020-06-01T12:32:19Z;Frankfurt;3585428;Study Chair;Johannes Schulze, MD;Johann Wolfgang Goethe University Hospital;Exercise challenge in a cold chamber | Methacholine challenge | Exercise challenge in room temperature;63627678;1;;;2013;2020-05-29;13;FALSE;;FALSE;TRUE;6;45;Years;Years;1;1;1
NCT02025205;ClinicalTrials.gov processed this data on May 29, 2020;2013-12-21;;;2019-07-09;2013-12-27;2013-12-31;Estimate;;;;;;;2019-07-09;2019-08-16;Actual;August 2014;Actual;2014-08-31;July 2019;2019-07-31;March 15, 2017;Actual;2017-03-15;April 2016;Actual;2016-04-30;;Interventional;IMPACT;;Improving Patient Outcomes by Selective Implantation of the Zephyr EBV - Study;A Multicentre, Prospective, Randomized, Controlled, One-way Crossover Investigation of Endobronchial Valve (EBV) Therapy vs. Standard of Care (SoC) in Homogeneous Emphysema;Completed;;N/A;93;Actual;Pulmonx Corporation;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:32:34Z;2020-06-01T12:32:34Z;Heidelberg;3585542;Principal Investigator;Felix Herth (co-principal investigator), MD;Heidelberg University;Endobronchial Valve;63627774;8;129;90;2013;2020-05-29;20;TRUE;32;FALSE;FALSE;40;;Years;;1;19;
NCT02021942;ClinicalTrials.gov processed this data on May 29, 2020;2013-12-20;;;2017-07-19;2013-12-20;2013-12-27;Estimate;;;;;;;2017-07-19;2018-02-05;Actual;March 2012;;2012-03-31;July 2017;2017-07-31;October 2015;Actual;2015-10-31;October 2015;Actual;2015-10-31;;Interventional;;;Efficacy of Medical Treatment With SOM230 LAR in Patients With Primary Inoperable Thymoma and/or With Local Recurrent Thymoma to Reduce Tumor Size;Efficacy of Medical Treatment With SOM230 LAR in Patients With Primary Inoperable Thymoma and/or With Local Recurrent Thymoma to Reduce Tumor Size;Completed;;Phase 2;16;Actual;University of Regensburg;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:33:15Z;2020-06-01T12:33:15Z;Regensburg;;;;;SOM230 LAR;63628021;1;102;22;2013;2020-05-29;43;TRUE;15;FALSE;TRUE;18;;Years;;1;2;4
NCT02019498;ClinicalTrials.gov processed this data on May 29, 2020;2013-12-18;;;2016-08-02;2013-12-18;2013-12-24;Estimate;;;;;;;2016-08-02;2016-08-03;Estimate;April 2014;;2014-04-30;February 2016;2016-02-29;July 2016;Actual;2016-07-31;February 2016;Actual;2016-02-29;;Interventional;Relaxback;;Effectiveness of App-based Relaxation for Patients With Chronic Low Back Pain (Relaxback);A Randomized Pragmatic Trial About the Effectiveness of an App Based Relaxation Technique for Patients With Chronic Low Back Pain;Terminated;;N/A;50;Actual;Charite University, Berlin, Germany;;2;;Recruitment problems;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:33:53Z;2020-06-01T12:33:53Z;Berlin;3586034;Principal Investigator;Claudia M Witt, Prof. Dr. med.;Charite University, Berlin, Germany;Relaxation exercise | ususal care;63628207;1;;;2013;2020-05-29;22;FALSE;;FALSE;TRUE;18;65;Years;Years;1;8;
NCT02019134;ClinicalTrials.gov processed this data on May 29, 2020;2013-12-18;;;2017-07-20;2013-12-18;2013-12-24;Estimate;;;;;;;2017-07-20;2017-07-21;Actual;March 31, 2014;Actual;2014-03-31;July 2017;2017-07-31;February 2017;Actual;2017-02-28;November 2016;Actual;2016-11-30;;Interventional;Relaxneck;;Effectiveness of App-based Relaxation for Patients With Chronic Neck Pain;A Randomized Pragmatic Trial About the Effectiveness of an App Based Relaxation Technique for Patients With Chronic Neck Pain;Completed;;N/A;220;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:34:05Z;2020-06-01T12:34:05Z;Berlin;3586064;Principal Investigator;Claudia M Witt, Prof. Dr. med;Institute for Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin;relaxation exercise | ususal care;63628235;1;;;2013;2020-05-29;32;FALSE;;FALSE;TRUE;18;65;Years;Years;1;8;
NCT02018848;ClinicalTrials.gov processed this data on May 29, 2020;2013-11-28;;;2014-11-11;2013-12-17;2013-12-23;Estimate;;;;;;;2014-11-11;2014-11-13;Estimate;October 2013;;2013-10-31;November 2014;2014-11-30;July 2014;Actual;2014-07-31;July 2014;Actual;2014-07-31;;Interventional;;;Internet-delivered Attention Training for Obsessive-Compulsive Disorder;Internet-delivered Attention Training for Obsessive-Compulsive Disorder;Completed;;N/A;108;Actual;Humboldt-Universität zu Berlin;;2;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T12:34:11Z;2020-06-01T12:34:11Z;Berlin;;;;;Attention Training Program;63628258;1;;;2013;2020-05-29;9;FALSE;;FALSE;TRUE;18;65;Years;Years;3;3;8
NCT02015312;ClinicalTrials.gov processed this data on May 29, 2020;2013-11-18;;;2017-10-16;2013-12-12;2013-12-19;Estimate;;;;;;;2017-10-16;2017-10-17;Actual;April 2013;;2013-04-30;October 2017;2017-10-31;October 11, 2017;Actual;2017-10-11;October 11, 2017;Actual;2017-10-11;;Interventional;TAME-AL;;A Trial for the Treatment of Cardiac AL-Amyloidosis With the Green Tea Compound Epigallocatechin-3-gallate (TAME-AL);A Randomised Trial for the Treatment of Cardiac AMyloid Light-chain Amyloidosis With the Green Tea Compound Epigallocatechin-3-gallate (TAME-AL);Completed;;Phase 2;38;Actual;University Hospital Heidelberg;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:34:54Z;2020-06-01T12:34:54Z;Heidelberg;3586410;Principal Investigator;Stefan Schönland, MD;University Hospital of Heidelberg;Epigallocatechin-3-gallate (EGCG) | Placebo;63628532;1;;;2013;2020-05-29;54;FALSE;;FALSE;TRUE;18;;Years;;1;6;
NCT02012985;ClinicalTrials.gov processed this data on May 29, 2020;2013-12-11;;;2015-10-14;2013-12-11;2013-12-17;Estimate;;;;;;;2015-10-14;2015-10-16;Estimate;December 2013;;2013-12-31;October 2015;2015-10-31;January 2015;Actual;2015-01-31;January 2015;Actual;2015-01-31;;Interventional;;;Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Patients With Primary Hyperoxaluria;A Phase 1/2, Randomised, Placebo-controlled, Double-blind, Multi-centre Study to Evaluate the Efficacy and Safety of OC5 to Reduce Urinary Oxalate in Subjects With Primary Hyperoxaluria;Completed;;Phase 1/Phase 2;28;Actual;OxThera;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:35:47Z;2020-06-01T12:35:47Z;Bonn;3586604;Principal Investigator;Bernd Hoppe, MD PhD;Universitätsklinikum Bonn, Dept of Paediatric Nephrology;Oxabact OC5 capsules | Placebo capsules;63628706;8;;;2013;2020-05-29;13;FALSE;;FALSE;FALSE;2;;Years;;1;10;
NCT02008721;ClinicalTrials.gov processed this data on May 29, 2020;2013-12-08;;;2016-12-28;2013-12-08;2013-12-11;Estimate;;;;;;;2016-12-28;2016-12-29;Estimate;January 2014;;2014-01-31;December 2016;2016-12-31;December 2016;Actual;2016-12-31;September 2016;Actual;2016-09-30;;Interventional;PROMESA;;Progression Rate of MSA Under EGCG Supplementation as Anti-Aggregation-Approach;Double-blind, Randomised, Placebo-controlled Parallel Group Study to Investigate the Effect of EGCG Supplementation on Disease Progression of Patients With Multiple System Atrophy (MSA);Completed;;Phase 3;92;Actual;Ludwig-Maximilians - University of Munich;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:36:53Z;2020-06-01T12:36:53Z;Munich;;;;;EGCG as putative neuroprotective agent | Placebo;63629030;12;;;2013;2020-05-29;32;FALSE;;FALSE;FALSE;18;;Years;;1;6;1
NCT02007811;ClinicalTrials.gov processed this data on May 29, 2020;2013-11-21;;;2014-03-24;2013-12-06;2013-12-11;Estimate;;;;;;;2014-03-24;2014-03-26;Estimate;November 2013;;2013-11-30;March 2014;2014-03-31;December 2015;Anticipated;2015-12-31;December 2015;Anticipated;2015-12-31;;Interventional;B-cell therapy;;Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination;Prospective, Open-label, Multicentre Clinical Trial, Phase I/IIa, to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates CD3+-Depleted, CD19+-Enriched, Cryopreserved (Single Administration After Day 120 Following Allogeneic Stem Cell Transplantation (SCT), Donor-identical) in 4 Groups With Escalating Doses for Immune Response Enhancement, Measured as Response to a Antedated Single Vaccination;Unknown status;;Phase 1/Phase 2;15;Anticipated;University of Erlangen-Nürnberg Medical School;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:37:12Z;2020-06-01T12:37:12Z;Erlangen;3587029;Principal Investigator;Julia Winkler, MD;University Hospital Erlangen;allogeneic donor derived B-lymphocytes;63629102;1;;;2013;2020-05-29;;FALSE;;FALSE;TRUE;18;75;Years;Years;3;5;
NCT02007772;ClinicalTrials.gov processed this data on May 29, 2020;2013-09-16;;;2018-11-14;2013-12-06;2013-12-11;Estimate;;;;;;;2018-11-14;2018-11-15;Actual;June 2011;;2011-06-30;November 2018;2018-11-30;July 2017;Actual;2017-07-31;July 2017;Actual;2017-07-31;;Interventional;TIBICO;;Effectiveness of TNI vs. BiPAP in Chronic Global Insufficiency in COPD Patients;Effectiveness of TNI (Nasal High-flow) vs. BiPAP (Biphasic Positive Airway Pressure) in Chronic Global Insufficiency in COPD (Chronic Obstructive Pulmonary Disease) Patients;Completed;;N/A;105;Actual;University of Leipzig;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:37:12Z;2020-06-01T12:37:12Z;Leipzig;3587032;Study Chair;Jens Braeunlich, Dr.;Medical Faculty University Leipzig;nHF | BiPAP;63629105;14;;;2013;2020-05-29;74;FALSE;;FALSE;FALSE;18;;Years;;1;16;
NCT02005237;ClinicalTrials.gov processed this data on May 29, 2020;2013-12-03;;;2017-06-23;2013-12-03;2013-12-09;Estimate;;;;;;;2017-06-23;2017-06-26;Actual;December 2013;;2013-12-31;June 2017;2017-06-30;November 2016;Actual;2016-11-30;May 2016;Actual;2016-05-31;;Interventional;AERCONN;;Exercise in Multiple Sclerosis: Effects on Cognitive Function and Brain Connectivity;Randomized Controlled Trial Investigating the Effects of a Standardized Aerobic Exercise Intervention on Cognitive Function and Brain Connectivity in Relapsing-remitting Multiple Sclerosis;Completed;;N/A;68;Actual;Universitätsklinikum Hamburg-Eppendorf;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:37:56Z;2020-06-01T12:37:56Z;Hamburg;3587234;Principal Investigator;Stefan M Gold, PhD;Center for Molecular Neurobiology, University Hospital Hamburg Eppendorf;Aerobic Exercise;63629296;1;;;2013;2020-05-29;29;FALSE;;FALSE;TRUE;18;65;Years;Years;1;3;2
NCT02004847;ClinicalTrials.gov processed this data on May 29, 2020;2013-11-19;;;2015-11-17;2013-12-03;2013-12-09;Estimate;;;;;;;2015-11-17;2015-12-18;Estimate;September 2013;;2013-09-30;November 2015;2015-11-30;May 2014;Actual;2014-05-31;May 2014;Actual;2014-05-31;;Interventional;;;Blue Light for Treating Psoriasis Vulgaris;Monocenter, Randomized, Double Blinded, Intraindividual, Exploratory Study of Effectiveness and Safety of 3 Months Treatment With 2 Peak Intensities of 453nm Blue Light for the Treatment of Mild Plaque Type Psoriasis Vulgaris;Completed;;N/A;47;Actual;Philips Electronics Nederland BV;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:38:01Z;2020-06-01T12:38:01Z;Aachen;3587270;Principal Investigator;Verena von Felbert, PD, Dr.;Clinic for Dermatology and Allergology, Medical Faculty of the RWTH Aachen, Germany;PSO-CT02;63629326;1;47;0;2013;2020-05-29;8;TRUE;14;FALSE;TRUE;18;75;Years;Years;1;11;4
NCT02004483;ClinicalTrials.gov processed this data on May 29, 2020;2013-11-11;;;2015-09-22;2013-12-03;2013-12-09;Estimate;;;;;;;2015-09-22;2015-09-23;Estimate;August 2010;;2010-08-31;September 2015;2015-09-30;December 2014;Actual;2014-12-31;December 2014;Actual;2014-12-31;;Interventional;PCI-Strain;;Analysis of Myocardial Layer Specific Systolic and Diastolic Function During and After PCI;Comprehensive Analysis of Myocardial Layer Specific Systolic and Diastolic Function in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention;Completed;;N/A;19;Actual;RWTH Aachen University;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:38:06Z;2020-06-01T12:38:06Z;Aachen;3587296;Principal Investigator;Rainer Hoffmann, Prof.Dr.;RWTH Aachen University Hospital;Percutaneous Coronary Intervention;63629354;1;;;2013;2020-05-29;52;FALSE;;FALSE;TRUE;18;90;Years;Years;1;1;
NCT02002871;ClinicalTrials.gov processed this data on May 29, 2020;2013-12-02;;;2015-06-24;2013-12-02;2013-12-06;Estimate;;;;;;;2015-06-24;2015-07-20;Estimate;October 2013;;2013-10-31;June 2015;2015-06-30;March 2014;Actual;2014-03-31;March 2014;Actual;2014-03-31;;Interventional;;;Blue Light for Treating Eczema;Monocenter, Randomized, Intraindividual, Open Label, Exploratory Study Comparing 4 Weeks of Treatment With 453nm Blue Light With no Treatment in Patients With Eczema;Completed;;N/A;21;Actual;Philips Electronics Nederland BV;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:38:45Z;2020-06-01T12:38:45Z;Aachen;3587416;Principal Investigator;Verena von Felbert, PD Dr.;Klinik for Dermatology and Allergy, medical faculty of the RWTH Aachen;PSO-CT02 device;63629477;1;0;0;2013;2020-05-29;5;TRUE;11;FALSE;TRUE;18;75;Years;Years;1;5;6
NCT02002481;ClinicalTrials.gov processed this data on May 29, 2020;2013-11-29;;;2015-05-02;2013-11-29;2013-12-05;Estimate;;;;;;;2015-05-02;2015-05-05;Estimate;December 2013;;2013-12-31;May 2015;2015-05-31;December 2015;Anticipated;2015-12-31;August 2015;Anticipated;2015-08-31;;Interventional;flights;;Comparison of the Quality of CPR by Professional Helpers (Emergency Physicians / Paramedics) During Flights;Vergleich Der Qualität Der Kardiopulmonalen Reanimation Durch Professioneller Helfer (Notärzte / Rettungsassistenten) während Lufttransporten;Unknown status;;N/A;50;Anticipated;University Hospital of Cologne;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:38:49Z;2020-06-01T12:38:49Z;Köln;3587447;Principal Investigator;Stefan Braunecker, MD;University Hospital Cologne;transport;63629507;1;;;2013;2020-05-29;;FALSE;;FALSE;TRUE;18;60;Years;Years;1;1;
NCT02001792;ClinicalTrials.gov processed this data on May 29, 2020;2012-04-14;;;2014-11-13;2013-12-04;2013-12-05;Estimate;;;;;;;2014-11-13;2014-11-14;Estimate;April 2012;;2012-04-30;November 2014;2014-11-30;November 2014;Actual;2014-11-30;February 2014;Actual;2014-02-28;;Interventional;PACSO;;Patient Positioning During Colonoscopy: Effects on Safety and Diagnostic Outcome;;Completed;;N/A;412;Actual;Technische Universität München;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:38:57Z;2020-06-01T12:38:57Z;Munich;3587523;Principal Investigator;Peter Klare, MD;Departmet for Internal Medicine and Gastroenterology, Technical University Munich, Germany;Position the patient during colonoscopy | pulse oximeter;63629561;2;;;2012;2020-05-29;22;FALSE;;FALSE;FALSE;18;90;Years;Years;1;1;
NCT02001480;ClinicalTrials.gov processed this data on May 29, 2020;2013-10-23;;;2016-01-19;2013-11-27;2013-12-05;Estimate;;;;;;;2016-01-19;2016-01-20;Estimate;October 2013;;2013-10-31;January 2016;2016-01-31;December 2015;Actual;2015-12-31;December 2015;Actual;2015-12-31;;Interventional;;;Surrogate Markers for Sudden Cardiac Death in Patients With Diabetes Mellitus and End Stage Renal Disease;;Completed;;N/A;60;Actual;RWTH Aachen University;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:39:00Z;2020-06-01T12:39:00Z;Aachen;3587544;Principal Investigator;Nikolaus Marx, Univ.-Prof.;Department of Internal Medicine University Hospital Aachen;12 lead Holter | CGM Continuous Glucose Monitoring;63629585;3;;;2013;2020-05-29;26;FALSE;;FALSE;FALSE;18;;Years;;1;1;
NCT02000505;ClinicalTrials.gov processed this data on May 29, 2020;2013-11-17;;;2015-05-02;2013-11-26;2013-12-04;Estimate;;;;;;;2015-05-02;2015-05-05;Estimate;November 2013;;2013-11-30;May 2015;2015-05-31;February 2016;Anticipated;2016-02-29;December 2015;Anticipated;2015-12-31;;Interventional;frequenz;;Comparison of the Quality of CPR by Lay Rescuers With and Without Feedback Devices;Comparison of the Quality of CPR by Lay Rescuers With and Without Telephone Instructions by a Simulated Rescue Coordination Center;Unknown status;;N/A;240;Anticipated;University Hospital of Cologne;;4;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:39:13Z;2020-06-01T12:39:13Z;Köln;3587615;Principal Investigator;Stefan Braunecker, MD;University Hospital Cologne;PocketCPR | Metronome | 110bpm Song;63629658;1;;;2013;2020-05-29;;FALSE;;FALSE;TRUE;18;60;Years;Years;1;1;
NCT01997424;ClinicalTrials.gov processed this data on May 29, 2020;2013-10-23;;;2013-11-27;2013-11-27;2013-11-28;Estimate;;;;;;;2013-11-27;2013-11-28;Estimate;May 2013;;2013-05-31;November 2013;2013-11-30;December 2014;Anticipated;2014-12-31;September 2014;Anticipated;2014-09-30;;Interventional;;;ASSOCIATION OF NON-ALCOHOLIC FATTY LIVER DISEASE AND DIABETES MELLITUS;ASSOCIATION OF NON-ALCOHOLIC FATTY LIVER DISEASE AND DIABETES MELLITUS;Unknown status;;N/A;340;Anticipated;Johann Wolfgang Goethe University Hospital;;;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:40:01Z;2020-06-01T12:40:01Z;Frankfurt;3587880;Principal Investigator;Mireen Friedrich-Rust, MD;University Hospital, Frankfurt;Controlled Attenuation Parameter (CAP), Echosens, Paris, France | FibroScan, Echosens, Paris, France;63629890;1;;;2013;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;2;
NCT01995292;ClinicalTrials.gov processed this data on May 29, 2020;2013-11-01;;;2014-11-05;2013-11-21;2013-11-26;Estimate;;;;;;;2014-11-05;2014-11-06;Estimate;October 2013;;2013-10-31;November 2014;2014-11-30;October 2014;Actual;2014-10-31;October 2014;Actual;2014-10-31;;Interventional;;;Comparison of Two Different Types of Spray as You go Technique for Awake Fiberoptic Intubation;Comparative Clinical Trial of Conventional and Modified Spray as You go Technique With the Enk Fiberoptic Atomizer Set for Awake Fiberoptic Intubation (Atomizer Study);Completed;;N/A;100;Actual;Johannes Gutenberg University Mainz;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:40:38Z;2020-06-01T12:40:38Z;Mainz;;;;;bronchoscope | Enk Fiberoptic Atomizer;63630052;1;;;2013;2020-05-29;12;FALSE;;FALSE;TRUE;18;;Years;;1;4;
NCT01994928;ClinicalTrials.gov processed this data on May 29, 2020;2013-11-20;;;2015-03-23;2013-11-20;2013-11-26;Estimate;;;;;;;2015-03-23;2015-03-24;Estimate;November 2013;;2013-11-30;March 2015;2015-03-31;November 2014;Actual;2014-11-30;November 2014;Actual;2014-11-30;;Interventional;;;Preoxygenation in the Intensive Care Unit Using a Nose-mouth Mask Versus High-flow Nasal Cannula Oxygen.;Prospective Randomised Study on Preoxygenation in the Intensive Care Unit Using a Nose-mouth Mask Versus High Flow Nasal Cannula Oxygen.;Completed;;N/A;40;Actual;Universitätsklinikum Hamburg-Eppendorf;;2;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T12:40:51Z;2020-06-01T12:40:51Z;Hamburg;;;;;Nose-mouth mask | High flow nasal cannula oxygen | Intubation;63630079;1;;;2013;2020-05-29;12;FALSE;;FALSE;TRUE;18;;Years;;1;1;1
NCT01991847;ClinicalTrials.gov processed this data on May 29, 2020;2013-11-18;;;2017-11-24;2013-11-18;2013-11-25;Estimate;;;;;;;2017-11-24;2017-11-28;Actual;January 2014;Actual;2014-01-31;November 2017;2017-11-30;April 2015;Actual;2015-04-30;April 2015;Actual;2015-04-30;;Interventional;F-PROTECT;;Tertiary Prevention by Exercise in Colorectal Cancer Therapy;Feasibility Study of the PROTECT-trial (The Potential and Role Of Tertiary Prevention by Exercise in Colorectal Cancer Therapy);Completed;;N/A;50;Actual;Technische Universität München;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:41:54Z;2020-06-01T12:41:54Z;Munich;3588352;Principal Investigator;Martin Halle, Prof. M.D.;Department of Prevention, Rehabilitation and Sports Medicine, Klinikum rechts der Isar, Technical University of Munich;Physical activity;63630316;1;;;2013;2020-05-29;15;FALSE;;FALSE;TRUE;40;80;Years;Years;1;8;
NCT01991691;ClinicalTrials.gov processed this data on May 29, 2020;2013-11-17;;;2016-05-22;2013-11-17;2013-11-25;Estimate;;;;;;;2016-05-22;2016-05-24;Estimate;September 2013;;2013-09-30;May 2016;2016-05-31;December 2015;Actual;2015-12-31;December 2015;Actual;2015-12-31;;Interventional;;;Tablet-based Patient Reported Outcome;Pilot Study for Tablet-based Questionnaire of Patient-reported Outcomes From Patients Undergoing Chemotherapy (TabPRO I);Completed;;N/A;57;Actual;University Hospital, Bonn;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:42:05Z;2020-06-01T12:42:05Z;Bonn;3588364;Principal Investigator;Michael Mallmann, MD;Department of Obstetrics & Gynecology, University Hospital Bonn;Tablet-based questionnaire;63630327;3;;;2013;2020-05-29;27;FALSE;;FALSE;FALSE;18;100;Years;Years;1;1;
NCT01989429;ClinicalTrials.gov processed this data on May 29, 2020;2013-10-28;;;2015-12-01;2013-11-14;2013-11-21;Estimate;;;;;;;2015-12-01;2015-12-31;Estimate;October 2013;;2013-10-31;December 2015;2015-12-31;December 2014;Actual;2014-12-31;December 2014;Actual;2014-12-31;;Interventional;;;Efficacy Study Comparing Topical M518101 and Vitamin D3 in Adult Psoriasis Patients;A Randomized, Double-blind, Parallel Group Phase III Multi-center Trial to Compare Twice Daily Topical Application of M518101, Daivonex® and Vehicle in Patients With Plaque Psoriasis III;Completed;;Phase 3;788;Actual;Maruho Europe Limited;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:42:41Z;2020-06-01T12:42:41Z;Lübeck;3588547;Principal Investigator;D Thaci, Prof.Dr;University of Lubeck, Dermatology Department;M518101;63630501;6;;;2013;2020-05-29;14;FALSE;;FALSE;FALSE;18;;Years;;1;1;
NCT01988818;ClinicalTrials.gov processed this data on May 29, 2020;2013-11-13;;;2016-05-10;2013-11-13;2013-11-20;Estimate;;;;;;;2016-05-10;2016-05-11;Estimate;April 2014;;2014-04-30;May 2016;2016-05-31;May 2016;Actual;2016-05-31;December 2015;Actual;2015-12-31;;Interventional;Close;;Prospective, Randomized Study of 2 Different Wound Dressings;A Mono-centre, Post CE-mark, Prospective-randomized Clinical Trial to Evaluate the Performance of a Flexible Self-adherent Absorbent Dressing Coated With a Soft Silicone Layer After Hip or Knee Arthroplasty or Primary Spine Surgery in Comparison to a Standard Wound Dressing (Cosmopor E®Steril, Fa. Hartmann);Completed;;N/A;200;Actual;University of Cologne;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:42:46Z;2020-06-01T12:42:46Z;Köln;3588605;Principal Investigator;Jan Bredow, physician;University Hospital of Cologne;Mepilex® Border Post-Op | standard wound dressing;63630549;1;;;2013;2020-05-29;20;FALSE;;FALSE;TRUE;18;;Years;;1;4;
NCT01986517;ClinicalTrials.gov processed this data on May 29, 2020;2013-11-11;;;2015-03-19;2013-11-11;2013-11-18;Estimate;;;;;;;2015-03-19;2015-03-20;Estimate;November 2013;;2013-11-30;March 2015;2015-03-31;March 2015;Actual;2015-03-31;March 2015;Actual;2015-03-31;;Interventional;;;Feedback and Psychotherapeutic Competencies;Impact of Feedback on the Devolpment of Psychotherapeutic Competencies: a Randomized Controlled Trial;Completed;;N/A;20;Actual;Goethe University;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:43:29Z;2020-06-01T12:43:29Z;Frankfurt;3588783;Principal Investigator;Florian Weck, PhD;Goethe University;No feedback | Feedback after every fourth session;63630720;1;;;2013;2020-05-29;16;FALSE;;FALSE;TRUE;18;65;Years;Years;1;12;
NCT01984788;ClinicalTrials.gov processed this data on May 29, 2020;2013-11-05;;;2014-08-14;2013-11-14;2013-11-15;Estimate;;;;;;;2014-08-14;2014-08-18;Estimate;November 2013;;2013-11-30;August 2014;2014-08-31;May 2014;Actual;2014-05-31;May 2014;Actual;2014-05-31;;Interventional;OPuS-1;;Safety and Efficacy of Oral BCX4161 as a Prophylactic Treatment for HAE;A Phase 2a Double-Blind Placebo-Controlled 2-Period Crossover Study to Evaluate the Safety and Efficacy of BCX4161 as a Prophylactic Treatment to Reduce the Frequency of Attacks in Subjects With Hereditary Angioedema;Completed;;Phase 2;24;Actual;BioCryst Pharmaceuticals;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:43:50Z;2020-06-01T12:43:50Z;Berlin;3588933;Principal Investigator;Marcus Maurer, MD;Charite University, Berlin, Germany;BCX4161 | Placebo;63630854;6;;;2013;2020-05-29;6;FALSE;;FALSE;FALSE;18;65;Years;Years;1;4;
NCT01974011;ClinicalTrials.gov processed this data on May 29, 2020;2013-10-28;;;2019-02-20;2013-10-28;2013-11-01;Estimate;;;;;;;2019-02-20;2019-02-21;Actual;November 25, 2013;Actual;2013-11-25;February 2019;2019-02-28;January 6, 2016;Actual;2016-01-06;January 5, 2016;Actual;2016-01-05;;Interventional;;;DPNB vs. Modified DPNB With Ventromedial Infiltration (DPNB According to Dalens' Technique);Comparison of Dorsal Penile Nerve Block (DPNB According to Dalens' Technique) to Dorsale Penile Nerve Block With Ventromedial Infiltration;Completed;;N/A;86;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:46:41Z;2020-06-01T12:46:41Z;Berlin;3589818;Study Director;Claudia Spies, MD, Prof.;Department of Anesthesiology and Intensive Care Medicine CVK/CCM, Charité - University Medicine Berlin;Performing dorsal penile nerve block (DPNB);63631675;1;;;2013;2020-05-29;25;FALSE;;FALSE;TRUE;1;17;Year;Years;1;5;
NCT01972750;ClinicalTrials.gov processed this data on May 29, 2020;2013-10-24;;;2016-04-18;2013-10-29;2013-10-30;Estimate;;;;;;;2016-04-18;2016-04-19;Estimate;October 2013;;2013-10-31;April 2016;2016-04-30;November 2016;Anticipated;2016-11-30;November 2016;Anticipated;2016-11-30;;Interventional;TKI258;;Dovitinib (TKI258) in the Treatment of Patients With Relapsed Glioblastoma;The Multi-targeted Tyrosine Kinase Inhibitor Dovitinib (TKI258) in the Treatment of Patients With Relapsed Glioblastoma;Unknown status;;Phase 1;12;Actual;University Hospital, Bonn;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:47:07Z;2020-06-01T12:47:07Z;Bonn;3589921;Principal Investigator;Martin Glas, MD;Neurooncology, University Hospital Bonn;Dovitinib;63631771;1;;;2013;2020-05-29;;FALSE;;FALSE;TRUE;18;100;Years;Years;1;5;
NCT01970384;ClinicalTrials.gov processed this data on May 29, 2020;2013-10-22;;;2015-10-12;2013-10-22;2013-10-28;Estimate;;;;;;;2015-10-12;2015-10-14;Estimate;June 2012;;2012-06-30;October 2015;2015-10-31;December 2014;Actual;2014-12-31;December 2014;Actual;2014-12-31;;Interventional;;;Transcranial Direct Current Stimulation for Dysphagia Therapy in Acute Stroke Patients;Transcranial Direct Current Stimulation for Dysphagia Therapy in Acute Stroke Patients;Completed;;N/A;60;Actual;University Hospital Muenster;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:47:58Z;2020-06-01T12:47:58Z;Münster;3590112;Principal Investigator;Rainer Dziewas, PhD;Department of Neurology, University of Muenster;Transcranial direct current stimulation | Sham stimulation;63631953;1;;;2013;2020-05-29;30;FALSE;;FALSE;TRUE;18;90;Years;Years;1;3;
NCT01969929;ClinicalTrials.gov processed this data on May 29, 2020;2013-10-18;;;2015-05-29;2013-10-21;2013-10-25;Estimate;;;;;;;2015-05-29;2015-06-01;Estimate;October 2013;;2013-10-31;May 2015;2015-05-31;October 2015;Anticipated;2015-10-31;October 2015;Anticipated;2015-10-31;;Interventional;20Gvs23G;;Comparison of Postoperative Aqueous Flare After 20G Versus 23G Pars Plana Vitrectomy;Comparison of Postoperative Aqueous Flare After 20G Versus 23G Pars Plana Vitrectomy;Unknown status;;N/A;100;Anticipated;University of Cologne;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:48:03Z;2020-06-01T12:48:03Z;Köln;;;;;20G Vitrectomy | 23G vitrectomy;63631988;1;;;2013;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;2;1
NCT01969045;ClinicalTrials.gov processed this data on May 29, 2020;2013-10-21;;;2016-02-17;2013-10-23;2013-10-24;Estimate;;;;;;;2016-02-17;2016-02-18;Estimate;February 2014;;2014-02-28;February 2016;2016-02-29;February 2016;Actual;2016-02-29;February 2016;Actual;2016-02-29;;Interventional;EnkAtomizer;;Effect of the EnkFiberoptic Atomizer Set on Usage of Anaesthetics During the Bronchoscopy;Effect of the EnkFiberoptic Atomizer Set on Usage of Anaesthetics During the Bronchoscopy;Completed;;Phase 4;30;Actual;RWTH Aachen University;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:48:16Z;2020-06-01T12:48:16Z;Aachen;3590220;Principal Investigator;Tobias Müller, Dr. med.;Department of Cardiology, Pneumology, Vascular Medicine and Intensive Care Medicine, RWTH Aachen University Hospital;Enk Fiberoptic Atomizer | bronchoscope;63632053;1;;;2013;2020-05-29;24;FALSE;;FALSE;TRUE;18;85;Years;Years;1;1;
NCT01968239;ClinicalTrials.gov processed this data on May 29, 2020;2013-10-18;;;2018-11-30;2013-10-18;2013-10-23;Estimate;;;;;;;2018-11-30;2018-12-03;Actual;October 2013;Actual;2013-10-31;November 2018;2018-11-30;December 20, 2016;Actual;2016-12-20;June 17, 2016;Actual;2016-06-17;;Interventional;RabOCT;;Proof of Concept Study of Re-treatment in BRVO With Ranibizumab Guided by OCT;A Randomized, Controlled Interventional Phase 2b (Proof of Concept) Study of the Efficacy, Safety, and Tolerability of Repeated Intravitreal Administration of Ranibizumab Guided by Morphological Changes Documented by Optical Coherence Tomography (OCT) in Subjects With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO);Completed;;Phase 2;27;Actual;University of Leipzig;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:48:31Z;2020-06-01T12:48:31Z;Leipzig;3590278;Principal Investigator;Matus Rehak, MD, Ph.D.;Department of Ophthalmology, University of Leipzig, Germany;Ranibizumab;63632115;1;;;2013;2020-05-29;32;FALSE;;FALSE;TRUE;18;;Years;;1;4;
NCT01967407;ClinicalTrials.gov processed this data on May 29, 2020;2013-10-15;;;2014-11-18;2013-10-17;2013-10-22;Estimate;;;;;;;2014-11-18;2014-11-19;Estimate;October 2013;;2013-10-31;November 2014;2014-11-30;January 2016;Anticipated;2016-01-31;December 2015;Anticipated;2015-12-31;;Interventional;IRENE;;IReversible Electroporation of Kidney Tumors Before Partial Nephrectomy.;Prospective, Monocentric, Clinical Phase-I/II Study of the Effectiveness of the Percutaneous Irreversible Electroporation (IRE) of Locally Confined Kidney Tumors (Renal Cell Carcinomas).;Unknown status;;Phase 1/Phase 2;20;Anticipated;University of Magdeburg;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:48:44Z;2020-06-01T12:48:44Z;Magdeburg;3590348;Principal Investigator;Uwe- B. Liehr, Dr. med.;Department of Urology, University Magdeburg, Germany.;Irreversible Electroporation (IRE);63632180;4;;;2013;2020-05-29;;FALSE;;FALSE;FALSE;18;;Years;;1;1;
NCT01967355;ClinicalTrials.gov processed this data on May 29, 2020;2013-07-26;;;2018-08-07;2013-10-17;2013-10-22;Estimate;;;;;;;2018-08-07;2018-08-09;Actual;April 2013;;2013-04-30;August 2018;2018-08-31;May 8, 2014;Actual;2014-05-08;May 8, 2014;Actual;2014-05-08;;Interventional;;;Prolongation of Pregnancy in Preeclampsia by Therapeutic Lipid Apheresis;Prolongation of Pregnancy in Preeclampsia by Therapeutic Lipid Apheresis;Completed;;N/A;6;Actual;University Hospital Freiburg;;1;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T12:48:44Z;2020-06-01T12:48:44Z;Freiburg;3590353;Principal Investigator;Karl Winkler, Prof.Dr.med.;Institute of Clinical Chemestry and Laboratory Medicine, University Hospital Freiburg;lipid apheresis;63632184;1;;;2013;2020-05-29;12;FALSE;;FALSE;TRUE;18;;Years;;1;1;2
NCT01966783;ClinicalTrials.gov processed this data on May 29, 2020;2013-10-09;;;2019-05-03;2013-10-21;2013-10-22;Estimate;;;;;;;2019-05-03;2019-05-07;Actual;September 2013;;2013-09-30;May 2019;2019-05-31;August 2015;Actual;2015-08-31;August 2015;Actual;2015-08-31;;Interventional;;;Budesonide vs. Mesalazine vs. Budesonide/Mesalazine Suppository Combination Therapy in Acute Ulcerative Proctitis;Randomized, Double-blind, Multicentre Study to Compare the Efficacy and Safety of Budesonide Versus Mesalazine Suppository Versus a Combination Therapy of Budesonide/Mesalazine Suppositories in Patients With Acute Ulcerative Proctitis;Completed;;Phase 2;320;Anticipated;Dr. Falk Pharma GmbH;;4;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:48:52Z;2020-06-01T12:48:52Z;Berlin;3590400;Principal Investigator;Britta Siegmund, Professor;Charité-Campus Benjamin Franklin Universitätsmedizin Berlin;Budesonide 2 mg suppository | Budesonide 4 mg suppository | Mesalazine 1 g suppository | Budesonide 2 mg suppository/Mesalazine 1 g suppository;63632228;2;;;2013;2020-05-29;23;FALSE;;FALSE;FALSE;18;75;Years;Years;1;4;
NCT01966146;ClinicalTrials.gov processed this data on May 29, 2020;2013-07-17;;;2014-12-01;2013-10-16;2013-10-21;Estimate;;;;;;;2014-12-01;2014-12-02;Estimate;May 2013;;2013-05-31;December 2014;2014-12-31;October 2014;Actual;2014-10-31;October 2014;Actual;2014-10-31;;Interventional;3D_TTE_TAVI;;Examination of Valve Insufficiency Before and After MitraClip or TAVI Procedure by 3D Echocardiography Compared to MRI;Quantitative Analysis of Catheter-based Interventional Therapies for Treating Valve Insufficiency by Using 3D Echocardiography.;Completed;;N/A;200;Anticipated;RWTH Aachen University;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:49:06Z;2020-06-01T12:49:06Z;Aachen;;;;;Echography GE Healthcare Vivid E9;63632277;1;;;2013;2020-05-29;17;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT01966120;ClinicalTrials.gov processed this data on May 29, 2020;2013-10-17;;;2016-10-26;2013-10-17;2013-10-21;Estimate;;;;;;;2016-10-26;2016-12-19;Estimate;October 2013;;2013-10-31;October 2016;2016-10-31;April 2015;Actual;2015-04-30;September 2014;Actual;2014-09-30;;Interventional;;;Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT);A Randomized, Double-blind, Phase III, Multi-center Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) Versus Placebo in the Field-directed Treatment of Mild to Moderate Actinic Keratosis With Photodynamic Therapy (PDT) When Using the BF-RhodoLED® Lamp;Completed;;Phase 3;87;Actual;Biofrontera Bioscience GmbH;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T12:49:06Z;2020-06-01T12:49:06Z;Bonn;3590451;Principal Investigator;Uwe Reinhold, Prof. Dr.;Dermatologisches Zentrum Bonn;BF-200 ALA gel | Placebo to BF-200 ALA gel | Photodynamic therapy with BF-RhodoLED;63632279;1;310;6;2013;2020-05-29;11;TRUE;20;FALSE;TRUE;18;85;Years;Years;2;7;
NCT01965028;ClinicalTrials.gov processed this data on May 29, 2020;2013-10-14;;;2016-03-04;2013-10-14;2013-10-18;Estimate;;;;;;;2016-03-04;2016-03-07;Estimate;October 2013;;2013-10-31;March 2016;2016-03-31;January 2016;Actual;2016-01-31;January 2016;Actual;2016-01-31;;Interventional;tRNS-tin;;Daily Bi-temporal Transcranial Random Noise Stimulation in Tinnitus;Effectiveness of Daily Bi-temporal Transcranial Random Noise Stimulation in Patients With Chronic Tinnitus;Completed;;N/A;30;Actual;University of Regensburg;;1;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T12:49:26Z;2020-06-01T12:49:26Z;Regensburg;3590578;Principal Investigator;Berthold Langguth, MD, Ph.D.;University of Regensburg;Transcranial random noise stimulation (tRNS);63632364;1;;;2013;2020-05-29;27;FALSE;;FALSE;TRUE;18;70;Years;Years;1;12;
NCT01963793;ClinicalTrials.gov processed this data on May 29, 2020;2013-09-18;;;2014-10-06;2013-10-11;2013-10-16;Estimate;;;;;;;2014-10-06;2014-10-07;Estimate;October 2013;;2013-10-31;February 2014;2014-02-28;July 2014;Actual;2014-07-31;July 2014;Actual;2014-07-31;;Interventional;iTAPP;;Topical Aprepitant in Prurigo Patients;Topical Aprepitant in Prurigo Patients An Exploratory Phase IIa Trial With Topically Applied Aprepitant in Patients With Prurigo;Completed;;Phase 2;20;Actual;LEO Pharma;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:49:46Z;2020-06-01T12:49:46Z;Berlin;3590673;Principal Investigator;Maurer (ICI) Marcus, Prof. Dr. med.;Allergie-Centrum-Charité, Charité Universitätsmedizin Berlin, Charitéplatz1, D-10117 Berlin;Aprepitant | Placebo;63632462;1;;;2013;2020-05-29;9;FALSE;;FALSE;TRUE;18;80;Years;Years;1;3;
NCT01963494;ClinicalTrials.gov processed this data on May 29, 2020;2013-09-30;;;2016-01-05;2013-10-11;2013-10-16;Estimate;;;;;;;2016-01-05;2016-01-06;Estimate;March 2013;;2013-03-31;January 2016;2016-01-31;January 2016;Actual;2016-01-31;February 2015;Actual;2015-02-28;;Interventional;DiM;;Days in Motion: A Planning Intervention Study With Couples to Enhance Daily Physical Activity;Days in Motion: A Planning Intervention Study With Couples to Enhance Daily Physical Activity (DiM);Completed;;N/A;346;Actual;Freie Universität Berlin;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:49:51Z;2020-06-01T12:49:51Z;Berlin;3590697;Study Chair;Nina Knoll, Univ.-Prof.;Freie Universität Berlin;Dyadic planning intervention | Individual planning intervention | General motivational treatment;63632487;1;;;2013;2020-05-29;23;FALSE;;FALSE;TRUE;18;;Years;;1;10;
NCT01959737;ClinicalTrials.gov processed this data on May 29, 2020;2013-10-07;;;2018-06-24;2013-10-09;2013-10-10;Estimate;;;;;;;2018-06-24;2018-06-26;Actual;October 2013;Actual;2013-10-31;June 2018;2018-06-30;January 2016;Actual;2016-01-31;July 2015;Actual;2015-07-31;;Interventional;deisy;;Delivery Room Skin-to-skin Study;Influence of Early SSC of Mothers and Their VLBW Infants on Maternal Sensitivity and Responsiveness, Attachment Patterns and Reactivity of HPA Axis. Molecular Characterization of SSC Influence on Stress Signaling Pathways.;Completed;;N/A;88;Anticipated;University of Cologne;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:50:49Z;2020-06-01T12:50:49Z;Köln;;;;;skin-to.skin-contact;63632774;1;;;2013;2020-05-29;21;FALSE;;FALSE;TRUE;;60;;Minutes;1;2;
NCT01959451;ClinicalTrials.gov processed this data on May 29, 2020;2013-10-08;;;2019-02-28;2013-10-08;2013-10-10;Estimate;;;;;;;2019-02-28;2019-03-01;Actual;September 2013;;2013-09-30;February 2019;2019-02-28;June 2017;Actual;2017-06-30;May 2016;Actual;2016-05-31;;Interventional;TROPICAL-ACS;;Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment For Acute Coronary Syndromes Trial;Platelet Function Guided Prasugrel Therapy in ACS Patients Undergoing PCI;Completed;;Phase 4;2600;Actual;Klinikum der Universitaet Muenchen;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:50:57Z;2020-06-01T12:50:57Z;Munich;3591028;Principal Investigator;Dirk Sibbing, MD;Munich University Hospital;Prasugrel | Clopidogrel;63632795;33;;;2013;2020-05-29;32;FALSE;;FALSE;FALSE;18;80;Years;Years;1;3;1
NCT01956175;ClinicalTrials.gov processed this data on May 29, 2020;2013-09-24;;;2015-02-19;2013-10-01;2013-10-08;Estimate;;;;;;;2015-02-19;2015-02-20;Estimate;June 2013;;2013-06-30;February 2015;2015-02-28;December 2014;Actual;2014-12-31;August 2014;Actual;2014-08-31;;Interventional;;;Electrical Pharyngeal Stimulation for Dysphagia Therapy in Tracheostomized Stroke Patients;A Single-centre, Double Blind, Randomised Controlled Clinical Trial to Evaluate the Effect of Electrical Pharyngeal Stimulation as a Treatment for Stroke-related Dysphagia in Tracheostomized Stroke Patients;Completed;;N/A;30;Actual;University Hospital Muenster;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:51:46Z;2020-06-01T12:51:46Z;Münster;3591289;Principal Investigator;Rainer Dziewas, PhD;Department of Neurology, University of Muenster;Electrical pharyngeal stimulation | Sham stimulation;63633050;1;;;2013;2020-05-29;14;FALSE;;FALSE;TRUE;18;90;Years;Years;1;3;
NCT01954836;ClinicalTrials.gov processed this data on May 29, 2020;2013-09-29;;;2016-12-12;2013-09-29;2013-10-07;Estimate;;;;;;;2016-12-12;2016-12-13;Estimate;October 2013;;2013-10-31;December 2016;2016-12-31;March 2015;Actual;2015-03-31;March 2015;Actual;2015-03-31;;Interventional;FIT;;Short-Term Fasting During Chemotherapy in Patients With Gynecological Cancer- a Randomized Controlled Cross-over Trial;Short-Term Fasting During Chemotherapy in Patients With Gynecological Cancer- a Randomized Controlled Cross-over Trial;Completed;;N/A;50;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T12:52:11Z;2020-06-01T12:52:11Z;Berlin;3591428;Principal Investigator;andreas A Michalsen, M.D.;Charite University;initial fasting | Secondary fasting;63633125;2;;;2013;2020-05-29;17;FALSE;;FALSE;FALSE;35;70;Years;Years;1;3;
NCT01954914;ClinicalTrials.gov processed this data on May 29, 2020;2013-09-27;;;2016-09-16;2013-09-27;2013-10-07;Estimate;;;;;;;2016-09-16;2016-09-19;Estimate;December 2013;;2013-12-31;September 2016;2016-09-30;January 2016;Actual;2016-01-31;January 2016;Actual;2016-01-31;;Interventional;MOBIL1;;Plerixafor as a Salvage Regimen to Mobilize Allogeneic Stem Cells in Healthy Volunteers;Plerixafor as a Salvage Regimen to Mobilize Allogeneic Stem Cells in Healthy Volunteers;Completed;;Phase 2;39;Actual;Technische Universität Dresden;;1;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T12:52:11Z;2020-06-01T12:52:11Z;Dresden;3591421;Principal Investigator;Kristina Hölig, Dr. med.;Universitätsklinikum Carl Gustav Carus, Medizinische Klinik und Poliklinik I, 01307 Dresden;Plerixafor;63633148;3;;;2013;2020-05-29;25;FALSE;;FALSE;FALSE;18;75;Years;Years;1;1;
NCT01953549;ClinicalTrials.gov processed this data on May 29, 2020;2013-06-28;;;2019-06-04;2013-09-26;2013-10-01;Estimate;;;;;;;2019-06-04;2019-06-06;Actual;October 2013;;2013-10-31;June 2019;2019-06-30;November 1, 2017;Actual;2017-11-01;July 6, 2017;Actual;2017-07-06;;Interventional;;;Physical Fitness Training in Subacute Stroke (PHYS-Stroke);Physical Fitness Training in Subacute Stroke (PHYS-Stroke);Completed;;Phase 3;200;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:52:45Z;2020-06-01T12:52:45Z;Berlin;;;;;physical fitness training | relaxation;63633253;7;;;2013;2020-05-29;44;FALSE;;FALSE;FALSE;18;99;Years;Years;1;11;12
NCT01949064;ClinicalTrials.gov processed this data on May 29, 2020;2013-09-17;;;2014-12-02;2013-09-23;2013-09-24;Estimate;;;;;;;2014-12-02;2014-12-03;Estimate;July 2011;;2011-07-31;December 2014;2014-12-31;January 2014;Actual;2014-01-31;January 2014;Actual;2014-01-31;;Interventional;;;Use of Electromyography With Bio-Feedback for the Treatment of Craniomandibular Disorders;Anwendung Von Elektromyographie Mit Gleichzeitigem Bio-Feedback Zur Behandlung Von Craniomandibulären Dysfunktionen Und/Oder Bruxismus.;Completed;;Phase 2;44;Actual;Heidelberg University;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:53:52Z;2020-06-01T12:53:52Z;Heidelberg;;;;;Grindcare | Michigan-type occlusal splint;63633597;1;;;2013;2020-05-29;30;FALSE;;FALSE;TRUE;18;70;Years;Years;1;;
NCT01948726;ClinicalTrials.gov processed this data on May 29, 2020;2013-08-23;;;2015-12-09;2013-09-18;2013-09-24;Estimate;;;;;;;2015-12-09;2015-12-10;Estimate;December 2013;;2013-12-31;December 2015;2015-12-31;March 2015;Actual;2015-03-31;March 2015;Actual;2015-03-31;;Interventional;;;Hypofractionation With Simultaneous Integrated Boost for Early Breast Cancer;Multicenter Phase-II-Trial of Evaluation of Acute Toxicity in Hypofractionation With Simultaneous Integrated Boost for Early Breast Cancer;Completed;;Phase 2;150;Actual;University of Schleswig-Holstein;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:53:57Z;2020-06-01T12:53:57Z;Kiel Lübeck;3592007;Study Chair;Juergen Dunst, Prof.;University Medical Center Schleswig-Holstein (UKSH);Hypofractionation with simultaneous integrated boost;63633623;19;;;2013;2020-05-29;15;FALSE;;FALSE;FALSE;18;;Years;;1;4;1
NCT01947595;ClinicalTrials.gov processed this data on May 29, 2020;2013-06-25;;;2017-08-22;2013-09-17;2013-09-20;Estimate;;;;;;;2017-08-22;2017-08-23;Actual;March 2012;;2012-03-31;August 2017;2017-08-31;August 2017;Actual;2017-08-31;August 2017;Actual;2017-08-31;;Interventional;PLIS;;Individualized Lifestyle Intervention in Subjects With Prediabetes;Prediabetes Lifestyle Intervention Study;Completed;;N/A;1145;Actual;University Hospital Tuebingen;;4;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T12:54:10Z;2020-06-01T12:54:10Z;Tübingen;3592096;Principal Investigator;Andreas Fritsche, Prof. Dr. med;University Hospital Tuebingen;intensified lifestyle intervention | normal lifestyle intervention | Single lifestyle advice;63633707;7;;;2013;2020-05-29;65;FALSE;;FALSE;FALSE;18;75;Years;Years;1;3;2
NCT01942473;ClinicalTrials.gov processed this data on May 29, 2020;2012-08-03;;;2014-11-25;2013-09-10;2013-09-16;Estimate;;;;;;;2014-11-25;2014-11-26;Estimate;August 2012;;2012-08-31;November 2014;2014-11-30;April 2014;Actual;2014-04-30;September 2013;Actual;2013-09-30;;Interventional;FiO2-Contr;;Effects of Automated Adjustment of FiO2 on Cerebral and Arterial Oxygenation in Preterm Infants;Effects of Automated Adjustment of Inspired Oxygen on Fluctuations of Regional Cerebral and Arterial Oxygenation in Preterm Infants With Frequent Desaturations;Completed;;N/A;17;Actual;University of Ulm;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:55:46Z;2020-06-01T12:55:46Z;Ulm;3592505;Principal Investigator;Markus Waitz, MD;Children's Hospital, University of Ulm;Automated FiO2 Control;63634100;1;;;2012;2020-05-29;13;FALSE;;FALSE;TRUE;;30;;Weeks;1;3;
NCT01942447;ClinicalTrials.gov processed this data on May 29, 2020;2013-09-05;;;2013-10-10;2013-09-13;2013-09-16;Estimate;;;;;;;2013-10-10;2013-10-11;Estimate;October 2013;;2013-10-31;October 2013;2013-10-31;May 2015;Anticipated;2015-05-31;December 2014;Anticipated;2014-12-31;;Interventional;TOCSIN;;Fecal Microbiota Transplantation in Recurrent or Refractory Clostridium Difficile Colitis;;Unknown status;;N/A;30;Anticipated;University Hospital Tuebingen;;2;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T12:55:47Z;2020-06-01T12:55:47Z;Tübingen;;;;;FMT | Vancomycin;63634102;1;;;2013;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;1;1
NCT01941550;ClinicalTrials.gov processed this data on May 29, 2020;2013-07-22;;;2016-09-12;2013-09-09;2013-09-13;Estimate;;;;;;;2016-09-12;2016-09-13;Estimate;July 2013;;2013-07-31;September 2016;2016-09-30;January 2016;Actual;2016-01-31;January 2016;Actual;2016-01-31;;Interventional;CLUBNET;;Neoadjuvant Chemotherapy With Cabazitaxel;Neoadjuvant Chemotherapy With Cabazitaxel in High Risk Prostate Cancer Patients Prior to Radical Prostatectomy;Terminated;;Phase 2;11;Actual;RWTH Aachen University;;1;;Investigator left the site. Site closed.;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:55:56Z;2020-06-01T12:55:56Z;Aachen;;;;;Cabazitaxel chemotherapy;63634167;1;;;2013;2020-05-29;30;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT01937767;ClinicalTrials.gov processed this data on May 29, 2020;2013-08-29;;;2020-01-15;2013-09-04;2013-09-10;Estimate;;;;;;;2020-01-15;2020-01-18;Actual;August 2013;;2013-08-31;January 2020;2020-01-31;February 19, 2014;Actual;2014-02-19;February 2014;Actual;2014-02-28;;Interventional;;;Remimazolam Phase II Cardiac Anesthesia Study;A Randomized, Single-blind Phase II Study Evaluating the Efficacy, Safety and Pharmacokinetics of Remimazolam in General Anesthesia in Adult Patients Undergoing Cardiac Surgery, Including Follow-up Sedation in the PACU/ICU;Completed;;Phase 2;90;Actual;Paion UK Ltd.;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:57:07Z;2020-06-01T12:57:07Z;Leipzig;3592878;Principal Investigator;Stefan Probst, MD;Heart Center Leipzig - University Hospital;Remimazolam | Propofol | Sevoflurane | Remifentanil | Fentanyl | Rocuronium;63634460;1;;;2013;2020-05-29;6;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT01937702;ClinicalTrials.gov processed this data on May 29, 2020;2013-08-27;;;2014-12-29;2013-09-04;2013-09-09;Estimate;;;;;;;2014-12-29;2014-12-30;Estimate;April 2014;;2014-04-30;December 2014;2014-12-31;September 2014;Actual;2014-09-30;September 2014;Actual;2014-09-30;;Interventional;;;A Trial Investigating the Influence of Injection Speed and Volume on the Perception of Subcutaneous Injection Pain;A Trial Investigating the Influence of Injection Speed and Volume on the Perception of Subcutaneous Injection Pain;Completed;;Phase 1;80;Actual;Profil Institut für Stoffwechselforschung GmbH;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:57:09Z;2020-06-01T12:57:09Z;Mainz;3592882;Principal Investigator;Thomas Forst, Prof, MD;Profil Mainz GmbH & Co KG;0.9% NaCl (sodium chloride);63634464;1;;;2013;2020-05-29;5;FALSE;;FALSE;TRUE;18;74;Years;Years;1;1;
NCT01937351;ClinicalTrials.gov processed this data on May 29, 2020;2013-09-04;;;2017-04-05;2013-09-04;2013-09-09;Estimate;;;;;;;2017-04-05;2017-05-12;Actual;July 2014;Actual;2014-07-31;April 2017;2017-04-30;May 2017;Anticipated;2017-05-31;May 2017;Anticipated;2017-05-31;;Interventional;VISION;;Evaluation of the Pantheris Atherectomy System;Evaluation of the Pantheris Optical Coherence Tomography Imaging Atherectomy System for Use in the Peripheral Vasculature;Unknown status;;N/A;162;Actual;Avinger, Inc.;;1;;;FALSE;;;;TRUE;FALSE;TRUE;;;;;;;;;No;;2020-06-01T12:57:14Z;2020-06-01T12:57:14Z;Münster;3592919;Principal Investigator;Arne Schwindt, MD;Muenster Hospital;Pantheris System;63634490;21;44;195;2013;2020-05-29;;TRUE;-1;TRUE;FALSE;18;;Years;;2;7;
NCT01935531;ClinicalTrials.gov processed this data on May 29, 2020;2013-08-30;;;2016-03-30;2013-09-04;2013-09-05;Estimate;;;;;;;2016-03-30;2016-03-31;Estimate;June 2013;;2013-06-30;March 2016;2016-03-31;March 2016;Actual;2016-03-31;January 2016;Actual;2016-01-31;;Interventional;;;Effects of Topical Diclofenac on Tumor Metabolism;Prospective, Controlled and Monocentric Study to Evaluate the Effects of Topical 3% Diclofenac in 2.5% Hyaluronic Acid Gel on Tumor Metabolism in the Treatment of Actinic Keratoses in Immunocompetent and Immunocompromised Patients;Completed;;Phase 4;38;Actual;University Hospital Regensburg;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:57:34Z;2020-06-01T12:57:34Z;Regensburg;;;;;3% diclofenac in 2.5% hyaluronic acid gel;63634631;1;;;2013;2020-05-29;31;FALSE;;FALSE;TRUE;18;;Years;;1;3;
NCT01935297;ClinicalTrials.gov processed this data on May 29, 2020;2013-07-05;;;2015-01-22;2013-08-30;2013-09-05;Estimate;;;;;;;2015-01-22;2015-01-26;Estimate;June 2013;;2013-06-30;January 2015;2015-01-31;January 2015;Actual;2015-01-31;January 2015;Actual;2015-01-31;;Interventional;SPORT:TAVI;;Exercise Training After Transcatheter Aortic Valve Implantation;Safety, Applicability and Outcome of Regular Exercise Training After Transcatheter Aortic Valve Implantation;Completed;;N/A;30;Actual;Technische Universität München;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:57:36Z;2020-06-01T12:57:36Z;Munich;3593082;Principal Investigator;Axel Pressler, MD;Prevention, Rehabilitation & Sports Medicine, Technische Universität München, Germany;Exercise;63634649;1;;;2013;2020-05-29;19;FALSE;;FALSE;TRUE;;;;;1;1;1
NCT01934699;ClinicalTrials.gov processed this data on May 29, 2020;2013-08-29;;;2015-09-22;2013-08-29;2013-09-04;Estimate;;;;;;;2015-09-22;2015-09-23;Estimate;June 2011;;2011-06-30;September 2015;2015-09-30;July 2016;Anticipated;2016-07-31;May 2016;Anticipated;2016-05-31;;Interventional;;;Intraprocedural Determination of Myocardial Vitality Using 2 Different Imaging Methods;Intraprocedural Determination of Myocardial Vitality Using Speckle Tracking Echocardiography Compared to Two-time MRI Diagnostics;Unknown status;;N/A;130;Actual;RWTH Aachen University;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:57:41Z;2020-06-01T12:57:41Z;Aachen;3593131;Principal Investigator;Michael Becker, MD;University Hospital, Aachen;Cardiac ultrasound | MRI scanner;63634693;1;;;2013;2020-05-29;;FALSE;;FALSE;TRUE;18;90;Years;Years;1;3;
NCT01931592;ClinicalTrials.gov processed this data on May 29, 2020;2013-08-26;;;2017-05-03;2013-08-26;2013-08-29;Estimate;;;;;;;2017-05-03;2017-05-08;Actual;January 2014;;2014-01-31;May 2017;2017-05-31;December 2016;Actual;2016-12-31;October 2016;Actual;2016-10-31;;Interventional;CLEAR;;Controling Intestinal Colonization With Extended Spectrum ß-Lactamase Producing Enterobacteriaceae ESBL-E;Controling Intestinal Colonization of High Risk Patients With Extended Spectrum ß-Lactamase Producing Enterobacteriaceae (ESBL-E) - A Randomized Trial (CLEAR);Terminated;;Phase 2/Phase 3;29;Actual;University of Cologne;;2;;One of the study drugs was no longer available on a worldwide level.;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:58:43Z;2020-06-01T12:58:43Z;Köln;3593366;Principal Investigator;Maria J Vehreschild, MD;University Hospital Cologne;ESBL eradication regimen | Placebo ESBL eradication;63634932;2;;;2013;2020-05-29;33;FALSE;;FALSE;FALSE;18;;Years;;1;10;
NCT01928823;ClinicalTrials.gov processed this data on May 29, 2020;2013-07-26;;;2014-05-16;2013-08-22;2013-08-27;Estimate;;;;;;;2014-05-16;2014-05-19;Estimate;November 2011;;2011-11-30;May 2014;2014-05-31;May 2014;Actual;2014-05-31;May 2014;Actual;2014-05-31;;Interventional;Exposure-DCS;;Augmentation of Psychotherapy With D-Cycloserine in Agoraphobia;Augmentation of Exposure Therapy With D-Cycloserine in Patients With Agoraphobia With or Without Panic Disorder;Completed;;Phase 2;73;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T12:59:25Z;2020-06-01T12:59:25Z;Berlin;3593585;Principal Investigator;Andreas Ströhle, Prof. Dr.;Charite University, Berlin, Germany;CBT | D-Cycloserine;63635147;1;;;2013;2020-05-29;30;FALSE;;FALSE;TRUE;18;75;Years;Years;1;6;1
NCT01928810;ClinicalTrials.gov processed this data on May 29, 2020;2013-07-26;;;2015-02-06;2013-08-26;2013-08-27;Estimate;;;;;;;2015-02-06;2015-02-09;Estimate;March 2011;;2011-03-31;February 2015;2015-02-28;February 2014;Actual;2014-02-28;February 2014;Actual;2014-02-28;;Interventional;;;Physical Activity and Cognitive Behavioural Therapy in Panic Disorder and Agoraphobia;The Influence of Physical Activity (Prior to In-vivo Exposure) on the Effect of Cognitive Behavioural Therapy in Patients With Panic Disorder and Agoraphobia;Completed;;N/A;78;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:59:25Z;2020-06-01T12:59:25Z;Berlin;3593586;Principal Investigator;Sophie Bischoff, Dipl.-Psych.;Charite;Cognitive Behavioural Therapy;63635148;;;;2013;2020-05-29;35;FALSE;;;FALSE;18;65;Years;Years;2;6;
NCT01928433;ClinicalTrials.gov processed this data on May 29, 2020;2013-07-17;;;2017-04-06;2013-08-20;2013-08-26;Estimate;;;;;;;2017-04-06;2017-06-20;Actual;December 2012;;2012-12-31;April 2017;2017-04-30;October 2015;Actual;2015-10-31;June 2014;Actual;2014-06-30;;Interventional;;;Finafloxacin for the Treatment of cUTI and/or Acute Pyelonephritis;A Multi-Dose, Double-Blind, Double-Dummy, Active- Control, Randomized Clinical (Phase II) Study of Two Dosing Regimens of Finafloxacin for the Treatment of cUTI and/or Acute Pyelonephritis Requiring Hospitalisation.;Completed;;Phase 2;225;Actual;MerLion Pharmaceuticals GmbH;;3;;;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T12:59:32Z;2020-06-01T12:59:32Z;Giessen Marburg;3593619;Principal Investigator;Florian Wagenlehner, Prof.;Germany: University Hospital Giessen and Marburg, Department of Urology;Finafloxacin 800 mg i.v. once daily | Finafloxacin placebo i.v. once daily | Finafloxacin 800 mg tablets once daily | Finafloxacin placebo tablets once daily | Ciprofloxacin 400 mg i.v. twice daily | Ciprofloxacin placebo i.v. twice daily | Ciprofloxacin 500 mg oral twice daily | Ciprofloxacin placebo oral twice daily;63635178;1;155;17;2013;2020-05-29;18;TRUE;30;FALSE;TRUE;18;;Years;;1;5;
NCT01927991;ClinicalTrials.gov processed this data on May 29, 2020;2013-08-17;;;2015-04-27;2013-08-20;2013-08-23;Estimate;;;;;;;2015-04-27;2015-04-28;Estimate;September 2012;;2012-09-30;April 2015;2015-04-30;May 2014;Actual;2014-05-31;December 2013;Actual;2013-12-31;;Interventional;;;Internet-based Self-help for Tinnitus: The Role of Support;Internet-based Self-help for Tinnitus: The Role of Support;Completed;;N/A;112;Actual;Philipps University Marburg Medical Center;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T12:59:52Z;2020-06-01T12:59:52Z;Marburg;3593651;Principal Investigator;Cornelia Weise, Dr.;Philipps-University Marburg, Dept. of Psychology, Division of Clinical Psychology and Psychotherapy;iCBT (internet-based, cognitive-behavioural therapy);63635213;1;;;2013;2020-05-29;15;FALSE;;FALSE;TRUE;18;;Years;;1;3;1
NCT01927549;ClinicalTrials.gov processed this data on May 29, 2020;2013-08-14;;;2017-11-07;2013-08-19;2013-08-22;Estimate;;;;;;;2017-11-07;2017-11-09;Actual;April 2013;;2013-04-30;November 2017;2017-11-30;October 2017;Actual;2017-10-31;July 2017;Actual;2017-07-31;;Interventional;CULPRIT-SHOCK;;Culprit Lesion Only PCI Versus Multivessel PCI in Cardiogenic Shock;Prospective Randomized Multicenter Study Comparing Immediate Multivessel Revascularization by PCI Versus Culprit Lesion PCI With Staged Non-culprit Lesion Revascularization in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock;Completed;;Phase 4;706;Actual;University of Luebeck;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:00:00Z;2020-06-01T13:00:00Z;Leipzig Lübeck;3593685;Study Chair;Holger Thiele, MD;Heart Center Leipzig - University Hospital;Immediate multivessel PCI | Culprit Lesion only PCI;63635246;3;;;2013;2020-05-29;51;FALSE;;FALSE;FALSE;18;90;Years;Years;1;19;
NCT01924962;ClinicalTrials.gov processed this data on May 29, 2020;2013-08-15;;;2017-11-03;2013-08-16;2013-08-19;Estimate;;;;;;;2017-11-03;2017-11-07;Actual;May 28, 2008;Actual;2008-05-28;November 2017;2017-11-30;June 16, 2017;Actual;2017-06-16;August 14, 2016;Actual;2016-08-14;;Interventional;REVASC;;Recovery of Left Ventricular Function in Chronic Total Occluded Coronary Arteries;A Randomized Comparison of Recanalisation With Implantation of Cypher Sirolimus Eluting Coronary Stents and Medical Therapy;Completed;;N/A;205;Actual;University Heart Center Freiburg - Bad Krozingen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:00:39Z;2020-06-01T13:00:39Z;Freiburg;3593920;Principal Investigator;Heinz Joachim Buettner, MD;Universitaets-Herzzentrum Freiburg-Bad Krozingen, Clinics for Cardiology and Angiology II, D-79189 Bad Krozingen, Germany;revascularisation;63635416;1;;;2013;2020-05-29;100;FALSE;;FALSE;TRUE;18;;Years;;1;2;
NCT01924702;ClinicalTrials.gov processed this data on May 29, 2020;2013-08-14;;;2015-02-03;2013-08-15;2013-08-16;Estimate;;;;;;;2015-02-03;2015-02-04;Estimate;January 2011;;2011-01-31;February 2015;2015-02-28;December 2015;Anticipated;2015-12-31;December 2015;Anticipated;2015-12-31;;Interventional;;;Chronic Aphasia - Improved by Intensive Training and Electrical Brain Stimulation (CATS);Chronic Aphasia - Improved by Intensive Training and Electrical Brain Stimulation (CATS);Unknown status;;Phase 2;24;Anticipated;Charité Neurocure AG Flöel;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:00:44Z;2020-06-01T13:00:44Z;Berlin;3593939;Principal Investigator;Agnes Floeel, Prof MD;Charite University, Berlin, Germany;Intensive language therapy | transcranial direct current stimulation;63635461;1;;;2013;2020-05-29;;FALSE;;FALSE;TRUE;18;80;Years;Years;1;5;
NCT01924338;ClinicalTrials.gov processed this data on May 29, 2020;2013-08-12;;;2014-08-20;2013-08-15;2013-08-16;Estimate;;;;;;;2014-08-20;2014-08-21;Estimate;September 2013;;2013-09-30;August 2014;2014-08-31;February 2015;Anticipated;2015-02-28;December 2014;Anticipated;2014-12-31;;Interventional;;;Validation of a Method to Measure Soft Tissue Thickness Using Near Infrared Laser Light;Validierung Der Bestimmung Der Gewebedicke Mit Hilfe Von Licht im Infrarotbereich;Unknown status;;N/A;25;Anticipated;University of Luebeck;;4;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:00:51Z;2020-06-01T13:00:51Z;Lübeck;3593966;Principal Investigator;Floris Ernst, PhD;University of Luebeck;MRI scan | Laser scan | Dental cast creation;63635488;2;;;2013;2020-05-29;;FALSE;;FALSE;FALSE;18;;Years;;1;6;
NCT01923961;ClinicalTrials.gov processed this data on May 29, 2020;2013-08-10;;;2018-07-27;2013-08-14;2013-08-16;Estimate;;;;;;;2018-07-27;2019-01-16;Actual;August 2013;Actual;2013-08-31;July 2018;2018-07-31;August 10, 2015;Actual;2015-08-10;March 30, 2015;Actual;2015-03-30;;Interventional;;;Sodium Chloride and Protein-Bound Toxin Removal in Hemodiafiltration;Impact of an Increased Sodium Chloride Concentration in the Infusion Fluid of Predilution Hemodiafiltration on the Removal of Protein-Bound Uremic Toxins;Completed;;N/A;8;Actual;EXcorLab GmbH;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:00:54Z;2020-06-01T13:00:54Z;Würzburg;3593998;Principal Investigator;Detlef H Krieter, MD;Wuerzburg University Hospital;HDF NaCl | Hemodialysis | Standard Predilution Hemodiafiltration;63635517;1;0;0;2013;2020-05-29;19;TRUE;28;FALSE;TRUE;18;;Years;;2;2;
NCT01923493;ClinicalTrials.gov processed this data on May 29, 2020;2013-08-13;;;2015-02-06;2013-08-13;2013-08-15;Estimate;;;;;;;2015-02-06;2015-02-09;Estimate;August 2013;;2013-08-31;February 2015;2015-02-28;June 2014;Actual;2014-06-30;April 2014;Actual;2014-04-30;;Interventional;tuina;;Tuina for Patients With Chronic Neck Pain;Chronic Neck Pain: a Randomized Controlled Trial in Patients With Chronic Neck Pain Comparing Tuina vs. no Intervention Waiting List;Completed;;N/A;92;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:01:01Z;2020-06-01T13:01:01Z;Berlin;3594030;Principal Investigator;Claudia M Witt, MD;Institute for Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin;tuina | no intervention;63635551;1;;;2013;2020-05-29;8;FALSE;;FALSE;TRUE;18;60;Years;Years;1;9;
NCT01921036;ClinicalTrials.gov processed this data on May 29, 2020;2013-07-05;;;2015-01-22;2013-08-08;2013-08-13;Estimate;;;;;;;2015-01-22;2015-01-26;Estimate;February 2011;;2011-02-28;January 2015;2015-01-31;January 2015;Actual;2015-01-31;January 2015;Actual;2015-01-31;;Interventional;DOPPELHERZ;;The Effects of Combined Exercise Training on Exercise Capacity in Cardiac Rehabilitation;Individuell Dosiertes Kraft-ausdauer-training in Ambulanten Herzgruppen - Einfluss Auf Koerperliche Belastbarkeit Von Herzpatienten.;Completed;;N/A;70;Actual;Technische Universität München;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:01:39Z;2020-06-01T13:01:39Z;Munich;;;;;traditional cardiac rehabilitation | combined exercise;63635743;1;;;2013;2020-05-29;47;FALSE;;FALSE;TRUE;;;;;1;9;
NCT01919866;ClinicalTrials.gov processed this data on May 29, 2020;2013-08-07;;;2014-10-07;2013-08-08;2013-08-09;Estimate;;;;;;;2014-10-07;2014-10-08;Estimate;March 2004;;2004-03-31;October 2014;2014-10-31;December 2015;Anticipated;2015-12-31;December 2014;Anticipated;2014-12-31;;Interventional;;;Safety Study of CD3/CD19 Depleted Haploidentical Stem Cells;Haploidentical Stem Cell Transplantation With CD3/CD19 Depleted Stem Cells in Pediatric Patients With Refractory Hematological and Oncological Diseases;Unknown status;;Phase 1/Phase 2;120;Anticipated;University Children’s Hospital Tuebingen;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:01:59Z;2020-06-01T13:01:59Z;Tübingen;3594354;Principal Investigator;Peter Lang, MD;University Children’s Hospital Tuebingen;Transplantation of CD3/CD19 depleted stem cells;63635832;5;;;2013;2020-05-29;;FALSE;;FALSE;FALSE;1;25;Year;Years;1;1;
NCT01916408;ClinicalTrials.gov processed this data on May 29, 2020;2013-05-15;;;2015-06-29;2013-08-01;2013-08-05;Estimate;;;;;;;2015-06-29;2015-06-30;Estimate;August 2013;;2013-08-31;June 2015;2015-06-30;August 2014;Actual;2014-08-31;January 2014;Actual;2014-01-31;;Interventional;Enzy-MagIC;;The Effects of Enzymes and Flavonoids on Inflammation and Coagulation After Marathon;The Effects of Oral Proteolytic and Hydrolytic Enzymes and Flavonoids on Inflammatory Markers and Coagulation After Marathon Running;Completed;;Phase 1;160;Actual;Technische Universität München;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:02:39Z;2020-06-01T13:02:39Z;Munich;;;;;Wobenzym plus | PL 1;63636093;1;;;2013;2020-05-29;5;FALSE;;FALSE;TRUE;20;65;Years;Years;1;3;1
NCT01914965;ClinicalTrials.gov processed this data on May 29, 2020;2013-07-31;;;2014-09-08;2013-07-31;2013-08-02;Estimate;;;;;;;2014-09-08;2014-09-09;Estimate;June 2012;;2012-06-30;September 2014;2014-09-30;May 2014;Actual;2014-05-31;May 2014;Actual;2014-05-31;;Interventional;Action-HD;;Apathy Cure Through Bupropion in Huntington's Disease;A Randomized, Double-blind, Placebo-controlled Prospective Crossover Trial Investigating the Efficacy and Safety of the Treatment With Bupropion in Patients With Apathy in Huntington's Disease;Completed;;Phase 2;40;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:02:54Z;2020-06-01T13:02:54Z;Berlin;3594741;Principal Investigator;Josef Priller, MD;Charite University, Berlin, Germany;Bupropion | Placebo;63636207;2;;;2013;2020-05-29;23;FALSE;;FALSE;FALSE;25;75;Years;Years;1;10;
NCT01914783;ClinicalTrials.gov processed this data on May 29, 2020;2013-07-30;;;2013-07-31;2013-07-31;2013-08-02;Estimate;;;;;;;2013-07-31;2013-08-02;Estimate;July 2013;;2013-07-31;July 2013;2013-07-31;December 2015;Anticipated;2015-12-31;December 2015;Anticipated;2015-12-31;;Interventional;Particles;;Experimental Exposure to Air Pollutants and Sympathetic Nerve Activity in Human Subjects;Experimental Exposure to Air Pollutants and Sympathetic Nerve Activity in Human Subjects;Unknown status;;N/A;30;Anticipated;Hannover Medical School;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:02:55Z;2020-06-01T13:02:55Z;Hannover;;;;;ultrafine particles | ultrafine particles and ozone | clean air;63636219;1;;;2013;2020-05-29;;FALSE;;FALSE;TRUE;50;;Years;;1;2;14
NCT01914497;ClinicalTrials.gov processed this data on May 29, 2020;2013-07-31;;;2017-11-29;2013-07-31;2013-08-02;Estimate;;;;;;;2017-11-29;2017-12-02;Actual;October 2014;;2014-10-31;November 2017;2017-11-30;November 2014;Actual;2014-11-30;November 2014;Actual;2014-11-30;;Interventional;DDRAMATIC;;Dipole Density Mapping of Typical Atrial Flutter;Dipole Density Right Atrial Mapping and Assessment of Therapy In Cavotricuspid Isthmus Flutter;Completed;;N/A;3;Actual;Acutus Medical;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:03:01Z;2020-06-01T13:03:01Z;Hamburg;3594781;Principal Investigator;Stephan Willems, MD;Universitätsklinikum Hamburg-Eppendorf;Acutus Medical System Mapping;63636227;1;;;2013;2020-05-29;1;FALSE;;FALSE;TRUE;18;75;Years;Years;2;;
NCT01914627;ClinicalTrials.gov processed this data on May 29, 2020;2013-07-17;;;2014-11-04;2013-07-30;2013-08-02;Estimate;;;;;;;2014-11-04;2014-11-05;Estimate;August 2013;;2013-08-31;February 2014;2014-02-28;January 2014;Actual;2014-01-31;January 2014;Actual;2014-01-31;;Interventional;;;Parallel Group Trial to Evaluate the Efficacy and Safety of Loion® Compared to 10% Salicylic Acid in Patients With Chronic Psoriasis Capitis;A Single-centre Randomised, Active-controlled, Observer-blinded, Parallel Group Trial to Evaluate the Efficacy and Safety of a Topical Dimeticone Formulation (Loion®) Compared to 10% Salicylic Acid in the Removal of Scaling in Patients With Chronic Psoriasis Capitis;Completed;;Phase 2;90;Actual;G. Pohl-Boskamp GmbH & Co. KG;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:03:00Z;2020-06-01T13:03:00Z;Hamburg;3594764;Principal Investigator;Matthias Augustin, Prof.;University Medical Center Hamburg-Eppendorf (UKE);Dimethicone | Salicylic Acid;63636232;1;;;2013;2020-05-29;5;FALSE;;FALSE;TRUE;18;;Years;;1;1;8
NCT01914341;ClinicalTrials.gov processed this data on May 29, 2020;2013-07-29;;;2014-01-22;2013-07-31;2013-08-02;Estimate;;;;;;;2014-01-22;2014-01-23;Estimate;July 2013;;2013-07-31;January 2014;2014-01-31;January 2014;Actual;2014-01-31;January 2014;Actual;2014-01-31;;Interventional;;;Short Term Effects of Live Music in Newborn Infants;Short-term Effects of Live Pentatonic Music on Physiological Parameters in Newborns Infants;Completed;;N/A;20;Actual;ARCIM Institute Academic Research in Complementary and Integrative Medicine;;2;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T13:03:03Z;2020-06-01T13:03:03Z;Tübingen;3594796;Principal Investigator;Jan Vagedes, Dr.;"ARCIM-Institute; University Hospital Tuebingen";Music;63636252;1;;;2013;2020-05-29;6;FALSE;;FALSE;TRUE;35;;Weeks;;1;11;
NCT01914159;ClinicalTrials.gov processed this data on May 29, 2020;2013-07-28;;;2019-07-03;2013-07-30;2013-08-01;Estimate;;;;;;;2019-07-03;2019-08-15;Actual;February 2013;;2013-02-28;July 2019;2019-07-31;March 2016;Actual;2016-03-31;March 2016;Actual;2016-03-31;;Interventional;RIP;;Ranibizumab In Pigment Epithelium Tears Secondary To Age-Related Macular Degeneration Study;;Completed;;Phase 2;24;Actual;University Hospital, Bonn;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:03:04Z;2020-06-01T13:03:04Z;Bonn;;;;;Ranibizumab (Lucentis, Novartis Pharma GmbH, Germany);63636266;3;2;0;2013;2020-05-29;37;TRUE;37;FALSE;FALSE;50;;Years;;1;2;
NCT01913899;ClinicalTrials.gov processed this data on May 29, 2020;2013-07-30;;;2013-07-30;2013-07-30;2013-08-01;Estimate;;;;;;;2013-07-30;2013-08-01;Estimate;April 2013;;2013-04-30;April 2012;2012-04-30;March 2014;Anticipated;2014-03-31;December 2013;Anticipated;2013-12-31;;Interventional;PPSS;;Short Term Effect of Post Surgical Treatment of Mirror Therapy of Phantom Limb Pain;Short Term Effect of Post Surgical Treatment of Mirror Therapy of Phantom Limb Pain;Unknown status;;N/A;70;Anticipated;Ruhr University of Bochum;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:03:08Z;2020-06-01T13:03:08Z;Bochum;3594825;Principal Investigator;Christoph Maier, Prof. Dr.;Ruhr University Bochum;Occupational/ physical therapy | Mirror therapy;63636286;1;;;2013;2020-05-29;;FALSE;;FALSE;TRUE;18;90;Years;Years;1;1;
NCT01908855;ClinicalTrials.gov processed this data on May 29, 2020;2013-07-19;;;2017-08-09;2013-07-25;2013-07-26;Estimate;;;;;;;2017-08-09;2017-08-11;Actual;October 2013;;2013-10-31;August 2017;2017-08-31;March 2017;Actual;2017-03-31;October 2016;Actual;2016-10-31;;Interventional;ENCERT;;Cognitive-Behavioral Therapy Enriched With Emotion Regulation Training for Multiple Somatoform Symptoms;Enriching Cognitive-Behavioral Therapy With Emotion Regulation Training in Patients With Chronic Multiple Somatoform Symptoms (ENCERT): A Randomized Controlled Trial;Completed;;N/A;255;Actual;Philipps University Marburg Medical Center;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:04:16Z;2020-06-01T13:04:16Z;Marburg;3595274;Principal Investigator;Winfried Rief, Ph.D.;Philipps University Marburg Medical Center;Cognitive-behavioral therapy + emotion regulation training for patients with multiple somatoform symptoms | Cognitive-behavioral therapy for patients with multiple somatoform symptoms;63636668;7;;;2013;2020-05-29;36;FALSE;;FALSE;FALSE;18;69;Years;Years;1;11;
NCT01908270;ClinicalTrials.gov processed this data on May 29, 2020;2013-07-23;;;2014-07-30;2013-07-24;2013-07-25;Estimate;;;;;;;2014-07-30;2014-07-31;Estimate;August 2013;;2013-08-31;July 2014;2014-07-31;February 2014;Actual;2014-02-28;November 2013;Actual;2013-11-30;;Interventional;;;Effects of Yoga on Menopausal Symptoms in Women With Breast Cancer;Randomized Controlled Trial of Yoga for Menopausal Symptoms in Women With Breast Cancer;Completed;;N/A;40;Actual;Universität Duisburg-Essen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:04:31Z;2020-06-01T13:04:31Z;Duisburg;3595318;Principal Investigator;Holger Cramer, PhD;Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen;Yoga | Usual care;63636713;1;;;2013;2020-05-29;3;FALSE;;FALSE;TRUE;30;65;Years;Years;1;11;8
NCT01907022;ClinicalTrials.gov processed this data on May 29, 2020;2013-07-19;;;2015-03-11;2013-07-19;2013-07-24;Estimate;;;;;;;2015-03-11;2015-03-12;Estimate;July 2013;;2013-07-31;March 2015;2015-03-31;October 2014;Actual;2014-10-31;July 2014;Actual;2014-07-31;;Interventional;RELAX;;Combined rTMS and Relaxation in Chronic Tinnitus;Effectiveness of Repetitive Transcranial Magnetic Stimulation (rTMS) in Combination With Relaxation Therapy in Patients With Chronic Tinnitus;Completed;;N/A;42;Actual;University of Regensburg;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:04:47Z;2020-06-01T13:04:47Z;Regensburg;3595416;Principal Investigator;Berthold Langguth, MD, Ph.D.;University of Regensburg - Dept of Psychiatry;Left DLPFC Butterfly Coil;63636806;1;;;2013;2020-05-29;12;FALSE;;FALSE;TRUE;18;70;Years;Years;1;14;
NCT01905475;ClinicalTrials.gov processed this data on May 29, 2020;2013-07-18;;;2016-06-09;2013-07-22;2013-07-23;Estimate;;;;;;;2016-06-09;2016-06-10;Estimate;July 2013;;2013-07-31;June 2016;2016-06-30;June 2016;Actual;2016-06-30;October 2015;Actual;2015-10-31;;Interventional;CATCH-AMI;;CXCR4 Antagonism for Cell Mobilisation and Healing in Acute Myocardial Infarction (CATCH-AMI);CXCR4 AnTagonism for Cell Mobilisation and Healing in Acute Myocardial Infarction (CATCH-AMI). A Phase IIa, Double-Blind, Placebo-Controlled, Randomised, Multi-centre Study of POL6326, a CXCR4 Antagonist, in Patients With Large Reperfused ST Elevation Myocardial Infarction;Completed;;Phase 2;120;Actual;Polyphor Ltd.;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:05:06Z;2020-06-01T13:05:06Z;Hannover;3595530;Principal Investigator;Kai C. Wollert, MD;Hannover Medical School;POL6326 | Placebo;63636922;17;;;2013;2020-05-29;27;FALSE;;FALSE;FALSE;18;80;Years;Years;1;4;
NCT01903395;ClinicalTrials.gov processed this data on May 29, 2020;2013-07-11;;;2016-10-24;2013-07-16;2013-07-19;Estimate;;;;;;;2016-10-24;2016-10-25;Estimate;March 2012;;2012-03-31;October 2016;2016-10-31;December 2015;Actual;2015-12-31;December 2015;Actual;2015-12-31;;Interventional;FAMKOL;;Risk-adapted Screening in First-degree Relatives of Patients With Colorectal Cancer;Nurse-led Colon Cancer Risk Counseling for First-degree Relatives to Enhance Use of Colonoscopy;Completed;;N/A;313;Actual;Martin-Luther-Universität Halle-Wittenberg;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:05:34Z;2020-06-01T13:05:34Z;Halle;3595695;Principal Investigator;Alexander Bauer, PhD;Martin-Luther-University Halle-Wittenberg, Medical Faculty, Institute for Health and Nursing Science;Nurse-led counselling;63637079;33;;;2013;2020-05-29;45;FALSE;;FALSE;FALSE;45;;Years;;1;5;
NCT01901458;ClinicalTrials.gov processed this data on May 29, 2020;2013-07-10;;;2015-03-18;2013-07-15;2013-07-17;Estimate;;;;;;;2015-03-18;2015-03-19;Estimate;March 2014;;2014-03-31;March 2015;2015-03-31;November 2014;Actual;2014-11-30;November 2014;Actual;2014-11-30;;Interventional;optiMaL;;Two Different Collection Sets for Peripheral Blood Progenitor Cell Apheresis With Spectra Optia®;Prospective Randomized Trial Comparing Efficiency of Peripheral Blood Progenitor Cell Collection in Allogeneic Donors Using the Spectra Optia® IDL Set in Comparison With the Spectra Optia® MNC Collection Set;Completed;;N/A;50;Actual;Heinrich-Heine University, Duesseldorf;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:05:56Z;2020-06-01T13:05:56Z;Düsseldorf;3595866;Principal Investigator;Johannes C Fischer, MD;Heinrich Heine University Hospital Duesseldorf;Spectra Optia® IDL-Set | Spectra Optia® Collection Set;63637229;2;;;2013;2020-05-29;8;FALSE;;FALSE;FALSE;18;60;Years;Years;1;5;3
NCT01900327;ClinicalTrials.gov processed this data on May 29, 2020;2013-06-27;;;2018-05-04;2013-07-11;2013-07-16;Estimate;;;;;;;2018-05-04;2018-05-11;Actual;February 2014;;2014-02-28;May 2018;2018-05-31;July 2017;Actual;2017-07-31;November 22, 2016;Actual;2016-11-22;;Interventional;NEOPA;;Neoadjuvant Treatment in Resectable Pancreatic Cancer;Sequential Neoadjuvant Chemoradiotherapy (CRT) Followed by Curative Surgery vs. Primary Surgery Alone for Resectable, Non-metastasized Pancreatic Adenocarcinoma;Terminated;;Phase 3;32;Actual;Universitätsklinikum Hamburg-Eppendorf;;2;;Recruitment failure;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:06:18Z;2020-06-01T13:06:18Z;Hamburg;3595941;Principal Investigator;Jakob R Izbicki, MD, FACS;Universitätsklinikum Hamburg-Eppendorf;External Beam Radiation | Gemcitabine neoadjuvant | Surgery | Gemcitabine adjuvant;63637316;16;;;2013;2020-05-29;33;FALSE;;FALSE;FALSE;18;;Years;;1;9;
NCT01899456;ClinicalTrials.gov processed this data on May 29, 2020;2013-07-10;;;2015-11-03;2013-07-12;2013-07-15;Estimate;;;;;;;2015-11-03;2015-11-05;Estimate;July 2013;;2013-07-31;November 2015;2015-11-30;November 2015;Actual;2015-11-30;March 2015;Actual;2015-03-31;;Interventional;ISAR-denerve;;Impact of Sympathetic Renal Denervation- a Study in Patients After Renal Transplantation;A Randomized Safety and Efficacy Study Investigating the Effects of Catheter-based Renal Denervation in Patients After Renal Transplantation;Completed;;N/A;18;Actual;Technische Universität München;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:06:28Z;2020-06-01T13:06:28Z;Munich;3596024;Principal Investigator;Simon Schneider, MD;1. Medizinische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Unversität München;Catheter-based renal denervation;63637378;1;;;2013;2020-05-29;20;FALSE;;FALSE;TRUE;18;85;Years;Years;1;1;
NCT01897558;ClinicalTrials.gov processed this data on May 29, 2020;2013-05-02;;;2015-02-12;2013-07-11;2013-07-12;Estimate;;;;;;;2015-02-12;2015-02-13;Estimate;April 2013;;2013-04-30;September 2014;2014-09-30;December 2014;Actual;2014-12-31;August 2014;Actual;2014-08-31;;Interventional;PACMAN;;Myocardial Micro-damage in Relation to Active and Passive Fixation Pacemaker Electrodes;Effect of Passive Versus Active Fixation Leads on the Magnitude of Troponin Release After Pacemaker Implantation (PACMAN Trial);Completed;;N/A;290;Anticipated;Deutsches Herzzentrum Muenchen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:07:04Z;2020-06-01T13:07:04Z;Munich;3596174;Principal Investigator;Christof Kolb, MD;Deutsches Herzzentrum München;Pacemaker implantation;63637525;5;;;2013;2020-05-29;16;FALSE;;FALSE;FALSE;18;;Years;;1;;
NCT01896245;ClinicalTrials.gov processed this data on May 29, 2020;2013-07-05;;;2014-10-03;2013-07-05;2013-07-11;Estimate;;;;;;;2014-10-03;2014-10-06;Estimate;July 2013;;2013-07-31;October 2014;2014-10-31;September 2014;Actual;2014-09-30;August 2014;Actual;2014-08-31;;Interventional;SEVODosage;;Laryngeal Injuries After Anesthesia Induction With Three Different Sevoflurane Concentrations (Without Muscle Relaxant);Laryngeal Injuries After Anesthesia Induction With Three Different Sevoflurane Concentrations (Without Muscle Relaxant);Completed;;N/A;90;Actual;University of Rostock;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:07:31Z;2020-06-01T13:07:31Z;Rostock;3596293;Principal Investigator;Thomas Mencke, Dr.;Dep. of Anesthesia and Intensive Care Medicine, University of Rostock, Germany;sevoflurane 1,0 | sevoflurane 1,2 | sevoflurane 1,4;63637621;1;;;2013;2020-05-29;13;FALSE;;FALSE;TRUE;18;80;Years;Years;1;2;
NCT01896154;ClinicalTrials.gov processed this data on May 29, 2020;2013-07-02;;;2016-11-16;2013-07-08;2013-07-11;Estimate;;;;;;;2016-11-16;2016-11-17;Estimate;August 2012;;2012-08-31;February 2015;2015-02-28;June 2014;Actual;2014-06-30;August 2013;Actual;2013-08-31;;Interventional;Fib-P-2012;;Pilot Study on Effect Size of Non-digestible Polysaccharides (NPS) on Immunity;A Randomized, Controlled Clinical Study on the Effect of Non-digestible Polysaccharides (NPS) on the Immune Response to Influenza Vaccination in Elderly;Completed;;Phase 1/Phase 2;239;Actual;Clinical Research Center Kiel GmbH;;6;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:07:33Z;2020-06-01T13:07:33Z;Kiel;3596307;Principal Investigator;Christiane Laue, MD;Clinical Research Center Kiel GmbH;NPS;63637628;;;;2013;2020-05-29;12;FALSE;;;FALSE;50;;Years;;1;;
NCT01894113;ClinicalTrials.gov processed this data on May 29, 2020;2013-07-02;;;2015-05-02;2013-07-02;2013-07-09;Estimate;;;;;;;2015-05-02;2015-05-05;Estimate;January 2012;;2012-01-31;May 2015;2015-05-31;May 2014;Actual;2014-05-31;May 2014;Actual;2014-05-31;;Interventional;TRABIS;;Prospective, Randomised Multicenter Study Comparing the Efficacy of Transbronchial Forceps Biopsy With Cryobiopsy to Diagnose Interstitial Lung Disease.;Prospective, Randomised Multicenter Study Comparing Transbronchial Forceps Biopsy With Cryobiopsy in Interstitial Lung Disease;Completed;;N/A;382;Anticipated;University Hospital Tuebingen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:08:04Z;2020-06-01T13:08:04Z;Tübingen;3596508;Principal Investigator;Jürgen Hetzel, MD;University Hospital Tuebingen;transbronchial lung biopsy;63637784;1;;;2013;2020-05-29;28;FALSE;;FALSE;TRUE;18;;Years;;1;1;1
NCT01892137;ClinicalTrials.gov processed this data on May 29, 2020;2013-06-23;;;2016-04-04;2013-06-30;2013-07-04;Estimate;;;;;;;2016-04-04;2016-04-05;Estimate;July 2013;;2013-07-31;March 2015;2015-03-31;May 2014;Actual;2014-05-31;March 2014;Actual;2014-03-31;;Interventional;;;Histological Confirmation of Clinical Clearance of Actinic Keratoses Following Treatment With Ingenol Mebutate Gel, 0.05%;Histological Confirmation of Clinical Clearance of Actinic Keratoses Following Treatment With Ingenol Mebutate Gel, 0.05%;Completed;;Phase 1;137;Actual;LEO Pharma;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:08:32Z;2020-06-01T13:08:32Z;Berlin;3596666;Principal Investigator;Martina Ulrich;Collegium Medicum Berlin GmbH, Germany;Ingenol mebutate gel 0.05%;63637935;10;;;2013;2020-05-29;8;FALSE;;FALSE;FALSE;18;;Years;;1;1;
NCT01891864;ClinicalTrials.gov processed this data on May 29, 2020;2013-06-24;;;2017-02-06;2013-06-28;2013-07-03;Estimate;;;;;;;2017-02-06;2017-03-27;Actual;June 2013;;2013-06-30;February 2017;2017-02-28;March 2015;Actual;2015-03-31;June 2014;Actual;2014-06-30;;Interventional;EGALITY;;Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Etanercept (GP2015) and Enbrel;A Randomized, Double-blind, Multicenter Study to Demonstrate Equivalent Efficacy and to Compare Safety and Immunogenicity of a Biosimilar Etanercept (GP2015) and Enbrel® in Patients With Moderate to Severe Chronic Plaque-type Psoriasis;Completed;;Phase 3;531;Actual;Sandoz;;2;;;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T13:08:35Z;2020-06-01T13:08:35Z;Kiel Lübeck;3596710;Principal Investigator;Sascha Gerdes, MD;Klinik für Dermatologie, Venerologie und Allergologie Universitätsklinikum Schleswig Holstein, Kiel, Germany;GP2015 Etanercept | Enbrel;63637955;74;748;62;2013;2020-05-29;12;TRUE;27;FALSE;FALSE;18;;Years;;1;4;
NCT01891357;ClinicalTrials.gov processed this data on May 29, 2020;2013-05-14;;;2019-09-16;2013-07-02;2013-07-03;Estimate;;;;;;;2019-09-16;2019-09-17;Actual;September 30, 2013;Actual;2013-09-30;September 2019;2019-09-30;November 16, 2016;Actual;2016-11-16;November 16, 2016;Actual;2016-11-16;;Interventional;;;Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer;A Multicenter Site, Open Label, Phase II Trial to Validate Predictive Markers for the Response Evaluation of a Combined Chemo-immunotherapy in Patients With HER2-positive Early Breast Cancer;Terminated;;Phase 2;64;Actual;West German Study Group;;1;;Early termination due to significant lack of relevant patient data for evaluation of~   objectives.;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:08:44Z;2020-06-01T13:08:44Z;Köln;3596747;Principal Investigator;Mathias Warm, MD;Krankenhaus Köln Holweide;Biopsy before and after three weeks of study treatment | paclitaxel | lapatinib | trastuzumab;63637994;10;473;37;2013;2020-05-29;38;TRUE;33;FALSE;FALSE;18;75;Years;Years;1;2;1
NCT01890317;ClinicalTrials.gov processed this data on May 29, 2020;2013-06-24;;;2018-07-03;2013-06-26;2013-07-01;Estimate;;;;;;;2018-07-03;2018-07-06;Actual;August 2012;;2012-08-31;July 2018;2018-07-31;March 2016;Actual;2016-03-31;November 2015;Actual;2015-11-30;;Interventional;SHOCK-COOL;;Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction;Randomized Pilot Study of Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction;Completed;;N/A;40;Actual;University of Leipzig;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:09:00Z;2020-06-01T13:09:00Z;Leipzig;3596829;Study Chair;Holger Thiele, MD;Heart Center Leipzig - University Hospital;Mild hypothermia;63638074;1;;;2013;2020-05-29;39;FALSE;;FALSE;TRUE;18;90;Years;Years;1;10;
NCT01888796;ClinicalTrials.gov processed this data on May 29, 2020;2013-06-20;;;2017-04-10;2013-06-25;2013-06-28;Estimate;;;;;;;2017-04-10;2017-04-12;Actual;September 2013;;2013-09-30;February 2015;2015-02-28;December 2014;Actual;2014-12-31;December 2014;Actual;2014-12-31;;Interventional;Diast Dysfkt;;Diastolic Dysfunction in Patients With Type 2 Diabetes Mellitus;Effect of Linagliptin Therapy on Myocardial Diastolic Function in Patients With Type 2 Diabetes Mellitus;Terminated;;Phase 3;8;Actual;RWTH Aachen University;;2;;bad recruitment of suitable participants, just 8 patients in one year;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:09:24Z;2020-06-01T13:09:24Z;Aachen;3597023;Principal Investigator;Nikolaus Marx, Univ.-Prof.;Department of Internal Medicine I, RWTH Aachen University Hospital;Linagliptin | placebo;63638192;1;;;2013;2020-05-29;15;FALSE;;FALSE;TRUE;50;;Years;;1;1;
NCT01888055;ClinicalTrials.gov processed this data on May 29, 2020;2013-06-25;;;2016-12-21;2013-06-26;2013-06-27;Estimate;;;;;;;2016-12-21;2016-12-22;Estimate;May 2013;;2013-05-31;December 2016;2016-12-31;December 2017;Anticipated;2017-12-31;October 2017;Anticipated;2017-10-31;;Interventional;;;Influence of tDCS on Cortical Plasticity in Healthy Older Adults;Influence of Transcranial Direct-current Stimulation on Cortical Plasticity in Healthy Older Adults;Unknown status;;N/A;15;Anticipated;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:09:35Z;2020-06-01T13:09:35Z;Berlin;;;;;transcranial direct current stimulation | sham stimulation;63638247;1;;;2013;2020-05-29;;FALSE;;FALSE;TRUE;50;80;Years;Years;1;4;
NCT01888029;ClinicalTrials.gov processed this data on May 29, 2020;2013-06-25;;;2016-12-21;2013-06-25;2013-06-27;Estimate;;;;;;;2016-12-21;2016-12-22;Estimate;May 2013;;2013-05-31;December 2016;2016-12-31;December 2017;Anticipated;2017-12-31;October 2017;Anticipated;2017-10-31;;Interventional;;;Influence of tDCS on Cortical Plasticity in Patients With Mild Cognitive Impairment (MCI);Influence of Transcranial Direct Current Stimulation on Cortical Plasticity in Patients With Mild Cognitive Impairment (MCI);Unknown status;;N/A;15;Anticipated;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:09:35Z;2020-06-01T13:09:35Z;Berlin;;;;;transcranial direct current stimulation | sham stimulation;63638249;1;;;2013;2020-05-29;;FALSE;;FALSE;TRUE;50;80;Years;Years;1;4;
NCT01887899;ClinicalTrials.gov processed this data on May 29, 2020;2013-06-25;;;2016-12-21;2013-06-25;2013-06-27;Estimate;;;;;;;2016-12-21;2016-12-22;Estimate;May 2013;;2013-05-31;December 2016;2016-12-31;December 2017;Anticipated;2017-12-31;October 2017;Anticipated;2017-10-31;;Interventional;;;Influence of tDCS on Cortical Plasticity in Patients With Dementia of the Alzheimer Type;Influence of Transcranial Direct-current Stimulation on Cortical Plasticity in Patients With Dementia of the Alzheimer Type;Unknown status;;N/A;15;Anticipated;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:09:41Z;2020-06-01T13:09:41Z;Berlin;;;;;transcranial direct current stimulation | sham stimulation;63638259;1;;;2013;2020-05-29;;FALSE;;FALSE;TRUE;50;80;Years;Years;1;4;
NCT01887041;ClinicalTrials.gov processed this data on May 29, 2020;2013-06-24;;;2016-02-05;2013-06-25;2013-06-26;Estimate;;;;;;;2016-02-05;2016-02-08;Estimate;January 2010;;2010-01-31;February 2016;2016-02-29;December 2015;Actual;2015-12-31;December 2015;Actual;2015-12-31;;Interventional;BYPAPA;;Quality of Life After BDA or Stents to Treat Biliary Obstruction in Pancreas Cancer;Quality of Life After Bilioenteric Anastomosis in Comparison to Endoscopically Placed Stents in Patients With Unresectable Pancreatic Cancer and Jaundice;Terminated;;Phase 4;24;Actual;Universitätsklinikum Hamburg-Eppendorf;;2;;Recruiting problems;FALSE;;;;TRUE;;;;;;;;;;;Undecided;;2020-06-01T13:09:51Z;2020-06-01T13:09:51Z;Hamburg;3597197;Principal Investigator;Jacob R Izbicki, MD;Universitätsklinik Hamburg;Stent | Biliodigestive anastomosis;63638326;1;;;2013;2020-05-29;72;FALSE;;FALSE;TRUE;18;90;Years;Years;1;1;
NCT01885403;ClinicalTrials.gov processed this data on May 29, 2020;2013-06-20;;;2015-09-22;2013-06-24;2013-06-25;Estimate;;;;;;;2015-09-22;2015-09-23;Estimate;June 2013;;2013-06-30;September 2015;2015-09-30;April 2016;Anticipated;2016-04-30;December 2015;Anticipated;2015-12-31;;Interventional;AcuteCHF;;Acute Congestive Heart Failure;Non-Invasive Pulmonary Monitoring in Patients With Cardiogenic Pulmonary Congestion and Edema;Unknown status;;N/A;50;Anticipated;RWTH Aachen University;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:10:13Z;2020-06-01T13:10:13Z;Aachen;3597315;Principal Investigator;Jörg Schröder, MD;Department of Cardiology, Pneumology, Angiology and Intensive Care, Internal Medicine I (MK I), University Hospital Aachen (UKA);non-invasive respiratory parameter measurements;63638451;1;;;2013;2020-05-29;;FALSE;;FALSE;TRUE;18;75;Years;Years;1;;
NCT01884376;ClinicalTrials.gov processed this data on May 29, 2020;2013-06-19;;;2015-06-17;2013-06-19;2013-06-24;Estimate;;;;;;;2015-06-17;2015-06-18;Estimate;July 2013;;2013-07-31;June 2015;2015-06-30;May 2015;Actual;2015-05-31;May 2015;Actual;2015-05-31;;Interventional;PeRepair;;Clinical Study for the Treatment of Peripheral Nerve Defects With Neuromaix;Klinische Interventionsstrategie Zur überbrückenden Behandlung Peripherer Nervendefekte Mit Neuromaix;Completed;;N/A;20;Actual;RWTH Aachen University;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:10:29Z;2020-06-01T13:10:29Z;Aachen;3597395;Principal Investigator;Ahmet Bozkurt, PD Dr. med.;Department of Plastic Surgery, Hand Surgery and Burn Center,University Hospital RWTH Aachen;Neuromaix;63638531;1;;;2013;2020-05-29;22;FALSE;;FALSE;TRUE;18;70;Years;Years;1;1;
NCT01883765;ClinicalTrials.gov processed this data on May 29, 2020;2013-02-21;;;2017-03-08;2013-06-18;2013-06-21;Estimate;;;;;;;2017-03-08;2017-03-13;Actual;February 2013;;2013-02-28;March 2017;2017-03-31;November 2016;Actual;2016-11-30;December 2015;Actual;2015-12-31;;Interventional;;;Efficacy of Neurofeedback Training in Adults With ADHD;Efficacy of a Neurofeedback Treatment in Adults With ADHD: a Triple-blind Randomized Placebo-controlled Study;Completed;;N/A;118;Actual;University Hospital Tuebingen;;3;;;FALSE;;;;;;;;;;;;;;;Undecided;;2020-06-01T13:10:37Z;2020-06-01T13:10:37Z;Tübingen;3597442;Principal Investigator;Michael Schönenberg, Dr;University Hospital Tuebingen;Neurofeedback active | Neurofeedback sham | Metacognitive Training;63638577;1;;;2013;2020-05-29;34;FALSE;;FALSE;TRUE;18;60;Years;Years;1;9;
NCT01883531;ClinicalTrials.gov processed this data on May 29, 2020;2013-06-17;;;2015-10-12;2013-06-19;2013-06-21;Estimate;;;;;;;2015-10-12;2015-10-14;Estimate;June 2013;;2013-06-30;October 2015;2015-10-31;October 2015;Actual;2015-10-31;October 2015;Actual;2015-10-31;;Interventional;;;Crossover Trial Determining the Efficacy of Dry Powder Mannitol to Improve Lung Function in Subjects Aged 6-17 Years;A Randomised, Multicentre, Double-blind, Placebo-controlled, Crossover Trial Determining the Efficacy of Dry Powder Mannitol in Improving Lung Function in Subjects With Cystic Fibrosis Aged Six to Seventeen Years;Completed;;Phase 2;95;Actual;Pharmaxis;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:10:38Z;2020-06-01T13:10:38Z;Tübingen;3597463;Principal Investigator;Joachim Riethmuller, Dr;Universitats Kinderklinik Tubingen, Germany;Inhaled Mannitol | Inhaled Placebo;63638594;1;;;2013;2020-05-29;28;FALSE;;FALSE;TRUE;6;17;Years;Years;1;4;
NCT01880216;ClinicalTrials.gov processed this data on May 29, 2020;2013-06-14;;;2016-02-03;2013-06-14;2013-06-18;Estimate;;;;;;;2016-02-03;2016-02-04;Estimate;June 2013;;2013-06-30;February 2016;2016-02-29;May 2015;Actual;2015-05-31;January 2015;Actual;2015-01-31;;Interventional;;;Efficacy of Bemiparin Versus Enoxaparin in the Treatment of DVT;A Multinational, Multicentre, Randomized, Open, Parallel Group Study on the Efficacy and Safety of Bemiparin Sodium (LMWH) Compared to Enoxaparin Sodium (LMWH) in the Treatment of Acute Deep Vein Thrombosis (DVT);Completed;;Phase 3;312;Actual;Berlin-Chemie AG Menarini Group;;2;;;FALSE;;;;FALSE;;;;;;;;;;;Undecided;;2020-06-01T13:11:19Z;2020-06-01T13:11:19Z;Berlin;3597786;Study Chair;Maria Th Kaltwasser, Dr.;Berlin-Chemie AG;Bemiparin sodium | Enoxaparin sodium;63638850;25;;;2013;2020-05-29;19;FALSE;;FALSE;FALSE;18;100;Years;Years;1;1;1
NCT01879878;ClinicalTrials.gov processed this data on May 29, 2020;2013-06-13;;;2015-05-27;2013-06-17;2013-06-18;Estimate;;;;;;;2015-05-27;2015-05-28;Estimate;December 2013;;2013-12-31;May 2015;2015-05-31;December 2015;Anticipated;2015-12-31;December 2015;Anticipated;2015-12-31;;Interventional;POUDER;;Pilot Study Evaluating Broccoli Sprouts in Advanced Pancreatic Cancer [POUDER Trial];Pilot Study Evaluating Broccoli Sprouts in Advanced Pancreatic Cancer [POUDER Trial];Unknown status;;N/A;40;Anticipated;Heidelberg University;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:11:25Z;2020-06-01T13:11:25Z;Heidelberg;3597809;Study Director;Peter Schemmer, Prof. Dr. med.;Heidelberg University;Verum, broccoli sprout grain | placebo;63638873;1;;;2013;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;1;1
NCT01879839;ClinicalTrials.gov processed this data on May 29, 2020;2013-06-13;;;2019-08-08;2013-06-13;2013-06-18;Estimate;;;;;;;2019-08-08;2019-08-09;Actual;July 2013;Actual;2013-07-31;August 2019;2019-08-31;December 2016;Actual;2016-12-31;October 2016;Actual;2016-10-31;;Interventional;CR_KMN;;Effect of a Pre-interventional Diet on Renal Function After Administration of Contrast Agent in Patients at Risk;Phase 4 Study of Effect of a Pre-interventional Calorie Restriction on Renal Function After Administration of Contrast Agent in Patients at Risk;Completed;;Phase 4;80;Actual;University of Cologne;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:11:26Z;2020-06-01T13:11:26Z;Köln;3597813;Principal Investigator;Volker Burst, MD;University of Cologne;Diet;63638876;1;;;2013;2020-05-29;39;FALSE;;FALSE;TRUE;18;;Years;;1;3;6
NCT01879241;ClinicalTrials.gov processed this data on May 29, 2020;2013-06-12;;;2016-10-24;2013-06-12;2013-06-17;Estimate;;;;;;;2016-10-24;2016-10-25;Estimate;June 2013;;2013-06-30;October 2016;2016-10-31;August 2016;Actual;2016-08-31;April 2016;Actual;2016-04-30;;Interventional;;;Study of Rasagiline in Patients With Amyotrophic Lateral Sclerosis;Efficacy, Safety and Tolerability Study of 1 mg Rasagiline in Patients With Amyotrophic Lateral Sclerosis (ALS) Receiving Standard Therapy (Riluzole) - An AMG Trial With a Market Authorized Substance;Completed;;Phase 2;252;Actual;University of Ulm;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:11:35Z;2020-06-01T13:11:35Z;Ulm;3597851;Principal Investigator;Albert C. Ludolph, MD, Prof.;Department of Neurology, University of Ulm;Rasagiline | Placebo;63638921;15;;;2013;2020-05-29;34;FALSE;;FALSE;FALSE;18;;Years;;1;3;
NCT01879111;ClinicalTrials.gov processed this data on May 29, 2020;2013-06-12;;;2014-12-15;2013-06-14;2013-06-17;Estimate;;;;;;;2014-12-15;2014-12-16;Estimate;October 2011;;2011-10-31;December 2014;2014-12-31;May 2014;Actual;2014-05-31;October 2013;Actual;2013-10-31;;Interventional;DEPSCREEN-INFO;;Increasing the Efficiency of Depression-screening Using Patient-targeted Feedback;Increasing the Efficiency of Depression-screening Using Patient-targeted Feedback: Randomized Controlled Trial;Completed;;N/A;4151;Actual;Universitätsklinikum Hamburg-Eppendorf;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:11:37Z;2020-06-01T13:11:37Z;Hamburg;3597869;Principal Investigator;Bernd Loewe, MD;Universitätsklinikum Hamburg-Eppendorf;patient-targeted feedback;63638931;2;;;2013;2020-05-29;24;FALSE;;FALSE;FALSE;18;;Years;;1;4;
NCT01872052;ClinicalTrials.gov processed this data on May 29, 2020;2013-05-02;;;2017-03-06;2013-06-05;2013-06-07;Estimate;;;;;;;2017-03-06;2017-03-07;Actual;March 2013;;2013-03-31;March 2017;2017-03-31;August 2014;Actual;2014-08-31;June 2014;Actual;2014-06-30;;Interventional;DDRAMATIC;;Dipole Density Right Atrial Mapping and Assessment of Therapy In Cavotricuspid Isthmus Flutter;Dipole Density Right Atrial Mapping and Assessment of Therapy In Cavotricuspid Isthmus Flutter;Completed;;N/A;9;Actual;Acutus Medical;;1;;;FALSE;;;;FALSE;;FALSE;;;;;;;;;Undecided;;2020-06-01T13:13:13Z;2020-06-01T13:13:13Z;Hamburg;3598464;Principal Investigator;Stephan Willems, MD;Universitätsklinikum Hamburg-Eppendorf;Acutus Medical System Mapping;63639466;1;;;2013;2020-05-29;15;FALSE;;FALSE;TRUE;18;75;Years;Years;2;;
NCT01871636;ClinicalTrials.gov processed this data on May 29, 2020;2013-05-12;;;2015-09-07;2013-06-05;2013-06-07;Estimate;;;;;;;2015-09-07;2015-09-09;Estimate;December 2012;;2012-12-31;September 2015;2015-09-30;August 2015;Actual;2015-08-31;May 2014;Actual;2014-05-31;;Interventional;;;ESD Versus EMR for Treatment of Early Barrett`s Adenocarcinoma;Water-jet Assisted Endoscopic Submucosal Dissection (ESD) Versus Endoscopic Mucosal Resection (EMR) for Treatment of Early Barrett`s Adenocarcinoma;Completed;;N/A;40;Actual;Evangelisches Krankenhaus Düsseldorf;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:13:23Z;2020-06-01T13:13:23Z;Düsseldorf;3598503;Principal Investigator;Horst Neuhaus, MD;Evangelisches Krankenhaus Duesseldorf;Endoscopic mucosal resection | Waterjet-assisted ESD | HybridKnife;63639498;1;;;2013;2020-05-29;17;FALSE;;FALSE;TRUE;18;;Years;;1;5;
NCT01870271;ClinicalTrials.gov processed this data on May 29, 2020;2013-03-19;;;2016-05-23;2013-06-03;2013-06-06;Estimate;;;;;;;2016-05-23;2016-05-24;Estimate;November 2012;;2012-11-30;May 2016;2016-05-31;October 2015;Actual;2015-10-31;March 2014;Actual;2014-03-31;;Interventional;Pilot-DCPT;;Pilot-Study DCPT for PTSD in Adolescents and Young Adults;Pilotstudie Developmentally Adapted Cognitive Processing Therapy für Jugendliche Und Junge Erwachsene Mit Posttraumatischer Belastungsstörung Nach Sexualisierter Und /Oder körperlicher Gewalt (Pilot DCPT);Completed;;N/A;12;Actual;Goethe University;;1;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T13:13:46Z;2020-06-01T13:13:46Z;Frankfurt;3598610;Principal Investigator;Regina Steil, PhD;Goethe University;Developmentally adapted cognitive processing therapy;63639603;1;;;2013;2020-05-29;16;FALSE;;FALSE;TRUE;14;21;Years;Years;1;2;1
NCT01867736;ClinicalTrials.gov processed this data on May 29, 2020;2013-05-27;;;2015-02-06;2013-05-30;2013-06-04;Estimate;;;;;;;2015-02-06;2015-02-09;Estimate;July 2012;;2012-07-31;February 2015;2015-02-28;July 2014;Actual;2014-07-31;January 2014;Actual;2014-01-31;;Interventional;BIOLUX P-II;;BIOLUX P-II First-in-Man Study to Compare the Passeo-18 Lux DRB Against POBA in Infrapopliteal Arteries;BIOTRONIK's - First in Men Study of the Passeo-18 LUX Drug Releasing PTA Balloon Catheter vs. the Uncoated Passeo 18 Balloon Catheter in Subjects Requiring Revascularization of Infrapopliteal Arteries (BIOLUX P-II).;Completed;;N/A;72;Actual;Biotronik AG;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:14:17Z;2020-06-01T13:14:17Z;Freiburg;3598810;Principal Investigator;Thomas Zeller, MD;Universitäts-Herzzentrum Freiburg - Bad Krozingen, Germany;Passeo-18 Lux DRB | Standard PTA (POBA);63639796;6;;;2013;2020-05-29;18;FALSE;;FALSE;FALSE;18;;Years;;2;12;
NCT01866449;ClinicalTrials.gov processed this data on May 29, 2020;2013-05-22;;;2017-10-25;2013-05-27;2013-05-31;Estimate;;;;;;;2017-10-25;2017-10-26;Actual;October 2013;;2013-10-31;September 2017;2017-09-30;August 25, 2017;Actual;2017-08-25;December 2016;Actual;2016-12-31;;Interventional;;;Prospective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma Multiforme;Prospective Controlled Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma Multiforme (GBM)- The C-GBM Study -;Completed;;Phase 2;24;Actual;University of Ulm;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:14:34Z;2020-06-01T13:14:34Z;Ulm;;;;;Cabazitaxel;63639892;3;;;2013;2020-05-29;38;FALSE;;FALSE;FALSE;18;;Years;;1;4;
NCT01865604;ClinicalTrials.gov processed this data on May 29, 2020;2012-12-18;;;2016-03-15;2013-05-28;2013-05-31;Estimate;;;;;;;2016-03-15;2016-03-16;Estimate;April 2012;;2012-04-30;March 2016;2016-03-31;March 2014;Actual;2014-03-31;March 2014;Actual;2014-03-31;;Interventional;;;Impact of tDCS on Cerebral Autoregulation;;Completed;;N/A;60;Actual;Charite University, Berlin, Germany;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:14:44Z;2020-06-01T13:14:44Z;Berlin;3598970;Principal Investigator;Agnes Flöel, Prof. MD;Charite University, Berlin, Germany;Anodal tDCS | Cathodal tDCS | sham tDCS;63639956;1;;;2012;2020-05-29;23;FALSE;;FALSE;TRUE;18;80;Years;Years;1;;
NCT01864707;ClinicalTrials.gov processed this data on May 29, 2020;2013-04-02;;;2016-01-27;2013-05-24;2013-05-30;Estimate;;;;;;;2016-01-27;2016-01-29;Estimate;April 2013;;2013-04-30;January 2016;2016-01-31;October 2015;Actual;2015-10-31;June 2015;Actual;2015-06-30;;Interventional;MS-Fatigue;;Acupuncture or MBSR for Patients With Fatigue and MS;Randomized Controlled Trial on the Efficacy of Acupuncture and the Efficacy of Mindfulness-Based Stress Reduction (MBSR) in Patients With Multiple Sclerosis Suffering From Fatigue;Completed;;N/A;104;Actual;Charite University, Berlin, Germany;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:14:55Z;2020-06-01T13:14:55Z;Berlin;3599042;Principal Investigator;Claudia M Witt, MD;Institute for Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin;Usual care + acupuncture | usual care+mbsr | usual care;63640023;1;;;2013;2020-05-29;26;FALSE;;FALSE;TRUE;18;65;Years;Years;1;14;3
NCT01861951;ClinicalTrials.gov processed this data on May 29, 2020;2013-04-11;;;2017-08-16;2013-05-22;2013-05-24;Estimate;;;;;;;2017-08-16;2017-08-21;Actual;October 2012;;2012-10-31;October 2016;2016-10-31;July 11, 2017;Actual;2017-07-11;July 11, 2017;Actual;2017-07-11;;Interventional;EPAZ;;A Trial Comparing Two Medications as First Treatment in Elderly Patients With Metastatic or Advanced Soft Tissue Sarcoma;A Randomized Phase II Trial Comparing Pazopanib With Doxorubicin as First Line Treatment in Elderly Patients With Metastatic or Advanced Soft Tissue Sarcoma;Completed;;Phase 2;120;Actual;Hannover Medical School;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:15:26Z;2020-06-01T13:15:26Z;Hannover;3599257;Principal Investigator;Viktor Gruenwald, MD, Prof.;Hannover Medical School;Pazopanib | Doxorubicin;63640230;11;;;2013;2020-05-29;57;FALSE;;FALSE;FALSE;60;;Years;;1;9;
NCT01859429;ClinicalTrials.gov processed this data on May 29, 2020;2013-05-17;;;2018-06-20;2013-05-17;2013-05-21;Estimate;;;;;;;2018-06-20;2018-06-25;Actual;April 2012;;2012-04-30;June 2018;2018-06-30;March 2015;Actual;2015-03-31;December 2014;Actual;2014-12-31;;Interventional;STEPPEDCARE;;Stepped Care - Optimising Psycho-oncological Care Provision by Structured Screening and Diagnosis;Stepped Care - Optimising Psycho-oncological Care Provision by Structured Screening and Diagnosis;Completed;;N/A;1012;Actual;University of Leipzig;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:15:55Z;2020-06-01T13:15:55Z;Leipzig Mainz;3599472;Principal Investigator;Susanne Singer, PhD;Johannes Gutenberg University of Mainz;Stepped Care;63640414;1;;;2013;2020-05-29;32;FALSE;;FALSE;TRUE;18;;Years;;1;4;
NCT01858987;ClinicalTrials.gov processed this data on May 29, 2020;2013-05-16;;;2017-10-06;2013-05-20;2013-05-21;Estimate;;;;;;;2017-10-06;2017-10-09;Actual;November 2, 2011;Actual;2011-11-02;October 2017;2017-10-31;August 14, 2014;Actual;2014-08-14;July 17, 2014;Actual;2014-07-17;;Interventional;CRUNSHII;;Stapler vs. LigaSure in Elective Hepatic Resection;Stapler vs. LigaSure for Transection of the Parenchyma in Elective Hepatic Resection: CRUNSH II - A Randomized Controlled Trial;Completed;;N/A;138;Actual;Heidelberg University;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:16:01Z;2020-06-01T13:16:01Z;Heidelberg;;;;;Stapler hepatectomy | LigaSure hepatectomy | Ligasure | vascular staple;63640447;1;;;2013;2020-05-29;32;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT01856244;ClinicalTrials.gov processed this data on May 29, 2020;2013-05-08;;;2016-10-04;2013-05-16;2013-05-17;Estimate;;;;;;;2016-10-04;2016-10-05;Estimate;June 2013;;2013-06-30;October 2016;2016-10-31;June 2016;Actual;2016-06-30;June 2016;Actual;2016-06-30;;Interventional;StaBLE;;Stability and Balance in Locomotion Through Exercise;Sensorimotor Treadmill Training to Improve Gait and Balance in Parkinson's Disease;Completed;;Phase 1;48;Actual;University of Erlangen-Nürnberg;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:16:49Z;2020-06-01T13:16:49Z;Erlangen;3599740;Principal Investigator;Klaus Pfeifer, Prof. Dr.;Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Institute of Sport Science and Sport;treadmill walking | Treadmill;63640656;1;;;2013;2020-05-29;36;FALSE;;FALSE;TRUE;18;;Years;;2;3;
NCT01855035;ClinicalTrials.gov processed this data on May 29, 2020;2013-05-07;;;2020-04-30;2013-05-15;2013-05-16;Estimate;;;;;;;2020-04-30;2020-05-04;Actual;May 2013;;2013-05-31;April 2020;2020-04-30;November 2017;Actual;2017-11-30;September 2017;Actual;2017-09-30;;Interventional;;;Finding Atrial Fibrillation in Stroke - Evaluation of Enhanced and Prolonged Holter Monitoring;A Prospective, Randomised, Controlled Study to Determine the Detection of Atrial Fibrillation by Prolonged and Enhanced Holter Monitoring as Compared to Usual Care in Stroke Patients;Completed;;N/A;402;Actual;Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:17:09Z;2020-06-01T13:17:09Z;Göttingen Mainz;3599847;Principal Investigator;Rolf Wachter, PD Dr. med.;Dept. of Cardiology and Pneumology, University Medical Center Goettingen;prolonged ECG monitoring | standard care;63640750;4;;;2013;2020-05-29;52;FALSE;;FALSE;FALSE;60;;Years;;1;13;
NCT01854255;ClinicalTrials.gov processed this data on May 29, 2020;2013-05-12;;;2016-11-13;2013-05-14;2013-05-15;Estimate;;;;;;;2016-11-13;2016-11-15;Estimate;November 2013;;2013-11-30;November 2016;2016-11-30;November 2016;Actual;2016-11-30;October 2016;Actual;2016-10-31;;Interventional;PIPAC-GA01;;Intraperitoneal Aerosol Chemotherapy in Gastric Cancer;Feasibility, Efficacy and Safety of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) With Cisplatin and Doxorubicin in Patients With Gastric Cancer and Peritoneal Carcinomatosis: an Open-label, Single-arm, Phase II Clinical Trial;Completed;;Phase 2;35;Actual;Ruhr University of Bochum;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:17:25Z;2020-06-01T13:17:25Z;Bochum;3599909;Principal Investigator;Marc A Reymond, MD;Ruhr University of Bochum;doxorubicin and cisplatin;63640808;1;;;2013;2020-05-29;35;FALSE;;FALSE;TRUE;18;80;Years;Years;1;1;1
NCT01853384;ClinicalTrials.gov processed this data on May 29, 2020;2013-05-08;;;2016-09-19;2013-05-10;2013-05-15;Estimate;;;;;;;2016-09-19;2016-10-03;Estimate;November 2013;;2013-11-30;September 2016;2016-09-30;February 2015;Actual;2015-02-28;December 2014;Actual;2014-12-31;;Interventional;;;Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers;A Phase 3 Randomized Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers (EU);Terminated;;Phase 3;252;Actual;Healthpoint;;2;;based on outcome of trial NCT01656889.;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:17:40Z;2020-06-01T13:17:40Z;Freiburg;3599981;Principal Investigator;Wolfgang Vanscheidt, Professor Dr;University Freiburg-Practice for Dermatology;HP802-247 | HP802-247 Vehicle;63640875;47;457;40;2013;2020-05-29;13;TRUE;20;FALSE;FALSE;18;;Years;;1;6;
NCT01852526;ClinicalTrials.gov processed this data on May 29, 2020;2013-05-08;;;2015-09-15;2013-05-08;2013-05-13;Estimate;;;;;;;2015-09-15;2015-09-16;Estimate;March 2013;;2013-03-31;September 2015;2015-09-30;July 2017;Anticipated;2017-07-31;February 2017;Anticipated;2017-02-28;;Interventional;D-Rod;;Efficacy of Hybrid Systems in Comparison to the Rigid Spondylodesis in Lumbar-spine Fusion;Clinical Trial (Phase II, Therapeutic Explorative) of the Efficacy of Hybrid Systems in Comparison to the Rigid Spondylodesis in Fusion-surgery in the Lumbar Spine: a Prospective, Randomised, Monocenter Pilotstudy;Terminated;;N/A;5;Actual;University of Cologne;;2;;device failure;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:17:51Z;2020-06-01T13:17:51Z;Köln;3600044;Principal Investigator;Jan Siewe, Dr.;University Hospital of Cologne;Experimental: hybrid system | Active Comparator: Plif;63640941;2;;;2013;2020-05-29;;FALSE;;FALSE;FALSE;30;;Years;;1;3;
NCT01852149;ClinicalTrials.gov processed this data on May 29, 2020;2013-05-07;;;2016-03-16;2013-05-08;2013-05-13;Estimate;;;;;;;2016-03-16;2016-03-18;Estimate;August 2009;;2009-08-31;March 2016;2016-03-31;September 2015;Actual;2015-09-30;March 2014;Actual;2014-03-31;;Interventional;;;Mitralign Percutaneous Annuloplasty First in Man Study;Mitralign Percutaneous Annuloplasty First in Man (FIM) Study;Completed;;N/A;35;Actual;Mitralign, Inc.;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:17:56Z;2020-06-01T13:17:56Z;Bonn;3600071;Principal Investigator;Eberhard Grube, MD;Universitats Klinikum Bonn;MPAS Implant;63640970;5;;;2013;2020-05-29;55;FALSE;;FALSE;FALSE;18;;Years;;1;1;
NCT01850875;ClinicalTrials.gov processed this data on May 29, 2020;2013-04-23;;;2016-05-13;2013-05-07;2013-05-10;Estimate;;;;;;;2016-05-13;2016-05-16;Estimate;May 2013;;2013-05-31;May 2016;2016-05-31;December 2015;Actual;2015-12-31;November 2014;Actual;2014-11-30;;Interventional;LOGIN - EMDR;;Eye Movement Desensitization and Reprocessing (EMDR) in Non-specific Chronic Back Pain;Localized and Generalized Musculoskeletal Pain: Psychobiological Mechanisms and Implications for Treatment (LOGIN) - Subgroups Characterized by Psychological Trauma, Mental Comorbidity, and Psychobiological Patterns and Their Specialized Treatment - Eye Movement Desensitization and Reprocessing (EMDR) in Non-specific Chronic Back Pain;Completed;;N/A;40;Actual;University Hospital Heidelberg;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:18:11Z;2020-06-01T13:18:11Z;Heidelberg;3600175;Principal Investigator;Wolfgang Eich, Prof. Dr.;University Hospital Heidelberg;Eye-Movement-Desensitization-Reprocessing;63641066;1;;;2013;2020-05-29;18;FALSE;;FALSE;TRUE;18;;Years;;1;;20
NCT01845142;ClinicalTrials.gov processed this data on May 29, 2020;2013-04-24;;;2015-06-24;2013-05-02;2013-05-03;Estimate;;;;;;;2015-06-24;2015-06-25;Estimate;February 2013;;2013-02-28;June 2015;2015-06-30;April 2014;Actual;2014-04-30;May 2013;Actual;2013-05-31;;Interventional;ViDImmun;;Immunologic Action of a Single Dose Cholecalciferol;Immunologic Functions of a Single Dose of 100.000 I.U. Cholecalciferol (Vitamin D3);Completed;;Phase 4;40;Actual;Charite University, Berlin, Germany;;4;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:19:27Z;2020-06-01T13:19:27Z;Berlin;3600685;Principal Investigator;Margitta Worm, Prof;Charite University, Berlin, Germany;single administration of 100.000 I.U. vitamin D | Placebo;63641495;1;;;2013;2020-05-29;3;FALSE;;FALSE;TRUE;18;60;Years;Years;1;4;
NCT01845129;ClinicalTrials.gov processed this data on May 29, 2020;2013-04-30;;;2013-04-30;2013-04-30;2013-05-03;Estimate;;;;;;;2013-04-30;2013-05-03;Estimate;April 2013;;2013-04-30;April 2013;2013-04-30;April 2014;Anticipated;2014-04-30;April 2014;Anticipated;2014-04-30;;Interventional;StimRAph;;Impact of Transcranial Direct Current Stimulation of the Motor Cortex on Language Functions in Residual Aphasia;Impact of Transcranial Direct Current Stimulation of the Motor Cortex on Language Functions in Residual Aphasia;Unknown status;;N/A;16;Anticipated;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:19:27Z;2020-06-01T13:19:27Z;Berlin;3600686;Principal Investigator;Marcus Meinzer, PhD;Charite, University Medicine, Neurology;atDCS | sham tDCS;63641496;1;;;2013;2020-05-29;;FALSE;;FALSE;TRUE;18;80;Years;Years;1;1;
NCT01841632;ClinicalTrials.gov processed this data on May 29, 2020;2013-04-19;;;2017-12-09;2013-04-23;2013-04-26;Estimate;;;;;;;2017-12-09;2018-08-17;Actual;April 2013;Actual;2013-04-30;December 2017;2017-12-31;December 2016;Actual;2016-12-31;December 2016;Actual;2016-12-31;;Interventional;;;Safety Study of Multipotent Progenitor Cells for Immunomodulation Therapy After Liver Transplantation;Safety and Feasibility of Multipotent Adult Progenitor Cells for Immunomodulation Therapy After Liver Transplantation: A Phase I Study of the MiSOT Study Consortium;Terminated;;Phase 1;3;Actual;University Hospital Regensburg;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:20:21Z;2020-06-01T13:20:21Z;Regensburg;;;;;MultiStem;63641762;1;81;15;2013;2020-05-29;44;TRUE;11;FALSE;TRUE;18;65;Years;Years;1;3;
NCT01841476;ClinicalTrials.gov processed this data on May 29, 2020;2013-04-02;;;2015-11-24;2013-04-23;2013-04-26;Estimate;;;;;;;2015-11-24;2015-11-25;Estimate;February 2012;;2012-02-29;November 2015;2015-11-30;September 2015;Actual;2015-09-30;August 2015;Actual;2015-08-31;;Interventional;;;Safety and Efficacy of POL6326 for Mobilization of Hematopoietic Stem Cells in Healthy Volunteers;POL6326 - A Phase I, Open, Single Intravenous Infusion Dose, Pharmacokinetic and Pharmacodynamic Study in Healthy Volunteers Who Are Volunteering as Haematopoietic Stem Cell (HSC) Donors;Completed;;Phase 1;27;Actual;Polyphor Ltd.;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:20:25Z;2020-06-01T13:20:25Z;Frankfurt;3600979;Principal Investigator;Halvard Boenig, M.D. Ph.D;German Red Cross Blood Service and Institute for Transfusion Medicine and Immunohematology of the Goethe University, Frankfurt, Germany;POL6326;63641774;1;;;2013;2020-05-29;42;FALSE;;FALSE;TRUE;18;55;Years;Years;1;2;
NCT01840865;ClinicalTrials.gov processed this data on May 29, 2020;2013-04-18;;;2016-03-15;2013-04-23;2013-04-26;Estimate;;;;;;;2016-03-15;2016-03-16;Estimate;October 2013;;2013-10-31;March 2016;2016-03-31;January 2015;Actual;2015-01-31;January 2015;Actual;2015-01-31;;Interventional;;;Effects of Brain Stimulation During Daytime Nap on Memory Consolidation in Younger, Healthy Subjects;Impact of Transcranial Slow Oscillating Stimulation on Memory Consolidation During Daytime Slow Wave Sleep in Younger, Healthy Subjects;Completed;;N/A;22;Anticipated;Charite University, Berlin, Germany;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:20:30Z;2020-06-01T13:20:30Z;Berlin;3601025;Principal Investigator;Agnes Flöel, Professor;Charite Universitätsmedizin Berlin - Neurologie;brain stimulation | no stimulation;63641820;1;;;2013;2020-05-29;15;FALSE;;FALSE;TRUE;18;35;Years;Years;1;4;
NCT01840839;ClinicalTrials.gov processed this data on May 29, 2020;2013-04-18;;;2018-01-29;2013-04-25;2013-04-26;Estimate;;;;;;;2018-01-29;2018-01-30;Actual;October 2013;;2013-10-31;January 2018;2018-01-31;August 2015;Actual;2015-08-31;May 2015;Actual;2015-05-31;;Interventional;;;Effects of Brain Stimulation During a Daytime Nap on Memory Consolidation in Older Adults;Impact of Transcranial Slow Oscillating Stimulation on Memory Consolidation During Slow Wave Sleep in Older Adults;Completed;;N/A;18;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:20:30Z;2020-06-01T13:20:30Z;Berlin;3601027;Study Chair;Agnes Flöel, Professor;Charite Universitätsmedizin Berlin - Neurologie;brain stimulation | Sham Stimulation;63641822;1;;;2013;2020-05-29;19;FALSE;;FALSE;TRUE;50;90;Years;Years;1;4;
NCT01839084;ClinicalTrials.gov processed this data on May 29, 2020;2013-04-09;;;2016-02-17;2013-04-19;2013-04-24;Estimate;;;;;;;2016-02-17;2016-02-18;Estimate;July 2013;;2013-07-31;February 2016;2016-02-29;February 2016;Actual;2016-02-29;February 2016;Actual;2016-02-29;;Interventional;PaNeX;;PaNeX: Partial Nephrectomy Under Xenon;Impact of Xenon-anesthesia on the Renal Function After Partial Nephrectomy - PaNeX: Partial Nephrectomy Under Xenon:a Pilot Study;Completed;;Phase 3;46;Actual;RWTH Aachen University;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:20:56Z;2020-06-01T13:20:56Z;Aachen;3601159;Principal Investigator;Astrid Fahlenkamp, Dr. med.;Department of Anesthesiology, University Hospital Aachen;Xenon | Isoflurane;63641960;1;;;2013;2020-05-29;31;FALSE;;FALSE;TRUE;18;;Years;;1;14;
NCT01839071;ClinicalTrials.gov processed this data on May 29, 2020;2013-03-21;;;2014-06-24;2013-04-19;2013-04-24;Estimate;;;;;;;2014-06-24;2014-06-25;Estimate;June 2010;;2010-06-30;November 2013;2013-11-30;May 2014;Actual;2014-05-31;May 2014;Actual;2014-05-31;;Interventional;;;Influence of Vasculary Inflammation on Development of Diabetes;Influence of Vasculary Inflammation on Development of Diabetes;Completed;;N/A;109;Actual;RWTH Aachen University;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:20:56Z;2020-06-01T13:20:56Z;Aachen;;;;;biopsy;63641961;1;;;2013;2020-05-29;47;FALSE;;FALSE;TRUE;18;90;Years;Years;1;1;
NCT01837901;ClinicalTrials.gov processed this data on May 29, 2020;2013-04-09;;;2014-04-28;2013-04-22;2013-04-23;Estimate;;;;;;;2014-04-28;2014-04-29;Estimate;July 2011;;2011-07-31;April 2014;2014-04-30;February 2014;Actual;2014-02-28;August 2013;Actual;2013-08-31;;Interventional;;;Transcorneal Electrostimulation for Therapy of Retinitis Pigmentosa;Transkorneale Elektrostimulation Zur Therapie Bei Retinitis Pigmentosa - Eine Prospektive, Randomisierte, Einfach Blinde Folgestudie;Completed;;N/A;55;Actual;Okuvision GmbH;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:21:17Z;2020-06-01T13:21:17Z;Tübingen;3601297;Principal Investigator;Florian Gekeler, Prof. Dr.;Eberhard-Karls-Universität Tübingen;transcorneal electrostimulation;63642047;1;;;2013;2020-05-29;25;FALSE;;FALSE;TRUE;18;80;Years;Years;1;5;
NCT01837082;ClinicalTrials.gov processed this data on May 29, 2020;2013-04-17;;;2016-05-11;2013-04-17;2013-04-22;Estimate;;;;;;;2016-05-11;2016-05-13;Estimate;April 2013;;2013-04-30;May 2016;2016-05-31;December 2015;Actual;2015-12-31;December 2015;Actual;2015-12-31;;Interventional;iCHF;;Iron in Congestive Heart Failure;Randomized, Double-blind, Placebo-controlled Trial of Ferric Carboxymaltose Versus Placebo in Patients With Congestive Heart Failure;Terminated;;Phase 3;18;Actual;University of Ulm;;2;;Insufficient recruitment;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:21:26Z;2020-06-01T13:21:26Z;Ulm;3601377;Principal Investigator;Mahir Karakas, MD;University of Ulm;ferric carboxymaltose | Placebo;63642109;3;;;2013;2020-05-29;32;FALSE;;FALSE;FALSE;18;;Years;;1;;
NCT01836848;ClinicalTrials.gov processed this data on May 29, 2020;2013-04-17;;;2013-04-17;2013-04-17;2013-04-22;Estimate;;;;;;;2013-04-17;2013-04-22;Estimate;June 2013;;2013-06-30;April 2013;2013-04-30;June 2016;Anticipated;2016-06-30;December 2015;Anticipated;2015-12-31;;Interventional;;;Non-invasive Measuring of Cerebral Perfusion After Severe Brain Injury With Near-infrared-spectroscopy and ICG;Continuous, Non-invasive Monitoring of Cerebral Oxygenation and Perfusion Using Near-infrared Spectroscopy With Indocyanine Green Perfusion Measurement in Patients With Traumatic Brain Injury, Intracerebral or Subarachnoid Hemorrhage;Unknown status;;N/A;30;Anticipated;University of Cologne;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:21:27Z;2020-06-01T13:21:27Z;Köln;3601394;Principal Investigator;Gerrit Brinker, physician;Universitiy of Cologne, Departement of General Neurosurgery;measuring cerebral perfusion by NIRS with ICG;63642127;1;;;2013;2020-05-29;;FALSE;;FALSE;TRUE;18;80;Years;Years;1;1;
NCT01836588;ClinicalTrials.gov processed this data on May 29, 2020;2013-03-13;;;2013-04-17;2013-04-17;2013-04-22;Estimate;;;;;;;2013-04-17;2013-04-22;Estimate;March 2013;;2013-03-31;April 2013;2013-04-30;April 2014;Anticipated;2014-04-30;April 2014;Anticipated;2014-04-30;;Interventional;;;New Gentle Biopsy Method of Cervix Lesions Using Superficial Curettage/Protocol ID: CX-CUR;;Unknown status;;N/A;300;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T13:21:29Z;2020-06-01T13:21:29Z;Berlin;3601417;Study Chair;Achim Schneider, Prof. Dr., MPH;Charité University Berlin, Germany;conventional cervix biopsy;63642148;1;;;2013;2020-05-29;;FALSE;;FALSE;TRUE;18;80;Years;Years;1;;
NCT01835678;ClinicalTrials.gov processed this data on May 29, 2020;2013-03-18;;;2018-01-11;2013-04-18;2013-04-19;Estimate;;;;;;;2018-01-11;2018-01-12;Actual;October 2012;;2012-10-31;January 2018;2018-01-31;April 2014;Actual;2014-04-30;March 2014;Actual;2014-03-31;;Interventional;;;Effects of Linagliptin on Renal Endothelium Function in Patients With Type 2 Diabetes.;Effects of Linagliptin on Renal Endothelium Function in Patients With Type 2 Diabetes;Completed;;Phase 3;65;Actual;University of Erlangen-Nürnberg Medical School;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:21:43Z;2020-06-01T13:21:43Z;Erlangen;3601491;Principal Investigator;Roland E Schmieder, MD;University of Erlangen-Nürnberg;Linagliptin | Placebo;63642215;2;;;2013;2020-05-29;17;FALSE;;FALSE;FALSE;18;70;Years;Years;1;10;
NCT01835340;ClinicalTrials.gov processed this data on May 29, 2020;2013-04-15;;;2017-12-09;2013-04-17;2013-04-18;Estimate;;;;;;;2017-12-09;2017-12-12;Actual;October 2012;;2012-10-31;December 2017;2017-12-31;December 9, 2017;Actual;2017-12-09;December 9, 2017;Actual;2017-12-09;;Interventional;;;Breath Gas Measurement of Propofol During Anesthesia in Patients With Endourological Procedures;Study to Estimate Central Propofol Effect by Measuring Exhaled Propofol Concentrations in Patients;Completed;;N/A;22;Actual;University of Luebeck;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:21:49Z;2020-06-01T13:21:49Z;Lübeck;3601511;Principal Investigator;Hartmut Gehring, Professor;University of Luebeck;Drug: Propofol Anesthesia Patients will undergo propofol anesthesia.;63642242;1;;;2013;2020-05-29;62;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT01835002;ClinicalTrials.gov processed this data on May 29, 2020;2013-04-15;;;2015-09-07;2013-04-17;2013-04-18;Estimate;;;;;;;2015-09-07;2015-09-09;Estimate;September 2012;;2012-09-30;September 2015;2015-09-30;August 2015;Actual;2015-08-31;July 2014;Actual;2014-07-31;;Interventional;;;Transcorneal Electrical Stimulation - Multicenter Safety Study;Transcorneal Electrical Stimulation for the Treatment of Retinitis Pigmentosa - a Multicenter Safety Study of the Okustim ® System;Completed;;N/A;105;Actual;Okuvision GmbH;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:21:56Z;2020-06-01T13:21:56Z;Tübingen;3601537;Principal Investigator;Florian Gekeler, Prof Dr med;Eberhard-Karls-Universität Tübingen;Electrostimulation;63642265;7;;;2013;2020-05-29;22;FALSE;;FALSE;FALSE;18;80;Years;Years;1;1;
NCT01833052;ClinicalTrials.gov processed this data on May 29, 2020;2013-04-10;;;2015-05-02;2013-04-15;2013-04-16;Estimate;;;;;;;2015-05-02;2015-05-05;Estimate;April 2013;;2013-04-30;May 2015;2015-05-31;June 2015;Anticipated;2015-06-30;June 2014;Actual;2014-06-30;;Interventional;CLEAN-TAVI;;CLaret Embolic Protection ANd TAVI - Trial;;Unknown status;;N/A;100;Anticipated;University of Leipzig;;2;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T13:22:17Z;2020-06-01T13:22:17Z;Leipzig;;;;;TAVI (Medtronic CoreValve) | Claret-Filter;63642416;1;;;2013;2020-05-29;14;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT01832740;ClinicalTrials.gov processed this data on May 29, 2020;2013-03-08;;;2016-03-15;2013-04-12;2013-04-16;Estimate;;;;;;;2016-03-15;2016-03-16;Estimate;January 2013;;2013-01-31;March 2016;2016-03-31;January 2015;Actual;2015-01-31;January 2015;Actual;2015-01-31;;Interventional;;;Effects of Brain Stimulation During Nocturnal Sleep on Memory Consolidation in Younger, Healthy Subjects;Impact of Transcranial Slow Oscillating Stimulation on Memory Consolidation During Nocturnal Slow Wave Sleep in Younger, Healthy Subjects;Completed;;N/A;22;Anticipated;Charite University, Berlin, Germany;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:22:23Z;2020-06-01T13:22:23Z;Berlin;3601707;Principal Investigator;Agnes Flöel, Professor;Charite Universitätsmedizin Berlin - Neurologie;brain stimulation | SHAM;63642440;1;;;2013;2020-05-29;24;FALSE;;FALSE;TRUE;18;35;Years;Years;1;4;
NCT01832389;ClinicalTrials.gov processed this data on May 29, 2020;2012-10-29;;;2019-03-11;2013-04-11;2013-04-16;Estimate;;;;;;;2019-03-11;2019-03-13;Actual;March 2013;;2013-03-31;March 2019;2019-03-31;December 2016;Actual;2016-12-31;November 2015;Actual;2015-11-30;;Interventional;PiSAH;;Goal Directed Therapy After Aneurysmal Subarachnoid Haemorrhage;Does a PiCCO-controlled Advanced Haemodynamic Monitoring Improve the Outcome After Aneurysmal Subarachnoid Haemorrhage?;Completed;;N/A;108;Actual;Technische Universität München;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:22:26Z;2020-06-01T13:22:26Z;Munich;3601735;Principal Investigator;Bettina Jungwirth, MD;Klinik für Anaesthesiologie, Klinikum rechts der Isar der Technischen Universität München;PiCCO;63642467;1;;;2012;2020-05-29;32;FALSE;;FALSE;TRUE;18;80;Years;Years;1;7;
NCT01828372;ClinicalTrials.gov processed this data on May 29, 2020;2013-03-14;;;2013-04-05;2013-04-05;2013-04-10;Estimate;;;;;;;2013-04-05;2013-04-10;Estimate;May 2013;;2013-05-31;April 2013;2013-04-30;March 2017;Anticipated;2017-03-31;April 2016;Anticipated;2016-04-30;;Interventional;;;Quantification of Drugs and Their Degradation Products;Quantification of Drugs and Their Metabolites in Patients at the Cologne University Hospital;Unknown status;;N/A;1000;Anticipated;University of Cologne;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:23:30Z;2020-06-01T13:23:30Z;Köln;;;;;additional blood withdrawals;63642772;1;;;2013;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT01822418;ClinicalTrials.gov processed this data on May 29, 2020;2013-03-11;;;2018-03-07;2013-03-27;2013-04-02;Estimate;;;;;;;2018-03-07;2018-03-08;Actual;January 2013;;2013-01-31;March 2018;2018-03-31;December 2015;Actual;2015-12-31;December 2015;Actual;2015-12-31;;Interventional;AGOPSYCH;;Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH);Agomelatine Treatment of Major Depressive Episodes in the Course of Schizophrenic Psychoses (AGOPSYCH);Completed;;Phase 4;27;Actual;Central Institute of Mental Health, Mannheim;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:24:50Z;2020-06-01T13:24:50Z;Mannheim;;;;;agomelatine;63643219;1;;;2013;2020-05-29;35;FALSE;;FALSE;TRUE;18;60;Years;Years;1;8;
NCT01818115;ClinicalTrials.gov processed this data on May 29, 2020;2012-02-29;;;2019-01-31;2013-03-25;2013-03-26;Estimate;;;;;;;2019-01-31;2019-02-04;Actual;January 2011;;2011-01-31;January 2019;2019-01-31;November 2015;Actual;2015-11-30;August 2015;Actual;2015-08-31;;Interventional;Hydrus II;;Safety and Efficacy Trial to Evaluate the Hydrus(TM) Implant in Subjects Undergoing Cataract Surgery.;A Prospective, Multi-Center, Randomized Controlled Trial to Evaluate the Safety and Effectiveness of the Hydrus Implant for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery.;Completed;;N/A;100;Actual;Ivantis, Inc.;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T13:25:40Z;2020-06-01T13:25:40Z;Mainz;3602992;Principal Investigator;Prof. Norbert Pfeiffer, MD;Universitatsmedizin Mainz;Hydrus Implant | IOL placement;63643549;7;;;2012;2020-05-29;55;FALSE;;FALSE;FALSE;21;80;Years;Years;1;4;
NCT01817738;ClinicalTrials.gov processed this data on May 29, 2020;2013-02-08;;;2017-02-15;2013-03-22;2013-03-25;Estimate;;;;;;;2017-02-15;2017-02-17;Actual;August 2012;;2012-08-31;April 2016;2016-04-30;January 2017;Actual;2017-01-31;August 2016;Actual;2016-08-31;;Interventional;;;Trial of RNActive®-Derived Prostate Cancer Vaccine in Metastatic Castrate-refractory Prostate Cancer;A Randomised, Double-blind, Placebo-controlled, Phase I/II Trial of RNActive®-Derived Cancer Vaccine (CV9104) in Asymptomatic or Minimally Symptomatic Patients With Metastatic Castrate-refractory Prostate Cancer;Terminated;;Phase 1/Phase 2;197;Actual;CureVac AG;;2;;Follow up period after primary analysis was prematurely stopped because more mature data will~   not impact the study outcome;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:25:46Z;2020-06-01T13:25:46Z;Tübingen;3603027;Principal Investigator;Arnulf Stenzl, Prof. Dr.;"University Hospital of Tübingen; Dept. of Urology";CV9104 | Placebo;63643575;48;;;2013;2020-05-29;48;FALSE;;FALSE;FALSE;18;;Years;;2;7;
NCT01816386;ClinicalTrials.gov processed this data on May 29, 2020;2012-10-28;;;2015-01-12;2013-03-21;2013-03-22;Estimate;;;;;;;2015-01-12;2015-01-13;Estimate;June 2012;;2012-06-30;January 2015;2015-01-31;December 2014;Actual;2014-12-31;June 2014;Actual;2014-06-30;;Interventional;;;Acupuncture Trial for Post Anaesthetic Recovery and Postoperative Pain;Acupuncture Randomized Trial for Post Anaesthetic Recovery and Postoperative Pain - a Pilot Study;Completed;;N/A;75;Actual;Ludwig-Maximilians - University of Munich;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:26:03Z;2020-06-01T13:26:03Z;Munich;3603174;Study Director;Dominik Irnich, PD Dr.;Department of Anaesthesiology, University of Munich;Acupuncture Regimen | Acupressure Regimen;63643677;1;;;2012;2020-05-29;24;FALSE;;FALSE;TRUE;18;;Years;;1;5;1
NCT01815528;ClinicalTrials.gov processed this data on May 29, 2020;2013-03-14;;;2015-02-17;2013-03-19;2013-03-21;Estimate;;;;;;;2015-02-17;2015-02-18;Estimate;March 2013;;2013-03-31;February 2015;2015-02-28;February 2014;Actual;2014-02-28;February 2014;Actual;2014-02-28;;Interventional;;;Feasibility and Clinical Activity of Initial Intraperitoneal Catumaxomab Followed by Chemotherapy in Patients With Recurrent Ovarian Cancer;Single -Arm, Multicenter Phase-II Trial for Catumaxomab and Chemotherapy in Patients With Recurrent Ovarian Cancer to Investigate the Feasibility and Clinical Activity of Initial Intraperitoneal Catumaxomab Followed by Chemotherapy Regimes;Completed;;Phase 2;2;Actual;Charite University, Berlin, Germany;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:26:14Z;2020-06-01T13:26:14Z;Berlin;;;;;Catumaxomab;63643743;1;;;2013;2020-05-29;11;FALSE;;FALSE;TRUE;18;;Years;;1;11;
NCT01812616;ClinicalTrials.gov processed this data on May 29, 2020;2013-03-14;;;2016-08-10;2013-03-14;2013-03-18;Estimate;;;;;;;2016-08-10;2016-08-11;Estimate;September 2014;;2014-09-30;August 2016;2016-08-31;June 2016;Actual;2016-06-30;June 2016;Actual;2016-06-30;;Interventional;;;A Safety Study of Sativex Compared With Placebo (Both With Dose-intense Temozolomide) in Recurrent Glioblastoma Patients;A Two Part Study to Assess the Tolerability, Safety and Pharmacodynamics of Sativex in Combination With Dose-intense Temozolomide in Patients With Recurrent Glioblastoma;Completed;;Phase 1/Phase 2;21;Actual;GW Research Ltd;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:27:00Z;2020-06-01T13:27:00Z;Aachen Düsseldorf Erlangen;3603539;Principal Investigator;Michael Sabel, MD;Zentrum für Neuroonkologie der Universität Duesseldorf;Sativex | Placebo;63643965;11;;;2013;2020-05-29;21;FALSE;;FALSE;FALSE;18;;Years;;1;2;
NCT01812291;ClinicalTrials.gov processed this data on May 29, 2020;2013-03-14;;;2016-01-13;2013-03-14;2013-03-18;Estimate;;;;;;;2016-01-13;2016-01-14;Estimate;February 2012;;2012-02-29;January 2016;2016-01-31;November 2015;Actual;2015-11-30;November 2015;Actual;2015-11-30;;Interventional;Ecce_homo;;Evaluation of a Stepped Care Approach to Manage Depression in Diabetes;Efficacy of a Stepped Care Approach to Manage Depression in Diabetic Patients and Putative Inflammatory Mechanisms Between Diabetes and Depression;Completed;;N/A;260;Actual;Forschungsinstitut der Diabetes Akademie Mergentheim;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:27:02Z;2020-06-01T13:27:02Z;Giessen;3603577;Principal Investigator;Johannes Kruse, Prof. Dr.;University of Giessen;Step 1: Diabetes-Specific CBT (5 group sessions) | Step 2: Depression-Specific CBT (6 single sessions) | Step 3: Referral to Psychotherapist and/or Psychiatrist | Standard Diabetes Education;63643990;1;;;2013;2020-05-29;45;FALSE;;FALSE;TRUE;18;70;Years;Years;1;7;2
NCT01811966;ClinicalTrials.gov processed this data on May 29, 2020;2013-03-13;;;2015-07-28;2013-03-14;2013-03-15;Estimate;;;;;;;2015-07-28;2015-07-29;Estimate;March 2013;;2013-03-31;July 2015;2015-07-31;February 2015;Actual;2015-02-28;February 2015;Actual;2015-02-28;;Interventional;;;Preoperative Volume Substitution in Elective Surgery Patients;Preoperative Volume Substitution in Fasting Patients Undergoing Elective Surgery - Impact on Hemodynamic Stability During Anesthesia;Completed;;N/A;220;Actual;Philipps University Marburg Medical Center;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:27:06Z;2020-06-01T13:27:06Z;Marburg;3603601;Principal Investigator;Thomas Kratz, MD;Department of Anesthesia and Intensive Care Medicine, University Hospital Marburg, Germany;Volume | Control;63644014;1;;;2013;2020-05-29;23;FALSE;;FALSE;TRUE;18;;Years;;1;4;
NCT01811914;ClinicalTrials.gov processed this data on May 29, 2020;2013-03-13;;;2014-04-16;2013-03-13;2013-03-15;Estimate;;;;;;;2014-04-16;2014-04-17;Estimate;March 2013;;2013-03-31;April 2014;2014-04-30;March 2014;Actual;2014-03-31;November 2013;Actual;2013-11-30;;Interventional;;;Focused TTE for Hemodynamic Instable High Risk Patients;Intraoperative Focused TTE - Impact on High Risk Patients´ Management in Hemodynamic Instabilities;Completed;;N/A;50;Actual;Philipps University Marburg Medical Center;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:27:07Z;2020-06-01T13:27:07Z;Marburg;3603606;Principal Investigator;Thomas Kratz, MD;Department of Anesthesia and Intensive Care Medicine, University Hospital Marburg, Germany;intraoperative TTE;63644018;1;;;2013;2020-05-29;8;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT01811589;ClinicalTrials.gov processed this data on May 29, 2020;2013-03-13;;;2019-06-04;2013-03-13;2013-03-14;Estimate;;;;;;;2019-06-04;2019-06-06;Actual;May 2013;;2013-05-31;June 2019;2019-06-30;January 2015;Actual;2015-01-31;January 2015;Actual;2015-01-31;;Interventional;GAVCA;;Guided Application of Ventricular Catheters;Randomized Controlled Multi-center Trial Comparing the Ventricular Catheter Location Between Instrument Guided and Freehand Placement.;Completed;;N/A;144;Actual;Aesculap AG;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:27:10Z;2020-06-01T13:27:10Z;Berlin;3603625;Principal Investigator;Ulrich W Thomale, PD Dr. med.;Charite University, Berlin, Germany;Thomale-Guide | Free-hand;63644044;9;;;2013;2020-05-29;20;FALSE;;FALSE;FALSE;;;;;1;;
NCT01809847;ClinicalTrials.gov processed this data on May 29, 2020;2012-12-18;;;2016-09-16;2013-03-11;2013-03-13;Estimate;;;;;;;2016-09-16;2016-09-19;Estimate;March 2013;;2013-03-31;September 2016;2016-09-30;January 2015;Actual;2015-01-31;January 2015;Actual;2015-01-31;;Interventional;;;Ofatumumab Induction and Maintenance in Elderly Patients With Poor Risk CLL in the Context of Allogeneic Transplantation;Ofatumumab Induction and Maintenance in Elderly Patients With Poor Risk CLL in the Context of Allogeneic Transplantation(CLL-X4 Trial);Completed;;Phase 2;20;Actual;Technische Universität Dresden;;1;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T13:27:29Z;2020-06-01T13:27:29Z;Dresden;3603774;Principal Investigator;Johannes Schetelig, PD Dr. med.;Universitätsklinikum Carl Gustav Carus, Medizinische Klinik und Poliklinik I, 01307 Dresden;Ofatumumab;63644176;11;;;2012;2020-05-29;22;FALSE;;FALSE;FALSE;56;;Years;;2;6;
NCT01809379;ClinicalTrials.gov processed this data on May 29, 2020;2013-03-08;;;2014-10-12;2013-03-08;2013-03-12;Estimate;;;;;;;2014-10-12;2014-10-15;Estimate;February 2013;;2013-02-28;October 2014;2014-10-31;September 2014;Actual;2014-09-30;March 2014;Actual;2014-03-31;;Interventional;;;Intraperitoneal Aerosol High-pressure Chemotherapy for Women With Recurrent Ovarian Cancer;Feasibility, Efficacy and Safety of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) With Cisplatin and Doxorubicin in Women With Recurrent Ovarian Cancer: an Open-label, Single-arm Phase II Clinical Trial;Completed;;Phase 2;69;Actual;Ruhr University of Bochum;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:27:33Z;2020-06-01T13:27:33Z;Bochum;3603809;Principal Investigator;Clemens Tempfer, MD;Runr University Bochum;chemotherapy with doxorubicin and cisplatin;63644211;1;;;2013;2020-05-29;13;FALSE;;FALSE;TRUE;18;80;Years;Years;1;1;1
NCT01803789;ClinicalTrials.gov processed this data on May 29, 2020;2013-03-01;;;2017-11-02;2013-03-01;2013-03-04;Estimate;;;;;;;2017-11-02;2017-11-06;Actual;May 2013;;2013-05-31;November 2017;2017-11-30;July 2017;Actual;2017-07-31;June 2017;Actual;2017-06-30;;Interventional;1-2-KiWI;;Single Versus Double Kirschner Wires for Intramedullary Fixation of Metacarpal V Fractures;Single Versus Double Kirschner Wires for Intramedullary Fixation of Metacarpal V Fractures;Completed;;N/A;292;Actual;University Medicine Greifswald;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T13:29:00Z;2020-06-01T13:29:00Z;Greifswald;3604263;Principal Investigator;Andreas Eisenschenk, Prof. Dr.;University Medicine Greifswald;Single Kirschner Wire | Double Kirschner Wire;63644637;12;;;2013;2020-05-29;49;FALSE;;FALSE;FALSE;18;;Years;;1;12;
NCT01803295;ClinicalTrials.gov processed this data on May 29, 2020;2013-02-21;;;2017-06-15;2013-02-28;2013-03-04;Estimate;;;;;;;2017-06-15;2017-06-16;Actual;June 2013;;2013-06-30;June 2017;2017-06-30;June 2017;Actual;2017-06-30;July 2016;Actual;2016-07-31;;Interventional;OPTIMA;;Pre-TURBT TC-3 Gel Intravesical Instillation in NMIBC;Evaluating the Effect of Pre-TURBT Intravesical Instillation of Mitomycin C (MMC) Mixed With TC-3 Gel in Patients With Non Muscle Invasive Bladder Cancer (NMIBC);Completed;;N/A;80;Actual;UroGen Pharma Ltd.;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:29:06Z;2020-06-01T13:29:06Z;Tübingen;3604310;Principal Investigator;Stenzl, Prof.;Tübingen Universitätsklinik für Urologie;40 mg MMC gel | Standard of care MMC mixed with water | 80 mg MMC gel;63644675;13;;;2013;2020-05-29;37;FALSE;;FALSE;FALSE;21;;Years;;2;;3
NCT01803217;ClinicalTrials.gov processed this data on May 29, 2020;2013-02-28;;;2017-04-07;2013-03-01;2013-03-04;Estimate;;;;;;;2017-04-07;2017-04-10;Actual;November 2007;Actual;2007-11-30;April 2017;2017-04-30;June 2016;Actual;2016-06-30;December 2011;Actual;2011-12-31;;Interventional;ADVANTAGE;;Evaluation of Pacemaker Algorithms to Avoid Unnecessary Right Ventricular Pacing;AV-Hysteresis Versus Mode Switch to AAI (MVP) for the Avoidance of Unnecessary Right Ventricular Pacing;Completed;;N/A;70;Actual;Deutsches Herzzentrum Muenchen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:29:12Z;2020-06-01T13:29:12Z;Munich;;;;;pacemaker programming to mode switch to atrial pacing versus atrioventricular hysteresis function;63644680;3;;;2013;2020-05-29;49;FALSE;;FALSE;FALSE;18;;Years;;1;1;1
NCT01801787;ClinicalTrials.gov processed this data on May 29, 2020;2013-02-26;;;2016-08-13;2013-02-27;2013-03-01;Estimate;;;;;;;2016-08-13;2016-08-16;Estimate;March 2013;;2013-03-31;August 2016;2016-08-31;December 2015;Actual;2015-12-31;December 2015;Actual;2015-12-31;;Interventional;;;Non-invasive Brain Stimulation for Auditory Verbal Hallucinations in Schizophrenia;The Mechanism of Non-invasive Brain Stimulation for Therapy of Chronic Auditory Verbal Hallucinations in Schizophrenia;Completed;;N/A;30;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T13:29:38Z;2020-06-01T13:29:38Z;Berlin;3604482;Principal Investigator;Robert Lindenberg, MD;Department of Neurology, Charité University Medicine Berlin;tDCS;63644790;2;;;2013;2020-05-29;33;FALSE;;FALSE;FALSE;18;80;Years;Years;1;1;3
NCT01801306;ClinicalTrials.gov processed this data on May 29, 2020;2013-02-25;;;2014-06-17;2013-02-26;2013-02-28;Estimate;;;;;;;2014-06-17;2014-06-18;Estimate;March 2013;;2013-03-31;June 2014;2014-06-30;February 2014;Actual;2014-02-28;February 2014;Actual;2014-02-28;;Interventional;;;A New Minimal-invasive Brain Tissue Probe Applying Near Infrared Spectroscopy;A New Multi-parameter Monitoring System Applying Near Infrared Spectroscopy and Indocyanine Green to Detect Cerebrovascular Events in Patients With Subarachnoid Hemorrhage;Completed;;N/A;3;Actual;NeMoDevices AG;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:29:44Z;2020-06-01T13:29:44Z;Heidelberg;3604530;Principal Investigator;Martin Seule, MD;Department of Neurosurgery, University Hospital Heidelberg;NeMo Probe;63644826;1;;;2013;2020-05-29;11;FALSE;;FALSE;TRUE;18;75;Years;Years;1;1;
NCT01801280;ClinicalTrials.gov processed this data on May 29, 2020;2013-02-13;;;2019-02-04;2013-02-26;2013-02-28;Estimate;;;;;;;2019-02-04;2019-02-21;Actual;January 2012;;2012-01-31;February 2019;2019-02-28;March 2014;Actual;2014-03-31;March 2013;Actual;2013-03-31;;Interventional;;;Influence of Pantoprazole on the Bioavailability of MMF and EC-MPS;Pharmacokinetic Cross-over Study to Evaluate the Influence of Pantoprazole on MPA Bioavailability Administered as Mycophenolate Mofetil and Enteric Coated Mycophenolate Sodium in Maintenance Renal Transplant Patients;Completed;;Phase 4;20;Actual;Charite University, Berlin, Germany;;4;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T13:29:45Z;2020-06-01T13:29:45Z;Berlin;3604532;Principal Investigator;Klemens Budde, Prof Dr;Charite University, Berlin, Germany;Mycophenolate sodium | Pantoprazole | Mycophenolate mofetil;63644828;1;22;4;2013;2020-05-29;14;TRUE;20;FALSE;TRUE;18;;Years;;1;;
NCT01799798;ClinicalTrials.gov processed this data on May 29, 2020;2013-02-14;;;2015-01-26;2013-02-24;2013-02-27;Estimate;;;;;;;2015-01-26;2015-01-27;Estimate;February 2013;;2013-02-28;January 2015;2015-01-31;January 2015;Actual;2015-01-31;January 2015;Actual;2015-01-31;;Interventional;OI-AK;;Translational Therapy in Patients With Osteogenesis Imperfecta - A Pilot Trial on Treatment With the Rankl-Antibody Denosumab;TRANSLATIONAL THERAPY IN PATIENTS WITH OSTEOGENESIS IMPERFECTA - A PILOT TRIAL ON TREATMENT WITH THE RANKL-ANTIBODY DENOSUMAB;Completed;;Phase 2;10;Actual;University of Cologne;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:30:08Z;2020-06-01T13:30:08Z;Köln;3604688;Principal Investigator;Joerg Oliver Semler, MD;University Cologne, Childrens Hospital, Cologne, Germany;Denosumab;63644940;1;;;2013;2020-05-29;23;FALSE;;FALSE;TRUE;5;11;Years;Years;1;4;
NCT01799525;ClinicalTrials.gov processed this data on May 29, 2020;2013-02-20;;;2014-12-09;2013-02-23;2013-02-26;Estimate;;;;;;;2014-12-09;2014-12-10;Estimate;January 2013;;2013-01-31;December 2014;2014-12-31;August 2014;Actual;2014-08-31;February 2014;Actual;2014-02-28;;Interventional;SAHCO2;;Hypercapnia to Prevent Secondary Ischemia in SAH;Therapeutical Hypercapnia to Prevent Secondary Ischemic Events in Aneurysmal Subarachnoid Hemorrhage (aSAH);Completed;;Phase 1;10;Actual;Wuerzburg University Hospital;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:30:14Z;2020-06-01T13:30:14Z;Würzburg;3604709;Principal Investigator;Thomas Westermaier, MD;Department of Neurosurgery, University of Wuerzburg, Germany;Hypercapnia by reduction of respiratory volume;63644961;1;;;2013;2020-05-29;13;FALSE;;FALSE;TRUE;18;;Years;;1;2;
NCT01799005;ClinicalTrials.gov processed this data on May 29, 2020;2013-02-24;;;2015-02-01;2013-02-24;2013-02-26;Estimate;;;;;;;2015-02-01;2015-02-03;Estimate;February 2013;;2013-02-28;February 2015;2015-02-28;August 2014;Actual;2014-08-31;August 2014;Actual;2014-08-31;;Interventional;FHS;;FLAVIOLA Health Study;Impact of Dietary Flavanols on Vascular Health in a General Population of Healthy Middle-aged Europeans: a Randomized Controlled Study;Completed;;N/A;100;Anticipated;Heinrich-Heine University, Duesseldorf;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:30:19Z;2020-06-01T13:30:19Z;Düsseldorf;;;;;Flavanol (410 mg) | Control (no flavanols);63645003;1;;;2013;2020-05-29;18;FALSE;;FALSE;TRUE;35;60;Years;Years;1;3;5
NCT01798771;ClinicalTrials.gov processed this data on May 29, 2020;2013-02-22;;;2013-02-25;2013-02-25;2013-02-26;Estimate;;;;;;;2013-02-25;2013-02-26;Estimate;March 2013;;2013-03-31;February 2013;2013-02-28;February 2016;Anticipated;2016-02-29;February 2015;Anticipated;2015-02-28;;Interventional;IMAGER;;Intraoperative MRI and 5-ALA Guidance to Improve the Extent of Resection in Brain Tumor Surgery;Intraoperative MRI and 5-ALA Guidance to Improve the Extent of Resection in Brain Tumor Surgery;Unknown status;;N/A;108;Anticipated;Johann Wolfgang Goethe University Hospital;;2;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T13:30:25Z;2020-06-01T13:30:25Z;Frankfurt;3604772;Principal Investigator;Christian Senft, MD PhD;Dept. of Neurosurgery, Johann Wolfgang Goethe University Hospital;Interventional arm | Control arm;63645021;1;;;2013;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;4;1
NCT01797887;ClinicalTrials.gov processed this data on May 29, 2020;2013-02-21;;;2014-12-22;2013-02-22;2013-02-25;Estimate;;;;;;;2014-12-22;2014-12-24;Estimate;May 2013;;2013-05-31;December 2014;2014-12-31;December 2014;Actual;2014-12-31;December 2014;Actual;2014-12-31;;Interventional;VEDA;;Ayurvedic Versus Conventional Counseling in Mothers With Burnout-Syndrome;Diet and Lifestyle Modification in Mothers With Burnout-Syndrome: Ayurvedic Versus Conventional Standard Counseling - A Randomized Controlled Clinical Pilot Study;Completed;;N/A;40;Anticipated;Charite University, Berlin, Germany;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:30:43Z;2020-06-01T13:30:43Z;Berlin;3604835;Principal Investigator;Andreas Michalsen, MD;Charité Medical University Berlin, Germany;Diet and Lifestyle Counseling;63645086;1;;;2013;2020-05-29;19;FALSE;;FALSE;TRUE;18;50;Years;Years;1;6;1
NCT01797861;ClinicalTrials.gov processed this data on May 29, 2020;2013-02-21;;;2017-10-09;2013-02-21;2013-02-25;Estimate;;;;;;;2017-10-09;2017-10-10;Actual;December 2013;Actual;2013-12-31;April 2016;2016-04-30;May 2017;Actual;2017-05-31;May 2017;Actual;2017-05-31;;Interventional;PLACE;;Prospective Randomized Controlled Treatment Trial for Chronic Central Serous Chorioretinopathy;A Prospective Randomized Controlled Multicentre Trial Comparing Half-dose Photodynamic Therapy (PDT) With High-density Subthreshold Micropulse Laser Treatment in Patients With Chronic Central Serous Chorioretinopathy (CSC);Completed;;Phase 4;140;Anticipated;Radboud University;;2;;;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T13:30:43Z;2020-06-01T13:30:43Z;Köln;3604838;Principal Investigator;Sacha Fauser, MD PhD;Cologne University Eye Clinic;Half-dose photodynamic therapy (PDT) | Micropulse laser (ML) treatment;63645088;5;;;2013;2020-05-29;41;FALSE;;FALSE;FALSE;18;;Years;;1;1;3
NCT01797601;ClinicalTrials.gov processed this data on May 29, 2020;2013-02-18;;;2015-12-02;2013-02-20;2013-02-22;Estimate;;;;;;;2015-12-02;2015-12-03;Estimate;February 2013;;2013-02-28;December 2015;2015-12-31;April 2014;Actual;2014-04-30;April 2014;Actual;2014-04-30;;Interventional;;;Insulin Sensitivity of the Human CNS System: fMRI Study With Intranasal Insulin Application;Insulinsensitivität Des Menschlichen Zentralnervensystems: Kernspintomographische Untersuchung Mit Intranasaler Gabe Von Insulin;Completed;;N/A;48;Actual;University Hospital Tuebingen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:30:46Z;2020-06-01T13:30:46Z;Tübingen;3604863;Principal Investigator;Andreas Fritsche, MD;Universität Tübingen;Human Insulin | Placebo;63645108;1;;;2013;2020-05-29;14;FALSE;;FALSE;TRUE;18;60;Years;Years;1;;
NCT01797484;ClinicalTrials.gov processed this data on May 29, 2020;2013-02-20;;;2018-01-11;2013-02-20;2013-02-22;Estimate;;;;;;;2018-01-11;2018-01-12;Actual;August 2013;;2013-08-31;January 2018;2018-01-31;June 2015;Actual;2015-06-30;June 2015;Actual;2015-06-30;;Interventional;RIMINI-Pilot;;Reduction of Ischemic Myocardium With Ranolazine-Treatment in Patients With Acute Myocardial Ischemia;Reduction of Ischemic Myocardium With Ranolazine-Treatment in Patients With Acute Myocardial Ischemia;Completed;;Phase 2/Phase 3;20;Actual;Universitätsklinikum Hamburg-Eppendorf;;2;;;FALSE;;;;TRUE;;;;;;;;;;;Yes;;2020-06-01T13:30:47Z;2020-06-01T13:30:47Z;Hamburg;3604875;Principal Investigator;Stefan Blankenberg, Prof. Dr.;Director of University Heart Center Hamburg Eppendorf;Ranolazine;63645117;1;0;0;2013;2020-05-29;22;TRUE;10;FALSE;TRUE;18;;Years;;1;;
NCT01797458;ClinicalTrials.gov processed this data on May 29, 2020;2013-02-20;;;2017-10-10;2013-02-21;2013-02-22;Estimate;;;;;;;2017-10-10;2017-11-13;Actual;May 2011;;2011-05-31;October 2017;2017-10-31;December 2014;Actual;2014-12-31;December 2013;Actual;2013-12-31;;Interventional;;;European Study on Three Different Approaches to Managing Class 2 Cavities in Primary Teeth;Randomised Control Trial on Three Different Approaches to Managing Class 2 Cavities in Primary Teeth;Completed;;N/A;169;Actual;University Medicine Greifswald;;3;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T13:30:48Z;2020-06-01T13:30:48Z;Greifswald;3604877;Study Chair;Christian H Splieth, Prof. Dr.;University Medicine Greifswald;Hall Technique | Non-Restorative Caries Treatment | Conventional Restoration;63645119;3;0;0;2013;2020-05-29;31;TRUE;41;FALSE;FALSE;3;8;Years;Years;1;1;3
NCT01796119;ClinicalTrials.gov processed this data on May 29, 2020;2013-02-18;;;2015-02-02;2013-02-20;2013-02-21;Estimate;;;;;;;2015-02-02;2015-02-04;Estimate;February 2013;;2013-02-28;February 2015;2015-02-28;February 2014;Actual;2014-02-28;November 2013;Actual;2013-11-30;;Interventional;;;Ridge Expansion in the Maxillary Aesthetic Zone Using Piezo-electric Surgery;Lateral Alveolar Ridge Expansion in the Maxillary Aesthetic Zone Using Piezo-electric Surgery and Threaded Osteotomes for Immediate Implant Placement.;Completed;;N/A;10;Actual;Clinique Dentaire et d'implantologie Dr.Vinh Nguyen;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:31:10Z;2020-06-01T13:31:10Z;Frankfurt;3604991;Principal Investigator;Vinh Nguyen, DDS.;Goethe University;Ridge Splitting | Implants placed using drilling technique;63645219;1;;;2013;2020-05-29;9;FALSE;;FALSE;TRUE;18;90;Years;Years;1;1;1
NCT01795482;ClinicalTrials.gov processed this data on May 29, 2020;2013-02-18;;;2014-12-15;2013-02-19;2013-02-20;Estimate;;;;;;;2014-12-15;2014-12-16;Estimate;January 2013;;2013-01-31;December 2014;2014-12-31;August 2014;Actual;2014-08-31;August 2014;Actual;2014-08-31;;Interventional;THER-6;;Preoperative Patient Warming for Prevention of Perioperative Hypothermia in Major Abdominal Surgery;The Effect of Preoperative Patient Warming in the Prevention of Perioperative Hypothermia in Major Abdominal Surgery Under Combined General/Epidural Anaesthesia;Completed;;N/A;99;Actual;University of Schleswig-Holstein;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:31:17Z;2020-06-01T13:31:17Z;Kiel Lübeck;3605037;Study Chair;Jan Hoecker, M.D.;University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany;Forced-air warming;63645270;2;;;2013;2020-05-29;19;FALSE;;FALSE;FALSE;18;;Years;;1;;
NCT01795053;ClinicalTrials.gov processed this data on May 29, 2020;2012-08-24;;;2017-03-14;2013-02-19;2013-02-20;Estimate;;;;;;;2017-03-14;2017-03-15;Actual;February 2012;;2012-02-29;March 2017;2017-03-31;October 2017;Anticipated;2017-10-31;July 2017;Anticipated;2017-07-31;;Interventional;;;Effects of Playtraining in ADHD Preschoolers on ADHD Symptoms and Play Persistence and Intensity;Randomized Controlled Trial to Evalualte Effects of Playtraining as Manualized in THOP, a Modulized German ADHD Manual, in 3 to 6 Year Old Children With a Diagnosis of ADHD on ADHD Symptoms and Play Persistence and Intensity;Unknown status;;N/A;60;Anticipated;University of Cologne;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:31:21Z;2020-06-01T13:31:21Z;Köln;3605068;Principal Investigator;Manfred Doepfner, Prof., PhD;University of Cologne;Experimental: playtraining | Placebo open play session;63645303;1;;;2012;2020-05-29;;FALSE;;FALSE;TRUE;3;6;Years;Years;1;1;
NCT01795040;ClinicalTrials.gov processed this data on May 29, 2020;2013-02-16;;;2017-03-14;2013-02-16;2013-02-20;Estimate;;;;;;;2017-03-14;2017-03-16;Actual;September 2010;;2010-09-30;March 2017;2017-03-31;May 2017;Anticipated;2017-05-31;April 2017;Anticipated;2017-04-30;;Interventional;;;Efficacy of Omega-3/Omega-6 Fatty Acids in Pre-school Children at Risk for ADHD;Efficacy of a Supplementary Balanced Diet With Omega-3/ Omega-6 Fatty Acids Among 3-6 Year Olds With Symptoms of ADHD;Unknown status;;N/A;40;Anticipated;University of Cologne;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:31:21Z;2020-06-01T13:31:21Z;Köln;3605069;Principal Investigator;Manfred Doepfner, Prof. Dr.;Department of Child and Adolescent Psychiatry Univ. Cologne;omega-3/omega-6 fatty acids (PUFAs);63645304;1;;;2013;2020-05-29;;FALSE;;FALSE;TRUE;3;6;Years;Years;1;4;1
NCT01791790;ClinicalTrials.gov processed this data on May 29, 2020;2013-02-13;;;2017-07-04;2013-02-13;2013-02-15;Estimate;;;;;;;2017-07-04;2017-07-06;Actual;January 2013;;2013-01-31;July 2017;2017-07-31;December 2017;Anticipated;2017-12-31;December 2017;Anticipated;2017-12-31;;Interventional;;;Effects of Brain Stimulation During Nocturnal Sleep on Memory Consolidation in Elderly Healthy Subjects;Impact of Transcranial Slow Oscillating Stimulation on Memory Consolidation During Nocturnal Slow Wave Sleep in Elderly Healthy Subjects;Unknown status;;N/A;22;Anticipated;Charite University, Berlin, Germany;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:32:12Z;2020-06-01T13:32:12Z;Berlin;3605395;Study Chair;Agnes Flöel, Professor;Charite Universitätsmedizin Berlin - Neurologie;Stimulation | SHAM;63645550;1;;;2013;2020-05-29;;FALSE;;FALSE;TRUE;50;90;Years;Years;1;1;
NCT01789918;ClinicalTrials.gov processed this data on May 29, 2020;2013-02-08;;;2018-07-05;2013-02-08;2013-02-12;Estimate;;;;;;;2018-07-05;2018-07-06;Actual;January 9, 2013;Actual;2013-01-09;July 2018;2018-07-31;March 2016;Actual;2016-03-31;March 2016;Actual;2016-03-31;;Interventional;ACHIEVE;;TrAnsCatHeter Intravascular Ultrasound Energy deliVery for rEnal Denervation (ACHIEVE);TrAnsCatHeter Intravascular Ultrasound Energy deliVery for rEnal Denervation;Completed;;N/A;96;Actual;ReCor Medical, Inc.;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:32:47Z;2020-06-01T13:32:47Z;Freiburg;3605529;Principal Investigator;Thomas Zeller, Professor;Universitäts-Herzzentrum Freiburg • Bad Krozingen;PARADISE percutaneous renal denervation;63645692;8;;;2013;2020-05-29;39;FALSE;;FALSE;FALSE;18;;Years;;2;3;2
NCT01789567;ClinicalTrials.gov processed this data on May 29, 2020;2013-02-06;;;2017-10-27;2013-02-08;2013-02-12;Estimate;;;;;;;2017-10-27;2018-07-26;Actual;May 2013;;2013-05-31;October 2017;2017-10-31;June 2015;Actual;2015-06-30;July 2014;Actual;2014-07-31;;Interventional;;;Engager Direct Aortic Clinical Study;Engager Direct Aortic Clinical Study: Medtronic Engager™ Transcatheter Aortic Valve Implantation System Via Direct Aortic Approach;Completed;;N/A;20;Actual;Medtronic Cardiovascular;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:32:50Z;2020-06-01T13:32:50Z;Halle Leipzig Munich;3605550;Principal Investigator;Hendrik Treede, MD;University Hospital Halle, Germany;Engager™ aortic valve;63645717;6;106;67;2013;2020-05-29;14;TRUE;25;FALSE;FALSE;18;;Years;;1;;3
NCT01788254;ClinicalTrials.gov processed this data on May 29, 2020;2013-01-31;;;2015-05-26;2013-02-07;2013-02-11;Estimate;;;;;;;2015-05-26;2015-05-27;Estimate;January 2012;;2012-01-31;May 2015;2015-05-31;May 2015;Actual;2015-05-31;May 2015;Actual;2015-05-31;;Interventional;IKP243;;Open Label Study for the Functional Characterization of Drug Metabolism and Transport;Open Label Study for the Functional Characterization of Drug Metabolism and Transport;Completed;;Phase 1;144;Actual;University Hospital Tuebingen;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:33:04Z;2020-06-01T13:33:04Z;Tübingen;3605666;Principal Investigator;Matthias Schwab, Prof., M.D.;Dr. Margarete Fischer Bosch Institute of Clinical Pharmacology and University of Tuebingen;Codeine | Midazolam | pravastatin | Talinolol | torsemide;63645721;2;;;2013;2020-05-29;40;FALSE;;FALSE;FALSE;18;65;Years;Years;5;1;
NCT01789112;ClinicalTrials.gov processed this data on May 29, 2020;2013-02-08;;;2018-07-03;2013-02-08;2013-02-11;Estimate;;;;;;;2018-07-03;2018-07-06;Actual;July 2012;Actual;2012-07-31;July 2018;2018-07-31;June 30, 2017;Actual;2017-06-30;June 30, 2017;Actual;2017-06-30;;Interventional;;;Acute Effects of a Non Excitatory Cardial Stimulation;Acute Neurotrophic Effects of a Non Excitatory Cardial Stimulation by Optimizer III System in Patients With Heart Failure;Completed;;N/A;13;Actual;RWTH Aachen University;;1;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T13:32:55Z;2020-06-01T13:32:55Z;Aachen;3605595;Principal Investigator;Sebastian Reith, MD;RWTH Aachen, Medical Departement I Univerity Hospital Aachen;Blood sample;63645753;1;;;2013;2020-05-29;59;FALSE;;FALSE;TRUE;18;90;Years;Years;1;;
NCT01785186;ClinicalTrials.gov processed this data on May 29, 2020;2012-12-17;;;2017-08-22;2013-02-04;2013-02-07;Estimate;;;;;;;2017-08-22;2017-09-20;Actual;April 2013;;2013-04-30;August 2017;2017-08-31;March 2015;Actual;2015-03-31;September 2014;Actual;2014-09-30;;Interventional;;;Evaluation of SQ109, High-dose Rifampicin, and Moxifloxacin in Adults With Smear-positive Pulmonary TB in a MAMS Design;A Multiple Arm, Multiple Stage, Phase 2, OL, Randomized, Controlled Trial to Evaluate 4 Treatment Regimens of SQ109, Increased Doses of Rifampicin, and Moxifloxacin in Adults With Newly Diagnosed, Smear-positive Pulmonary Tuberculosis;Completed;;Phase 2;365;Actual;Ludwig-Maximilians - University of Munich;;5;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:33:54Z;2020-06-01T13:33:54Z;Munich;3605976;Study Chair;Michael Hoelscher, MD;Klinikum of the University of Munich;SQ109 | Rifampicin | Moxifloxacin | isoniazid | pyrazinamide | ethambutol | pyridoxine;63646047;7;1127;48;2012;2020-05-29;17;TRUE;35;FALSE;FALSE;18;;Years;;1;10;
NCT01785082;ClinicalTrials.gov processed this data on May 29, 2020;2013-01-25;;;2018-10-23;2013-02-04;2013-02-07;Estimate;;;;;;;2018-10-23;2018-10-25;Actual;January 2013;Actual;2013-01-31;October 2018;2018-10-31;September 2015;Actual;2015-09-30;September 2015;Actual;2015-09-30;;Interventional;;;Fast-track LiveR: Study for the Early Identification of Low-risk Patients After Partial Liver Resection by the LiMAx-test;Prospective, Randomized, Controlled, Multi-centric, Phase III Study for the Early Identification of Low-risk Patients After Partial Liver Resection by the LiMAx-test;Completed;;Phase 3;149;Actual;Humedics GmbH;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:33:56Z;2020-06-01T13:33:56Z;Berlin;3605985;Principal Investigator;Martin Stockmann, PD Dr. med.;Dept. of General-, Visceral- and Graft Surgery, Charité Campus Virchow-Hospital, Augustenburger Platz 1, 13353 Berlin, Germany;13-C-Methacetin;63646055;4;;;2013;2020-05-29;32;FALSE;;FALSE;FALSE;18;;Years;;1;9;1
NCT01784367;ClinicalTrials.gov processed this data on May 29, 2020;2013-01-30;;;2017-06-16;2013-02-02;2013-02-05;Estimate;;;;;;;2017-06-16;2017-06-19;Actual;December 2012;;2012-12-31;June 2017;2017-06-30;April 2015;Actual;2015-04-30;April 2015;Actual;2015-04-30;;Interventional;ECLAIR;;Extracorporeal Lung Assist to Avoid Intubation in Patients Failing NIV for Hypercapnic ARF;Extracorporeal Lung Assist to Avoid Intubation in Patients Failing Noninvasive Ventilation for Acute Hypercapnic Respiratory Failure;Completed;;N/A;30;Actual;Universitätsklinikum Hamburg-Eppendorf;;1;;;FALSE;;;;TRUE;FALSE;FALSE;;;;;;;;;No;;2020-06-01T13:34:04Z;2020-06-01T13:34:04Z;Hamburg;3606030;Principal Investigator;Stefan Kluge, MD;Department of Intensive Care Medicine, University Medical-Center Hamburg-Eppendorf;vv-ECCO2R (Novalung GmbH, Germany);63646110;1;;;2013;2020-05-29;28;FALSE;;FALSE;TRUE;18;;Years;;1;6;
NCT01783639;ClinicalTrials.gov processed this data on May 29, 2020;2013-01-13;;;2017-06-29;2013-02-01;2013-02-05;Estimate;;;;;;;2017-06-29;2017-08-07;Actual;February 2013;;2013-02-28;June 2017;2017-06-30;April 2015;Actual;2015-04-30;December 2013;Actual;2013-12-31;;Interventional;WISE;;Safety and Performance Evaluation of WIRION™ EPD in Patients Undergoing Carotid Artery Stenting;The WISE Study is a Pivotal Study Evaluating the Safety and Performance of WIRION™ EPD in Patients Undergoing Carotid Artery Stenting;Completed;;N/A;120;Actual;Gardia Medical;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:34:14Z;2020-06-01T13:34:14Z;Frankfurt Hamburg Leipzig Munich;3606074;Principal Investigator;Dierk Scheinert, MD;Herzzentrum Leipzig GmbH and Park-Krankenhaus Leipzig;Carotid Artery Stent;63646166;10;0;36;2013;2020-05-29;10;TRUE;17;FALSE;FALSE;18;;Years;;1;6;
NCT01782391;ClinicalTrials.gov processed this data on May 29, 2020;2012-06-05;;;2016-12-20;2013-01-31;2013-02-01;Estimate;;;;;;;2016-12-20;2016-12-21;Estimate;April 2013;;2013-04-30;December 2016;2016-12-31;December 2017;Anticipated;2017-12-31;December 2017;Anticipated;2017-12-31;;Interventional;;;Effects of Brain Stimulation During Nocturnal Sleep on Memory Consolidation in Patients With Mild Cognitive Impairments;Impact of Transcranial Slow Oscillating Stimulation on Memory Consolidation During Nocturnal Slow Wave Sleep in Patients With Mild Cognitive Impairments(MCI);Unknown status;;N/A;22;Anticipated;Charite University, Berlin, Germany;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:34:39Z;2020-06-01T13:34:39Z;Berlin;3606184;Study Chair;Agnes Flöel, Professor;Charite Universitätsmedizin Berlin - Neurologie;Stimulation | SHAM;63646262;1;;;2012;2020-05-29;;FALSE;;FALSE;TRUE;50;90;Years;Years;1;1;
NCT01782365;ClinicalTrials.gov processed this data on May 29, 2020;2013-01-31;;;2017-07-04;2013-01-31;2013-02-01;Estimate;;;;;;;2017-07-04;2017-07-06;Actual;April 2013;;2013-04-30;July 2017;2017-07-31;December 2017;Anticipated;2017-12-31;August 2016;Actual;2016-08-31;;Interventional;;;Effects of Brain Stimulation During a Daytime Nap on Memory Consolidation in Patients With Mild Cognitive Impairment;Impact of Transcranial Slow Oscillating Stimulation on Memory Consolidation During Slow Wave Sleep of a Daytime Nap in Patients With Mild Cognitive Impairment(MCI);Unknown status;;N/A;16;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:34:40Z;2020-06-01T13:34:40Z;Berlin;3606187;Study Chair;Agnes Flöel, Professor;Charite Universitätsmedizin Berlin - Neurologie;SHAM stimulation | 0,75 Hz stimulation;63646264;1;;;2013;2020-05-29;40;FALSE;;FALSE;TRUE;50;90;Years;Years;1;1;
NCT01779479;ClinicalTrials.gov processed this data on May 29, 2020;2013-01-25;;;2017-07-31;2013-01-28;2013-01-30;Estimate;;;;;;;2017-07-31;2017-08-01;Actual;February 2013;;2013-02-28;February 2016;2016-02-29;February 2016;Actual;2016-02-29;August 2015;Actual;2015-08-31;;Interventional;;;Efficacy and Safety of Cabazitaxel Versus Weekly Paclitaxel as Neo-adjuvant Treatment in Patients With Triple Negative or Luminal B/HER2 Normal BC (GENEVIEVE);Randomized, Open-label, Phase II Study Comparing the Efficacy and the Safety of Cabazitaxel Versus Weekly Paclitaxel Given as Neo-adjuvant Treatment in Patients With Operable Triple Negative or Luminal B/HER2 Normal Breast Cancer (GENEVIEVE);Completed;;Phase 2;333;Actual;German Breast Group;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:35:27Z;2020-06-01T13:35:27Z;Düsseldorf;3606423;Principal Investigator;Gunter von Minckwitz, Prof. Dr.;Luisenkrankenhaus Düsseldorf;Cabacitaxel | Paclitaxel;63646482;1;;;2013;2020-05-29;30;FALSE;;FALSE;TRUE;18;;Years;;1;14;
NCT01776112;ClinicalTrials.gov processed this data on May 29, 2020;2012-01-01;;;2015-05-26;2013-01-22;2013-01-25;Estimate;;;;;;;2015-05-26;2015-05-27;Estimate;January 2011;;2011-01-31;May 2015;2015-05-31;August 2014;Actual;2014-08-31;March 2014;Actual;2014-03-31;;Interventional;EXERCISE-II;;Enhancing Synaptic Plasticity and Cognition in Schizophrenia;Enhancing Synaptic Plasticity and Cognition by Physical Exercise and Cognitive Training in Schizophrenia: A Randomised Controlled Trial;Completed;;N/A;66;Actual;University Medical Center Goettingen;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:36:28Z;2020-06-01T13:36:28Z;Göttingen;3606708;Principal Investigator;Peter Falkai, MD, PhD;Head, Dept. of Psychiatry and Psychotherapy University Medical Center Goettingen Georg-August-University von-Siebold-Strasse 5 D-37075 Goettingen Germany P: +49-(0)551-39-6610;Exercise | TableSoccer;63646737;1;;;2012;2020-05-29;38;FALSE;;FALSE;TRUE;18;55;Years;Years;1;2;
NCT01774838;ClinicalTrials.gov processed this data on May 29, 2020;2013-01-16;;;2015-06-10;2013-01-21;2013-01-24;Estimate;;;;;;;2015-06-10;2015-06-11;Estimate;October 2014;;2014-10-31;June 2015;2015-06-30;June 2015;Actual;2015-06-30;June 2015;Actual;2015-06-30;;Interventional;;;Vasoactive and Anti-inflammatory Effects of Prasugrel in Acute Coronary Syndrome;Vasoactive and Anti-inflammatory Effects of Prasugrel in Acute Coronary Syndrome;Completed;;Phase 3;49;Actual;University of Cologne;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:36:51Z;2020-06-01T13:36:51Z;Köln;3606813;Principal Investigator;Tanja Rudolph, MD;University Hospital of Cologne;Prasugrel | Clopidogrel;63646836;1;;;2013;2020-05-29;8;FALSE;;FALSE;TRUE;18;75;Years;Years;1;;
NCT01773902;ClinicalTrials.gov processed this data on May 29, 2020;2013-01-15;;;2018-05-09;2013-01-18;2013-01-23;Estimate;;;;;;;2018-05-09;2018-05-15;Actual;October 2012;;2012-10-31;May 2018;2018-05-31;July 2016;Actual;2016-07-31;December 2014;Actual;2014-12-31;;Interventional;;;Protein for Premies;High Versus Standard Dose Protein for Very Preterm Infants;Completed;;N/A;60;Anticipated;University Hospital Tuebingen;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:37:15Z;2020-06-01T13:37:15Z;Tübingen;3606891;Principal Investigator;Axel Franz, MD;Universität Tübingen;High Dose Protein (Individualized) | High Dose Protein (Standardized) | Standard Protein Supplementation;63646906;1;;;2013;2020-05-29;26;FALSE;;FALSE;TRUE;;7;;Days;1;1;1
NCT01770990;ClinicalTrials.gov processed this data on May 29, 2020;2013-01-08;;;2015-07-13;2013-01-15;2013-01-18;Estimate;;;;;;;2015-07-13;2015-07-14;Estimate;September 2012;;2012-09-30;July 2015;2015-07-31;April 2015;Actual;2015-04-30;April 2015;Actual;2015-04-30;;Interventional;Tel-PT;;Trial of Telephone-based Psychotherapy for Depression With and Without Adjunctive Supportive Mail;Randomized Trial of Telephone-Based Psychotherapy for Depression With and Without Adjunctive Supportive Mail;Completed;;N/A;59;Actual;Universitätsklinikum Hamburg-Eppendorf;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:37:51Z;2020-06-01T13:37:51Z;Hamburg;3607143;Study Director;Birgit Watzke, Prof. Dr.;Centre for Psychosocial Medicine, Department of Medical Psychology, University Medical Centre Hamburg-Eppendorf , Hamburg, Germany;Tel-PT including mail | Tel-PT without mail;63647127;1;;;2013;2020-05-29;31;FALSE;;FALSE;TRUE;18;;Years;;1;3;
NCT01770080;ClinicalTrials.gov processed this data on May 29, 2020;2013-01-09;;;2015-12-29;2013-01-15;2013-01-17;Estimate;;;;;;;2015-12-29;2015-12-30;Estimate;February 2013;;2013-02-28;December 2015;2015-12-31;September 2015;Actual;2015-09-30;September 2015;Actual;2015-09-30;;Interventional;CAS/B/016611;;Efficacy of Euminz® for Tension-Type Headache;"Efficacy and Safety of Euminz® (10% Ethanolic Solution of Peppermint Oil for Topical Use) Compared to Placebo in Patients With Episodic Tension-type Headache (ETTH); Phase IV Clinical Trial";Completed;;Phase 4;211;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:38:02Z;2020-06-01T13:38:02Z;Berlin;3607271;Study Director;Yatin Shah, MD;Charite University, Berlin, Germany;Euminz® | Placebo;63647196;1;;;2013;2020-05-29;31;FALSE;;FALSE;TRUE;18;65;Years;Years;1;1;1
NCT01769313;ClinicalTrials.gov processed this data on May 29, 2020;2013-01-14;;;2014-10-30;2013-01-15;2013-01-16;Estimate;;;;;;;2014-10-30;2014-10-31;Estimate;January 2013;;2013-01-31;October 2014;2014-10-31;October 2014;Actual;2014-10-31;October 2014;Actual;2014-10-31;;Interventional;;;A Single Centre Study to Analyze Cataract Surgery Following Femtosecond Laser-Assisted and Manual Cataract Surgery;A Single Centre Study to Analyze Cataract Surgery Following Femtosecond Laser-Assisted and Manual Cataract Surgery;Completed;;Phase 4;30;Actual;Technolas Perfect Vision GmbH;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:38:15Z;2020-06-01T13:38:15Z;Heidelberg;3607338;Principal Investigator;Gerd U Auffarth, Prof. Dr.;Universitäts-Augenklinik Heidelberg;Laser-assisted cataract surgery | Manually performed cataract surgery;63647255;1;;;2013;2020-05-29;21;FALSE;;FALSE;TRUE;18;;Years;;1;3;
NCT01768585;ClinicalTrials.gov processed this data on May 29, 2020;2013-01-11;;;2013-01-14;2013-01-14;2013-01-15;Estimate;;;;;;;2013-01-14;2013-01-15;Estimate;December 2012;;2012-12-31;January 2013;2013-01-31;December 2014;Anticipated;2014-12-31;December 2014;Anticipated;2014-12-31;;Interventional;;;Study to Investigate the Effect of Heart Rate Reduction With Ivabradine on Vascular Elastic Properties and Endothelial Function in Patients With Stable Coronary Heart Disease;A Randomised, Placebo Controlled, Double Blind, Cross-over, Single Center Clinical Study to Investigate the Effect of Heart Rate Reduction With Ivabradine on Vascular Elastic Properties and Endothelial Function in Patients With Stable Coronary Heart Disease;Unknown status;;Phase 4;50;Anticipated;University Hospital, Saarland;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:38:25Z;2020-06-01T13:38:25Z;Homburg;3607397;Principal Investigator;Ulrich Laufs;Saarland University Hospital;Ivabradine | Placebo;63647310;1;;;2013;2020-05-29;;FALSE;;FALSE;TRUE;18;90;Years;Years;1;1;
NCT01767220;ClinicalTrials.gov processed this data on May 29, 2020;2013-01-07;;;2014-01-29;2013-01-11;2013-01-14;Estimate;;;;;;;2014-01-29;2014-01-30;Estimate;November 2012;;2012-11-30;January 2013;2013-01-31;November 2014;Anticipated;2014-11-30;November 2014;Anticipated;2014-11-30;;Interventional;VTeee;;Endo- and Epicardial vs. Endocardial Ablation of Ventricular Tachycardia in Patients With Cardiac Disease;Primary Endo- and Epicardial vs. Endocardial Ablation of Sustained Ventricular Tachycardia in Patients With Underlying Cardiac Disease (VTeee);Unknown status;;N/A;40;Anticipated;University of Rostock;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:38:46Z;2020-06-01T13:38:46Z;Rostock;3607520;Principal Investigator;Dietmar Baensch, Prof. Dr.;University Hospital of Rostock, Dept. of Cardiology;Strategy 1 - endocardial ablation | Strategy 2 - endocardial and epicardial ablation;63647415;1;;;2013;2020-05-29;;FALSE;;FALSE;TRUE;18;80;Years;Years;1;3;
NCT01767181;ClinicalTrials.gov processed this data on May 29, 2020;2013-01-10;;;2017-08-02;2013-01-11;2013-01-14;Estimate;;;;;;;2017-08-02;2017-08-03;Actual;February 2013;;2013-02-28;August 2017;2017-08-31;December 2016;Actual;2016-12-31;December 2016;Actual;2016-12-31;;Interventional;;;Light and Exercise in Night-shift Workers;Effects of Timed Intensive Light Therapy or Timed Physical Exercise on Markers of Central and Peripheral Circadian Rhythm and on Cardiometabolic Function in Night Shift Workers;Completed;;N/A;154;Actual;Universitätsklinikum Hamburg-Eppendorf;;4;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T13:38:47Z;2020-06-01T13:38:47Z;Hamburg;3607523;Principal Investigator;Rainer Böger, MD;Universitätsklinikum Hamburg-Eppendorf;Intensive light therapy | Exercise;63647418;1;;;2013;2020-05-29;46;FALSE;;FALSE;TRUE;18;;Years;;1;7;
NCT01766791;ClinicalTrials.gov processed this data on May 29, 2020;2013-01-07;;;2014-03-20;2013-01-10;2013-01-11;Estimate;;;;;;;2014-03-20;2014-03-21;Estimate;January 2013;;2013-01-31;March 2014;2014-03-31;March 2014;Actual;2014-03-31;March 2014;Actual;2014-03-31;;Interventional;;;Resistance Exercise, Muscle Mass, Strength and Body Composition;Effects of Resistance Exercise on Muscle Mass, Strength, Body Composition and Heart in Men 30-50 Years Old.;Completed;;Phase 3;120;Actual;University of Erlangen-Nürnberg Medical School;;4;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:38:52Z;2020-06-01T13:38:52Z;Erlangen;3607555;Study Director;Wolfgang Kemmler, PhD;University of Erlangen-Nürnberg Medical School;HIT-exercise, low repetition range | HIT-exercise, high repetition range | HIT-exercise with protein | Control;63647450;1;;;2013;2020-05-29;14;FALSE;;FALSE;TRUE;30;50;Years;Years;1;1;4
NCT01764880;ClinicalTrials.gov processed this data on May 29, 2020;2013-01-07;;;2017-10-20;2013-01-08;2013-01-10;Estimate;;;;;;;2017-10-20;2017-10-23;Actual;November 2012;;2012-11-30;October 2017;2017-10-31;November 2016;Actual;2016-11-30;November 2016;Actual;2016-11-30;;Interventional;;;SST0001 (Roneparstat) in Advanced Multiple Myeloma;Phase I Dose Finding Study Assessing Safety and Tolerability of SST0001 in Advanced Multiple Myeloma.;Completed;;Phase 1;19;Actual;Sigma Tau Research Switzerland SA;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:39:21Z;2020-06-01T13:39:21Z;Würzburg;3607709;Principal Investigator;Manik Chatterjee, MD;Universitätsklinik Würzburg, Medizinische Klinik und Poliklinik II (ZIM), Würzburg, Germany;SST0001 (Roneparstat);63647597;5;;;2013;2020-05-29;48;FALSE;;FALSE;FALSE;18;;Years;;1;9;
NCT01763112;ClinicalTrials.gov processed this data on May 29, 2020;2013-01-04;;;2015-03-30;2013-01-07;2013-01-08;Estimate;;;;;;;2015-03-30;2015-03-31;Estimate;January 2013;;2013-01-31;March 2015;2015-03-31;June 2015;Anticipated;2015-06-30;June 2015;Anticipated;2015-06-30;;Interventional;GALILEO-PAH;;Training With Whole Body Vibration Device in Patients With PAH;Influence of Training With Whole Body Vibration Device (Galileo) on Quality of Life (QoL), Exercise Capacity, as Well as on the Effects of Muscle Power and Muscle Function in Patients With Pulmonal Arterial Hypertension (PAH). (GALILEO PAH);Unknown status;;N/A;20;Actual;Klinikum der Universität Köln;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:40:07Z;2020-06-01T13:40:07Z;Köln;3607902;Principal Investigator;Felix Gerhardt, PhD;Klinik III für Innere Medizin Uniklinik Köln;Exercise Group Galileo PAH;63647729;1;;;2013;2020-05-29;;FALSE;;FALSE;TRUE;18;90;Years;Years;1;3;
NCT01759238;ClinicalTrials.gov processed this data on May 29, 2020;2012-12-17;;;2015-02-04;2013-01-02;2013-01-03;Estimate;;;;;;;2015-02-04;2015-02-06;Estimate;May 2013;;2013-05-31;February 2015;2015-02-28;October 2014;Actual;2014-10-31;October 2014;Actual;2014-10-31;;Interventional;OLGA;;Chemoradiotherapy for Patients With Oligometastatic Colorectal Cancer;Capecitabine and Bevacizumab With Radiotherapy After 3-6 Months Chemotherapy for Patients With Oligometastatic Colorectal Cancer (OLGA Trial);Terminated;;Phase 2;1;Actual;Universitätsklinikum Hamburg-Eppendorf;;1;;slow accrual;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:40:54Z;2020-06-01T13:40:54Z;Hamburg;3608261;Principal Investigator;Cordula Petersen, Prof.;Universitätsklinikum Hamburg-Eppendorf;Capecitabine | Bevacizumab | Radiotherapy;63648024;1;;;2012;2020-05-29;17;FALSE;;FALSE;TRUE;18;;Years;;1;6;
NCT01757613;ClinicalTrials.gov processed this data on May 29, 2020;2012-12-18;;;2014-05-13;2012-12-21;2012-12-31;Estimate;;;;;;;2014-05-13;2014-05-14;Estimate;December 2012;;2012-12-31;May 2014;2014-05-31;January 2014;Actual;2014-01-31;January 2014;Actual;2014-01-31;;Interventional;;;Study Whose Purpose is to Find an Optimal Dose for the Treatment With AK 3012 in Patients With Actinic Keratosis;Three-armed, Randomized, Double-blind Dose-finding Trial on Efficiency and Safety of AK 3012 in 3 Different Concentrations in Patients With Actinic Keratosis Olsen Grade I/II;Completed;;Phase 2;150;Anticipated;Dolorgiet GmbH & Co. KG;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:41:10Z;2020-06-01T13:41:10Z;Tübingen;3608417;Principal Investigator;Amir Yazdi, Dr. med;Eberhard-Karls-Universität Tübingen;AK 3012;63648149;9;;;2012;2020-05-29;13;FALSE;;FALSE;FALSE;18;;Years;;1;3;
NCT01756118;ClinicalTrials.gov processed this data on May 29, 2020;2012-12-19;;;2017-08-16;2012-12-19;2012-12-24;Estimate;;;;;;;2017-08-16;2017-08-21;Actual;June 2012;;2012-06-30;August 2017;2017-08-31;December 2017;Anticipated;2017-12-31;December 2017;Anticipated;2017-12-31;;Interventional;;;A Phase I, Dose-finding Study of BEZ235 in Adult Patients With Relapsed or Refractory Acute Leukemia;A Phase I, Dose-finding Study of the Oral, Dual Phosphatidylinositol 3(PI3)-Kinase / Mammilian Target of Rapamycin (mTOR) Inhibitor BEZ235 in Adult Patients With Relapsed or Refractory Acute Leukemia;Unknown status;;Phase 1;23;Anticipated;Johann Wolfgang Goethe University Hospital;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:41:32Z;2020-06-01T13:41:32Z;Frankfurt;3608546;Study Director;Joerg Chromik, Dr.;Johann Wolfgang Goethe University Hospital;BEZ235;63648262;1;;;2012;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;2;7;
NCT01755871;ClinicalTrials.gov processed this data on May 29, 2020;2012-12-19;;;2016-06-08;2012-12-19;2012-12-24;Estimate;;;;;;;2016-06-08;2016-06-09;Estimate;January 2013;;2013-01-31;June 2015;2015-06-30;February 2016;Actual;2016-02-29;January 2016;Actual;2016-01-31;;Interventional;BiobankII;;Long-term Effect of Fingolimod on Circulating Immunocompetent Mononuclear Cells in Patients With Multiple Sclerosis;The Long-term Effect of Fingolimod on Circulating Immunocompetent Mononuclear Cells in Patients With Multiple Sclerosis;Terminated;;Phase 4;8;Actual;Heinrich-Heine University, Duesseldorf;;1;;lack of recruitment;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:41:34Z;2020-06-01T13:41:34Z;Düsseldorf;3608569;Principal Investigator;Bernd Kieseier, Prof.;Heinrich Heine Universität Düsseldorf;Fingolimod;63648281;1;;;2012;2020-05-29;36;FALSE;;FALSE;TRUE;18;65;Years;Years;1;1;1
NCT01755507;ClinicalTrials.gov processed this data on May 29, 2020;2012-12-19;;;2016-08-02;2012-12-21;2012-12-24;Estimate;;;;;;;2016-08-02;2016-08-03;Estimate;December 2012;;2012-12-31;August 2016;2016-08-31;December 2015;Actual;2015-12-31;October 2015;Actual;2015-10-31;;Interventional;NUC-3;;Norursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis;Double-blind,Randomized, Placebo-controlled, Phase II Dose-finding Study Comparing Different Doses of Norursodeoxycholic Acid Capsules With Placebo in the Treatment of Primary Sclerosing Cholangitis;Completed;;Phase 2;159;Actual;Dr. Falk Pharma GmbH;;4;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:41:43Z;2020-06-01T13:41:43Z;Hannover;3608604;Principal Investigator;Michael P Manns, Prof;Med. Hochschule Hannover;norUDCA | Placebo;63648309;3;;;2012;2020-05-29;34;FALSE;;FALSE;FALSE;18;80;Years;Years;1;1;1
NCT01742767;ClinicalTrials.gov processed this data on May 29, 2020;2012-12-03;;;2012-12-04;2012-12-04;2012-12-05;Estimate;;;;;;;2012-12-04;2012-12-05;Estimate;November 2012;;2012-11-30;December 2012;2012-12-31;April 2015;Anticipated;2015-04-30;May 2014;Anticipated;2014-05-31;;Interventional;PemSplitCisp;;Cisplatinum/Pemetrexed Versus Split-dose Cisplatinum/Pemetrexed In NSCLC;Randomized Phase II Trial of Three-weekly Cisplatinum and Pemetrexed Versus Split-dose d1 and d8 Cisplatinum and Pemetrexed In Advanced and Inoperable Non-squamous Non-small-cell Lung Cancer (NSCLC);Unknown status;;Phase 2;;;Universität Duisburg-Essen;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:44:49Z;2020-06-01T13:44:49Z;Duisburg;;;;;Cisplatinum | Pemetrexed;63649285;1;;;2012;2020-05-29;;FALSE;;FALSE;TRUE;18;75;Years;Years;1;;
NCT01741792;ClinicalTrials.gov processed this data on May 29, 2020;2012-11-28;;;2016-11-09;2012-12-03;2012-12-05;Estimate;;;;;;;2016-11-09;2017-01-06;Estimate;July 2012;;2012-07-31;November 2016;2016-11-30;September 2015;Actual;2015-09-30;July 2014;Actual;2014-07-31;;Interventional;;;Clinical Study With Blinatumomab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL);An Open Label, Multicenter, Exploratory Phase 2 Study to Evaluate the Efficacy and Safety of the Bispecific T-Cell Engager (BiTE®) Blinatumomab in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL);Completed;;Phase 2;25;Actual;Amgen Research (Munich) GmbH;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:45:02Z;2020-06-01T13:45:02Z;Munich;;;;;Blinatumomab;63649357;6;784;216;2012;2020-05-29;24;TRUE;11;FALSE;FALSE;18;;Years;;1;37;
NCT01741532;ClinicalTrials.gov processed this data on May 29, 2020;2012-12-03;;;2019-06-27;2012-12-03;2012-12-05;Estimate;;;;;;;2019-06-27;2019-07-05;Actual;December 13, 2012;Actual;2012-12-13;June 2019;2019-06-30;January 11, 2017;Actual;2017-01-11;October 21, 2016;Actual;2016-10-21;;Interventional;;;Efficacy and Safety Study of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN);A Randomized, Double-blind, Placebo-controlled Trial of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN);Completed;;Phase 3;89;Actual;ApoPharma;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:45:07Z;2020-06-01T13:45:07Z;Munich;3609759;Principal Investigator;Thomas Klopstock, MD;Friedrich-Baur-Institute, Department of Neurology, University of Munich Ziemssenstr;Deferiprone oral solution | Placebo;63649377;4;509;94;2012;2020-05-29;46;TRUE;30;TRUE;FALSE;4;;Years;;2;6;
NCT01736436;ClinicalTrials.gov processed this data on May 29, 2020;2012-11-14;;;2016-08-23;2012-11-26;2012-11-29;Estimate;;;;;;;2016-08-23;2016-08-24;Estimate;January 2013;;2013-01-31;August 2016;2016-08-31;December 2015;Actual;2015-12-31;December 2015;Actual;2015-12-31;;Interventional;APG101 in MDS;;APG101 in Myelodysplastic Syndrome;APG101 in Transfusion-Dependent Patients With Low or Intermediate Risk Myelodysplastic Syndrome;Completed;;Phase 1;20;Actual;Apogenix GmbH;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:46:35Z;2020-06-01T13:46:35Z;Mannheim;3610180;Principal Investigator;Florian Nolte, MD;Universitaetsmedizin Mannheim, III. Medizinische Klinik, Hämatologie und Onkologie, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany;Treatment with APG101 | Bone marrow collection | Blood drawings;63649767;2;;;2012;2020-05-29;35;FALSE;;FALSE;FALSE;18;;Years;;1;4;
NCT01735513;ClinicalTrials.gov processed this data on May 29, 2020;2012-11-22;;;2016-05-11;2012-11-27;2012-11-28;Estimate;;;;;;;2016-05-11;2016-05-12;Estimate;July 2012;;2012-07-31;May 2016;2016-05-31;September 2015;Actual;2015-09-30;April 2014;Actual;2014-04-30;;Interventional;TAo-EmbolX;;Intraprocedural Intraaortic Embolic Protection With the EmbolX Device in Patients Undergoing Transaortic Transcatheter Aortic Valve Implantation;Intraprocedural Intraaortic Embolic Protection With the EmbolX Device in Patients Undergoing Transaortic Transcatheter Aortic Valve Implantation: a Randomized-controlled Trial;Completed;;N/A;30;Actual;University Hospital, Essen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:46:47Z;2020-06-01T13:46:47Z;Duisburg;;;;;"Intra-aortic embolic protection management system; Embol-X";63649836;1;;;2012;2020-05-29;21;FALSE;;FALSE;TRUE;18;;Years;;1;1;1
NCT01731717;ClinicalTrials.gov processed this data on May 29, 2020;2012-11-12;;;2015-07-10;2012-11-16;2012-11-22;Estimate;;;;;;;2015-07-10;2015-07-13;Estimate;September 2012;;2012-09-30;July 2015;2015-07-31;May 2015;Actual;2015-05-31;March 2015;Actual;2015-03-31;;Interventional;SCM;;Cluster Randomized Trial of Stepped Care Intervention vs. Treatment as Usual for Patients With Depression;Effektivität Und Effizienz Von Behandlungspfaden für Patienten Mit Depressiven Erkrankungen: Stepped Care Als Ansatz für Ein Leitliniengerechtes Und Integriertes Versorgungsmanagement;Completed;;N/A;737;Actual;Universitätsklinikum Hamburg-Eppendorf;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:47:46Z;2020-06-01T13:47:46Z;Hamburg;3610534;Study Director;Birgit Watzke, Prof. Dr.;Centre for Psychosocial Medicine, Department of Medical Psychology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany;Active monitoring | Bibliotherapy | Online self-help | Outpatient psychotherapy | Psychiatric treatment | Combined psychotherapy and psychopharmacological treatment | Control group: treatment as usual;63650127;1;;;2012;2020-05-29;30;FALSE;;FALSE;TRUE;18;;Years;;1;11;
NCT01731158;ClinicalTrials.gov processed this data on May 29, 2020;2012-09-28;;;2019-02-04;2012-11-16;2012-11-21;Estimate;;;;;;;2019-02-04;2019-02-06;Actual;October 2012;;2012-10-31;February 2019;2019-02-28;September 2016;Actual;2016-09-30;September 2016;Actual;2016-09-30;;Interventional;BERAT;;Sequential Therapy in Metastatic Renal Cell Carinoma;A Prospective, Open-label, Multicenter, Randomized Phase II Trial: Sequential Therapy With BEvacizumab, RAd001 (Everolimus) and Tyrosinekinase Inhibitors (TKI) in Metastatic Renal Cell Carcinoma (mRCC) (BERAT Study);Completed;;Phase 2;22;Actual;Central European Society for Anticancer Drug Research;;2;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T13:47:51Z;2020-06-01T13:47:51Z;Hannover;3610572;Study Chair;Viktor Grünwald, MD;University Hospital Hannover, Germany;Avastin in combination with Roferon-A | Afinitor | TKI: Sutent, Nexavar or Votrient;63650168;13;;;2012;2020-05-29;47;FALSE;;FALSE;FALSE;18;;Years;;1;6;
NCT01729481;ClinicalTrials.gov processed this data on May 29, 2020;2012-10-23;;;2017-07-16;2012-11-13;2012-11-20;Estimate;;;;;;;2017-07-16;2017-07-19;Actual;July 2012;;2012-07-31;July 2017;2017-07-31;December 2017;Anticipated;2017-12-31;July 2015;Actual;2015-07-31;;Interventional;ML22774;;Gemcitabine Plus Erlotinib in RASH-positive Patients With Metastatic Pancreatic Cancer;Phase II Study to Evaluatate the Efficacy of Gemcitabine Plus Erlotinib for RASH-positive Patients With Metastatic Pancreatic Cancer and Friendly Risk Circumstances;Unknown status;;Phase 2;150;Actual;Ludwig-Maximilians - University of Munich;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:48:28Z;2020-06-01T13:48:28Z;Munich;;;;;Folinic Acid | Irinotecan | Oxaliplatin | Gemcitabine | Erlotinib | 5-FU;63650295;1;;;2012;2020-05-29;36;FALSE;;FALSE;TRUE;18;75;Years;Years;1;3;
NCT01728441;ClinicalTrials.gov processed this data on May 29, 2020;2012-11-13;;;2014-05-19;2012-11-13;2012-11-19;Estimate;;;;;;;2014-05-19;2014-05-20;Estimate;October 2012;;2012-10-31;May 2014;2014-05-31;May 2014;Actual;2014-05-31;May 2014;Actual;2014-05-31;;Interventional;;;Evaluation of Paclitaxel Eluting Stent vs Paclitaxel Eluting Balloon Treating Peripheral Artery Disease of the Femoral Artery;REAL PTX - Randomized Evaluation of the Zilver PTX Stent vs. Paclitaxel-Eluting Balloons for Treatment of Symptomatic Peripheral Artery Disease of the Femoropopliteal Artery;Completed;;N/A;150;Actual;Provascular GmbH;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:48:46Z;2020-06-01T13:48:46Z;Leipzig;3610875;Principal Investigator;Dierk Scheinert, MD;Park Hospital Leipzig;Paclitaxel Eluting Stent | Paclitaxel Eluting Balloon;63650374;5;;;2012;2020-05-29;19;FALSE;;FALSE;FALSE;18;;Years;;2;9;
NCT01727778;ClinicalTrials.gov processed this data on May 29, 2020;2012-11-12;;;2015-10-20;2012-11-15;2012-11-16;Estimate;;;;;;;2015-10-20;2015-10-22;Estimate;October 2012;;2012-10-31;October 2015;2015-10-31;April 2014;Actual;2014-04-30;April 2014;Actual;2014-04-30;;Interventional;;;Safety and Preliminary Efficacy Study of the Antibody PAT-SM6 in Patients With Relapsed or Refractory Multiple Myeloma;Open-label, Single-centre, Phase I, Multi-dose Escalating Study to Investigate the Safety and Preliminary Efficacy of an i.v. Infusion of the Anti-GRP78 Monoclonal IgM Antibody PAT-SM6 in Patients With Relapsed or Refractory Multiple Myeloma;Completed;;Phase 1;12;Actual;Patrys Ltd.;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:48:54Z;2020-06-01T13:48:54Z;Würzburg;3610929;Principal Investigator;Max Top, MD;Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Zentrum für Innere Medizin,;Anti-GRP78 monoclonal IgM antibody PAT-SM6;63650426;1;;;2012;2020-05-29;18;FALSE;;FALSE;TRUE;18;;Years;;1;1;2
NCT01727362;ClinicalTrials.gov processed this data on May 29, 2020;2012-11-07;;;2017-07-21;2012-11-12;2012-11-16;Estimate;;;;;;;2017-07-21;2017-07-24;Actual;October 2012;;2012-10-31;July 2017;2017-07-31;December 2016;Actual;2016-12-31;December 2016;Actual;2016-12-31;;Interventional;;;Evaluation of Effectiveness of Acupuncture on Quality of Life in Patients With Breast Cancer Receiving Chemotherapy;Evaluation of Effectiveness of Acupuncture on Quality of Life in Patients With Breast Cancer Receiving Chemotherapy- A Pragmatic Randomized Trial;Completed;;N/A;140;Anticipated;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:49:01Z;2020-06-01T13:49:01Z;Berlin Hamburg;3610957;Principal Investigator;Martin Carstensen, Prof. MD;Mammazentrum am Krankenhaus Jerusalem, Hamburg, Germany;Usual care + acupuncture | Usual care;63650457;1;;;2012;2020-05-29;50;FALSE;;FALSE;TRUE;18;;Years;;1;1;22
NCT01726933;ClinicalTrials.gov processed this data on May 29, 2020;2012-11-12;;;2015-12-01;2012-11-12;2012-11-15;Estimate;;;;;;;2015-12-01;2015-12-02;Estimate;November 2012;;2012-11-30;December 2015;2015-12-31;November 2015;Actual;2015-11-30;October 2014;Actual;2014-10-31;;Interventional;;;LAS41008 in Moderate to Severe Chronic Plaque Psoriasis;A Multi-center, Randomized, Double-blind, Three-arm, 16 Week, Adaptive Phase III Clinical Study to Investigate the Efficacy and Safety of LAS41008 vs LASW1835 and vs Placebo in Patients With Moderate to Severe Chronic Plaque Psoriasis;Completed;;Phase 3;839;Actual;Almirall, S.A.;;3;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:49:07Z;2020-06-01T13:49:07Z;Kiel Lübeck;3610998;Principal Investigator;Ulrich Mrowietz, MD, Prof;University Medical Center, Schleswig-Holstein, Department of Dermatology, Schittenhelmstr. 7, 24105 Kiel, Germany;LAS41008 | LASW1835 | Placebo;63650488;4;;;2012;2020-05-29;23;FALSE;;FALSE;FALSE;18;;Years;;2;5;1
NCT01726387;ClinicalTrials.gov processed this data on May 29, 2020;2012-11-03;;;2018-02-02;2012-11-13;2012-11-14;Estimate;;;;;;;2018-02-02;2018-02-06;Actual;March 2013;;2013-03-31;February 2018;2018-02-28;September 2015;Actual;2015-09-30;September 2015;Actual;2015-09-30;;Interventional;SMADS;;Self-Management for Anxiety, Depression and Somatoform Disorders;Self-Management Support in Primary Care;Completed;;N/A;364;Actual;Universitätsklinikum Hamburg-Eppendorf;;2;;;FALSE;;;;FALSE;;;;;;;;;;;Undecided;;2020-06-01T13:49:13Z;2020-06-01T13:49:13Z;Hamburg;3611056;Principal Investigator;Martin Scherer, Prof.;UK Hamburg-Eppendorf (Germany), Department of Primary Medical Care;Psychosocial Counseling | Usual Care;63650529;1;;;2012;2020-05-29;30;FALSE;;FALSE;TRUE;18;65;Years;Years;1;2;1
NCT01724879;ClinicalTrials.gov processed this data on May 29, 2020;2012-02-03;;;2016-02-10;2012-11-07;2012-11-12;Estimate;;;;;;;2016-02-10;2016-02-11;Estimate;November 2011;;2011-11-30;February 2016;2016-02-29;September 2015;Actual;2015-09-30;September 2015;Actual;2015-09-30;;Interventional;;;Study of Frontline Dasatinib Plus Chemotherapy in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (PH+ALL);Open Label Phase II Study to Evaluate the Safety of Standard Induction and Consolidation Therapy in Combination With Dasatinib in Newly Diagnosed Adult Patients With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (PH+ALL);Completed;;Phase 2;19;Actual;Johann Wolfgang Goethe University Hospital;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:49:40Z;2020-06-01T13:49:40Z;Frankfurt;3611163;Principal Investigator;Nicola Gökbuget, Dr.med;Johann Wolfgang Goethe University Hospital;Dasatinib;63650641;22;;;2012;2020-05-29;46;FALSE;;FALSE;FALSE;18;55;Years;Years;1;3;
NCT01721538;ClinicalTrials.gov processed this data on May 29, 2020;2012-11-01;;;2012-11-02;2012-11-02;2012-11-05;Estimate;;;;;;;2012-11-02;2012-11-05;Estimate;October 2012;;2012-10-31;November 2012;2012-11-30;April 2015;Anticipated;2015-04-30;April 2015;Anticipated;2015-04-30;;Interventional;SCENARIO;;Secondary Prevention of Stroke Through Non-drug Therapeutic Weight Reduction;Secondary Prevention of Stroke Through Participation in the Non-drug Therapeutic Weight Reduction Program: A Single-blinded Randomized Controlled Multicenter Trial;Unknown status;;N/A;200;Anticipated;Philipps University Marburg Medical Center;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:50:33Z;2020-06-01T13:50:33Z;Marburg;;;;;Weight reduction program | Lecture on healthy nutrition;63650893;1;;;2012;2020-05-29;;FALSE;;FALSE;TRUE;20;85;Years;Years;1;4;
NCT01719263;ClinicalTrials.gov processed this data on May 29, 2020;2012-10-26;;;2015-10-27;2012-10-29;2012-11-01;Estimate;;;;;;;2015-10-27;2015-10-29;Estimate;June 2013;;2013-06-30;October 2015;2015-10-31;October 2015;Actual;2015-10-31;October 2015;Actual;2015-10-31;;Interventional;;;Sequential Segmental Treatment of Emphysema With Upper Lobe Predominance (STEP-UP) Study;Sequential Segmental Treatment of Emphysema With Upper Lobe Predominance (STEP-UP) Study;Completed;;N/A;69;Actual;Uptake Medical Corp;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:51:13Z;2020-06-01T13:51:13Z;Heidelberg;3611635;Principal Investigator;Felix JF Herth, MD;Heidelberg University;InterVapor® treatment plus Optimal Medical Therapy | Optimal Medical Therapy;63651066;17;;;2012;2020-05-29;28;FALSE;;FALSE;FALSE;40;75;Years;Years;2;4;
NCT01716923;ClinicalTrials.gov processed this data on May 29, 2020;2012-10-26;;;2015-08-24;2012-10-29;2012-10-30;Estimate;;;;;;;2015-08-24;2015-08-26;Estimate;April 2013;;2013-04-30;June 2015;2015-06-30;October 2014;Actual;2014-10-31;July 2014;Actual;2014-07-31;;Interventional;;;Study to Assess S303 RBCs and Evaluate Safety and Efficacy in Patients Requiring Transfusion Support of Acute Anemia;A Randomized Controlled Double-Blind Phase 3 Study to Assess Characteristics of S 303 Treated RBC Components and Evaluate Safety and Efficacy in Patients Requiring Transfusion Support of Acute Anemia;Completed;;Phase 3;81;Actual;Cerus Corporation;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:51:51Z;2020-06-01T13:51:51Z;Frankfurt;3611820;Principal Investigator;Arndt H Kiessling, MD;Klinikum der J.-W.-G.-Universität Frankfurt;S-303 Red Blood Cells (RBCs) - Test | Conventional, untreated red blood cells (RBCs) - Control;63651245;2;;;2012;2020-05-29;15;FALSE;;FALSE;FALSE;18;;Years;;2;3;3
NCT01714999;ClinicalTrials.gov processed this data on May 29, 2020;2012-10-24;;;2014-04-14;2012-10-24;2012-10-26;Estimate;;;;;;;2014-04-14;2014-04-16;Estimate;April 2014;;2014-04-30;April 2014;2014-04-30;December 2015;Anticipated;2015-12-31;September 2015;Anticipated;2015-09-30;;Interventional;;;Treatment of Acute Traumatic Laceration of the Olecranon and Prepatellar Bursa;A Prospective Evaluation of the Current Treatment Regime for Acute Traumatic Laceration of the Olecranon and Prepatellar Bursa;Unknown status;;N/A;100;Anticipated;Ludwig-Maximilians - University of Munich;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:52:41Z;2020-06-01T13:52:41Z;Munich;3611998;Principal Investigator;Sebastian F Baumbach, MD;Ludwig-Maximilians - University of Munich;Bursectomy | Bursal reconstruction;63651392;2;;;2012;2020-05-29;;FALSE;;FALSE;FALSE;18;60;Years;Years;1;1;1
NCT01714414;ClinicalTrials.gov processed this data on May 29, 2020;2012-10-25;;;2018-03-06;2012-10-25;2012-10-26;Estimate;;;;;;;2018-03-06;2018-03-07;Actual;December 2012;;2012-12-31;March 2018;2018-03-31;February 2017;Actual;2017-02-28;June 2014;Actual;2014-06-30;;Interventional;FATI-01;;A Trial to Confirm a Sustained Virological Suppression Defined as HIV-RNA <50 Copies/ml of 3 Different Doses of Fozivudine in Context to a Standard Zidovudine Based Antiretroviral Therapy Regimen;A Prospective, Multicenter, Open, Randomized Phase 2a Trial to Confirm a Sustained Virological Suppression Defined as HIV-RNA <50 Copies/ml of 3 Different Doses of Fozivudine in Context to a Standard Zidovudine Based Antiretroviral Therapy Regimen After 24 Weeks of Treatment in ART naïve, Non Subtype B HIV-1 Infected Individuals From Tanzania and Ivory Coast;Completed;;Phase 2;120;Actual;Ludwig-Maximilians - University of Munich;;4;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:52:51Z;2020-06-01T13:52:51Z;Munich;3612062;Study Director;Michael Hoelscher, Prof.;Department for Infectious Diseases and Tropical Medicine, Klinikum of the University of Munich, Leopoldstrasse 5, 80802, Munich, Germany;FZD | 3TC | EFV | AZT;63651436;2;;;2012;2020-05-29;18;FALSE;;FALSE;FALSE;18;;Years;;1;10;
NCT01713790;ClinicalTrials.gov processed this data on May 29, 2020;2012-10-14;;;2015-07-22;2012-10-23;2012-10-25;Estimate;;;;;;;2015-07-22;2015-07-23;Estimate;October 2012;;2012-10-31;July 2015;2015-07-31;April 2015;Actual;2015-04-30;April 2015;Actual;2015-04-30;;Interventional;;;Innovative Training Methods for Frail Elderly in the Training Gain Stage;Effects of Whole Body Vibration With Stochastic Resonance and Exergames in the Elderly in Need of Care: Effects on Physical Functional Performance;Completed;;N/A;40;Actual;Bern University of Applied Sciences;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:53:02Z;2020-06-01T13:53:02Z;Frankfurt;3612120;Study Director;Dietmar Schmidtbleicher, Prof., PhD;Johann Wolfgang Goethe University, Department Sport Science;Stochastic resonance whole-body vibration | Exergame | Leg press;63651483;1;;;2012;2020-05-29;30;FALSE;;FALSE;TRUE;65;;Years;;1;7;
NCT01713374;ClinicalTrials.gov processed this data on May 29, 2020;2012-10-18;;;2015-03-31;2012-10-22;2012-10-24;Estimate;;;;;;;2015-03-31;2015-04-01;Estimate;October 2012;;2012-10-31;March 2015;2015-03-31;March 2014;Actual;2014-03-31;March 2013;Actual;2013-03-31;;Interventional;PAN;;Physiological Assessment of the Endothelium - Circadian Rhythm and Role of the Sympathetic Nervous System;Studies on the Physiological Meaning of Flow-mediated Constriction, Flow-mediated Dilatation and Vasomotion/Flowmotion: Circadian Variability and Role of the Sympathetic Nervous System.;Completed;;N/A;40;Actual;Johannes Gutenberg University Mainz;;4;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:53:39Z;2020-06-01T13:53:39Z;Mainz;3612160;Principal Investigator;Tommaso Gori, MD PhD;University Medical Center Mainz;Mental stress | no intervention | Myogenic activation | Cold pressure test;63651515;1;;;2012;2020-05-29;5;FALSE;;FALSE;TRUE;18;40;Years;Years;1;1;
NCT01712464;ClinicalTrials.gov processed this data on May 29, 2020;2012-10-15;;;2018-04-30;2012-10-19;2012-10-23;Estimate;;;;;;;2018-04-30;2018-05-01;Actual;October 18, 2013;Actual;2013-10-18;April 2018;2018-04-30;August 7, 2016;Actual;2016-08-07;August 7, 2016;Actual;2016-08-07;;Interventional;;;Modulation of Reinforcement Learning;Modulation of Reinforcement Learning and Neuronal Activation in Ventral Stratum by Oxytocin - a Pilot Study at Autism Spectrum Disorder;Completed;;N/A;60;Actual;RWTH Aachen University;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:54:02Z;2020-06-01T13:54:02Z;Aachen;3612222;Study Director;Martin Schulte-Rüther, Dr. rer. nat;University Hospital, Aachen;Oxytocin vs. Placebo;63651584;1;;;2012;2020-05-29;34;FALSE;;FALSE;TRUE;18;26;Years;Years;1;1;
NCT01703273;ClinicalTrials.gov processed this data on May 29, 2020;2012-08-07;;;2018-06-12;2012-10-09;2012-10-10;Estimate;;;;;;;2018-06-12;2018-06-13;Actual;July 2012;;2012-07-31;June 2018;2018-06-30;December 2014;Actual;2014-12-31;December 2014;Actual;2014-12-31;;Interventional;STEREO;;Low-level Intervention for Adolescents With Extreme Obesity;Structured Low-level Intervention vs. Treatment as Usual Evaluated in a Randomized Controlled Trial for Adolescents With Extreme Obesity, Subproject 2;Completed;;N/A;119;Actual;University of Ulm;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:58:22Z;2020-06-01T13:58:22Z;Berlin Duisburg Leipzig Ulm Witten-Herdecke;3613017;Principal Investigator;Martin Wabitsch, Prof. Dr. med.;University of Ulm;manual based low key group intervention (innovation) | standardized, manual based routine care;63652288;6;;;2012;2020-05-29;29;FALSE;;FALSE;FALSE;14;24;Years;Years;1;8;
NCT01702597;ClinicalTrials.gov processed this data on May 29, 2020;2012-10-03;;;2012-10-04;2012-10-04;2012-10-08;Estimate;;;;;;;2012-10-04;2012-10-08;Estimate;October 2012;;2012-10-31;October 2012;2012-10-31;April 2014;Anticipated;2014-04-30;April 2013;Anticipated;2013-04-30;;Interventional;WBV and ALAS;;WBV and Acute Lateral Ankle Sprain;The Effect of Whole Body Vibration and Acute Unilateral Unstable Lateral Ankle Sprain - A Biphasic Randomized Controlled Trial -;Unknown status;;N/A;60;Anticipated;Ludwig-Maximilians - University of Munich;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T13:58:32Z;2020-06-01T13:58:32Z;Munich;3613093;Principal Investigator;Matthias Schieker, Prof.;Ludwig-Maximilians - University of Munich;Whole body vibration (Galileo® Med M Plus, Novotec, Pforzheim, Germany) | Physiotherapy;63652341;;;;2012;2020-05-29;;FALSE;;;FALSE;18;40;Years;Years;1;1;
NCT01700322;ClinicalTrials.gov processed this data on May 29, 2020;2012-09-04;;;2016-09-04;2012-10-03;2012-10-04;Estimate;;;;;;;2016-09-04;2016-09-07;Estimate;August 2012;;2012-08-31;September 2016;2016-09-30;September 2016;Actual;2016-09-30;July 2016;Actual;2016-07-31;;Interventional;EST;;Endothelium, Stenting, and Antiplatelet Therapy (EST) - Clopidogrel, Prasugrel, Ticagrelor Study;Effects of Clopidogrel vs Prasugel vs Ticagrelor on Endothelial Function, Inflammatory and Oxidative Stress Parameters and Platelet Function in Patients Undergoing Coronary Artery Stenting. A Randomised, Prospective Study.;Completed;;Phase 4;126;Actual;Johannes Gutenberg University Mainz;;3;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T13:59:17Z;2020-06-01T13:59:17Z;Mainz;3613273;Study Chair;Thomas Munzel, MD Prof.;University Medical Center Mainz;Coronary stenting | Ticagrelor | Clopidogrel | Prasugrel;63652518;1;;;2012;2020-05-29;47;FALSE;;FALSE;TRUE;18;75;Years;Years;1;4;
NCT01694849;ClinicalTrials.gov processed this data on May 29, 2020;2012-09-24;;;2016-01-13;2012-09-26;2012-09-27;Estimate;;;;;;;2016-01-13;2016-01-14;Estimate;September 2012;;2012-09-30;January 2016;2016-01-31;December 2015;Actual;2015-12-31;February 2015;Actual;2015-02-28;;Interventional;;;Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH);A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).;Completed;;Phase 2;270;Actual;Genfit;;3;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:00:31Z;2020-06-01T14:00:31Z;Hannover;3613756;Principal Investigator;Pr. Michael Manns, M.D.;National Coordinator - Medical School of Hannover - Hannover - Germany;GFT505 80mg | GFT505 120mg | Placebo;63652941;56;;;2012;2020-05-29;29;FALSE;;TRUE;FALSE;18;75;Years;Years;1;13;
NCT01693393;ClinicalTrials.gov processed this data on May 29, 2020;2012-09-14;;;2015-07-27;2012-09-24;2012-09-26;Estimate;;;;;;;2015-07-27;2015-07-29;Estimate;March 2010;;2010-03-31;July 2015;2015-07-31;October 2014;Actual;2014-10-31;October 2014;Actual;2014-10-31;;Interventional;CYPRESS;;Low Dose Cyclosporin A in Primary Sjögren Syndrome;A Phase II Pilot-Study With Low-dose Sandimmun Optoral (Cyclosporin A) for the Treatment of Primary Sjögren Syndrome;Completed;;Phase 2;30;Actual;Charite University, Berlin, Germany;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:00:50Z;2020-06-01T14:00:50Z;Berlin;3613881;Principal Investigator;Eugen Feist, Dr. med.;Charite University, Berlin, Germany;Cyclosporine A;63653053;1;;;2012;2020-05-29;55;FALSE;;FALSE;TRUE;18;75;Years;Years;1;1;2
NCT01690572;ClinicalTrials.gov processed this data on May 29, 2020;2012-09-19;;;2017-04-27;2012-09-19;2012-09-21;Estimate;;;;;;;2017-04-27;2017-04-28;Actual;October 2012;;2012-10-31;April 2017;2017-04-30;April 2017;Actual;2017-04-30;December 2016;Actual;2016-12-31;;Interventional;;;Drug Eluting Balloon for Prevention of Constrictive Remodeling;Drug Coated Balloon (DCB) for the Prevention of Constrictive Remodeling and Restenosis in Small Vessel Coronary Disease;Terminated;;N/A;14;Actual;Herz-Zentrums Bad Krozingen;;2;;recruitment was not sufficient.;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:01:40Z;2020-06-01T14:01:40Z;Freiburg;3614134;Principal Investigator;Christoph Hehrlein, Prof. Dr.;Department of Cardiology and Angiology I, Heart Center, Freiburg University;Paclitaxel coated balloon catheter | uncoated balloon catheter sprinter legend;63653273;1;;;2012;2020-05-29;50;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT01690325;ClinicalTrials.gov processed this data on May 29, 2020;2012-09-18;;;2018-08-09;2012-09-18;2012-09-21;Estimate;;;;;;;2018-08-09;2018-08-13;Actual;September 2012;;2012-09-30;August 2018;2018-08-31;November 2016;Actual;2016-11-30;November 2016;Actual;2016-11-30;;Interventional;;;Imaging for Response Assessment of Neoadjuvant Chemotherapy in Primary Breast Cancer (GALADON);Molecular Imaging for Response Assessment of Bevacizumab + Docetaxel as Neoadjuvant Chemotherapy in Primary Breast Cancer;Terminated;;Phase 2;21;Actual;West German Study Group;;2;;Therapy of HER2+ patients according to protocol was no longer appropriate. Patient enrolment~   behind planned schedule and challenges of site performance;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:01:44Z;2020-06-01T14:01:44Z;Munich;3614153;Principal Investigator;Nadia Harbeck, Prof. Dr. med.;Head of Breast Centre, University of Munich, Grosshadern Hospital, Germany;Bevacizumab | Epirubicin | Cyclophosphamid | Docetaxel | Trastuzumab;63653291;1;;;2012;2020-05-29;50;FALSE;;FALSE;TRUE;18;65;Years;Years;1;;
NCT01690117;ClinicalTrials.gov processed this data on May 29, 2020;2012-09-17;;;2016-10-05;2012-09-20;2012-09-21;Estimate;;;;;;;2016-10-05;2016-11-29;Estimate;October 2012;;2012-10-31;October 2016;2016-10-31;January 2015;Actual;2015-01-31;January 2015;Actual;2015-01-31;;Interventional;GE-REACH;;German Adaptation of REACH II;German Adaptation of Resources to Enhance Alzheimer`s Caregiver Health;Completed;;N/A;92;Actual;University of Leipzig;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T14:01:48Z;2020-06-01T14:01:48Z;Leipzig;3614170;Principal Investigator;Hermann-Josef Gertz, Prof. Dr.;Klinik und Poliklinik für Psychiatrie der Universität Leipzig;GE-REACH-program;63653307;1;0;0;2012;2020-05-29;27;TRUE;17;FALSE;TRUE;;;;;2;14;
NCT01684150;ClinicalTrials.gov processed this data on May 29, 2020;2012-09-06;;;2016-08-02;2012-09-10;2012-09-12;Estimate;;;;;;;2016-08-02;2016-08-04;Estimate;September 2012;;2012-09-30;August 2016;2016-08-31;February 2016;Actual;2016-02-29;November 2015;Actual;2015-11-30;;Interventional;;;A Phase 1, Open-Label, Dose-Escalation & Expanded Cohort, Continuous IV Infusion, Multi-center Study of the Safety, Tolerability,PK & PD of EPZ-5676 in Treatment Relapsed/Refractory Patients With Leukemias Involving;A Phase 1, Open-Label, Dose-Escalation & Expanded Cohort, Continuous IV Infusion, Multi-center Study of the Safety, Tolerability,PK & PD of EPZ-5676 in Treatment Relapsed/Refractory Patients With Leukemias Involving Translocation of the MLL Gene at 11q23 or Advanced Hematologic Malignancies;Completed;;Phase 1;51;Actual;Epizyme, Inc.;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:03:26Z;2020-06-01T14:03:26Z;Ulm;3614656;Principal Investigator;Hartmut Döhner, MD;Universitätsklinikum Ulm;EPZ-5676;63653769;8;;;2012;2020-05-29;38;FALSE;;TRUE;FALSE;18;90;Years;Years;1;5;
NCT01683864;ClinicalTrials.gov processed this data on May 29, 2020;2012-09-06;;;2017-06-27;2012-09-11;2012-09-12;Estimate;;;;;;;2017-06-27;2018-01-30;Actual;September 2012;;2012-09-30;October 2016;2016-10-31;May 2015;Actual;2015-05-31;May 2015;Actual;2015-05-31;;Interventional;HIPECStomach;;Randomized Controlled Trial to Prevent Peritoneal Seeding in Gastric Cancer;Randomized Controlled Trial to Prevent Peritoneal Seeding in Gastric Cancer;Terminated;;Phase 2/Phase 3;3;Actual;University Hospital Tuebingen;;3;;Recruitment problems;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T14:03:30Z;2020-06-01T14:03:30Z;Tübingen;3614677;Principal Investigator;Alfred Königsrainer, MD;University Hospital Tuebingen;positive cytology with HIPEC;63653791;1;0;0;2012;2020-05-29;32;TRUE;17;FALSE;TRUE;18;;Years;;2;;2
NCT01683240;ClinicalTrials.gov processed this data on May 29, 2020;2012-07-06;;;2016-05-10;2012-09-06;2012-09-11;Estimate;;;;;;;2016-05-10;2016-05-11;Estimate;February 2011;;2011-02-28;May 2016;2016-05-31;February 2016;Actual;2016-02-29;February 2016;Actual;2016-02-29;;Interventional;SAC;;Prospective Multicenter Evaluation of a New Short-access-cholangioscope for Biliary Duct Strictures and Gall Stones;Prospective Multicenter Evaluation of a New Short-access-cholangioscope for Biliary Duct Strictures and Gall Stones;Completed;;N/A;59;Actual;Universitätsklinikum Hamburg-Eppendorf;;1;;;FALSE;;;;FALSE;;;;;;;;;;;Undecided;;2020-06-01T14:03:41Z;2020-06-01T14:03:41Z;Hamburg;3614723;Principal Investigator;Thomas Rösch, Prof. Dr.;Universitätsklinikum Hamburg-Eppendorf;cholangioscopy (Frimberger);63653838;5;;;2012;2020-05-29;60;FALSE;;FALSE;FALSE;18;;Years;;1;3;
NCT01679405;ClinicalTrials.gov processed this data on May 29, 2020;2012-08-17;;;2019-08-26;2012-08-31;2012-09-06;Estimate;;;;;;;2019-08-26;2019-09-06;Actual;August 2012;;2012-08-31;August 2019;2019-08-31;April 2016;Actual;2016-04-30;April 2016;Actual;2016-04-30;;Interventional;;;BIBW 2992 as add-on to Gem/Cis in Advanced Biliary Tract Cancer;Open-label, Uncontrolled, Multicenter Phase I/Ib Trial to Investigate Safety and Efficacy of BIBW 2992 and Standard Gemcitabine/Cisplatin in Chemo-naïve Patients With Advanced Biliary Tract Adenocarcinoma;Terminated;;Phase 1;9;Actual;Johannes Gutenberg University Mainz;;2;;No sufficient clinical or molecular signals for efficacy were observed.;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T14:04:37Z;2020-06-01T14:04:37Z;Mainz;3615098;Principal Investigator;Markus Moehler, Prof. Dr. med.;University Medical Center of the Johannes Gutenberg-University Mainz;BIBW 2992;63654138;1;91;26;2012;2020-05-29;44;TRUE;10;FALSE;TRUE;18;;Years;;1;4;
NCT01673776;ClinicalTrials.gov processed this data on May 29, 2020;2012-08-20;;;2018-08-06;2012-08-23;2012-08-28;Estimate;;;;;;;2018-08-06;2018-08-08;Actual;March 2012;;2012-03-31;August 2018;2018-08-31;October 15, 2016;Actual;2016-10-15;October 2016;Actual;2016-10-31;;Interventional;FEMO;;Multimodal Approach to Improve the Outcome of Patients With a Proximal Femoral Fracture;Can a Multimodal Approach Improve the Outcome of Patients With a Proximal Femoral Fracture?;Completed;;N/A;132;Actual;Technische Universität München;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:06:13Z;2020-06-01T14:06:13Z;Munich;3615634;Principal Investigator;Bettina Jungwirth, MD;Klinik für Anaesthesiologie, Klinikum rechts der Isar der Technischen Universität München, Ismaninger Str. 22, 81675 München;PulsioFlex® Monitoring;63654566;1;;;2012;2020-05-29;55;FALSE;;FALSE;TRUE;60;;Years;;1;3;
NCT01673763;ClinicalTrials.gov processed this data on May 29, 2020;2011-10-17;;;2017-10-11;2012-08-27;2012-08-28;Estimate;;;;;;;2017-10-11;2017-10-13;Actual;July 2010;Actual;2010-07-31;October 2017;2017-10-31;August 2017;Actual;2017-08-31;June 2016;Actual;2016-06-30;;Interventional;PEPSI;;Post-ERCP Pancreatitis Prevention by Stent Insertion;Study to Reduce Incidence of Post-ERCP Pancreatitis by Stent Insertion in the Main Pancreatic Duct After Unintended Cannulation of the Main Pancreatic Duct;Completed;;N/A;169;Actual;Technische Universität München;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:06:13Z;2020-06-01T14:06:13Z;Munich;3615635;Principal Investigator;Hana Algül, MD, MPH;II. Medizinische Klinik, Klinikum rechts der Isar, Ismaniger Strasse 22, 81675 Munich;Stent insertion into the main pancreatic duct;63654567;4;;;2011;2020-05-29;72;FALSE;;FALSE;FALSE;18;100;Years;Years;1;;
NCT01672216;ClinicalTrials.gov processed this data on May 29, 2020;2012-08-07;;;2013-09-20;2012-08-21;2012-08-24;Estimate;;;;;;;2013-09-20;2013-09-23;Estimate;August 2012;;2012-08-31;September 2013;2013-09-30;May 2015;Anticipated;2015-05-31;May 2014;Anticipated;2014-05-31;;Interventional;3T-CO;;Multicenter Randomized Controlled Trial to Compare the Outcome of Conservative Triple Target Treatment With EMG-Biofeedback in Chronic Obstipation;Triple Target Treatment (3T) Combining Amplitude Modulated Middle Frequency (AM-MF) Stimulation With Electromyography (EMG)EMG-Biofeedback Versus EMG-Biofeedback in Chronic Obstipation;Unknown status;;Phase 3;140;Anticipated;University of Giessen;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:06:39Z;2020-06-01T14:06:39Z;Giessen;3615744;Principal Investigator;Thilo Schwandner, Dr.;University of Giessen;Combination of EMG-biofeedback plus EMG-triggered AM-MF-stimulation | EMG-biofeedback alone;63654686;1;;;2012;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;7;
NCT01668498;ClinicalTrials.gov processed this data on May 29, 2020;2012-08-16;;;2016-04-18;2012-08-17;2012-08-20;Estimate;;;;;;;2016-04-18;2016-04-19;Estimate;May 2011;;2011-05-31;April 2016;2016-04-30;March 2016;Actual;2016-03-31;January 2015;Actual;2015-01-31;;Interventional;;;Comparison of Two Preemptive Treatment Strategies of Panitumumab Mediated Skin Toxicity and Assessment of QoL in Patient With Ras-wt Colorectal Cancer;Comparison of Two Preemptive Treatment Strategies of Panitumumab Mediated Skin Toxicity and Assessment of Quality of Life in Patients With Ras-wildtype Colorectal Cancer;Completed;;Phase 2;88;Actual;AIO-Studien-gGmbH;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:07:29Z;2020-06-01T14:07:29Z;Mannheim;3616032;Principal Investigator;Melanie Kripp, Dr. med.;III. Medizinische Klinik, Universitätsmedizin Mannheim;Erythromycin | Doxycycline;63654973;1;;;2012;2020-05-29;44;FALSE;;FALSE;TRUE;18;;Years;;1;5;
NCT01666600;ClinicalTrials.gov processed this data on May 29, 2020;2012-07-12;;;2017-10-30;2012-08-10;2012-08-16;Estimate;;;;;;;2017-10-30;2017-11-01;Actual;August 2012;;2012-08-31;October 2017;2017-10-31;September 2017;Actual;2017-09-30;March 2017;Actual;2017-03-31;;Interventional;;;NOA-12: BIBF1120 and R-RT in Glioblastoma;A Phase I/II, Randomized, Open-label, Multi-centre Study of BIBF1120 + Reirradiation (R-RT) Versus Reirradiation in the Treatment of Patients With First or Second Progression of Glioblastoma;Terminated;;Phase 1/Phase 2;63;Actual;University Hospital Heidelberg;;2;;Interim Analysis for Feasibility;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:08:01Z;2020-06-01T14:08:01Z;Heidelberg;;;;;BIBF 1120 | radiotherapy;63655124;2;;;2012;2020-05-29;55;FALSE;;FALSE;FALSE;18;;Years;;1;6;
NCT01665885;ClinicalTrials.gov processed this data on May 29, 2020;2012-08-13;;;2015-02-16;2012-08-13;2012-08-15;Estimate;;;;;;;2015-02-16;2015-02-18;Estimate;August 2012;;2012-08-31;June 2013;2013-06-30;November 2015;Anticipated;2015-11-30;August 2015;Anticipated;2015-08-31;;Interventional;HAIS-SE;;Hypothermia in Acute Ischemic Stroke - Surface Versus Endovascular Cooling (HAIS-SE);HAIS-SE (Hypothermia in Acute Ischemic Stroke - Surface Versus Endovascular Cooling): A Randomized Trial Comparing Surface Versus Endovascular Cooling in Awake Stroke Patients Treated With Thrombolysis;Unknown status;;Phase 2;60;Anticipated;University Hospital Heidelberg;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:08:10Z;2020-06-01T14:08:10Z;Heidelberg;3616261;Principal Investigator;Sven Poli, Dr. med.;University Hospital Heidelberg;ZOLL Thermogard XP | BARD/Medivance Arctic Sun 5000;63655178;1;;;2012;2020-05-29;;FALSE;;FALSE;TRUE;18;90;Years;Years;1;4;
NCT01663818;ClinicalTrials.gov processed this data on May 29, 2020;2012-08-06;;;2018-08-06;2012-08-09;2012-08-13;Estimate;;;;;;;2018-08-06;2018-08-08;Actual;August 2012;;2012-08-31;August 2018;2018-08-31;October 2015;Actual;2015-10-31;December 2014;Actual;2014-12-31;;Interventional;TOBA;;Tack Optimized Balloon Angioplasty (TOBA) Study;Tack Optimized Balloon Angioplasty (TOBA) Study for Femoropopliteal Arteries Using the Tack-IT Endovascular Stapler;Completed;;N/A;138;Actual;Intact Vascular;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:08:41Z;2020-06-01T14:08:41Z;Leipzig;3616421;Principal Investigator;Dierk Scheinert, MD;Park Hospital, Leipzig;Tack-It Endovascular Stapler;63655319;1;;;2012;2020-05-29;28;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT01663649;ClinicalTrials.gov processed this data on May 29, 2020;2012-08-08;;;2015-03-24;2012-08-08;2012-08-13;Estimate;;;;;;;2015-03-24;2015-03-25;Estimate;June 2012;;2012-06-30;March 2015;2015-03-31;February 2014;Actual;2014-02-28;December 2013;Actual;2013-12-31;;Interventional;;;Effectiveness of Web-based Treatment for Depression in Patients With Neurologic Disorders;Evaluation of the Effectiveness of a Web-based Treatment Program for Depression (Deprexis) for the Reduction of Depressive Symptoms in Patients With Multiple Sclerosis and Epilepsy. A Randomized Controlled Trial;Completed;;N/A;180;Actual;Universitätsklinikum Hamburg-Eppendorf;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:08:46Z;2020-06-01T14:08:46Z;Hamburg;3616434;Principal Investigator;Steffen Moritz, Prof.;Universitätsklinikum Hamburg-Eppendorf;Wait-list | Deprexis;63655333;2;;;2012;2020-05-29;18;FALSE;;FALSE;FALSE;18;65;Years;Years;1;1;4
NCT01663324;ClinicalTrials.gov processed this data on May 29, 2020;2012-07-23;;;2016-05-17;2012-08-08;2012-08-13;Estimate;;;;;;;2016-05-17;2016-05-18;Estimate;July 2012;;2012-07-31;May 2016;2016-05-31;January 2015;Actual;2015-01-31;August 2014;Actual;2014-08-31;;Interventional;Multisite rTMS;;rTMS for the Treatment of Chronic Tinnitus: Optimization by Simulation of the Cortical Tinnitus Network;Repetitive Transcranial Magnetic Stimulation for the Treatment of Chronic Tinnitus: Optimization by Stimulation of the Cortical Tinnitus Network;Completed;;N/A;50;Actual;University of Regensburg;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:08:59Z;2020-06-01T14:08:59Z;Regensburg;3616457;Principal Investigator;Berthold Langguth, MD, Ph.D.;University of Regensburg, Dept of Psychiatry;rTMS intervention 1 | rTMS intervention 2;63655357;1;;;2012;2020-05-29;25;FALSE;;FALSE;TRUE;18;70;Years;Years;2;16;
NCT01660425;ClinicalTrials.gov processed this data on May 29, 2020;2012-08-06;;;2014-03-12;2012-08-07;2012-08-08;Estimate;;;;;;;2014-03-12;2014-03-13;Estimate;May 2012;;2012-05-31;March 2014;2014-03-31;March 2015;Anticipated;2015-03-31;December 2014;Anticipated;2014-12-31;;Interventional;;;Enhancement of Methylphenidate Treatment by Psychosocial Intervention and Support;Enhancement of Psychosocial Functioning, Quality of Life, Satisfaction With Medication and Medication Compliance of Methylphenidate Treatment by Psychosocial Intervention and Support;Unknown status;;N/A;100;Anticipated;University of Cologne;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:09:43Z;2020-06-01T14:09:43Z;Köln;3616701;Principal Investigator;Manfred Doepfner, PhD;University of Cologne;Enhancement with psychosocial intervention;63655582;1;;;2012;2020-05-29;;FALSE;;FALSE;TRUE;6;12;Years;Years;1;6;
NCT01657305;ClinicalTrials.gov processed this data on May 29, 2020;2012-07-29;;;2017-05-27;2012-08-03;2012-08-06;Estimate;;;;;;;2017-05-27;2018-01-23;Actual;August 2012;;2012-08-31;May 2017;2017-05-31;September 2014;Actual;2014-09-30;August 2013;Actual;2013-08-31;;Interventional;;;Oleogel-S10 in Wound Healing of Split-Thickness Skin Graft Donor Sites (BSH-12);Open, Blindly Evaluated, Prospective, Controlled, Randomized, Multicenter Phase III Clinical Trial to Compare Intra-individually the Efficacy and Tolerance of Oleogel-S10 Versus Standard of Care in Accelerating the Wound Healing of Split-Thickness Skin Graft Donor Sites;Completed;;Phase 3;107;Actual;Amryt Pharma;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T14:10:24Z;2020-06-01T14:10:24Z;Greifswald;3616982;Principal Investigator;Hans Robert Metelmann, Prof;Universitätsmedizin Greifswald MKG-Chirurgie/Plastische Operationen;Oleogel-S10, non-adhesive wound dressing | Non-adhesive wound dressing only;63655815;24;0;4;2012;2020-05-29;12;TRUE;25;FALSE;FALSE;18;;Years;;1;12;
NCT01657292;ClinicalTrials.gov processed this data on May 29, 2020;2012-07-29;;;2015-08-28;2012-08-03;2012-08-06;Estimate;;;;;;;2015-08-28;2015-09-28;Estimate;August 2012;;2012-08-31;August 2015;2015-08-31;July 2014;Actual;2014-07-31;July 2013;Actual;2013-07-31;;Interventional;;;Oleogel-S10 Versus Standard of Care in Healing of Grade 2a Burn Wounds;Open, Blindly Evaluated, Prospective, Controlled, Randomized, Multicenter Phase III Clinical Trial to Compare Intra-individually the Efficacy and Tolerance of Oleogel-S10 Versus Standard of Care in Accelerating the Healing of Grade 2a Partial-Thickness Burn Wounds;Completed;;Phase 3;61;Actual;Amryt Pharma;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:10:25Z;2020-06-01T14:10:25Z;Berlin;3616983;Principal Investigator;Bernd Hartmann, Dr.;Trauma Hospital Berlin, Warener Str. 7, 12683 Berlin, Germany;Oleogel-S10 ointment | Octenilin® wound gel;63655816;9;0;16;2012;2020-05-29;11;TRUE;24;FALSE;FALSE;18;;Years;;1;10;
NCT01656135;ClinicalTrials.gov processed this data on May 29, 2020;2012-07-31;;;2016-03-08;2012-08-01;2012-08-02;Estimate;;;;;;;2016-03-08;2016-03-09;Estimate;December 2012;;2012-12-31;March 2016;2016-03-31;December 2015;Actual;2015-12-31;December 2015;Actual;2015-12-31;;Interventional;;;Reference Group Trial for The ONE Study;Reference Group Trial for The ONE Study: A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation;Completed;;Phase 4;70;Actual;University of Regensburg;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:10:45Z;2020-06-01T14:10:45Z;Regensburg;3617093;Study Director;Edward K. Geissler, Ph.D.;University of Regensburg;Blood drawing for immune monitoring and questionnaires;63655903;8;;;2012;2020-05-29;36;FALSE;;TRUE;FALSE;18;;Years;;1;9;2
NCT01656096;ClinicalTrials.gov processed this data on May 29, 2020;2012-07-31;;;2016-10-27;2012-07-31;2012-08-02;Estimate;;;;;;;2016-10-27;2016-10-28;Estimate;July 2012;;2012-07-31;October 2016;2016-10-31;July 2014;Actual;2014-07-31;July 2014;Actual;2014-07-31;;Interventional;;;Renal Sympathetic Denervation in Mild Refractory Hypertension;Renal Sympathetic Denervation in Patients With Mild Refractory Hypertension;Completed;;Phase 4;71;Actual;University of Leipzig;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:10:46Z;2020-06-01T14:10:46Z;Leipzig;3617096;Principal Investigator;Steffen Desch, MD;Heart Center Leipzig - University Hospital;Renal sympathetic denervation (Symplicity ablation catheter, Medtronic Inc. Minneapolis, Minnesota, USA) | Sham procedure;63655906;1;;;2012;2020-05-29;24;FALSE;;FALSE;TRUE;18;75;Years;Years;1;;
NCT01655368;ClinicalTrials.gov processed this data on May 29, 2020;2012-06-14;;;2016-06-14;2012-07-30;2012-08-01;Estimate;;;;;;;2016-06-14;2016-06-15;Estimate;May 2012;;2012-05-31;June 2016;2016-06-30;June 2015;Actual;2015-06-30;June 2015;Actual;2015-06-30;;Interventional;STEM;;Group Intervention for Improving Stigma Coping and Empowerment of People With Mental Illness (STEM);Group Intervention for Improving Stigma Coping and Empowerment of People With Mental Illness (STEM);Completed;;N/A;486;Actual;Heinrich-Heine University, Duesseldorf;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:10:54Z;2020-06-01T14:10:54Z;Düsseldorf;3617151;Principal Investigator;Wolfgang Gaebel, Prof. Dr.;LVR-Klinikum Düsseldorf Kliniken der Heinrich-Heine-Universität Düsseldorf;psychotherapeutic STEM modules | Interventional control of normal psychoeducational treatment;63655963;20;;;2012;2020-05-29;37;FALSE;;FALSE;FALSE;18;65;Years;Years;1;3;
NCT01655290;ClinicalTrials.gov processed this data on May 29, 2020;2012-07-30;;;2019-07-02;2012-07-30;2012-08-01;Estimate;;;;;;;2019-07-02;2019-07-05;Actual;August 2012;;2012-08-31;July 2019;2019-07-31;June 2014;Actual;2014-06-30;May 2013;Actual;2013-05-31;;Interventional;Gadovit;;Comparison of Gadobutrol and Gadobenate Dimeglumin for Delayed Enhancement Cardiac MRI;Single Dose Gadobutrol in Comparison to Single Dose Gadobenate Dimeglumine for Magnetic Resonance Imaging of Chronic Myocardial Infarction at 3 Tesla;Completed;;Phase 2;20;Anticipated;Technische Universität München;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:10:55Z;2020-06-01T14:10:55Z;Munich;;;;;Gadovist® (Gadobutrol), Multihance® (Gadobenate dimeglumin);63655969;1;;;2012;2020-05-29;9;FALSE;;FALSE;TRUE;18;80;Years;Years;1;;
NCT01651832;ClinicalTrials.gov processed this data on May 29, 2020;2012-07-25;;;2016-10-24;2012-07-25;2012-07-27;Estimate;;;;;;;2016-10-24;2016-10-25;Estimate;July 2012;;2012-07-31;October 2016;2016-10-31;December 2015;Actual;2015-12-31;December 2015;Actual;2015-12-31;;Interventional;SCAN;;Supportive Cancer Care Networkers (SCAN);Supportive Cancer Care Networkers - a Prospective Randomized Controlled Multi-center Trial;Completed;;N/A;261;Actual;Martin-Luther-Universität Halle-Wittenberg;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:11:48Z;2020-06-01T14:11:48Z;Halle;3617418;Study Director;Margarete Landenberger, Prof. Dr.;Martin-Luther-University Halle-Wittenberg, Medical Faculty, Institute for Health and Nursing Science;SCAN;63656231;9;;;2012;2020-05-29;41;FALSE;;FALSE;FALSE;18;85;Years;Years;1;6;
NCT01651780;ClinicalTrials.gov processed this data on May 29, 2020;2012-07-24;;;2017-03-09;2012-07-26;2012-07-27;Estimate;;;;;;;2017-03-09;2017-04-07;Actual;October 2012;;2012-10-31;March 2017;2017-03-31;June 2015;Actual;2015-06-30;June 2015;Actual;2015-06-30;;Interventional;BRAVO 2/3;;Open-label, Randomized Trial in Participants Undergoing TAVR to Determine Safety & Efficacy of Bivalirudin vs UFH;Effect of Bivalirudin on Aortic Valve Intervention Outcomes 2/3 (BRAVO 2/3);Completed;;Phase 3;803;Actual;The Medicines Company;;2;;;FALSE;;;;TRUE;;;;;TRUE;;;;;;;;2020-06-01T14:11:49Z;2020-06-01T14:11:49Z;Bonn;3617423;Principal Investigator;Eberhardt Grube, MD;University Hospital, Bonn;Bivalirudin | Unfractionated Heparin;63656235;33;286;511;2012;2020-05-29;32;TRUE;18;FALSE;FALSE;18;;Years;;2;10;
NCT01651390;ClinicalTrials.gov processed this data on May 29, 2020;2012-07-24;;;2016-09-23;2012-07-26;2012-07-27;Estimate;;;;;;;2016-09-23;2016-09-26;Estimate;June 2012;;2012-06-30;September 2016;2016-09-30;July 2016;Actual;2016-07-31;January 2015;Actual;2015-01-31;;Interventional;BIOLUX-RCT;;Clinical Performance of the Pantera Lux Balloon Versus the Orsiro Stent in Patients With In-stent Restenosis.;BIOLUX RCT - Clinical Performance of the Pantera LUX Paclitaxel Releasing Balloon Versus the Drug Eluting Orsiro Hybrid Stent System in Patients With In-stent Restenosis - a Randomized Controlled Trial;Completed;;N/A;231;Actual;Biotronik AG;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:11:53Z;2020-06-01T14:11:53Z;Duisburg;3617457;Principal Investigator;Christoph K Naber, MD;Contilia Heart- and Vascular Center, Elisabeth Krankenhaus, Klara-Kopp-Weg 1, 45138 Essen, Germany;Percutaneous coronary intervention | Percutaneous coronary intervention;63656266;14;;;2012;2020-05-29;31;FALSE;;FALSE;FALSE;18;;Years;;1;9;
NCT01647880;ClinicalTrials.gov processed this data on May 29, 2020;2012-07-23;;;2020-04-14;2012-07-23;2012-07-24;Estimate;;;;;;;2020-04-14;2020-04-15;Actual;July 2013;;2013-07-31;April 2020;2020-04-30;April 2016;Actual;2016-04-30;April 2016;Actual;2016-04-30;;Interventional;MOVING;;MOdification of VIsual Outcomes After Optic Neuritis in CIS or MS by Gilenya (MOVING Study);Phase II/III Study to Investigate the Effects of Fingolimod Versus Interferon Beta-1b on Visual Recovery After Optic Neuritis;Terminated;;Phase 2/Phase 3;15;Actual;Charite University, Berlin, Germany;;2;;delayed recruitment;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:13:01Z;2020-06-01T14:13:01Z;Berlin;3617730;Study Director;Olaf Hoffmann, PD Dr. med.;Charite- NeuroCure;Verum arm receiving Gilenya® | Active Comparator receiving Extavia®;63656527;2;;;2012;2020-05-29;33;FALSE;;FALSE;FALSE;18;55;Years;Years;1;1;
NCT01647854;ClinicalTrials.gov processed this data on May 29, 2020;2012-07-16;;;2015-09-22;2012-07-19;2012-07-24;Estimate;;;;;;;2015-09-22;2015-09-23;Estimate;August 2012;;2012-08-31;September 2015;2015-09-30;May 2015;Actual;2015-05-31;May 2015;Actual;2015-05-31;;Interventional;;;Operation of a Mobile Telemedicine System in the EMS;Introduction and Operation of a Mobile Telemedicine System to Support Paramedics in the Emergency Medical Service;Completed;;N/A;425;Actual;RWTH Aachen University;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:13:01Z;2020-06-01T14:13:01Z;Aachen;3617733;Study Chair;Rolf Rossaint, Prof. Dr.;University Hospital Aachen, Germany, Department of Anesthesiology;Teleconsultation;63656529;1;;;2012;2020-05-29;33;FALSE;;FALSE;TRUE;;;;;1;4;
NCT01645150;ClinicalTrials.gov processed this data on May 29, 2020;2012-06-11;;;2016-03-21;2012-07-19;2012-07-20;Estimate;;;;;;;2016-03-21;2016-03-22;Estimate;May 2012;;2012-05-31;March 2016;2016-03-31;December 2015;Actual;2015-12-31;December 2015;Actual;2015-12-31;;Interventional;RECAP;;Reduction of Cancer Related Fatigue in Patients During TKI Therapy;Pilot Study on the Effects of Strength Training on Cancer Related Fatigue in Cancer Patients During Tyrosine Kinase Inhibitor Therapy;Completed;;N/A;20;Actual;German Cancer Research Center;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:13:32Z;2020-06-01T14:13:32Z;Heidelberg;3617895;Principal Investigator;Carsten Grüllich, MD;National Center for Tumor Diseases Heidelberg (GermanCRC/University Hospital Heidelberg) Germany;Progressive strength training;63656696;1;;;2012;2020-05-29;43;FALSE;;FALSE;TRUE;18;80;Years;Years;1;7;
NCT01644071;ClinicalTrials.gov processed this data on May 29, 2020;2012-06-20;;;2015-09-28;2012-07-17;2012-07-18;Estimate;;;;;;;2015-09-28;2015-09-29;Estimate;February 2012;;2012-02-29;September 2015;2015-09-30;June 2014;Actual;2014-06-30;February 2014;Actual;2014-02-28;;Interventional;Serogen;;Serotonergic System and Violent Video Games;Genetic-pharmacological Neuroimaging of the Serotonergic System in Violent Video Games;Completed;;N/A;47;Actual;RWTH Aachen University;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:13:52Z;2020-06-01T14:13:52Z;Aachen;;;;;cipralex;63656777;1;;;2012;2020-05-29;24;FALSE;;FALSE;TRUE;18;60;Years;Years;1;;
NCT01644045;ClinicalTrials.gov processed this data on May 29, 2020;2012-07-12;;;2015-09-21;2012-07-16;2012-07-18;Estimate;;;;;;;2015-09-21;2015-09-22;Estimate;August 2012;;2012-08-31;September 2015;2015-09-30;September 2015;Actual;2015-09-30;July 2013;Actual;2013-07-31;;Interventional;;;Prehospital Emergency Care of Obstructive Respiratory Emergencies With the Use of Teleconsultation;Prehospital Emergency Care of Obstructive Respiratory Emergencies With the Use of Teleconsultation;Completed;;N/A;17;Actual;RWTH Aachen University;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:13:52Z;2020-06-01T14:13:52Z;Aachen;3617991;Study Chair;Rolf Rossaint, Prof. Dr.;University Hospital Aachen, Germany, Department of Anesthesiology;Teleconsultation;63656779;1;;;2012;2020-05-29;11;FALSE;;FALSE;TRUE;;;;;1;3;
NCT01644032;ClinicalTrials.gov processed this data on May 29, 2020;2012-07-12;;;2015-09-21;2012-07-16;2012-07-18;Estimate;;;;;;;2015-09-21;2015-09-22;Estimate;August 2012;;2012-08-31;September 2015;2015-09-30;September 2015;Actual;2015-09-30;July 2013;Actual;2013-07-31;;Interventional;;;Telemedically Supported Analgesia in the Emergency Medical Service;Telemedically Supported Analgesia in the Emergency Medical Service;Completed;;N/A;106;Actual;RWTH Aachen University;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:13:52Z;2020-06-01T14:13:52Z;Aachen;3617993;Study Chair;Rolf Rossaint, Prof. Dr.;University Hospital Aachen, Germany, Department of Anesthesiology;Teleconsultation;63656780;1;;;2012;2020-05-29;11;FALSE;;FALSE;TRUE;;;;;1;4;
NCT01644019;ClinicalTrials.gov processed this data on May 29, 2020;2012-07-12;;;2015-09-21;2012-07-16;2012-07-18;Estimate;;;;;;;2015-09-21;2015-09-22;Estimate;August 2012;;2012-08-31;September 2015;2015-09-30;September 2015;Actual;2015-09-30;July 2013;Actual;2013-07-31;;Interventional;;;Prehospital Telemedical Support in Acute Stroke;Prehospital Telemedical Support in Acute Stroke;Completed;;N/A;28;Actual;RWTH Aachen University;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:13:53Z;2020-06-01T14:13:53Z;Aachen;3617995;Study Chair;Rolf Rossaint, Prof. Dr.;University Hospital Aachen, Germany, Department of Anesthesiology;Teleconsultation;63656781;1;;;2012;2020-05-29;11;FALSE;;FALSE;TRUE;18;;Years;;1;4;
NCT01644006;ClinicalTrials.gov processed this data on May 29, 2020;2012-07-12;;;2015-09-21;2012-07-16;2012-07-18;Estimate;;;;;;;2015-09-21;2015-09-22;Estimate;August 2012;;2012-08-31;September 2015;2015-09-30;September 2015;Actual;2015-09-30;July 2013;Actual;2013-07-31;;Interventional;;;Telemedical Support in Prehospital Emergency Care of Acute Coronary Syndrome;Telemedical Support in Prehospital Emergency Care of Acute Coronary Syndromes;Completed;;N/A;39;Actual;RWTH Aachen University;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:13:53Z;2020-06-01T14:13:53Z;Aachen;3617997;Study Chair;Rolf Rossaint, Prof. Dr.;University Hospital Aachen, Germany, Department of Anesthesiology;Teleconsultation;63656782;1;;;2012;2020-05-29;11;FALSE;;FALSE;TRUE;18;;Years;;1;5;
NCT01641185;ClinicalTrials.gov processed this data on May 29, 2020;2012-07-06;;;2017-05-01;2012-07-13;2012-07-16;Estimate;;;;;;;2017-05-01;2017-05-04;Actual;May 2012;;2012-05-31;May 2017;2017-05-31;December 2015;Actual;2015-12-31;December 2015;Actual;2015-12-31;;Interventional;IPI;;Ion Prostate Irradiation;Hypofractionated Ion Irradiation (Carbon Ions Versus Protons) of the Prostate;Completed;;Phase 2;92;Actual;Heidelberg University;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:14:57Z;2020-06-01T14:14:57Z;Heidelberg;3618218;Principal Investigator;Klaus Herfarth, Prof. Dr.;University Hospital of Heidelberg;radiation;63656999;1;;;2012;2020-05-29;43;FALSE;;FALSE;TRUE;40;80;Years;Years;1;3;
NCT01639781;ClinicalTrials.gov processed this data on May 29, 2020;2012-06-06;;;2014-12-14;2012-07-10;2012-07-13;Estimate;;;;;;;2014-12-14;2014-12-16;Estimate;November 2011;;2011-11-30;December 2014;2014-12-31;August 2014;Actual;2014-08-31;August 2014;Actual;2014-08-31;;Interventional;;;Age-dependent Effects of Flavanols on Vascular Status;Age-dependent Effects of Flavanol Metabolism and Absorption on Vascular Status After Acute and Chronic Application.;Completed;;Phase 1;44;Anticipated;Heinrich-Heine University, Duesseldorf;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:15:18Z;2020-06-01T14:15:18Z;Düsseldorf;;;;;Flavanol rich intervention | Flavanol free control;63657103;1;;;2012;2020-05-29;33;FALSE;;FALSE;TRUE;18;80;Years;Years;1;8;
NCT01639261;ClinicalTrials.gov processed this data on May 29, 2020;2012-07-09;;;2012-07-11;2012-07-11;2012-07-12;Estimate;;;;;;;2012-07-11;2012-07-12;Estimate;July 2012;;2012-07-31;July 2012;2012-07-31;September 2014;Anticipated;2014-09-30;December 2013;Anticipated;2013-12-31;;Interventional;IFN_BOSZT_01;;A Phase II Trial on Treatment of Steroid-refractory Bronchiolitis Obliterans With Interferon Gamma 1b After Allogeneic SCT;Eine Phase II Studie über Interferon Gamma 1b Zur Behandlung Der steroidrefraktären Bronchiolitis Obliterans Nach Allogener SZT;Unknown status;;Phase 2;10;Anticipated;University Hospital Regensburg;;;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:15:25Z;2020-06-01T14:15:25Z;Regensburg;3618377;Principal Investigator;Ernst Holler, Professor MD;University Hospital Regensburg;Interferon gamma 1b;63657143;1;;;2012;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT01636752;ClinicalTrials.gov processed this data on May 29, 2020;2012-07-05;;;2018-10-09;2012-07-05;2012-07-10;Estimate;;;;;;;2018-10-09;2018-10-12;Actual;July 2012;;2012-07-31;October 2018;2018-10-31;February 2017;Actual;2017-02-28;February 2015;Actual;2015-02-28;;Interventional;EVIDENT;;Effectiveness of Internet-based Depression Treatment;;Completed;;N/A;1013;Actual;University of Luebeck;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:16:02Z;2020-06-01T14:16:02Z;Lübeck;;;;;Deprexis;63657334;4;;;2012;2020-05-29;31;FALSE;;FALSE;FALSE;18;65;Years;Years;1;3;
NCT01635660;ClinicalTrials.gov processed this data on May 29, 2020;2012-07-04;;;2015-08-01;2012-07-06;2012-07-09;Estimate;;;;;;;2015-08-01;2015-08-04;Estimate;October 2011;;2011-10-31;August 2015;2015-08-31;June 2015;Actual;2015-06-30;July 2014;Actual;2014-07-31;;Interventional;;;Out-of-Hospital Randomized Comparison of Video-assisted Endotracheal Intubation;Prospective, Randomized, Multicentre Evaluation of Different Video-assisted, for Emergency Use Designed Intubation Aids for Out-of-hospital Endotracheal Intubation. Comparison of C-MAC System PM (Karl Storz), AP Advance (Venner Medical), and King Vision (King Systems) at Four German HEMS.;Completed;;N/A;182;Actual;University of Schleswig-Holstein;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:16:23Z;2020-06-01T14:16:23Z;Kiel Lübeck;;;;;Intubation;63657416;3;;;2012;2020-05-29;33;FALSE;;FALSE;FALSE;18;;Years;;1;2;
NCT01635634;ClinicalTrials.gov processed this data on May 29, 2020;2012-07-03;;;2018-05-04;2012-07-06;2012-07-09;Estimate;;;;;;;2018-05-04;2018-05-11;Actual;June 2012;;2012-06-30;May 2018;2018-05-31;March 2015;Actual;2015-03-31;July 2014;Actual;2014-07-31;;Interventional;CuFib;;Cupping in Fibromyalgia;Randomized Controlled Pilot Trial: The Effectiveness of Cupping in Patients With Fibromyalgia;Completed;;N/A;141;Actual;Universität Duisburg-Essen;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:16:23Z;2020-06-01T14:16:23Z;Duisburg;3618671;Principal Investigator;Jost Langhorst, MD, Prof;University of Duisburg-Essen;Cupping therapy;63657418;1;;;2012;2020-05-29;25;FALSE;;FALSE;TRUE;18;75;Years;Years;1;12;
NCT01635114;ClinicalTrials.gov processed this data on May 29, 2020;2012-07-03;;;2016-10-24;2012-07-03;2012-07-06;Estimate;;;;;;;2016-10-24;2016-10-25;Estimate;June 2012;;2012-06-30;October 2016;2016-10-31;September 2015;Actual;2015-09-30;December 2013;Actual;2013-12-31;;Interventional;resVida NAFL;;Effect of resVida on Liver Fat Content;Evaluate the Effects of resVidaTM on Liver Fat Content, Body Fat Distribution and Insulin Sensitivity;Completed;;N/A;112;Actual;University Hospital Tuebingen;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:16:27Z;2020-06-01T14:16:27Z;Tübingen;3618718;Principal Investigator;Norbert Stefan, MD;University Hospital Tuebingen;resveratrol | Placebo;63657459;1;;;2012;2020-05-29;18;FALSE;;FALSE;TRUE;18;70;Years;Years;1;5;
NCT01632371;ClinicalTrials.gov processed this data on May 29, 2020;2012-06-26;;;2016-11-18;2012-06-28;2012-07-02;Estimate;;;;;;;2016-11-18;2016-11-21;Estimate;June 2012;;2012-06-30;November 2016;2016-11-30;November 2016;Actual;2016-11-30;August 2015;Actual;2015-08-31;;Interventional;ISAR-DESIRE 4;;Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-Stent Restenosis 4;ISAR-DESIRE 4: Randomized Trial Of Scoring Balloon in Patients With Restenosis in Limus-Eluting Coronary Stents Undergoing Angioplasty With Paclitaxel-Coated Balloon;Completed;;Phase 4;252;Actual;Deutsches Herzzentrum Muenchen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:17:01Z;2020-06-01T14:17:01Z;Munich;3618946;Study Chair;Adnan Kastrati, MD;Deutsches Herzzentrum Munich;Paclitaxel Eluting Balloon + Scoring Balloon | Paclitaxel Eluting Balloon;63657667;2;;;2012;2020-05-29;38;FALSE;;FALSE;FALSE;18;;Years;;1;6;
NCT01630434;ClinicalTrials.gov processed this data on May 29, 2020;2012-06-25;;;2018-09-10;2012-06-26;2012-06-28;Estimate;;;;;;;2018-09-10;2018-09-12;Actual;November 2011;;2011-11-30;May 2016;2016-05-31;April 2016;Actual;2016-04-30;September 2014;Actual;2014-09-30;;Interventional;INSPIRE;;International Randomized Study of the TransMedics Organ Care System (OCS Lung) for Lung Preservation and Transplantation;Prospective, International, Multi-Center, Randomized Clinical Investigation of TransMedics Organ Care System (OCS LUNG) for Lung Preservation and Transplantation;Completed;;N/A;316;Actual;TransMedics;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:17:28Z;2020-06-01T14:17:28Z;Hannover;3619102;Study Director;Gregor Warnecke, MD;Hannover Medical Center, Germany;OCS Lung | Cold flush and storage;63657815;21;;;2012;2020-05-29;34;FALSE;;TRUE;FALSE;18;;Years;;1;3;
NCT01627938;ClinicalTrials.gov processed this data on May 29, 2020;2012-05-30;;;2014-11-04;2012-06-25;2012-06-26;Estimate;;;;;;;2014-11-04;2014-11-05;Estimate;April 2012;;2012-04-30;November 2014;2014-11-30;April 2016;Anticipated;2016-04-30;April 2015;Anticipated;2015-04-30;;Interventional;MSCardioPro;;Study to Evaluate the Reduction of Cardiac Problems in Multiple Sclerosis Patients With Mitoxantrone and Dexrazoxane in Combination;A Phase II Proof of Concept Study Evaluating the Reduction of Mitoxantrone-induced Cardiotoxicity and Neurological Outcome in the Combined Use of Mitoxantrone and Dexrazoxane (Cardioxane®) in Multiple Sclerosis (MSCardioPro);Unknown status;;Phase 2;50;Anticipated;Ruhr University of Bochum;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:17:59Z;2020-06-01T14:17:59Z;Bochum;3619302;Principal Investigator;Andrew Chan, PD Dr.;Department of Neurology, St. Josef-Hospital Bochum, Ruhr-University Bochum;Dexrazoxane (DRZ) plus Mitoxantrone (MX) | Placebo plus Mitoxantrone (MX);63658003;1;;;2012;2020-05-29;;FALSE;;FALSE;TRUE;18;55;Years;Years;1;10;
NCT01627379;ClinicalTrials.gov processed this data on May 29, 2020;2012-06-13;;;2018-03-01;2012-06-21;2012-06-25;Estimate;;;;;;;2018-03-01;2018-03-02;Actual;May 2012;;2012-05-31;March 2018;2018-03-31;May 2017;Actual;2017-05-31;May 2015;Actual;2015-05-31;;Interventional;POWER;;Cisplatin and 5-FU +/- Panitumumab for Patients With Nonresectable,Advanced or Metastatic Esophageal Squamous Cell Cancer;An Open-label, Randomized Phase III Trial of Cisplatin and 5-fluorouracil With or Without Panitumumab for Patients With Nonresectable, Advanced or Metastatic Esophageal Squamous Cell Cancer;Terminated;;Phase 3;300;Anticipated;AIO-Studien-gGmbH;;2;;Sponsor decision due to recommendation of the IDMC.;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:18:07Z;2020-06-01T14:18:07Z;Mainz;3619345;Principal Investigator;Markus Möhler, PD Dr.;I. Medizinische KLinik und Poliklinik, Johannes-Gutenberg-Universität Mainz;Cisplatin, 5-FU | Panitumumab;63658045;1;;;2012;2020-05-29;36;FALSE;;FALSE;TRUE;18;;Years;;1;5;
NCT01627015;ClinicalTrials.gov processed this data on May 29, 2020;2012-06-21;;;2015-03-06;2012-06-21;2012-06-25;Estimate;;;;;;;2015-03-06;2015-03-09;Estimate;June 2012;;2012-06-30;March 2015;2015-03-31;April 2014;Actual;2014-04-30;April 2014;Actual;2014-04-30;;Interventional;;;Safety, Acceptance and Metabolic Effects in Infants Receiving a Novel Low Glycaemic Index follow-on Formula;Safety, Acceptance and Metabolic Effects in Infants Receiving a Novel Low Glycaemic Index follow-on Formula;Completed;;N/A;50;Actual;Ludwig-Maximilians - University of Munich;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:18:12Z;2020-06-01T14:18:12Z;Munich;3619376;Study Director;Berthold Koletzko, Prof.;Germany, Hauner Childrens Hospital, Ludwig-Maximilians - University of Munich;Modified infant follow-on formula | Standard infant follow-on formula;63658074;1;;;2012;2020-05-29;22;FALSE;;FALSE;TRUE;4;6;Months;Months;1;;
NCT01625572;ClinicalTrials.gov processed this data on May 29, 2020;2012-06-19;;;2016-07-28;2012-06-20;2012-06-21;Estimate;;;;;;;2016-07-28;2016-07-29;Estimate;July 2012;;2012-07-31;July 2016;2016-07-31;December 2015;Actual;2015-12-31;July 2015;Actual;2015-07-31;;Interventional;TAPPro;;Ultrasound-assisted Bilateral Transversus Abdominis Plane Block for Open Prostatectomy;Ultrasound-assisted Bilateral Transversus Abdominis Plane Block for Open Prostatectomy;Completed;;N/A;66;Actual;Charite University, Berlin, Germany;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:18:35Z;2020-06-01T14:18:35Z;Berlin;3619511;Principal Investigator;Jürgen Birnbaum, MD;Charite, Department of Anesthesiology and Intensive Care, Campus Mitte, Universitätsmedizin Berlin;Transversus abdominis plane blockade | Morphine-patient-controlled-analgesia-device;63658185;1;;;2012;2020-05-29;36;FALSE;;FALSE;TRUE;18;;Years;;1;8;
NCT01620710;ClinicalTrials.gov processed this data on May 29, 2020;2012-06-13;;;2018-10-13;2012-06-13;2012-06-15;Estimate;;;;;;;2018-10-13;2018-10-16;Actual;February 2012;Actual;2012-02-29;October 2018;2018-10-31;September 30, 2017;Actual;2017-09-30;September 2015;Actual;2015-09-30;;Interventional;PRIAMOS;;Safety Study of a Shorter (Hypofractionated) Radiotherapy for the Prostate Bed With or Without the Pelvic Lymph Nodes;Hypofractionated Helical Intensity-Modulated Radiotherapy of the Prostate Bed After Prostatectomy With or Without the Pelvic Lymph Nodes - the PRIAMOS Trial;Completed;;Phase 2;80;Actual;Heidelberg University;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:19:53Z;2020-06-01T14:19:53Z;Heidelberg;3619949;Principal Investigator;Klaus Herfarth, MD;Heidelberg University;hypofractionated helical IMRT | hypofractionated helical IMRT;63658551;1;;;2012;2020-05-29;43;FALSE;;FALSE;TRUE;18;80;Years;Years;1;3;
NCT01619657;ClinicalTrials.gov processed this data on May 29, 2020;2012-06-12;;;2017-10-25;2012-06-12;2012-06-14;Estimate;;;;;;;2017-10-25;2017-10-26;Actual;June 2012;;2012-06-30;October 2017;2017-10-31;October 2017;Actual;2017-10-31;November 2016;Actual;2016-11-30;;Interventional;PRESIS;;Preventive Inhalation of Hypertonic Saline in Infants With Cystic Fibrosis;Randomized, Double-blind, Controlled Pilot Study on Safety of Hypertonic Saline as Preventive Inhalation Therapy in Newborns and Infants With Cystic Fibrosis;Completed;;Phase 2;42;Actual;Heidelberg University;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:20:10Z;2020-06-01T14:20:10Z;Heidelberg;3620046;Principal Investigator;Marcus A Mall, MD;University Hospital Heidelberg;6% Hypertonic Saline (HS), 4mL | 0.9% Isotonic Saline (IS), 4mL;63658633;4;;;2012;2020-05-29;53;FALSE;;FALSE;FALSE;;4;;Months;1;10;
NCT01617980;ClinicalTrials.gov processed this data on May 29, 2020;2012-04-10;;;2014-03-14;2012-06-11;2012-06-13;Estimate;;;;;;;2014-03-14;2014-03-17;Estimate;April 2012;;2012-04-30;March 2014;2014-03-31;March 2014;Actual;2014-03-31;March 2014;Actual;2014-03-31;;Interventional;HIL;;Multimodal Hypoxia Imaging and Intensity Modulated Radiotherapy for Inoperable Non-small-cell Lung Cancer;;Terminated;;N/A;4;Actual;German Cancer Research Center;;1;;Slow accrual;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:20:30Z;2020-06-01T14:20:30Z;Heidelberg;3620194;Principal Investigator;Jürgen Debus, Professor;University Clinic Heidelberg and German Cancer Research Center;Multimodal hypoxia imaging;63658761;1;;;2012;2020-05-29;23;FALSE;;FALSE;TRUE;18;;Years;;1;3;
NCT01617343;ClinicalTrials.gov processed this data on May 29, 2020;2012-06-05;;;2014-04-07;2012-06-11;2012-06-12;Estimate;;;;;;;2014-04-07;2014-04-08;Estimate;August 2012;;2012-08-31;April 2014;2014-04-30;February 2014;Actual;2014-02-28;February 2014;Actual;2014-02-28;;Interventional;;;The HEP-OKS Study - Hemifield Eye Patching and Optokinetic Stimulation to Treat Hemispatial Neglect in Stroke Patients;The HEP-OKS Pilot Study - a Randomized Controlled Trial of Hemifield Eye Patching and Optokinetic Stimulation to Treat Hemispatial Neglect in Stroke Patients;Completed;;Phase 3;23;Actual;University of Luebeck;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:20:39Z;2020-06-01T14:20:39Z;Lübeck;3620250;Principal Investigator;Bjoern Machner, MD;University of Luebeck;hemifield eye patching (HEP) + optokinetic stimulation (OKS);63658810;1;;;2012;2020-05-29;18;FALSE;;FALSE;TRUE;18;90;Years;Years;2;5;
NCT01615172;ClinicalTrials.gov processed this data on May 29, 2020;2012-06-04;;;2014-08-05;2012-06-06;2012-06-08;Estimate;;;;;;;2014-08-05;2014-08-06;Estimate;January 2011;;2011-01-31;August 2014;2014-08-31;December 2014;Anticipated;2014-12-31;December 2014;Anticipated;2014-12-31;;Interventional;;;Cannulation of the Artery Axiliaris for Extracorporeal Circulation;Cannulation of the Artery Axiliaris for Extracorporeal Circulation;Unknown status;;N/A;120;Anticipated;Johann Wolfgang Goethe University Hospital;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:21:04Z;2020-06-01T14:21:04Z;Frankfurt;3620424;Principal Investigator;Andreas Zierer, PD.Dr;Goethe University;cannulation;63658976;1;;;2012;2020-05-29;;FALSE;;FALSE;TRUE;40;85;Years;Years;1;;
NCT01614301;ClinicalTrials.gov processed this data on May 29, 2020;2012-06-05;;;2012-06-05;2012-06-05;2012-06-07;Estimate;;;;;;;2012-06-05;2012-06-07;Estimate;May 2012;;2012-05-31;June 2012;2012-06-30;May 2016;Anticipated;2016-05-31;May 2014;Anticipated;2014-05-31;;Interventional;;;Phase I and Consecutive Phase II, Two-arm, Randomized Multi-center Trial in Patients With Advanced Melanoma;A Prospective Phase I and Consecutive Phase II, Two-arm, Randomized Multi-center Trial of Temsirolimus in Combination With Pioglitazone, Etoricoxib and Metronomic Low-dose Trofosfamide Versus Dacarbazine (DTIC) in Patients With Advanced Melanoma;Unknown status;;Phase 1/Phase 2;136;Anticipated;University of Regensburg;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:21:17Z;2020-06-01T14:21:17Z;Regensburg;3620493;Principal Investigator;Albrecht Reichle, Professor;University of Regensburg;dacarbazine (DTIC), Trofosfamide, Etoricoxib, Pioglitazone, Temsirolimus;63659042;1;;;2012;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT01612312;ClinicalTrials.gov processed this data on May 29, 2020;2012-05-30;;;2017-05-01;2012-06-01;2012-06-05;Estimate;;;;;;;2017-05-01;2017-05-02;Actual;March 2011;;2011-03-31;May 2017;2017-05-31;October 2016;Actual;2016-10-31;June 2013;Actual;2013-06-30;;Interventional;;;Thrombus Aspiration in ThrOmbus Containing culpRiT Lesions in Non-ST-Elevation Myocardial Infarction (TATORT-NSTEMI);Thrombus Aspiration in ThrOmbus Containing culpRiT Lesions in Non-ST-Elevation Myocardial Infarction (TATORT-NSTEMI);Completed;;Phase 4;400;Anticipated;University of Leipzig;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:21:40Z;2020-06-01T14:21:40Z;Leipzig;3620674;Principal Investigator;Holger Thiele, MD;Heart Center Leipzig, University of Leipzig, Germany;Thrombectomy | Standard percutaneous coronary intervention;63659191;7;;;2012;2020-05-29;27;FALSE;;FALSE;FALSE;18;90;Years;Years;1;9;
NCT01611207;ClinicalTrials.gov processed this data on May 29, 2020;2012-03-28;;;2013-05-17;2012-06-01;2012-06-04;Estimate;;;;;;;2013-05-17;2013-05-20;Estimate;June 2012;;2012-06-30;May 2013;2013-05-31;June 2014;Anticipated;2014-06-30;December 2013;Anticipated;2013-12-31;;Interventional;ISAW;;Evaluate the Efficacy of the Treatment of Iatrogenic Subcutaneous Abdominal Wounds (ISAW) After Surgery by Application of Negative Pressure Wound Therapy (NPWT) in Comparison to Standard Conventional Wound Therapy (SCWT) of the Clinical Routine;Randomised Controlled Study to Evaluate the Efficacy of the Treatment of Iatrogenic Subcutaneous Abdominal Wounds (ISAW) After Surgery by Application of Negative Pressure Wound Therapy (NPWT) in Comparison to Standard Conventional Wound Therapy (SCWT) of the Clinical Routine.;Terminated;;N/A;12;Actual;University of Witten/Herdecke;;2;;The patient recruitment was behind target, no successful completion of the planned patient~   numbers within trial period could be expected;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:21:52Z;2020-06-01T14:21:52Z;Witten-Herdecke;;;;;Negative Pressure Wound Therapy | Standard Wound Therapy;63659277;34;;;2012;2020-05-29;;FALSE;;FALSE;FALSE;18;;Years;;1;9;
NCT01611116;ClinicalTrials.gov processed this data on May 29, 2020;2012-05-25;;;2019-08-15;2012-05-31;2012-06-04;Estimate;;;;;;;2019-08-15;2019-08-16;Actual;May 2012;;2012-05-31;August 2019;2019-08-31;April 26, 2017;Actual;2017-04-26;April 26, 2017;Actual;2017-04-26;;Interventional;TOR-AML;;Study With Temsirolimus Added to Standard Chemotherapy for Patients Over 60 Years With Acute Myeloblastic Leukemia;A Double-blind, Placebo-controlled, Randomized, Multicenter Phase II Trial to Assess the Efficacy of Temsirolimus Added to Standard Primary Therapy in Elderly Patients With Newly Diagnosed AML;Completed;;Phase 2;33;Actual;Goethe University;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:21:55Z;2020-06-01T14:21:55Z;Frankfurt;3620773;Study Director;Christian Brandts, MD;University Hospital, Frankfurt;sodium chloride solution 0.9% | temsirolimus;63659284;5;;;2012;2020-05-29;59;FALSE;;FALSE;FALSE;61;;Years;;2;12;
NCT01609946;ClinicalTrials.gov processed this data on May 29, 2020;2012-05-30;;;2018-03-30;2012-05-31;2012-06-01;Estimate;;;;;;;2018-03-30;2018-04-02;Actual;June 2012;;2012-06-30;March 2018;2018-03-31;December 2014;Actual;2014-12-31;December 2013;Actual;2013-12-31;;Interventional;;;Realtime-Elastography (RTE) and Thyroid Nodules;Evaluation of Realtime-Elastography for Differentiation of Thyroid Nodules: a Multicenter Study;Completed;;N/A;602;Anticipated;Johann Wolfgang Goethe University Hospital;;;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:22:18Z;2020-06-01T14:22:18Z;Frankfurt;3620866;Principal Investigator;Joerg Bojunga, MD;Klinikum der J. W. Goethe-Universität, Frankfurt, Germany;Realtime-Elastography, linear ultrasound probe, Hitachi EUB-900, Japan | Cytology (FNAB) or Surgery;63659373;10;;;2012;2020-05-29;18;FALSE;;FALSE;FALSE;18;;Years;;1;1;
NCT01608984;ClinicalTrials.gov processed this data on May 29, 2020;2012-05-29;;;2013-07-15;2012-05-30;2012-05-31;Estimate;;;;;;;2013-07-15;2013-07-16;Estimate;May 2012;;2012-05-31;July 2013;2013-07-31;December 2015;Anticipated;2015-12-31;June 2015;Anticipated;2015-06-30;;Interventional;RIPCON;;Effects of Remote Ischemic PreConditioning in Off-pump Versus On-pump Coronary Artery Bypass Grafting(RIPCON);Effects of Remote Ischemic PreConditioning in Off-pump Versus On-pump Coronary;Unknown status;;Phase 1;100;Anticipated;Heinrich-Heine University, Duesseldorf;;4;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:22:35Z;2020-06-01T14:22:35Z;Düsseldorf Duisburg;3620958;Principal Investigator;Payam Akhyari, MD;Dept. of Cardiovascular Surgery, University Hospital, Heinrich Heine University, Duesseldorf, Germany;Remote ischemic preconditioning (RIPC) | Coronary artery bypass grafting (CABG) without remote ischemic preconditioning protocol | Off-pump Coronary artery bypass surgery without remote ischemic preconditioning;63659447;1;;;2012;2020-05-29;;FALSE;;FALSE;TRUE;18;80;Years;Years;1;5;
NCT01607099;ClinicalTrials.gov processed this data on May 29, 2020;2012-05-24;;;2014-11-13;2012-05-25;2012-05-28;Estimate;;;;;;;2014-11-13;2014-11-14;Estimate;September 2012;;2012-09-30;November 2014;2014-11-30;November 2014;Actual;2014-11-30;February 2014;Actual;2014-02-28;;Interventional;;;Sodium Picosulfate Plus Magnesium Citrate Versus Macrogol 4000 in the Bowel Cleansing Procedure: a Comparison of Efficiency and Compatibility;Sodium Picosulfate Plus Magnesium Citrate Versus Macrogol 4000 in the Bowel Cleansing Procedure: a Comparison of Efficiency and Compatibility;Completed;;N/A;220;Actual;Technische Universität München;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:22:57Z;2020-06-01T14:22:57Z;Munich;3621121;Principal Investigator;Peter Klare, MD;Technische Universität München;Compatibility;63659592;1;;;2012;2020-05-29;17;FALSE;;FALSE;TRUE;18;90;Years;Years;1;1;
NCT01605487;ClinicalTrials.gov processed this data on May 29, 2020;2012-05-11;;;2014-10-14;2012-05-21;2012-05-25;Estimate;;;;;;;2014-10-14;2014-10-15;Estimate;June 2012;;2012-06-30;April 2014;2014-04-30;October 2014;Actual;2014-10-31;September 2013;Actual;2013-09-30;;Interventional;PAFCUTIII;;Study to Assess Efficacy, Safety and Mechanism of Rupatadine in Cold Urticaria;Double-blind, Three-way Cross-over, Placebo-controlled Study to Assess the Efficacy, Safety and Mechanisms of Treatment With Rupatadine 20 mg and 40 mg in Cold Contact Urticaria (CCU);Completed;;Phase 2;24;Actual;Charite University, Berlin, Germany;;6;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:23:27Z;2020-06-01T14:23:27Z;Berlin;3621259;Principal Investigator;Karoline Krause, MD;Charite University, Berlin, Germany;Rupatadine | Rupatadine | Rupatadine | Rupatadine | Rupatadine | Rupatadine;63659718;1;;;2012;2020-05-29;15;FALSE;;FALSE;TRUE;18;;Years;;2;2;
NCT01600573;ClinicalTrials.gov processed this data on May 29, 2020;2012-05-09;;;2016-10-10;2012-05-16;2012-05-17;Estimate;;;;;;;2016-10-10;2016-10-11;Estimate;May 2012;;2012-05-31;October 2016;2016-10-31;March 2017;Anticipated;2017-03-31;March 2017;Anticipated;2017-03-31;;Interventional;;;Pazopanib and Weekly Topotecan in Patients Recurrent Ovarian Cancer (TOPAZ);A Phase I/II Study of Pazopanib and Weekly Topotecan in Patients With Platinum-resistant or Intermediate-sensitive Recurrent Ovarian Cancer;Unknown status;;Phase 1/Phase 2;68;Anticipated;Charite University, Berlin, Germany;;1;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T14:24:46Z;2020-06-01T14:24:46Z;Berlin;3621710;Principal Investigator;jalid Sehouli, Prof. Dr.;Charite University, Berlin, Germany;pazopanib in combination with weekly topotecan;63660094;1;;;2012;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;2;8;
NCT01600014;ClinicalTrials.gov processed this data on May 29, 2020;2012-05-14;;;2016-04-04;2012-05-15;2012-05-16;Estimate;;;;;;;2016-04-04;2016-05-09;Estimate;May 2012;;2012-05-31;April 2016;2016-04-30;February 2014;Actual;2014-02-28;February 2014;Actual;2014-02-28;;Interventional;;;Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp;Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp;Completed;;Phase 3;463;Actual;LEO Pharma;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:24:52Z;2020-06-01T14:24:52Z;Tübingen;3621754;Principal Investigator;Claus Garbe, MD;University Hospital Tuebingen;Ingenol mebutate gel, 0.015% | Vehicle gel;63660137;13;554;22;2012;2020-05-29;21;TRUE;21;FALSE;FALSE;18;;Years;;1;2;
NCT01598948;ClinicalTrials.gov processed this data on May 29, 2020;2012-05-12;;;2015-09-01;2012-05-12;2012-05-15;Estimate;;;;;;;2015-09-01;2015-09-02;Estimate;August 2012;;2012-08-31;September 2015;2015-09-30;June 2015;Actual;2015-06-30;May 2015;Actual;2015-05-31;;Interventional;MICA;;Effect of Mipomersen on LDL-Cholesterol Levels in Patients Treated by Regular Apheresis;Effect of Mipomersen on LDL-Cholesterol Levels in Patients With Severe LDL-Hypercholesterolemia and Atherosclerosis Treated by Regular LDL-Apheresis;Completed;;Phase 3;17;Actual;Ludwig-Maximilians - University of Munich;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:25:11Z;2020-06-01T14:25:11Z;Munich;;;;;mipomersen;63660220;1;;;2012;2020-05-29;33;FALSE;;FALSE;TRUE;18;;Years;;2;3;
NCT01594892;ClinicalTrials.gov processed this data on May 29, 2020;2012-05-07;;;2019-09-02;2012-05-07;2012-05-09;Estimate;;;;;;;2019-09-02;2019-09-04;Actual;April 2012;;2012-04-30;August 2019;2019-08-31;July 2017;Actual;2017-07-31;July 2015;Actual;2015-07-31;;Interventional;DOSIS;;Fractionated Radiosurgery for Painful Spinal Metastases;Dose-intensified Image-Guided Fractionated Radiosurgery for Spinal Metastases (DOSIS);Completed;;N/A;60;Actual;Wuerzburg University Hospital;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:26:23Z;2020-06-01T14:26:23Z;Würzburg;3622196;Principal Investigator;Matthias Guckenberger, MD;Department of Radiation Oncology, University of Wuerzburg;Radiosurgery;63660530;5;;;2012;2020-05-29;39;FALSE;;FALSE;FALSE;19;;Years;;1;7;
NCT01594177;ClinicalTrials.gov processed this data on May 29, 2020;2012-05-03;;;2014-03-12;2012-05-07;2012-05-08;Estimate;;;;;;;2014-03-12;2014-03-13;Estimate;May 2012;;2012-05-31;March 2014;2014-03-31;March 2014;Actual;2014-03-31;March 2014;Actual;2014-03-31;;Interventional;DAFNE;;Dual Blockage With Afatinib and Trastuzumab as Neoadjuvant Treatment for Patients With Locally Advanced or Operable Breast Cancer Receiving Taxane-anthracycline Containing Chemotherapy;Dual Blockage With Afatinib and Trastuzumab as Neoadjuvant Treatment for Patients With Locally Advanced or Operable Breast Cancer Receiving Taxane-anthracycline Containing Chemotherapy;Completed;;Phase 2;65;Actual;German Breast Group;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:26:34Z;2020-06-01T14:26:34Z;Munich;3622256;Principal Investigator;Claus A Hanusch, MD, PhD;Rotkreuzklinikum München, 80634 München, Rotkreuzplatz 8;Afatinib | Trastuzumab | Paclitaxel | Epirubicin | Cyclophosphamide;63660585;1;;;2012;2020-05-29;22;FALSE;;FALSE;TRUE;18;;Years;;1;6;
NCT01590992;ClinicalTrials.gov processed this data on May 29, 2020;2012-04-11;;;2018-10-22;2012-05-02;2012-05-03;Estimate;;;;;;;2018-10-22;2018-10-24;Actual;May 2012;;2012-05-31;October 2018;2018-10-31;December 2017;Actual;2017-12-31;December 2017;Actual;2017-12-31;;Interventional;;;Treatment of Globus Sensations With Psychotherapy;Psychotherapy and Psychobiology of Somatoform Disorders (Globus Sensations): A Randomized Controlled Trial;Completed;;N/A;175;Actual;University Hospital, Basel, Switzerland;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:27:17Z;2020-06-01T14:27:17Z;Bochum;3622527;Study Director;Gunther Meinlschmidt, Ph.D.;University of Basel, Ruhr-University Bochum;Exposure-based psychotherapy for somatic symptoms | Relaxation therapy;63660830;1;;;2012;2020-05-29;68;FALSE;;FALSE;TRUE;18;85;Years;Years;4;11;
NCT01589913;ClinicalTrials.gov processed this data on May 29, 2020;2011-10-05;;;2019-04-29;2012-05-01;2012-05-02;Estimate;;;;;;;2019-04-29;2019-05-01;Actual;May 2012;Actual;2012-05-31;April 2019;2019-04-30;August 2016;Actual;2016-08-31;July 2015;Actual;2015-07-31;;Interventional;REACH-ICD;;REmote Web Assisted Care for Heart Failure Patients With Implantable Cardioverter Defibrillators;Remote Care for Reducing Cardiac Fear, Fear of Dying, Depression, and Increasing Quality of Life in ICD‐Patients With Cardiac Insufficiency/at Risk for Fatal Cardiac Arrhythmia.;Completed;;N/A;118;Actual;Wuerzburg University Hospital;;2;;;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T14:27:32Z;2020-06-01T14:27:32Z;Würzburg;3622619;Principal Investigator;Paul Pauli, Prof. Dr.;University of Würzburg;ICD-Forum;63660914;7;;;2011;2020-05-29;38;FALSE;;FALSE;FALSE;18;75;Years;Years;1;3;
NCT01584869;ClinicalTrials.gov processed this data on May 29, 2020;2012-04-23;;;2015-01-28;2012-04-24;2012-04-25;Estimate;;;;;;;2015-01-28;2015-01-29;Estimate;December 2011;;2011-12-31;January 2015;2015-01-31;March 2014;Actual;2014-03-31;March 2014;Actual;2014-03-31;;Interventional;;;Emergency Capsule Endoscopy in Severe GI-bleeding;Emergency Capsule Endoscopy in Severe GI-bleeding;Completed;;Phase 2/Phase 3;20;Anticipated;Technische Universität München;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:29:08Z;2020-06-01T14:29:08Z;Munich;;;;;capsule endoscopy;63661297;1;;;2012;2020-05-29;27;FALSE;;FALSE;TRUE;18;;Years;;1;2;
NCT01582724;ClinicalTrials.gov processed this data on May 29, 2020;2012-04-18;;;2015-08-03;2012-04-19;2012-04-23;Estimate;;;;;;;2015-08-03;2015-08-04;Estimate;December 2012;;2012-12-31;August 2015;2015-08-31;March 2015;Actual;2015-03-31;September 2014;Actual;2014-09-30;;Interventional;AKUD;;Effectiveness of Additional Self-care Acupressure for Women With Menstrual Pain Compared to Usual Care Alone;Randomized Pragmatic Trial for Women With Menstrual Pain Comparing Additional Self-care Acupressure to Usual Care Alone;Completed;;N/A;220;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:29:37Z;2020-06-01T14:29:37Z;Berlin;3623274;Principal Investigator;Claudia M Witt, MD;Institue of Social Science, Epidemiology and Health Economics, Charité University Medical Center Berlin Germany;Self-care acupressure at three predefined points;63661459;1;;;2012;2020-05-29;21;FALSE;;FALSE;TRUE;18;25;Years;Years;1;8;
NCT01582048;ClinicalTrials.gov processed this data on May 29, 2020;2012-04-16;;;2018-05-02;2012-04-19;2012-04-20;Estimate;;;;;;;2018-05-02;2018-05-08;Actual;April 2012;;2012-04-30;May 2018;2018-05-31;August 17, 2016;Actual;2016-08-17;August 17, 2016;Actual;2016-08-17;;Interventional;;;Multicenter Study of Peritransplantation Immunosuppression for Mismatched Hematopoietic Cell Transplantation After Reduced Intensity Conditioning;Multicenter Phase II Study of Peritransplantation Immunosuppression Using ATG, Rituximab, Sirolimus and Mycophenolate Mofetil in Patient Receiving Mismatched Hematopoietic Cell Transplantation After Reduced Intensity Conditioning With Fludarabine and Treosulfan;Terminated;;Phase 2;9;Actual;University Hospital Tuebingen;;;;slow enrollment;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:29:52Z;2020-06-01T14:29:52Z;Tübingen;3623356;Principal Investigator;Wolfgang A Bethge, MD;Medical Center University Hospital of Tuebingen;immunosuppression;63661511;4;;;2012;2020-05-29;52;FALSE;;FALSE;FALSE;18;75;Years;Years;2;16;
NCT01580592;ClinicalTrials.gov processed this data on May 29, 2020;2012-04-18;;;2017-02-23;2012-04-18;2012-04-19;Estimate;;;;;;;2017-02-23;2017-04-07;Actual;April 2012;;2012-04-30;February 2017;2017-02-28;February 2015;Actual;2015-02-28;December 2014;Actual;2014-12-31;;Interventional;CUTEX;;Cold Urticaria Treatment With Xolair;A Two-center, Double Blind, Placebo-controlled Study in Parallel Design to Assess the Efficacy and Safety of 150 and 300 mg Omalizumab in Subjects With Antihistamine-resistant Cold Contact Urticaria (CCU);Completed;;Phase 2;31;Actual;Charite University, Berlin, Germany;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:30:09Z;2020-06-01T14:30:09Z;Berlin;3623474;Principal Investigator;Martin Metz, MD;Charité;Omalizumab | Omalizumab | Placebo;63661619;3;29;0;2012;2020-05-29;32;TRUE;10;FALSE;FALSE;18;;Years;;1;1;
NCT01580124;ClinicalTrials.gov processed this data on May 29, 2020;2012-04-16;;;2019-04-28;2012-04-17;2012-04-18;Estimate;;;;;;;2019-04-28;2019-05-01;Actual;November 2010;;2010-11-30;April 2019;2019-04-30;February 2015;Actual;2015-02-28;February 2014;Actual;2014-02-28;;Interventional;CHASE-AF;;CatHeter Ablation of perSistEnd Atrial Fibrillation: Pulmonary Vein Isolation Versus Defragmentation. The CHASE-AF Study;CatHeter Ablation of perSistEnd Atrial Fibrillation: Pulmonary Vein Isolation Versus Defragmentation. The CHASE-AF Study.;Completed;;N/A;150;Actual;Universitätsklinikum Hamburg-Eppendorf;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T14:30:15Z;2020-06-01T14:30:15Z;Hamburg;3623508;Principal Investigator;Stephan Willems, MD;University Heart Center Hamburg;PVI alone | PVI + Defragmentation + linear lesions;63661655;1;;;2012;2020-05-29;39;FALSE;;FALSE;TRUE;18;80;Years;Years;1;1;
NCT01578525;ClinicalTrials.gov processed this data on May 29, 2020;2012-04-13;;;2015-10-29;2012-04-13;2012-04-17;Estimate;;;;;;;2015-10-29;2015-10-30;Estimate;April 2012;;2012-04-30;May 2012;2012-05-31;April 2014;Actual;2014-04-30;April 2014;Actual;2014-04-30;;Interventional;;;Medication Safety of Elderly Patients in Hospital and Ambulatory Setting;Medication Safety of Elderly Patients in Hospital and Ambulatory Setting Considering the Transitions of Care for Home-cared Patients and Nursing Home Residents;Completed;;N/A;61;Actual;RWTH Aachen University;;2;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T14:30:53Z;2020-06-01T14:30:53Z;Aachen Bonn;3623627;Study Director;Albrecht Eisert, Dr. rer. nat.;University Hospital Aachen, Hospital Pharmacy, Steinbergweg 20, 52074 Aachen, Germany;Pharmaceutical Care Service;63661779;1;;;2012;2020-05-29;24;FALSE;;FALSE;TRUE;65;;Years;;1;7;
NCT01577134;ClinicalTrials.gov processed this data on May 29, 2020;2012-03-19;;;2015-03-26;2012-04-12;2012-04-13;Estimate;;;;;;;2015-03-26;2015-03-31;Estimate;April 2012;;2012-04-30;March 2015;2015-03-31;December 2014;Actual;2014-12-31;August 2013;Actual;2013-08-31;;Interventional;PREFER;;Personal Resources of Elderly People With Multimorbidity;Personal Resources of Elderly People With Multimorbidity: Fortification of Effective Health Behaviour;Completed;;N/A;310;Actual;German Centre of Gerontology;;3;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:31:25Z;2020-06-01T14:31:25Z;Berlin;3623768;Study Chair;Ralf Schwarzer, Prof. Dr.;Freie Universität Berlin;Social-cognitive resource intervention | Social-cognitive resource intervention | no intervention;63661883;1;;;2012;2020-05-29;16;FALSE;;FALSE;TRUE;64;;Years;;1;2;
NCT01569412;ClinicalTrials.gov processed this data on May 29, 2020;2012-03-09;;;2016-05-04;2012-03-30;2012-04-03;Estimate;;;;;;;2016-05-04;2016-05-05;Estimate;March 2012;;2012-03-31;May 2016;2016-05-31;May 2016;Actual;2016-05-31;May 2016;Actual;2016-05-31;;Interventional;;;Open Label, Dose Escalating Study With Ertumaxomab In Patients With HER-2/Neu Expressing Advanced Solid Tumors;Phase I/II, Open Label, Dose Escalating Study To Investigate Safety, Tolerability, And Preliminary Efficacy Of The Trifunctional Anti-HER-2/Neu x Anti-CD3 Antibody Ertumaxomab In Patients With HER-2/Neu Expressing (1+/SISH Positive, 2+ and 3+) Solid Tumors Progressing After Standard Therapy;Terminated;;Phase 1/Phase 2;14;Actual;Krankenhaus Nordwest;;1;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T14:33:50Z;2020-06-01T14:33:50Z;Frankfurt;3624420;Principal Investigator;Salah-Eddin Al-Batran, MD;Institute of Clinical Cancer Research (IKF), UCT - University Cancer Center, Frankfurt, Germany;Ertumaxomab;63662464;1;;;2012;2020-05-29;50;FALSE;;FALSE;TRUE;18;;Years;;1;3;
NCT01569204;ClinicalTrials.gov processed this data on May 29, 2020;2012-04-02;;;2018-10-26;2012-04-02;2012-04-03;Estimate;;;;;;;2018-10-26;2018-10-29;Actual;October 2012;;2012-10-31;October 2018;2018-10-31;December 2017;Actual;2017-12-31;March 2014;Actual;2014-03-31;;Interventional;;;Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Classical Hodgkin Lymphoma;;Completed;;Phase 2;100;Anticipated;University of Cologne;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:33:55Z;2020-06-01T14:33:55Z;Köln;3624437;Principal Investigator;Peter Borchmann, Prof.;University of Cologne, German Hodgkin Study Group;Etoposide | Cyclophosphamide | Doxorubicin | Prednisone | Procarbazine | Dexamethasone | Dacarbazine | Brentuximab Vedotin;63662481;1;;;2012;2020-05-29;17;FALSE;;FALSE;TRUE;18;60;Years;Years;2;5;
NCT01567241;ClinicalTrials.gov processed this data on May 29, 2020;2012-03-22;;;2012-03-30;2012-03-29;2012-03-30;Estimate;;;;;;;2012-03-30;2012-04-02;Estimate;March 2012;;2012-03-31;March 2012;2012-03-31;March 2014;Anticipated;2014-03-31;August 2013;Anticipated;2013-08-31;;Interventional;;;Clinical Hypnosis During Insemination or Embryotransfer;Prospective Off-center Randomised Trial of Clinical Hypnosis Versus Relaxation Music;Unknown status;;N/A;282;Anticipated;Johann Wolfgang Goethe University Hospital;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:34:27Z;2020-06-01T14:34:27Z;Frankfurt;3624609;Principal Investigator;Joscha Reinhard, Priv-Doz. Dr. med. MBBS BSc;Goethe University;clinical hypnosis or relaxation music;63662630;1;;;2012;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT01566955;ClinicalTrials.gov processed this data on May 29, 2020;2012-03-22;;;2015-05-26;2012-03-27;2012-03-30;Estimate;;;;;;;2015-05-26;2015-05-27;Estimate;April 2012;;2012-04-30;May 2015;2015-05-31;December 2014;Actual;2014-12-31;December 2014;Actual;2014-12-31;;Interventional;TG-Adnex;;Feasability Study of Removing the Ovaries and Fallopian Tubes;Feasability of Transgastric Adnexectomy;Completed;;N/A;6;Actual;Heidelberg University;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:34:30Z;2020-06-01T14:34:30Z;Heidelberg Mannheim;3624631;Study Chair;"Marc Suetterlin, MD; PhD";University of Heidelberg, University Medical Center Mannheim Department of Obstetric and Gynaecology;transgastric adnexectomy;63662652;1;;;2012;2020-05-29;32;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT01564004;ClinicalTrials.gov processed this data on May 29, 2020;2012-03-24;;;2012-03-26;2012-03-26;2012-03-27;Estimate;;;;;;;2012-03-26;2012-03-27;Estimate;February 2011;;2011-02-28;March 2012;2012-03-31;September 2014;Anticipated;2014-09-30;February 2014;Anticipated;2014-02-28;;Interventional;;;Clinical Hypnosis Before External Cephalic Version (ECV);Clinical Hypnosis Versus Neuro-linguistic Programming Before External Cephalic Version (ECV) - a Prospective Off-centre Randomised Controlled Trial;Unknown status;;N/A;716;Anticipated;Johann Wolfgang Goethe University Hospital;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:35:28Z;2020-06-01T14:35:28Z;Frankfurt;;;;;Clinical hypnosis or neuro-linguistic programming;63662879;1;;;2012;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT01563614;ClinicalTrials.gov processed this data on May 29, 2020;2012-03-09;;;2016-04-18;2012-03-22;2012-03-27;Estimate;;;;;;;2016-04-18;2016-04-19;Estimate;March 2012;;2012-03-31;April 2016;2016-04-30;November 2015;Actual;2015-11-30;November 2015;Actual;2015-11-30;;Interventional;;;A Clinical Trial to Assess the Safety & Efficacy of the Treatment of Patients With Metastasis From Malignant Melanoma - Treatment Consists of the Substances Lomustine (Capsules) & Cytarabine (Injected Into an Area Near the Spinal Cord), Accompanied by Radiotherapy of the Brain;Safety and Efficacy of Liposomal Cytarabine in Combination With Radiotherapy (RT) and Lomustine for the Treatment of Leptomeningeal Metastasis From Malignant Melanoma;Terminated;;Phase 1;1;Actual;University Hospital, Bonn;;1;;No patients can be recruited for this trial anymore due to other therapeutical approaches that~   became available.;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:35:31Z;2020-06-01T14:35:31Z;Bonn;3624942;Principal Investigator;Martin Glas, PD Dr.;Neurologische Universitaetsklinik Bonn;Brain radiotherapy (WBRT alone, SRT/SRS alone or WBRT plus SRT/SRS) | Lomustine | Liposomal cytarabine;63662906;1;;;2012;2020-05-29;44;FALSE;;FALSE;TRUE;18;;Years;;1;3;
NCT01561118;ClinicalTrials.gov processed this data on May 29, 2020;2012-03-20;;;2017-11-06;2012-03-20;2012-03-22;Estimate;;;;;;;2017-11-06;2017-11-07;Actual;September 2012;;2012-09-30;November 2017;2017-11-30;October 2017;Actual;2017-10-31;October 2017;Actual;2017-10-31;;Interventional;DiaSport;;DiaSport - Endurance-orientated Training Program With Children and Adolescents on Maintenance Hemodialysis;DiaSport - Ausdauerorientiertes Trainingsprogramm Mit Kindern Und Jugendlichen an Der Dialyse (DiaSport - Endurance-orientated Training Program With Children and Adolescents on Maintenance Hemodialysis);Completed;;N/A;66;Actual;University Hospital, Bonn;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:36:15Z;2020-06-01T14:36:15Z;Bonn Köln;3625193;Study Chair;Bernd Hoppe, MD;University Hospital of Bonn;Bicycle-Ergometer Training;63663096;1;;;2012;2020-05-29;61;FALSE;;FALSE;TRUE;6;19;Years;Years;1;8;
NCT01560754;ClinicalTrials.gov processed this data on May 29, 2020;2012-03-09;;;2015-09-28;2012-03-21;2012-03-22;Estimate;;;;;;;2015-09-28;2015-09-29;Estimate;October 2012;;2012-10-31;September 2015;2015-09-30;December 2016;Anticipated;2016-12-31;August 2016;Anticipated;2016-08-31;;Interventional;NIC-PD;;Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease;A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA;Unknown status;;Phase 2;160;Anticipated;University of Vermont;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:36:20Z;2020-06-01T14:36:20Z;Marburg;3625221;Principal Investigator;Wolfgang Oertel, MD;Philipps-University Marburg, Germany / Global and German Principal Investigator;nicotine transdermal patch;63663124;24;;;2012;2020-05-29;;FALSE;;TRUE;FALSE;30;;Years;;1;12;
NCT01548677;ClinicalTrials.gov processed this data on May 29, 2020;2012-03-05;;;2019-03-12;2012-03-05;2012-03-08;Estimate;;;;;;;2019-03-12;2019-03-13;Actual;April 2013;;2013-04-30;March 2019;2019-03-31;March 2017;Actual;2017-03-31;March 2017;Actual;2017-03-31;;Interventional;TREAT-CTC;;Efficacy Study of Herceptin to Treat HER2-negative CTC Breast Cancer;TRastuzumab in HER2-negative Early Breast Cancer as Adjuvant Treatment for Circulating Tumor Cells (CTC) (TREAT CTC Trial);Completed;;Phase 2;1317;Actual;European Organisation for Research and Treatment of Cancer - EORTC;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:39:10Z;2020-06-01T14:39:10Z;Munich;3626288;Study Chair;Brigitte Rack, MD;Ludwig-Maximilians-Universitaet Muenchen - Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe - Innenstadt, Munich, Germany;trastuzumab;63664045;80;;;2012;2020-05-29;47;FALSE;;FALSE;FALSE;18;;Years;;1;7;
NCT01544686;ClinicalTrials.gov processed this data on May 29, 2020;2012-02-22;;;2015-12-08;2012-02-28;2012-03-06;Estimate;;;;;;;2015-12-08;2015-12-09;Estimate;February 2012;;2012-02-29;December 2015;2015-12-31;October 2015;Actual;2015-10-31;October 2015;Actual;2015-10-31;;Interventional;COAT;;Antimicrobial Catheter Securement Dressings for the Prevention of Cvc-related Bloodstream Infections in Cancer Patients;Chlorhexidine Containing Iv-securement Dressings for the Prevention of Central Venous Catheter-related Blood Stream Infections in Neutropenic Patients: a Randomized Trial;Completed;;N/A;630;Actual;University of Cologne;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:40:10Z;2020-06-01T14:40:10Z;Köln;3626616;Principal Investigator;Maria JG Vehreschild, Dr. med.;University Hospital of Cologne;3M™ Tegaderm™ CHG IV and 3M™ Tegaderm™ Advanced IV;63664351;5;;;2012;2020-05-29;44;FALSE;;FALSE;FALSE;18;;Years;;1;11;
NCT01541865;ClinicalTrials.gov processed this data on May 29, 2020;2012-02-21;;;2015-10-23;2012-02-27;2012-03-01;Estimate;;;;;;;2015-10-23;2015-11-25;Estimate;February 2012;;2012-02-29;October 2015;2015-10-31;June 2015;Actual;2015-06-30;November 2013;Actual;2013-11-30;;Interventional;REDUCE-HTN;;Treatment of Resistant Hypertension Using a Radiofrequency Percutaneous Transluminal Angioplasty Catheter;Treatment of Resistant Hypertension Using a Radiofrequency Percutaneous Transluminal Angioplasty Catheter (REDUCE-HTN) - POST MARKET APPROVAL CLINICAL SURVEILLANCE STUDY;Completed;;N/A;146;Actual;Boston Scientific Corporation;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:41:04Z;2020-06-01T14:41:04Z;Frankfurt;3626852;Principal Investigator;Horst Sievert, M.D.;CardioVascular Center Frankfurt, Germany;Renal Denervation;63664564;26;182;199;2012;2020-05-29;21;TRUE;21;FALSE;FALSE;18;75;Years;Years;2;10;
NCT01541605;ClinicalTrials.gov processed this data on May 29, 2020;2012-02-16;;;2016-06-09;2012-02-23;2012-03-01;Estimate;;;;;;;2016-06-09;2016-06-10;Estimate;March 2012;;2012-03-31;June 2016;2016-06-30;May 2016;Actual;2016-05-31;May 2016;Actual;2016-05-31;;Interventional;;;Methylphenidate for the Treatment of Acute Mania;International Randomised Double-blind Placebo-controlled Study on the Initial Treatment of Acute Mania With Methylphenidate;Completed;;Phase 3;42;Actual;University of Leipzig;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:41:08Z;2020-06-01T14:41:08Z;Leipzig;3626877;Principal Investigator;Ulrich Hegerl, Prof. Dr.;University of Leipzig;methylphenidate | Placebo;63664584;10;;;2012;2020-05-29;50;FALSE;;FALSE;FALSE;18;75;Years;Years;1;3;
NCT01541579;ClinicalTrials.gov processed this data on May 29, 2020;2012-02-21;;;2019-11-27;2012-02-29;2012-03-01;Estimate;;;;;;;2019-11-27;2019-11-29;Actual;July 2012;;2012-07-31;November 2019;2019-11-30;November 2016;Actual;2016-11-30;July 2015;Actual;2015-07-31;;Interventional;ADMIRE-CD;;Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease;A Phase III, Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicentre Study to Assess Efficacy and Safety of Expanded Allogeneic Adipose-derived Stem Cells (eASCs) for the Treatment of Perianal Fistulising Crohn's Disease Over a Period of 24 Weeks and an Extended Follow-up Period up to 104 Weeks.;Completed;;Phase 3;278;Anticipated;Takeda;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:41:08Z;2020-06-01T14:41:08Z;Berlin Frankfurt Köln;3626887;Principal Investigator;Daniel C Baumgart, Professor;Charite University, Berlin, Germany;Cx601 | Saline solution;63664586;52;;;2012;2020-05-29;36;FALSE;;FALSE;FALSE;18;;Years;;1;4;
NCT01540383;ClinicalTrials.gov processed this data on May 29, 2020;2012-02-06;;;2017-09-25;2012-02-22;2012-02-28;Estimate;;;;;;;2017-09-25;2017-09-26;Actual;April 2012;;2012-04-30;September 2017;2017-09-30;January 2015;Actual;2015-01-31;January 2015;Actual;2015-01-31;;Interventional;FCET2EC;;Effectiveness of Intensive Aphasia Therapy Under Routine Clinical Conditions;From Controlled Experimental Trial to Everyday Communication: How Effective is Intensive Aphasia Therapy Under Routine Clinical Conditions?;Completed;;N/A;156;Actual;University Hospital Muenster;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:41:26Z;2020-06-01T14:41:26Z;Berlin Munich Münster;3627033;Principal Investigator;Caterina Breitenstein, PhD;Neurology, University of Muenster;Intensive integrative aphasia therapy | Waiting list control group;63664677;1;;;2012;2020-05-29;33;FALSE;;FALSE;TRUE;18;70;Years;Years;1;10;
NCT01540344;ClinicalTrials.gov processed this data on May 29, 2020;2012-02-19;;;2018-08-31;2012-02-27;2012-02-28;Estimate;;;;;;;2018-08-31;2018-09-05;Actual;October 2010;Actual;2010-10-31;August 2018;2018-08-31;October 2017;Actual;2017-10-31;September 2015;Actual;2015-09-30;;Interventional;COMBATAC;;Combined Anticancer Treatment of Advanced Colon Cancer;Multimodality Treatment Including Pre- and Postoperative Systemic Chemotherapy Plus Cetuximab, Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Peritoneal Carcinomatosis Arising From Wild Type K-ras Colon Cancer: A Prospective Multicenter Phase II Study.;Terminated;;Phase 2;26;Actual;University of Regensburg;;1;;Slow recruitment.;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:41:27Z;2020-06-01T14:41:27Z;Regensburg;3627039;Principal Investigator;Pompiliu Piso, Prof. MD;University of Regensburg;CRS | HIPEC;63664680;7;;;2012;2020-05-29;59;FALSE;;FALSE;FALSE;18;71;Years;Years;1;4;
NCT01539746;ClinicalTrials.gov processed this data on May 29, 2020;2012-02-21;;;2013-01-30;2012-02-24;2012-02-27;Estimate;;;;;;;2013-01-30;2013-01-31;Estimate;January 2013;;2013-01-31;January 2013;2013-01-31;December 2014;Anticipated;2014-12-31;December 2014;Anticipated;2014-12-31;;Interventional;SIMPLIFy TAVI;;Transcatheter Aortic Valve Implantation Without Predilation;Use of the Self-Expanding Medtronic CoreValve Prosthesis Without Predilation in Patients With Severely IMPaired Left-VentrIcular Ejection Fraction for TAVI Trial - The SIMPLIFy TAVI Trial;Unknown status;;N/A;110;Anticipated;University Hospital, Bonn;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:41:31Z;2020-06-01T14:41:31Z;Bonn;3627082;Principal Investigator;Georg Nickenig, MD;Department of Medicine II, University Hospital Bonn;TAVI without BAV | TAVI standard procedure;63664723;6;;;2012;2020-05-29;;FALSE;;FALSE;FALSE;18;;Years;;1;12;
NCT01538979;ClinicalTrials.gov processed this data on May 29, 2020;2012-02-07;;;2015-12-17;2012-02-24;2012-02-27;Estimate;;;;;;;2015-12-17;2015-12-18;Estimate;March 2012;;2012-03-31;December 2015;2015-12-31;March 2015;Actual;2015-03-31;December 2014;Actual;2014-12-31;;Interventional;;;Phase II Study of Grass Pollen Allergy Vaccine BM32;Phase IIb Study on the Safety and Efficacy of BM32, a Recombinant Hypoallergenic Vaccine for Immunotherapy of Grass Pollen Allergy;Completed;;Phase 2;181;Actual;Biomay AG;;3;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:41:44Z;2020-06-01T14:41:44Z;Munich;3627166;Study Chair;Johannes Ring, Prof.;Technical University Munich, Klinik und Poliklinik für Dermatologie and Allergologie;BM32 | BM32 | Placebo;63664781;11;;;2012;2020-05-29;33;FALSE;;FALSE;FALSE;18;60;Years;Years;1;14;
NCT01538355;ClinicalTrials.gov processed this data on May 29, 2020;2012-02-15;;;2018-12-06;2012-02-23;2012-02-24;Estimate;;;;;;;2018-12-06;2018-12-10;Actual;December 2011;;2011-12-31;December 2018;2018-12-31;January 2015;Actual;2015-01-31;February 2013;Actual;2013-02-28;;Interventional;IGEL;;A Pilot Trial to Test the Feasibility of Prolonged Fasting and Ketogenic Diet in Relapsing-remitting Multiple Sclerosis;A Randomised Controlled Pilot Study to Compare the Effects of Prolonged Fasting and Ketogenic Low Glycemic Load Treatment on Health Related Quality of Life in Relapsing-remitting Multiple Sclerosis.;Completed;;N/A;48;Actual;Charite University, Berlin, Germany;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:41:49Z;2020-06-01T14:41:49Z;Berlin;3627213;Principal Investigator;Markus Bock, MD;Charité-Universitätsmedizin Berlin, Berlin Germany;Prolonged Fasting | Ketogenic low glycemic load treatment | Control diet;63664830;1;;;2012;2020-05-29;14;FALSE;;FALSE;TRUE;18;68;Years;Years;1;1;
NCT01538316;ClinicalTrials.gov processed this data on May 29, 2020;2012-02-20;;;2012-05-13;2012-02-20;2012-02-24;Estimate;;;;;;;2012-05-13;2012-05-15;Estimate;March 2012;;2012-03-31;May 2012;2012-05-31;April 2014;Anticipated;2014-04-30;March 2014;Anticipated;2014-03-31;;Interventional;QUERGEN;;Prostate Cancer Prevention Trial With Quercetin and Genistein;Clinical Trial on the Effectiveness of the Flavonoids Genistein and Quercetin in Men With Rising Prostate-specific Antigen;Unknown status;;N/A;60;Anticipated;University of Hohenheim;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:41:50Z;2020-06-01T14:41:50Z;Tübingen;3627220;Study Director;Arnulf Stenzl, MD, Prof.;Dept. of Urology, University Hospital Tübingen, Germany;Quercetin supplement | Genistein supplement | Placebo;63664833;2;;;2012;2020-05-29;;FALSE;;FALSE;FALSE;18;65;Years;Years;1;4;
NCT01534858;ClinicalTrials.gov processed this data on May 29, 2020;2012-02-10;;;2018-07-31;2012-02-14;2012-02-17;Estimate;;;;;;;2018-07-31;2018-08-02;Actual;March 2012;;2012-03-31;September 2015;2015-09-30;June 2015;Actual;2015-06-30;June 2015;Actual;2015-06-30;;Interventional;;;A Prospective, Descriptive Cohort Study With Prontosan® Wound Gel X in Partial and Full Thickness Burns Requiring Split Thickness Skin Grafts;A Prospective, Descriptive Cohort Study With Prontosan® Wound Gel X in Partial and Full Thickness Burns Requiring Split Thickness Skin Grafts;Completed;;N/A;51;Actual;B. Braun Ltd. Centre of Excellence Infection Control;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:42:43Z;2020-06-01T14:42:43Z;Bochum Leipzig;3627541;Principal Investigator;Adrien Daigeler, Prof.;Berufsgenossenschaftliches Unfallklinikum Bergmannsheil Bochum;Prontosan Wound Gel X;63665093;3;;;2012;2020-05-29;39;FALSE;;FALSE;FALSE;18;;Years;;4;3;
NCT01534702;ClinicalTrials.gov processed this data on May 29, 2020;2012-02-14;;;2012-02-17;2012-02-16;2012-02-17;Estimate;;;;;;;2012-02-17;2012-02-20;Estimate;January 2012;;2012-01-31;February 2012;2012-02-29;September 2015;Anticipated;2015-09-30;April 2013;Anticipated;2013-04-30;;Interventional;CIARA;;Dose Escalation of Clofarabine in Combination With Cytarabine and Idarubicin as Induction Therapy in High Risk AML;Phase I/II Study on Cytarabine and Idarubicin Combined With Escalating Doses of Clofarabine as Induction Therapy in Patients With Acute Myeloid Leukemia and High Risk for Induction Failure (AMLSG 17-10);Unknown status;;Phase 1/Phase 2;60;Anticipated;Hannover Medical School;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:42:44Z;2020-06-01T14:42:44Z;Hannover;3627555;Principal Investigator;Juergen Krauter, MD;Hannover Medical School;clofarabine, cytarabine, idarubicin;63665104;7;;;2012;2020-05-29;;FALSE;;FALSE;FALSE;18;;Years;;1;7;
NCT01534455;ClinicalTrials.gov processed this data on May 29, 2020;2012-02-08;;;2016-02-09;2012-02-13;2012-02-16;Estimate;;;;;;;2016-02-09;2016-02-10;Estimate;February 2012;;2012-02-29;February 2016;2016-02-29;March 2015;Actual;2015-03-31;March 2015;Actual;2015-03-31;;Interventional;;;Efficacy and Tolerability of Eribulin Plus Lapatinib in Patients With Metastatic Breast Cancer (E-VITA);A Randomized Phase II Study to Determine the Efficacy and Tolerability of Two Doses of Eribulin Plus Lapatinib in Trastuzumab Pre-treated Patients With HER2-positive Metastatic Breast Cancer (E-VITA);Terminated;;Phase 2;43;Actual;German Breast Group;;2;;very slow patient recruitment and concerns about the actuality of the study design;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:42:48Z;2020-06-01T14:42:48Z;Magdeburg;3627593;Principal Investigator;Joachim Bischoff, MD;University Women's Hospital Magdeburg;Lapatinib + 1,23 mg Eribulin | Lapatinib + 1,76 mg Eribulin;63665122;1;;;2012;2020-05-29;37;FALSE;;FALSE;TRUE;18;;Years;;3;4;
NCT01534364;ClinicalTrials.gov processed this data on May 29, 2020;2012-01-30;;;2019-08-08;2012-02-15;2012-02-16;Estimate;;;;;;;2019-08-08;2019-08-09;Actual;January 2012;;2012-01-31;August 2019;2019-08-31;February 2015;Actual;2015-02-28;February 2015;Actual;2015-02-28;;Interventional;CR_KCH;;Brief Title:Effect of a Preoperative Calorie Restriction on Renal Function After Cardiac Surgery;Effect of a Preoperative Calorie Restriction on Renal Function After Cardiac Surgery;Completed;;N/A;82;Actual;University of Cologne;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:42:49Z;2020-06-01T14:42:49Z;Köln;3627601;Principal Investigator;Volker Burst, MD;University of Cologne;calorie restriction;63665130;1;;;2012;2020-05-29;37;FALSE;;FALSE;TRUE;18;;Years;;1;15;
NCT01532453;ClinicalTrials.gov processed this data on May 29, 2020;2012-02-09;;;2015-12-03;2012-02-09;2012-02-14;Estimate;;;;;;;2015-12-03;2016-01-08;Estimate;November 2010;;2010-11-30;December 2015;2015-12-31;January 2014;Actual;2014-01-31;January 2014;Actual;2014-01-31;;Interventional;;;Prevention of UV-induced Carcinogenic Skin Alterations in Immunosuppressed Solid Organ Transplanted Patients;Open, Multicentre, Randomised, Comparative, Prospective Trial With MD-3511356 Versus Standard Sun Protection Measures in Immunosuppressed Solid Organ Transplanted Patients for Prevention of UV-induced Carcinogenic Skin Alterations;Terminated;;Phase 3;244;Actual;Spirig Pharma Ltd.;;2;;For futility reasons and potential loss of chance for MD 3511356 group;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:43:28Z;2020-06-01T14:43:28Z;Berlin;3627757;Principal Investigator;Claas Ulrich, MD;Klinikum der Charité Universitätsmedizin, Hauttumorzentrum Charité, D-10117 Berlin/Germany;MD-3511356 | Standard Sun Protection Measures;63665274;10;46;137;2012;2020-05-29;38;TRUE;17;FALSE;FALSE;40;;Years;;1;1;
NCT01530139;ClinicalTrials.gov processed this data on May 29, 2020;2012-02-01;;;2016-02-25;2012-02-08;2012-02-09;Estimate;;;;;;;2016-02-25;2016-02-26;Estimate;August 2012;;2012-08-31;February 2016;2016-02-29;December 2014;Actual;2014-12-31;August 2014;Actual;2014-08-31;;Interventional;Food4Me;;Strategies for Personalised Nutrition;Personalised Nutrition: An Integrative Analysis of Opportunities and Challenges;Completed;;N/A;1607;Actual;Newcastle University;;4;;;FALSE;;;;FALSE;;;;;;;;;;;Yes;Data will be available upon request from the Project leader Professor Mike Gibney and Professor John Mathers.;2020-06-01T14:44:04Z;2020-06-01T14:44:04Z;Munich;3627950;Principal Investigator;Hannelore Daniel, Professor;Technische Universitaet Muenchen, Germany;Level 1 | Level 2 | Level 3 | Level 0;63665449;8;;;2012;2020-05-29;24;FALSE;;FALSE;FALSE;18;;Years;;1;1;
NCT01525667;ClinicalTrials.gov processed this data on May 29, 2020;2012-01-31;;;2015-09-07;2012-02-02;2012-02-03;Estimate;;;;;;;2015-09-07;2015-09-21;Estimate;November 2012;;2012-11-30;January 2015;2015-01-31;June 2015;Actual;2015-06-30;December 2013;Actual;2013-12-31;;Interventional;;;Safety and Efficacy of IM Injections of PLX-PAD for the Regeneration of Injured Gluteal Musculature After Total Hip Arthroplasty;A Phase I/II, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Intramuscular Injections of Allogeneic PLX-PAD Cells for the Regeneration of Injured Gluteal Musculature After Total Hip Arthroplasty;Completed;;Phase 1/Phase 2;20;Actual;Pluristem Ltd.;;3;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:45:30Z;2020-06-01T14:45:30Z;Berlin;3628318;Principal Investigator;Carsten Perka, MD;Charité Universitätsmedizin Berlin, Dept. Of Orthopedic Surgery, Charitéplatz 1, 10117 Berlin, Germany;150M PLX-PAD | 300M PLX-PAD | Placebo;63665794;1;72;5;2012;2020-05-29;13;TRUE;12;FALSE;TRUE;50;75;Years;Years;1;4;
NCT01524679;ClinicalTrials.gov processed this data on May 29, 2020;2012-01-31;;;2020-02-05;2012-01-31;2012-02-02;Estimate;;;;;;;2020-02-05;2020-02-18;Actual;August 2012;;2012-08-31;February 2020;2020-02-29;August 28, 2017;Actual;2017-08-28;August 28, 2017;Actual;2017-08-28;;Interventional;PADD-ON;;Peg-interferon ADDed to an Ongoing Nucleos(t)Ide Based Treatment in Patients With Chronic Hepatitis B to Induce Decrease of HBs-Antigen;A Prospective, Randomised, Open-label Phase IIb Clinical Trial Assessing the Effect of Pegylated Interferon Alfa-2a (Pegasys®)180 μg Once Weekly for 48 Weeks in Addition to an Ongoing Nucelos(t)Ide Based Treatment on Quantitative HBsAg Levels in Patients With Chronic HBeAg-negative Hepatitis B;Completed;;Phase 2;170;Actual;Johannes Gutenberg University Mainz;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:46:06Z;2020-06-01T14:46:06Z;Mainz;3628399;Principal Investigator;Peter R. Galle, Univ.-Prof. Dr. med.;I. Medizinische Klinik und Poliklinik, Universitätsmedizin Mainz;Pegylated interferon alfa-2a plus nucleos(t)ide(s);63665866;24;536;40;2012;2020-05-29;60;TRUE;12;FALSE;FALSE;18;70;Years;Years;1;2;
NCT01523938;ClinicalTrials.gov processed this data on May 29, 2020;2012-01-30;;;2016-08-09;2012-01-30;2012-02-01;Estimate;;;;;;;2016-08-09;2016-08-10;Estimate;March 2012;;2012-03-31;August 2016;2016-08-31;July 2016;Actual;2016-07-31;April 2014;Actual;2014-04-30;;Interventional;HYPNOC;;Influence of Perioperative Hypnotherapy on Postoperative Improvement in Cognitive Performance;Influence of Perioperative Hypnotherapy on Postoperative Improvement in Cognitive Performance. A Randomized-controlled Open Clinical Monocentric Interventional Study.;Terminated;;N/A;72;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:46:17Z;2020-06-01T14:46:17Z;Berlin;3628458;Study Director;Claudia Spies, MD Prof.;Department of Anaesthesiology and Intensive Care Medicine, Campus Virchow-Klinikum (CVK) and Campus Charite Mitte (CCM), Charite - Universitätsmedizin Berlin;Hypnotherapy;63665921;1;;;2012;2020-05-29;25;FALSE;;FALSE;TRUE;18;;Years;;1;13;1
NCT01522612;ClinicalTrials.gov processed this data on May 29, 2020;2012-01-27;;;2016-06-09;2012-01-30;2012-01-31;Estimate;;;;;;;2016-06-09;2016-06-10;Estimate;April 2013;;2013-04-30;June 2016;2016-06-30;January 2015;Actual;2015-01-31;January 2015;Actual;2015-01-31;;Interventional;;;Colorectal Cancer (CRC) Cetuximab Elderly Frail;Treatment of Patients With KRAS Wild Type Advanced Colorectal Cancer (CRC) With 5-Fluorouracil (5-FU) or 5- FU Plus an Epidermal Growth Factor Receptor (EGFR) Inhibitor (Cetuximab) Based on a Comprehensive Geriatric Assessment (CGA).;Terminated;;Phase 2;5;Actual;European Organisation for Research and Treatment of Cancer - EORTC;;2;;poor accrual;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:46:40Z;2020-06-01T14:46:40Z;Jena;3628572;Study Chair;Ulrich Wedding, MD;UNIVERSITAETSKLINIKUM JENA, Jena, Germany;Cetuximab | 5-fluorouracil | leucovorin;63666024;3;;;2012;2020-05-29;21;FALSE;;FALSE;FALSE;70;;Years;;1;11;
NCT01522209;ClinicalTrials.gov processed this data on May 29, 2020;2012-01-03;;;2015-01-14;2012-01-27;2012-01-31;Estimate;;;;;;;2015-01-14;2015-01-15;Estimate;December 2011;;2011-12-31;January 2015;2015-01-31;January 2015;Actual;2015-01-31;December 2014;Actual;2014-12-31;;Interventional;CEIOUS-Liver;;Detection Rate of Liver Metastases With Contrast Enhanced Intraoperative Ultrasound Compared to Regular Imaging;Value of Contrast Enhanced Intraoperative Ultrasound Compared to Preoperative CEUS, CT and MRT in the Treatment of Colorectal Liver Metastases.;Completed;;N/A;59;Actual;Asklepios Kliniken Hamburg GmbH;;;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:46:48Z;2020-06-01T14:46:48Z;Hamburg;3628599;Principal Investigator;Gregor A Stavrou, Dr.med;Dpt. of General and Visceral Surgery, Asklepios Hospital Barmbek, Hamburg, Germany;Liver Surgery | Contrast Enhanced Ultrasound | CT Scan (standard) | Primovist MRI (3 Tesla);63666055;1;;;2012;2020-05-29;36;FALSE;;FALSE;TRUE;18;;Years;;1;3;
NCT01521715;ClinicalTrials.gov processed this data on May 29, 2020;2011-12-21;;;2017-08-22;2012-01-26;2012-01-31;Estimate;;;;;;;2017-08-22;2017-08-23;Actual;January 24, 2012;Actual;2012-01-24;August 2017;2017-08-31;July 31, 2017;Actual;2017-07-31;June 30, 2017;Actual;2017-06-30;;Interventional;FLIPPER;;First Line Pazopanib in Poor Risk Patients With Metastatic Renal Cell Carcinoma;A Single Arm Multicentre Study Evaluating Pazopanib in First-line Treatment of Poor-risk Patients With Locally Advanced or Metastatic Renal Cell Carcinoma;Completed;;Phase 4;44;Actual;iOMEDICO AG;;1;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T14:46:56Z;2020-06-01T14:46:56Z;Munich;3628635;Principal Investigator;Michael Staehler, PD MD;Ludwig-Maximilians-Universität München, Klinikum Grosshadern;Pazopanib;63666095;8;;;2011;2020-05-29;66;FALSE;;FALSE;FALSE;18;;Years;;1;5;
NCT01520103;ClinicalTrials.gov processed this data on May 29, 2020;2012-01-25;;;2017-08-08;2012-01-26;2012-01-27;Estimate;;;;;;;2017-08-08;2017-08-09;Actual;January 2012;Actual;2012-01-31;August 2017;2017-08-31;October 31, 2016;Actual;2016-10-31;October 31, 2016;Actual;2016-10-31;;Interventional;VicTORia;;Study to Compare Vinorelbine In Combination With the mTOR Inhibitor Everolimus vs. Vinorelbin Monotherapy for Second-line Treatment in Advanced Breast Cancer;Randomized Phase II Study to Compare Vinorelbine In Combination With the mTOR Inhibitor Everolimus vs. Vinorelbin Monotherapy for Second-line Treatment in Advanced Breast Cancer;Completed;;Phase 2;139;Actual;AIO-Studien-gGmbH;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:47:19Z;2020-06-01T14:47:19Z;Münster;3628783;Principal Investigator;Christian Lerchenmüller, Dr.;Hämatologisch-onkologische Gemeinschaftspraxis, Münster;Vinorebine, Everolimus | Vinorelbine;63666215;1;;;2012;2020-05-29;57;FALSE;;FALSE;TRUE;18;;Years;;1;4;
NCT01517776;ClinicalTrials.gov processed this data on May 29, 2020;2012-01-11;;;2015-06-26;2012-01-20;2012-01-25;Estimate;;;;;;;2015-06-26;2015-07-21;Estimate;January 2012;;2012-01-31;June 2015;2015-06-30;April 2014;Actual;2014-04-30;March 2014;Actual;2014-03-31;;Interventional;HGG-CilMetro;;Cilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and Adolescents;Cilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and Adolescents - A Phase II Study HIT-HGG-CilMetro - A Clinical Phase II Trial of the HIT-HGG Study Group -;Terminated;;Phase 2;28;Actual;Martin-Luther-Universität Halle-Wittenberg;;1;;due to an altered benefit/risk assessment.;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:47:56Z;2020-06-01T14:47:56Z;Halle;3628987;Study Chair;Christof M. Kramm, MD;University Children´s Hospital, Halle, Germany;Cilengitide | Temozolomide;63666392;1;;;2012;2020-05-29;26;FALSE;;FALSE;TRUE;3;17;Years;Years;1;3;
NCT01516827;ClinicalTrials.gov processed this data on May 29, 2020;2011-12-13;;;2017-10-25;2012-01-19;2012-01-25;Estimate;;;;;;;2017-10-25;2017-10-27;Actual;February 2012;;2012-02-29;October 2017;2017-10-31;June 2016;Actual;2016-06-30;June 2016;Actual;2016-06-30;;Interventional;TCT;;Effectiveness of Trauma-Focused Cognitive-Behavioral Therapy (TF-CBT) for Children With Post-traumatic Stress Disorder (TreatChildTrauma);Effectiveness of Trauma-Focused Cognitive-Behavioral Therapy (TF-CBT) for Children With Post-traumatic Stress Disorder;Completed;;N/A;159;Actual;University of Ulm;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:48:09Z;2020-06-01T14:48:09Z;Ulm;3629061;Principal Investigator;Lutz Goldbeck, Ph.D.;University Ulm;Trauma-Focused Cognitive Behavioral Therapy (TF-CBT);63666464;8;;;2011;2020-05-29;52;FALSE;;FALSE;FALSE;7;16;Years;Years;1;46;
NCT01515852;ClinicalTrials.gov processed this data on May 29, 2020;2012-01-23;;;2013-02-20;2012-01-23;2012-01-24;Estimate;;;;;;;2013-02-20;2013-02-21;Estimate;January 2012;;2012-01-31;February 2013;2013-02-28;January 2014;Anticipated;2014-01-31;January 2014;Anticipated;2014-01-31;;Interventional;GALAXY;;General Anesthesia vs. Local Anesthesia in Stereotaxy;General Anesthesia vs. Local Anesthesia in Stereotaxy;Unknown status;;N/A;80;Anticipated;Johann Wolfgang Goethe University Hospital;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:48:22Z;2020-06-01T14:48:22Z;Frankfurt;;;;;general anesthesia in stereotactic biopsy | local anesthesia in stereotactic biopsy;63666539;1;;;2012;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT01510080;ClinicalTrials.gov processed this data on May 29, 2020;2011-12-12;;;2015-01-19;2012-01-10;2012-01-13;Estimate;;;;;;;2015-01-19;2015-01-21;Estimate;January 2012;;2012-01-31;January 2015;2015-01-31;August 2014;Actual;2014-08-31;August 2014;Actual;2014-08-31;;Interventional;;;Acceptance and Efficacy of Live Supervision;Live Supervision Put to Test - Studies of Acceptance and Efficacy of Computer-assisted Live Supervision;Completed;;N/A;42;Actual;Goethe University;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:50:01Z;2020-06-01T14:50:01Z;Frankfurt;3629661;Principal Investigator;Florian Weck, PhD;Goethe University;Computer-assisted live supervision | Delayed video-based supervision;63666977;1;;;2011;2020-05-29;31;FALSE;;FALSE;TRUE;18;65;Years;Years;4;9;
NCT01508377;ClinicalTrials.gov processed this data on May 29, 2020;2011-12-22;;;2016-01-30;2012-01-11;2012-01-12;Estimate;;;;;;;2016-01-30;2016-02-02;Estimate;December 2011;;2011-12-31;January 2016;2016-01-31;December 2015;Actual;2015-12-31;December 2015;Actual;2015-12-31;;Interventional;;;Effects of an Internet-based Intervention for Posttraumatic Stress Disorder;Additive Effect of Cognitive Restructuring in a Web-based Treatment for Traumatized Arab People;Completed;;N/A;293;Actual;Berlin Center for the Treatment of Torture Victims;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:50:28Z;2020-06-01T14:50:28Z;Berlin;3629833;Study Chair;Christine Knaevelsrud, PhD;Freie Universität Berlin;Exposure for PTSD with cognitive restructuring | Exposure for PTSD without cognitive restructuring;63667103;1;;;2011;2020-05-29;48;FALSE;;FALSE;TRUE;18;;Years;;1;3;
NCT01504256;ClinicalTrials.gov processed this data on May 29, 2020;2012-01-03;;;2018-01-19;2012-01-04;2012-01-05;Estimate;;;;;;;2018-01-19;2018-01-23;Actual;October 2011;;2011-10-31;January 2018;2018-01-31;July 2017;Actual;2017-07-31;March 2017;Actual;2017-03-31;;Interventional;CatuNeo;;Catumaxomab for Treatment of Peritoneal Carcinomatosis in Patients With Gastric Adenocarcinomas;Explorative Trial to Investigate Catumaxomab (Anti-EpCAM x Anti-CD3) for Treatment of Peritoneal Carcinomatosis in Patients With Gastric Adenocarcinomas Prior to Gastrectomy;Completed;;Phase 2;42;Anticipated;AIO-Studien-gGmbH;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:51:32Z;2020-06-01T14:51:32Z;Leipzig;3630204;Principal Investigator;Florian Lordick, Prof. Dr.;Universitäres Krebszentrum Leipzig (UCCL), Universität Leipzig, Medizinische Fakultät;catumaxomab, Fluorouracil, leucovorin, oxaliplatin, docetaxel | Fluorouracil, leucovorin, oxaliplatin, docetaxel;63667423;1;;;2012;2020-05-29;65;FALSE;;FALSE;TRUE;18;;Years;;1;7;
NCT01503372;ClinicalTrials.gov processed this data on May 29, 2020;2011-12-22;;;2019-02-11;2012-01-01;2012-01-04;Estimate;;;;;;;2019-02-11;2019-02-12;Actual;November 2011;;2011-11-30;February 2019;2019-02-28;December 14, 2017;Actual;2017-12-14;December 14, 2017;Actual;2017-12-14;;Interventional;PaFLO;;FLO +/- Pazopanib as First-line Treatment in Advanced Gastric Cancer;"Pazopanib With 5-Fluorouracil, Leucovorin and Oxaliplatin (FLO) as 1st-line Treatment in Advanced Gastric Cancer; a Randomized Phase-II-study of the Arbeitsgemeinschaft Internistische Onkologie";Completed;;Phase 2;75;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:51:38Z;2020-06-01T14:51:38Z;Berlin;3630275;Study Chair;Peter Thuss-Patience, MD;Charite University medicine;Pazopanib | 5-FU, Oxaliplatin, Leukovorin (FLO);63667489;1;;;2011;2020-05-29;73;FALSE;;FALSE;TRUE;18;;Years;;1;9;
NCT01498835;ClinicalTrials.gov processed this data on May 29, 2020;2011-12-21;;;2017-08-25;2011-12-22;2011-12-23;Estimate;;;;;;;2017-08-25;2017-08-28;Actual;February 2012;;2012-02-29;August 2017;2017-08-31;February 2015;Actual;2015-02-28;November 2014;Actual;2014-11-30;;Interventional;SunRaSe;;Safety Study of Preoperative Sunitinib and Radiation in Soft Tissue Sarcoma;Phase 1 Trial of Concurrent Sunitinib and Radiation Therapy as Preoperative Treatment for Locally Advanced or Recurrent Soft Tissue Sarcoma.;Completed;;Phase 1;9;Actual;Heidelberg University;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:52:49Z;2020-06-01T14:52:49Z;Heidelberg;3630666;Principal Investigator;Peter Hohenberger, MD PhD;Heidelberg University;Sunitinib;63667835;2;;;2011;2020-05-29;33;FALSE;;FALSE;FALSE;18;;Years;;1;1;
NCT01495533;ClinicalTrials.gov processed this data on May 29, 2020;2011-12-13;;;2014-05-05;2011-12-15;2011-12-20;Estimate;;;;;;;2014-05-05;2014-05-06;Estimate;December 2011;;2011-12-31;May 2014;2014-05-31;July 2014;Anticipated;2014-07-31;December 2013;Actual;2013-12-31;;Interventional;;;Paclitaxel-coated or Uncoated AngioSculpt Scoring Balloon Catheter;Treatment of Coronary In-stent Restenosis by a Paclitaxel Coated AngioSculpt Scoring Balloon - a First-in-man Pilot Study;Unknown status;;Phase 3;60;Anticipated;University Hospital, Saarland;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:53:34Z;2020-06-01T14:53:34Z;Homburg;;;;;uncoated AngioSculpt(R) | Drug coated AngioSculpt(R);63668090;3;;;2011;2020-05-29;24;FALSE;;FALSE;FALSE;18;;Years;;1;2;
NCT01491152;ClinicalTrials.gov processed this data on May 29, 2020;2011-12-09;;;2014-03-06;2011-12-12;2011-12-13;Estimate;;;;;;;2014-03-06;2014-03-07;Estimate;January 2012;;2012-01-31;September 2013;2013-09-30;February 2014;Actual;2014-02-28;February 2014;Actual;2014-02-28;;Interventional;;;Pilot Study of Whole Body Vibration for Children With Cerebral Palsy (CP) From 12 Months of Age;Side-alternating Whole Body Vibration in Children With Cerebral Palsy (CP) From 12 Months of Age - Pilot Study;Completed;;N/A;24;Actual;University of Cologne;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:54:46Z;2020-06-01T14:54:46Z;Köln;3631267;Principal Investigator;Christina Stark, MSc.;Children's Hospital University of Cologne;Galileo® tilt table for children;63668421;1;;;2011;2020-05-29;25;FALSE;;FALSE;TRUE;12;24;Months;Months;1;4;
NCT01488955;ClinicalTrials.gov processed this data on May 29, 2020;2011-12-07;;;2014-08-07;2011-12-07;2011-12-08;Estimate;;;;;;;2014-08-07;2014-08-08;Estimate;February 2012;;2012-02-29;August 2014;2014-08-31;July 2014;Actual;2014-07-31;February 2014;Actual;2014-02-28;;Interventional;;;Immediate vs. Conditional Use of Antibiotics in Uncomplicated Urinary Tract Infection (UTI) - ICUTI;Immediate vs. Conditional Use of Antibiotics in Uncomplicated Urinary Tract Infection (UTI) - a Comparative Effectiveness Study in General Practice (ICUTI);Completed;;Phase 4;494;Actual;Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:55:22Z;2020-06-01T14:55:22Z;Göttingen;3631475;Principal Investigator;Eva Hummers-Pradier, Prof.;Abt. Allgemeinmedizin, Universitätsmedizin Göttingen, Humboldtallee 38, 37073 Göttingen;Ibuprofen | Fosfomycin-Trometamol;63668588;2;;;2011;2020-05-29;24;FALSE;;FALSE;FALSE;18;65;Years;Years;1;8;
NCT01486329;ClinicalTrials.gov processed this data on May 29, 2020;2011-12-02;;;2015-06-05;2011-12-05;2011-12-06;Estimate;;;;;;;2015-06-05;2015-06-08;Estimate;December 2011;;2011-12-31;June 2015;2015-06-30;December 2014;Actual;2014-12-31;October 2014;Actual;2014-10-31;;Interventional;;;VXM01 Phase I Dose Escalation Study in Patients With Locally Advanced, Inoperable and Stage IV Pancreatic Cancer;VXM01 Phase I Dose Escalation Study in Patients With Locally Advanced, Inoperable and Stage IV Pancreatic Cancer to Examine Safety, Tolerability, and Immune Response to the Investigational VEGFR-2 DNA Vaccine VXM01;Completed;;Phase 1;72;Actual;Vaximm GmbH;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:55:53Z;2020-06-01T14:55:53Z;Heidelberg;3631685;Principal Investigator;Thomas Schmidt, MD;University Clinics, Heidelberg;VXM01 | Placebo;63668791;1;;;2011;2020-05-29;34;FALSE;;FALSE;TRUE;18;;Years;;1;3;
NCT01484418;ClinicalTrials.gov processed this data on May 29, 2020;2011-11-28;;;2017-09-01;2011-12-01;2011-12-02;Estimate;;;;;;;2017-09-01;2017-09-05;Actual;August 2011;;2011-08-31;September 2017;2017-09-30;August 2017;Actual;2017-08-31;August 2015;Actual;2015-08-31;;Interventional;ETABP;;Exposure-based Treatment for Avoidant Back Pain Patients;Exposure Therapy in Chronic Low Back Pain Patients;Completed;;N/A;68;Actual;Philipps University Marburg Medical Center;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:56:20Z;2020-06-01T14:56:20Z;Marburg;3631846;Study Director;Winfried Rief, Prof.;Philipps University Marburg, Department of Clinical Psychology and Psychotherapy;Exposure in vivo | Cognitive Behavioural Psychotherapy;63668938;1;;;2011;2020-05-29;48;FALSE;;FALSE;TRUE;18;65;Years;Years;2;5;
NCT01483339;ClinicalTrials.gov processed this data on May 29, 2020;2011-11-16;;;2017-10-05;2011-11-30;2011-12-01;Estimate;;;;;;;2017-10-05;2017-10-06;Actual;November 2011;;2011-11-30;October 2017;2017-10-31;August 2017;Actual;2017-08-31;July 2017;Actual;2017-07-31;;Interventional;;;Metacognitive Therapy for Patients With Obsessive-Compulsive Disorder;Metacognitive Therapy Versus Exposition With Response Prevention for Patients With Obsessive-Compulsive Disorder;Completed;;N/A;37;Actual;Philipps University Marburg Medical Center;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:56:37Z;2020-06-01T14:56:37Z;Leipzig Marburg;3631927;Principal Investigator;Cornelia Exner, Prof. Dr.;University of Leipzig;Metacognitive Therapy | Exposure and Response Prevention;63669020;1;;;2011;2020-05-29;69;FALSE;;FALSE;TRUE;18;65;Years;Years;1;11;
NCT01480362;ClinicalTrials.gov processed this data on May 29, 2020;2011-11-23;;;2020-04-30;2011-11-25;2011-11-28;Estimate;;;;;;;2020-04-30;2020-05-05;Actual;November 2011;;2011-11-30;April 2020;2020-04-30;April 2015;Actual;2015-04-30;February 2015;Actual;2015-02-28;;Interventional;DiaFu;;Treatment Study of Negative Pressure Wound Therapy for Diabetic Foot Wounds;Randomized, Controlled Clinical Trial Evaluating the Efficacy and Clinical Effectiveness of Negative Pressure Wound Therapy for the Treatment of Diabetic Foot Wounds When Compared to Standard Wound Therapy;Completed;;N/A;360;Actual;University of Witten/Herdecke;;2;;;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T14:57:10Z;2020-06-01T14:57:10Z;Witten-Herdecke;3632216;Principal Investigator;Dörthe Seidel;Witten Herdecke University;Negative Pressure Wound Therapy | Standard Wound Therapy;63669249;42;;;2011;2020-05-29;39;FALSE;;FALSE;FALSE;18;;Years;;2;13;
NCT01480323;ClinicalTrials.gov processed this data on May 29, 2020;2011-11-23;;;2015-07-17;2011-11-25;2011-11-28;Estimate;;;;;;;2015-07-17;2015-07-21;Estimate;February 2012;;2012-02-29;July 2015;2015-07-31;June 2015;Actual;2015-06-30;September 2014;Actual;2014-09-30;;Interventional;;;A Phase II Study to Evaluate Safety and Efficacy of Combined Treatment With Ipilimumab and Intratumoral Interleukin-2;A Phase II Study to Evaluate Safety and Efficacy of Combined Treatment With Ipilimumab and Intratumoral Interleukin-2 in Pretreated Patients With Stage IV Melanoma;Completed;;Phase 2;15;Actual;University Hospital Tuebingen;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:57:11Z;2020-06-01T14:57:11Z;Tübingen;3632220;Principal Investigator;Benjamin Weide, Dr. med.;University Hospital Tübingen;Interleukin-2 | Ipilimumab;63669252;1;;;2011;2020-05-29;31;FALSE;;FALSE;TRUE;18;;Years;;1;10;
NCT01475669;ClinicalTrials.gov processed this data on May 29, 2020;2011-11-17;;;2014-09-17;2011-11-17;2011-11-21;Estimate;;;;;;;2014-09-17;2014-09-18;Estimate;January 2012;;2012-01-31;September 2014;2014-09-30;September 2014;Actual;2014-09-30;July 2014;Actual;2014-07-31;;Interventional;REPLACE;;Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery;REPLACE (Randomized Evaluation of Fibrinogen Versus Placebo in Complex Cardiovascular Surgery): a Prospective, Multinational, Multicenter, Randomized, Double-blind, Placebo-controlled, Phase III Study for the Use of Fibrinogen Concentrate (Human) (FCH) in Complex Cardiovascular Surgery;Completed;;Phase 3;152;Actual;CSL Behring;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:58:30Z;2020-06-01T14:58:30Z;Hannover;3632622;Principal Investigator;Niels Rahe-Meyer, MD, PhD;Hannover Medical School;Fibrinogen Concentrate (Human) (FCH) | Placebo;63669607;35;;;2011;2020-05-29;30;FALSE;;FALSE;FALSE;18;;Years;;1;22;
NCT01473966;ClinicalTrials.gov processed this data on May 29, 2020;2011-11-10;;;2011-11-14;2011-11-14;2011-11-17;Estimate;;;;;;;2011-11-14;2011-11-17;Estimate;November 2011;;2011-11-30;November 2011;2011-11-30;June 2014;Anticipated;2014-06-30;December 2013;Anticipated;2013-12-31;;Interventional;;;Coffee Against Obstipation in Intensive Care Treatment;Coffee Against Obstipation in Intensive Care Treatment;Unknown status;;N/A;120;Anticipated;University Hospital Heidelberg;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T14:59:08Z;2020-06-01T14:59:08Z;Heidelberg;3632756;Principal Investigator;Christoph Eisenbach;University of Heidelberg, Heidelberg, Germany;coffee | coffee rectally;63669740;1;;;2011;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;5;
NCT01472029;ClinicalTrials.gov processed this data on May 29, 2020;2011-10-24;;;2017-06-16;2011-11-11;2011-11-16;Estimate;;;;;;;2017-06-16;2017-06-19;Actual;December 2011;;2011-12-31;June 2017;2017-06-30;September 12, 2016;Actual;2016-09-12;August 25, 2014;Actual;2014-08-25;;Interventional;HerFLOT;;Explorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or Stomach;Multicenter, Explorative Phase II Study of Perioperative 5-FU, Leucovorin, Docetaxel, and Oxaliplatin (FLOT) in Combination With Trastuzumab in Patients With HER2-positive, Locally Advanced, Resectable Adenocarcinoma of the Gastroesophageal Junction or Stomach (HerFLOT);Completed;;Phase 2;53;Actual;AIO-Studien-gGmbH;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:59:43Z;2020-06-01T14:59:43Z;Mannheim;3632910;Principal Investigator;Ralf D Hofheinz, Prof. Dr.;Tagestherapiezentrum am ITM & III. Medizinische Klinik, Universitätsmedizin Mannheim, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim;5-FU, leucovorin, docetaxel, oxaliplatin (FLOT), trastuzumab | Post-operative treatment trastuzumab mono therapy;63669887;1;;;2011;2020-05-29;32;FALSE;;FALSE;TRUE;18;;Years;;1;3;
NCT01471782;ClinicalTrials.gov processed this data on May 29, 2020;2011-10-28;;;2016-12-16;2011-11-10;2011-11-16;Estimate;;;;;;;2016-12-16;2017-02-08;Estimate;January 2012;;2012-01-31;December 2016;2016-12-31;May 2016;Actual;2016-05-31;August 2014;Actual;2014-08-31;;Interventional;;;Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia;A Single-Arm Multicenter Phase II Study Preceded by Dose Evaluation to Investigate the Efficacy, Safety, and Tolerability of the BiTE® Antibody Blinatumomab (MT103) in Pediatric and Adolescent Patients With Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL);Completed;;Phase 1/Phase 2;93;Actual;Amgen Research (Munich) GmbH;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T14:59:45Z;2020-06-01T14:59:45Z;Berlin Munich;3632930;Study Chair;Arend von Stackelberg, MD;Charite University, Berlin, Germany;Blinatumomab;63669907;30;2178;342;2011;2020-05-29;31;TRUE;25;TRUE;FALSE;;17;;Years;2;8;
NCT01470677;ClinicalTrials.gov processed this data on May 29, 2020;2011-07-12;;;2016-01-19;2011-11-09;2011-11-11;Estimate;;;;;;;2016-01-19;2016-01-20;Estimate;November 2011;;2011-11-30;January 2016;2016-01-31;January 2016;Actual;2016-01-31;January 2016;Actual;2016-01-31;;Interventional;;;Tachosil for the Prevention of Symptomatic Lymph Cysts;A Collagen-Fibrin Patch (Tachosil®) for the Prevention of Symptomatic Lymphoceles After Pelvic Lymphadenectomy in Women With Gynecologic Malignancies: a Randomized Clinical Trial;Completed;;Phase 3;220;Actual;Ruhr University of Bochum;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:00:02Z;2020-06-01T15:00:02Z;Bochum;3633066;Principal Investigator;Clemens Tempfer, MD;Ruhr University Bochum, Germany;Tachosil fibrin patch;63669989;2;;;2011;2020-05-29;50;FALSE;;FALSE;FALSE;18;70;Years;Years;1;1;
NCT01468766;ClinicalTrials.gov processed this data on May 29, 2020;2011-10-11;;;2016-04-18;2011-11-07;2011-11-09;Estimate;;;;;;;2016-04-18;2016-04-19;Estimate;February 2011;;2011-02-28;April 2016;2016-04-30;July 2014;Actual;2014-07-31;July 2013;Actual;2013-07-31;;Interventional;BEST;;Effects of a Supervised Progressive Resistance Training With Breast Cancer Patients During Adjuvant Radiotherapy;Effects of a Supervised Progressive Resistance Training With Breast Cancer Patients During Adjuvant Radiotherapy - A Randomised Controlled Intervention Trial;Completed;;N/A;160;Actual;German Cancer Research Center;;2;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T15:00:37Z;2020-06-01T15:00:37Z;Heidelberg;3633214;Principal Investigator;Karin Potthoff, Dr.;University Hospital Heidelberg;Supervised progressive resistance training | Supervised progressive muscle relaxation training (Jacobson method);63670138;1;;;2011;2020-05-29;29;FALSE;;FALSE;TRUE;18;;Years;;1;11;
NCT01466465;ClinicalTrials.gov processed this data on May 29, 2020;2011-11-01;;;2015-06-24;2011-11-07;2011-11-08;Estimate;;;;;;;2015-06-24;2015-06-25;Estimate;October 2011;;2011-10-31;June 2015;2015-06-30;January 2015;Actual;2015-01-31;January 2015;Actual;2015-01-31;;Interventional;;;Vitamin D and Grass Pollen Specific Immunotherapy;;Completed;;Phase 2;35;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:01:24Z;2020-06-01T15:01:24Z;Berlin;3633453;Principal Investigator;Worm Margitta, MD, Prof.;Charite University, Berlin, Germany;Cholecalciferol | middle-chain fatty acids (carrier);63670312;1;;;2011;2020-05-29;39;FALSE;;FALSE;TRUE;18;55;Years;Years;1;;
NCT01466179;ClinicalTrials.gov processed this data on May 29, 2020;2011-10-28;;;2017-07-18;2011-11-04;2011-11-06;Estimate;;;;;;;2017-07-18;2017-08-18;Actual;December 2011;;2011-12-31;July 2017;2017-07-31;January 2017;Actual;2017-01-31;October 2013;Actual;2013-10-31;;Interventional;;;Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL);An Open Label, Multicenter, Phase II Study to Evaluate Efficacy and Safety of the BiTE® Antibody Blinatumomab in Adult Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL);Completed;;Phase 2;225;Actual;Amgen Research (Munich) GmbH;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:01:28Z;2020-06-01T15:01:28Z;Frankfurt Munich Würzburg;3633482;Principal Investigator;Nicola Gökbuget, MD;Klinikum der Goethe Universität Frankfurt;Blinatumomab;63670339;39;1488;412;2011;2020-05-29;22;TRUE;13;TRUE;FALSE;18;;Years;;1;14;
NCT01465594;ClinicalTrials.gov processed this data on May 29, 2020;2011-11-02;;;2015-05-19;2011-11-04;2011-11-06;Estimate;;;;;;;2015-05-19;2015-05-20;Estimate;November 2011;;2011-11-30;May 2015;2015-05-31;April 2015;Actual;2015-04-30;April 2015;Actual;2015-04-30;;Interventional;;;Study Comparing Urinary Diversion (Transurethral/Suprapubic) After Radical Prostatectomy;Randomized Study Comparing Urinary Diversion by Suprapubic Catheter With Transurethral Catheter in Patients After Radical Prostatectomy;Completed;;N/A;106;Actual;Heinrich-Heine University, Duesseldorf;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:01:39Z;2020-06-01T15:01:39Z;Düsseldorf;3633521;Principal Investigator;Christian Arsov, Dr;Heinrich Heine Universität;transurethral catheter after EERPE/ RALP | suprapubic catheter after EERPE /RALP;63670377;1;;;2011;2020-05-29;41;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT01462994;ClinicalTrials.gov processed this data on May 29, 2020;2011-10-25;;;2016-03-16;2011-10-27;2011-11-01;Estimate;;;;;;;2016-03-16;2016-03-17;Estimate;November 2011;;2011-11-30;March 2016;2016-03-31;March 2016;Actual;2016-03-31;December 2015;Actual;2015-12-31;;Interventional;;;Detection of CF-DNA in Patients With Gastrointestinal Stromal Tumors (GIST);Prospective, Explorative Trial for the Detection of Circulating Cell-free Tumor DNA in the Plasma of Patients With Gastrointestinal Stromal Tumors (GIST)Harboring Activating Mutations of CKIT or PDGFRA Pre/Post Surgery or Pre/Under Treatment With a Tyrosine Kinase Inhibitor or Progressive Disease Irrespective of Current or Planned Treatment. An Open-label, Non-randomized, Multicenter Phase IIIb Clinical Trial;Completed;;Phase 3;25;Actual;Technische Universität München;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:02:22Z;2020-06-01T15:02:22Z;Munich;;;;;Blood will be withdrawn at baseline and in intervals of 3 months for a total period of 2 years;63670578;1;;;2011;2020-05-29;49;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT01462838;ClinicalTrials.gov processed this data on May 29, 2020;2011-10-25;;;2015-06-22;2011-10-27;2011-10-31;Estimate;;;;;;;2015-06-22;2015-06-23;Estimate;August 2011;;2011-08-31;June 2015;2015-06-30;May 2015;Actual;2015-05-31;January 2015;Actual;2015-01-31;;Interventional;;;Immune Therapy of HPV-induced Cancers;Phase I/IIa Study of Immunization With a p16INK4a Peptide Combined With MONTANIDE ISA-51 VG in Patients With Advanced HPV-associated Cancers;Completed;;Phase 1/Phase 2;26;Actual;Oryx GmbH & Co. KG;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:02:27Z;2020-06-01T15:02:27Z;Frankfurt;3633776;Principal Investigator;Elke Jäger, Prof. Dr.;Krankenhaus Nordwest Frankfurt;P16_37-63;63670590;1;;;2011;2020-05-29;41;FALSE;;FALSE;TRUE;18;;Years;;1;2;
NCT01461148;ClinicalTrials.gov processed this data on May 29, 2020;2011-10-25;;;2015-06-22;2011-10-26;2011-10-27;Estimate;;;;;;;2015-06-22;2015-06-23;Estimate;August 2011;;2011-08-31;June 2015;2015-06-30;May 2015;Actual;2015-05-31;March 2015;Actual;2015-03-31;;Interventional;;;Vaccination Against MSI Colorectal Cancer;Phase I/IIa Study of Immunization With Frameshift Peptides Administered With Montanide® ISA-51 VG in Patients With Advanced MSI-H Colorectal Cancer;Completed;;Phase 1/Phase 2;22;Actual;Oryx GmbH & Co. KG;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:03:02Z;2020-06-01T15:03:02Z;Frankfurt;3633951;Principal Investigator;Elke Jäger, Prof. Dr.;Krankenhaus Nordwest Frankfurt;FSP peptides;63670720;1;;;2011;2020-05-29;43;FALSE;;FALSE;TRUE;18;;Years;;1;2;
NCT01456702;ClinicalTrials.gov processed this data on May 29, 2020;2011-09-29;;;2013-12-30;2011-10-20;2011-10-21;Estimate;;;;;;;2013-12-30;2013-12-31;Estimate;October 2014;;2014-10-31;December 2013;2013-12-31;March 2016;Anticipated;2016-03-31;December 2015;Anticipated;2015-12-31;;Interventional;;;Risk Stratification and Goal-directed Volume Therapy;Influence of Pre-operative Risk Stratefiction and Intraoperaitve Monitoring on Perioperative Volume Therapy and Postoperative Outcome;Unknown status;;N/A;300;Anticipated;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:04:14Z;2020-06-01T15:04:14Z;Berlin;3634353;Principal Investigator;Michael Sander, MD;Dept. of Anesthesiology CCM/CVK Charité Universitätsmedizin Berlin;risk stratification group;63671057;1;;;2011;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;4;
NCT01456364;ClinicalTrials.gov processed this data on May 29, 2020;2011-10-18;;;2013-10-31;2011-10-18;2011-10-20;Estimate;;;;;;;2013-10-31;2013-11-01;Estimate;September 2011;;2011-09-30;October 2013;2013-10-31;May 2014;Anticipated;2014-05-31;April 2014;Anticipated;2014-04-30;;Interventional;ISAR ADAPT PF;;Intracoronary Stenting and Antithrombotic Regimen: ADjusting Antiplatelet Treatment in PatienTs Based on Platelet Function Testing;Prospective, Randomized Study of the Platelet Inhibitory Efficacy of Ticagrelor Versus Prasugrel in Clopidogrel Low Responders After Percutaneous Coronary Intervention;Unknown status;;Phase 4;70;Anticipated;Deutsches Herzzentrum Muenchen;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:04:17Z;2020-06-01T15:04:17Z;Munich;3634378;Principal Investigator;Katharina Mayer, MD;Deutsches Herzzentrum München;Ticagrelor | Prasugrel;63671081;3;;;2011;2020-05-29;;FALSE;;FALSE;FALSE;18;80;Years;Years;1;2;
NCT01455675;ClinicalTrials.gov processed this data on May 29, 2020;2011-10-18;;;2017-07-03;2011-10-19;2011-10-20;Estimate;;;;;;;2017-07-03;2017-07-06;Actual;October 2011;;2011-10-31;July 2017;2017-07-31;June 27, 2017;Actual;2017-06-27;June 27, 2017;Actual;2017-06-27;;Interventional;PsAer-IgY;;Efficacy Study of IgY (Antibody Against Pseudomonas) in Cystic Fibrosis Patients;Phase III Study to Evaluate Clinical Efficacy and Safety of Avian Polyclonal Anti-Pseudomonas Antibodies (IgY) in Prevention of Recurrence of Pseudomonas Aeruginosa Infection in Cystic Fibrosis Patients;Completed;;Phase 3;164;Actual;Mukoviszidose Institut gGmbH;;2;;;FALSE;;;;TRUE;;;;;;;;;;;Undecided;;2020-06-01T15:04:34Z;2020-06-01T15:04:34Z;Düsseldorf;3634433;Principal Investigator;Antje Schuster, Prof. Dr.;Universitätsklinikum Düsseldorf;IgY | Placebo;63671134;42;;;2011;2020-05-29;68;FALSE;;FALSE;FALSE;5;;Years;;1;8;
NCT01453179;ClinicalTrials.gov processed this data on May 29, 2020;2011-09-30;;;2017-04-13;2011-10-12;2011-10-17;Estimate;;;;;;;2017-04-13;2017-04-14;Actual;October 2011;;2011-10-31;April 2015;2015-04-30;March 2015;Actual;2015-03-31;March 2015;Actual;2015-03-31;;Interventional;LEIDA 2;;Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2);Long-term Effects of Aldara® 5% Cream and Solaraze® 3% Gel in the Treatment of Actinic Keratoses on the Face or Scalp With Respect to the Risk of Progression to In-situ and Invasive Squamous Cell Carcinoma;Completed;;Phase 4;221;Actual;MEDA Pharma GmbH & Co. KG;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:05:26Z;2020-06-01T15:05:26Z;Magdeburg;3634665;Principal Investigator;Harald Gollnick, Prof. Dr.;Otto-von-Guericke-University of Magdeburg;Imiquimod | Diclofenac;63671325;17;;;2011;2020-05-29;41;FALSE;;FALSE;FALSE;18;;Years;;1;4;
NCT01450124;ClinicalTrials.gov processed this data on May 29, 2020;2011-09-18;;;2020-02-22;2011-10-07;2011-10-12;Estimate;;;;;;;2020-02-22;2020-02-25;Actual;September 2011;;2011-09-30;February 2020;2020-02-29;December 2014;Actual;2014-12-31;December 2014;Actual;2014-12-31;;Interventional;SABA;;Safety, Tolerability And Mechanism Of Action Of Boswellic Acids (BA) In Multiple Sclerosis (SABA);Safety, Tolerability And Mechanism Of Action Of Boswellic Acids In Multiple Sclerosis and Clinically Isolated Syndrome: A MRI-Controlled, Multicenter, Baseline-To-Treatment, 32-Weeks, Open-Label, Phase IIa Trial;Completed;;Phase 2;29;Actual;Universitätsklinikum Hamburg-Eppendorf;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:06:11Z;2020-06-01T15:06:11Z;Hamburg;3634923;Principal Investigator;Christoph Heesen, MD;Universitätsklinikum Hamburg-Eppendorf;Boswellic acids (BOSWELAN);63671563;2;;;2011;2020-05-29;39;FALSE;;FALSE;FALSE;18;65;Years;Years;1;2;
NCT01448798;ClinicalTrials.gov processed this data on May 29, 2020;2011-10-06;;;2011-10-06;2011-10-06;2011-10-07;Estimate;;;;;;;2011-10-06;2011-10-07;Estimate;October 2011;;2011-10-31;October 2011;2011-10-31;January 2014;Anticipated;2014-01-31;January 2013;Anticipated;2013-01-31;;Interventional;AnPro;;Athermal Nerve-sparing During Robotic-assisted Radical Prostatectomy Using a Hemostatic Matrix.;Prospective Randomized Investigation of Athermal Nerve-sparing During Robotic-assisted Laparoscopic Prostatectomy Using a Hemostatic Gelatin-thrombin Matrix;Unknown status;;N/A;50;Anticipated;Johann Wolfgang Goethe University Hospital;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:06:46Z;2020-06-01T15:06:46Z;Frankfurt;3635017;Principal Investigator;Axel Haferkamp, Prof.;Johann Wolfgang Goethe University Hospitals, Germany;Application of a hemostatic gelatin-thrombin matrix | Use of mono- and bipolar electrocautery and surgical clips;63671663;1;;;2011;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;3;
NCT01448213;ClinicalTrials.gov processed this data on May 29, 2020;2011-10-04;;;2014-08-22;2011-10-05;2011-10-07;Estimate;;;;;;;2014-08-22;2014-09-03;Estimate;October 2011;;2011-10-31;August 2014;2014-08-31;January 2014;Actual;2014-01-31;January 2014;Actual;2014-01-31;;Interventional;;;Comparison of Two Steroid Regimens to Prevent Transplant Rejection After Corneal Transplant (DMEK);Comparison Of Two Corticosteroid Dosing Regimens For Prevention Of Corneal Transplant Rejection Episodes After Descemet's Membrane Endothelial Keratoplasty;Completed;;Phase 2;264;Actual;Price Vision Group;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:06:51Z;2020-06-01T15:06:51Z;Erlangen;3635067;Principal Investigator;Friedrich Kruse, MD;University of Erlangen, Germany;Prednisolone acetate | Fluorometholone;63671709;2;26;0;2011;2020-05-29;27;TRUE;6;TRUE;FALSE;18;;Years;;1;1;
NCT01445808;ClinicalTrials.gov processed this data on May 29, 2020;2011-09-30;;;2016-02-25;2011-09-30;2011-10-04;Estimate;;;;;;;2016-02-25;2016-02-26;Estimate;October 2011;;2011-10-31;February 2016;2016-02-29;February 2015;Actual;2015-02-28;December 2014;Actual;2014-12-31;;Interventional;PMT;;Psychodynamic Motivation and Training Program;Psychodynamic Motivation and Training Program (PMT) as Secondary Prevention in Patients With Stable Coronary Heart Disease;Completed;;N/A;90;Actual;Johannes Gutenberg University Mainz;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:07:28Z;2020-06-01T15:07:28Z;Mainz;3635267;Principal Investigator;Matthias Michal, PD Dr. med.;University Medical Center Mainz, Department of Psychosomatic Medicine and Psychotherapy;Psychodynamic Motivation and Training Program (PMT) | Advice in Exercise Training (+Ex) | Treatment as usual (TAU);63671890;1;;;2011;2020-05-29;38;FALSE;;FALSE;TRUE;18;75;Years;Years;1;10;
NCT01445171;ClinicalTrials.gov processed this data on May 29, 2020;2011-08-05;;;2020-02-06;2011-09-30;2011-10-03;Estimate;;;;;;;2020-02-06;2020-02-17;Actual;January 2010;;2010-01-31;February 2020;2020-02-29;December 2017;Actual;2017-12-31;December 2017;Actual;2017-12-31;;Interventional;TRITON;;Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve;Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve;Completed;;N/A;295;Actual;Edwards Lifesciences;;1;;;FALSE;;;;TRUE;FALSE;TRUE;;;TRUE;;;;;;;;2020-06-01T15:07:37Z;2020-06-01T15:07:37Z;Hannover;3635308;Study Director;Prof Axel Haverich;MHH Hannover;Aortic Valve Replacement with EDWARDS INTUITY Valve System;63671931;6;579;968;2011;2020-05-29;96;TRUE;24;FALSE;FALSE;18;;Years;;2;;15
NCT01443260;ClinicalTrials.gov processed this data on May 29, 2020;2011-09-20;;;2015-03-09;2011-09-27;2011-09-29;Estimate;;;;;;;2015-03-09;2015-03-10;Estimate;February 2012;;2012-02-29;March 2014;2014-03-31;September 2014;Actual;2014-09-30;September 2014;Actual;2014-09-30;;Interventional;;;A Study of GL-ONC1, an Oncolytic Vaccinia Virus, in Patients With Advanced Peritoneal Carcinomatosis;Phase I/II Study of Intraperitoneal Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Peritoneal Carcinomatosis;Completed;;Phase 1/Phase 2;9;Actual;Genelux Corporation;;;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:08:06Z;2020-06-01T15:08:06Z;Tübingen;3635451;Principal Investigator;Ulrich M. Lauer, Prof. Dr. med.;University Hospital Tuebingen;GL-ONC1;63672072;1;;;2011;2020-05-29;31;FALSE;;FALSE;TRUE;18;;Years;;1;2;
NCT01442610;ClinicalTrials.gov processed this data on May 29, 2020;2011-09-23;;;2016-01-20;2011-09-27;2011-09-28;Estimate;;;;;;;2016-01-20;2016-01-21;Estimate;October 2011;;2011-10-31;January 2016;2016-01-31;September 2015;Actual;2015-09-30;March 2015;Actual;2015-03-31;;Interventional;RaSPar;;Effects of Rasagiline on Sleep Disturbances in Parkinson's Disease;Effects of Rasagiline on Sleep Disturbances in PD: A Single Center, Randomized, Double-blind, Placebo run-in, Polysomnographic Clinical Phase IV Trial;Completed;;Phase 4;30;Actual;Technische Universität Dresden;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:08:18Z;2020-06-01T15:08:18Z;Dresden;3635573;Principal Investigator;Alexander Storch, MD;Dresden University of Technology, Dept. of Neurology;Rasagiline | Placebo;63672122;1;;;2011;2020-05-29;41;FALSE;;FALSE;TRUE;50;85;Years;Years;2;3;
NCT01440062;ClinicalTrials.gov processed this data on May 29, 2020;2011-09-19;;;2020-04-14;2011-09-23;2011-09-26;Estimate;;;;;;;2020-04-14;2020-04-15;Actual;December 2011;;2011-12-31;April 2020;2020-04-30;June 2017;Actual;2017-06-30;June 2017;Actual;2017-06-30;;Interventional;;;Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS);Phase II Study of Efficacy of Vitamin D Supplementation in Multiple Sclerosis;Terminated;;Phase 2;55;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:09:00Z;2020-06-01T15:09:00Z;Berlin;3635791;Study Director;Jan-Markus Dörr, Dr.;Charite;Verum arm receiving Vitamin D oil | low dose arm receiving neutral oil and 400 IU/g of Vitamin D every second day;63672317;6;;;2011;2020-05-29;66;FALSE;;FALSE;FALSE;18;65;Years;Years;1;1;
NCT01439958;ClinicalTrials.gov processed this data on May 29, 2020;2011-09-22;;;2015-04-13;2011-09-22;2011-09-23;Estimate;;;;;;;2015-04-13;2015-04-14;Estimate;February 2012;;2012-02-29;April 2015;2015-04-30;December 2014;Actual;2014-12-31;July 2013;Actual;2013-07-31;;Interventional;;;Long-term Safety Follow-up Study in the Prevention of Bronchiolitis Obliterans Syndrome (BOS);A Long-term Safety Follow-up Study of L-CsA Therapy for Patients Who Participated in Study 12011.201 and Volunteered to Continue or to Cross-over to L-CsA Inhalation Therapy;Terminated;;Phase 3;14;Actual;Pari Pharma GmbH;;1;;Core study 12011.201 was terminated.;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:09:03Z;2020-06-01T15:09:03Z;Munich;3635799;Principal Investigator;Claus Neurohr, MD;Ludwig-Maximilians - University of Munich;Inhalation;63672325;1;;;2011;2020-05-29;17;FALSE;;FALSE;TRUE;18;80;Years;Years;1;1;
NCT01435057;ClinicalTrials.gov processed this data on May 29, 2020;2011-05-11;;;2015-05-27;2011-09-14;2011-09-15;Estimate;;;;;;;2015-05-27;2015-05-28;Estimate;April 2011;;2011-04-30;May 2015;2015-05-31;April 2016;Anticipated;2016-04-30;January 2016;Anticipated;2016-01-31;;Interventional;;;Effects of Different Exercise Training Regimens on Visceral Fat Dynamic and Resting Energy Expenditure in Obese Patients;Monocentric, Randomized, Controlled Study for Reduction on Visceral Fat Dynamic and Resting Energy Expenditure in Obese Patients Via Strength Versus Endurance Training (STEN Study - STrength Versus ENdurance Training);Unknown status;;N/A;200;Anticipated;University of Leipzig;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:10:28Z;2020-06-01T15:10:28Z;Leipzig;3636229;Principal Investigator;Matthias Blüher, prof., MD;University of Leipzig;exercise training;63672701;1;;;2011;2020-05-29;;FALSE;;FALSE;TRUE;18;60;Years;Years;1;8;
NCT01434589;ClinicalTrials.gov processed this data on May 29, 2020;2011-09-08;;;2017-10-10;2011-09-14;2011-09-15;Estimate;;;;;;;2017-10-10;2017-10-11;Actual;January 2012;;2012-01-31;October 2017;2017-10-31;August 2017;Actual;2017-08-31;June 2017;Actual;2017-06-30;;Interventional;STICA;;Effects of a Manualized Short-term Treatment of Internet and Computer Game Addiction;Effects of a Manualized Short-term Treatment of Internet and Computer Game Addiction;Completed;;N/A;187;Actual;Johannes Gutenberg University Mainz;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:10:39Z;2020-06-01T15:10:39Z;Mainz;3636265;Principal Investigator;M. E. Beutel, Prof. Dr.;University Medical Center Mainz, Department of Psychosomatic Medicine and Psychotherapy;STICA Intervention;63672736;4;;;2011;2020-05-29;65;FALSE;;FALSE;FALSE;17;55;Years;Years;1;6;
NCT01433523;ClinicalTrials.gov processed this data on May 29, 2020;2011-08-26;;;2017-01-27;2011-09-13;2011-09-14;Estimate;;;;;;;2017-01-27;2017-01-30;Estimate;August 2011;;2011-08-31;January 2017;2017-01-31;February 2014;Actual;2014-02-28;April 2013;Actual;2013-04-30;;Interventional;MITRA;;House Dust Mite Treatment of Asthma. The MITRA Trial House Dust Mite Treatment of Asthma;Efficacy of ALK House Dust Mite Allergy Immunotherapy Tablet in Subjects With House Dust Mite Induced Asthma. The MITRA Trial;Completed;;Phase 3;834;Actual;ALK-Abelló A/S;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:10:49Z;2020-06-01T15:10:49Z;Rostock;3636354;Principal Investigator;Christian Virchow, Prof.Dr.med.;Dept. fof Pneumology, University Clinic Rostock, Ernst-Heydemann-Str. 6, 18057 Rostock, Germany;ALK HDM AIT Placebo | ALK HDM AIT 6 DU | ALK HDM AIT 12 DU;63672815;1;;;2011;2020-05-29;20;FALSE;;FALSE;TRUE;18;;Years;;1;6;
NCT01431222;ClinicalTrials.gov processed this data on May 29, 2020;2011-09-07;;;2011-09-08;2011-09-08;2011-09-09;Estimate;;;;;;;2011-09-08;2011-09-09;Estimate;September 2011;;2011-09-30;September 2011;2011-09-30;September 2014;Anticipated;2014-09-30;September 2013;Anticipated;2013-09-30;;Interventional;ISAR-CLIP;;Abrogation of Mitral Regurgitation Using the MitraClip System in High-Risk Patients Unsuitable for Surgery;Interventional Strategy to Abrogate Mitral Regurgitation Using the MitraClip System in High-Risk Patients Considered Unsuitable for Surgery (ISAR-CLIP);Unknown status;;Phase 4;100;Anticipated;Deutsches Herzzentrum Muenchen;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:11:33Z;2020-06-01T15:11:33Z;Munich;3636539;Study Chair;Joerg Hausleiter, MD;Deutsches Herzzentrum Muenchen;percutaneous treatment by implanting a Mitra Clip device;63672990;1;;;2011;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT01427686;ClinicalTrials.gov processed this data on May 29, 2020;2011-08-31;;;2016-04-05;2011-08-31;2011-09-01;Estimate;;;;;;;2016-04-05;2016-04-06;Estimate;June 2011;;2011-06-30;April 2016;2016-04-30;December 2016;Anticipated;2016-12-31;February 2015;Actual;2015-02-28;;Interventional;;;Dopamine Versus Dobutamine for Treatment of Arterial Hypotension in Term and Preterm Neonates;Effect of Dobutamine as Compared to Dopamine on Cerebral Oxygenation, Mean Arterial Pressure and Cerebral Hemodynamics in Term and Preterm Neonates With Arterial Hypotension;Unknown status;;Phase 4;20;Anticipated;University of Ulm;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:12:17Z;2020-06-01T15:12:17Z;Ulm;3636839;Principal Investigator;Manuel B Schmid, Dr. med.;University of Ulm;Dobutamine | Dopamine;63673256;1;;;2011;2020-05-29;44;FALSE;;FALSE;TRUE;;44;;Weeks;1;2;
NCT01426633;ClinicalTrials.gov processed this data on May 29, 2020;2011-08-29;;;2014-12-15;2011-08-30;2011-08-31;Estimate;;;;;;;2014-12-15;2014-12-16;Estimate;November 2011;;2011-11-30;December 2014;2014-12-31;December 2014;Actual;2014-12-31;December 2014;Actual;2014-12-31;;Interventional;;;Combination Therapy of Gemcitabine and Trabectedin in L-sarcomas;Phase I Dose Escalating Trial Evaluating the Combination of Gemcitabine and Trabectedin in Patients With Advanced and/or Metastatic Leiomyosarcoma or Liposarcoma;Completed;;Phase 1;5;Actual;Heidelberg University;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:12:33Z;2020-06-01T15:12:33Z;Heidelberg Mannheim;3636921;Principal Investigator;Bernd Kasper, MD, PhD;University of Heidelberg, Mannheim University Medical Center;Gemcitabine + Trabectedin;63673337;1;;;2011;2020-05-29;37;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT01425957;ClinicalTrials.gov processed this data on May 29, 2020;2011-08-26;;;2015-10-30;2011-08-29;2011-08-30;Estimate;;;;;;;2015-10-30;2015-11-02;Estimate;December 2011;;2011-12-31;October 2015;2015-10-31;October 2015;Actual;2015-10-31;August 2015;Actual;2015-08-31;;Interventional;;;Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment;Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment: a Two-part Clinical Study. PartA: Multisite MRI Acquisition, Protocol Harmonization. PartB: Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment: a Clinical Study;Completed;;N/A;229;Actual;Qualissima;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:12:45Z;2020-06-01T15:12:45Z;Duisburg Leipzig;3636976;Principal Investigator;Peter Schönknecht, MD;Universitätsklinikum Leipzig, Department of Psychiatry and Nuclear Medicine, Leipzig, Germany;Lumbar puncture;63673389;13;;;2011;2020-05-29;44;FALSE;;FALSE;FALSE;50;90;Years;Years;2;7;
NCT01423747;ClinicalTrials.gov processed this data on May 29, 2020;2011-08-25;;;2015-06-25;2011-08-25;2011-08-26;Estimate;;;;;;;2015-06-25;2015-06-26;Estimate;July 2003;;2003-07-31;June 2015;2015-06-30;September 2016;Anticipated;2016-09-30;September 2011;Actual;2011-09-30;;Interventional;;;Allogeneic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia;Allogeneic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia;Unknown status;;Phase 3;400;Anticipated;St. Anna Kinderkrebsforschung;;3;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:13:25Z;2020-06-01T15:13:25Z;Berlin Kiel;3637149;Study Chair;Arend v. Stackelberg, MD, PhD;ALL-REZ BFM Study Center Berlin Germany;VP16 | TBI | VP16, ATG | TBI | Fludarabine, OKT3, Treosulfan, Thiotepa | VP16, ATG | TBI;63673559;24;;;2011;2020-05-29;99;FALSE;;FALSE;FALSE;3;18;Months;Years;1;5;
NCT01422499;ClinicalTrials.gov processed this data on May 29, 2020;2011-08-03;;;2018-04-10;2011-08-23;2011-08-24;Estimate;;;;;;;2018-04-10;2018-04-11;Actual;March 2012;Actual;2012-03-31;April 2018;2018-04-30;March 24, 2017;Actual;2017-03-24;March 24, 2017;Actual;2017-03-24;;Interventional;;;Vorinostat in Children;Phase I/II Intra-patient Dose Escalation Study of Vorinostat in Children With Relapsed Solid Tumor, Lymphoma or Leukemia;Completed;;Phase 1/Phase 2;50;Actual;National Center for Tumor Diseases, Heidelberg;;;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:13:39Z;2020-06-01T15:13:39Z;Heidelberg;3637280;Principal Investigator;Olaf Witt, Prof. Dr.;University Hospital Heidelberg and German Cancer Research Center (DKFZ);zolinza/vorinostat;63673655;10;;;2011;2020-05-29;60;FALSE;;FALSE;FALSE;3;18;Years;Years;1;5;
NCT01420744;ClinicalTrials.gov processed this data on May 29, 2020;2011-08-19;;;2015-07-28;2011-08-19;2011-08-22;Estimate;;;;;;;2015-07-28;2015-07-29;Estimate;August 2011;;2011-08-31;July 2015;2015-07-31;April 2015;Actual;2015-04-30;February 2015;Actual;2015-02-28;;Interventional;CIGMA;;Safety and Efficacy Study of BT086 to Evaluate Adjunctive Therapy in sCAP;A Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group, Adaptive Group-sequential Phase II Study, to Determine the Efficacy and Safety of BT086 as an Adjunctive Treatment in Severe Community Acquired Pneumonia (sCAP);Completed;;Phase 2;160;Actual;Biotest;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:14:09Z;2020-06-01T15:14:09Z;Hannover;3637438;Principal Investigator;Tobias Welte, MD;Hannover Medical School;BT086 | 1% Human Albumin infusion;63673786;36;;;2011;2020-05-29;42;FALSE;;FALSE;FALSE;18;;Years;;1;7;
NCT01419002;ClinicalTrials.gov processed this data on May 29, 2020;2011-08-13;;;2015-07-27;2011-08-16;2011-08-17;Estimate;;;;;;;2015-07-27;2015-07-29;Estimate;October 2011;;2011-10-31;July 2015;2015-07-31;October 2014;Actual;2014-10-31;October 2014;Actual;2014-10-31;;Interventional;Net-Pac;;Study to Evaluate if Neoadjuvant Radiotherapy Improves Recurrence Free Survival in Pancreatic Head Cancer;Neoadjuvant Radiotherapy in Patients With Primary Resectable Adenocarcinoma of the Pancreatic Head Plus Adjuvant Chemotherapy: a Randomized Controlled Phase III Trial;Terminated;;Phase 3;5;Actual;CHIR-Net;;2;;lack of recruitment;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:14:36Z;2020-06-01T15:14:36Z;Munich;3637589;Principal Investigator;Helmut M Friess, Prof. MD;Technische Universität München;neoadjuvant RTx | Surgery;63673919;1;;;2011;2020-05-29;36;FALSE;;FALSE;TRUE;18;;Years;;1;7;
NCT01417949;ClinicalTrials.gov processed this data on May 29, 2020;2011-08-10;;;2016-11-25;2011-08-15;2011-08-16;Estimate;;;;;;;2016-11-25;2016-11-28;Estimate;August 2011;;2011-08-31;September 2016;2016-09-30;May 2015;Actual;2015-05-31;May 2015;Actual;2015-05-31;;Interventional;IDEAL;;Immediate Versus Deferred Antiretroviral Therapy in HIV-infected Patients Presenting With Acute AIDS-defining Events;Immediate Versus Deferred Antiretroviral Therapy in HIV-infected Patients Presenting With Acute AIDS-defining Events (IDEAL-Study);Completed;;Phase 4;61;Actual;Universitätsklinikum Hamburg-Eppendorf;;2;;;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T15:14:46Z;2020-06-01T15:14:46Z;Hamburg;3637678;Principal Investigator;Stefan Schmiedel, MD;Infectious Diseases Unit, University Medical Center Hamburg-Eppendorf;Time of starting antiretroviral therapy;63674002;17;;;2011;2020-05-29;45;FALSE;;FALSE;FALSE;18;;Years;;1;6;
NCT01414231;ClinicalTrials.gov processed this data on May 29, 2020;2011-08-05;;;2011-08-10;2011-08-10;2011-08-11;Estimate;;;;;;;2011-08-10;2011-08-11;Estimate;April 2002;;2002-04-30;April 2008;2008-04-30;July 2014;Anticipated;2014-07-31;December 2013;Anticipated;2013-12-31;;Interventional;OSHO#061;;Comparison of the OSHO Protocol to a Standard Arm Protocol of the German AML Intergroup in Patients With AML<60a;Randomised Comparison of OSHO Induction vs. the German AML Intergroup Standard, Randomised Comparison of AraC/Mtx vs. Flu/AraC/Mtx in Pts Without CR After One Induction Cycle and Randomized Comparison of One vs. Two Consolidation Therapies.;Unknown status;;Phase 3;850;Anticipated;University of Leipzig;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:15:32Z;2020-06-01T15:15:32Z;Leipzig;3637954;Principal Investigator;Dietger Niederwieser, MD;University of Leipzig;Cytarabine;63674283;1;;;2011;2020-05-29;;FALSE;;FALSE;TRUE;18;60;Years;Years;1;3;
NCT01413243;ClinicalTrials.gov processed this data on May 29, 2020;2011-08-08;;;2016-05-05;2011-08-09;2011-08-10;Estimate;;;;;;;2016-05-05;2016-05-06;Estimate;September 2012;;2012-09-30;May 2016;2016-05-31;June 2017;Anticipated;2017-06-30;December 2016;Anticipated;2016-12-31;;Interventional;TRIOMS;;Trichuris Suis Ova (TSO)in Recurrent Remittent Multiple Sclerosis and Clinically Isolated Syndrome;Trichuris Suis Ova (TSO)in Recurrent Remittent Multiple Sclerosis and Clinically Isolated Syndrome - A Monocentric, Prospective, Randomized, Double-blind and Placebo-controlled Phase 2 Trial;Terminated;;Phase 2;50;Anticipated;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:15:41Z;2020-06-01T15:15:41Z;Berlin;3638026;Principal Investigator;Berit Rosche, M.D.;Charité-University;Trichuris suis ova;63674354;1;;;2011;2020-05-29;;FALSE;;FALSE;TRUE;18;65;Years;Years;1;5;
NCT01412970;ClinicalTrials.gov processed this data on May 29, 2020;2011-08-08;;;2015-08-11;2011-08-08;2011-08-09;Estimate;;;;;;;2015-08-11;2015-08-13;Estimate;July 2016;;2016-07-31;August 2015;2015-08-31;March 2017;Anticipated;2017-03-31;December 2016;Anticipated;2016-12-31;;Interventional;;;Non-invasive Measurement of Central Hemodynamics by Electrical Impedance Tomography;Non-invasive Measurement of Central Hemodynamics and Heart-lung Interactions by Electrical Impedance Tomography;Unknown status;;N/A;30;Anticipated;Universitätsklinikum Hamburg-Eppendorf;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:15:46Z;2020-06-01T15:15:46Z;Hamburg;3638069;Principal Investigator;Daniel A Reuter, MD;Universitätsklinikum Hamburg-Eppendorf;volume loading;63674373;1;;;2011;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT01409876;ClinicalTrials.gov processed this data on May 29, 2020;2011-08-03;;;2011-08-03;2011-08-03;2011-08-04;Estimate;;;;;;;2011-08-03;2011-08-04;Estimate;September 2011;;2011-09-30;March 2011;2011-03-31;September 2016;Anticipated;2016-09-30;September 2014;Anticipated;2014-09-30;;Interventional;;;HistScanning- Based PDR Brachytherapy in Prostate Cancer HistoScanning- Based Interstitial PDR Brachytherapy;HistoScanning- Based Dose-painting Image-guided Interstitial PDR-brachytherapy in Prostate Cancer - a Phase II Trial;Unknown status;;Phase 2;100;Anticipated;University Hospital Erlangen;;1;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T15:16:34Z;2020-06-01T15:16:34Z;Erlangen;;;;;brachytherapy;63674613;1;;;2011;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT01409824;ClinicalTrials.gov processed this data on May 29, 2020;2011-08-03;;;2011-08-03;2011-08-03;2011-08-04;Estimate;;;;;;;2011-08-03;2011-08-04;Estimate;May 2009;;2009-05-31;February 2010;2010-02-28;April 2014;Anticipated;2014-04-30;September 2010;Actual;2010-09-30;;Interventional;QUALMAT;;Health Care Intervention Research- Improving Pre-natal and Maternal Care;Health Care Intervention Research-Quality of Prenatal and Maternal Care: Bridging the Know-do Gap (QUALMAT);Unknown status;;N/A;36;Anticipated;Heidelberg University;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:16:34Z;2020-06-01T15:16:34Z;Heidelberg;;;;;CDSS;63674617;1;;;2011;2020-05-29;16;FALSE;;FALSE;TRUE;12;45;Years;Years;1;1;
NCT01407965;ClinicalTrials.gov processed this data on May 29, 2020;2011-07-26;;;2016-10-14;2011-08-01;2011-08-02;Estimate;;;;;;;2016-10-14;2016-10-17;Estimate;April 2012;;2012-04-30;October 2016;2016-10-31;July 2015;Actual;2015-07-31;July 2015;Actual;2015-07-31;;Interventional;;;Pharmacokinetics of Carbapenem Antibiotics in Obese Patients.;Offene, Monozentrische, Nicht Kontrollierte Und Nicht Randomisierte Phase IV-Studie Zur Bestimmung Der Pharmakokinetik Von Carbapenemen in adipösen Patienten.;Completed;;Phase 4;13;Actual;University of Ulm;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:16:58Z;2020-06-01T15:16:58Z;Ulm;3638490;Principal Investigator;Doris Henne-Bruns, PhD;University of Ulm;microdialysis catheter | microdialysis catheter;63674760;2;;;2011;2020-05-29;39;FALSE;;FALSE;FALSE;18;;Years;;1;3;
NCT01407861;ClinicalTrials.gov processed this data on May 29, 2020;2011-08-01;;;2014-12-02;2011-08-01;2011-08-02;Estimate;;;;;;;2014-12-02;2014-12-03;Estimate;July 2011;;2011-07-31;December 2014;2014-12-31;November 2014;Actual;2014-11-30;November 2014;Actual;2014-11-30;;Interventional;ARMIG;;Aerobic Endurance Training vs. Relaxation Training in Patients With Migraine;Aerobic Endurance Training Versus Relaxation Training in Migraine Prophylaxis;Completed;;N/A;56;Actual;Universität Duisburg-Essen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:16:59Z;2020-06-01T15:16:59Z;Duisburg;3638498;Principal Investigator;Charly Gaul, MD;Department of Neurology, University of Duisburg-Essen;Relaxation Training | Aerobic endurance Training;63674768;1;;;2011;2020-05-29;40;FALSE;;FALSE;TRUE;18;65;Years;Years;1;5;
NCT01407848;ClinicalTrials.gov processed this data on May 29, 2020;2011-07-28;;;2015-09-22;2011-08-01;2011-08-02;Estimate;;;;;;;2015-09-22;2015-09-23;Estimate;January 2012;;2012-01-31;September 2015;2015-09-30;July 2015;Actual;2015-07-31;July 2015;Actual;2015-07-31;;Interventional;;;Trial on Treatment With Inhaled Furosemide of Preterm and Term Neonates With Transient Tachypnoea;Trial on Treatment With Inhaled Furosemide of Preterm and Term Neonates With Transient Tachypnoea;Completed;;Phase 2;20;Actual;University of Cologne;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:17:00Z;2020-06-01T15:17:00Z;Köln;3638499;Principal Investigator;Bernhard Roth, Prof. Dr.;University Cologne;Furosemide | Saline 0,9%;63674769;1;;;2011;2020-05-29;42;FALSE;;FALSE;TRUE;;;;;1;6;
NCT01407679;ClinicalTrials.gov processed this data on May 29, 2020;2011-08-01;;;2016-05-30;2011-08-01;2011-08-02;Estimate;;;;;;;2016-05-30;2016-06-01;Estimate;August 2011;;2011-08-31;May 2016;2016-05-31;April 2014;Actual;2014-04-30;April 2014;Actual;2014-04-30;;Interventional;AliCLE;;Efficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus Erythematosus;Efficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus Erythematosus: A Multicentre, Open-Label, Prospective Pilot Study;Terminated;;Phase 2;7;Actual;University Hospital Muenster;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:17:01Z;2020-06-01T15:17:01Z;Münster;3638514;Principal Investigator;Annegret Kuhn, Prof. Dr.;Department of Dermatology, University Hospital Muenster, Muenster, Germany;Alitretinoin;63674783;3;;;2011;2020-05-29;32;FALSE;;FALSE;FALSE;18;75;Years;Years;1;5;
NCT01407055;ClinicalTrials.gov processed this data on May 29, 2020;2011-07-25;;;2016-02-02;2011-07-29;2011-08-01;Estimate;;;;;;;2016-02-02;2016-02-03;Estimate;July 2011;;2011-07-31;February 2016;2016-02-29;April 2015;Actual;2015-04-30;April 2015;Actual;2015-04-30;;Interventional;;;Optimizing Expectations in Cardiac Surgery Patients;Clinical Applications of Placebo Research: Optimizing Expectation Effects in Cardiac Surgery Patients;Completed;;Phase 2;124;Actual;Philipps University Marburg Medical Center;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:17:09Z;2020-06-01T15:17:09Z;Marburg;3638568;Principal Investigator;Winfried Rief, Prof. Dr.;Department of Clinical Psychology and Psychothearpy, Philipps University of Marburg;Expectation Manipulation Intervention | Supportive Therapy;63674826;1;;;2011;2020-05-29;45;FALSE;;FALSE;TRUE;18;80;Years;Years;1;20;
NCT01405469;ClinicalTrials.gov processed this data on May 29, 2020;2011-05-26;;;2019-10-06;2011-07-28;2011-07-29;Estimate;;;;;;;2019-10-06;2019-10-15;Actual;November 2010;;2010-11-30;October 2019;2019-10-31;November 2016;Actual;2016-11-30;June 2011;Actual;2011-06-30;;Interventional;POEM;;Endoscopic Peroral Myotomy for Treatment of Achalasia;Endoscopic Peroral Myotomy for Treatment of Achalasia: Pilot Study;Completed;;N/A;16;Actual;Universitätsklinikum Hamburg-Eppendorf;;1;;;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T15:17:29Z;2020-06-01T15:17:29Z;Hamburg;3638725;Principal Investigator;Thomas Roesch, Prof. Dr.;Universitätsklinikum Hamburg-Eppendorf;Peroral Endoscopic Myotomy;63674944;1;2;4;2011;2020-05-29;7;TRUE;38;FALSE;TRUE;18;;Years;;1;8;
NCT01405417;ClinicalTrials.gov processed this data on May 29, 2020;2011-05-26;;;2019-06-05;2011-07-28;2011-07-29;Estimate;;;;;;;2019-06-05;2019-06-07;Actual;April 2011;Actual;2011-04-30;April 2019;2019-04-30;September 2017;Actual;2017-09-30;July 2012;Actual;2012-07-31;;Interventional;;;Endoscopic Peroral Myotomy for Treatment of Achalasia;Endoscopic Peroral Myotomy for Treatment of Achalasia: Multicenter Study;Terminated;;N/A;70;Actual;Universitätsklinikum Hamburg-Eppendorf;;1;;not enough data collected;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:17:30Z;2020-06-01T15:17:30Z;Hamburg;3638729;Principal Investigator;Thomas Roesch, Prof. Dr.;Universitätsklinikum Hamburg-Eppendorf;Endoscopic Peroral Myotomy;63674948;5;;;2011;2020-05-29;15;FALSE;;FALSE;FALSE;18;;Years;;1;2;
NCT01405235;ClinicalTrials.gov processed this data on May 29, 2020;2011-07-27;;;2012-04-11;2011-07-28;2011-07-29;Estimate;;;;;;;2012-04-11;2012-04-12;Estimate;September 2006;;2006-09-30;September 2006;2006-09-30;January 2015;Anticipated;2015-01-31;June 2012;Anticipated;2012-06-30;;Interventional;AGO-Zervix-1;;Study on Paclitaxel Plus Topotecan in Comparison With Topotecan Plus Cisplatin in Recurrent or Persistent Cervical Carcinoma;A Prospective, Randomized Phase III Study to Compare the Effects of Paclitaxel and Topotecan to Those of Cisplatin and Topotecan for Treatment of Patients With Recurrent and Persistent Cervical Cancer;Unknown status;;Phase 3;312;Anticipated;Institut fuer Frauengesundheit;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:17:31Z;2020-06-01T15:17:31Z;Erlangen;3638742;Study Chair;Falk Thiel, Dr. med.;Frauenklinik Universitätsklinikum Erlangen;Paclitaxel | Cisplatin/Paclitaxel;63674961;1;;;2011;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT01404910;ClinicalTrials.gov processed this data on May 29, 2020;2011-07-26;;;2017-03-14;2011-07-27;2011-07-28;Estimate;;;;;;;2017-03-14;2017-03-16;Actual;May 2013;;2013-05-31;March 2017;2017-03-31;September 2015;Actual;2015-09-30;September 2015;Actual;2015-09-30;;Interventional;RAAPID-II;;Removal of Anti-Angiogenic Proteins in Preeclampsia Before Delivery;Phase 1b Proof-of-Concept Study of Apheresis to Reduce Soluble Fms-like Tyrosine Kinase-1 (sFlt-1) in Pregnant Women With Preeclampsia Using a Dextran Sulfate Adsorption (DSA) Column (LIPOSORBER® LA-15 System);Completed;;N/A;11;Actual;Massachusetts General Hospital;;1;;;FALSE;;;;TRUE;FALSE;FALSE;;;;;;;;;No;;2020-06-01T15:17:38Z;2020-06-01T15:17:38Z;Leipzig;3638768;Principal Investigator;Holger Stepan, MD;University of Leipzig;Apheresis using Liposorber LA-15 System;63674986;3;;;2011;2020-05-29;28;FALSE;;TRUE;FALSE;18;45;Years;Years;1;2;
NCT01403779;ClinicalTrials.gov processed this data on May 29, 2020;2010-10-29;;;2019-01-22;2011-07-26;2011-07-27;Estimate;;;;;;;2019-01-22;2019-01-23;Actual;July 2010;;2010-07-31;January 2019;2019-01-31;February 2, 2017;Actual;2017-02-02;February 2, 2017;Actual;2017-02-02;;Interventional;KOSIMA;;Comparison of the Cosmetic Outcome of Hypofractionated Versus Normofractionated IMRT in Treatment of Breast Cancer;Comparison of the Cosmetic Outcome of Hypofractionated Versus Normofractionated Intensity Modulated Radiotherapy (IMRT) in Treatment of Breast Cancer: The KOSIMA Trial;Completed;;Phase 3;226;Actual;Universitätsmedizin Mannheim;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:17:50Z;2020-06-01T15:17:50Z;Mannheim;;;;;intensity modulated radiotherapy (IMRT) for breast cancer;63675072;1;;;2010;2020-05-29;79;FALSE;;FALSE;TRUE;60;;Years;;1;1;
NCT01402739;ClinicalTrials.gov processed this data on May 29, 2020;2011-07-25;;;2015-06-12;2011-07-25;2011-07-26;Estimate;;;;;;;2015-06-12;2015-06-15;Estimate;August 2011;;2011-08-31;June 2015;2015-06-30;June 2015;Actual;2015-06-30;June 2015;Actual;2015-06-30;;Interventional;HEART-PoC;;Algorithm-Guided Transfusions in Cardiac Surgery Patients for Reduction of Drainage Blood Losses;Monocentric Pilot Study of Algorithm-Guided Transfusions in Cardiac Surgery Patients for Reduction of Drainage Blood Losses;Terminated;;N/A;100;Actual;Charite University, Berlin, Germany;;2;;Study terminated prematurely due to futility;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:18:03Z;2020-06-01T15:18:03Z;Berlin;3638961;Principal Investigator;Michael Sander, MD;Dept. of Anesthesiology CCM/CVK Charité Universitätsmedizin Berlin;Point of Care Coagulation Monitoring Guided Transfusion Algorithm | standard coagulation monitoring guided transfusion algorithm;63675153;1;;;2011;2020-05-29;46;FALSE;;FALSE;TRUE;18;80;Years;Years;1;4;
NCT01402414;ClinicalTrials.gov processed this data on May 29, 2020;2011-07-19;;;2014-02-20;2011-07-25;2011-07-26;Estimate;;;;;;;2014-02-20;2014-02-21;Estimate;April 2011;;2011-04-30;February 2014;2014-02-28;February 2014;Actual;2014-02-28;February 2014;Actual;2014-02-28;;Interventional;;;Narrow-band (NB)-UVB vs. Bath-PUVA and NB-UVB Plus Salt Water Baths in Atopic Dermatitis;Study Comparing the Effectiveness of Narrow-band UVB vs. Bath-PUVA and Narrow-band UVB + Salt Water Baths in Atopic Dermatitis;Terminated;;N/A;10;Actual;Ruhr University of Bochum;;3;;Difficulties with the Recruitement;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:18:06Z;2020-06-01T15:18:06Z;Bochum;3638995;Principal Investigator;Thilo Gambichler, adjunct professor;Ruhr University Bochum;NB-UVB | Bath-PUVA | NB-UVB plus salt water baths;63675178;1;;;2011;2020-05-29;34;FALSE;;FALSE;TRUE;18;;Years;;1;3;
NCT01397149;ClinicalTrials.gov processed this data on May 29, 2020;2011-06-30;;;2015-05-27;2011-07-18;2011-07-19;Estimate;;;;;;;2015-05-27;2015-05-28;Estimate;October 2011;;2011-10-31;May 2015;2015-05-31;November 2014;Actual;2014-11-30;November 2013;Actual;2013-11-30;;Interventional;;;Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG);A Phase I/II, Multi-centre Trial to Assess the Safety, Efficacy, and Pharmacokinetics of Eltrombopag, Administered to Thrombocytopenic Chronic Lymphocytic Leukemia Patients Prior to Alkylating Agents and/or Purine Analogue-based Therapy;Terminated;;Phase 1/Phase 2;4;Actual;University of Ulm;;2;;Insufficient recruitment;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:19:16Z;2020-06-01T15:19:16Z;Ulm;3639455;Principal Investigator;Stephan Stilgenbauer, Prof. Dr.;Universitätsklinikum Ulm, Medizinische Klinik III;Placebo | Eltrombopag;63675577;10;;;2011;2020-05-29;25;FALSE;;FALSE;FALSE;18;;Years;;1;9;
NCT01394367;ClinicalTrials.gov processed this data on May 29, 2020;2011-06-28;;;2019-12-19;2011-07-13;2011-07-14;Estimate;;;;;;;2019-12-19;2019-12-23;Actual;June 2010;;2010-06-30;December 2019;2019-12-31;May 2015;Actual;2015-05-31;May 2015;Actual;2015-05-31;;Interventional;;;Influence of Respiratory and Exercise Therapy on Oxygen Uptake, Quality of Life and Right Ventricular Function in Severe Pulmonary Hypertension;Study of Influence of Respiratory and Exercise Therapy on Oxygen Uptake, Quality of Life and Right Ventricular Function in Severe Pulmonary Hypertension;Completed;;N/A;90;Actual;Heidelberg University;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:20:01Z;2020-06-01T15:20:01Z;Heidelberg;3639672;Study Director;Ekkehard Grünig, Professor;Center for pulmonary hypertension, Thoraxclinic Heidelberg;respiratory and exercise therapy;63675792;1;;;2011;2020-05-29;59;FALSE;;FALSE;TRUE;18;75;Years;Years;1;1;
NCT01394354;ClinicalTrials.gov processed this data on May 29, 2020;2011-06-21;;;2016-04-05;2011-07-13;2011-07-14;Estimate;;;;;;;2016-04-05;2016-04-06;Estimate;August 2011;;2011-08-31;April 2016;2016-04-30;December 2015;Actual;2015-12-31;December 2015;Actual;2015-12-31;;Interventional;VBDD;;Vorinostat in Combination With Bortezomib, Doxorubicin and Dexamethasone (VBDD) in Patients With Refractory or Relapsed Multiple Myeloma (MM);Safety of Vorinostat in Combination With Bortezomib, Doxorubicin and Dexamethasone (VBDD) in Patients With Refractory or Relapsed Multiple Myeloma, A Phase I/II Study, Short Title: VBDD;Completed;;Phase 1/Phase 2;34;Actual;University Hospital Freiburg;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:20:01Z;2020-06-01T15:20:01Z;Freiburg;3639673;Principal Investigator;Monika Engelhardt, MD;University of Freiburg Medical School;Dexamethasone | Vorinostat | Bortezomib | Doxorubicin;63675793;1;;;2011;2020-05-29;52;FALSE;;FALSE;TRUE;18;;Years;;1;6;
NCT01393067;ClinicalTrials.gov processed this data on May 29, 2020;2011-07-12;;;2016-08-27;2011-07-12;2011-07-13;Estimate;;;;;;;2016-08-27;2016-08-30;Estimate;March 2011;;2011-03-31;August 2016;2016-08-31;March 2015;Actual;2015-03-31;March 2015;Actual;2015-03-31;;Interventional;;;cSEMS vs. NEPS in Stricture of Biliary Anastomosis After Liver Transplantation;Comparison of Use of Covered, Self-expandable Metal Stents (cSEMS) and Non-expandable Plastic Stents (NEPS) in Temporary Endoscopic Treatment of Stenosis of the Bilio-biliary Anastomosis After Liver Transplantation;Completed;;N/A;60;Actual;Johann Wolfgang Goethe University Hospital;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:20:32Z;2020-06-01T15:20:32Z;Frankfurt;3639766;Principal Investigator;Jörg Albert, MD;Johann Wolfgang Goethe University Hospital and Clinics Department of Internal Medicine I;Non-expandable plastic stent (plastic endoprosthesis) | Covered self-expandable metal stent (cSEMS);63675888;4;;;2011;2020-05-29;48;FALSE;;FALSE;FALSE;18;90;Years;Years;1;1;
NCT01392079;ClinicalTrials.gov processed this data on May 29, 2020;2011-06-28;;;2019-10-21;2011-07-11;2011-07-12;Estimate;;;;;;;2019-10-21;2019-10-24;Actual;February 2008;;2008-02-29;October 2019;2019-10-31;March 2016;Actual;2016-03-31;January 2012;Actual;2012-01-31;;Interventional;;;Subcutaneous Alemtuzumab Combined With Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allo-SCT in CLL With 17p- or Refractory to Fludarabine;A Prospective, Multi-center Phase II Study of Subcutaneous Alemtuzumab Combined With Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Stem-cell Transplantation, in Chronic Lymphocytic Leukemia Which is Associated With 17p Deletion or is Refractory to Fludarabine;Completed;;Phase 2;135;Actual;University of Ulm;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:20:49Z;2020-06-01T15:20:49Z;Ulm;3639855;Principal Investigator;Stephan Stilgenbauer, Prof Dr med;University of Ulm;Alemtuzumab;63675965;38;;;2011;2020-05-29;47;FALSE;;FALSE;FALSE;18;;Years;;1;4;
NCT01389375;ClinicalTrials.gov processed this data on May 29, 2020;2011-07-05;;;2016-06-08;2011-07-06;2011-07-08;Estimate;;;;;;;2016-06-08;2016-06-10;Estimate;July 2011;;2011-07-31;July 2014;2014-07-31;July 2014;Actual;2014-07-31;July 2014;Actual;2014-07-31;;Interventional;ISAR-CLOSURE;;Instrumental Sealing of Arterial Puncture Site Closure Device Versus Manual Compression Trial;Instrumental Sealing of Arterial Puncture Site Closure Device Versus Manual Compression Trial;Completed;;Phase 4;4524;Actual;Deutsches Herzzentrum Muenchen;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:21:35Z;2020-06-01T15:21:35Z;Munich;3640071;Principal Investigator;Maryam Linhardt, MD;Deutsches Herzzentrum München, Klinik für Herz- und Kreislauferkrankungen;FemoSeal® | ExoSeal® | Manual compression;63676172;2;;;2011;2020-05-29;36;FALSE;;FALSE;FALSE;18;85;Years;Years;1;4;
NCT01388621;ClinicalTrials.gov processed this data on May 29, 2020;2011-05-17;;;2013-08-19;2011-07-04;2011-07-06;Estimate;;;;;;;2013-08-19;2013-08-20;Estimate;October 2011;;2011-10-31;August 2013;2013-08-31;July 2015;Anticipated;2015-07-31;July 2014;Anticipated;2014-07-31;;Interventional;PROVE;;Carboplatin-based Chemotherapy With or Without Panitumumab in Platinum-sensitive Recurrent Ovarian Cancer;PROVE A Randomized Phase II Trial of Standard Carboplatin-based Chemotherapy With or Without Panitumumab in Platinum-sensitive Recurrent Ovarian Cancer;Unknown status;;Phase 2;140;Anticipated;WiSP Wissenschaftlicher Service Pharma GmbH;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:21:45Z;2020-06-01T15:21:45Z;Berlin;3640127;Principal Investigator;Jalid Sehouli, MD (Prof. Dr. med.);Frauenklinik Charité - Universitätsmedizin Berlin Campus Virchow-Klinikum;Panitumumab | pegylated liposomal doxorubicin (PLD) | Carboplatin | Gemcitabine | Carboplatin | Panitumumab;63676229;18;;;2011;2020-05-29;;FALSE;;FALSE;FALSE;18;;Years;;1;5;
NCT01384994;ClinicalTrials.gov processed this data on May 29, 2020;2011-05-02;;;2012-07-05;2011-06-28;2011-06-29;Estimate;;;;;;;2012-07-05;2012-07-09;Estimate;August 2011;;2011-08-31;July 2012;2012-07-31;August 2014;Anticipated;2014-08-31;August 2013;Anticipated;2013-08-31;;Interventional;;;Panitumumab After Resection of Liver Metastases From Colorectal Cancer in KRAS Wild-type Patients;;Unknown status;;Phase 2;111;Anticipated;Ludwig-Maximilians - University of Munich;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:22:32Z;2020-06-01T15:22:32Z;Munich;;;;;Folic Acid | 5-FU | 5-FU | Oxaliplatin | Panitumumab | Panitumumab | Folic Acid | 5-FU | 5-FU | Oxaliplatin;63676506;1;;;2011;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;2;
NCT01382147;ClinicalTrials.gov processed this data on May 29, 2020;2011-06-23;;;2017-12-04;2011-06-24;2011-06-27;Estimate;;;;;;;2017-12-04;2017-12-06;Actual;July 1, 2009;Actual;2009-07-01;December 2017;2017-12-31;July 5, 2017;Actual;2017-07-05;August 2012;Actual;2012-08-31;;Interventional;AMLCG 2008;;Evaluation of Dose-dense Therapy by S-HAM in Comparison to Conventionally Timed Double Induction in Patients With Acute Myeloid Leukemia (AML);A Randomized, Risk and Age Adapted Comparison of the Dose-Dense Regimen S-HAM (Sequential High Dose Cytosine Arabinoside and Mitoxantrone) Versus Standard Double Induction for Initial Chemotherapy of Adult Patients With Acute Myeloid Leukemia;Completed;;Phase 3;396;Actual;Ludwig-Maximilians - University of Munich;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:23:07Z;2020-06-01T15:23:07Z;Munich;3640664;Principal Investigator;Wolfgang Hiddemann, Prof. Dr.;Hospital of the University of Munich;Ara-C, Mitoxantrone, Daunorubicin, Thioguanin;63676725;32;;;2011;2020-05-29;38;FALSE;;FALSE;FALSE;18;;Years;;1;;
NCT01379248;ClinicalTrials.gov processed this data on May 29, 2020;2011-06-20;;;2016-10-27;2011-06-21;2011-06-23;Estimate;;;;;;;2016-10-27;2016-10-28;Estimate;June 2011;;2011-06-30;October 2016;2016-10-31;May 2015;Actual;2015-05-31;November 2014;Actual;2014-11-30;;Interventional;;;Effect of Thrombus Aspiration in Patients With Myocardial Infarction Presenting Late After Symptom Onset;;Completed;;Phase 4;152;Actual;University of Leipzig;;2;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T15:23:54Z;2020-06-01T15:23:54Z;Leipzig;;;;;manual thrombus aspiration (Export catheter, Medtronic Inc. Minneapolis, Minnesota, USA);63676947;1;;;2011;2020-05-29;41;FALSE;;FALSE;TRUE;18;90;Years;Years;1;;
NCT01378845;ClinicalTrials.gov processed this data on May 29, 2020;2011-06-16;;;2014-12-12;2011-06-20;2011-06-22;Estimate;;;;;;;2014-12-12;2014-12-15;Estimate;July 2011;;2011-07-31;December 2014;2014-12-31;September 2015;Anticipated;2015-09-30;June 2015;Anticipated;2015-06-30;;Interventional;Anti-Vasospasm;;Prognostic Influence of Light Rheography Measurement of Patients With Secondary Raynaud Syndrome With Ulcers on Hands;Monocenter, IIT, Open Controlled and Prospectiv Study to Define the Prognostic Influence of Light Rheography Measurement of Patients With Secundary Raynaud Syndrome With Ulcers at Fingertips Throughout the Medicinal Therapy;Unknown status;;N/A;30;Anticipated;University of Freiburg;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:24:00Z;2020-06-01T15:24:00Z;Freiburg;3640923;Principal Investigator;Mark Kerber, Dr. med.;Universitätsklinik Freiburg;Tracleer | Prostavasin;63676979;1;;;2011;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT01377025;ClinicalTrials.gov processed this data on May 29, 2020;2011-06-14;;;2014-12-02;2011-06-17;2011-06-20;Estimate;;;;;;;2014-12-02;2014-12-03;Estimate;June 2011;;2011-06-30;December 2014;2014-12-31;June 2017;Anticipated;2017-06-30;June 2016;Anticipated;2016-06-30;;Interventional;STREAM;;A Study of Sorafenib in Patients With Chemonaive Metastatic Uveal Melanoma;A Randomized Discontinuation, Blinded, Placebo-Controlled Phase II Study of Sorafenib in Patients With Chemonaive Metastatic Uveal Melanoma;Unknown status;;Phase 2;200;Anticipated;University Hospital, Essen;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:24:19Z;2020-06-01T15:24:19Z;Duisburg;3641071;Principal Investigator;Max E. Scheulen, Prof.;Universiätsklinikum Essen;Placebo | Sorafenib | Sorafenib;63677114;3;;;2011;2020-05-29;;FALSE;;FALSE;FALSE;18;;Years;;1;2;
NCT01372735;ClinicalTrials.gov processed this data on May 29, 2020;2011-06-09;;;2011-06-10;2011-06-10;2011-06-14;Estimate;;;;;;;2011-06-10;2011-06-14;Estimate;August 2011;;2011-08-31;June 2011;2011-06-30;August 2017;Anticipated;2017-08-31;August 2013;Anticipated;2013-08-31;;Interventional;NEOPANC;;Trial of Neoadjuvant Short Course IMRT Followed by Surgery and IORT for Resectable Pancreatic Cancer;Clinical Phase I/II Trial to Investigate Neoadjuvant Intensity-Modulated Short Term Radiation Therapy (5x5 Gy) and Intraoperative Radiation Therapy (15 Gy) in Patients With Primarily Resectable Pancreatic Cancer - NEOPANC;Unknown status;;Phase 1/Phase 2;46;Anticipated;University Hospital Heidelberg;;;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:25:40Z;2020-06-01T15:25:40Z;Heidelberg;3641458;Principal Investigator;Falk FF Roeder, MD;Department of Radiation Oncology, University Hospital Heidelberg;neoadjuvant short course IMRT | IORT;63677440;3;;;2011;2020-05-29;;FALSE;;FALSE;FALSE;50;;Years;;1;2;
NCT01370044;ClinicalTrials.gov processed this data on May 29, 2020;2011-05-20;;;2018-01-24;2011-06-08;2011-06-09;Estimate;;;;;;;2018-01-24;2018-01-26;Actual;August 2012;;2012-08-31;January 2018;2018-01-31;June 2015;Actual;2015-06-30;June 2015;Actual;2015-06-30;;Interventional;CARDIF;;Carbon Dioxide (Carbogen) for the Treatment of Febrile Seizures;Carbon Dioxide (Carbogen) for the Treatment of Febrile Seizures;Terminated;;Phase 2/Phase 3;96;Actual;Charite University, Berlin, Germany;;2;;results of interim analysis (not safety relevant);FALSE;;;;;;;;;;;;;;;;;2020-06-01T15:26:22Z;2020-06-01T15:26:22Z;Berlin;3641678;Principal Investigator;Markus Schülke-Gerstenfeld;Charite - NeuroCure;Carbogen | Placebo;63677645;1;;;2011;2020-05-29;34;FALSE;;FALSE;TRUE;12;5;Months;Years;1;4;
NCT01362582;ClinicalTrials.gov processed this data on May 29, 2020;2010-11-25;;;2014-09-24;2011-05-27;2011-05-30;Estimate;;;;;;;2014-09-24;2014-09-25;Estimate;March 2010;;2010-03-31;September 2014;2014-09-30;September 2014;Actual;2014-09-30;August 2014;Actual;2014-08-31;;Interventional;PANUSCO;;Comparing Parenteral Nutrition vs Best Supportive Nutritional Care in Patients With Pancreatic Cancer;Open-label Randomized Multicentre Phase IIIb Trial Comparing Parenteral Substitution Versus Best Supportive Nutritional Care in Patients With Pancreatic Cancer Receiving 2nd Line Chemotherapy;Terminated;;Phase 3;32;Actual;National Center for Tumor Diseases, Heidelberg;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:28:32Z;2020-06-01T15:28:32Z;Heidelberg;3642354;Principal Investigator;Dirk Jäger, Prof. Dr.;University of Heidelberg / National Center for Tumordiseases;SMOF Kabiven;63678213;4;;;2010;2020-05-29;53;FALSE;;FALSE;FALSE;18;;Years;;1;1;
NCT01362361;ClinicalTrials.gov processed this data on May 29, 2020;2011-05-25;;;2019-09-18;2011-05-27;2011-05-30;Estimate;;;;;;;2019-09-18;2019-09-19;Actual;June 2011;;2011-06-30;September 2019;2019-09-30;December 2016;Actual;2016-12-31;June 2016;Actual;2016-06-30;;Interventional;AIO-KRK-0111;;TRICC-C (AIO-KRK-0111): BIBF 1120 Versus Placebo in Patients Receiving Oxaliplatin Plus Fluorouracil and Leucovorin (mFOLFOX6) for Advanced, Chemorefractory Metastatic Colorectal Cancer (mCRC);TRICC-C: A Multicenter, Randomized, Phase II Trial: BIBF 1120 vs. Placebo in Patients Receiving Oxaliplatin Plus Fluorouracil and Leucovorin (mFOLFOX6) for Advanced, Chemorefractory Metastatic Colorectal Cancer (mCRC);Completed;;Phase 2;54;Actual;Martin-Luther-Universität Halle-Wittenberg;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:28:38Z;2020-06-01T15:28:38Z;Halle;;;;;mFOLFOX6 + BIBF 1120 | mFOLFOX6+placebo;63678228;12;;;2011;2020-05-29;60;FALSE;;FALSE;FALSE;18;;Years;;1;;
NCT01361334;ClinicalTrials.gov processed this data on May 29, 2020;2011-05-17;;;2017-03-14;2011-05-25;2011-05-26;Estimate;;;;;;;2017-03-14;2017-03-15;Actual;June 2011;;2011-06-30;May 2016;2016-05-31;March 2016;Actual;2016-03-31;March 2016;Actual;2016-03-31;;Interventional;PAZOPANIB-AML;;Pilot Clinical Trial of Pazopanib in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or at Initial Diagnosis When no Intensive Treatment is Possible;Phase II Pilot Clinical Trial of Pazopanib in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or at Initial Diagnosis When no Intensive Treatment is Possible;Completed;;Phase 2;20;Actual;University Hospital Muenster;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:28:57Z;2020-06-01T15:28:57Z;Münster;3642451;Principal Investigator;Torsten Kessler, MD;University of Münster, Department of Medicine A, Germany;Pazopanib;63678306;1;;;2011;2020-05-29;57;FALSE;;FALSE;TRUE;18;;Years;;2;4;
NCT01358292;ClinicalTrials.gov processed this data on May 29, 2020;2011-01-14;;;2016-06-16;2011-05-20;2011-05-23;Estimate;;;;;;;2016-06-16;2016-06-17;Estimate;February 2011;;2011-02-28;November 2015;2015-11-30;October 2015;Actual;2015-10-31;September 2015;Actual;2015-09-30;;Interventional;TrigenMETA;;Efficacy Study of Surgical Technique in Intramedullary Tibia Nailing, Using Trigen META Tibia Nails;Semi-extended Position vs. 90 Degrees of Flexion for Intramedullary Nailing of the Tibia: a Randomized Clinical Trial;Completed;;Phase 4;95;Actual;Smith & Nephew, Inc.;;2;;;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T15:29:54Z;2020-06-01T15:29:54Z;Aachen;3642780;Study Chair;Markus Graf, Dr.;Medizinisches Zentrum StädteRegion Aachen;Semi-extended Surgical Technique | Standard Surgical Technique;63678537;5;;;2011;2020-05-29;55;FALSE;;FALSE;FALSE;18;70;Years;Years;1;1;
NCT01357681;ClinicalTrials.gov processed this data on May 29, 2020;2011-05-19;;;2015-06-15;2011-05-20;2011-05-23;Estimate;;;;;;;2015-06-15;2015-06-16;Estimate;September 2011;;2011-09-30;June 2015;2015-06-30;May 2015;Actual;2015-05-31;May 2015;Actual;2015-05-31;;Interventional;ETON;;Effects of EGCG (Epigallocatechin Gallate) in Huntington's Disease (ETON-Study);Effects of EGCG (Epigallocatechin Gallate) in Huntington's Disease The ETON-Study - A Randomized, Double-blind, Stratified, Placebo-controlled Prospective Investigator Initiated Multicenter Trial -;Completed;;Phase 2;54;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:30:06Z;2020-06-01T15:30:06Z;Berlin;3642826;Principal Investigator;Josef Priller, MD;Department of Neuropsychiatry, Charité Universitätsmedizin Berlin, Germany;(2)-epigallocatechin-3-gallate (EGCG) | Placebo;63678570;3;;;2011;2020-05-29;44;FALSE;;FALSE;FALSE;18;;Years;;1;15;
NCT01357694;ClinicalTrials.gov processed this data on May 29, 2020;2011-05-18;;;2015-01-23;2011-05-19;2011-05-23;Estimate;;;;;;;2015-01-23;2015-01-26;Estimate;May 2011;;2011-05-31;January 2015;2015-01-31;September 2014;Actual;2014-09-30;February 2013;Actual;2013-02-28;;Interventional;BRIA;;BRIA - Bridging Intervention in Anesthesiology;Open Monocentric Randomized Clinical Trial on the Efficacy of the Psychotherapeutic Bridging Intervention in Anesthesiology (BRIA);Completed;;N/A;220;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:30:06Z;2020-06-01T15:30:06Z;Berlin;3642825;Study Director;Claudia D Spies, MD, Prof.;Department of Anesthesiology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Germany;psychotherapeutic contacts;63678583;1;;;2011;2020-05-29;21;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT01353443;ClinicalTrials.gov processed this data on May 29, 2020;2011-04-18;;;2014-11-18;2011-05-12;2011-05-13;Estimate;;;;;;;2014-11-18;2014-11-19;Estimate;February 2011;;2011-02-28;November 2014;2014-11-30;September 2015;Anticipated;2015-09-30;August 2015;Anticipated;2015-08-31;;Interventional;;;Prophylactic Mesh Implantation After Abdominal Aortic Aneurysm Repair;Prophylactic Mesh Implantation After Abdominal Aortic Aneurysm Repair. A Prospective, Randomised, Controlled Study;Unknown status;;Phase 4;282;Anticipated;Universitätsklinikum Hamburg-Eppendorf;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:31:04Z;2020-06-01T15:31:04Z;Hamburg;3643180;Principal Investigator;Sebastian Debus, Prof. Dr.;University Heart Center Hamburg - Eppendorf;Optilene® Mesh Elastic;63678908;9;;;2011;2020-05-29;;FALSE;;FALSE;FALSE;18;;Years;;1;;
NCT01352988;ClinicalTrials.gov processed this data on May 29, 2020;2011-04-29;;;2014-02-27;2011-05-11;2011-05-12;Estimate;;;;;;;2014-02-27;2014-02-28;Estimate;July 2011;;2011-07-31;February 2014;2014-02-28;February 2014;Actual;2014-02-28;October 2013;Actual;2013-10-31;;Interventional;FumaCLE;;Efficacy and Safety of Fumaric Acid Esters (Fumaderm®) in the Treatment of Patients With Cutaneous Lupus Erythematosus;Efficacy and Safety of Fumaric Acid Esters (Fumaderm®) in the Treatment of Patients With Cutaneous Lupus Erythematosus: A Mono-Centre, Open-Label, Prospective Pilot Study;Completed;;Phase 2;11;Actual;University Hospital Muenster;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:31:09Z;2020-06-01T15:31:09Z;Münster;3643233;Principal Investigator;Annegret Kuhn, Prof. Dr.;Department of Dermatology, University Hospital Muenster;Fumaric acid esters;63678943;1;;;2011;2020-05-29;27;FALSE;;FALSE;TRUE;18;70;Years;Years;1;5;
NCT01352702;ClinicalTrials.gov processed this data on May 29, 2020;2011-05-11;;;2015-02-04;2011-05-11;2011-05-12;Estimate;;;;;;;2015-02-04;2015-02-05;Estimate;May 2011;;2011-05-31;February 2015;2015-02-28;May 2014;Actual;2014-05-31;May 2014;Actual;2014-05-31;;Interventional;Dabi-ADP-2;;Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation;Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation;Terminated;;Phase 4;46;Actual;Deutsches Herzzentrum Muenchen;;2;;"Slow recruitment; Study was terminated for futility reasons";FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:31:16Z;2020-06-01T15:31:16Z;Munich;3643253;Principal Investigator;Julinda Mehilli, MD;Deutsches Herzzentrum München, Klinik für Herz- und Kreislauferkrankungen;Dabigatran | Phenprocoumon;63678964;1;;;2011;2020-05-29;36;FALSE;;FALSE;TRUE;18;;Years;;1;2;
NCT01352403;ClinicalTrials.gov processed this data on May 29, 2020;2011-05-10;;;2011-05-10;2011-05-10;2011-05-11;Estimate;;;;;;;2011-05-10;2011-05-11;Estimate;May 2011;;2011-05-31;December 2008;2008-12-31;June 2016;Anticipated;2016-06-30;;;;;Interventional;WAS;;Severe Obesity: Bariatric Surgery vs. Life-Style-Intervention;Severe Obesity: Bariatric Surgery vs. Life-Style-Intervention Wurzburg Adipositas Study - WAS;Unknown status;;N/A;60;Anticipated;University of Wuerzburg;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:31:20Z;2020-06-01T15:31:20Z;Würzburg;;;;;gastric bypass | intensive life style intervention;63678988;1;;;2011;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT01351610;ClinicalTrials.gov processed this data on May 29, 2020;2011-05-10;;;2015-12-14;2011-05-10;2011-05-11;Estimate;;;;;;;2015-12-14;2015-12-15;Estimate;March 2011;;2011-03-31;December 2015;2015-12-31;October 2015;Actual;2015-10-31;October 2014;Actual;2014-10-31;;Interventional;;;Tolerability and Efficacy of Intravenous Infusion of Autologous MSC_Apceth for the Treatment of Critical Limb Ischemia;Open, Randomized, Mono-Centre, Two-Parallel Group Clinical Phase I/II Trial on the Evaluation of Tolerability and Efficacy of an Intravenous Infusion of Human Bone Marrow Derived Autologous, CD34-Negative Mesenchymal Stem Cells for the Treatment of Critical Limb Ischemia in Patients With Advanced Peripheral Arterial Occlusive Disease Subsequent to Percutaneous Transluminal Angioplasty;Completed;;Phase 1/Phase 2;25;Actual;Apceth GmbH & Co. KG;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:31:28Z;2020-06-01T15:31:28Z;Munich;3643334;Principal Investigator;Peter Heider, MD, PhD;Isar Medizin Zentrum, München;PTA + Infusion of MSC_Apceth | PTA;63679048;1;;;2011;2020-05-29;43;FALSE;;FALSE;TRUE;40;80;Years;Years;4;1;
NCT01351246;ClinicalTrials.gov processed this data on May 29, 2020;2011-05-02;;;2014-04-14;2011-05-09;2011-05-10;Estimate;;;;;;;2014-04-14;2014-04-15;Estimate;May 2010;;2010-05-31;April 2014;2014-04-30;March 2014;Actual;2014-03-31;February 2014;Actual;2014-02-28;;Interventional;;;Guided Self-Help for Parents of Children With Attention-Deficit/Hyperactivity Disorder (ADHD);Guided Self-Help for Parents of Children With Attention-Deficit/Hyperactivity Disorder (ADHD): A Feasibility and Effectiveness Study;Completed;;N/A;300;Actual;University of Cologne;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:31:34Z;2020-06-01T15:31:34Z;Köln;3643359;Principal Investigator;Manfred Döpfner, PhD;University of Cologne;CBT Based Self-help Workbook + Counseling Telephone;63679074;1;;;2011;2020-05-29;45;FALSE;;FALSE;TRUE;6;12;Years;Years;1;2;
NCT01349296;ClinicalTrials.gov processed this data on May 29, 2020;2011-05-05;;;2016-05-19;2011-05-05;2011-05-06;Estimate;;;;;;;2016-05-19;2016-05-20;Estimate;July 2012;;2012-07-31;May 2016;2016-05-31;May 2016;Actual;2016-05-31;October 2014;Actual;2014-10-31;;Interventional;BARIS;;BIBF 1120 and RAD001 in Solid Tumors - Phase I;BARIS - BIBF1120 and RAD001 in Solid Tumors. A Phase I Trial to Evaluate the Safety and Tolerability of Combined BIBF 1120 and RAD001 in Solid Tumors and to Determine the Maximum Tolerated Dose (MTD) of the Combination;Completed;;Phase 1;18;Actual;University of Cologne;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:32:12Z;2020-06-01T15:32:12Z;Köln;3643544;Principal Investigator;Juergen Wolf, Prof.;University Hospital of Cologne;Everolimus + BIBF 1120;63679228;1;;;2011;2020-05-29;27;FALSE;;FALSE;TRUE;18;;Years;;2;4;
NCT01348269;ClinicalTrials.gov processed this data on May 29, 2020;2011-05-02;;;2017-06-07;2011-05-04;2011-05-05;Estimate;;;;;;;2017-06-07;2017-06-08;Actual;May 2011;Actual;2011-05-31;April 2017;2017-04-30;August 26, 2015;Actual;2015-08-26;August 26, 2015;Actual;2015-08-26;;Interventional;ZoMARS;;Assessment of Efficacy of Zoledronic Acid in the Treatment of Bone Marrow Edema Syndrome;A Prospective, Bi-centric,Randomized, Primary Double-blind, Placebo-controlled Phase III Study to Assess the Efficacy of Zoledronic Acid in the Treatment of Bone Marrow Edema Syndrome;Completed;;Phase 3;63;Actual;Wuerzburg University Hospital;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:32:27Z;2020-06-01T15:32:27Z;Würzburg;3643633;Study Chair;Rainer Meffert, Prof. Dr.;Department of trauma, hand, reconstructive and plastic, University of Wuerzburg;Aclasta | Placebo;63679303;2;;;2011;2020-05-29;51;FALSE;;FALSE;FALSE;18;;Years;;1;6;
NCT01347567;ClinicalTrials.gov processed this data on May 29, 2020;2011-05-03;;;2014-02-04;2011-05-03;2011-05-04;Estimate;;;;;;;2014-02-04;2014-02-06;Estimate;April 2011;;2011-04-30;February 2014;2014-02-28;January 2014;Actual;2014-01-31;March 2013;Actual;2013-03-31;;Interventional;HOME;;Heart Failure (HF) Outpatient Monitoring Evaluation (HOME) Study;HF Outpatient Monitoring Evaluation (HOME) Study;Completed;;N/A;145;Actual;Alere San Diego;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:32:47Z;2020-06-01T15:32:47Z;Berlin;3643695;Principal Investigator;Franz Kleber, Professor;Klinikum Ernst von Bergmann, Akademisches Lehrankenhaus der Charite Universitätsmedizin Berlin, Germany;Interventions with heart failure medications;63679358;7;;;2011;2020-05-29;23;FALSE;;FALSE;FALSE;18;75;Years;Years;1;;
NCT01344707;ClinicalTrials.gov processed this data on May 29, 2020;2011-04-12;;;2015-03-31;2011-04-28;2011-04-29;Estimate;;;;;;;2015-03-31;2015-04-01;Estimate;March 2011;;2011-03-31;January 2014;2014-01-31;March 2015;Actual;2015-03-31;March 2015;Actual;2015-03-31;;Interventional;;;Oral Histone Deacetylase Inhibitor 4SC-202 in Patients With Advanced Hematologic Malignancies (TOPAS);Open Label, Dose Escalation Study of 4SC-202 in Patients With Advanced Hematologic Malignancies: First-In-Man Study of a Newly Developed, Oral Histone Deacetylase Inhibitor;Completed;;Phase 1;36;Anticipated;4SC AG;;;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:33:35Z;2020-06-01T15:33:35Z;Köln;3643932;Principal Investigator;Andreas Engert, Prof. MD;Universitätsklinikum Köln;4SC-202;63679576;3;;;2011;2020-05-29;48;FALSE;;FALSE;FALSE;18;;Years;;5;5;
NCT01341106;ClinicalTrials.gov processed this data on May 29, 2020;2011-04-20;;;2015-09-22;2011-04-21;2011-04-25;Estimate;;;;;;;2015-09-22;2015-09-23;Estimate;April 2011;;2011-04-30;September 2015;2015-09-30;April 2015;Actual;2015-04-30;January 2015;Actual;2015-01-31;;Interventional;INFIRE;;Induction of Fibrosis Regression on Patients With Chronic Hepatitis B Infection;Induction of Fibrosis Regression on Patients With Chronic Hepatitis B Infection;Terminated;;Phase 4;7;Actual;RWTH Aachen University;;1;;insufficient patient numbers have been recruited;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:34:26Z;2020-06-01T15:34:26Z;Aachen;3644214;Principal Investigator;Christian Trautwein, Professor MD;Department of Internal Medicine III, University Hospital Aachen;Treatment with entecavir(Baraclude®);63679853;1;;;2011;2020-05-29;45;FALSE;;FALSE;TRUE;18;75;Years;Years;1;7;
NCT01340690;ClinicalTrials.gov processed this data on May 29, 2020;2011-04-07;;;2017-09-19;2011-04-21;2011-04-22;Estimate;;;;;;;2017-09-19;2017-09-20;Actual;March 8, 2011;Actual;2011-03-08;September 2017;2017-09-30;March 1, 2017;Actual;2017-03-01;March 31, 2016;Actual;2016-03-31;;Interventional;PAD;;Efficacy Study of Polyunsaturated Fatty Acids in Children and Adolescents With Attention Deficit/ Hyperactivity Disorder;PAD-study: Nutritional Efficacy of Polyunsaturated Fatty Acids (Omega-3 and Omega-6) in Combination With Zinc and Magnesium Versus Placebo in Children and Adolescents With Attention Deficit/ Hyperactivity Disorder (ADHD);Terminated;;Phase 3;284;Actual;Johannes Gutenberg University Mainz;;2;;The sample size of the planned interims analysis was achieved;FALSE;;;;TRUE;;;;;;;;;;;Undecided;;2020-06-01T15:34:35Z;2020-06-01T15:34:35Z;Mainz;3644245;Principal Investigator;Michael Huss, Prof. Dr.;University Medicine, Mainz, Dep. of Child and Adolescent Psychiatry;ω-3 fatty acids suspension | placebo suspension;63679885;5;;;2011;2020-05-29;61;FALSE;;FALSE;FALSE;6;17;Years;Years;1;6;
NCT01338922;ClinicalTrials.gov processed this data on May 29, 2020;2011-04-07;;;2018-01-31;2011-04-19;2011-04-20;Estimate;;;;;;;2018-01-31;2018-02-05;Actual;April 2011;;2011-04-30;January 2018;2018-01-31;August 2016;Actual;2016-08-31;July 2015;Actual;2015-07-31;;Interventional;pumpkin;;Psychosocial Issues in Insulin Pump Therapy in Children With Type 1 Diabetes Mellitus (DM);Psychosocial Issues in Insulin Pump Therapy in Children With Type 1 DM - a Randomised Controlled Trial;Completed;;N/A;211;Actual;University of Schleswig-Holstein;;2;;;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T15:35:13Z;2020-06-01T15:35:13Z;Kiel Lübeck;3644381;Principal Investigator;Verena Wagner, MD;University of Schleswig-Holstein;Continuous subcutaneous insulin infusion therapy | Multiple daily injection therapy;63680021;24;;;2011;2020-05-29;51;FALSE;;FALSE;FALSE;6;16;Years;Years;2;6;
NCT01337011;ClinicalTrials.gov processed this data on May 29, 2020;2011-04-14;;;2018-03-23;2011-04-15;2011-04-18;Estimate;;;;;;;2018-03-23;2018-03-27;Actual;July 2011;Actual;2011-07-31;March 2018;2018-03-31;July 17, 2017;Actual;2017-07-17;March 2, 2016;Actual;2016-03-02;;Interventional;AlsterMACS;;Intra-coronary Versus Intramyocardial Application of Enriched CD133pos Autologous Bone Marrow Derived Stem Cells;Pilot Study Comparing the Effect of Intra-coronary Versus Intramyocardial Application of Enriched CD133pos Autologous Bone Marrow Derived Stem Cells for Improving Left Ventricular Function in Chronic Ischemic Cardiomyopathy;Terminated;;Phase 1;10;Actual;Asklepios proresearch;;2;;study was stopped due to funding issues;FALSE;;;;FALSE;;;;;;;;;;;Undecided;;2020-06-01T15:35:37Z;2020-06-01T15:35:37Z;Hamburg;3644529;Principal Investigator;Martin Bergmann, PD Dr.;Asklepios Kliniken Hamburg GmbH;autologous CD133pos stem cell application;63680156;1;;;2011;2020-05-29;55;FALSE;;FALSE;TRUE;18;80;Years;Years;1;6;
NCT01336530;ClinicalTrials.gov processed this data on May 29, 2020;2011-04-01;;;2017-05-18;2011-04-14;2011-04-18;Estimate;;;;;;;2017-05-18;2017-05-19;Actual;April 2011;Actual;2011-04-30;February 2017;2017-02-28;January 2017;Actual;2017-01-31;January 2017;Actual;2017-01-31;;Interventional;;;Tepilta® Versus Oxetacaine, Antacids and Placebo;Clinical Trial to Assess the Efficacy of Fixed Combination Product Tepilta® in the Treatment of Radiation-induced Oesophagitis Compared to Its Active Ingredients Oxetacaine and Antacids, and to Placebo;Terminated;;Phase 3;40;Actual;MEDA Pharma GmbH & Co. KG;;4;;The study stopped prematurely due to and administrative reasons, not based on grounds of~   safety.;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:35:50Z;2020-06-01T15:35:50Z;Hannover;3644567;Principal Investigator;Frank Bruns, Dr. med.;Hannover Medical School;oxetacaine, aluminium and magnesium hydroxide | oxetacaine | magnesium and aluminium hydroxide | Vehicle;63680194;32;;;2011;2020-05-29;70;FALSE;;FALSE;FALSE;18;;Years;;1;8;
NCT01331473;ClinicalTrials.gov processed this data on May 29, 2020;2011-03-30;;;2011-12-02;2011-04-06;2011-04-08;Estimate;;;;;;;2011-12-02;2011-12-05;Estimate;May 2011;;2011-05-31;March 2011;2011-03-31;June 2014;Anticipated;2014-06-30;May 2014;Anticipated;2014-05-31;;Interventional;PROVENON;;PROximal Protection VErsus NON-Protection in Carotid Artery Stenting;PROximal Protection VErsus NON-Protection in Carotid Artery Stenting (PROVENON Study) A Randomized Prospective MRI-based Trial.;Unknown status;;Phase 3;220;Anticipated;Saarland University;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:37:32Z;2020-06-01T15:37:32Z;Homburg;3645020;Principal Investigator;Wolfgang Reith, MD;Saarland University Hospital;Carotid Artery Stenting with Proximal Protection | Carotid Artery Stenting without Protection;63680576;1;;;2011;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;3;
NCT01330485;ClinicalTrials.gov processed this data on May 29, 2020;2011-04-04;;;2019-04-08;2011-04-05;2011-04-07;Estimate;;;;;;;2019-04-08;2019-04-10;Actual;November 2010;;2010-11-30;April 2019;2019-04-30;September 2014;Actual;2014-09-30;April 2014;Actual;2014-04-30;;Interventional;;;Deficits in Emotion Regulation Skills as a Maintaining Factor in Major Depressive Disorder;Deficits in Emotion Regulation Skills as a Maintaining Factor in Major Depressive Disorder;Completed;;N/A;218;Actual;Friedrich-Alexander-Universität Erlange-Nürnberg;;3;;;FALSE;;;;FALSE;;;;;;;;From January 2018 to January 2028;Credible and legitimate reason for request;;Yes;Deidentified IPD will be made available to other researchers upon reguest.;2020-06-01T15:37:43Z;2020-06-01T15:37:43Z;Erlangen;3645105;Principal Investigator;Matthias Berking, Prof. Dr.;Friedrich-Alexander-University Erlangen-Nuremberg;Affect Regulation Training | Common Factor Control Condition;63680652;3;;;2011;2020-05-29;41;FALSE;;FALSE;FALSE;18;;Years;;1;1;2
NCT01326767;ClinicalTrials.gov processed this data on May 29, 2020;2011-03-29;;;2016-01-26;2011-03-30;2011-03-31;Estimate;;;;;;;2016-01-26;2016-01-27;Estimate;March 2011;;2011-03-31;January 2016;2016-01-31;December 2014;Actual;2014-12-31;December 2014;Actual;2014-12-31;;Interventional;CEPAC-TDM;;Central European Society for Anticancer Research (CESAR) Study of Paclitaxel Therapeutic Drug Monitoring;An Open-Label, Randomized, Parallel Group Study of Patients Treated With Paclitaxel With Standard Dosing Versus Pharmacokinetic Guided Dose Adjustment in Patients With Advanced Non Small Cell Lung Cancer (NSCLC);Completed;;Phase 3;366;Actual;Central European Society for Anticancer Drug Research;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:39:00Z;2020-06-01T15:39:00Z;Tübingen;3645529;Principal Investigator;Frank Mayer, MD;Eberhard-Karls-Universität Tübingen;Paclitaxel dosing according to SmPC | Individualized pharmacokinetically driven paclitaxel dosing;63680929;11;;;2011;2020-05-29;45;FALSE;;FALSE;FALSE;18;75;Years;Years;1;9;
NCT01320254;ClinicalTrials.gov processed this data on May 29, 2020;2011-03-21;;;2017-10-11;2011-03-21;2011-03-22;Estimate;;;;;;;2017-10-11;2017-10-12;Actual;June 2011;;2011-06-30;October 2017;2017-10-31;September 12, 2016;Actual;2016-09-12;September 12, 2016;Actual;2016-09-12;;Interventional;PiCCA;;PiCCA Study (Panitumumab in Combination With Cisplatin/Gemcitabine);Panitumumab in Combination With Cisplatin/Gemcitabine Chemotherapy in Patients With Cholangiocarcinomas - a Randomized Clinical Phase II Study;Completed;;Phase 2;93;Actual;Hannover Medical School;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:40:28Z;2020-06-01T15:40:28Z;Hannover;3646108;Study Chair;Arndt Vogel, PD Dr. MD;Hannover Medical School;Cisplatin, Gemcitabine, Panitumumab | Cisplatin, Gemcitabine;63681422;16;;;2011;2020-05-29;63;FALSE;;FALSE;FALSE;18;;Years;;1;5;
NCT01317134;ClinicalTrials.gov processed this data on May 29, 2020;2011-03-15;;;2016-01-26;2011-03-15;2011-03-17;Estimate;;;;;;;2016-01-26;2016-01-27;Estimate;July 2010;;2010-07-31;January 2016;2016-01-31;July 2016;Anticipated;2016-07-31;December 2015;Actual;2015-12-31;;Interventional;;;Endothelial Function in Patients With Pulmonary Arterial Hypertension;Serological and Non-invasive Evaluation of Endothelial Function in Patients With Pulmonary Arterial Hypertension;Unknown status;;N/A;90;Actual;Universitätsklinikum Hamburg-Eppendorf;;3;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T15:41:14Z;2020-06-01T15:41:14Z;Hamburg;3646374;Study Director;Hans FE Klose, MD;Department of Respiratory Medicine, University Medical Center Hamburg-Eppendorf;EndoPAT measurement | Blood Test;63681662;1;;;2011;2020-05-29;65;FALSE;;FALSE;TRUE;18;;Years;;1;6;
NCT01312623;ClinicalTrials.gov processed this data on May 29, 2020;2011-03-08;;;2016-10-31;2011-03-09;2011-03-10;Estimate;;;;;;;2016-10-31;2016-11-01;Estimate;March 2010;;2010-03-31;October 2016;2016-10-31;May 2014;Actual;2014-05-31;March 2014;Actual;2014-03-31;;Interventional;RIPHeart;;Organ Protection by Remote Ischemic Preconditioning for Surgical Treatment of Pediatric Congenital Heart Disease;Organ Protection by Remote Ischemic Preconditioning for Surgical Treatment of Pediatric Congenital Heart Disease;Terminated;;N/A;31;Actual;University of Schleswig-Holstein;;2;;Terminated, because it is not possible to recruit enough participants;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T15:42:47Z;2020-06-01T15:42:47Z;Kiel Lübeck;3646749;Principal Investigator;Axel Fudickar, Dr.;University Hospital Schleswig-Holstein, Campus Kiel;Remote ischemic preconditioning;63681999;1;;;2011;2020-05-29;48;FALSE;;FALSE;TRUE;;16;;Years;1;;
NCT01303952;ClinicalTrials.gov processed this data on May 29, 2020;2011-02-24;;;2017-07-17;2011-02-24;2011-02-25;Estimate;;;;;;;2017-07-17;2017-07-19;Actual;January 2011;Actual;2011-01-31;July 2017;2017-07-31;June 2015;Actual;2015-06-30;September 2014;Actual;2014-09-30;;Interventional;DECADE;;Therapy of Chronic Cold Agglutinin Disease With Eculizumab;Therapy for Chronic Cold Agglutinin Disease: A Prospective, Non-Randomized Multi-Center Study Demonstrating the Efficacy of Terminal Complement Inhibition in Patients With Cold Agglutinin Disease Using Eculizumab;Completed;;Phase 2;13;Actual;University Hospital, Essen;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:45:30Z;2020-06-01T15:45:30Z;Duisburg;3647498;Principal Investigator;Alexander Roeth, MD;Department of Hematology, University Hospital Essen;Eculizumab;63682655;1;;;2011;2020-05-29;44;FALSE;;FALSE;TRUE;18;;Years;;1;12;
NCT01303250;ClinicalTrials.gov processed this data on May 29, 2020;2011-02-22;;;2015-12-17;2011-02-22;2011-02-24;Estimate;;;;;;;2015-12-17;2015-12-18;Estimate;April 2011;;2011-04-30;December 2015;2015-12-31;April 2015;Actual;2015-04-30;April 2015;Actual;2015-04-30;;Interventional;KoKris;;Perioperative Colloid vs Crystalloid in Patients Undergoing Colorectal Surgery;Balanced 6 % HES 130/0.4 vs. Balanced Crystalloid-based Infusion in Patients Undergoing Colorectal Surgery;Terminated;;Phase 4;31;Actual;University Hospital Muenster;;2;;The final decision of the review of HES-containing solution shall be awaited.;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:45:41Z;2020-06-01T15:45:41Z;Münster;3647563;Principal Investigator;Hugo Van Aken, Prof. MD;Department of Anesthesia and Intensive Care, University Hospital Muenster;balanced 6% hydroxyethylstarch 130/0.4 | balanced crystalloid;63682708;1;;;2011;2020-05-29;48;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT01301430;ClinicalTrials.gov processed this data on May 29, 2020;2011-02-21;;;2015-12-03;2011-02-22;2011-02-23;Estimate;;;;;;;2015-12-03;2015-12-04;Estimate;September 2011;;2011-09-30;March 2015;2015-03-31;May 2015;Actual;2015-05-31;May 2015;Actual;2015-05-31;;Interventional;ParvOryx01;;Parvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme.;Phase I/IIa Study of Intratumoral/Intracerebral or Intravenous/Intracerebral Administration of Parvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme.;Completed;;Phase 1/Phase 2;18;Actual;Oryx GmbH & Co. KG;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:46:16Z;2020-06-01T15:46:16Z;Heidelberg;3647693;Principal Investigator;Andreas Unterberg, Prof. Dr.;Department of Neurosurgery, University Hospital Heidelberg;H-1PV;63682847;1;;;2011;2020-05-29;44;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT01291693;ClinicalTrials.gov processed this data on May 29, 2020;2011-02-04;;;2015-12-01;2011-02-07;2011-02-08;Estimate;;;;;;;2015-12-01;2015-12-03;Estimate;February 2011;;2011-02-28;December 2015;2015-12-31;November 2014;Actual;2014-11-30;November 2014;Actual;2014-11-30;;Interventional;PECO;;Testing Delivery Channels of Brief Motivational Alcohol Intervention;Testing Delivery Channels of Brief Motivational Alcohol Intervention Among General Hospital Inpatients With Risky Drinking: Personal Counseling Versus Computer-generated Feedback Letters;Completed;;Phase 2/Phase 3;975;Actual;University Medicine Greifswald;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:48:47Z;2020-06-01T15:48:47Z;Berlin Greifswald;3648476;Principal Investigator;Jennis Freyer-Adam, PhD;Institute of Social Medicine and Prevention, University Medicine Greifswald;Personal Counseling | Computer-generated feedback letters;63683591;1;;;2011;2020-05-29;45;FALSE;;FALSE;TRUE;18;64;Years;Years;1;7;
NCT01289938;ClinicalTrials.gov processed this data on May 29, 2020;2011-02-02;;;2016-05-12;2011-02-03;2011-02-04;Estimate;;;;;;;2016-05-12;2016-05-13;Estimate;July 2009;;2009-07-31;May 2016;2016-05-31;June 2015;Actual;2015-06-30;June 2015;Actual;2015-06-30;;Interventional;MalD;;Pharmacogenetic Factors and Side Effects of Metoclopramide and Diphenhydramine;Pharmacogenetic Factors and Side Effects of Metoclopramide and Diphenhydramine;Terminated;;Phase 1;49;Actual;University Hospital Tuebingen;;2;;To unsuccessful recruitment of rare UM-genotype. All other planned genotype groups are~   completed (EM, IM and PM).;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:49:17Z;2020-06-01T15:49:17Z;Tübingen;;;;;Diphenhydramine | Metoclopramide;63683728;1;;;2011;2020-05-29;72;FALSE;;FALSE;TRUE;18;65;Years;Years;2;4;
NCT01283776;ClinicalTrials.gov processed this data on May 29, 2020;2011-01-25;;;2014-06-08;2011-01-25;2011-01-26;Estimate;;;;;;;2014-06-08;2014-06-10;Estimate;March 2011;;2011-03-31;June 2014;2014-06-30;June 2014;Actual;2014-06-30;December 2013;Actual;2013-12-31;;Interventional;OCTET-CY;;Cyclophosphamide as Sole Graft-Versus-Host-Prophylaxis After Allogeneic Stem Cell Transplantation;A Phase II Study to Investigate the Efficacy of Cyclophosphamide as Sole Graft-Versus-Host-Prophylaxis After Allogeneic Stem Cell Transplantation;Completed;;Phase 2;11;Actual;University of Cologne;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:51:24Z;2020-06-01T15:51:24Z;Köln;3649208;Principal Investigator;Christoph Scheid, MD PhD;University of Cologne;Cyclophosphamide;63684197;1;;;2011;2020-05-29;33;FALSE;;FALSE;TRUE;18;;Years;;1;7;
NCT01282918;ClinicalTrials.gov processed this data on May 29, 2020;2011-01-18;;;2015-06-22;2011-01-24;2011-01-25;Estimate;;;;;;;2015-06-22;2015-06-23;Estimate;February 2011;;2011-02-28;June 2015;2015-06-30;May 2015;Actual;2015-05-31;December 2014;Actual;2014-12-31;;Interventional;;;NORDIC ICD (Cardioverter Defibrillator Implantation) Trial;NO Regular Defibrillation Testing In Cardioverter Defibrillator Implantation (NORDIC ICD) Trial;Completed;;N/A;1077;Actual;Biotronik SE & Co. KG;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:51:42Z;2020-06-01T15:51:42Z;Rostock;3649294;Principal Investigator;Dietmar Bänsch, Prof. Dr. med.;Rostock University Hospital;ICD implantation w/o DF test | ICD implantation with DF test;63684263;2;;;2011;2020-05-29;46;FALSE;;FALSE;FALSE;18;;Years;;1;2;
NCT01279577;ClinicalTrials.gov processed this data on May 29, 2020;2011-01-18;;;2015-02-09;2011-01-18;2011-01-19;Estimate;;;;;;;2015-02-09;2015-02-10;Estimate;November 2010;;2010-11-30;February 2015;2015-02-28;February 2014;Actual;2014-02-28;February 2014;Actual;2014-02-28;;Interventional;TRUST-2;;Trichuris Suis Ova (TSO) Suspension Versus Placebo in Active Crohn's Disease;Double-blind, Randomised, Placebo-controlled, Multi-centre Phase II Study to Evaluate the Efficacy and Safety of Three Different Dosages of Oral Trichuris Suis Ova (TSO) Suspension in Active Crohn's Disease;Completed;;Phase 2;254;Actual;Dr. Falk Pharma GmbH;;4;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:52:26Z;2020-06-01T15:52:26Z;Frankfurt;3649579;Principal Investigator;Jürgen Schölmerich, Prof.;Klinikum der Johann Wolfgang Goethe-Universität;Placebo | Low dose TSO | Medium dose TSO | High dose TSO;63684518;1;;;2011;2020-05-29;39;FALSE;;FALSE;TRUE;18;75;Years;Years;1;2;
NCT01279174;ClinicalTrials.gov processed this data on May 29, 2020;2011-01-18;;;2015-12-08;2011-01-18;2011-01-19;Estimate;;;;;;;2015-12-08;2015-12-09;Estimate;June 2012;;2012-06-30;December 2015;2015-12-31;October 2015;Actual;2015-10-31;June 2015;Actual;2015-06-30;;Interventional;;;Galileo-Hip Whole Body Vibration /Conventional Physiotherapy /Coxarthrosis;Whole Body Vibration Compared to Conventional Physiotherapy in Patients With Coxarthrosis: a Randomized, Controlled Study;Completed;;Phase 4;40;Actual;University of Cologne;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:52:29Z;2020-06-01T15:52:29Z;Köln;3649623;Principal Investigator;Peter Knöll;University Hospital of Cologne;Conventional physiotherapy;63684550;1;;;2011;2020-05-29;36;FALSE;;FALSE;TRUE;30;80;Years;Years;1;2;
NCT01278537;ClinicalTrials.gov processed this data on May 29, 2020;2011-01-18;;;2014-03-13;2011-01-18;2011-01-19;Estimate;;;;;;;2014-03-13;2014-03-14;Estimate;February 2011;;2011-02-28;March 2014;2014-03-31;February 2014;Actual;2014-02-28;January 2014;Actual;2014-01-31;;Interventional;PERATECS;;Patient Empowerment and Risk-assessed Treatment to Improve Outcome in the Elderly After Onco-surgery;Patient Empowerment and Risk-assessed Treatment to Improve Outcome in the Elderly After Gastrointestinal, Thoracical or Urogenital Cancer Surgery.;Completed;;N/A;690;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:52:37Z;2020-06-01T15:52:37Z;Berlin;3649664;Study Chair;Claudia Spies, MD Prof.;Department of Anesthesiology and Intensive Care Medicine, Campus Virchow-Klinikum and Campus Charité Mitte, Charité - Universitaetsmedizin Berlin;Information;63684598;3;;;2011;2020-05-29;35;FALSE;;FALSE;FALSE;65;;Years;;2;5;
NCT01277406;ClinicalTrials.gov processed this data on May 29, 2020;2011-01-10;;;2015-03-31;2011-01-13;2011-01-14;Estimate;;;;;;;2015-03-31;2015-04-01;Estimate;January 2011;;2011-01-31;March 2015;2015-03-31;February 2015;Actual;2015-02-28;February 2013;Actual;2013-02-28;;Interventional;SHORE;;4SC-201 (Resminostat) in Advanced Colorectal Carcinoma;A Phase I/II Study to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of Resminostat (4SC-201) in Combination With a Second-line Treatment in Patients With K-ras Mutated Advanced Colorectal Carcinoma;Completed;;Phase 1/Phase 2;17;Actual;4SC AG;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:52:54Z;2020-06-01T15:52:54Z;Heidelberg;3649783;Principal Investigator;Dirk Jäger, Prof. Dr.;"Medical Oncology National Centre for Tumor Diseases (NCT); University of Heidelberg";4SC-201(Resminostat) | FOLFIRI;63684684;3;;;2011;2020-05-29;25;FALSE;;FALSE;FALSE;18;;Years;;2;13;
NCT01276002;ClinicalTrials.gov processed this data on May 29, 2020;2011-01-12;;;2015-12-04;2011-01-12;2011-01-13;Estimate;;;;;;;2015-12-04;2015-12-07;Estimate;January 2011;;2011-01-31;December 2015;2015-12-31;December 2016;Anticipated;2016-12-31;December 2016;Anticipated;2016-12-31;;Interventional;Disduct;;Evaluation of Pancreatic Duct Stenting in Patients With Pancreatic Pseudocysts.;Randomized Multicenter Study on Pancreatic Duct Stenting in Disrupted or Obstructed Ducts in Context With Endoscopic Treatment of Pancreatic Pseudocysts.;Unknown status;;N/A;120;Anticipated;University of Schleswig-Holstein;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:53:17Z;2020-06-01T15:53:17Z;Kiel Lübeck;3649899;Principal Investigator;Mark Ellrichmann, MD;Interdisciplinary Endoscopy, University hospital Schleswig-Holstein, Campus Kiel, Germany;pancreatic duct stenting;63684794;1;;;2011;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT01272557;ClinicalTrials.gov processed this data on May 29, 2020;2011-01-06;;;2014-03-31;2011-01-06;2011-01-07;Estimate;;;;;;;2014-03-31;2014-04-01;Estimate;December 2010;;2010-12-31;March 2014;2014-03-31;December 2014;Anticipated;2014-12-31;September 2014;Anticipated;2014-09-30;;Interventional;SoraDox;;Sorafenib Plus Doxorubicin Versus Sorafenib Alone for the Treatment of Advanced Hepatocellular Carcinoma: a Randomized Phase II Trial;Sorafenib Plus Doxorubicin Versus Sorafenib Alone for the Treatment of Advanced Hepatocellular Carcinoma: a Randomized Phase II Trial;Unknown status;;Phase 2;170;Anticipated;Martin-Luther-Universität Halle-Wittenberg;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:54:07Z;2020-06-01T15:54:07Z;Halle;;;;;Doxorubicin | Sorafenib;63685058;6;;;2011;2020-05-29;;FALSE;;FALSE;FALSE;18;;Years;;1;1;
NCT01269151;ClinicalTrials.gov processed this data on May 29, 2020;2011-01-03;;;2015-04-07;2011-01-03;2011-01-04;Estimate;;;;;;;2015-04-07;2015-04-08;Estimate;October 2010;;2010-10-31;April 2015;2015-04-30;April 2014;Actual;2014-04-30;March 2013;Actual;2013-03-31;;Interventional;LucERG;;Ranibizumab Short- and Log-term Effects on Retinal Function in wAMD;A Prospective, Non-randomized, Mono-center, Cohort Study to Evaluate the Short- and Long-term Effects of 0.5mg Intraocular Ranibizumab (Lucentis) Injections on Retinal Function in Patients With Wet Age-related Macular Degeneration During Twelve Month;Completed;;N/A;20;Actual;University of Luebeck;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:55:01Z;2020-06-01T15:55:01Z;Lübeck;3650573;Principal Investigator;Salvatore Grisanti, M.D. Prof.;University of Luebeck - Department of Ophthalmology: Germany;Lucentis (Ranibizumab);63685319;1;;;2011;2020-05-29;29;FALSE;;FALSE;TRUE;50;;Years;;1;3;
NCT01267838;ClinicalTrials.gov processed this data on May 29, 2020;2010-12-28;;;2016-09-04;2010-12-28;2010-12-29;Estimate;;;;;;;2016-09-04;2016-09-07;Estimate;February 2010;;2010-02-28;September 2016;2016-09-30;April 2016;Actual;2016-04-30;February 2015;Actual;2015-02-28;;Interventional;BBK2;;Culotte Technique Versus TAP Stunting for the Treatment of de Novo Coronary Bifurcation Lesion With Drug-eluting Stents;Randomised Comparison of T-stenting Versus Culotte Technique for the Treatment of de Novo Coronary Bifurcation Lesion With Drug-eluting Stents.;Completed;;Phase 4;300;Actual;University Heart Center Freiburg - Bad Krozingen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T15:55:15Z;2020-06-01T15:55:15Z;Freiburg;;;;;PCI;63685420;1;;;2010;2020-05-29;60;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT01266837;ClinicalTrials.gov processed this data on May 29, 2020;2010-12-23;;;2017-11-10;2010-12-23;2010-12-24;Estimate;;;;;;;2017-11-10;2017-11-14;Actual;March 2011;;2011-03-31;November 2017;2017-11-30;October 31, 2017;Actual;2017-10-31;September 26, 2017;Actual;2017-09-26;;Interventional;MARC-2;;Open Label, Single Arm Trial to Characterize Patients With Metastatic RCC Treated With Everolimus After Failure of the First VEGF-targeted Therapy (MARC-2);An Open Label, Single Arm Trial to Characterize Patients With Metastatic Renal Cell Carcinoma Treated With Everolimus After Failure of the First VEGF-targeted Therapy;Completed;;Phase 4;64;Actual;iOMEDICO AG;;1;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T15:55:31Z;2020-06-01T15:55:31Z;Munich;3650743;Study Director;Michael Staehler, Dr. med;Ludwig-Maximilians-University Munich, Hospital Grosshadern;Everolimus;63685497;8;;;2010;2020-05-29;79;FALSE;;FALSE;FALSE;18;;Years;;1;1;
NCT01266655;ClinicalTrials.gov processed this data on May 29, 2020;2010-12-23;;;2014-09-04;2010-12-23;2010-12-24;Estimate;;;;;;;2014-09-04;2014-09-05;Estimate;February 2011;;2011-02-28;September 2014;2014-09-30;May 2014;Actual;2014-05-31;May 2014;Actual;2014-05-31;;Interventional;BACLAD;;Baclofen for the Treatment of Alcohol Dependence;Baclofen for the Treatment of Alcohol Dependence - BACLAD;Completed;;Phase 2/Phase 3;56;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:55:33Z;2020-06-01T15:55:33Z;Berlin;3650761;Principal Investigator;Andreas Heinz, Prof., M.D.;Department of Psychiatry, Charité Campus Mitte, Charité - Universitätsmedizin Berlin, Germany;Baclofen | Placebo;63685511;1;;;2010;2020-05-29;39;FALSE;;FALSE;TRUE;18;64;Years;Years;1;1;
NCT01266187;ClinicalTrials.gov processed this data on May 29, 2020;2010-12-20;;;2015-09-21;2010-12-22;2010-12-24;Estimate;;;;;;;2015-09-21;2015-09-22;Estimate;July 2011;;2011-07-31;September 2015;2015-09-30;September 2015;Actual;2015-09-30;September 2015;Actual;2015-09-30;;Interventional;;;Treatment Regimens for Patients With Resectable Liver Metastases (PANTER Study);Perioperative Chemotherapy With FOLFOX Plus Cetuximab Versus Adjuvant FOLFOX Plus Cetuximab for Patients With Resectable Liver Metastases of Colorectal Carcinoma;Terminated;;N/A;16;Actual;RWTH Aachen University;;2;;Recruitment difficulities;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:55:38Z;2020-06-01T15:55:38Z;Aachen;3650805;Study Director;Ulf P Neumann, Prof.;RWTH Aachen University Hospital;adjuvant surgery + FOLFOX + cetuximab | perioperative/Folfox + cetuximab;63685546;1;;;2010;2020-05-29;50;FALSE;;FALSE;TRUE;18;;Years;;2;1;
NCT01264549;ClinicalTrials.gov processed this data on May 29, 2020;2010-12-21;;;2018-11-28;2010-12-21;2010-12-22;Estimate;;;;;;;2018-11-28;2018-11-29;Actual;December 2010;;2010-12-31;November 2018;2018-11-30;October 2014;Actual;2014-10-31;October 2014;Actual;2014-10-31;;Interventional;STRAWINSKI;;Stroke Adverse Outcome is Associated With Nosocomial Infections: PCTus- Guided Antibacterial Therapy in Severe Ischemic Stroke Patients (STRAWINSKI);Stroke Adverse Outcome is Associated With Nosocomial Infections: PCTus- Guided Antibacterial Therapy in Severe Ischemic Stroke Patients;Completed;;N/A;230;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:56:06Z;2020-06-01T15:56:06Z;Berlin;3650928;Principal Investigator;Andreas Meisel, MD;Charité University Berlin (Center for Stroke Research Berlin CSB & NeuroCure Clinical Research Center NCRC);Procalcitonin assay - B.R.A.H.M.S PCT ultrasensitive Kryptor;63685671;6;;;2010;2020-05-29;46;FALSE;;FALSE;FALSE;18;;Years;;1;15;
NCT01263977;ClinicalTrials.gov processed this data on May 29, 2020;2010-12-20;;;2014-06-05;2010-12-20;2010-12-21;Estimate;;;;;;;2014-06-05;2014-06-06;Estimate;December 2010;;2010-12-31;June 2014;2014-06-30;May 2014;Actual;2014-05-31;May 2014;Actual;2014-05-31;;Interventional;THEMIS;;Thermodilution - Controlled Management of Volume Therapy in Septic Shock;A Randomized Mono-center Study Looking at the Effect of Thermodilution Controlled Therapy for Volume Optimization on the Duration of Septic Shock in Patients With Septic Shock;Completed;;N/A;60;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:56:12Z;2020-06-01T15:56:12Z;Berlin;3651002;Study Director;Claudia D Spies, MD, Prof.;Dept. of Anesthesiology and Intensive Care Medicine, CCM and CVK, Charité - Universitaetsmedizin Berlin;Picco- thermodilution catheter;63685715;1;;;2010;2020-05-29;41;FALSE;;FALSE;TRUE;18;;Years;;1;4;
NCT01262729;ClinicalTrials.gov processed this data on May 29, 2020;2010-12-16;;;2015-09-22;2010-12-16;2010-12-17;Estimate;;;;;;;2015-09-22;2015-09-23;Estimate;September 2011;;2011-09-30;September 2015;2015-09-30;December 2014;Actual;2014-12-31;November 2014;Actual;2014-11-30;;Interventional;10-015;;Xenon and Therapeutical Hypothermia After Successful Cardiopulmonary Resuscitation;Xenon and Therapeutical Hypothermia After Successful Cardiopulmonary Resuscitation;Terminated;;Phase 2;5;Actual;RWTH Aachen University;;2;;Feasibility and Recruitment problems;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:56:52Z;2020-06-01T15:56:52Z;Aachen;3651116;Principal Investigator;Michael Fries, PD Dr. med.;Surgical Intensive Care - Adults, University Hospital Aachen;therapeutical hypothermia | Xenon Inhalation;63685810;1;;;2010;2020-05-29;38;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT01259830;ClinicalTrials.gov processed this data on May 29, 2020;2010-12-13;;;2014-05-22;2010-12-13;2010-12-14;Estimate;;;;;;;2014-05-22;2014-05-23;Estimate;March 2011;;2011-03-31;May 2014;2014-05-31;April 2014;Actual;2014-04-30;April 2014;Actual;2014-04-30;;Interventional;;;Effectiveness of Etoricoxib as an Additive Analgesic to Epidural Analgesia in Colon or Rectal Fast-track Surgery;A Double-blind, Randomized, Placebo Controlled Study to Evaluate the Effectiveness of Etoricoxib as an Additive Analgesic to Epidural Analgesia in Colon or Rectal Fast-track Surgery;Terminated;;Phase 4;81;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:57:45Z;2020-06-01T15:57:45Z;Berlin;3651376;Study Director;Claudia Spies, MD, Prof.;Dept. of Anesthesiology and Intensive Care, Charité, Universitätsmedizin Berlin;Arcoxia®120 mg | P Tablet White Lichtenstein;63686032;4;;;2010;2020-05-29;37;FALSE;;FALSE;FALSE;18;;Years;;1;10;
NCT01258257;ClinicalTrials.gov processed this data on May 29, 2020;2010-12-09;;;2017-02-02;2010-12-09;2010-12-10;Estimate;;;;;;;2017-02-02;2017-02-03;Estimate;January 2011;;2011-01-31;February 2017;2017-02-28;September 2016;Actual;2016-09-30;August 2016;Actual;2016-08-31;;Interventional;EARLYDRAIN;;EARLYdrain - Outcome After Early Lumbar CSF-drainage in Aneurysmal SAH;EARLYdrain - Prospective Outcome Study of Early Lumbar Drainage in Aneurysmal Subarachnoid Hemorrhage;Completed;;Phase 3;300;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;TRUE;;;;;;;;;;;Yes;Full anonymized data is planned to be shared among collaborators.;2020-06-01T15:58:17Z;2020-06-01T15:58:17Z;Berlin;3651497;Principal Investigator;Stefan Wolf, Dr.;Charite University medicine / department of neurosurgery;Insertion of a lumbar drain;63686154;1;;;2010;2020-05-29;67;FALSE;;FALSE;TRUE;18;;Years;;1;9;
NCT01258153;ClinicalTrials.gov processed this data on May 29, 2020;2010-12-09;;;2015-05-26;2010-12-09;2010-12-10;Estimate;;;;;;;2015-05-26;2015-06-10;Estimate;November 2010;;2010-11-30;May 2015;2015-05-31;March 2014;Actual;2014-03-31;December 2013;Actual;2013-12-31;;Interventional;no-cry;;Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant Colic;Double-blind, Randomised, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Oral Administration of Nepadutant in Infant Colic;Completed;;Phase 2;115;Actual;Menarini Group;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T15:58:18Z;2020-06-01T15:58:18Z;Munich;3651503;Study Chair;Sibylle Koletzko, MD;Dr. v. Haunersches Kinderspital Ludwig Maximilians University D- 80337 München, Germany;Placebo matching Nepadutant oral solution | Nepadutant oral solution | Nepadutant oral solution;63686162;9;40;2;2010;2020-05-29;37;TRUE;16;FALSE;FALSE;;20;;Weeks;1;5;
NCT01257360;ClinicalTrials.gov processed this data on May 29, 2020;2010-12-01;;;2016-01-12;2010-12-08;2010-12-09;Estimate;;;;;;;2016-01-12;2016-01-13;Estimate;December 2010;;2010-12-31;January 2016;2016-01-31;July 2016;Anticipated;2016-07-31;January 2016;Actual;2016-01-31;;Interventional;NEO-RIT;;Panitumumab in Combination With Radiotherapy in Patients With Locally Advanced RAS Wildtype Rectal Cancer (Clinical Stages II and III);NEO-RIT - Panitumumab in Combination With Radiotherapy in Patients With Locally Advanced RAS Wildtype Rectal Cancer (Clinical Stages II and III);Unknown status;;Phase 2;59;Actual;WiSP Wissenschaftlicher Service Pharma GmbH;;;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:58:30Z;2020-06-01T15:58:30Z;Mannheim;3651637;Principal Investigator;Ralf Hofheinz, Prof. Dr. med.;Tagestherapiezentrum am ITM & III. Medizinische Klinik, Universitätsmedizin Mannheim;Panitumumab | Radiation of the pelvis;63686224;5;;;2010;2020-05-29;61;FALSE;;FALSE;FALSE;18;;Years;;1;6;
NCT01252459;ClinicalTrials.gov processed this data on May 29, 2020;2010-12-02;;;2010-12-15;2010-12-02;2010-12-03;Estimate;;;;;;;2010-12-15;2010-12-16;Estimate;July 2011;;2011-07-31;December 2010;2010-12-31;July 2014;Anticipated;2014-07-31;July 2013;Anticipated;2013-07-31;;Interventional;GLIAA;;Amino-acid PET Versus MRI Guided Re-irradiation in Patients With Recurrent Glioblastoma Multiforme;Amino-acid PET Versus MRI Guided Re-irradiation in Patients With Recurrent Glioblastoma Multiforme - a Randomised Phase II Trial;Unknown status;;Phase 2;200;Anticipated;University Hospital Freiburg;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T15:59:52Z;2020-06-01T15:59:52Z;Freiburg;3652011;Study Chair;Anca-Ligia Grosu, Prof. Dr. med.;Department of Radiotherapy, University Hospital Freiburg;Radiation Therapy | Radiation Therapy;63686594;1;;;2010;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;7;
NCT01249638;ClinicalTrials.gov processed this data on May 29, 2020;2010-11-29;;;2011-03-11;2010-11-29;2010-11-30;Estimate;;;;;;;2011-03-11;2011-03-14;Estimate;December 2010;;2010-12-31;November 2010;2010-11-30;December 2016;Anticipated;2016-12-31;December 2013;Anticipated;2013-12-31;;Interventional;;;Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRC;Randomized, Open, Multicenter Phase III Study With Capecitabine Plus Bevacizumab Versus Capecitabine Plus Irinotecan Plus Bevacizumab as First-line Therapy in Patients With Metastatic Colorectal Cancer;Unknown status;;Phase 3;516;Anticipated;Ludwig-Maximilians - University of Munich;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:00:57Z;2020-06-01T16:00:57Z;Munich;3652229;Principal Investigator;Volker Heinemann, Prof. Dr. med.;University of Munich - Klinikum der Universitaet Muenchen;Capecitabine | Bevacizumab | Capecitabine | Irinotecan | Bevacizumab;63686808;1;;;2010;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT01247792;ClinicalTrials.gov processed this data on May 29, 2020;2010-11-11;;;2017-08-08;2010-11-23;2010-11-24;Estimate;;;;;;;2017-08-08;2017-08-09;Actual;August 2010;;2010-08-31;August 2017;2017-08-31;September 30, 2014;Actual;2014-09-30;September 30, 2014;Actual;2014-09-30;;Interventional;EIDECS;;End-of-life Decision-making in Patients With Sepsis-related Organ Failure;A Time-series Intervention Analysis of End-of-life Decision-making in Patients With Sepsis-related Organ Failure;Completed;;N/A;174;Actual;Center for Sepsis Control and Care, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T16:01:25Z;2020-06-01T16:01:25Z;Jena;3652398;Principal Investigator;Christiane S Hartog, MD;Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital;SOPs for decision-making and communication;63686950;1;;;2010;2020-05-29;49;FALSE;;FALSE;TRUE;;;;;2;7;
NCT01246752;ClinicalTrials.gov processed this data on May 29, 2020;2010-11-22;;;2014-12-02;2010-11-22;2010-11-23;Estimate;;;;;;;2014-12-02;2014-12-03;Estimate;November 2010;;2010-11-30;December 2014;2014-12-31;December 2017;Anticipated;2017-12-31;December 2017;Anticipated;2017-12-31;;Interventional;AML;;Haematopoietic Stem Cell Transplantation (HSCT) in Comparison to Conventional Consolidation Therapy for Patients With Acute Myeloid Leukemia (AML) (Intermediate Risk) <= 60y. After First CR;Randomised Trial on Allogeneic Haematopoietic Stem Cell Transplantation in Patients Under the Age of 60 Years With Acute Myeloid Leukemia of Intermediate Risk in First Complete Remission and a Matched Sibling or Unrelated Donor (ETAL-1);Unknown status;;Phase 3;356;Anticipated;University Hospital Carl Gustav Carus;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:01:41Z;2020-06-01T16:01:41Z;Dresden;3652506;Principal Investigator;Martin Bornhaeuser, Prof. (MD);Universitätsklinikum Dresden, Medizinische Klinik und Poliklinik I, Germany;Human Stem Cell Transplantation | Consolidation chemotherapy, i.e. High-dose Cytarabine (HiDAC);63687030;27;;;2010;2020-05-29;;FALSE;;FALSE;FALSE;18;60;Years;Years;1;4;
NCT01245075;ClinicalTrials.gov processed this data on May 29, 2020;2010-11-19;;;2016-12-06;2010-11-19;2010-11-22;Estimate;;;;;;;2016-12-06;2016-12-07;Estimate;January 2011;;2011-01-31;December 2016;2016-12-31;December 2017;Anticipated;2017-12-31;June 2017;Anticipated;2017-06-30;;Interventional;NASA;;Deep Brain Stimulation of the Nucleus Accumbens as a Novel Treatment in Severe Opioid Addiction;Deep Brain Stimulation of the Nucleus Accumbens as a Novel Treatment in Severe Opioid Addiction;Unknown status;;Early Phase 1;10;Anticipated;University of Cologne;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:02:05Z;2020-06-01T16:02:05Z;Köln;3652651;Principal Investigator;Veerle Visser-Vandewalle, MD;University of Cologne;Deep brain stimulation | Placebo;63687158;1;;;2010;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT01244958;ClinicalTrials.gov processed this data on May 29, 2020;2010-09-28;;;2016-03-23;2010-11-19;2010-11-22;Estimate;;;;;;;2016-03-23;2016-03-24;Estimate;August 2010;;2010-08-31;March 2016;2016-03-31;February 2015;Actual;2015-02-28;February 2015;Actual;2015-02-28;;Interventional;;;Addition of Rituximab to Leflunomide in Patients With Active Rheumatoid Arthritis;Addition of Rituximab to Leflunomide in Patients With Active Rheumatoid Arthritis - a Multicenter Randomised Double-blind Clinical Trial;Completed;;Phase 3;156;Actual;Johann Wolfgang Goethe University Hospital;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:02:10Z;2020-06-01T16:02:10Z;Frankfurt;3652658;Principal Investigator;Frank Behrens, Dr. med.;Department of Medicine II / Rheumatology Johann Wolfgang Goethe-Universität;Rituximab | Placebo;63687168;45;;;2010;2020-05-29;54;FALSE;;FALSE;FALSE;18;75;Years;Years;2;25;
NCT01242956;ClinicalTrials.gov processed this data on May 29, 2020;2010-11-16;;;2015-09-22;2010-11-16;2010-11-17;Estimate;;;;;;;2015-09-22;2015-09-23;Estimate;September 2011;;2011-09-30;September 2015;2015-09-30;September 2015;Actual;2015-09-30;November 2014;Actual;2014-11-30;;Interventional;;;Video-based Training for Rehabilitation of Upper Limb Functions After Stroke;Video-based Training for Rehabilitation of Upper Limb Functions After Stroke: a New Treatment Exploiting the Mirror Neuron System;Terminated;;Phase 2;100;Actual;RWTH Aachen University;;2;;Problem to recruit sufficient patient number;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:02:55Z;2020-06-01T16:02:55Z;Aachen;;;;;verum group | Placebo group;63687319;1;;;2010;2020-05-29;38;FALSE;;FALSE;TRUE;30;80;Years;Years;1;1;
NCT01242631;ClinicalTrials.gov processed this data on May 29, 2020;2010-11-16;;;2015-02-24;2010-11-16;2010-11-17;Estimate;;;;;;;2015-02-24;2015-02-25;Estimate;November 2010;;2010-11-30;February 2015;2015-02-28;March 2014;Actual;2014-03-31;March 2014;Actual;2014-03-31;;Interventional;RADIT;;Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer;A Single Arm, Open-label Multicenter Phase II Trial of Everolimus in Patients With Relapsed/Refractory Germ Cell Cancer;Completed;;Phase 2;25;Actual;Hannover Medical School;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T16:03:00Z;2020-06-01T16:03:00Z;Hannover;3652847;Principal Investigator;Martin H Fenner, MD;Hannover Medical School;Everolimus;63687343;8;;;2010;2020-05-29;40;FALSE;;FALSE;FALSE;18;;Years;;1;3;
NCT01238770;ClinicalTrials.gov processed this data on May 29, 2020;2010-11-10;;;2016-02-08;2010-11-10;2010-11-11;Estimate;;;;;;;2016-02-08;2016-02-10;Estimate;November 2010;;2010-11-30;February 2016;2016-02-29;October 2015;Actual;2015-10-31;October 2014;Actual;2014-10-31;;Interventional;;;Phase I/II Study of Pazopanib and Cyclophosphamide in Patients With Platinum-resistant Recurrent Ovarian Cancer;A Phase I/II Study of Pazopanib (GW786034) and Cyclophosphamide in Patients With Platinum-resistant Recurrent, Pre-treated Ovarian Cancer;Completed;;Phase 1/Phase 2;10;Actual;University Hospital Heidelberg;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:04:17Z;2020-06-01T16:04:17Z;Heidelberg;3653167;Principal Investigator;Michael Eichbaum, PD Dr. med.;Medizinische Fakultät Heidelberg Abteilung für Frauenheilkunde und Geburtshilfe;Pazopanib;63687636;5;;;2010;2020-05-29;47;FALSE;;FALSE;FALSE;18;;Years;;2;5;
NCT01236807;ClinicalTrials.gov processed this data on May 29, 2020;2010-11-08;;;2016-12-26;2010-11-08;2010-11-09;Estimate;;;;;;;2016-12-26;2016-12-28;Estimate;December 2010;;2010-12-31;December 2016;2016-12-31;December 2016;Actual;2016-12-31;August 2016;Actual;2016-08-31;;Interventional;;;MR INFORM - MR Perfusion Imaging to Guide Management of Patients With Stable Coronary Artery Disease;MR INFORM - a Randomized Non-inferiority Multicenter Trial Comparing MR Perfusion Imaging and Fractional Flow Reserve (FFR) to Guide Management of Patients With Stable Coronary Artery Disease;Completed;;N/A;915;Actual;King's College London;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:04:41Z;2020-06-01T16:04:41Z;Frankfurt;3653345;Principal Investigator;Eike Nagel, MD, PhD;Goethe University Frankfurt;MR perfusion guidance | FFR guidance;63687784;1;;;2010;2020-05-29;69;FALSE;;FALSE;TRUE;18;;Years;;1;5;
NCT01234324;ClinicalTrials.gov processed this data on May 29, 2020;2010-10-28;;;2018-01-19;2010-11-03;2010-11-04;Estimate;;;;;;;2018-01-19;2018-01-23;Actual;October 2010;Actual;2010-10-31;January 2018;2018-01-31;August 2017;Actual;2017-08-31;August 2016;Actual;2016-08-31;;Interventional;NEOPECX;;ECX + Panitumumab vs. ECX Alone in Locally Advanced Gastric Cancer or Cancer of the Gastroesophageal Junction;An Open Label Randomized Controlled Phase II Trial of Panitumumab in Combination With Epirubicin, Cisplatin and Capecitabine (ECX) Versus ECX Alone in Subjects With Locally Advanced Gastric Cancer or Cancer of the Gastroesophageal Junction.;Completed;;Phase 2;171;Actual;AIO-Studien-gGmbH;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:05:41Z;2020-06-01T16:05:41Z;Duisburg;3653549;Principal Investigator;M. Stahl, Prof. Dr. med.;Klinken Essen-Mitte Evang. Huyssens-Stiftung;Epirubicin, Cisplatin, Capecitabine, Panitumumab | Epirubicin, Cisplatin, Capecitabine;63687978;1;;;2010;2020-05-29;71;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT01230073;ClinicalTrials.gov processed this data on May 29, 2020;2010-10-26;;;2018-05-23;2010-10-27;2010-10-28;Estimate;;;;;;;2018-05-23;2018-05-24;Actual;February 2011;;2011-02-28;May 2018;2018-05-31;December 2017;Actual;2017-12-31;July 2014;Actual;2014-07-31;;Interventional;SAN REMO 2;;Treatment Satisfaction in Implantable Cardioverter Defibrillator Recipients;Treatment Satisfaction With Remote Monitoring in Implantable Cardioverter Defibrillator Recipients;Completed;;Phase 4;120;Actual;Deutsches Herzzentrum Muenchen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T16:06:56Z;2020-06-01T16:06:56Z;Munich;;;;;Home-Monitoring | Follow-up by Home-Monitoring;63688298;1;;;2010;2020-05-29;41;FALSE;;FALSE;TRUE;;;;;1;1;
NCT01229774;ClinicalTrials.gov processed this data on May 29, 2020;2010-10-27;;;2014-09-12;2010-10-27;2010-10-28;Estimate;;;;;;;2014-09-12;2014-09-15;Estimate;February 2011;;2011-02-28;September 2010;2010-09-30;August 2014;Actual;2014-08-31;August 2014;Actual;2014-08-31;;Interventional;;;Use of Etoricoxib Compared to Diclofenac in the Perioperative Treatment of Patients After Total Hip Arthroplasty;Use of Etoricoxib Compared to Diclofenac in the Perioperative Treatment of Patients After Total Hip Arthroplasty, a Prospective, Double Blind, Phase III Study;Completed;;Phase 3;100;Actual;University of Regensburg;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T16:07:02Z;2020-06-01T16:07:02Z;Regensburg;;;;;Etoricoxib | Diclofenac;63688321;1;;;2010;2020-05-29;42;FALSE;;FALSE;TRUE;55;85;Years;Years;1;4;
NCT01229631;ClinicalTrials.gov processed this data on May 29, 2020;2010-10-26;;;2019-03-14;2010-10-27;2010-10-28;Estimate;;;;;;;2019-03-14;2019-03-18;Actual;May 22, 2017;Actual;2017-05-22;March 2019;2019-03-31;September 27, 2017;Actual;2017-09-27;June 30, 2017;Actual;2017-06-30;;Interventional;ENURGISE;;The Effect of Daily Dietary Intake of Dried Juice Concentrates of Fruit, Vegetables and Berries Upon Outcomes of Chronic Periodontitis;The Effect of Daily Dietary Intake of Dried Juice Concentrates of Fruit, Vegetables and Berries (Juice Plus+) Upon Periodontal Outcomes in Chronic Periodontitis: A Multicentre Randomised Controlled Trial;Completed;;N/A;108;Actual;Birmingham Community Healthcare NHS;;2;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;;;2020-06-01T16:07:05Z;2020-06-01T16:07:05Z;Würzburg;3653936;Principal Investigator;Ulrich Schlagenhauf, PhD;University of Wuerzburg;Juice plus+ | Placebo non active capsules;63688332;3;;;2010;2020-05-29;1;FALSE;;FALSE;FALSE;18;75;Years;Years;2;2;
NCT01229306;ClinicalTrials.gov processed this data on May 29, 2020;2010-10-26;;;2013-05-02;2010-10-26;2010-10-27;Estimate;;;;;;;2013-05-02;2013-05-03;Estimate;July 2010;;2010-07-31;May 2013;2013-05-31;January 2014;Anticipated;2014-01-31;July 2013;Anticipated;2013-07-31;;Interventional;;;Repeat Ablation Procedure in Patients With Relapse of Atrial Fibrillation;Repeat Ablation Procedure in Patients With Relapse of Paroxysmal Atrial Fibrillation Using Reisolation of Pulmonary Vein Versus Reisolation of Pulmonary Vein With Additional Anterior Line;Unknown status;;N/A;108;Anticipated;Deutsches Herzzentrum Muenchen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T16:07:11Z;2020-06-01T16:07:11Z;Munich;;;;;Ablation;63688356;1;;;2010;2020-05-29;;FALSE;;FALSE;TRUE;18;80;Years;Years;1;1;
NCT01229033;ClinicalTrials.gov processed this data on May 29, 2020;2010-10-26;;;2017-04-10;2010-10-26;2010-10-27;Estimate;;;;;;;2017-04-10;2017-04-11;Actual;January 2010;;2010-01-31;April 2017;2017-04-30;January 2014;Actual;2014-01-31;January 2013;Actual;2013-01-31;;Interventional;ATTAC CFAE;;Ablating Atrial Tachycardias Occuring During Ablation of Complex Fractionated Electrograms in Persistent AF;Ablating Atrial Tachycardias Occuring During Ablation of Complex Fractionated Electrograms in Persistent AF - ATTAC CFAE Trial;Completed;;N/A;186;Anticipated;Deutsches Herzzentrum Muenchen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T16:07:24Z;2020-06-01T16:07:24Z;Munich;3653975;Study Chair;Isabel Deisenhofer, MD;Deutsches Herzzentrum München;Ablation | Cardioversion;63688378;2;;;2010;2020-05-29;36;FALSE;;FALSE;FALSE;18;80;Years;Years;1;1;
NCT01228149;ClinicalTrials.gov processed this data on May 29, 2020;2010-08-20;;;2017-06-27;2010-10-25;2010-10-26;Estimate;;;;;;;2017-06-27;2017-08-01;Actual;August 2010;;2010-08-31;March 2017;2017-03-31;April 2014;Actual;2014-04-30;April 2014;Actual;2014-04-30;;Interventional;;;COSOPT-S® Treatment Versus Acetazolamide Before Trabeculectomy;Investigation of the Efficacy and Safety of Preoperative Intraocular Pressure (IOP) Reduction With Preservative-free COSOPT-S® (Dorzolamide/Timolol, MSD) Eye Drops Versus Oral Acetazolamide and Dexamethasone Eye Drops;Completed;;Phase 4;62;Actual;Johannes Gutenberg University Mainz;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:07:34Z;2020-06-01T16:07:34Z;Mainz;3654049;Principal Investigator;Katrin Lorenz, MD;Johannes Gutenberg University Mainz;Trabeculectomy with preoperative Diamox/DexaEDO treatment | Trabeculectomy with preoperative Cosopt S treatment;63688443;1;264;16;2010;2020-05-29;44;TRUE;12;FALSE;TRUE;18;;Years;;1;8;
NCT01225133;ClinicalTrials.gov processed this data on May 29, 2020;2010-10-06;;;2015-03-30;2010-10-19;2010-10-20;Estimate;;;;;;;2015-03-30;2015-03-31;Estimate;October 2010;;2010-10-31;March 2015;2015-03-31;March 2015;Actual;2015-03-31;July 2014;Actual;2014-07-31;;Interventional;CARAKA;;Complex Āyurvedic Treatment in Osteoarthritis of the Knee Compared to Standard Care.;The CARAKA-Trial: Complex Āyurvedic Treatment in Osteoarthritis of the Knee Against Standard Care.A Multicentre, Randomized, Controlled Clinical Trial Based on Traditional Āyurveda-Diagnosis.;Completed;;Phase 3;150;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:08:53Z;2020-06-01T16:08:53Z;Berlin;3654265;Principal Investigator;Andreas Michalsen, Prof. Dr.;Charité Medical University Berlin;Complex Ayurvedic Treatment | Conventional Care;63688670;2;;;2010;2020-05-29;45;FALSE;;FALSE;FALSE;40;70;Years;Years;1;11;
NCT01223677;ClinicalTrials.gov processed this data on May 29, 2020;2010-10-12;;;2014-12-01;2010-10-18;2010-10-19;Estimate;;;;;;;2014-12-01;2014-12-03;Estimate;October 2010;;2010-10-31;December 2014;2014-12-31;September 2014;Actual;2014-09-30;September 2014;Actual;2014-09-30;;Interventional;;;Rumination-focused CBT Training for the Prevention of Depression and Anxiety;Randomized Controlled Trial Evaluating Two Versions of a Rumination-focused CBT Training for the Presence of Depression and Anxiety in Adolescents and Young Adults;Completed;;Phase 1;251;Actual;VU University of Amsterdam;;3;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:09:13Z;2020-06-01T16:09:13Z;Münster;3654386;Principal Investigator;Thomas Ehring, PhD;Westfalische Wilhelms Universitat Munster;Rumination Focused CBT;63688782;1;;;2010;2020-05-29;47;FALSE;;FALSE;TRUE;15;22;Years;Years;1;1;
NCT01221779;ClinicalTrials.gov processed this data on May 29, 2020;2010-10-13;;;2013-08-26;2010-10-14;2010-10-15;Estimate;;;;;;;2013-08-26;2013-08-27;Estimate;January 2011;;2011-01-31;August 2013;2013-08-31;December 2014;Anticipated;2014-12-31;August 2014;Anticipated;2014-08-31;;Interventional;CATS;;Chronic Aphasia - Improved by Intensive Training and Electrical Brain Stimulation;Chronic Aphasia - Improved by Intensive Training and Electrical Brain;Unknown status;;Phase 2;40;Anticipated;Charite University, Berlin, Germany;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:09:42Z;2020-06-01T16:09:42Z;Berlin;3654580;Principal Investigator;Marcus Meinzer, PhD;Charite, University Medicine, Neurology;Intensive language therapy | Intensive language therapy;63688924;1;;;2010;2020-05-29;;FALSE;;FALSE;TRUE;18;70;Years;Years;1;3;
NCT01220856;ClinicalTrials.gov processed this data on May 29, 2020;2010-10-07;;;2014-06-27;2010-10-13;2010-10-14;Estimate;;;;;;;2014-06-27;2014-06-30;Estimate;July 2010;;2010-07-31;June 2014;2014-06-30;June 2014;Actual;2014-06-30;September 2012;Actual;2012-09-30;;Interventional;;;Reparixin in Pancreatic Islet Transplantation;A Phase 2 Multicenter, Randomized, Open Label, Parallel Assignment, Pilot Study to Assess the Efficacy and Safety of Reparixin Following Islet Transplantation in Patients With Type 1 Diabetes Mellitus;Completed;;Phase 2;9;Actual;Dompé Farmaceutici S.p.A;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T16:09:55Z;2020-06-01T16:09:55Z;Dresden;3654669;Principal Investigator;Barbara Ludwig, MD;"University Hospital Carl Gustav Carus - Dresden; Germany";Reparixin;63688996;2;;;2010;2020-05-29;26;FALSE;;FALSE;FALSE;18;65;Years;Years;10;12;
NCT01220752;ClinicalTrials.gov processed this data on May 29, 2020;2010-10-12;;;2013-04-23;2010-10-13;2010-10-14;Estimate;;;;;;;2013-04-23;2013-04-24;Estimate;November 2010;;2010-11-30;April 2013;2013-04-30;November 2016;Anticipated;2016-11-30;November 2014;Anticipated;2014-11-30;;Interventional;IMRT-HIT-SNT;;Treatment of Malignant Sinonasal Tumours With Intensity-modulated Radiotherapy (IMRT) and Carbon Ion Boost (C12);Treatment of Malignant Sinonasal Tumours With Intensity-modulated Radiotherapy (IMRT) and Carbon Ion Boost (C12);Unknown status;;Phase 2;30;Anticipated;Heidelberg University;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T16:09:56Z;2020-06-01T16:09:56Z;Heidelberg;3654675;Principal Investigator;Juergen Debus, MD PhD;Heidelberg University;carbon ion boost;63689002;1;;;2010;2020-05-29;;FALSE;;FALSE;TRUE;18;80;Years;Years;1;5;
NCT01219244;ClinicalTrials.gov processed this data on May 29, 2020;2010-10-12;;;2017-07-26;2010-10-12;2010-10-13;Estimate;;;;;;;2017-07-26;2017-07-28;Actual;August 2010;;2010-08-31;July 2017;2017-07-31;December 2016;Actual;2016-12-31;July 2016;Actual;2016-07-31;;Interventional;;;Effects of Dietary Interventions on the Brain in Mild Cognitive Impairment (MCI);Enhancing Memory Functions in Patients With Mild Cognitive Impairment by Dietary Interventions and in Combination With Exercise and Cognitive Training - Proof of Concept and Mechanisms;Completed;;Phase 2/Phase 3;330;Anticipated;Charite University, Berlin, Germany;;6;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:10:16Z;2020-06-01T16:10:16Z;Berlin;3654790;Study Chair;Agnes Floeel, Prof.;Charité University Berlin;caloric restriction | omega-3 supplementation | resveratrol supplementation | Placebo | 2nd step: intervention + physical / cognitive training | 2nd step: intervention + control;63689114;1;;;2010;2020-05-29;72;FALSE;;FALSE;TRUE;50;80;Years;Years;1;2;
NCT01219231;ClinicalTrials.gov processed this data on May 29, 2020;2010-10-12;;;2016-03-15;2010-10-12;2010-10-13;Estimate;;;;;;;2016-03-15;2016-03-16;Estimate;August 2010;;2010-08-31;March 2016;2016-03-31;January 2015;Actual;2015-01-31;January 2015;Actual;2015-01-31;;Interventional;;;Effects of Physical Activity on the Brain in Impaired Glucose Tolerance (IGT);Exercise in Elderly Individuals With Impaired Glucose Tolerance: Beneficial for Vasculature and Neurons?;Completed;;Phase 4;46;Anticipated;Charite University, Berlin, Germany;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:10:17Z;2020-06-01T16:10:17Z;Berlin;3654791;Principal Investigator;Agnes Flöel, MD, Prof.;Charité University Berlin;Exercise;63689115;1;;;2010;2020-05-29;53;FALSE;;FALSE;TRUE;50;65;Years;Years;1;2;
NCT01216696;ClinicalTrials.gov processed this data on May 29, 2020;2010-09-27;;;2016-08-11;2010-10-06;2010-10-07;Estimate;;;;;;;2016-08-11;2016-08-12;Estimate;November 2010;;2010-11-30;August 2016;2016-08-31;August 2016;Actual;2016-08-31;August 2016;Actual;2016-08-31;;Interventional;CTLA4 NY-ESO-1;;Ipilimumab in Patients With Advanced Melanoma and Spontaneous Preexisting Immune Response to NY-ESO-1;Phase II Trial of Ipilimumab in Patients With Advanced Melanoma and Spontaneous Preexisting Immune Response to NY-ESO-1;Completed;;Phase 2;25;Actual;National Center for Tumor Diseases, Heidelberg;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:11:22Z;2020-06-01T16:11:22Z;Heidelberg;3654995;Principal Investigator;Dirk Jäger, MD;NCT Heidelberg, Dep. of Medical Oncology;ipilimumab;63689309;1;;;2010;2020-05-29;70;FALSE;;FALSE;TRUE;18;;Years;;1;3;
NCT01213667;ClinicalTrials.gov processed this data on May 29, 2020;2010-10-01;;;2016-10-24;2010-10-01;2010-10-04;Estimate;;;;;;;2016-10-24;2016-10-26;Estimate;January 2010;;2010-01-31;October 2016;2016-10-31;December 2017;Anticipated;2017-12-31;December 2017;Anticipated;2017-12-31;;Interventional;RESPONSE;;Genetics in Non-response to Anti-VEGF Treatment in Exudative AMD;Pharmacogenetics in Anti-VEGF Treatment Non-responders Suffering Exudative Age-related Macular Degeneration (AMD): Genetic Correlations and Intraocular Cytokine Concentrations;Unknown status;;Phase 4;110;Anticipated;University of Cologne;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T16:12:28Z;2020-06-01T16:12:28Z;Köln;3655244;Principal Investigator;Philipp S Muether, MD;Center of Ophthalmology, University of Cologne;Ranibizumab;63689542;1;;;2010;2020-05-29;;FALSE;;FALSE;TRUE;60;;Years;;1;4;
NCT01209286;ClinicalTrials.gov processed this data on May 29, 2020;2010-09-23;;;2017-01-23;2010-09-24;2010-09-27;Estimate;;;;;;;2017-01-23;2017-03-06;Actual;October 2010;;2010-10-31;July 2016;2016-07-31;October 2016;Actual;2016-10-31;March 2012;Actual;2012-03-31;;Interventional;;;Study of the BiTE® Blinatumomab (MT103) in Adult Patients With Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL);An Open Label, Multicenter, Exploratory Phase II Study to Evaluate the Efficacy, Safety, and Tolerability of the BiTE® Antibody Blinatumomab in Adult Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL);Completed;;Phase 2;36;Actual;Amgen Research (Munich) GmbH;;3;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:13:53Z;2020-06-01T16:13:53Z;Munich Würzburg;3655619;Principal Investigator;Max Topp, MD;University of Wuerzburg;Blinatumomab;63689876;9;1164;164;2010;2020-05-29;17;TRUE;33;FALSE;FALSE;18;;Years;;1;12;
NCT01209208;ClinicalTrials.gov processed this data on May 29, 2020;2010-09-23;;;2017-07-25;2010-09-24;2010-09-27;Estimate;;;;;;;2017-07-25;2017-07-26;Actual;May 2010;;2010-05-31;July 2017;2017-07-31;June 2017;Actual;2017-06-30;June 2017;Actual;2017-06-30;;Interventional;;;Budesonide Versus Mesalazine Versus Placebo in Lymphocytic Colitis;Double-blind, Double-dummy, Randomised, Placebo-controlled, Multi-centre Phase III Study on the Efficacy and Tolerability of a 8-week Treatment With Budesonide vs. Mesalazine vs. Placebo in Patients With Lymphocytic Colitis;Completed;;Phase 3;57;Actual;Dr. Falk Pharma GmbH;;3;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:13:55Z;2020-06-01T16:13:55Z;Hamburg;3655626;Principal Investigator;Stephan Miehlke, Professor;Magen-Darm-Zentrum, IKE - Internistische Kooperation Eppendorf, Hamburg, Germany;Budesonide | Mesalamine | Placebo;63689882;1;;;2010;2020-05-29;86;FALSE;;FALSE;TRUE;18;90;Years;Years;1;1;
NCT01203228;ClinicalTrials.gov processed this data on May 29, 2020;2010-09-15;;;2015-04-02;2010-09-15;2010-09-16;Estimate;;;;;;;2015-04-02;2015-04-03;Estimate;May 2004;;2004-05-31;April 2015;2015-04-30;February 2015;Actual;2015-02-28;January 2015;Actual;2015-01-31;;Interventional;RICMAC;;Dose-reduced Versus Standard Conditioning in MDS/sAML;Dose-reduced Versus Standard Conditioning Followed by Allogeneic Stem Cell Transplantation in Patients With MDS or sAML: A Randomised Phase III Study (RICMAC);Terminated;;Phase 3;129;Actual;European Group for Blood and Marrow Transplantation;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:15:39Z;2020-06-01T16:15:39Z;Halle Hamburg Heidelberg Kiel Köln Leipzig Münster;3656297;Study Chair;Nicolaus Kröger, MD;Universitätsklinikum Hamburg-Eppendorf;Reduced Intensity Conditioning | Myeloablative conditioning;63690339;14;;;2010;2020-05-29;129;FALSE;;FALSE;FALSE;18;65;Years;Years;1;9;
NCT01200121;ClinicalTrials.gov processed this data on May 29, 2020;2010-09-09;;;2015-04-10;2010-09-10;2010-09-13;Estimate;;;;;;;2015-04-10;2015-04-13;Estimate;February 2010;;2010-02-28;April 2015;2015-04-30;December 2014;Actual;2014-12-31;August 2014;Actual;2014-08-31;;Interventional;;;Bevacizumab as a Palliative Treatment for Patients With Symptomatic Malignant Ascites Due to Advanced-stage Gastrointestinal Cancers;Double-blind, Placebo-controlled, Randomized Phase II-study Investigating the Efficacy of Bevacizumab for Symptom Control in Patients With Malignant Ascites Due to Advanced-stage Gastrointestinal Cancers;Completed;;Phase 2;53;Actual;AIO-Studien-gGmbH;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:16:36Z;2020-06-01T16:16:36Z;Halle;3656582;Principal Investigator;Karin Jordan, Dr. med.;Universitätslinikum der Martin-Luther Universität Halle-Wittenberg;Bevacizumab | Placebo;63690573;26;;;2010;2020-05-29;54;FALSE;;FALSE;FALSE;18;;Years;;1;9;
NCT01199276;ClinicalTrials.gov processed this data on May 29, 2020;2010-09-09;;;2015-07-24;2010-09-09;2010-09-10;Estimate;;;;;;;2015-07-24;2015-07-27;Estimate;September 2010;;2010-09-30;July 2015;2015-07-31;October 2014;Actual;2014-10-31;October 2014;Actual;2014-10-31;;Interventional;HIPELD;;Hip Fracture Surgery in Elderly Patients;An International, Multi-center, Randomized, Controlled Trial Evaluating The Effect of Xenon on Post-operative Delirium in Elderly Patients Undergoing Hip Fracture Surgery;Completed;;Phase 2;256;Actual;Air Liquide Santé International;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T16:16:47Z;2020-06-01T16:16:47Z;Aachen;3656660;Study Chair;Mark COBURN, MD;University Hospital Aachen - Germany;Xenon | Sevoflurane;63690638;13;;;2010;2020-05-29;49;FALSE;;FALSE;FALSE;75;;Years;;1;5;
NCT01197885;ClinicalTrials.gov processed this data on May 29, 2020;2010-09-06;;;2017-06-30;2010-09-08;2010-09-09;Estimate;;;;;;;2017-06-30;2017-07-02;Actual;September 2010;;2010-09-30;December 2015;2015-12-31;August 2015;Actual;2015-08-31;August 2015;Actual;2015-08-31;;Interventional;;;Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer;International, Multicenter, Open-label, Phase II Study to Investigate the Efficacy and Safety of Multiple Doses of IMAB362 in Patients With Advanced Adenocarcinoma of the Stomach or the Lower Esophagus;Completed;;Phase 2;54;Actual;Astellas Pharma Inc;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:17:15Z;2020-06-01T16:17:15Z;Duisburg;3656773;Principal Investigator;Martin Schuler, Prof. Dr. med.;Innere Klinik Universitätsklinikum Essen;IMAB362;63690742;21;;;2010;2020-05-29;59;FALSE;;FALSE;FALSE;18;;Years;;1;3;
NCT01192087;ClinicalTrials.gov processed this data on May 29, 2020;2010-08-30;;;2013-04-23;2010-08-30;2010-08-31;Estimate;;;;;;;2013-04-23;2013-04-24;Estimate;June 2012;;2012-06-30;April 2013;2013-04-30;July 2017;Anticipated;2017-07-31;July 2015;Anticipated;2015-07-31;;Interventional;ACCEPT;;Adenoid Cystic Carcinoma, Erbitux, and Particle Therapy;"Combined Treatment of Adenoid Cystic Carcinoma With Cetuximab and IMRT Plus C12 Heavy Ion Boost - ACCEPT - (ACC, Erbitux, and Particle Therapy); Phase I/II Feasibility Study";Unknown status;;Phase 1/Phase 2;49;Anticipated;Heidelberg University;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:19:22Z;2020-06-01T16:19:22Z;Heidelberg;3657288;Principal Investigator;Jürgen Debus, Prof. Dr. Dr.;Dept. of Radiation Oncology, INF 400, 69120 Heidelberg, Germany;Cetuximab;63691179;1;;;2010;2020-05-29;;FALSE;;FALSE;TRUE;18;70;Years;Years;2;4;
NCT01187303;ClinicalTrials.gov processed this data on May 29, 2020;2010-08-19;;;2015-10-30;2010-08-23;2010-08-24;Estimate;;;;;;;2015-10-30;2015-11-02;Estimate;May 2011;;2011-05-31;October 2015;2015-10-31;September 2015;Actual;2015-09-30;November 2013;Actual;2013-11-30;;Interventional;;;Ofatumumab in Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL);Ofatumumab in Relapsed Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL);Completed;;Phase 2;28;Actual;University of Cologne;;;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T16:20:50Z;2020-06-01T16:20:50Z;Köln;3657872;Principal Investigator;Andreas Engert, MD;University of Cologne;Ofatumumab;63691542;1;;;2010;2020-05-29;30;FALSE;;FALSE;TRUE;18;75;Years;Years;1;3;
NCT01184430;ClinicalTrials.gov processed this data on May 29, 2020;2010-08-17;;;2013-08-08;2010-08-18;2010-08-19;Estimate;;;;;;;2013-08-08;2013-08-12;Estimate;August 2013;;2013-08-31;August 2013;2013-08-31;December 2014;Anticipated;2014-12-31;March 2014;Anticipated;2014-03-31;;Interventional;Algebra;;Effect of Perioperative Hemodynamic Optimization on the Immune Function Parameters of Peripheral Blood Monocytes After Cardiac Surgery;Monocentric Pilot Study of Effect of Perioperative Hemodynamic Optimization on the Immune Function Parameters of Peripheral Blood Monocytes After Cardiac Surgery;Unknown status;;N/A;40;Anticipated;Charite University, Berlin, Germany;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:21:42Z;2020-06-01T16:21:42Z;Berlin;3658132;Principal Investigator;Michael Sander, MD;Dept. of Anesthesiology Charité Universitaetsmedizin Berlin;Pulse contour cardiac output device;63691760;1;;;2010;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT01181401;ClinicalTrials.gov processed this data on May 29, 2020;2010-08-12;;;2019-01-29;2010-08-12;2010-08-13;Estimate;;;;;;;2019-01-29;2019-01-31;Actual;August 2010;;2010-08-31;January 2019;2019-01-31;August 2015;Actual;2015-08-31;April 2015;Actual;2015-04-30;;Interventional;ICRAT;;InductionChemo-Radio-Antibody-Treatment;Randomized Phase II Study of Two Different Regimens of TPF Induction Chemotherapy Regimen Followed by Radiation Therapy Plus Cetuximab (TPF-CET-HART) vs. HART and Cis-platinum, 5-FU (PF-HART) in Patients With Locally Advanced Unresectable Squamous Cell Carcinomas of the Head and Neck;Completed;;Phase 2;94;Actual;Charite University, Berlin, Germany;;3;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:22:27Z;2020-06-01T16:22:27Z;Berlin;3658422;Principal Investigator;Volker Budach, MD, PhD;Charité Universitaetsmedizin Berlin;TPF induction chemotherapy | TPF experimental | Standard Radiochemotherapy (HART);63691988;5;;;2010;2020-05-29;56;FALSE;;FALSE;FALSE;18;;Years;;1;1;
NCT01181206;ClinicalTrials.gov processed this data on May 29, 2020;2010-08-11;;;2017-09-19;2010-08-12;2010-08-13;Estimate;;;;;;;2017-09-19;2017-09-21;Actual;August 2010;;2010-08-31;December 2012;2012-12-31;February 2014;Actual;2014-02-28;August 2013;Actual;2013-08-31;;Interventional;BaFo;;Covering of the Abdominal Wall in Laparotomies: Differences in Surgical Site Infections Between an Approved Abdominal 3M™ Steri-Drape™ Wound Edge Protector and Standard Woven Swabs at Technische Universität München;Standard-Bauchwandabdeckung Mit Bauchtüchern vs. Abdeckung Mittels ringförmiger Folie: Eine Doppelblinde Randomisiert-kontrollierte Studie;Completed;;N/A;516;Actual;Technische Universität München;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T16:22:30Z;2020-06-01T16:22:30Z;Munich;3658439;Principal Investigator;Helmut Friess, M.D.;Department of Surgery, Klinikum rechts der Isar der Technischen Universität München;Intervention Arm 1: Covering with approved abdominal 3M™ Steri-Drape™ Wound Edge Protector Intervention Arm 2: Covering with standard woven swabs;63692003;1;;;2010;2020-05-29;36;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT01180504;ClinicalTrials.gov processed this data on May 29, 2020;2010-08-11;;;2010-08-11;2010-08-11;2010-08-12;Estimate;;;;;;;2010-08-11;2010-08-12;Estimate;August 2010;;2010-08-31;August 2010;2010-08-31;August 2016;Anticipated;2016-08-31;August 2013;Anticipated;2013-08-31;;Interventional;OVAR-IMRT-02;;Consolidation Whole Abdominal Intensity-Modulated Radiation Therapy (IMRT) in Advanced Ovarian Cancer;Consolidation Intensity-Modulated Whole Abdominal Radiotherapy for High-Risk Patients With Ovarian Cancer Stage FIGO III;Unknown status;;Phase 2;36;Anticipated;University Hospital Heidelberg;;;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:22:41Z;2020-06-01T16:22:41Z;Heidelberg;3658488;Principal Investigator;Andreas Schneeweiss, MD;Department of Gyneacology and Obstetrics, Unversity of Heidelberg;intensity-modulated whole-abdominal radiotherapy;63692057;1;;;2010;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;7;
NCT01180322;ClinicalTrials.gov processed this data on May 29, 2020;2010-08-02;;;2013-08-30;2010-08-11;2010-08-12;Estimate;;;;;;;2013-08-30;2013-09-02;Estimate;November 2010;;2010-11-30;August 2013;2013-08-31;October 2016;Anticipated;2016-10-31;June 2012;Actual;2012-06-30;;Interventional;azacitidine;;Trial Evaluating Induction Therapy With Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy With Azacitidine;Randomized Phase-II Trial Evaluating Induction Therapy With Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy With Azacitidine;Unknown status;;Phase 2;336;Anticipated;University of Ulm;;4;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:22:43Z;2020-06-01T16:22:43Z;Ulm;3658517;Principal Investigator;Richard F Schlenk, MD;University Hospital of Ulm;Cytarabine | Idarubicin | Etoposide | Azacitidine | Lenograstim;63692071;44;;;2010;2020-05-29;19;FALSE;;FALSE;FALSE;18;;Years;;1;13;
NCT01176214;ClinicalTrials.gov processed this data on May 29, 2020;2010-07-26;;;2014-04-25;2010-08-04;2010-08-05;Estimate;;;;;;;2014-04-25;2014-04-28;Estimate;July 2010;;2010-07-31;April 2014;2014-04-30;April 2014;Actual;2014-04-30;April 2014;Actual;2014-04-30;;Interventional;WEANING;;WEANING-Study: Weaning by Early Versus lAte Tracheostomy iN supratentorIal iNtracerebral Bleedings;Weaning by Early Versus lAte Tracheostomy iN supratentorIal iNtracerebral Bleedings;Terminated;;Phase 2;7;Actual;University of Erlangen-Nürnberg Medical School;;2;;slow recruitment of patients;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T16:23:51Z;2020-06-01T16:23:51Z;Erlangen;3658866;Principal Investigator;Hagen B Huttner, MD;Department of Neurology, University of Erlangen-Nuremberg, Germany;Early tracheostomy | Late tracheostomy;63692385;1;;;2010;2020-05-29;45;FALSE;;FALSE;TRUE;18;85;Years;Years;1;5;
NCT01175694;ClinicalTrials.gov processed this data on May 29, 2020;2010-08-04;;;2010-08-19;2010-08-04;2010-08-05;Estimate;;;;;;;2010-08-19;2010-08-20;Estimate;January 2010;;2010-01-31;June 2010;2010-06-30;January 2015;Anticipated;2015-01-31;June 2012;Anticipated;2012-06-30;;Interventional;;;Dose Optimization for Pulsed-dose-rate (PDR)/High-dose-rate (HDR) Brachytherapy Alone for Early Breast Cancer;Phase II Study - Dose Optimization PDR/HDR Brachytherapy Alone for Early Breast Cancer;Unknown status;;Phase 2;200;Anticipated;University Hospital Erlangen;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T16:23:59Z;2020-06-01T16:23:59Z;Erlangen;3658918;Principal Investigator;Vratislav Strnad, MD, Prof.;University Hospital Erlangen;Interstitial multicatheter brachytherapy;63692425;1;;;2010;2020-05-29;;FALSE;;FALSE;TRUE;50;;Years;;1;1;
NCT01170988;ClinicalTrials.gov processed this data on May 29, 2020;2010-07-27;;;2014-08-05;2010-07-27;2010-07-28;Estimate;;;;;;;2014-08-05;2014-08-06;Estimate;August 2010;;2010-08-31;August 2014;2014-08-31;August 2014;Actual;2014-08-31;August 2014;Actual;2014-08-31;;Interventional;;;Coronary Flow Rate Measurement in T-Grafts;Comparison of Coronary Flow Reserve in Two Different Bypass Techniques (T-graft Technique Versus Isolated Graft Technique) Using Magnetic Resonance Technology (MRT);Completed;;N/A;20;Anticipated;Johann Wolfgang Goethe University Hospital;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T16:25:18Z;2020-06-01T16:25:18Z;Frankfurt;;;;;T-Graft;63692784;1;;;2010;2020-05-29;48;FALSE;;FALSE;TRUE;18;80;Years;Years;1;;
NCT01166308;ClinicalTrials.gov processed this data on May 29, 2020;2010-07-19;;;2018-05-11;2010-07-20;2010-07-21;Estimate;;;;;;;2018-05-11;2018-05-17;Actual;December 2010;Actual;2010-12-31;May 2018;2018-05-31;April 2016;Actual;2016-04-30;April 2016;Actual;2016-04-30;;Interventional;CINDERELLA;;Carbon Ion Radiotherapy for Recurrent Gliomas;Randomised Phase I/II Study to Evaluate Carbon Ion Radiotherapy Versus Fractionated Stereotactic Radiotherapy in Patients With Recurrent or Progressive Gliomas: The CINDERELLA Trial;Completed;;N/A;56;Actual;University Hospital Heidelberg;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:26:30Z;2020-06-01T16:26:30Z;Heidelberg;;;;;Carbon Ion Radiotherapy | Fractionated Stereotactic Radiotherapy (FSRT);63693137;1;;;2010;2020-05-29;64;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT01165671;ClinicalTrials.gov processed this data on May 29, 2020;2010-07-13;;;2020-04-02;2010-07-19;2010-07-20;Estimate;;;;;;;2020-04-02;2020-04-03;Actual;July 2010;Actual;2010-07-31;May 2018;2018-05-31;January 2015;Actual;2015-01-31;January 2015;Actual;2015-01-31;;Interventional;CLEOPATRA;;Carbon Ion Radiotherapy for Primary Glioblastoma;Randomized Phase II Study Evaluating a Carbon Ion Boost Applied After Combined Radiochemotherapy With Temozolomide Versus a Proton Boost After Radiochemotherapy With Temozolomide in Patients With Primary Glioblastoma;Completed;;N/A;100;Actual;University Hospital Heidelberg;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:26:37Z;2020-06-01T16:26:37Z;Heidelberg;;;;;Carbon Ion Radiotherapy | Proton Radiotherapy;63693186;1;;;2010;2020-05-29;54;FALSE;;FALSE;TRUE;18;;Years;;1;2;
NCT01160419;ClinicalTrials.gov processed this data on May 29, 2020;2009-10-22;;;2010-10-27;2010-07-09;2010-07-12;Estimate;;;;;;;2010-10-27;2010-10-28;Estimate;December 2009;;2009-12-31;December 2009;2009-12-31;May 2014;Anticipated;2014-05-31;May 2011;Anticipated;2011-05-31;;Interventional;;;Multicenter Study to Perioperative Chemotherapy for Resectable Adenocarcinoma in Gastric Cancer;;Unknown status;;Phase 2;49;Anticipated;Ludwig-Maximilians - University of Munich;;1;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T16:28:18Z;2020-06-01T16:28:18Z;Munich;;;;;Docetaxel 50 mg/m2, 1-hour-Infusion, day 1 | Oxaliplatin 85 mg/m², 2-hour-Infusion, day 1 | Folinic acid 200 mg/m², 1-2-hour-Infusion, day 1 | 5-FU 2600 mg/m², 24-hour-Infusion, day 1;63693588;1;;;2009;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT01149707;ClinicalTrials.gov processed this data on May 29, 2020;2010-06-22;;;2018-04-27;2010-06-22;2010-06-23;Estimate;;;;;;;2018-04-27;2018-05-01;Actual;June 1, 2010;;2010-06-01;April 2018;2018-04-30;June 20, 2015;Actual;2015-06-20;October 1, 2014;Actual;2014-10-01;;Interventional;;;Safety, Tolerability, Efficacy Study of PUR 0110 Rectal Enema in Mild-to-Moderate Distal Ulcerative Colitis;A 2-Week Exploratory Randomized, Double-Blind, Parallel-Group, Dose-Ranging, Placebo-Controlled Safety, Tolerability, Biomarker and Efficacy Clinical Study of PUR 0110 Rectal Enema in Mild-to-Moderate Distal Ulcerative Colitis;Completed;;Phase 2;34;Actual;PurGenesis Technologies Inc.;;4;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T16:31:02Z;2020-06-01T16:31:02Z;Duisburg;3661003;Principal Investigator;Michael Rünzi, Prof. Dr. med.;Essen-Werden, Germany;PUR 0110 Rectal Enema 250 mg | PUR 0110 Rectal Enema 500 mg | PUR 0110 Rectal Enema 1000 mg | Placebo Enema;63694403;6;;;2010;2020-05-29;52;FALSE;;FALSE;FALSE;18;75;Years;Years;1;12;
NCT01149109;ClinicalTrials.gov processed this data on May 29, 2020;2010-06-14;;;2017-06-13;2010-06-22;2010-06-23;Estimate;;;;;;;2017-06-13;2017-06-14;Actual;October 2010;;2010-10-31;June 2017;2017-06-30;April 6, 2017;Actual;2017-04-06;April 6, 2017;Actual;2017-04-06;;Interventional;CeTeG;;Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients;Phase III Trial of CCNU/Temozolomide (TMZ) Combination Therapy vs. Standard TMZ Therapy for Newly Diagnosed MGMT-methylated Glioblastoma Patients;Completed;;Phase 3;141;Actual;University Hospital, Bonn;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:31:16Z;2020-06-01T16:31:16Z;Bonn;3661044;Study Director;Ulrich Herrlinger, Prof. Dr.;Division of Neurooncology, Departement of Neurology, University Hospital Bonn;Temozolomide and lomustine | Temozolomide;63694446;12;;;2010;2020-05-29;78;FALSE;;FALSE;FALSE;18;70;Years;Years;1;6;
NCT01148264;ClinicalTrials.gov processed this data on May 29, 2020;2010-06-21;;;2016-05-10;2010-06-21;2010-06-22;Estimate;;;;;;;2016-05-10;2016-05-11;Estimate;July 2010;;2010-07-31;May 2016;2016-05-31;October 2014;Actual;2014-10-31;October 2013;Actual;2013-10-31;;Interventional;COMFORT;;Comparison of Olanzapine and Metoclopramide For Treatment Of bReakThrough Emesis;Efficacy of Olanzapine in Break-through Emesis After Prophylaxis With Dexamethasone, 5-HT3 Receptor Antagonists and Aprepitant Compared to Metoclopramide;Terminated;;Phase 2;23;Actual;Martin-Luther-Universität Halle-Wittenberg;;2;;poor enrolment;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T16:31:28Z;2020-06-01T16:31:28Z;Halle;3661116;Principal Investigator;Karin Jordan, MD;Martin-Luther-University Halle-Wittenberg;olanzapine | metoclopramide;63694511;1;;;2010;2020-05-29;39;FALSE;;FALSE;TRUE;18;;Years;;1;3;
NCT01146821;ClinicalTrials.gov processed this data on May 29, 2020;2010-06-17;;;2017-04-17;2010-06-17;2010-06-22;Estimate;;;;;;;2017-04-17;2017-04-19;Actual;October 2013;;2013-10-31;April 2017;2017-04-30;April 2017;Actual;2017-04-30;April 2017;Actual;2017-04-30;;Interventional;FOILED;;Fish OIL Optimal dosE Determination Study;Multi-centre, Open-label, Phase II Clinical Trial for Determination of the Optimal Dose of Fish Oil in Patients With Severe Sepsis;Terminated;;Phase 2;7;Actual;University Hospital Carl Gustav Carus;;3;;Low enrollment/ expiration of the grant;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T16:32:04Z;2020-06-01T16:32:04Z;Dresden;3661264;Principal Investigator;Axel R. Heller, MD;University Hospital Dresden, Germany;0.20 gm/kg fish oil | 0.50 gm/kg fish oil;63694622;2;;;2010;2020-05-29;42;FALSE;;FALSE;FALSE;18;;Years;;1;2;
NCT01143233;ClinicalTrials.gov processed this data on May 29, 2020;2010-06-11;;;2017-11-29;2010-06-11;2010-06-14;Estimate;;;;;;;2017-11-29;2017-11-30;Actual;April 2010;;2010-04-30;November 2017;2017-11-30;August 2017;Actual;2017-08-31;July 2014;Actual;2014-07-31;;Interventional;HippHA;;Low-protein Infant Formula With Partial or Extensive Proteinhydrolysate 4 Year Follow-up;Suitability of an Infant Formula With Reduced Protein Content Based on a Partial Respectively an Extensive Proteinhydrolysate With and Without Pro- and Prebiotics for the Particular Nutritional Use by Infants.-Extension by 4 Year Follow-up;Completed;;N/A;503;Actual;HiPP GmbH & Co. Vertrieb KG;;5;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:33:08Z;2020-06-01T16:33:08Z;Berlin;3661585;Principal Investigator;Ulrich Wahn, Prof.;Charité - Universitätsmedizin. Campus Virchow-Klinikum. Klinik für Pädiatrie mit Schwerpunkt Pneumologie/Immunologie;control formula | intervention formula 1 | intervention formula 2 | intervention formula 3;63694891;5;;;2010;2020-05-29;51;FALSE;;FALSE;FALSE;;27;;Days;1;5;
NCT01138579;ClinicalTrials.gov processed this data on May 29, 2020;2010-06-04;;;2016-04-25;2010-06-04;2010-06-07;Estimate;;;;;;;2016-04-25;2016-04-26;Estimate;August 2010;;2010-08-31;December 2015;2015-12-31;June 2016;Anticipated;2016-06-30;May 2016;Anticipated;2016-05-31;;Interventional;STP-LYM-01;;Study of the Trifunctional Antibody FBTA05 and Donor Lymphocyte Infusion in B-cell Lymphoma After Allogeneic Stem Cell Transplantation;Phase I/II Dose-escalation Study of the Investigational Trifunctional Bispecific Anti-CD20 x Anti-CD3 Antibody FBTA05 in Combination With Donor Lymphocyte Infusion (DLI) in Patients With CD20 Positive Chronic Lymphocytic Leukemia (CLL), Low and High Grade Non-Hodgkin´s Lymphoma (NHL) After Allogeneic Stem Cell Transplantation;Terminated;;Phase 1/Phase 2;9;Actual;Technische Universität München;;1;;Recruitment delayed, trial medication no loner available;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:34:10Z;2020-06-01T16:34:10Z;Munich;;;;;FBTA05;63695247;1;;;2010;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;2;;
NCT01137916;ClinicalTrials.gov processed this data on May 29, 2020;2010-06-02;;;2017-05-02;2010-06-04;2010-06-07;Estimate;;;;;;;2017-05-02;2017-05-03;Actual;June 2010;;2010-06-30;May 2017;2017-05-31;December 2016;Actual;2016-12-31;December 2016;Actual;2016-12-31;;Interventional;;;Study to Evaluate Imatinib in Desmoid Tumors;Phase II Study to Evaluate Glivec (Imatinib Mesylate) to Induce Progression Arrest in Aggressive Fibromatosis / Desmoid Tumors Not Amenable to Surgical Resection With R0 Intent or Accompanied by Unacceptable Function Loss;Completed;;Phase 2;39;Actual;Heidelberg University;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:34:19Z;2020-06-01T16:34:19Z;Heidelberg Mannheim;3662091;Principal Investigator;Bernd Kasper, PD Dr. med.;University of Heidelberg, Mannheim University Medical Center;Imatinib;63695297;1;;;2010;2020-05-29;79;FALSE;;FALSE;TRUE;18;;Years;;1;4;
NCT01137734;ClinicalTrials.gov processed this data on May 29, 2020;2010-05-24;;;2014-12-22;2010-06-03;2010-06-04;Estimate;;;;;;;2014-12-22;2014-12-23;Estimate;March 2010;;2010-03-31;December 2014;2014-12-31;January 2014;Actual;2014-01-31;February 2012;Actual;2012-02-29;;Interventional;;;CARDINAL Adjustable Annuloplasty Ring System For Treatment of Mitral Regurgitation;Valtech Cardinal Adjustable Semi-Rigid Annuloplasty Ring System For Treatment of Mitral Valve Regurgitation in Open Surgical Repair;Completed;;Phase 2;30;Actual;Edwards Lifesciences;;;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:34:22Z;2020-06-01T16:34:22Z;Leipzig;3662107;Principal Investigator;Fredrich Mohr, Prof ,MD;University Leipzig, Germany;Adjustable Annuloplasty Ring with option to adjust off pump. | Device: Adjustable Annuloplasty Ring (with option to adjust off-pump);63695310;2;;;2010;2020-05-29;23;FALSE;;FALSE;FALSE;18;80;Years;Years;1;1;
NCT01135745;ClinicalTrials.gov processed this data on May 29, 2020;2010-05-05;;;2018-01-18;2010-05-31;2010-06-03;Estimate;;;;;;;2018-01-18;2018-01-23;Actual;April 2010;;2010-04-30;January 2018;2018-01-31;May 2015;Actual;2015-05-31;May 2015;Actual;2015-05-31;;Interventional;;;Deep Brain Stimulation for Obsessive Compulsive Disorder (OCD PMCF);Reclaim® Deep Brain Stimulation Therapy for Obsessive-Compulsive Disorder: Post-Market Clinical Follow-up Study (OCD PMCF);Completed;;Phase 4;32;Actual;MedtronicNeuro;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:34:53Z;2020-06-01T16:34:53Z;Freiburg Lübeck;3662259;Principal Investigator;Andreas Wahl-Kordon, MD;University Hospital Lübeck;Reclaim® Deep Brain Stimulation;63695460;8;;;2010;2020-05-29;61;FALSE;;FALSE;FALSE;18;;Years;;1;1;
NCT01119469;ClinicalTrials.gov processed this data on May 29, 2020;2010-05-05;;;2014-08-05;2010-05-06;2010-05-07;Estimate;;;;;;;2014-08-05;2014-08-06;Estimate;June 2010;;2010-06-30;August 2014;2014-08-31;August 2014;Actual;2014-08-31;August 2014;Actual;2014-08-31;;Interventional;;;Comparing Cognitive Therapy and Exposure Therapy in Individuals With Hypochondriasis;Dysfunctional Illness-related Cognitions in Individuals With Hypochondriasis and Change Thereof;Completed;;Phase 3;84;Actual;Goethe University;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T16:40:05Z;2020-06-01T16:40:05Z;Frankfurt;3663719;Principal Investigator;Florian Weck, PhD;Goethe University;Psychotherapy (CT or ET);63696693;1;;;2010;2020-05-29;50;FALSE;;FALSE;TRUE;18;65;Years;Years;1;7;
NCT01117662;ClinicalTrials.gov processed this data on May 29, 2020;2010-04-28;;;2018-08-21;2010-05-04;2010-05-05;Estimate;;;;;;;2018-08-21;2018-08-22;Actual;May 2012;;2012-05-31;August 2018;2018-08-31;August 23, 2016;Actual;2016-08-23;May 2016;Actual;2016-05-31;;Interventional;RIACT;;Efficacy of Rituximab in Acute Cellular Rejection in Renal Transplant Patients;Efficacy of Rituximab in Acute Cellular Rejection With B-cell Infiltrates in Renal Transplant Patients - Randomized Placebo Controlled Double Blind Trial;Terminated;;Phase 3;13;Actual;Hannover Medical School;;2;;The planned recruitment number of 180 Patient could not been achieved.;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:40:39Z;2020-06-01T16:40:39Z;Hannover;;;;;Rituximab | Placebo;63696830;14;;;2010;2020-05-29;48;FALSE;;FALSE;FALSE;18;;Years;;1;1;
NCT01117597;ClinicalTrials.gov processed this data on May 29, 2020;2010-05-04;;;2016-08-24;2010-05-04;2010-05-05;Estimate;;;;;;;2016-08-24;2016-08-25;Estimate;April 2010;;2010-04-30;November 2014;2014-11-30;September 2014;Actual;2014-09-30;September 2013;Actual;2013-09-30;;Interventional;TETRA;;Terrestrial Trunked Radio (TETRA) and Cognitive Functions in Healthy Subjects;Experimental Study on Possible Effects of Radiofrequency (RF) Signal Characteristics Used for the TETRA Standard on Cognitive Functions in Healthy Subjects;Completed;;N/A;32;Actual;Charite University, Berlin, Germany;;3;;;FALSE;;;;TRUE;;;;;;;;;;;Undecided;;2020-06-01T16:40:43Z;2020-06-01T16:40:43Z;Berlin;3663882;Principal Investigator;Heidi Danker-Hopfe, PhD;Charite University, Berlin, Germany;low RF exposure level | sham exposure | high RF exposure;63696834;1;;;2010;2020-05-29;41;FALSE;;FALSE;TRUE;18;30;Years;Years;1;1;
NCT01115621;ClinicalTrials.gov processed this data on May 29, 2020;2010-04-07;;;2010-04-30;2010-04-30;2010-05-04;Estimate;;;;;;;2010-04-30;2010-05-04;Estimate;February 2001;;2001-02-28;April 2010;2010-04-30;December 2016;Anticipated;2016-12-31;December 2009;Actual;2009-12-31;;Interventional;;;BABYDIET-Study - Primary Prevention of Type 1 Diabetes in Relatives at Increased Genetic Risk;BABYDIET-Study - Primary Prevention of Type 1 Diabetes in Relatives at Increased Genetic Risk;Unknown status;;N/A;150;Actual;Institut fur Diabetesforschung, Munich, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T16:41:13Z;2020-06-01T16:41:13Z;Munich;3664112;Principal Investigator;Anette G Ziegler, MD;Institut für Diabetesforschung, München, Germany;Glutenfree diet during the first year of life;63696980;1;;;2010;2020-05-29;107;FALSE;;FALSE;TRUE;;3;;Months;1;1;
NCT01112579;ClinicalTrials.gov processed this data on May 29, 2020;2010-04-16;;;2015-10-01;2010-04-27;2010-04-28;Estimate;;;;;;;2015-10-01;2015-10-29;Estimate;April 2010;;2010-04-30;October 2015;2015-10-31;April 2015;Actual;2015-04-30;January 2014;Actual;2014-01-31;;Interventional;DEFEAT-HF;;Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Heart Failure;Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Heart Failure;Completed;;Phase 2;81;Actual;Medtronic Cardiac Rhythm and Heart Failure;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:41:54Z;2020-06-01T16:41:54Z;Berlin;3664387;Principal Investigator;Heinz Theres, M.D.;Charite Universitatsmedizin Berlin - Campus Charite Mitte;Medtronic PrimeADVANCED Neurostimulator | Medtronic PrimeADVANCED Neurostimulator;63697214;19;80;159;2010;2020-05-29;45;TRUE;20;TRUE;FALSE;18;;Years;;1;2;
NCT01111448;ClinicalTrials.gov processed this data on May 29, 2020;2010-04-23;;;2015-02-12;2010-04-26;2010-04-27;Estimate;;;;;;;2015-02-12;2015-02-13;Estimate;April 2010;;2010-04-30;February 2015;2015-02-28;June 2014;Actual;2014-06-30;June 2013;Actual;2013-06-30;;Interventional;TEMDS;;Temsirolimus in Myelodysplastic Syndrome (MDS);Treatment of MDS Patients With Single Agent Temsirolimus - a Pilot Study;Terminated;;Phase 2;20;Actual;Technische Universität Dresden;;1;;Unfavourable Risk-Benefit-Ratio;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:42:07Z;2020-06-01T16:42:07Z;Dresden;3664464;Principal Investigator;Uwe Platzbecker, MD, PhD;Medizinische Klinik I, Universitätsklinikum Carl-Gustav-Carus, Dresden, Germany;Temsirolimus;63697301;7;;;2010;2020-05-29;38;FALSE;;FALSE;FALSE;18;;Years;;1;6;
NCT01108042;ClinicalTrials.gov processed this data on May 29, 2020;2010-04-14;;;2016-05-17;2010-04-20;2010-04-21;Estimate;;;;;;;2016-05-17;2016-05-18;Estimate;November 2009;;2009-11-30;May 2016;2016-05-31;February 2016;Actual;2016-02-29;January 2016;Actual;2016-01-31;;Interventional;;;TPF-Induction Chemotherapy of Oropharyngeal and Cavity of the Mouth Cancer;Phase I/II Study of Split-dose TPF-Induction Chemotherapy Before Surgery of Oropharyngeal and Cavity of the Mouth Cancer;Completed;;Phase 1/Phase 2;71;Actual;University of Jena;;1;;;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T16:42:57Z;2020-06-01T16:42:57Z;Jena;3664744;Principal Investigator;Orlando Guntinas-Lichius, Prof. Dr.;Friedrich-Schiller-University Jena;Taxotere, Cisplatin, 5-Fluorouracil (5-FU);63697558;4;;;2010;2020-05-29;75;FALSE;;FALSE;FALSE;18;80;Years;Years;1;5;
NCT01106820;ClinicalTrials.gov processed this data on May 29, 2020;2010-04-14;;;2016-12-16;2010-04-19;2010-04-20;Estimate;;;;;;;2016-12-16;2016-12-19;Estimate;April 2010;;2010-04-30;December 2016;2016-12-31;October 2014;Actual;2014-10-31;October 2013;Actual;2013-10-31;;Interventional;BEATE;;Progressive Resistance Training Versus Relaxation for Breast Cancer Patients During Chemotherapy: Biological Mechanisms and Effects on Fatigue and Quality of Life;Progressive Resistance Training vs. Relaxation for Breast Cancer Patients During Chemotherapy: A Randomized Controlled Intervention Trial to Evaluate the Biological Mechanisms and Effects of Resistance Training on Fatigue and Quality of Life;Completed;;N/A;101;Actual;German Cancer Research Center;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T16:43:27Z;2020-06-01T16:43:27Z;Heidelberg;3664847;Principal Investigator;Karen Steindorf, Prof. Dr.;NCT Heidelberg;Supervised progressive resistance training | Supervised progressive muscle relaxation training (Jacobsen method);63697651;1;;;2010;2020-05-29;42;FALSE;;FALSE;TRUE;18;;Years;;1;6;
NCT01106391;ClinicalTrials.gov processed this data on May 29, 2020;2010-04-16;;;2016-11-16;2010-04-16;2010-04-19;Estimate;;;;;;;2016-11-16;2017-01-04;Estimate;March 2010;;2010-03-31;November 2016;2016-11-30;October 2016;Actual;2016-10-31;August 2011;Actual;2011-08-31;;Interventional;INNOVATION;;A MULTICENTER, OPEN LABEL, PROSPECTIVE, NON-RANDOMIZED STUDY OF INCRAFT™ IN SUBJECTS WITH ABDOMINAL AORTIC ANEURYSMS (INNOVATION);A Multicenter, Open Label, Prospective, Non-Randomized Study Of INCRAFT™ In Subjects With Abdominal Aortic Aneurysms;Completed;;Phase 2;60;Actual;Cordis Corporation;;1;;;FALSE;;;;TRUE;;;;;;;;;;;Undecided;;2020-06-01T16:43:38Z;2020-06-01T16:43:38Z;Leipzig;3664885;Principal Investigator;Dierk Scheinert, PhD, MD.;Universität Leipzig - Herzzentrum;Cordis AAA stent graft system INCRAFT TM;63697685;1;96;18;2010;2020-05-29;17;TRUE;25;FALSE;TRUE;18;;Years;;2;;
NCT01105403;ClinicalTrials.gov processed this data on May 29, 2020;2010-04-13;;;2014-04-22;2010-04-15;2010-04-16;Estimate;;;;;;;2014-04-22;2014-04-23;Estimate;April 2009;;2009-04-30;April 2014;2014-04-30;April 2014;Actual;2014-04-30;February 2014;Actual;2014-02-28;;Interventional;;;Exploratory Study on POL6326 in Stem Cell Mobilization;A Phase IIa, Proof of Concept Study is to Determine the Degree of Mobilisation of CD34+ Cells Following Administration of POL6326 in Patients With Multiple Myeloma;Completed;;Phase 2;21;Actual;Polyphor Ltd.;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:43:59Z;2020-06-01T16:43:59Z;Heidelberg;3664961;Principal Investigator;Hartmut Goldschmidt, MD;Heidelberg University;POL6326;63697760;1;;;2010;2020-05-29;58;FALSE;;FALSE;TRUE;18;70;Years;Years;1;2;
NCT01105143;ClinicalTrials.gov processed this data on May 29, 2020;2010-04-14;;;2017-12-18;2010-04-15;2010-04-16;Estimate;;;;;;;2017-12-18;2017-12-20;Actual;March 2012;Actual;2012-03-31;December 2017;2017-12-31;May 2017;Actual;2017-05-31;May 2015;Actual;2015-05-31;;Interventional;;;Effects of Negative Energy Balance on Muscle Mass Regulation;Effects of Negative Energy Balance on Muscle Mass Regulation;Completed;;N/A;81;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T16:44:03Z;2020-06-01T16:44:03Z;Berlin;3664982;Principal Investigator;Knut Mai, Prof;Charite;multimodal lifestyle intervention | placebo;63697781;1;;;2010;2020-05-29;38;FALSE;;FALSE;TRUE;40;80;Years;Years;2;6;9
NCT01103284;ClinicalTrials.gov processed this data on May 29, 2020;2010-04-13;;;2016-04-19;2010-04-13;2010-04-14;Estimate;;;;;;;2016-04-19;2016-05-26;Estimate;April 2010;;2010-04-30;April 2016;2016-04-30;October 2014;Actual;2014-10-31;October 2014;Actual;2014-10-31;;Interventional;DIA-AID2;;Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults;A Phase 3, Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Clinical Efficacy and Safety of DiaPep277 in Newly Diagnosed Type 1 Diabetes Subjects;Completed;;Phase 3;475;Actual;Andromeda Biotech Ltd.;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:44:35Z;2020-06-01T16:44:35Z;Giessen;3665128;Principal Investigator;Thomas Linn, MD;University of Giessen;DiaPep277 | Placebo;63697925;75;1021;52;2010;2020-05-29;54;TRUE;12;TRUE;FALSE;20;45;Years;Years;1;3;1
NCT01097967;ClinicalTrials.gov processed this data on May 29, 2020;2010-04-01;;;2015-10-23;2010-04-01;2010-04-02;Estimate;;;;;;;2015-10-23;2015-10-26;Estimate;July 2010;;2010-07-31;October 2015;2015-10-31;April 2016;Anticipated;2016-04-30;April 2016;Anticipated;2016-04-30;;Interventional;SAS-CARE;;Sleep Disordered Breathing in Transient Ischemic Attack (TIA)/Ischemic Stroke and Continuous Positive Airway Pressure (CPAP) Treatment Efficacy;Sleep Disordered Breathing in TIA/Ischemic Stroke: Effects on Short- and Long-term Outcome and CPAP Treatment Efficacy: an Open, Observational, Clinical, Multicentre Trial With a Randomized Arm;Unknown status;;Phase 4;246;Actual;Ospedale Civico, Lugano;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T16:46:03Z;2020-06-01T16:46:03Z;Münster;3665550;Study Chair;Peter Young, Prof. MD;Universitätsklinik Münster, Zentrum für Schlafmedizin;CPAP;63698327;5;;;2010;2020-05-29;;FALSE;;FALSE;FALSE;35;75;Years;Years;1;3;
NCT01092533;ClinicalTrials.gov processed this data on May 29, 2020;2010-03-23;;;2017-05-05;2010-03-24;2010-03-25;Estimate;;;;;;;2017-05-05;2017-05-09;Actual;March 2010;;2010-03-31;May 2017;2017-05-31;October 2015;Actual;2015-10-31;October 2015;Actual;2015-10-31;;Interventional;MYCUV-IIT02;;Myfortic for the Treatment of Non-infectious Intermediate Uveitis;Myfortic (Enteric-coated Mycophenolate Sodium) for the Treatment of Non-infectious Intermediate Uveitis - a Prospective, Controlled, Randomized Multicenter Trial;Completed;;Phase 3;44;Actual;STZ eyetrial;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:47:32Z;2020-06-01T16:47:32Z;Tübingen;3666106;Principal Investigator;Christoph Deuter, Dr.;Centre for Ophthalmology, University of Tuebingen;Myfortic | Decortin;63698742;5;;;2010;2020-05-29;68;FALSE;;FALSE;FALSE;18;80;Years;Years;1;;
NCT01089075;ClinicalTrials.gov processed this data on May 29, 2020;2010-02-02;;;2015-04-07;2010-03-17;2010-03-18;Estimate;;;;;;;2015-04-07;2015-04-08;Estimate;February 2010;;2010-02-28;April 2015;2015-04-30;March 2015;Actual;2015-03-31;March 2015;Actual;2015-03-31;;Interventional;CSMünchen01;;Neuropsychological Effects of Hydrocortisone in Patients With Partial Adrenal Insufficiency;Phase IV Study to Evaluate the Neuropsychological Effects of Hydrocortisone Substitution in Patients With Partial Adrenal Insufficiency After Traumatic Brain Injury or Subarachnoidal Haemorrhage;Terminated;;Phase 4;32;Actual;Max-Planck-Institute of Psychiatry;;2;;Insufficient recruitment of suitable patients.;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T16:48:30Z;2020-06-01T16:48:30Z;Munich;3666396;Study Director;Günter K. Stalla, Prof. Dr.;Max-Planck-Institute, Munich;Hydrocortisone | Placebo;63699006;1;;;2010;2020-05-29;61;FALSE;;FALSE;TRUE;18;75;Years;Years;1;1;
NCT01088620;ClinicalTrials.gov processed this data on May 29, 2020;2010-03-16;;;2013-03-13;2010-03-16;2010-03-17;Estimate;;;;;;;2013-03-13;2013-03-14;Estimate;April 2010;;2010-04-30;March 2013;2013-03-31;January 2014;Anticipated;2014-01-31;January 2013;Actual;2013-01-31;;Interventional;;;Panitumumab Plus Pemetrexed and Cisplatin (PemCisP) Versus PemCis in the First-line Treatment of Patients With Non-small Cell Lung Cancer;CHAMP - An Open-label, Randomised, Multicentre, Phase II Clinical Study of Panitumumab Plus Pemetrexed and Cisplatin (PemCisP) Versus PemCis in the First-line Treatment of Patients With Stage IIIB or IV Primary Nonsquamous Non-small Cell Lung Cancer, With Particular Regard to the KRAS Status;Suspended;;Phase 2;134;Anticipated;WiSP Wissenschaftlicher Service Pharma GmbH;;2;;the DSMB stopped the trial due to unacceptable side effects in the experimental arm which has~   not yet been verified;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:48:36Z;2020-06-01T16:48:36Z;Halle;3666434;Principal Investigator;Wolfgang Schütte, MD;Krankenhaus Martha-Maria Halle-Dölau;Panitumumab | Pemetrexed | Cisplatin;63699041;20;;;2010;2020-05-29;33;FALSE;;FALSE;FALSE;18;;Years;;1;5;
NCT01083394;ClinicalTrials.gov processed this data on May 29, 2020;2010-02-26;;;2014-03-07;2010-03-08;2010-03-09;Estimate;;;;;;;2014-03-07;2014-03-10;Estimate;March 2010;;2010-03-31;April 2010;2010-04-30;December 2015;Anticipated;2015-12-31;December 2014;Anticipated;2014-12-31;;Interventional;ISAR-PEBIS;;Paclitaxel Eluting Balloon and Conventional Balloon for In-Stent Restenosis of the Superficial Femoral Artery;Randomized Trial of Paclitaxel Eluting Balloon or Conventional Balloon for Treatment of In-Stent Restenosis of the Superficial Femoral Artery in Patients With Symptomatic Peripheral Artery Disease (ISAR-PEBIS);Unknown status;;Phase 4;70;Anticipated;Deutsches Herzzentrum Muenchen;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T16:50:20Z;2020-06-01T16:50:20Z;Munich;3666905;Study Chair;Adnan Kastrati, MD;Deutsches Herzzentrum Muenchen;PTA | PTA with PEB | Percutaneous Transluminal Angioplasty (PTA);63699437;2;;;2010;2020-05-29;;FALSE;;FALSE;FALSE;18;;Years;;1;5;
NCT01081093;ClinicalTrials.gov processed this data on May 29, 2020;2010-03-04;;;2014-08-05;2010-03-04;2010-03-05;Estimate;;;;;;;2014-08-05;2014-08-06;Estimate;April 2010;;2010-04-30;August 2014;2014-08-31;August 2014;Actual;2014-08-31;August 2014;Actual;2014-08-31;;Interventional;BIVENT;;Biventricular Pacing in Hypertrophic Cardiomyopathy After Aortic Valve Replacement;Biventricular Pacing in Hypertrophic Cardiomyopathy After Aortic Valve Replacement;Completed;;N/A;72;Anticipated;Johann Wolfgang Goethe University Hospital;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T16:50:58Z;2020-06-01T16:50:58Z;Frankfurt;;;;;additional temporary pacewire;63699614;1;;;2010;2020-05-29;52;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT01078142;ClinicalTrials.gov processed this data on May 29, 2020;2010-02-18;;;2017-09-08;2010-03-01;2010-03-02;Estimate;;;;;;;2017-09-08;2017-09-11;Actual;February 2, 2010;Actual;2010-02-02;May 2017;2017-05-31;September 8, 2017;Actual;2017-09-08;September 8, 2017;Actual;2017-09-08;;Interventional;BERT;;Temsirolimus, Bendamustine and Rituximab for Relapsed Follicular Lymphoma or Mantle Cell Lymphoma;A Phase I/II Trial to Evaluate the Safety, Feasibility and Efficacy of the Addition of Temsirolimus to a Regimen of Bendamustine and Rituximab for the Treatment of Patients With Follicular Lymphoma or Mantle Cell Lymphoma in First to Third Relapse;Completed;;Phase 1/Phase 2;39;Actual;Johannes Gutenberg University Mainz;;1;;;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T16:52:09Z;2020-06-01T16:52:09Z;Mainz;3667342;Principal Investigator;Georg Hess, MD;Department of Hematology, Oncology and Pneumology, Universitätsmedizin der Johannes Gutenberg-Universität, Mainz, Germany;Temsirolimus, Rituximab, Bendamustin;63699836;1;;;2010;2020-05-29;92;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT01074697;ClinicalTrials.gov processed this data on May 29, 2020;2010-02-23;;;2015-04-23;2010-02-23;2010-02-24;Estimate;;;;;;;2015-04-23;2015-04-24;Estimate;April 2010;;2010-04-30;April 2015;2015-04-30;April 2015;Actual;2015-04-30;April 2015;Actual;2015-04-30;;Interventional;GAND-emesis;;Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin;A Multinational, Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Tolerability of Palonosetron and Dexamethasone Plus Fosaprepitant or Placebo in Patients Receiving Radiotherapy and Weekly Cisplatin.;Completed;;Phase 3;246;Actual;Odense University Hospital;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:53:35Z;2020-06-01T16:53:35Z;Berlin Kiel Lübeck;3667612;Principal Investigator;Petra Feyer, MD, DMSci;Vivantes Klinikum Neukölln in Berlin;Fosaprepitant dimeglumine | Placebo;63700099;8;;;2010;2020-05-29;60;FALSE;;FALSE;FALSE;18;;Years;;1;7;
NCT01071837;ClinicalTrials.gov processed this data on May 29, 2020;2010-02-18;;;2015-06-15;2010-02-18;2010-02-19;Estimate;;;;;;;2015-06-15;2015-06-16;Estimate;December 2009;;2009-12-31;June 2015;2015-06-30;October 2014;Actual;2014-10-31;October 2014;Actual;2014-10-31;;Interventional;;;APG101 in Glioblastoma;A Phase II, Randomized, Open-label, Multi-centre Study of Weekly APG101 + Reirradiation Versus Reirradiation in the Treatment of Patients With First or Second Progression of Glioblastoma;Completed;;Phase 2;84;Actual;Apogenix GmbH;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:54:37Z;2020-06-01T16:54:37Z;Heidelberg;3667867;Study Director;Wolfgang Wick, MD;University Hospital Heidelberg, Dept. of Neurooncology, Germany;APG101 | Blood drawing;63700318;21;;;2010;2020-05-29;58;FALSE;;FALSE;FALSE;18;;Years;;1;7;
NCT01067703;ClinicalTrials.gov processed this data on May 29, 2020;2010-02-10;;;2015-12-01;2010-02-10;2010-02-11;Estimate;;;;;;;2015-12-01;2015-12-03;Estimate;December 2010;;2010-12-31;September 2014;2014-09-30;May 2015;Actual;2015-05-31;May 2014;Actual;2014-05-31;;Interventional;;;Remote Ischaemic Preconditioning for Heart Surgery (RIPHeart-Study);Remote Ischaemic Preconditioning for Heart Surgery;Terminated;;Phase 3;1400;Actual;University of Schleswig-Holstein;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:55:59Z;2020-06-01T16:55:59Z;Frankfurt Kiel Lübeck;3668231;Principal Investigator;Patrick Meybohm, MD;University Hospital Frankfurt/ University Hospital Schleswig-Holstein;Remote Ischemic Preconditioning | Control/sham procedure (blood pressure cuff);63700631;10;;;2010;2020-05-29;41;FALSE;;FALSE;FALSE;18;90;Years;Years;1;5;
NCT01065025;ClinicalTrials.gov processed this data on May 29, 2020;2010-02-05;;;2015-04-10;2010-02-08;2010-02-09;Estimate;;;;;;;2015-04-10;2015-04-13;Estimate;January 2010;;2010-01-31;April 2015;2015-04-30;April 2015;Actual;2015-04-30;April 2015;Actual;2015-04-30;;Interventional;AEGIS;;Open Label, Dose Escalation Trial of Oral Eg5 Kinesin-spindle Inhibitor 4SC-205 in Patients With Advanced Malignancies;Open Label, Dose Escalation Trial of Oral 4SC-205 in Patients With Advanced Malignancies: First-In-Man Study of a Newly Developed, Oral Inhibitor of Kinesin-spindle Protein, Eg5;Completed;;Phase 1;60;Anticipated;4SC AG;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:56:45Z;2020-06-01T16:56:45Z;Freiburg;3668551;Principal Investigator;Klaus Mross, PD Dr. med.;Klinik für Tumorbiologie an der Albert-Ludwigs-Universität Freiburg (KTB);4SC-205;63700838;2;;;2010;2020-05-29;63;FALSE;;FALSE;FALSE;18;;Years;;1;3;
NCT01060423;ClinicalTrials.gov processed this data on May 29, 2020;2010-01-27;;;2016-10-25;2010-02-01;2010-02-02;Estimate;;;;;;;2016-10-25;2016-10-26;Estimate;February 2010;;2010-02-28;October 2016;2016-10-31;May 2015;Actual;2015-05-31;December 2012;Actual;2012-12-31;;Interventional;DEBIRITUX;;TACE With Irinotecan Drug-eluting Beads and Intravenous (IV) Cetuximab in Refractory Colorectal Cancer;A Randomized Phase II Trial of Irinotecan Drug-eluting Beads Administered by Hepatic Chemoembolization With Intravenous Cetuximab (DEBIRITUX) Versus Systemic Treatment With Intravenous Cetuximab and Irinotecan in Patients With Refractory Metastatic Colorectal Cancer and K-ras Wild-type Tumours;Terminated;;Phase 2;8;Actual;Martin-Luther-Universität Halle-Wittenberg;;2;;Terminated due to poor subject enrolment;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T16:58:10Z;2020-06-01T16:58:10Z;Halle;;;;;Cetuximab | Irinotecan | Irinotecan eluting BEADS;63701187;13;;;2010;2020-05-29;34;FALSE;;FALSE;FALSE;18;;Years;;1;5;
NCT01056679;ClinicalTrials.gov processed this data on May 29, 2020;2009-09-08;;;2018-03-21;2010-01-25;2010-01-26;Estimate;;;;;;;2018-03-21;2018-03-22;Actual;April 2010;;2010-04-30;March 2018;2018-03-31;February 2016;Actual;2016-02-29;April 2014;Actual;2014-04-30;;Interventional;AVD-Rev;;Adriamycin, Vinblastine, DTIC and Revlimid in Elderly Hodgkin Lymphoma Patients;Phase I Trial of AVD Plus Lenalidomide (Revlimid) in Elderly Intermediate or Advanced Stage Hodgkin Lymphoma Patients;Completed;;Phase 1;30;Anticipated;University of Cologne;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T16:59:19Z;2020-06-01T16:59:19Z;Köln;3669268;Principal Investigator;Andreas Engert, Prof.;University of Cologne;Doxorubicine | DTIC | Lenalidomide | Vinblastine;63701468;1;;;2009;2020-05-29;48;FALSE;;FALSE;TRUE;60;75;Years;Years;1;2;
NCT01055522;ClinicalTrials.gov processed this data on May 29, 2020;2010-01-22;;;2014-02-24;2010-01-22;2010-01-25;Estimate;;;;;;;2014-02-24;2014-02-25;Estimate;June 2008;;2008-06-30;October 2012;2012-10-31;February 2014;Actual;2014-02-28;February 2013;Actual;2013-02-28;;Interventional;;;Clinical Study Phase II of L19IL2 in Combination With Dacarbazine in Patients With Metastatic Melanoma;Dose Definition and Activity Evaluation Study of the Tumor-Targeting Human L19IL2 Monoclonal Antibody-Cytokine Fusion Protein in Combination With Dacarbazine in Patients With Metastatic Melanoma;Terminated;;Phase 2;102;Actual;Philogen S.p.A.;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T16:59:37Z;2020-06-01T16:59:37Z;Tübingen;3669364;Principal Investigator;Claus Garbe, Prof. M.D.;University Hospital Tuebingen (Germany);Arm 1: L19IL2 + Dacarbazine | Arm 3: Dacarbazine | ARM 2: L19IL2 + Dacarbazine;63701556;10;;;2010;2020-05-29;56;FALSE;;FALSE;FALSE;18;;Years;;2;7;
NCT01051167;ClinicalTrials.gov processed this data on May 29, 2020;2010-01-15;;;2017-05-03;2010-01-15;2010-01-18;Estimate;;;;;;;2017-05-03;2017-05-08;Actual;February 2009;;2009-02-28;May 2017;2017-05-31;September 2016;Actual;2016-09-30;September 2016;Actual;2016-09-30;;Interventional;CEBIFOX;;Bi-weekly Cetuximab Combined With 5-fluorouracil/Leucovorin/Oxaliplatin (FOLFOX-6) in Metastatic Colorectal Cancer;Bi-weekly Cetuximab Combined With FOLFOX-6 as First-line Treatment in Metastatic Colorectal Cancer Patients With Wild-type K-ras Status;Completed;;Phase 2;59;Actual;Universität Duisburg-Essen;;1;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T17:00:51Z;2020-06-01T17:00:51Z;Duisburg;3669712;Study Director;Martin Schuler, Prof.Dr.med.;University of Duisburg-Essen Medical School;Cetuximab;63701888;3;;;2010;2020-05-29;92;FALSE;;FALSE;FALSE;18;;Years;;1;1;
NCT01050686;ClinicalTrials.gov processed this data on May 29, 2020;2010-01-14;;;2015-02-11;2010-01-14;2010-01-15;Estimate;;;;;;;2015-02-11;2015-02-12;Estimate;March 2010;;2010-03-31;February 2015;2015-02-28;February 2015;Actual;2015-02-28;November 2014;Actual;2014-11-30;;Interventional;DRASTAR;;Need for Subcutaneous Wound Drains in Ileostomy Reversal;Need for Subcutaneous Wound Drains in Ileostomy Reversal;Completed;;N/A;102;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T17:00:59Z;2020-06-01T17:00:59Z;Berlin;3669750;Principal Investigator;Johannes C Lauscher, MD;Charite University, Berlin, Germany;insertion of subcutaneous wound drain | no insertion of subcutaneous wound drain;63701925;1;;;2010;2020-05-29;56;FALSE;;FALSE;TRUE;18;;Years;;1;7;
NCT01049100;ClinicalTrials.gov processed this data on May 29, 2020;2010-01-13;;;2010-01-14;2010-01-13;2010-01-14;Estimate;;;;;;;2010-01-14;2010-01-15;Estimate;April 2009;;2009-04-30;August 2009;2009-08-31;April 2017;Anticipated;2017-04-30;April 2013;Anticipated;2013-04-30;;Interventional;uterus11;;Surgical Staging in Cervical Cancer Prior to Chemoradiation;Prospective, Randomised and Multi-centric Therapy Optimisation Study for Examining the Influence of Surgical Staging on the Oncological Results for Patients With Cervix Carcinoma of the FIGO Stages IIB-IV After Chemoradiation;Unknown status;;N/A;250;Anticipated;Charite University, Berlin, Germany;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T17:01:25Z;2020-06-01T17:01:25Z;Berlin;3669890;Study Chair;Simone Marnitz, PD;Department of Radiooncology (Charité Campus Mitte und Virchow), Charitéplatz 1, 10117 Berlin, Germany;lymphadenectomy | Standard Staging;63702048;2;;;2010;2020-05-29;;FALSE;;FALSE;FALSE;18;70;Years;Years;1;1;
NCT01047891;ClinicalTrials.gov processed this data on May 29, 2020;2010-01-12;;;2015-02-17;2010-01-12;2010-01-13;Estimate;;;;;;;2015-02-17;2015-02-18;Estimate;January 2010;;2010-01-31;February 2015;2015-02-28;February 2015;Actual;2015-02-28;February 2015;Actual;2015-02-28;;Interventional;TRIAS 2009;;Efficacy and Safety Study of Sorafenib With Topotecan in Patients With Platinum-resistant Recurrent Ovarian Cancer;A Randomized, Double-blind, Placebo Controlled, Multicenter Phase II Study to Assess the Efficacy and Safety of Sorafenib Added to Standard Treatment With Topotecan in Patients With Platinum-resistant Recurrent Ovarian Cancer;Completed;;Phase 2;174;Actual;Charite University, Berlin, Germany;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T17:01:39Z;2020-06-01T17:01:39Z;Berlin;3669996;Principal Investigator;Jalid Sehouli Sehouli, Professor;Charité Campus Virchow-Klinikum, Berlin;Sorafenib;63702138;1;;;2010;2020-05-29;61;FALSE;;FALSE;TRUE;18;;Years;;1;6;
NCT01047254;ClinicalTrials.gov processed this data on May 29, 2020;2010-01-11;;;2017-05-08;2010-01-11;2010-01-12;Estimate;;;;;;;2017-05-08;2017-05-09;Actual;January 2010;;2010-01-31;May 2017;2017-05-31;July 2014;Actual;2014-07-31;July 2014;Actual;2014-07-31;;Interventional;APA-AD;;Bupropion for the Treatment of Apathy in Alzheimer's Dementia;A 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Bupropion for the Treatment of Apathy in Alzheimer's Dementia(Apa-AD);Completed;;Phase 3;110;Actual;University Hospital, Bonn;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T17:01:51Z;2020-06-01T17:01:51Z;Bonn;3670054;Principal Investigator;Frank Jessen, MD;University Bonn;Elontril | placebo;63702185;1;;;2010;2020-05-29;54;FALSE;;FALSE;TRUE;55;90;Years;Years;1;1;
NCT01047059;ClinicalTrials.gov processed this data on May 29, 2020;2010-01-10;;;2016-05-19;2010-01-11;2010-01-12;Estimate;;;;;;;2016-05-19;2016-05-20;Estimate;January 2010;;2010-01-31;May 2016;2016-05-31;May 2016;Actual;2016-05-31;October 2012;Actual;2012-10-31;;Interventional;MIMEB;;Molecular Imaging With Erlotinib and Bevacizumab;Clinical Pilot to Evaluate the Accuracy of FDG-/FLT-PET and DCE-MRI for Early Prediction of Non-Progression in Patients With Advanced Non Squamous Cell Non Small Cell Lung Cancer (NSCLC) Treated With Erlotinib and Bevacizumab and to Associate Imaging Findings With Molecular Markers;Completed;;Phase 2;40;Actual;University of Cologne;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T17:01:53Z;2020-06-01T17:01:53Z;Köln;3670070;Principal Investigator;Jürgen Wolf, MD, Prof.;Lung Cancer Group Cologne (LCGC);Erlotinib, Bevacizumab | Fluoro-D-glucose | Fluoro-L-thymidine | Gadolinium-DPTA;63702199;1;;;2010;2020-05-29;33;FALSE;;FALSE;TRUE;18;99;Years;Years;1;1;
NCT01046799;ClinicalTrials.gov processed this data on May 29, 2020;2010-01-09;;;2014-11-04;2010-01-09;2010-01-12;Estimate;;;;;;;2014-11-04;2014-11-05;Estimate;March 2008;;2008-03-31;November 2014;2014-11-30;October 2014;Actual;2014-10-31;June 2014;Actual;2014-06-30;;Interventional;;;Prevention of Hepatitis B Virus Reinfection After Liver Transplantation With Entecavir;Prevention of HBV Reinfection After Liver Transplantation Using Entecavir Monotherapy After Short-term HBIg Administration: A Pilot Study;Completed;;Phase 3;20;Anticipated;HepNet Study House, German Liverfoundation;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T17:01:57Z;2020-06-01T17:01:57Z;Hannover;3670098;Principal Investigator;Michael P Manns, MD;Hannover Medical School;Entecavir;63702218;3;;;2010;2020-05-29;76;FALSE;;FALSE;FALSE;18;;Years;;1;1;
NCT01045512;ClinicalTrials.gov processed this data on May 29, 2020;2010-01-08;;;2015-01-27;2010-01-08;2010-01-11;Estimate;;;;;;;2015-01-27;2015-01-28;Estimate;October 2009;;2009-10-31;January 2015;2015-01-31;September 2014;Actual;2014-09-30;September 2014;Actual;2014-09-30;;Interventional;AntiCardAgeing;;The Role of the Inflammatory/ Pathogen Burden for Cardiac Ageing;The Role of the Inflammatory/ Pathogen Burden for Cardiac Ageing;Terminated;;Phase 2;96;Actual;Martin-Luther-Universität Halle-Wittenberg;;2;;unsufficient recruitment;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T17:02:14Z;2020-06-01T17:02:14Z;Halle;3670206;Study Chair;Ursula Müller-Werdan, Prof.Dr.med.;Martin-Luther-University Halle-Wittenberg, Medical Faculty;fluvastatin;63702315;1;;;2010;2020-05-29;59;FALSE;;FALSE;TRUE;60;75;Years;Years;1;6;
NCT01041950;ClinicalTrials.gov processed this data on May 29, 2020;2010-01-04;;;2016-10-25;2010-01-04;2010-01-05;Estimate;;;;;;;2016-10-25;2016-10-27;Estimate;May 2012;;2012-05-31;October 2016;2016-10-31;July 2015;Actual;2015-07-31;July 2015;Actual;2015-07-31;;Interventional;LUCAS-IVH;;A Randomised Controlled Trial of Lumbar Drainage to Treat Communicating Hydrocephalus After Severe Intraventricular Hemorrhage;Lumbar Drainage for Communicating Hydrocephalus After Intraventricular Hemorrhage: a Randomised, Controlled Trial(LUCAS-IVH: LUmbar CAtheter for Severe IntraVentricular Hemorrhage);Completed;;Phase 2/Phase 3;30;Actual;University of Erlangen-Nürnberg Medical School;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T17:03:13Z;2020-06-01T17:03:13Z;Erlangen Freiburg;3670516;Principal Investigator;Hagen Huttner, MD;Neurology Department, University of Erlangen-Nuremberg;Lumbar drainage;63702587;1;;;2010;2020-05-29;38;FALSE;;FALSE;TRUE;18;85;Years;Years;1;2;
NCT01035190;ClinicalTrials.gov processed this data on May 29, 2020;2009-12-17;;;2016-07-04;2009-12-17;2009-12-18;Estimate;;;;;;;2016-07-04;2016-07-06;Estimate;April 2010;;2010-04-30;July 2016;2016-07-31;July 2016;Actual;2016-07-31;October 2013;Actual;2013-10-31;;Interventional;NEuroSIS;;Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia;Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia;Completed;;Phase 3;863;Actual;University Children’s Hospital Tuebingen;;1;;;FALSE;;;;TRUE;;;;;;;;;;;Undecided;;2020-06-01T17:04:58Z;2020-06-01T17:04:58Z;Tübingen;3671069;Principal Investigator;Prof. Dr. med. Dirk Bassler, MSc;University Children's Hospital Tuebingen / University Hospital Zurich, Department of Neonatology;Budesonide;63703047;40;;;2009;2020-05-29;42;FALSE;;FALSE;FALSE;;12;;Hours;1;1;
NCT01029769;ClinicalTrials.gov processed this data on May 29, 2020;2009-12-09;;;2015-05-22;2009-12-09;2009-12-10;Estimate;;;;;;;2015-05-22;2015-05-27;Estimate;December 2009;;2009-12-31;May 2015;2015-05-31;March 2015;Actual;2015-03-31;March 2014;Actual;2014-03-31;;Interventional;;;Efficacy of an Early Antipsychotic Switch in Case of Poor Initial Response to the Treatment of Schizophrenia;The Switch Study - Efficacy of Early Antipsychotic Switch Versus Maintenance in Patients With Schizophrenia Poorly Responding to Two Weeks of Antipsychotic Treatment;Completed;;N/A;351;Actual;Technische Universität München;;5;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T17:06:31Z;2020-06-01T17:06:31Z;Munich;3671534;Principal Investigator;Stefan Leucht, MD;Psychiatrische Klinik und Poliklinik fuer Psychiatrie und Psychotherapie der Technischen Universität München am Klinikum rechts der Isar;Olanzapine or amisulpride;63703460;1;;;2009;2020-05-29;51;FALSE;;FALSE;TRUE;18;65;Years;Years;1;3;
NCT01027884;ClinicalTrials.gov processed this data on May 29, 2020;2009-12-08;;;2015-09-23;2009-12-08;2009-12-09;Estimate;;;;;;;2015-09-23;2015-10-19;Estimate;July 2009;;2009-07-31;September 2015;2015-09-30;April 2014;Actual;2014-04-30;January 2014;Actual;2014-01-31;;Interventional;DELOS;;Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD);A Phase III Double-Blind, Randomised, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Idebenone in 10-18 Year Old Patients With Duchenne Muscular Dystrophy;Completed;;Phase 3;65;Actual;Santhera Pharmaceuticals;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T17:06:54Z;2020-06-01T17:06:54Z;Duisburg Freiburg;3671739;Principal Investigator;Dr. Ulrike Schara, MD, PhD;Universitätsklinikum Essen, D-45122 Essen, Germany;Placebo | Idebenone;63703600;23;208;20;2009;2020-05-29;54;TRUE;16;TRUE;FALSE;10;18;Years;Years;1;4;
NCT01023542;ClinicalTrials.gov processed this data on May 29, 2020;2009-12-01;;;2011-06-30;2009-12-01;2009-12-02;Estimate;;;;;;;2011-06-30;2011-07-01;Estimate;June 2011;;2011-06-30;June 2011;2011-06-30;December 2014;Anticipated;2014-12-31;July 2014;Anticipated;2014-07-31;;Interventional;BUILT_01;;CNI-free Bottom-up Immunosuppression in Patients Undergoing Liver Transplantation;A 3-Armed Prospective Randomized Controlled, Open-Labeled Phase II Trial to Evaluate Late Introduction of Cyclosporine or Everolimus Versus a 5-day Delay of Cyclosporine in Combination With MMF in Liver Transplant Recipients With MELD-Scores≥25;Unknown status;;Phase 2/Phase 3;45;Anticipated;University of Regensburg;;3;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T17:08:21Z;2020-06-01T17:08:21Z;Regensburg;3672128;Principal Investigator;Andreas A Schnitzbauer, MD;Regensburg University Hospital, Department of Surgery;delayed, low-dose CNI | BU-CNI | BU-Everolimus;63703927;1;;;2009;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT01021202;ClinicalTrials.gov processed this data on May 29, 2020;2009-10-06;;;2015-07-15;2009-11-25;2009-11-26;Estimate;;;;;;;2015-07-15;2015-07-16;Estimate;October 2009;;2009-10-31;July 2015;2015-07-31;October 2017;Anticipated;2017-10-31;October 2017;Anticipated;2017-10-31;;Interventional;;;Timing of Dilation Tracheostomy in Mechanically Ventilated Chronic Obstructive Pulmonary Disease (COPD) Patients;Early vs. Late Percutaneous Dilation Tracheostomy in Mechanically Ventilated Patients With Chronic Obstructive Pulmonary Disease;Suspended;;N/A;40;Anticipated;Universitätsklinikum Hamburg-Eppendorf;;2;;unexpectedly slow recruitment;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T17:08:56Z;2020-06-01T17:08:56Z;Hamburg;3672313;Principal Investigator;Stefan Kluge, MD;Department of Critical Care Medicine, University Medical Center Hamburg - Eppendorf;Percutaneous dilation tracheostomy;63704105;1;;;2009;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;5;
NCT01019434;ClinicalTrials.gov processed this data on May 29, 2020;2009-11-24;;;2018-07-06;2009-11-24;2009-11-25;Estimate;;;;;;;2018-07-06;2018-07-09;Actual;October 2009;;2009-10-31;July 2018;2018-07-31;March 2014;Actual;2014-03-31;December 2013;Actual;2013-12-31;;Interventional;;;Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma;Radiation Therapy and Concurrent Plus Adjuvant Temsirolimus (CCI-779) Versus Chemo-Irradiation With Temozolomide in Newly Diagnosed Glioblastoma Without Methylation of the MGMT Gene Promoter - A Randomized Multicenter, Open-Label, Phase II Study.;Completed;;Phase 2;111;Actual;European Organisation for Research and Treatment of Cancer - EORTC;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T17:09:16Z;2020-06-01T17:09:16Z;Heidelberg;3672497;Study Chair;Wolfgang Wick;Universitatsklinikum Heidelberg;temozolomide | temsirolimus;63704231;13;;;2009;2020-05-29;50;FALSE;;FALSE;FALSE;18;120;Years;Years;1;3;
NCT01018602;ClinicalTrials.gov processed this data on May 29, 2020;2009-11-20;;;2011-06-24;2009-11-20;2009-11-23;Estimate;;;;;;;2011-06-24;2011-06-27;Estimate;January 2008;;2008-01-31;June 2011;2011-06-30;June 2015;Anticipated;2015-06-30;June 2012;Anticipated;2012-06-30;;Interventional;;;PINGUIN (Postpartum Intervention in Women With Gestational Diabetes Using Insulin);A Phase II, Randomized, Double-blind, 2-arm Controlled Study to Evaluate Efficacy of the DPPIV-inhibitor Vildagliptin for Prevention of Type 2 Diabetes in Women With a Recent History of Insulin-requiring Gestational Diabetes;Unknown status;;Phase 2;140;Anticipated;Institut fur Diabetesforschung, Munich, Germany;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T17:09:29Z;2020-06-01T17:09:29Z;Munich;;;;;vildagliptin | inactive pill;63704298;1;;;2009;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT01015469;ClinicalTrials.gov processed this data on May 29, 2020;2009-11-17;;;2011-02-16;2009-11-17;2009-11-18;Estimate;;;;;;;2011-02-16;2011-02-17;Estimate;February 2009;;2009-02-28;February 2011;2011-02-28;March 2015;Anticipated;2015-03-31;March 2014;Anticipated;2014-03-31;;Interventional;GABY;;Banded Versus Conventional Laparoscopic Roux-en-Y (GABY);International, Multi Centre, Open, Prospective, Randomized Study: Banded Versus Conventional Laparoscopic Roux-en-Y (GABY);Unknown status;;Phase 4;384;Anticipated;ClinTrio Ltd.;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T17:10:25Z;2020-06-01T17:10:25Z;Freiburg;3672810;Principal Investigator;Konrad W Karcz, MD;Albert-Ludwigs-University of Freiburg;Conventional laparoscopic Roux-en-Y gastric bypass | conventional laparoscopic Roux-en-Y gastric bypass with additional restrictive silastic ring;63704532;14;;;2009;2020-05-29;;FALSE;;FALSE;FALSE;18;60;Years;Years;1;;
NCT01011920;ClinicalTrials.gov processed this data on May 29, 2020;2009-11-09;;;2017-08-22;2009-11-10;2009-11-11;Estimate;;;;;;;2017-08-22;2017-08-23;Actual;November 2009;;2009-11-30;July 2016;2016-07-31;March 2017;Actual;2017-03-31;March 2015;Actual;2015-03-31;;Interventional;;;Trial for Patients With Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma;Randomized Phase II Trial On Primary Chemotherapy With High-Dose Methotrexate And High-Dose Cytarabine With Or Without Thiotepa, And With Or Without Rituximab, Followed By Brain Irradiation Vs. High-Dose Chemotherapy Supported By Autologous Stem Cells Transplantation For Immunocompetent Patients With Newly Diagnosed Primary CNS Lymphoma;Completed;;Phase 2;126;Actual;International Extranodal Lymphoma Study Group (IELSG);;5;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T17:11:34Z;2020-06-01T17:11:34Z;Freiburg;3673126;Study Chair;Gerald Illerhaus, MD;University Medical Center, Freiburg, Germany;Methotrexate | Ara-C | Rituximab | Thiotepa | radiotherapy | BCNU | APBSCT;63704802;23;;;2009;2020-05-29;64;FALSE;;FALSE;FALSE;18;65;Years;Years;1;2;
NCT01010243;ClinicalTrials.gov processed this data on May 29, 2020;2009-11-06;;;2012-05-29;2009-11-06;2009-11-09;Estimate;;;;;;;2012-05-29;2012-05-30;Estimate;October 2009;;2009-10-31;May 2012;2012-05-31;October 2016;Anticipated;2016-10-31;October 2013;Anticipated;2013-10-31;;Interventional;MM03;;Third-line Therapy of Multiple Myeloma a Prospective Phase I /II Trial;Third-line Therapy of Multiple Myeloma With Lenalidomide in Combination With Pioglitazone, Dexamethasone and Metronomic Low-dose Chemotherapy With Treosulfan;Unknown status;;Phase 1/Phase 2;54;Anticipated;University of Regensburg;;;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T17:12:04Z;2020-06-01T17:12:04Z;Regensburg;3673277;Principal Investigator;Albrecht Reichle, Professor;University of Regensburg;Lenalidomide, Pioglitazone, dexamethasone, treosulfan;63704931;6;;;2009;2020-05-29;;FALSE;;FALSE;FALSE;18;;Years;;1;1;
NCT01006577;ClinicalTrials.gov processed this data on May 29, 2020;2009-10-19;;;2009-11-02;2009-11-02;2009-11-03;Estimate;;;;;;;2009-11-02;2009-11-03;Estimate;June 2010;;2010-06-30;November 2009;2009-11-30;October 2015;Anticipated;2015-10-31;July 2015;Anticipated;2015-07-31;;Interventional;SAVE;;Side-to-end Anastomosis Versus Colon J Pouch for Reconstruction After Low Anterior Resection for Rectal Cancer (SAVE);Side-to-end Anastomosis Versus Colon J Pouch for Reconstruction After Low Anterior Resection for Rectal Cancer (SAVE);Unknown status;;N/A;306;Anticipated;Charite University, Berlin, Germany;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T17:13:12Z;2020-06-01T17:13:12Z;Berlin;3673554;Principal Investigator;Johannes C Lauscher, MD;"Charité Campus Benjamin Franklin; Department of General, Vascular and Thoracic Surgery";side-to-end anastomosis | colon j pouch;63705207;1;;;2009;2020-05-29;;FALSE;;FALSE;TRUE;18;80;Years;Years;1;9;
NCT01002703;ClinicalTrials.gov processed this data on May 29, 2020;2009-10-23;;;2011-08-11;2009-10-26;2009-10-27;Estimate;;;;;;;2011-08-11;2011-08-12;Estimate;September 2009;;2009-09-30;October 2009;2009-10-31;October 2014;Anticipated;2014-10-31;October 2012;Anticipated;2012-10-31;;Interventional;;;Treatment With Lenalidomide, Bendamustine and Prednisone (RBP) in Patients With Relapsed or Refractory Multiple Myeloma;Treatment With Lenalidomide, Bendamustine and Prednisone (RBP) in Patients With Relapsed or Refractory Multiple Myeloma After Autologous Stem Cell Transplantation or Conventional Chemotherapy OSHO #077;Unknown status;;Phase 1/Phase 2;50;Anticipated;University of Leipzig;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T17:14:20Z;2020-06-01T17:14:20Z;Leipzig;;;;;Lenalidomide, Bendamustine, Prednisone;63705504;1;;;2009;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT00998556;ClinicalTrials.gov processed this data on May 29, 2020;2009-10-19;;;2020-01-23;2009-10-19;2009-10-20;Estimate;;;;;;;2020-01-23;2020-01-27;Actual;June 2010;;2010-06-30;January 2020;2020-01-31;August 2016;Actual;2016-08-31;March 2016;Actual;2016-03-31;;Interventional;PPCM;;Effect of Bromocriptine on Left Ventricular Function in Women With Peripartum Cardiomyopathy;Effect of Bromocriptine on LV Function in Women With Peripartum Cardiomyopathy A Randomized, Controlled Clinical Trial to Evaluate the Efficacy and Safety of Bromocriptine for Improvement of Left Ventricular Function of Women With PPCM;Completed;;Phase 2;64;Actual;Hannover Medical School;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T17:15:39Z;2020-06-01T17:15:39Z;Hannover;3674275;Principal Investigator;Johann Bauersachs, Prof. Dr.;Hannover Medical School, Hannover, Germany;Bromocriptine;63705825;1;;;2009;2020-05-29;70;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT00996229;ClinicalTrials.gov processed this data on May 29, 2020;2009-10-14;;;2013-04-18;2009-10-15;2009-10-16;Estimate;;;;;;;2013-04-18;2013-04-19;Estimate;November 2009;;2009-11-30;April 2013;2013-04-30;February 2014;Anticipated;2014-02-28;December 2013;Anticipated;2013-12-31;;Interventional;;;Effects of Dietary Interventions on the Aging Brain;Phase IV Interventional Study: Effects of Dietary Interventions on Brain Functions in Healthy Elderly People;Unknown status;;Phase 3;300;Anticipated;University Hospital Muenster;;4;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T17:16:40Z;2020-06-01T17:16:40Z;Berlin Münster;3674479;Study Chair;Agnes Flöel, Professor;Charite University, Berlin, Germany;Caloric restriction | Omega-3 (fish oil capsules) | Placebo | Resveratrol;63706008;1;;;2009;2020-05-29;;FALSE;;FALSE;TRUE;50;80;Years;Years;1;2;
NCT00986752;ClinicalTrials.gov processed this data on May 29, 2020;2009-09-29;;;2014-03-06;2009-09-29;2009-09-30;Estimate;;;;;;;2014-03-06;2014-03-07;Estimate;July 2009;;2009-07-31;January 2010;2010-01-31;March 2015;Anticipated;2015-03-31;December 2014;Anticipated;2014-12-31;;Interventional;ISAR-STATH;;Efficacy Study of Stenting, Paclitaxel Eluting Balloon or Atherectomy to Treat Peripheral Artery Disease;Randomized Trial of Stenting After Dilation With or Without Paclitaxel Eluting Balloon or Atherectomy in Patients With Symptomatic Peripheral Artery Disease;Unknown status;;Phase 4;150;Anticipated;Deutsches Herzzentrum Muenchen;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T17:19:08Z;2020-06-01T17:19:08Z;Munich;3675321;Study Chair;Adnan Kastrati, MD;Deutsches Herzzentrum München;Stenting (Smart Stent) | Stenting after PEB (Smart Stent, Invatec) | Atherectomy (SilverHawk device);63706740;2;;;2009;2020-05-29;;FALSE;;FALSE;FALSE;18;;Years;;1;6;
NCT00977340;ClinicalTrials.gov processed this data on May 29, 2020;2009-09-14;;;2018-06-28;2009-09-14;2009-09-15;Estimate;;;;;;;2018-06-28;2018-07-02;Actual;October 2009;Actual;2009-10-31;June 2018;2018-06-30;November 8, 2017;Actual;2017-11-08;November 8, 2017;Actual;2017-11-08;;Interventional;;;Study on the Psychotherapeutic Treatment of Chronic Nightmares;Psychotherapeutic Treatment of Chronic Nightmares: Differential Efficacy of Imagery Rehearsal Therapy Compared to Confrontation and Psychotherapeutic Placebo;Completed;;N/A;122;Actual;Goethe University;;3;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T17:22:39Z;2020-06-01T17:22:39Z;Frankfurt;3676099;Principal Investigator;Regina Steil, PhD;Johann Wolfgang Goethe University - Department of Clinical Psychology and Ppsychotherapy;Imagery Rehearsal Treatment | confrontation | imagination;63707450;1;;;2009;2020-05-29;97;FALSE;;FALSE;TRUE;18;65;Years;Years;3;5;
NCT00977132;ClinicalTrials.gov processed this data on May 29, 2020;2009-09-14;;;2015-03-17;2009-09-14;2009-09-15;Estimate;;;;;;;2015-03-17;2015-03-18;Estimate;October 2009;;2009-10-31;March 2015;2015-03-31;May 2014;Actual;2014-05-31;May 2013;Actual;2013-05-31;;Interventional;VALENA;;Efficacy and Tolerability of the Combination of Valproic Acid and Lenalidomide in the Treatment of Patients With Myelodysplastic Syndrome;Phase II Study for the Determination of Efficacy and Tolerability of the Combination of Valproic Acid and Lenalidomide in the Treatment of Patients With Myelodysplastic Syndrome With Favorable Risk Profile;Terminated;;Phase 2;23;Actual;Heinrich-Heine University, Duesseldorf;;1;;delayed recruitment;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T17:22:42Z;2020-06-01T17:22:42Z;Düsseldorf;;;;;Valproic aicd | Lenalidomide;63707466;6;;;2009;2020-05-29;43;FALSE;;FALSE;FALSE;18;;Years;;1;3;
NCT00976456;ClinicalTrials.gov processed this data on May 29, 2020;2009-09-11;;;2016-02-11;2009-09-11;2009-09-14;Estimate;;;;;;;2016-02-11;2016-03-10;Estimate;September 2009;;2009-09-30;February 2016;2016-02-29;October 2014;Actual;2014-10-31;October 2014;Actual;2014-10-31;;Interventional;65plus;;Efficacy Study of Avastin® With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung Cancer;Open-label Study of Bevacizumab (Avastin®) in Combination With Pemetrexed or Pemetrexed and Carboplatin as First-line Treatment of Patients With Advanced or Recurrent Non-squamous Non-small Cell Lung Cancer;Completed;;Phase 3;271;Actual;Martha-Maria Krankenhaus Halle-Dölau gGmbH;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T17:23:10Z;2020-06-01T17:23:10Z;Halle;3676168;Study Chair;Wolfgang Schuette, PhD MD.;Krankenhaus Martha-Maria Halle-Doelau;Bevacizumab + Pemetrexed | Bevacizumab + Pemetrexed + Carboplatin;63707520;1;316;30;2009;2020-05-29;61;TRUE;14;FALSE;TRUE;65;;Years;;1;1;
NCT00976222;ClinicalTrials.gov processed this data on May 29, 2020;2009-09-11;;;2017-09-27;2009-09-11;2009-09-14;Estimate;;;;;;;2017-09-27;2017-09-29;Actual;December 2008;;2008-12-31;September 2017;2017-09-30;December 2015;Actual;2015-12-31;December 2014;Actual;2014-12-31;;Interventional;;;Intravitreal Ranibizumab in Retinal Pigment Epithelial Detachments;Intravitreal Ranibizumab in Patients With Retinal Pigment Epithelial Detachments Secondary to Age-related Macular Degeneration;Completed;;Phase 4;40;Actual;University Hospital Muenster;;1;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T17:23:14Z;2020-06-01T17:23:14Z;Münster;3676185;Principal Investigator;Nicole Eter, MD;Dept. of Ophthalmology, University of Muenster Medical Center;intravitreal injection with ranibizumab;63707525;2;;;2009;2020-05-29;73;FALSE;;FALSE;FALSE;50;;Years;;1;5;
NCT00976092;ClinicalTrials.gov processed this data on May 29, 2020;2009-09-11;;;2014-01-06;2009-09-11;2009-09-14;Estimate;;;;;;;2014-01-06;2014-01-07;Estimate;September 2009;;2009-09-30;January 2014;2014-01-31;February 2015;Anticipated;2015-02-28;February 2014;Anticipated;2014-02-28;;Interventional;BRAVE-4;;Efficacy Study of Combined Prasugrel and Bivalirudin Versus Clopidogrel and Heparin in Myocardial Infarction;Randomized Trial of Prasugrel Plus Bivalirudin vs. Clopidogrel Plus Heparin in Patients With Acute STEMI;Unknown status;;Phase 4;548;Actual;Deutsches Herzzentrum Muenchen;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T17:23:16Z;2020-06-01T17:23:16Z;Munich;3676192;Principal Investigator;Julinda Mehilli, MD;Deutsches Herzzentrum Muenchen;Prasugrel | Bivalirudin | Clopidogrel | Heparin;63707547;3;;;2009;2020-05-29;;FALSE;;FALSE;FALSE;18;;Years;;1;3;
NCT00974155;ClinicalTrials.gov processed this data on May 29, 2020;2009-09-09;;;2015-03-31;2009-09-09;2009-09-10;Estimate;;;;;;;2015-03-31;2015-04-01;Estimate;September 2009;;2009-09-30;March 2015;2015-03-31;May 2014;Actual;2014-05-31;May 2014;Actual;2014-05-31;;Interventional;EMC;;The Early Medication Change (EMC) Trial;Randomised Clinical Trial Comparing Early Medication Change (EMC) Strategy With Treatment as Usual (TAU) in Patients With Major Depressive Disorder - the EMC Trial;Completed;;Phase 4;889;Actual;Johannes Gutenberg University Mainz;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T17:23:58Z;2020-06-01T17:23:58Z;Mainz;3676373;Principal Investigator;Klaus Lieb, Prof.;Clinic of Psychiatry and Psychotherapy Mainz;Escitalopram, venlafaxine, lithium | Escitalopram, venlafaxine;63707694;1;;;2009;2020-05-29;56;FALSE;;FALSE;TRUE;18;65;Years;Years;1;8;
NCT00973609;ClinicalTrials.gov processed this data on May 29, 2020;2009-08-19;;;2015-08-31;2009-09-08;2009-09-09;Estimate;;;;;;;2015-08-31;2015-09-01;Estimate;August 2009;;2009-08-31;August 2015;2015-08-31;August 2015;Actual;2015-08-31;December 2014;Actual;2014-12-31;;Interventional;;;Optimal Maintenance Therapy With Bevacizumab After Induction in Metastatic Colorectal Cancer (CRC);Randomized Three Arm Phase III Trial on Induction Treatment With a Fluoropyrimidine-, Oxaliplatin- and Bevacizumab-based Chemotherapy for 24 Weeks Followed by Maintenance Treatment With a Fluoropyrimidine and Bevacizumab vs. Bevacizumab Alone vs. no Maintenance Treatment and Reinduction in Case of Progression for First-line Treatment of Patients With Metastatic Colorectal Cancer;Completed;;Phase 3;853;Actual;AIO-Studien-gGmbH;;3;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T17:24:08Z;2020-06-01T17:24:08Z;Hamburg;3676413;Principal Investigator;Susanna Hegewisch-Becker, Prof. Dr.;Onkologische Schwerpunktpraxis Eppendorf 20249 Hamburg Germany;"5-Fluorouracil, Folic acid, Capecitabine; Bevacizumab | 5-Fluorouracil, Folic acid, Capecitabine; Bevacizumab | 5-Fluorouracil, Folic acid, Capecitabine; Bevacizumab";63707734;1;;;2009;2020-05-29;64;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT00970437;ClinicalTrials.gov processed this data on May 29, 2020;2009-09-01;;;2017-07-03;2009-09-01;2009-09-02;Estimate;;;;;;;2017-07-03;2017-07-05;Actual;April 2010;;2010-04-30;July 2017;2017-07-31;December 2014;Actual;2014-12-31;October 2013;Actual;2013-10-31;;Interventional;;;A Comparison of Cognitive Behavioral Analysis System of Psychotherapy (CBASP) and System of Supportive Psychotherapy (SYSP) for Early Onset Chronic Depression;A Comparison of Cognitive Behavioral Analysis System of Psychotherapy (CBASP) and System of Supportive Psychotherapy (SYSP) for Early Onset Chronic Depression;Completed;;N/A;268;Actual;University Hospital Freiburg;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T17:25:08Z;2020-06-01T17:25:08Z;Freiburg Hamburg;3676664;Principal Investigator;Elisabeth Schramm, PhD;University Medical Center Freiburg, Department of Psychiatry and Psychotherapy;Cognitive Behavioral Analysis System of Psychotherapy | System of Supportive Psychotherapy;63707977;1;;;2009;2020-05-29;42;FALSE;;FALSE;TRUE;18;65;Years;Years;1;;
NCT00961142;ClinicalTrials.gov processed this data on May 29, 2020;2009-08-17;;;2018-05-02;2009-08-17;2009-08-18;Estimate;;;;;;;2018-05-02;2018-05-08;Actual;June 2009;;2009-06-30;May 2018;2018-05-31;December 30, 2015;Actual;2015-12-30;December 30, 2015;Actual;2015-12-30;;Interventional;CD3/CD19 Haplo;;Haploidentical Stem Cell Transplantation With CD3/CD19 Depletion and Reduced Intensity Conditioning in Patients With Acute Leukemia;Multicenter Phase II Study of Haploidentical Hematopoietic Cell Transplantation With CD3/CD19 Depleted Grafts After a Reduced Intensity Conditioning Regimen for Adult Patients With Acute Leukemia;Terminated;;Phase 2;23;Actual;University Hospital Tuebingen;;;;slow recruitment;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T17:27:37Z;2020-06-01T17:27:37Z;Tübingen;3677449;Principal Investigator;Wolfgang A. Bethge, MD;Medical Center University Hospital Tuebingen;Fludarabine, Thiotepa, Melphalan, Thymoglobuline (ATG);63708679;8;;;2009;2020-05-29;79;FALSE;;FALSE;FALSE;18;65;Years;Years;1;4;
NCT00953511;ClinicalTrials.gov processed this data on May 29, 2020;2009-08-03;;;2016-10-19;2009-08-05;2009-08-06;Estimate;;;;;;;2016-10-19;2016-10-21;Estimate;August 2009;;2009-08-31;October 2016;2016-10-31;August 2015;Actual;2015-08-31;April 2015;Actual;2015-04-30;;Interventional;CERP;;Cologne Esophageal Response Prediction Study (CERP-Study);Prospective Study to Analyze the Predictive Role of Factors Implicated in the Signaling Pathway of ERCC1 in Response to Treatment With Neoadjuvant Radiochemotherapy in Patients With Esophageal Cancer;Completed;;N/A;80;Actual;University of Cologne;;1;;;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T17:29:42Z;2020-06-01T17:29:42Z;Köln;3678177;Principal Investigator;Arnulf H. Hölscher, MD;Department of General, Visceral and Cancer Surgery, University of Cologne;ERCC1 pathways analysis;63709264;1;;;2009;2020-05-29;68;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT00951834;ClinicalTrials.gov processed this data on May 29, 2020;2009-08-03;;;2020-04-14;2009-08-03;2009-08-04;Estimate;;;;;;;2020-04-14;2020-04-15;Actual;October 2009;;2009-10-31;April 2020;2020-04-30;February 2015;Actual;2015-02-28;February 2015;Actual;2015-02-28;;Interventional;SUN-AK;;Sunphenon EGCg (Epigallocatechin-Gallate) in the Early Stage of Alzheimer´s Disease;Sunphenon EGCg (Epigallocatechin-Gallate) in the Early Stage of Alzheimer´s Disease;Completed;;Phase 2/Phase 3;21;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T17:30:11Z;2020-06-01T17:30:11Z;Berlin;3678302;Principal Investigator;Friedemann Paul, MD;Charite University Medicine Berlin, NeuroCure;Epigallocatechin-Gallate | Placebo;63709390;3;;;2009;2020-05-29;64;FALSE;;FALSE;FALSE;60;;Years;;1;7;
NCT00950274;ClinicalTrials.gov processed this data on May 29, 2020;2009-07-30;;;2018-08-15;2009-07-30;2009-07-31;Estimate;;;;;;;2018-08-15;2018-08-16;Actual;July 2009;;2009-07-31;August 2018;2018-08-31;September 2017;Actual;2017-09-30;March 2016;Actual;2016-03-31;;Interventional;PERFECT;;Intramyocardial Transplantation of Bone Marrow Stem Cells in Addition to Coronary Artery Bypass Graft (CABG) Surgery;Intramyocardial Transplantation of Bone Marrow Stem Cells for Improvement of Post-infarct Myocardial Regeneration in Addition to CABG Surgery: a Controlled, Prospective, Randomized, Double Blinded Multicenter Trial (PERFECT);Terminated;;Phase 3;81;Actual;Miltenyi Biotec B.V. & Co. KG;;2;;Recruitment stopped due to slow recruitment;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T17:30:50Z;2020-06-01T17:30:50Z;Rostock;3678445;Principal Investigator;Gustav Steinhoff, M.D.;Universitiy of Rostock;CD133+ autologous bone marrow stem cell | Placebo;63709512;6;;;2009;2020-05-29;81;FALSE;;FALSE;FALSE;18;79;Years;Years;1;6;
NCT00949364;ClinicalTrials.gov processed this data on May 29, 2020;2009-07-28;;;2017-09-21;2009-07-29;2009-07-30;Estimate;;;;;;;2017-09-21;2017-09-25;Actual;December 2009;;2009-12-31;September 2017;2017-09-30;December 14, 2016;Actual;2016-12-14;December 14, 2016;Actual;2016-12-14;;Interventional;;;Pomalidomide in Patients With Myeloproliferative Neoplasms in Fibrotic Stage;Multi-Center Phase II Study With Pomalidomide in Patients With Myeloproliferative Neoplasms in Fibrotic Stage;Completed;;Phase 2;103;Actual;University of Ulm;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T17:31:05Z;2020-06-01T17:31:05Z;Ulm;;;;;Pomalidomide;63709580;15;;;2009;2020-05-29;84;FALSE;;FALSE;FALSE;50;;Years;;1;4;
NCT00945126;ClinicalTrials.gov processed this data on May 29, 2020;2009-07-21;;;2018-08-13;2009-07-22;2009-07-23;Estimate;;;;;;;2018-08-13;2018-08-15;Actual;December 2006;;2006-12-31;August 2018;2018-08-31;August 2017;Actual;2017-08-31;August 2017;Actual;2017-08-31;;Interventional;;;Allogeneic Stem Cell Transplantation in Pediatric Patients With Malignant and Non-malignant High-risk Diseases;Allogeneic Stem Cell Transplantation With CD3/CD19 Depleted Stem Cells of Related or Unrelated Haploidentical Donors in Pediatric Patients With Malignant and Non-malignant Diseases;Terminated;;Phase 2;68;Actual;Johann Wolfgang Goethe University Hospital;;;;Poor accrural;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T17:32:13Z;2020-06-01T17:32:13Z;Frankfurt;3678859;Principal Investigator;Peter Bader, Professor;University Hospital Frankfurt, Dept. for Children and Adolescents, Division for Stem Cell Transplantation, Goethe University.;Hematopoietic stem cell product from haploidentical or unrelated donor CD3/CD19 depleted with CliniMACS;63709909;1;;;2009;2020-05-29;129;FALSE;;FALSE;TRUE;;30;;Years;1;1;
NCT00942747;ClinicalTrials.gov processed this data on May 29, 2020;2009-07-20;;;2013-04-15;2009-07-20;2009-07-21;Estimate;;;;;;;2013-04-15;2013-04-17;Estimate;July 2009;;2009-07-31;April 2013;2013-04-30;June 2014;Anticipated;2014-06-30;December 2013;Anticipated;2013-12-31;;Interventional;;;Temsirolimus in Recurrent Primary Central Nervous System (CNS) Lymphoma;Phase 2 Study of Temsirolimus in Refractory and Recurrent Primary CNS Lymphoma;Unknown status;;Phase 2;37;Anticipated;Charite University, Berlin, Germany;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T17:32:56Z;2020-06-01T17:32:56Z;Berlin;3679034;Principal Investigator;Agnieszka Korfel, MD;Charite University, Berlin, Germany;temsirolimus;63710092;6;;;2009;2020-05-29;;FALSE;;FALSE;FALSE;18;75;Years;Years;1;3;
NCT00941733;ClinicalTrials.gov processed this data on May 29, 2020;2009-07-16;;;2018-01-31;2009-07-17;2009-07-20;Estimate;;;;;;;2018-01-31;2018-02-28;Actual;September 2009;;2009-09-30;January 2018;2018-01-31;November 30, 2017;Actual;2017-11-30;August 2013;Actual;2013-08-31;;Interventional;INPACT-DEEP;;Study of IN.PACT Amphirion™ Drug Eluting Balloon vs. Standard PTA for the Treatment of Below the Knee Critical Limb Ischemia;Randomized Study of IN.PACT Amphirion™ Drug Eluting Balloon vs. Standard PTA (Percutaneous Transluminal Angioplasty) for the Treatment of Below the Knee Critical Limb Ischemia;Completed;;N/A;358;Actual;Medtronic Endovascular;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T17:33:19Z;2020-06-01T17:33:19Z;Freiburg Leipzig;3679113;Principal Investigator;Dierk Scheinert, MD;Heart Center Leipzig - University Hospital;IN.PACT Amphirion | Standard PTA;63710168;13;990;1140;2009;2020-05-29;47;TRUE;12;FALSE;FALSE;18;85;Years;Years;3;15;
NCT00933777;ClinicalTrials.gov processed this data on May 29, 2020;2009-07-02;;;2016-05-24;2009-07-06;2009-07-07;Estimate;;;;;;;2016-05-24;2016-05-25;Estimate;July 2009;;2009-07-31;May 2016;2016-05-31;February 2015;Actual;2015-02-28;February 2014;Actual;2014-02-28;;Interventional;SORAVE;;SORAVE - Sorafenib and Everolimus in Solid Tumors;SORAVE-Sorafenib and Everolimus in Solid Tumors. A Phase I Clinical Trial to Evaluate the Safety of Combined Sorafenib and Everolimus Treatment in Patients With Relapsed Solid Tumors;Completed;;Phase 1;36;Actual;University of Cologne;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T17:35:33Z;2020-06-01T17:35:33Z;Köln;3679851;Principal Investigator;Juergen Wolf, MD, Prof.;Lung Cancer Group Cologne, Center for Integrated Oncology, Dep.I of Internal Medicine, University Hospital Cologne, Germany;Combination of sorafenib and everolimus;63710775;1;;;2009;2020-05-29;55;FALSE;;FALSE;TRUE;18;;Years;;1;4;
NCT00932971;ClinicalTrials.gov processed this data on May 29, 2020;2009-07-03;;;2018-01-26;2009-07-06;2009-07-07;Estimate;;;;;;;2018-01-26;2018-01-29;Actual;June 2009;;2009-06-30;January 2018;2018-01-31;August 2, 2017;Actual;2017-08-02;August 2017;Actual;2017-08-31;;Interventional;HIDIT-II;;HIDIT II - PegIFN-alfa2a Plus Tenofovir in Chronic Delta Hepatitis;A Multicenter Randomised Study Comparing the Efficacy of PegIFN-alfa2a Plus Placebo vs. PegIFN-alfa2a Plus Tenofovir for the Treatment of Chronic Delta Hepatitis-The Hep-Net International Delta Hepatitis Interventional Trial II (HIDIT-II);Completed;;Phase 2;70;Actual;HepNet Study House, German Liverfoundation;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T17:35:43Z;2020-06-01T17:35:43Z;Hannover;3679918;Study Director;Michael P. Manns, Prof. Dr.;Hannover Medical School;PEG-IFN alfa-2a, Tenofovir | PEG-IFN alfa-2a, placebo;63710838;10;;;2009;2020-05-29;99;FALSE;;FALSE;FALSE;18;;Years;;1;11;
NCT00928915;ClinicalTrials.gov processed this data on May 29, 2020;2009-06-25;;;2016-10-24;2009-06-25;2009-06-26;Estimate;;;;;;;2016-10-24;2016-10-26;Estimate;July 2009;;2009-07-31;October 2016;2016-10-31;January 2015;Actual;2015-01-31;January 2015;Actual;2015-01-31;;Interventional;INCH;;International Normalized Ratio (INR) Normalization in Coumadin Associated Intracerebral Haemorrhage;Multicenter, Prospective Randomized Trial on the Use of Prothrombin Complex and Fresh Frozen Plasma in Patients With Intracerebral Hemorrhage Related to Vitamin K Antagonists;Completed;;Phase 4;54;Actual;Heidelberg University;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T17:36:56Z;2020-06-01T17:36:56Z;Heidelberg;3680256;Principal Investigator;Thorsten Steiner, MR, PhD, MME;Department of Neurology, Heidelberg University Hospital Germany;"Prothrombin complex concentrate (PCC); fresh frozen plasma (FFP)";63711144;1;;;2009;2020-05-29;67;FALSE;;FALSE;TRUE;18;;Years;;1;3;
NCT00923793;ClinicalTrials.gov processed this data on May 29, 2020;2009-06-17;;;2015-05-20;2009-06-17;2009-06-18;Estimate;;;;;;;2015-05-20;2015-05-21;Estimate;June 2009;;2009-06-30;May 2015;2015-05-31;April 2014;Actual;2014-04-30;April 2014;Actual;2014-04-30;;Interventional;;;Comparison of Individual Computer Aided Design/Manufactured (CAD/CAM) - Based Implants Consisting on Hydroxylapatite and Titanium to be Used in Cranioplasty;Comparison of Individual CAD/CAM-based Implants Consisting on Hydroxylapatite and Titanium to be Used in Cranioplasty - a Randomized Multicenter Clinical Trial;Terminated;;Phase 3;53;Actual;University of Leipzig;;2;;Recruitment was stopped, due to slow recruitment rate;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T17:38:35Z;2020-06-01T17:38:35Z;Leipzig;3680700;Study Director;Dirk Lindner, Dr. med.;Universität Leipzig KöR Medizinische Falkutät Klinif für Neurochirurgie;Titanium implant (CranioConstruct™) | Hydroxylapatite (CustomBone);63711535;1;;;2009;2020-05-29;58;FALSE;;FALSE;TRUE;18;;Years;;1;6;
NCT00916409;ClinicalTrials.gov processed this data on May 29, 2020;2009-06-05;;;2017-04-07;2009-06-08;2009-06-09;Estimate;;;;;;;2017-04-07;2017-04-10;Actual;June 2009;;2009-06-30;April 2017;2017-04-30;March 2017;Actual;2017-03-31;December 2016;Actual;2016-12-31;;Interventional;;;Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM);A Prospective, Multi-center Trial of NovoTTF-100A Together With Temozolomide Compared to Temozolomide Alone in Patients With Newly Diagnosed GBM.;Completed;;Phase 3;700;Anticipated;NovoCure Ltd.;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T17:40:25Z;2020-06-01T17:40:25Z;Hamburg;3681335;Study Director;Manfred Westphal, Prof. MD;Universitätsklinikum Hamburg-Eppendorf;NovoTTF-100A device | Temozolomide;63712079;89;;;2009;2020-05-29;91;FALSE;;TRUE;FALSE;18;;Years;;1;1;
NCT00904254;ClinicalTrials.gov processed this data on May 29, 2020;2009-05-18;;;2012-02-02;2009-05-18;2009-05-19;Estimate;;;;;;;2012-02-02;2012-02-03;Estimate;January 2015;;2015-01-31;February 2012;2012-02-29;January 2016;Anticipated;2016-01-31;January 2016;Anticipated;2016-01-31;;Interventional;;;The Use of Anti-CD4 mAb-Fragment for Imaging of Local Inflammation in Patients With Carotid Artery Stenosis;The Use of Anti-CD4 mAb-Fragment for Imaging of Local Inflammation in Patients With Asymptomatic and Symptomatic Carotid Artery Stenosis - an Open Proof of Concept Study.;Unknown status;;Phase 2;21;Anticipated;Technische Universität Dresden;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T17:44:01Z;2020-06-01T17:44:01Z;Dresden;3682413;Principal Investigator;Christoph Schindler Schindler, MD;Institute of Clinical Pharmacology, Medical Faculty, Technical University Dresden;EP 1645/Solution For Injection, 99mTC;63713001;;;;2009;2020-05-29;;FALSE;;;FALSE;50;80;Years;Years;1;1;
NCT00893373;ClinicalTrials.gov processed this data on May 29, 2020;2009-05-04;;;2016-02-04;2009-05-04;2009-05-06;Estimate;;;;;;;2016-02-04;2016-02-05;Estimate;March 2009;;2009-03-31;February 2016;2016-02-29;September 2014;Actual;2014-09-30;November 2011;Actual;2011-11-30;;Interventional;SORAML;;Study Evaluating Sorafenib Added to Standard Primary Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Less Than 60 Years of Age;A Double-blind, Placebo-controlled, Randomized, Multicenter Phase-II Trial to Assess the Efficacy of Sorafenib Added to Standard Primary Therapy in Patients With Newly Diagnosed AML ≤60 Years of Age;Completed;;Phase 2;276;Actual;Technische Universität Dresden;;2;;;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T17:46:54Z;2020-06-01T17:46:54Z;Dresden;3683305;Principal Investigator;Gerhard Ehninger, Prof, MD;University Hospital Dresden;placebo | sorafenib;63713800;9;;;2009;2020-05-29;32;FALSE;;FALSE;FALSE;18;60;Years;Years;1;3;
NCT00874848;ClinicalTrials.gov processed this data on May 29, 2020;2009-04-01;;;2016-10-06;2009-04-02;2009-04-03;Estimate;;;;;;;2016-10-06;2016-11-29;Estimate;August 2009;;2009-08-31;October 2016;2016-10-31;August 2015;Actual;2015-08-31;November 2012;Actual;2012-11-30;;Interventional;;;Efficacy/Safety of Imprime PGG With Cetuximab & Paclitaxel/Carboplatin Therapy in Pts With Untreated Advanced Non-Small Cell Lung Cancer;Efficacy and Safety Study of Imprime PGG® Injection in Combination With Cetuximab and Concomitant Paclitaxel and Carboplatin Therapy in Patients With Previously Untreated Advanced (Stage IIIB or IV) Non-Small Cell Lung Cancer;Completed;;Phase 2;90;Actual;Biothera;;2;;;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T17:52:47Z;2020-06-01T17:52:47Z;Munich;3684899;Principal Investigator;Folker Schneller, MD;Technical University, Munich;Imprime PGG Injection | Cetuximab | Paclitaxel | Carboplatin;63715209;14;994;134;2009;2020-05-29;39;TRUE;44;TRUE;FALSE;18;75;Years;Years;1;5;
NCT00874107;ClinicalTrials.gov processed this data on May 29, 2020;2009-04-01;;;2017-03-01;2009-04-01;2009-04-02;Estimate;;;;;;;2017-03-01;2017-03-03;Actual;June 2009;;2009-06-30;March 2017;2017-03-31;May 2016;Actual;2016-05-31;April 2016;Actual;2016-04-30;;Interventional;;;Efficacy/Safety of Imprime PGG® Injection With Bevacizumab and Paclitaxel/Carboplatin in Patients With Untreated Advanced Non-Small Cell Lung Cancer (NSCLC);A Phase 2, Randomized, Efficacy and Safety Study of Imprime PGG® Injection in Combination With Bevacizumab and Concomitant Paclitaxel and Carboplatin Therapy in Patients With Previously Untreated Advanced (Stage IIIB or IV) Non-Small Cell Lung Cancer;Completed;;Phase 2;90;Actual;Biothera;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T17:53:00Z;2020-06-01T17:53:00Z;Munich;3684996;Principal Investigator;Folker Schneller, MD;Klinikum rechts der Isar der Technischen Universitaet Muenchen;Imprime PGG® Injection | Bevacizumab | Paclitaxel | Carboplatin;63715264;10;;;2009;2020-05-29;83;FALSE;;TRUE;FALSE;18;75;Years;Years;1;7;
NCT00867672;ClinicalTrials.gov processed this data on May 29, 2020;2009-03-23;;;2016-08-30;2009-03-23;2009-03-24;Estimate;;;;;;;2016-08-30;2016-08-31;Estimate;August 2011;;2011-08-31;August 2016;2016-08-31;February 2016;Actual;2016-02-29;February 2015;Actual;2015-02-28;;Interventional;DECIDER;;Study of Decitabine Alone or in Combination With Valproic Acid and All-trans Retinoic Acid in Acute Myeloid Leukemia;Prospective Randomized Multicenter Phase II Trial of Low-dose Decitabine (DAC) Administered Alone or in Combination With the Histone Deacetylase Inhibitor Valproic Acid (VPA) and All-trans Retinoic Acid (ATRA) in Patients > 60 Years With Acute Myeloid Leukemia Who Are Ineligible for Induction Chemotherapy;Completed;;Phase 2;204;Actual;University Hospital Freiburg;;4;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T17:55:51Z;2020-06-01T17:55:51Z;Freiburg;3685519;Principal Investigator;Michael Lübbert, MD, PhD;Department of Hematology/Oncology, University of Freiburg Medical Center;Decitabine | VPA | ATRA;63715752;27;;;2009;2020-05-29;42;FALSE;;FALSE;FALSE;60;;Years;;1;5;
NCT00865982;ClinicalTrials.gov processed this data on May 29, 2020;2009-03-19;;;2011-08-04;2009-03-19;2009-03-20;Estimate;;;;;;;2011-08-04;2011-08-05;Estimate;September 2008;;2008-09-30;August 2011;2011-08-31;September 2015;Anticipated;2015-09-30;September 2014;Anticipated;2014-09-30;;Interventional;DCXAIOCHARITE;;Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal Cancer;Multicenter, Open Lable Phase II Study to Evaluate the Safety and Efficacy of a Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine in Patients With Gastric Adenocarcinoma, Adenocarcinoma of the Gastro-esophageal Junction or the Distal Esophagus;Unknown status;;Phase 2;50;Anticipated;Charite University, Berlin, Germany;;;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T17:56:27Z;2020-06-01T17:56:27Z;Berlin;3685658;Study Chair;Peter Thuss-Patience, Dr. med.;Charite University, Berlin, Germany;Docetaxel, Cisplatin, Capecitabine;63715882;9;;;2009;2020-05-29;;FALSE;;FALSE;FALSE;18;75;Years;Years;1;10;
NCT00865969;ClinicalTrials.gov processed this data on May 29, 2020;2009-03-19;;;2014-12-04;2009-03-19;2009-03-20;Estimate;;;;;;;2014-12-04;2014-12-08;Estimate;December 2008;;2008-12-31;December 2014;2014-12-31;October 2014;Actual;2014-10-31;October 2014;Actual;2014-10-31;;Interventional;PTCL;;Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma;A Multicenter, Open-Label Trial of Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma;Completed;;Phase 2;129;Actual;Spectrum Pharmaceuticals, Inc;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T17:56:27Z;2020-06-01T17:56:27Z;Göttingen Halle Mainz Marburg Ulm;3685679;Principal Investigator;Lorenz Trümper, MD;Universität Göttingen, Abteilung Hämatologie und Onkologie, Göttingen, Germany;PXD101;63715883;117;;;2009;2020-05-29;71;FALSE;;TRUE;FALSE;18;;Years;;1;1;
NCT00862511;ClinicalTrials.gov processed this data on May 29, 2020;2009-03-16;;;2017-01-24;2009-03-16;2009-03-17;Estimate;;;;;;;2017-01-24;2017-01-25;Estimate;March 2009;Actual;2009-03-31;January 2017;2017-01-31;January 2017;Actual;2017-01-31;December 2012;Actual;2012-12-31;;Interventional;;;Serum Metal Ion Concentration After Total Knee Arthroplasty (TKA);A Prospective Randomized Comparison of Serum Metal Ion Levels After Implantation of Coated and Uncoated Knee Prostheses;Completed;;N/A;120;Actual;Technische Universität Dresden;;2;;;FALSE;;;;FALSE;FALSE;FALSE;;;;;;;;;No;;2020-06-01T17:57:57Z;2020-06-01T17:57:57Z;Dresden;3686026;Principal Investigator;Jörg Lützner, MD;University Hospital Dresden, Orthopaedic Department;Coated Total Knee Arthroplasty | Standard Total Knee Arthroplasty;63716149;1;;;2009;2020-05-29;45;FALSE;;FALSE;TRUE;;;;;1;1;
NCT00860730;ClinicalTrials.gov processed this data on May 29, 2020;2009-03-11;;;2019-01-17;2009-03-11;2009-03-12;Estimate;;;;;;;2019-01-17;2019-01-22;Actual;January 2009;;2009-01-31;January 2019;2019-01-31;October 2015;Actual;2015-10-31;October 2009;Actual;2009-10-31;;Interventional;;;PERCEVAL Pivotal Trial;PERCEVAL Pivotal Trial;Completed;;N/A;150;Actual;LivaNova;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T17:58:24Z;2020-06-01T17:58:24Z;Hannover;3686158;Principal Investigator;Axel Haverich, Prof;Hannover Medizinische Hochschule;Aortic valve replacement with Perceval aortic heart valve;63716281;9;;;2009;2020-05-29;9;FALSE;;FALSE;FALSE;75;;Years;;1;1;
NCT00858793;ClinicalTrials.gov processed this data on May 29, 2020;2009-03-09;;;2017-05-26;2009-03-09;2009-03-10;Estimate;;;;;;;2017-05-26;2017-05-30;Actual;November 28, 2008;Actual;2008-11-28;May 2017;2017-05-31;August 31, 2016;Actual;2016-08-31;August 31, 2016;Actual;2016-08-31;;Interventional;;;High-dose Chemotherapy With Transplantation of Gene-modified Haematopoietic Stem Cells for HIV-positive Patients With Malignant Diseases Indicating an HSCT;High-dose Chemotherapy With Transplantation of Gene-modified Haematopoietic Stem Cells for HIV-positive Patients With Malignant Diseases Indicating an HSCT;Completed;;Phase 1/Phase 2;5;Actual;Universitätsklinikum Hamburg-Eppendorf;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T17:58:49Z;2020-06-01T17:58:49Z;Hamburg;3686325;Principal Investigator;Nicolaus Kroeger;University Medical Center Hamburg-Eppendorf, Department for Stem Cell Transplantation;PBSC-M87o, Gene (M87o)-modified, CD34+ peripheral blood progenitor cells (PBSC);63716421;1;;;2009;2020-05-29;94;FALSE;;FALSE;TRUE;18;65;Years;Years;1;5;
NCT00854256;ClinicalTrials.gov processed this data on May 29, 2020;2009-03-02;;;2013-04-12;2009-03-02;2009-03-03;Estimate;;;;;;;2013-04-12;2013-04-15;Estimate;April 2009;;2009-04-30;April 2013;2013-04-30;May 2014;Anticipated;2014-05-31;December 2013;Anticipated;2013-12-31;;Interventional;;;Trabeculectomy Versus Canaloplasty to Treat Glaucoma;Comparison of Canaloplasty and Trabeculectomy in Patients With Open Angle Glaucoma and Inadequate Local Eye Pressure Lowering Therapy - a Prospective, Randomized Study;Unknown status;;N/A;60;Anticipated;University of Cologne;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T18:00:23Z;2020-06-01T18:00:23Z;Köln;;;;;Canaloplasty | Trabeculectomy with mitomycin C;63716769;1;;;2009;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT00850629;ClinicalTrials.gov processed this data on May 29, 2020;2009-02-17;;;2018-01-12;2009-02-24;2009-02-25;Estimate;;;;;;;2018-01-12;2018-01-17;Actual;January 2010;Actual;2010-01-31;January 2018;2018-01-31;January 2016;Actual;2016-01-31;December 2015;Actual;2015-12-31;;Interventional;;;Hormonal Regulation of Body Weight Maintenance;Hormonal Regulation of Body Weight Maintenance;Completed;;N/A;286;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T18:01:42Z;2020-06-01T18:01:42Z;Berlin;3686984;Principal Investigator;Knut Mai, Prof;Charite;multimodal lifestyle intervention | placebo;63717039;1;;;2009;2020-05-29;72;FALSE;;FALSE;TRUE;10;90;Years;Years;1;33;
NCT00850382;ClinicalTrials.gov processed this data on May 29, 2020;2009-02-23;;;2016-02-29;2009-02-24;2009-02-25;Estimate;;;;;;;2016-02-29;2016-03-01;Estimate;June 2009;;2009-06-30;February 2016;2016-02-29;November 2015;Actual;2015-11-30;November 2015;Actual;2015-11-30;;Interventional;;;Dasatinib (Sprycel™) in Patients With Newly Diagnosed Core Binding Factor (CBF) Acute Myeloid Leukemia (AML);Open-Label, Multicenter Phase Ib/IIa Study For the Evaluation of Dasatinib (Sprycel™) Following Induction and Consolida-tion Therapy as Well as in Maintenance Therapy in Patients With Newly Diagnosed Core Binding Factor (CBF) Acute Myeloid Leukemia (AML);Completed;;Phase 1/Phase 2;89;Actual;University of Ulm;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T18:01:46Z;2020-06-01T18:01:46Z;Ulm;3687001;Principal Investigator;Hartmut Doehner, MD;University Hospital of Ulm;Dasatinib | daunorubicin | Cytarabine;63717054;50;;;2009;2020-05-29;78;FALSE;;FALSE;FALSE;18;;Years;;1;2;
NCT00849615;ClinicalTrials.gov processed this data on May 29, 2020;2009-02-23;;;2016-04-05;2009-02-23;2009-02-24;Estimate;;;;;;;2016-04-05;2016-04-06;Estimate;February 2009;;2009-02-28;April 2016;2016-04-30;January 2016;Actual;2016-01-31;January 2012;Actual;2012-01-31;;Interventional;FLOT3;;Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction;A Prospective Multicenter Study With 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction;Completed;;Phase 2;252;Actual;Krankenhaus Nordwest;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T18:02:01Z;2020-06-01T18:02:01Z;Frankfurt;3687052;Study Chair;Salah Al-Batan, MD;Institute of Clinical Cancer Research IKF, UCT - University Cancer Center, Frankfurt, Germany;Docetaxel | 5-Fluorouracil | Oxaliplatin | folinic acid;63717111;1;;;2009;2020-05-29;35;FALSE;;FALSE;TRUE;18;;Years;;1;4;
NCT00847444;ClinicalTrials.gov processed this data on May 29, 2020;2009-02-17;;;2013-04-17;2009-02-17;2009-02-19;Estimate;;;;;;;2013-04-17;2013-04-19;Estimate;February 2009;;2009-02-28;April 2013;2013-04-30;September 2016;Anticipated;2016-09-30;September 2011;Actual;2011-09-30;;Interventional;SUCCESS-C;;Docetaxel Based Anthracycline Free Adjuvant Treatment Evaluation, as Well as Life Style Intervention;Simultaneous Study of Docetaxel Based Anthracycline Free Adjuvant Treatment Evaluation, as Well as Life Style Intervention Strategies;Unknown status;;Phase 3;3547;Anticipated;Ludwig-Maximilians - University of Munich;;3;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T18:02:51Z;2020-06-01T18:02:51Z;Düsseldorf Munich;3687215;Study Director;Wolfgang Janni, Prof. Dr. med.;Klinikum der Heinrich-Heine-Universität Düsseldorf;Drug-based intervention | Lifestyle-based Intervention;63717270;1;;;2009;2020-05-29;31;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT00845286;ClinicalTrials.gov processed this data on May 29, 2020;2008-09-19;;;2016-03-16;2009-02-16;2009-02-18;Estimate;;;;;;;2016-03-16;2016-03-17;Estimate;September 2008;;2008-09-30;March 2016;2016-03-31;August 2014;Actual;2014-08-31;March 2014;Actual;2014-03-31;;Interventional;MAGIC;;Marathon, Genetics, Inflammation and the Cardiovascular System: MAGIC-Trial;Investigation of Myocardial Function and Vascular Adaptation in Association With Genotype in Marathon Runners;Completed;;N/A;162;Actual;Technische Universität München;;;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T18:03:21Z;2020-06-01T18:03:21Z;Munich;;;;;Munich Marathon;63717437;1;;;2008;2020-05-29;66;FALSE;;FALSE;TRUE;30;60;Years;Years;1;1;
NCT00841256;ClinicalTrials.gov processed this data on May 29, 2020;2008-04-22;;;2015-10-15;2009-02-10;2009-02-11;Estimate;;;;;;;2015-10-15;2015-10-16;Estimate;February 2008;;2008-02-29;October 2015;2015-10-31;August 2015;Actual;2015-08-31;June 2012;Actual;2012-06-30;;Interventional;;;Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children;... Study to Evaluate Efficacy and Safety of Perennial Sublingual SIT With a Solution of Grass Pollen Allergen ... in Children With Clinically Relevant Grass Pollen Sensitivity in Comparison to a ... Standard Treatment With Add on Placebo;Completed;;Phase 3;207;Actual;Allergopharma GmbH & Co. KG;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T18:04:25Z;2020-06-01T18:04:25Z;Berlin;3687783;Principal Investigator;Ulrich Wahn, MD;Charite University, Berlin, Germany;Grass pollen allergens in a water/glycerol solution | Placebo;63717738;1;;;2008;2020-05-29;52;FALSE;;FALSE;TRUE;4;11;Years;Years;1;1;
NCT00834314;ClinicalTrials.gov processed this data on May 29, 2020;2009-02-02;;;2015-12-07;2009-02-02;2009-02-03;Estimate;;;;;;;2015-12-07;2015-12-08;Estimate;February 2010;;2010-02-28;December 2015;2015-12-31;May 2014;Actual;2014-05-31;May 2014;Actual;2014-05-31;;Interventional;ABDOVAC;;Randomized Pilot Study Comparing Two Vacuum-wound-dressings for Open Abdomen Treatment;Vacuum-Therapy in Open Abdomen Treatment - Randomized Pilot-trial Comparing Fascial Closure and Survival With Vacuum-Pack-Technique vs. Abdominal Dressing;Terminated;;N/A;3;Actual;Universitätsmedizin Mannheim;;2;;extended obligations of amended medical device law in Germany 2010 did not allow to continue~   and complete the trial due to budget limitation;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T18:06:17Z;2020-06-01T18:06:17Z;Mannheim;3688358;Principal Investigator;Stefan Post, Prof. Dr.;University Medical Center Mannheim, Germany, Surgical Department;Vacuum-Pack-technique for temporary abdominal closure | Abdominal-dressing-technique for temporary abdominal closure;63718265;1;;;2009;2020-05-29;51;FALSE;;FALSE;TRUE;18;;Years;;1;6;
NCT00827619;ClinicalTrials.gov processed this data on May 29, 2020;2009-01-22;;;2015-12-03;2009-01-22;2009-01-23;Estimate;;;;;;;2015-12-03;2015-12-04;Estimate;February 2009;;2009-02-28;December 2015;2015-12-31;November 2015;Actual;2015-11-30;November 2011;Actual;2011-11-30;;Interventional;;;Zilver® Flex™ Vascular Stent Study;Evaluation of the Zilver® Flex™ Vascular Stent in the Above-the-Knee Femoropopliteal Artery;Completed;;N/A;110;Actual;Cook Group Incorporated;;1;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T18:08:25Z;2020-06-01T18:08:25Z;Magdeburg;3688903;Principal Investigator;Jens Ricke, MD;Universitatsklinikum Magdeburg;Zilver® Flex™ Vascular Stent;63718774;3;;;2009;2020-05-29;33;FALSE;;FALSE;FALSE;18;;Years;;1;1;
NCT00822393;ClinicalTrials.gov processed this data on May 29, 2020;2009-01-13;;;2018-03-26;2009-01-13;2009-01-14;Estimate;;;;;;;2018-03-26;2018-03-27;Actual;November 2008;;2008-11-30;March 2018;2018-03-31;December 31, 2017;Actual;2017-12-31;December 31, 2017;Actual;2017-12-31;;Interventional;;;Clinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC);Clinical Phase III Trial to Compare Treosulfan-based Conditioning Therapy With Busulfan-based Reduced-intensity Conditioning (RIC) Prior to Allogeneic Haematopoietic Stem Cell Transplantation in Patients With AML or MDS Considered Ineligible to Standard Conditioning Regimens;Completed;;Phase 3;570;Actual;medac GmbH;;2;;;FALSE;;;;TRUE;;;;;;;;;;;Undecided;;2020-06-01T18:09:47Z;2020-06-01T18:09:47Z;Duisburg;3689340;Principal Investigator;Dietrich W. Beelen, MD;University Hospital, Essen;Busulfan | Treosulfan;63719170;33;;;2009;2020-05-29;110;FALSE;;FALSE;FALSE;18;70;Years;Years;1;1;
NCT00810472;ClinicalTrials.gov processed this data on May 29, 2020;2008-12-17;;;2016-10-24;2008-12-17;2008-12-18;Estimate;;;;;;;2016-10-24;2016-10-25;Estimate;September 2009;;2009-09-30;October 2016;2016-10-31;May 2015;Actual;2015-05-31;May 2015;Actual;2015-05-31;;Interventional;FANCY;;Functional Antigen Matching in Corneal Transplantation;Clinical Trial to Investigate Superiority of HLA Matching in Comparison to Random Graft Assignment With Respect to the Endpoint 'Time to First Endothelial Graft Rejection' in Penetrating Keratoplasty.;Completed;;N/A;650;Anticipated;University Hospital Freiburg;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T18:13:27Z;2020-06-01T18:13:27Z;Freiburg;;;;;HLA Matching | Penetrating keratoplasty;63720076;1;;;2008;2020-05-29;68;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT00808600;ClinicalTrials.gov processed this data on May 29, 2020;2008-12-15;;;2009-08-18;2008-12-15;2008-12-16;Estimate;;;;;;;2009-08-18;2009-08-19;Estimate;October 2009;;2009-10-31;August 2009;2009-08-31;January 2014;Anticipated;2014-01-31;July 2013;Anticipated;2013-07-31;;Interventional;;;Empowerment of Lung and Heart-lung Transplant Patients;Empowerment of Lung and Heart-lung Transplant Patients by a Multimodal Resource-activating Behavioural Training Programme and Cardiopulmonary Exercise - a Randomised Controlled Study;Unknown status;;N/A;132;Anticipated;Hannover Medical School;;4;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T18:14:07Z;2020-06-01T18:14:07Z;Hannover;3690561;Principal Investigator;Harald Gündel, Prof. Dr.;Dept. of Psychosomatics and Psychotherapy, Hannover Medical School;resource-activating behavioural training programme | Relaxation training | Intensified anaerobic exercise training | Moderate aerobic exercise training;63720218;1;;;2008;2020-05-29;;FALSE;;FALSE;TRUE;18;68;Years;Years;4;6;
NCT00807300;ClinicalTrials.gov processed this data on May 29, 2020;2008-12-09;;;2015-12-02;2008-12-10;2008-12-11;Estimate;;;;;;;2015-12-02;2015-12-03;Estimate;October 2006;;2006-10-31;December 2015;2015-12-31;December 2015;Actual;2015-12-31;December 2015;Actual;2015-12-31;;Interventional;CEAL;;Computed Tomography (CT) - Guided Brachytherapy Versus Transarterial Chemoembolization in Patients With Unresectable Hepatocellular Carcinoma;Phase-III-Study to Evaluate the Efficacy of CT-guided Brachytherapy Versus Transarterial Chemoembolization in Patients With Unresectable Hepatocellular Carcinoma.;Completed;;Phase 2;77;Actual;University of Magdeburg;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T18:14:40Z;2020-06-01T18:14:40Z;Magdeburg;3690688;Principal Investigator;Jens Ricke, M.D.;Clinic of Diagnostic Radiology and Nuclear Medicine, University Magdeburg;CT-guided brachytherapy | transarterial chemoembolization;63720320;1;;;2008;2020-05-29;111;FALSE;;FALSE;TRUE;18;;Years;;1;2;
NCT00799890;ClinicalTrials.gov processed this data on May 29, 2020;2008-11-28;;;2020-04-14;2008-11-28;2008-12-01;Estimate;;;;;;;2020-04-14;2020-04-15;Actual;May 2009;;2009-05-31;April 2020;2020-04-30;March 2016;Actual;2016-03-31;March 2016;Actual;2016-03-31;;Interventional;SUPREMES;;Sunphenon in Progressive Forms of Multiple Sclerosis;Monocentric, Prospective, Doubleblind, Randomised/Stratified, Placebocontrolled Two-arm Study to Evaluate the Effect of Sunphenon EGCg (Main Component Epigallocatechin-Gallat) on the Increase of Brain Atrophy in the Cerebral Magnetic Resonance Tomography in a 36-months Treatment Time in Patients With Primary or Secondary Chronic-progressive Multiple Sclerosis;Completed;;Phase 2/Phase 3;61;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T18:17:01Z;2020-06-01T18:17:01Z;Berlin;3691258;Principal Investigator;Friedemann Paul, Dr.;Charite University (NeuroCure Clinical Research Center);Sunphenon EGCG | Placebo;63720878;1;;;2008;2020-05-29;83;FALSE;;FALSE;TRUE;18;65;Years;Years;1;4;
NCT00794326;ClinicalTrials.gov processed this data on May 29, 2020;2008-11-18;;;2015-02-26;2008-11-19;2008-11-20;Estimate;;;;;;;2015-02-26;2015-02-27;Estimate;October 2008;;2008-10-31;September 2014;2014-09-30;December 2014;Actual;2014-12-31;December 2014;Actual;2014-12-31;;Interventional;PDOne;;Clinical Evaluation of Low Sodium Peritoneal Dialysis (PD) Solution on Hypertensive Patients Treated With PD;Multicentric, Parallel, Controlled, Randomized, Single-blind Clinical Evaluation of New Low Sodium Peritoneal Dialysis Solution on Patients With Hypertension Treated With Continuous Ambulatory or Automated Peritoneal Dialysis;Completed;;Phase 3;140;Anticipated;Fresenius Medical Care Deutschland GmbH;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T18:18:31Z;2020-06-01T18:18:31Z;Heidelberg;3691685;Study Chair;Vedat Schwenger, Dr;Universitätsklinik University Hospital, Heidelberg, Germany;Solution for Peritoneal Dialysis;63721295;29;;;2008;2020-05-29;75;FALSE;;FALSE;FALSE;18;;Years;;1;7;
NCT00787293;ClinicalTrials.gov processed this data on May 29, 2020;2008-11-05;;;2011-02-10;2008-11-05;2008-11-07;Estimate;;;;;;;2011-02-10;2011-02-14;Estimate;October 2008;;2008-10-31;February 2011;2011-02-28;November 2015;Anticipated;2015-11-30;November 2010;Actual;2010-11-30;;Interventional;PTOLEMY-2;;Study of Safety and Efficacy of the Percutaneous Reduction of Mitral Valve Regurgitation in Heart Failure Patients;A Multi-center Study of the Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty System to Reduce Mitral Valve Regurgitation in Patients With Heart Failure;Suspended;;Phase 2;30;Anticipated;Viacor;;1;;Company ended operations January 2011;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T18:20:49Z;2020-06-01T18:20:49Z;Aachen Munich;3692258;Principal Investigator;Stefan Sack, Md, PhD;Klinikum Schwabing, Staedtisches Klinikum Muenchen GmbH;PTMA (Percutaneous Transvenous Mitral Annuloplasty) Implant;63721828;13;;;2008;2020-05-29;25;FALSE;;FALSE;FALSE;50;;Years;;1;3;
NCT00785109;ClinicalTrials.gov processed this data on May 29, 2020;2008-11-04;;;2017-04-20;2008-11-04;2008-11-05;Estimate;;;;;;;2017-04-20;2017-04-21;Actual;January 2010;;2010-01-31;April 2017;2017-04-30;August 2015;Actual;2015-08-31;August 2015;Actual;2015-08-31;;Interventional;08-002;;Vitamin K Supplement for Inhibition of the Progress in Aortic Valve Calcification;Vitamin K Containing Nutritional Supplement for Activation of Matrix-GIa-proteins (MGP) and Inhibition of Aortic Valve Calcification Process;Completed;;Phase 3;99;Actual;RWTH Aachen University;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T18:21:28Z;2020-06-01T18:21:28Z;Aachen;3692453;Principal Investigator;Ralf Koos, MD;RWTH Aachen University Departement of Cardiology, Pulmonology and Vascular Medicine;Vitamin K supplementation;63721992;1;;;2008;2020-05-29;67;FALSE;;FALSE;TRUE;50;;Years;;1;1;
NCT00781807;ClinicalTrials.gov processed this data on May 29, 2020;2008-10-28;;;2009-08-24;2008-10-28;2008-10-29;Estimate;;;;;;;2009-08-24;2009-08-25;Estimate;November 2008;;2008-11-30;August 2009;2009-08-31;April 2014;Anticipated;2014-04-30;October 2013;Anticipated;2013-10-31;;Interventional;;;Rehabilitation and Outcome for Patients on LVAD Support;Multi-module Rehabilitation for Patients on LVAD Support - Impact on Long-term Outcomes;Unknown status;;N/A;80;Anticipated;Hannover Medical School;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T18:22:32Z;2020-06-01T18:22:32Z;Hannover;3692693;Principal Investigator;Christiane Kugler;Hannover Medical School;multi-module rehabilitation program;63722243;2;;;2008;2020-05-29;;FALSE;;FALSE;FALSE;18;;Years;;1;5;
NCT00776633;ClinicalTrials.gov processed this data on May 29, 2020;2008-10-20;;;2016-08-29;2008-10-20;2008-10-21;Estimate;;;;;;;2016-08-29;2016-08-30;Estimate;September 2008;;2008-09-30;August 2014;2014-08-31;September 2014;Anticipated;2014-09-30;December 2013;Actual;2013-12-31;;Interventional;ISAR-TRIPLE;;Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation;Intracoronary Stenting and Antithrombotic Regimen: Testing of a Six-week Versus a Six-month Clopidogrel Treatment Regimen in Patients With Concomitant Aspirin and Oral Anticoagulant Therapy Following Drug-eluting Stenting;Unknown status;;Phase 4;614;Actual;Deutsches Herzzentrum Muenchen;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T18:24:02Z;2020-06-01T18:24:02Z;Munich;3693058;Study Chair;Adnan Kastrati, MD;Deutsches Herzzentum München;aspirin | clopidogrel | oral anticoagulation;63722633;3;;;2008;2020-05-29;63;FALSE;;FALSE;FALSE;18;;Years;;1;2;
NCT00772655;ClinicalTrials.gov processed this data on May 29, 2020;2008-10-14;;;2012-07-31;2008-10-14;2008-10-15;Estimate;;;;;;;2012-07-31;2012-08-02;Estimate;October 2007;;2007-10-31;July 2012;2012-07-31;June 2015;Anticipated;2015-06-30;June 2010;Actual;2010-06-30;;Interventional;;;Zevalin® First Line in Follicular Lymphoma;Multicenter European Pilot Study of 90Yttrium-Ibritumomab Tiuxetan as First Line Therapy for Stage III - IV Follicular Lymphoma (and Selected Patients With Extended Stage II) Followed by Consolidation Rituximab for Patients in Complete Remission But With Persistent Molecular Disease;Unknown status;;Phase 2;60;Anticipated;Charite University, Berlin, Germany;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T18:25:07Z;2020-06-01T18:25:07Z;Berlin;3693344;Principal Investigator;Antonio Pezzutto, Prof.;Dept. of Hematology, Charité Berlin, Germany;90Yttrium-Ibritumomab Tiuxetan (Zevalin®)+Rituximab | Rituximab;63722935;;;;2008;2020-05-29;32;FALSE;;;FALSE;50;;Years;;1;3;
NCT00770783;ClinicalTrials.gov processed this data on May 29, 2020;2008-10-09;;;2018-08-03;2008-10-09;2008-10-10;Estimate;;;;;;;2018-08-03;2018-08-06;Actual;February 2005;Actual;2005-02-28;August 2018;2018-08-31;May 2014;Actual;2014-05-31;September 2013;Actual;2013-09-30;;Interventional;;;Magnetic Seizure Therapy (MST) for Treatment Resistant Major Depression;Efficacy of Magnetic Seizure Therapy (MST) in Refractory Major Depression;Completed;;Phase 3;30;Anticipated;University Hospital, Bonn;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T18:25:51Z;2020-06-01T18:25:51Z;Bonn;3693494;Principal Investigator;Thomas E. Schlaepfer, MD;University Hospital, Bonn;Thymatron | Tonica MagPro MST;63723077;1;;;2008;2020-05-29;104;FALSE;;FALSE;TRUE;18;65;Years;Years;1;1;
NCT00769457;ClinicalTrials.gov processed this data on May 29, 2020;2008-10-08;;;2016-05-25;2008-10-08;2008-10-09;Estimate;;;;;;;2016-05-25;2016-05-27;Estimate;September 2008;;2008-09-30;May 2016;2016-05-31;November 2014;Actual;2014-11-30;November 2014;Actual;2014-11-30;;Interventional;OptiLink-HF;;OptiLink HF Study: Optimization of Heart Failure Management Using Medtronic OptiVol Fluid Status Monitoring and CareLink Network;OptiLink HF Study (Optimization of Heart Failure Management Using Medtronic OptiVol® Fluid Status Monitoring and Medtronic CareLink® Network);Completed;;Phase 4;1002;Actual;Medtronic Bakken Research Center;;2;;;FALSE;;;;TRUE;;;;;;;;;;;No;;2020-06-01T18:26:13Z;2020-06-01T18:26:13Z;Homburg;3693591;Principal Investigator;Michael Boehm, Professor;Universitätsklinikum des Saarlandes, Homburg-Saar;Access Arm;63723175;1;;;2008;2020-05-29;75;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT00766233;ClinicalTrials.gov processed this data on May 29, 2020;2008-10-02;;;2016-01-15;2008-10-02;2008-10-03;Estimate;;;;;;;2016-01-15;2016-01-18;Estimate;January 2008;;2008-01-31;January 2016;2016-01-31;February 2016;Anticipated;2016-02-29;January 2016;Actual;2016-01-31;;Interventional;;;Optimal Application Dose of Superficial Hyperthermia;Phase III Study for Analysis of the Optimal Application Dose of Superficial Hyperthermia;Unknown status;;Phase 3;17;Actual;Universitätsmedizin Mannheim;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T18:27:09Z;2020-06-01T18:27:09Z;Mannheim;;;;;Hyperthermal treatment;63723418;1;;;2008;2020-05-29;97;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT00753441;ClinicalTrials.gov processed this data on May 29, 2020;2008-09-15;;;2017-10-26;2008-09-15;2008-09-16;Estimate;;;;;;;2017-10-26;2017-10-27;Actual;February 1, 2009;Actual;2009-02-01;October 2017;2017-10-31;August 16, 2017;Actual;2017-08-16;August 16, 2017;Actual;2017-08-16;;Interventional;STENTBY;;Endoscopic Stenting Versus Surgical Bypass for Low Bile Duct Obstruction by Cancer of the Pancreatic Head;Endoscopic Biliary Stenting on Demand Versus Surgical Biliary Bypass for Palliation of Patients With Advanced Cancer of the Pancreatic Head: STENTBY - A Randomized Controlled Trial;Terminated;;N/A;24;Actual;Heidelberg University;;2;;Low patient accrual;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T18:30:27Z;2020-06-01T18:30:27Z;Heidelberg;3694853;Principal Investigator;Bruno Schmied, MD;Department of General, Visceral and Transplantation Surgery, University of Heidelberg;Surgical bypass | Endoscopic stenting;63724384;1;;;2008;2020-05-29;103;FALSE;;FALSE;TRUE;18;;Years;;2;1;
NCT00749723;ClinicalTrials.gov processed this data on May 29, 2020;2008-09-05;;;2018-07-18;2008-09-05;2008-09-09;Estimate;;;;;;;2018-07-18;2018-07-20;Actual;February 1, 2006;;2006-02-01;July 2018;2018-07-31;January 31, 2016;Actual;2016-01-31;January 31, 2015;Actual;2015-01-31;;Interventional;HIT-REZ-2005;;Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children;Therapy-Optimization Trial and Phase II Study for the Treatment of Relapsed or Refractory of Primitive Neuroectodermal Brain Tumors and Ependymomas in Children and Adolescents;Completed;;Phase 2/Phase 3;174;Actual;University Hospital, Bonn;;4;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T18:31:28Z;2020-06-01T18:31:28Z;Bonn Duisburg;3695168;Principal Investigator;Gudrun Fleischhack, MD;Department of Pediatric Hematology & Oncology, Pediatrics III, University Children's Hospital Essen;carboplatin | etoposide | temozolomide | thiotepa, carboplatin, etoposide | temozolomide, thiotepa | autologous stem cell transplantation | intraventricular etoposide | trofosfamide, etoposide;63724668;54;;;2008;2020-05-29;109;FALSE;;FALSE;FALSE;3;30;Months;Years;3;5;
NCT00733343;ClinicalTrials.gov processed this data on May 29, 2020;2008-02-14;;;2020-04-29;2008-08-11;2008-08-13;Estimate;;;;;;;2020-04-29;2020-05-12;Actual;February 2008;;2008-02-29;April 2020;2020-04-30;June 2015;Actual;2015-06-30;April 2015;Actual;2015-04-30;;Interventional;Serve-HF;;Treatment of Predominant Central Sleep Apnoea by Adaptive Servo Ventilation in Patients With Heart Failure;Treatment of Sleep-Disordered Breathing With Predominant Central Sleep Apnea by Adaptive Servo Ventilation in Patients With Heart Failure;Completed;;N/A;1325;Actual;ResMed;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T18:35:36Z;2020-06-01T18:35:36Z;Duisburg;3696678;Principal Investigator;Helmut Teschler, Prof.;Universitätsklinikum Essen;Europe: AutoSet CS (USA: VPAP Adapt SV);63725917;267;0;5794;2008;2020-05-29;87;TRUE;24;FALSE;FALSE;22;;Years;;3;39;
NCT00732953;ClinicalTrials.gov processed this data on May 29, 2020;2008-08-07;;;2014-06-07;2008-08-08;2008-08-12;Estimate;;;;;;;2014-06-07;2014-06-10;Estimate;February 2009;;2009-02-28;June 2014;2014-06-30;February 2014;Actual;2014-02-28;January 2010;Actual;2010-01-31;;Interventional;;;Prevention of Restenosis After Genous Stent Implantation Using a Paclitaxel Eluting Balloon in Coronary Arteries;Prevention of Restenosis After Genous Stent Implantation Using a Paclitaxel Eluting Balloon in Coronary Arteries - a Randomized Clinical Trial.;Completed;;Phase 2/Phase 3;120;Actual;University of Ulm;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T18:35:45Z;2020-06-01T18:35:45Z;Ulm;3696711;Principal Investigator;Jochen Wöhrle, MD;University of Ulm;Genous stent implantation with paclitaxel-eluting balloon dilation | Genous stent implantation;63725946;3;;;2008;2020-05-29;11;FALSE;;FALSE;FALSE;18;;Years;;1;7;
NCT00727207;ClinicalTrials.gov processed this data on May 29, 2020;2008-07-31;;;2012-12-13;2008-07-31;2008-08-01;Estimate;;;;;;;2012-12-13;2012-12-17;Estimate;May 2008;;2008-05-31;December 2012;2012-12-31;September 2014;Anticipated;2014-09-30;May 2011;Actual;2011-05-31;;Interventional;;;Everolimus in Treating Older Patients With Mantle Cell Lymphoma Previously Treated With First-Line or Second-Line Chemotherapy;Phase II Trial on Efficacy of mTOR Inhibitor RAD001 as Maintenance Therapy for Patients Above 60 Years in Mantle Cell Lymphoma After First and Second Line Chemotherapy;Terminated;;Phase 2;35;Anticipated;Technische Universität München;;;;Lack of participations (8 of 25);FALSE;;;;;;;;;;;;;;;;;2020-06-01T18:37:17Z;2020-06-01T18:37:17Z;Munich;3697191;Principal Investigator;Ulrich Keller, MD;Technische Universität München;everolimus;63726387;1;;;2008;2020-05-29;36;FALSE;;FALSE;TRUE;40;;Years;;1;4;
NCT00725231;ClinicalTrials.gov processed this data on May 29, 2020;2008-07-25;;;2012-05-04;2008-07-25;2008-07-30;Estimate;;;;;;;2012-05-04;2012-05-07;Estimate;February 2008;;2008-02-29;May 2012;2012-05-31;March 2014;Anticipated;2014-03-31;March 2014;Anticipated;2014-03-31;;Interventional;A-CHOP-14;;Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOP;Phase III Study of CHOP-14 Plus or Minus Alemtuzumab in Peripheral T-cell Lymphoma of the Elderly;Unknown status;;Phase 3;274;Anticipated;University of Göttingen;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T18:37:47Z;2020-06-01T18:37:47Z;Göttingen;3697329;Principal Investigator;Lorenz H Trümper, MD;University of Göttingen;alemtuzumab | chemotherapy;63726537;1;;;2008;2020-05-29;;FALSE;;FALSE;TRUE;61;80;Years;Years;1;5;
NCT00724022;ClinicalTrials.gov processed this data on May 29, 2020;2008-07-25;;;2014-09-30;2008-07-28;2008-07-29;Estimate;;;;;;;2014-09-30;2014-10-01;Estimate;June 2008;;2008-06-30;September 2014;2014-09-30;July 2014;Actual;2014-07-31;July 2014;Actual;2014-07-31;;Interventional;Harmony;;Phase IV Study to Evaluate Calcineurin Inhibitor Reduced, Steroid Free Immunosuppression After Renal Transplantation;Triple Arm, Prospectively Randomized Multi Centre Study Phase IV to Evaluate Calcineurin Inhibitor Reduced, Steroid Free Immunosuppression After Renal Transplantation in Non-risk Patients;Completed;;Phase 4;600;Anticipated;University Hospital Freiburg;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T18:38:11Z;2020-06-01T18:38:11Z;Erlangen Freiburg;3697402;Study Director;Ulrich Hopt, Prof.Dr.Dr.;University Hospital Freiburg;Basiliximab, Tacrolimus, MMF, Prednisolon | Basiliximab, Tacrolimus, MMF | Tacrolimus, MMF, rATG;63726629;25;;;2008;2020-05-29;74;FALSE;;FALSE;FALSE;18;75;Years;Years;1;20;
NCT00714311;ClinicalTrials.gov processed this data on May 29, 2020;2008-07-09;;;2015-02-04;2008-07-09;2008-07-14;Estimate;;;;;;;2015-02-04;2015-02-16;Estimate;October 2004;;2004-10-31;February 2015;2015-02-28;February 2015;Actual;2015-02-28;February 2009;Actual;2009-02-28;;Interventional;;;Efficacy of Transference-Focused Psychotherapy for Borderline Personality Disorder;A Randomized-Controlled Trial of Transference-Focused Psychotherapy vs. Treatment by Experienced Community Psychotherapists for Borderline Personality Disorder;Completed;;N/A;104;Actual;University Hospital Muenster;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T18:41:00Z;2020-06-01T18:41:00Z;Münster;3698247;Principal Investigator;Stephan Doering, MD;University of Muenster, Germany;Transference-Focused Psychotherapy | treatment by experienced community psychotherapists;63727362;2;0;0;2008;2020-05-29;52;TRUE;72;FALSE;FALSE;18;45;Years;Years;2;6;
NCT00712218;ClinicalTrials.gov processed this data on May 29, 2020;2008-07-03;;;2020-03-03;2008-07-08;2008-07-09;Estimate;;;;;;;2020-03-03;2020-03-04;Actual;December 2008;;2008-12-31;March 2020;2020-03-31;December 2017;Actual;2017-12-31;December 2017;Actual;2017-12-31;;Interventional;LION;;Lymphadenectomy In Ovarian Neoplasms;Randomized, Multicentre Trial for Lymphadenectomy In Ovarian Neoplasms;Completed;;N/A;640;Actual;Philipps University Marburg Medical Center;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T18:41:28Z;2020-06-01T18:41:28Z;Marburg;3698438;Principal Investigator;Uwe Wagner, MD, Prof;University Marburg;No Lymphadenectomy (LNE) | Lymphadenectomy (LNE);63727524;59;;;2008;2020-05-29;109;FALSE;;FALSE;FALSE;18;75;Years;Years;1;1;
NCT00711542;ClinicalTrials.gov processed this data on May 29, 2020;2008-07-08;;;2017-01-11;2008-07-08;2008-07-09;Estimate;;;;;;;2017-01-11;2017-01-12;Estimate;September 2008;;2008-09-30;January 2017;2017-01-31;December 2015;Actual;2015-12-31;December 2014;Actual;2014-12-31;;Interventional;REPAIR-ACS;;Effects of Intracoronary Progenitor Cell Therapy on Coronary Flow Reserve After Acute MI;Reinfusion of Enriched Progenitor Cells And Infarct Remodeling in Acute Coronary Syndrome: REPAIR - ACS;Terminated;;Phase 1/Phase 2;31;Actual;Johann Wolfgang Goethe University Hospital;;2;;Slow recruitment;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T18:41:39Z;2020-06-01T18:41:39Z;Frankfurt;3698494;Principal Investigator;Andreas M Zeiher, MD;Goethe University;autologous bone marrow-derived progenitor cells | placebo medium;63727576;2;;;2008;2020-05-29;76;FALSE;;FALSE;FALSE;18;80;Years;Years;1;4;
NCT00711230;ClinicalTrials.gov processed this data on May 29, 2020;2008-07-04;;;2020-01-27;2008-07-07;2008-07-08;Estimate;;;;;;;2020-01-27;2020-01-28;Actual;April 2008;;2008-04-30;January 2020;2020-01-31;January 1, 2015;Actual;2015-01-01;December 2011;Actual;2011-12-31;;Interventional;GIEU006;;Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients;A Phase II Randomized, Placebo-Controlled, Multi-Center Study to Evaluate the Safety, Tolerability, Immunogenicity, and Antiretroviral Activity of DermaVir Patch (LC002) in Treatment-Naïve HIV-1-Infected Patients;Completed;;Phase 2;36;Actual;Genetic Immunity;;6;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T18:41:45Z;2020-06-01T18:41:45Z;Hamburg;3698524;Principal Investigator;Jan Van Lunzen, PhD, MD;Universitätsklinikum Hamburg-Eppendorf;DermaVir | Placebo;63727599;3;;;2008;2020-05-29;44;FALSE;;FALSE;FALSE;18;50;Years;Years;1;3;
NCT00697333;ClinicalTrials.gov processed this data on May 29, 2020;2008-06-11;;;2016-07-13;2008-06-12;2008-06-13;Estimate;;;;;;;2016-07-13;2016-07-14;Estimate;May 2009;;2009-05-31;July 2016;2016-07-31;May 2017;Anticipated;2017-05-31;November 2016;Anticipated;2016-11-30;;Interventional;PET-Plan;;Radiotherapy Planning Based on Positron Emission Tomography With Fluoro-deoxyglucose For Advanced NSCLC;Optimisation of Radiotherapy-Planning in Patients With Inoperable Locally Advanced Non-Small-Cell Lung Cancer by FDG-PET;Unknown status;;Phase 2;200;Anticipated;Arbeitsgemeinschaft Nuklearmedizin und Strahlentherapie der DEGRO und DGN;;2;;;FALSE;;;;TRUE;;;;;;;;;;;Yes;;2020-06-01T18:46:17Z;2020-06-01T18:46:17Z;Freiburg;3699750;Principal Investigator;Ursula Nestle, Prof.;Universitätsklinikum Freiburg, Germany;restriction of radiotherapy to FDG-PET positive areas only;63728647;2;;;2008;2020-05-29;;FALSE;;FALSE;FALSE;18;;Years;;1;3;
NCT00688571;ClinicalTrials.gov processed this data on May 29, 2020;2008-05-30;;;2015-10-28;2008-06-02;2008-06-03;Estimate;;;;;;;2015-10-28;2015-10-29;Estimate;October 2007;;2007-10-31;October 2015;2015-10-31;December 2014;Actual;2014-12-31;December 2014;Actual;2014-12-31;;Interventional;;;Melody Transcatheter Pulmonary Valve (TPV) Post-Market Surveillance Study;Melody TPV Post-Market Surveillance Study;Completed;;N/A;63;Actual;Medtronic Cardiovascular;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T18:48:49Z;2020-06-01T18:48:49Z;Munich;3700590;Principal Investigator;John Hess, Prof.;Deutsches Herzzentrum München;Melody Transcatheter Pulmonary Valve;63729079;7;;;2008;2020-05-29;87;FALSE;;FALSE;FALSE;5;;Years;;1;3;
NCT00678275;ClinicalTrials.gov processed this data on May 29, 2020;2008-05-08;;;2015-05-12;2008-05-14;2008-05-15;Estimate;;;;;;;2015-05-12;2015-05-13;Estimate;October 2006;;2006-10-31;May 2015;2015-05-31;March 2015;Actual;2015-03-31;February 2014;Actual;2014-02-28;;Interventional;;;Chronic Graft-versus-host Disease (cGvHD) Prophylaxis With or Without ATG Prior to Stem Cell Transplantation (SCT) From HLA-identical Siblings in Patients With Acute Leukemia;Prophylaxis of Chronic Graft-versus-host Disease (cGvHD) With or Without Anti-T-lymphocyte-globulin (ATG Fresenius) Prior Allogeneic Peripheral Stem Cell Transplantation From HLA-identical Siblings After Myeloablative Conditioning in Patients With Acute Leukemia: A Randomized Phase III-study;Completed;;Phase 3;161;Actual;Universitätsklinikum Hamburg-Eppendorf;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T18:51:55Z;2020-06-01T18:51:55Z;Hamburg;3701462;Principal Investigator;Nicolaus Kroeger, Prof. Dr.;University Medical Center Hamburg-Eppendorf, Department for Stem Cell Transplantation;ATG FRESENIUS (Anti-Lymphocyte-Globulin) | ATG FRESENIUS (Anti-Lymphocyte-Globulin);63730087;1;;;2008;2020-05-29;89;FALSE;;FALSE;TRUE;18;65;Years;Years;1;2;
NCT00677638;ClinicalTrials.gov processed this data on May 29, 2020;2008-05-12;;;2009-12-02;2008-05-12;2008-05-14;Estimate;;;;;;;2009-12-02;2009-12-03;Estimate;June 2008;;2008-06-30;December 2009;2009-12-31;December 2014;Anticipated;2014-12-31;January 2010;Anticipated;2010-01-31;;Interventional;;;Transapical Implantation of Ventor Embracer™ Valve in Patients With Severe Aortic Valve Disease;Catheter-Based Transapical Implantation of the Ventor Embracer™ Heart Valve Prosthesis in Patients With Severe Aortic Valve Disease;Unknown status;;N/A;30;Anticipated;Ventor Technologies;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T18:52:04Z;2020-06-01T18:52:04Z;Leipzig;3701508;Principal Investigator;Friedrich Mohr, MD;Universität Leipzig;Ventor Embracer;63730136;3;;;2008;2020-05-29;;FALSE;;FALSE;FALSE;75;;Years;;2;6;
NCT00670436;ClinicalTrials.gov processed this data on May 29, 2020;2008-04-29;;;2014-06-07;2008-04-30;2008-05-01;Estimate;;;;;;;2014-06-07;2014-06-10;Estimate;February 2008;;2008-02-29;June 2014;2014-06-30;March 2014;Actual;2014-03-31;September 2009;Actual;2009-09-30;;Interventional;PEPCAD-CTO;;The Paclitaxel-Eluting Percutaneous Transluminal Coronary Angioplasty (PTCA) - Balloon Catheter in Coronary Artery Disease to Treat Chronic Total Occlusions;The Paclitaxel-Eluting PTCA-Balloon Catheter in Coronary Artery Disease to Treat Chronic Total Occlusions;Completed;;Phase 2;48;Actual;University of Ulm;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T18:54:00Z;2020-06-01T18:54:00Z;Ulm;3702208;Principal Investigator;"Jochen Wöhrle, MD; FESC";University of Ulm, Ulm, Germany;paclitaxel eluting PTCA balloon catheter (SeQuent Please) | paclitaxel eluting Taxus stent (Boston Scientific);63730682;2;;;2008;2020-05-29;19;FALSE;;FALSE;FALSE;18;90;Years;Years;1;6;
NCT00661206;ClinicalTrials.gov processed this data on May 29, 2020;2008-04-15;;;2014-10-08;2008-04-17;2008-04-18;Estimate;;;;;;;2014-10-08;2014-10-09;Estimate;September 2008;;2008-09-30;October 2014;2014-10-31;November 2014;Anticipated;2014-11-30;November 2014;Anticipated;2014-11-30;;Interventional;ISAR-SAFE;;Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting;Randomized, Double-Blind, Placebo-controlled Trial of 6 vs. 12 Months Clopidogrel Therapy After Implantation of a Drug-Eluting Stent;Unknown status;;Phase 4;4005;Actual;Deutsches Herzzentrum Muenchen;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T18:56:38Z;2020-06-01T18:56:38Z;Munich;3702996;Study Chair;Adnan Kastrati, MD;Deutsches Herzzentrum Muenchen;Clopidogrel | Placebo;63731387;40;;;2008;2020-05-29;;FALSE;;TRUE;FALSE;18;;Years;;1;1;
NCT00659867;ClinicalTrials.gov processed this data on May 29, 2020;2008-04-14;;;2016-09-26;2008-04-14;2008-04-16;Estimate;;;;;;;2016-09-26;2016-09-27;Estimate;December 2008;;2008-12-31;September 2016;2016-09-30;September 2016;Actual;2016-09-30;July 2015;Actual;2015-07-31;;Interventional;;;Endomicroscopy in Ulcerative Colitis;Chromoscopy-guided Endomicroscopy With the PENTAX EC-3870CIFK / EC-3870CILK Confocal Colonoscopes for the Detection of Intraepithelial Neoplasias in Subjects With Long Standing Ulcerative Colitis;Terminated;;N/A;182;Actual;PENTAX Europe GmbH;;2;;Recruitment problems;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T18:57:01Z;2020-06-01T18:57:01Z;Mainz;3703111;Principal Investigator;Ralf Kiesslich, Prof. Dr.;Johannes Gutenberg-Universität Mainz, I. Med. Klinik;PENTAX EC-3870CIFK / EC-3870CILK confocal colonoscopes | PENTAX EC-3870CIFK / EC-3870CILK confocal colonoscopes;63731492;5;;;2008;2020-05-29;80;FALSE;;FALSE;FALSE;18;;Years;;1;1;
NCT00652522;ClinicalTrials.gov processed this data on May 29, 2020;2008-03-20;;;2019-01-31;2008-03-31;2008-04-03;Estimate;;;;;;;2019-01-31;2019-02-04;Actual;January 2008;Actual;2008-01-31;January 2019;2019-01-31;July 13, 2017;Actual;2017-07-13;July 13, 2017;Actual;2017-07-13;;Interventional;AMICA;;Atrial Fibrillation Management in Congestive Heart Failure With Ablation;Atrial Fibrillation Management in Congestive Heart Failure With Ablation;Completed;;N/A;202;Actual;Abbott Medical Devices;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T18:59:05Z;2020-06-01T18:59:05Z;Hamburg;3703724;Principal Investigator;Karl-Heinz Kuck, Prof.;Asklepios Klinik St. Georg - Hamburg;ICD/CRT implant | AF ablation | Best Medical Treatment;63732050;16;;;2008;2020-05-29;115;FALSE;;FALSE;FALSE;18;75;Years;Years;1;7;
NCT00639743;ClinicalTrials.gov processed this data on May 29, 2020;2008-03-13;;;2015-03-26;2008-03-19;2008-03-20;Estimate;;;;;;;2015-03-26;2015-03-27;Estimate;November 2007;;2007-11-30;March 2015;2015-03-31;June 2015;Anticipated;2015-06-30;July 2012;Actual;2012-07-31;;Interventional;PEITHO;;PEITHO Pulmonary Embolism Thrombolysis Study;Comparison Trial Evaluating Efficacy and Safety of Single i.v. Bolus Tenecteplase Plus Standard Anticoagulation as Compared With Standard Anticoagulation in Normotensive Patients;Unknown status;;Phase 3;1005;Actual;Assistance Publique - Hôpitaux de Paris;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T19:02:28Z;2020-06-01T19:02:28Z;Göttingen;3704785;Principal Investigator;Stavros Konstantinides, MD, PhD;Department of Cardiology and Pulmonolog - Universitaetsmedizin Goettingen - 37099 Goettingen, Germany;placebo ( group B) | tenecteplase (group A);63733024;12;;;2008;2020-05-29;56;FALSE;;FALSE;FALSE;18;;Years;;2;6;
NCT00635596;ClinicalTrials.gov processed this data on May 29, 2020;2008-03-07;;;2015-01-12;2008-03-07;2008-03-14;Estimate;;;;;;;2015-01-12;2015-01-13;Estimate;March 2008;;2008-03-31;January 2015;2015-01-31;January 2015;Actual;2015-01-31;January 2014;Actual;2014-01-31;;Interventional;MT110-101;;Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer;An Open-label, Multi-center Dose Escalation Phase I Study to Investigate the Safety and Tolerability of a Continuous Infusion of the Bispecific T-cell Engager (BiTE) MT110 in Locally Advanced, Recurrent or Metastatic Solid Tumors Which Commonly Express EpCAM and Are Not Amenable to Curative Treatment;Completed;;Phase 1;65;Actual;Amgen Research (Munich) GmbH;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T19:03:35Z;2020-06-01T19:03:35Z;Hamburg Munich;3705149;Principal Investigator;Walter Fiedler, MD, Prof.;Universitätsklinikum Hamburg-Eppendorf;MT110;63733338;4;;;2008;2020-05-29;71;FALSE;;FALSE;FALSE;18;;Years;;1;1;
NCT00617084;ClinicalTrials.gov processed this data on May 29, 2020;2008-02-04;;;2014-05-27;2008-02-14;2008-02-15;Estimate;;;;;;;2014-05-27;2014-06-06;Estimate;April 2008;;2008-04-30;May 2014;2014-05-31;February 2014;Actual;2014-02-28;May 2010;Actual;2010-05-31;;Interventional;RESOLUTE-AC;;Randomized, Two-arm, Non-inferiority Study Comparing Endeavor-Resolute Stent With Abbot Xience-V Stent;RESOLUTE-III All-comers Trial: A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention;Completed;;Phase 4;2292;Actual;Medtronic Vascular;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T19:09:19Z;2020-06-01T19:09:19Z;Munich;3706780;Principal Investigator;Sigmund Silber, MD;Kardiologische Praxis und Praxisklinik, Munich, Germany;Medtronic Endeavor Resolute | Abbott Xience V;63734734;1;118;2264;2008;2020-05-29;25;TRUE;5;FALSE;TRUE;18;;Years;;1;1;
NCT00609310;ClinicalTrials.gov processed this data on May 29, 2020;2008-01-24;;;2012-02-02;2008-02-06;2008-02-07;Estimate;;;;;;;2012-02-02;2012-02-03;Estimate;May 2015;;2015-05-31;February 2012;2012-02-29;December 2016;Anticipated;2016-12-31;December 2016;Anticipated;2016-12-31;;Interventional;;;Dietary Bioflavonoid Supplementation for the Prevention of Neoplasia Recurrence;Dietary Supplementation With Bioflavonoids for the Prevention of the Recurrence of Neoplasia in Patients With Resected Colorectal Carcinoma;Suspended;;Phase 2;382;Anticipated;Technische Universität Dresden;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T19:11:33Z;2020-06-01T19:11:33Z;Dresden;;;;;Flavonoids;63735314;1;;;2008;2020-05-29;;FALSE;;FALSE;TRUE;50;75;Years;Years;1;1;
NCT00596765;ClinicalTrials.gov processed this data on May 29, 2020;2008-01-08;;;2016-05-24;2008-01-08;2008-01-17;Estimate;;;;;;;2016-05-24;2016-05-25;Estimate;September 2007;;2007-09-30;May 2016;2016-05-31;March 2015;Actual;2015-03-31;October 2014;Actual;2014-10-31;;Interventional;;;Neuropsychological Cognitive Behavioral Therapy for Patients With Acquired Brain Injury;Phase 2 Study of Neuropsychological Therapy for Patients With Acquired Brain Injury Focusing on the Role of Psychosocial Adjustment Using a Cognitive Behavioral Approach;Completed;;N/A;62;Actual;Philipps University Marburg Medical Center;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T19:15:29Z;2020-06-01T19:15:29Z;Marburg;3708733;Principal Investigator;Cornelia Exner, Dr. (PhD);Philipps University Marburg, Department of Clinical Psychology and Psychotherapy;Neuropsychological Cognitive Behavioral Therapy;63736239;2;;;2008;2020-05-29;86;FALSE;;FALSE;FALSE;18;65;Years;Years;1;4;
NCT00595647;ClinicalTrials.gov processed this data on May 29, 2020;2008-01-04;;;2015-04-19;2008-01-15;2008-01-16;Estimate;;;;;;;2015-04-19;2015-04-21;Estimate;February 2008;;2008-02-29;April 2015;2015-04-30;March 2014;Actual;2014-03-31;March 2014;Actual;2014-03-31;;Interventional;BASKET-SAVAGE;;Study to Test the Efficacy and Safety of Drug Eluting vs. Bare-Metal Stents for Saphenous Vein Graft Interventions;BAsel Stent Kosten Effektivitäts Trial - SAphenous Venous Graft Angioplasty Using Glycoprotein IIb/IIIa Receptor Inhibitors and Drug-Eluting Stents;Terminated;;Phase 4;162;Actual;University Hospital, Basel, Switzerland;;2;;insufficient enrollment;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T19:15:46Z;2020-06-01T19:15:46Z;Leipzig;3708835;Principal Investigator;Sven Möbius-Winkler, MD;University of Leipzig/Heart Center, Germany;Drug eluting stent | Bare metal stent;63736322;5;;;2008;2020-05-29;74;FALSE;;FALSE;FALSE;18;;Years;;1;1;
NCT00590447;ClinicalTrials.gov processed this data on May 29, 2020;2007-12-28;;;2017-03-06;2007-12-28;2008-01-10;Estimate;;;;;;;2017-03-06;2017-03-07;Actual;December 2006;;2006-12-31;March 2017;2017-03-31;July 2015;Actual;2015-07-31;December 2014;Actual;2014-12-31;;Interventional;PTLD-1/3;;Risk Stratified Sequential Treatment for CD20-positive PTLD;Treatment of Patients With Posttransplant Lymphoproliferative Disorder (PTLD) With a Sequential Treatment Consisting of Anti-CD20 Antibody Rituximab and CHOP+GCSF Chemotherapy (PTLD-1/3);Completed;;Phase 2;152;Actual;Charite University, Berlin, Germany;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T19:17:10Z;2020-06-01T19:17:10Z;Berlin;3709309;Principal Investigator;Hanno Riess, MD;Charité, Campus Virchow-Klinikum Berlin, Germany;rituximab monotherapy | sequential R-CHOP;63736712;7;;;2007;2020-05-29;97;FALSE;;FALSE;FALSE;16;;Years;;1;1;
NCT00561990;ClinicalTrials.gov processed this data on May 29, 2020;2007-11-20;;;2015-10-13;2007-11-20;2007-11-21;Estimate;;;;;;;2015-10-13;2015-10-15;Estimate;September 2007;;2007-09-30;October 2015;2015-10-31;January 2014;Actual;2014-01-31;January 2013;Actual;2013-01-31;;Interventional;;;Nimotuzumab in Adults With Pancreatic Cancer;A RANDOMIZED, MULTICENTER, PHASE IIB/IIIA STUDY OF GEMCITABINE AND THE MONOCLONAL ANTIBODY NIMOTUZUMAB (OSAG 101) VERSUS GEMCITABINE AND PLACEBO FOR THE TREATMENT OF CHEMOTHERAPY-NAIVE PATIENTS WITH LOCALLY ADVANCED OR METASTATIC PANCREATIC CANCER;Completed;;Phase 2/Phase 3;188;Anticipated;Oncoscience AG;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T19:24:26Z;2020-06-01T19:24:26Z;Bochum;3711802;Principal Investigator;Dirk Strumberg, MD;University Bochum;Nimotuzumab;63738839;1;;;2007;2020-05-29;65;FALSE;;FALSE;TRUE;18;100;Years;Years;1;1;
NCT00560794;ClinicalTrials.gov processed this data on May 29, 2020;2007-11-19;;;2015-01-12;2007-11-19;2007-11-20;Estimate;;;;;;;2015-01-12;2015-01-26;Estimate;January 2008;;2008-01-31;December 2014;2014-12-31;November 2014;Actual;2014-11-30;September 2009;Actual;2009-09-30;;Interventional;;;Phase II Study of the BiTE® Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL);Open-label, Multicenter Phase II Study to Investigate the Efficacy, Safety, and Tolerability of the Bispecific T-cell Engager (BiTE®) MT103 in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia;Completed;;Phase 2;21;Actual;Amgen Research (Munich) GmbH;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T19:24:54Z;2020-06-01T19:24:54Z;Munich Würzburg;3711917;Principal Investigator;Ralf Bargou, Professor;Julius-Maximilians-Universität Würzburg;Blinatumomab (MT103);63738930;6;309;29;2007;2020-05-29;20;TRUE;63;FALSE;FALSE;18;;Years;;1;13;
NCT00554502;ClinicalTrials.gov processed this data on May 29, 2020;2007-10-29;;;2015-09-21;2007-11-05;2007-11-07;Estimate;;;;;;;2015-09-21;2015-09-22;Estimate;February 2008;;2008-02-29;September 2015;2015-09-30;February 2015;Actual;2015-02-28;February 2015;Actual;2015-02-28;;Interventional;STOP-IgAN;;Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA Nephropathy;Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA Nephropathy;Completed;;Phase 3;148;Anticipated;RWTH Aachen University;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T19:27:07Z;2020-06-01T19:27:07Z;Aachen;3712515;Principal Investigator;Juergen Floege, Prof. Dr.;Medical Clinic II, University Hospital Aachen;supportive therapy with: ACE-inhibitor / ARB / Statin | supportive and immunosuppressive therapy;63739389;34;;;2007;2020-05-29;85;FALSE;;FALSE;FALSE;18;70;Years;Years;2;6;
NCT00554164;ClinicalTrials.gov processed this data on May 29, 2020;2007-11-05;;;2017-05-04;2007-11-05;2007-11-06;Estimate;;;;;;;2017-05-04;2017-05-05;Actual;November 2007;;2007-11-30;May 2017;2017-05-31;March 2017;Actual;2017-03-31;March 2017;Actual;2017-03-31;;Interventional;PETAL;;Positron Emission Tomography Guided Therapy of Aggressive Non-Hodgkin's Lymphomas;Positron Emission Tomography Guided Therapy of Aggressive Non-Hodgkin's Lymphomas;Completed;;Phase 3;1073;Actual;University Hospital, Essen;;4;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T19:27:12Z;2020-06-01T19:27:12Z;Duisburg;3712553;Principal Investigator;Ulrich Duehrsen, Prof. Dr.;Department of Hematology, University Hospital Essen, Hufelandstrasse 55, 45122 Essen, Germany;(R-)CHOP protocol | B-ALL protocol | (R-)CHOP protocol | (R-)CHOP protocol;63739417;1;;;2007;2020-05-29;113;FALSE;;FALSE;TRUE;18;80;Years;Years;1;1;
NCT00546845;ClinicalTrials.gov processed this data on May 29, 2020;2007-10-17;;;2011-08-04;2007-10-17;2007-10-19;Estimate;;;;;;;2011-08-04;2011-08-08;Estimate;September 2007;;2007-09-30;October 2007;2007-10-31;June 2014;Anticipated;2014-06-30;March 2012;Anticipated;2012-03-31;;Interventional;XXS;;Balloon Angioplasty Versus Xpert Stent in CLI Patients XXS Study;Xpert Stent Versus Balloon Angioplasty in Complex Lesions of Small Arteries Below the Knee;Unknown status;;Phase 4;180;Anticipated;University Hospital Tuebingen;;;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T19:29:55Z;2020-06-01T19:29:55Z;Tübingen;3713234;Principal Investigator;Gunnar Tepe, MD;University Hospital Tuebingen;Balloon angioplasty | Use of self-expanding Expert stent;63739965;1;;;2007;2020-05-29;;FALSE;;FALSE;TRUE;18;;Years;;1;4;
NCT00540813;ClinicalTrials.gov processed this data on May 29, 2020;2007-10-05;;;2017-02-22;2007-10-05;2007-10-08;Estimate;;;;;;;2017-02-22;2017-02-23;Actual;October 2007;;2007-10-31;February 2017;2017-02-28;October 2016;Actual;2016-10-31;May 2011;Actual;2011-05-31;;Interventional;PEPCAD V;;Paclitaxel-Eluting Balloon Angioplasty and Coroflex™-Stents in the Treatment of Bifurcated Coronary Lesions;Paclitaxel-Eluting Balloon Angioplasty and Coroflex™-Stents in the Treatment of Bifurcated Coronary Lesions;Completed;;N/A;28;Actual;Heart Centre Rotenburg;;1;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T19:31:51Z;2020-06-01T19:31:51Z;Berlin Hamburg;3713763;Principal Investigator;D. G. Mathey, MD;Hamburg University Cardiovascular Center GmbH;drug eluting balloon;63740423;2;;;2007;2020-05-29;43;FALSE;;FALSE;FALSE;18;;Years;;1;1;
NCT00530738;ClinicalTrials.gov processed this data on May 29, 2020;2007-09-14;;;2014-07-17;2007-09-14;2007-09-17;Estimate;;;;;;;2014-07-17;2014-07-18;Estimate;September 2007;;2007-09-30;July 2014;2014-07-31;January 2014;Actual;2014-01-31;January 2014;Actual;2014-01-31;;Interventional;;;Safety and Efficacy of Longterm HPN With Two Lipid Emulsions;Efficacy, Safety and Quality of Life of a Long-term Home Parenteral Nutrition Regimen With Either LIPIDEM® or LIPOFUNDIN® MCT a Mono-center, Randomized, Double Blind Study;Completed;;Phase 4;42;Actual;B. Braun Melsungen AG;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T19:35:13Z;2020-06-01T19:35:13Z;Berlin;3714749;Principal Investigator;Paul Thul, MD;Charité, University Hospital Berlin;Lipoplus | Lipofundin MCT;63741187;1;;;2007;2020-05-29;77;FALSE;;FALSE;TRUE;18;80;Years;Years;1;1;
NCT00515970;ClinicalTrials.gov processed this data on May 29, 2020;2007-08-13;;;2010-06-14;2007-08-13;2007-08-14;Estimate;;;;;;;2010-06-14;2010-06-15;Estimate;December 2007;;2007-12-31;June 2010;2010-06-30;December 2014;Anticipated;2014-12-31;December 2014;Anticipated;2014-12-31;;Interventional;;;Curettage Versus Excision in Nodular and Superficial Basal Cell Carcinomas;Prospective Randomized Trial: Curettage Versus Excision in Nodular and Superficial Basal Cell Carcinomas;Suspended;;N/A;400;Anticipated;University Hospital Tuebingen;;4;;Problems with the electronic data collection program;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T19:39:35Z;2020-06-01T19:39:35Z;Tübingen;3716192;Study Chair;Helmut Breuninger, M.D.;Department of Dermatology, Eberhard Karls University Tuebingen;Curettage | Deep excision | Shave excision | Curettage;63742291;1;;;2007;2020-05-29;;FALSE;;FALSE;TRUE;;;;;1;12;
NCT00508664;ClinicalTrials.gov processed this data on May 29, 2020;2007-07-27;;;2015-06-01;2007-07-27;2007-07-30;Estimate;;;;;;;2015-06-01;2015-06-02;Estimate;July 2007;;2007-07-31;June 2015;2015-06-30;February 2015;Actual;2015-02-28;February 2015;Actual;2015-02-28;;Interventional;DeLOS II;;Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA);Randomised Phase II Screening Study to be Used in an TP/TPF-chemotherapy (Short Induction) Before TP/TPF-induction, Radiotherapy With or Without Cetuximab in the Primary Therapy of the Only by Laryngectomy Operable Carcinoma of the Larynx/Hypopharynx;Completed;;Phase 2;180;Actual;University of Leipzig;;2;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T19:41:38Z;2020-06-01T19:41:38Z;Leipzig;3716919;Study Director;Andreas Dietz, Dr. med.;University of Leipzig;Radiation | Cetuximab | Docetaxel | Cisplatin (TP) | 5-Fluorouracil (TPF) (only until Feb 2009);63742839;27;;;2007;2020-05-29;92;FALSE;;FALSE;FALSE;18;75;Years;Years;1;2;
NCT00491036;ClinicalTrials.gov processed this data on May 29, 2020;2007-06-22;;;2017-05-01;2007-06-22;2007-06-25;Estimate;;;;;;;2017-05-01;2017-05-02;Actual;June 2009;;2009-06-30;May 2017;2017-05-31;October 2016;Actual;2016-10-31;June 2012;Actual;2012-06-30;;Interventional;IABP-SHOCK II;;Intraaortic Balloon Pump in Cardiogenic Shock II;Randomized Clinical Study of Intraaortic Balloon Pump Use in Cardiogenic Shock Complicating Acute Myocardial Infarction;Completed;;Phase 4;600;Actual;University of Leipzig;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T19:46:35Z;2020-06-01T19:46:35Z;Leipzig;3718564;Study Chair;Holger Thiele, MD;Heart Center Leipzig - University Hospital;Intraaortic balloon pump;63744158;20;;;2007;2020-05-29;36;FALSE;;FALSE;FALSE;18;90;Years;Years;1;13;
NCT00437307;ClinicalTrials.gov processed this data on May 29, 2020;2007-02-19;;;2016-09-21;2007-02-20;2007-02-21;Estimate;;;;;;;2016-09-21;2016-09-22;Estimate;March 2007;;2007-03-31;September 2016;2016-09-30;June 2015;Actual;2015-06-30;July 2013;Actual;2013-07-31;;Interventional;HECTOR;;Hycamtin Plus Carboplatin Versus Established Regimens for the Treatment of Ovarian Cancer Relapse;Topotecan Plus Carboplatin im Vergleich Zur Standardtherapie (Paclitaxel Plus Carboplatin Oder Gemcitabin Plus Carboplatin) in Der Therapie Von Patientinnen Mit Platin-sensitivem Rezidivierten Epithelialen Ovarialkarzinom, Peritonealkarzinom Oder Tubenkarzinom;Completed;;Phase 3;550;Actual;North Eastern German Society of Gynaecological Oncology;;2;;;FALSE;;;;;;;;;;;;;;;No;;2020-06-01T20:03:24Z;2020-06-01T20:03:24Z;Berlin;3723683;Study Chair;Jalid Sehouli;Charité Campus Vichow Klinikum;Topotecan;63748191;1;;;2007;2020-05-29;77;FALSE;;FALSE;TRUE;18;;Years;;1;1;
NCT00433927;ClinicalTrials.gov processed this data on May 29, 2020;2007-02-09;;;2014-03-13;2007-02-09;2007-02-12;Estimate;;;;;;;2014-03-13;2014-03-14;Estimate;January 2007;;2007-01-31;March 2014;2014-03-31;December 2016;Anticipated;2016-12-31;April 2014;Anticipated;2014-04-30;;Interventional;;;5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC);Multicenter Randomized Trial Evaluating FOLFIRI Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment of Metastatic Colorectal Cancer.;Unknown status;;Phase 3;568;Anticipated;Ludwig-Maximilians - University of Munich;;2;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T20:04:37Z;2020-06-01T20:04:37Z;Munich;3724046;Principal Investigator;Volker Heinemann, MD;University of Munich - Klinikum Grosshadern;5-FU | folinic acid | irinotecan | cetuximab | bevacizumab;63748450;1;;;2007;2020-05-29;;FALSE;;FALSE;TRUE;18;75;Years;Years;1;4;
NCT00425425;ClinicalTrials.gov processed this data on May 29, 2020;2007-01-19;;;2014-04-30;2007-01-19;2007-01-23;Estimate;;;;;;;2014-04-30;2014-05-01;Estimate;July 2006;;2006-07-31;April 2014;2014-04-30;May 2015;Anticipated;2015-05-31;May 2010;Actual;2010-05-31;;Interventional;;;Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer;Neoadjuvant Radiochemotherapy in Local Advanced Squamous Cell Carcinoma of the Esophagus With Weekly Cetuximab Plus Oxaliplatin Plus Continuous IV. 5-FU and Conventional Fractionated External Multi-Field Irradiation up to 45 Gray. A Phase I/II Study;Unknown status;;Phase 1/Phase 2;43;Anticipated;Technische Universität München;;;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T20:07:09Z;2020-06-01T20:07:09Z;Munich;3724941;Study Chair;Florian Lordick, MD;Technische Universität München;cetuximab | fluorouracil | oxaliplatin | conventional surgery | neoadjuvant therapy | radiation therapy;63749079;3;;;2007;2020-05-29;46;FALSE;;FALSE;FALSE;18;70;Years;Years;2;6;
NCT00413127;ClinicalTrials.gov processed this data on May 29, 2020;2006-12-18;;;2015-06-25;2006-12-18;2006-12-19;Estimate;;;;;;;2015-06-25;2015-06-26;Estimate;September 2007;;2007-09-30;June 2015;2015-06-30;March 2015;Actual;2015-03-31;March 2014;Actual;2014-03-31;;Interventional;;;Perioperative Protective Effects of Lidocaine;Perioperative Protective Effects of Lidocaine - Clinical Study on the Route and Timing of Administration;Terminated;;Phase 2/Phase 3;78;Actual;University Hospital Muenster;;5;;Less patients than expected for inclusion, therefore patient recruitment is to low;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T20:11:34Z;2020-06-01T20:11:34Z;Münster;3726267;Study Chair;K Hahnenkamp, MD;Department of Anesthesiology and Intensive Care, University Hospital Muenster;lidocaine | NaCl 0,9%;63750005;3;;;2006;2020-05-29;79;FALSE;;FALSE;FALSE;18;85;Years;Years;1;7;
NCT00390702;ClinicalTrials.gov processed this data on May 29, 2020;2006-10-19;;;2018-11-05;2006-10-19;2006-10-20;Estimate;;;;;;;2018-11-05;2018-11-07;Actual;October 2006;Actual;2006-10-31;November 2018;2018-11-30;May 2017;Actual;2017-05-31;August 2012;Actual;2012-08-31;;Interventional;pfm-01/2005;;Safety and Effectiveness of the Nit-Occlud® Lê VSD Spiral Coil System;International Multicentre Clinical Device Investigation on Safety and Effectiveness of the Nit-Occlud® Lê VSD Spiral Coil System for VSD Occlusion Developed by Pfm AG, Cologne;Completed;;N/A;103;Actual;pfm medical ag;;1;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T20:18:41Z;2020-06-01T20:18:41Z;Hamburg;3728320;Principal Investigator;Thomas Meinertz, Prof Dr med;University Hospital Hamburg Eppendorf, Germany;transcatheter implantation of a VSD occluder (Nitinol coil);63751687;6;;;2006;2020-05-29;71;FALSE;;FALSE;FALSE;2;;Years;;1;;
NCT00373438;ClinicalTrials.gov processed this data on May 29, 2020;2006-09-06;;;2009-01-05;2006-09-06;2006-09-08;Estimate;;;;;;;2009-01-05;2009-01-06;Estimate;January 2009;;2009-01-31;January 2009;2009-01-31;July 2014;Anticipated;2014-07-31;January 2014;Anticipated;2014-01-31;;Interventional;;;Fetoscopic Tracheal Balloon Occlusion in Left Diaphragmatic Hernia;Randomized Clinical Trial in Order to Assess the Effect of Fetoscopic Tracheal Balloon Occlusion on the Postnatal Disease Course in Neonates With Left Congenital Diaphragmatic Hernia - FDH-ECMO/BALLOON-TRIAL;Unknown status;;Phase 2;98;Anticipated;University Hospital, Bonn;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T20:23:38Z;2020-06-01T20:23:38Z;Bonn Mannheim;3729948;Principal Investigator;Thomas Kohl, MD;German Center for Fetal Surgery & Minimally-Invasive Therapy, University of Bonn, Germany;Fetoscopic tracheal balloon occlusion;63752991;1;;;2006;2020-05-29;;FALSE;;FALSE;TRUE;18;50;Years;Years;1;8;
NCT00355862;ClinicalTrials.gov processed this data on May 29, 2020;2006-07-24;;;2014-07-29;2006-07-24;2006-07-25;Estimate;;;;;;;2014-07-29;2014-07-30;Estimate;January 2006;;2006-01-31;July 2009;2009-07-31;May 2014;Actual;2014-05-31;April 2009;Actual;2009-04-30;;Interventional;;;Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma;A Prospective Randomised, Open-labeled, Trial Comparing Sirolimus-Containing Versus mTOR-Inhibitor-Free Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma;Completed;;Phase 3;525;Actual;University of Regensburg;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T20:28:45Z;2020-06-01T20:28:45Z;Regensburg;3731568;Study Chair;Edward K Geissler, Prof. PhD;Regensburg University Medical Center, Head of Experimental Surgery;CNI, MMF, Steroids, Aza etc. (mTOR inhibitor free) | Sirolimus;63754293;1;;;2006;2020-05-29;39;FALSE;;FALSE;TRUE;18;;Years;;1;;
NCT00349089;ClinicalTrials.gov processed this data on May 29, 2020;2006-07-04;;;2019-09-16;2006-07-04;2006-07-06;Estimate;;;;;;;2019-09-16;2019-09-19;Actual;September 26, 2006;Actual;2006-09-26;September 2019;2019-09-30;April 14, 2014;Actual;2014-04-14;April 14, 2014;Actual;2014-04-14;;Interventional;;;Trial on Refinement of Early Stage Lung Cancer Adjuvant Therapy;Adjuvant Chemotherapy With Pemetrexed and Cisplatin vs. Vinorelbine and Cisplatin in NSCLC IB, IIA, IIB, T3N1: a Randomized Phase II Study;Completed;;Phase 2;132;Actual;Thoraxklinik-Heidelberg gGmbH;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T20:30:18Z;2020-06-01T20:30:18Z;Heidelberg;3732255;Principal Investigator;Michael Thomas, Prof. Dr.;Clinic for thoracic diseases at the University of Heidelberg, Germany;Pemetrexed | Cisplatin | Vinorelbine;63754795;14;;;2006;2020-05-29;91;FALSE;;FALSE;FALSE;18;74;Years;Years;1;8;
NCT00349076;ClinicalTrials.gov processed this data on May 29, 2020;2006-07-05;;;2016-07-29;2006-07-05;2006-07-06;Estimate;;;;;;;2016-07-29;2016-08-01;Estimate;July 2006;;2006-07-31;July 2016;2016-07-31;June 2016;Actual;2016-06-30;December 2015;Actual;2015-12-31;;Interventional;;;Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy With 5-Fluorouracil and Oxaliplatin Versus 5-Fluorouracil Alone in Rectal Cancer;Prospective Randomised Multicenter Phase-III-study: Preoperative Radiochemotherapy and Adjuvant Chemotherapy With 5-Fluorouracil Plus Oxaliplatin Versus Preoperative Radiochemotherapy and Adjuvant Chemotherapy With 5-Fluorouracil for Locally Advanced Rectal Cancer;Completed;;Phase 3;1256;Actual;University of Erlangen-Nürnberg Medical School;;2;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T20:30:18Z;2020-06-01T20:30:18Z;Erlangen;3732259;Principal Investigator;Rolf Sauer, M.D.;Dept. of Radiation Therapy, University of Erlangen, Germany;5-FU and oxaliplatin | 5-FU;63754796;89;;;2006;2020-05-29;114;FALSE;;FALSE;FALSE;18;;Years;;1;1;
NCT00338689;ClinicalTrials.gov processed this data on May 29, 2020;2006-06-19;;;2015-09-14;2006-06-19;2006-06-20;Estimate;;;;;;;2015-09-14;2015-09-15;Estimate;October 2002;;2002-10-31;September 2015;2015-09-30;September 2015;Anticipated;2015-09-30;August 2006;Actual;2006-08-31;;Interventional;CHOP;;European Childhood Obesity Project: Early Programming by Infant Nutrition?;Childhood Obesity - Programming by Infant Nutrition;Unknown status;;N/A;1678;Actual;Ludwig-Maximilians - University of Munich;;3;;;FALSE;;;;FALSE;;;;;;;;;;;;;2020-06-01T20:32:41Z;2020-06-01T20:32:41Z;Munich;;;;;"Lower protein formula; Higher protein formula";63755508;5;;;2006;2020-05-29;46;FALSE;;FALSE;FALSE;;8;;Weeks;1;5;
NCT00275054;ClinicalTrials.gov processed this data on May 29, 2020;2006-01-10;;;2019-05-21;2006-01-10;2006-01-11;Estimate;;;;;;;2019-05-21;2019-05-23;Actual;October 2005;;2005-10-31;May 2019;2019-05-31;June 2015;Actual;2015-06-30;July 2007;Actual;2007-07-31;;Interventional;;;Rituximab, Fludarabine, and Cyclophosphamide or Observation Alone in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia;Randomized Phase III Trial Comparing Early Treatment With Fludarabine/Cyclophosphamide + Rituximab Versus Deferred Treatment in Untreated Binet Stage A Patients With CLL and High Risk of Progression;Completed;;Phase 3;825;Actual;German CLL Study Group;;3;;;FALSE;;;;;;;;;;;;;;;No;;2020-06-01T20:50:03Z;2020-06-01T20:50:03Z;Köln;3739068;Principal Investigator;Michael Hallek, MD;Medizinische Universitaetsklinik I at the University of Cologne;Fludarabine | Cyclophosphamide | Rituximab;63760245;91;;;2006;2020-05-29;21;FALSE;;FALSE;FALSE;18;;Years;;2;10;
NCT00204529;ClinicalTrials.gov processed this data on May 29, 2020;2005-09-12;;;2017-05-02;2005-09-12;2005-09-20;Estimate;;;;;;;2017-05-02;2017-05-03;Actual;October 2004;Actual;2004-10-31;May 2017;2017-05-31;December 2016;Actual;2016-12-31;May 2013;Actual;2013-05-31;;Interventional;;;Pegylated Interferon-alpha-2a in Patients With Malignant Melanoma Stage IIA-IIIB;Randomized, Multicenter, Open Label Study to Compare the Efficacy and Tolerability of Pegylated Interferon-alpha-2 (PEG-IFN) to 'Low-dose' Interferon-alpha-2a in Patients With Malignant Melanoma in Stages IIA (T3a) - IIIB (AJCC 2002);Completed;;Phase 3;901;Actual;University Hospital Tuebingen;;2;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T21:06:00Z;2020-06-01T21:06:00Z;Tübingen;3745445;Principal Investigator;Claus Garbe, MD;Skin Cancer Program, Department of Dermatology, University of Tübingen, Liebermeisterstr. 20, 72076 Tübingen, Germany;pegylated interferon-alpha-2a | interferon-alpha-2a;63765531;1;;;2005;2020-05-29;104;FALSE;;FALSE;TRUE;18;75;Years;Years;1;4;
NCT00196872;ClinicalTrials.gov processed this data on May 29, 2020;2005-09-12;;;2014-07-16;2005-09-12;2005-09-20;Estimate;;;;;;;2014-07-16;2014-07-17;Estimate;July 2004;;2004-07-31;August 2012;2012-08-31;June 2014;Actual;2014-06-30;June 2014;Actual;2014-06-30;;Interventional;;;A Study to Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients With Node-positive Primary Breast Cancer (GAIN);A Phase III Trial to Compare ETC vs, EC-TX and Ibandronate vs. Observation in Patients With Node-positive Primary Breast Cancer (GAIN);Completed;;Phase 3;3000;Anticipated;German Breast Group;;4;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T21:07:19Z;2020-06-01T21:07:19Z;Frankfurt;3746156;Principal Investigator;Volker Möbus, Prof. Dr.;Städtische Kliniken Frankfurt a.M.-Höchst, Gotenstr. 6-8, 65929 Frankfurt, Germany;Cyclophosphamide | Taxol | Xeloda | Ibandronat | Epirubicine;63766093;1;;;2005;2020-05-29;120;FALSE;;FALSE;TRUE;18;65;Years;Years;2;8;
NCT00187278;ClinicalTrials.gov processed this data on May 29, 2020;2005-09-13;;;2015-08-06;2005-09-13;2005-09-16;Estimate;;;;;;;2015-08-06;2015-08-07;Estimate;May 2003;;2003-05-31;August 2015;2015-08-31;October 2014;Actual;2014-10-31;May 2014;Actual;2014-05-31;;Interventional;;;Biopace Study: Biventricular Pacing for Atrioventricular Block to Prevent Cardiac Desynchronization;Biventricular Pacing for Atrioventricular Block in Left Ventricular Dysfunction to Prevent Cardiac Desynchronization;Completed;;N/A;1833;Actual;Abbott Medical Devices;;2;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T21:09:25Z;2020-06-01T21:09:25Z;Marburg;3747050;Principal Investigator;Reinhard Funck, MD;Klinikum der Philipps-Universität Marburg, Germany;Biventricular Pacing | RV Pacing;63766822;1;;;2005;2020-05-29;133;FALSE;;FALSE;TRUE;18;;Years;;2;12;
NCT00170274;ClinicalTrials.gov processed this data on May 29, 2020;2005-09-12;;;2018-01-29;2005-09-12;2005-09-15;Estimate;;;;;;;2018-01-29;2018-01-30;Actual;August 2000;;2000-08-31;January 2018;2018-01-31;October 2014;Actual;2014-10-31;June 2011;Actual;2011-06-30;;Interventional;;;APART: Prevention and Automatic Therapy of Atrial Arrhythmias in Patients With Paroxysmal Supraventricular Tachycardias;Prevention and Automatic Therapy of Atrial Arrhythmias in Patients With Paroxysmal Supraventricular Tachycardias Who Need Cardiac Pacing;Completed;;N/A;156;Actual;Medtronic Bakken Research Center;;2;;;FALSE;;;;FALSE;;;;;;;;;;;No;;2020-06-01T21:12:13Z;2020-06-01T21:12:13Z;Kiel Lübeck Mannheim;3748443;Principal Investigator;Uwe Wiegand, MD;Universitätsklinik Lübeck Schleswig-Holstein, Campus Lübeck;Activation of preventive and therapeutic algorithms for treatment of AF | AF Prevention and Therapy Algorithms On;63768084;6;;;2005;2020-05-29;131;FALSE;;FALSE;FALSE;18;;Years;;2;8;
NCT00167583;ClinicalTrials.gov processed this data on May 29, 2020;2005-09-09;;;2018-05-14;2005-09-09;2005-09-14;Estimate;;;;;;;2018-05-14;2018-05-17;Actual;November 2004;;2004-11-30;May 2016;2016-05-31;December 2014;Actual;2014-12-31;December 2014;Actual;2014-12-31;;Interventional;INCYTOB;;Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet`s Disease (INCYTOB);Phase III Study of Recombinant Human Interferon-alpha2a Versus Cyclosporin A for the Treatment of Ocular Behcet`s Disease - a National,Randomised, Single-masked Controlled Trial (INCYTOB);Completed;;Phase 3;37;Actual;University Hospital Tuebingen;;2;;;FALSE;;;;TRUE;;;;;;;;;;;Undecided;;2020-06-01T21:12:46Z;2020-06-01T21:12:46Z;Tübingen;3748702;Principal Investigator;Ina Koetter, MD;Tuebingen University Hospital;Cyclosporin A | Interferon-alpha2a;63768285;1;;;2005;2020-05-29;122;FALSE;;FALSE;TRUE;18;75;Years;Years;2;5;
NCT00111371;ClinicalTrials.gov processed this data on May 29, 2020;2005-05-19;;;2014-12-04;2005-05-19;2005-05-20;Estimate;;;;;;;2014-12-04;2014-12-05;Estimate;January 2005;;2005-01-31;September 2006;2006-09-30;October 2015;Anticipated;2015-10-31;;;;;Interventional;;;Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dyslexia;Dopaminergic Enhancement of Learning and Memory (LL_001, Project on Dyslexia);Unknown status;;Phase 4;100;Anticipated;University Hospital Muenster;;;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T21:26:55Z;2020-06-01T21:26:55Z;Münster;3753856;Principal Investigator;Stefan Knecht, Prof. Dr.;Dept. of Neurology, Universityclinic of Muenster;Levodopa;63772519;1;;;2005;2020-05-29;;FALSE;;FALSE;TRUE;18;35;Years;Years;3;1;
NCT00111345;ClinicalTrials.gov processed this data on May 29, 2020;2005-05-19;;;2012-05-21;2005-05-19;2005-05-20;Estimate;;;;;;;2012-05-21;2012-05-23;Estimate;March 2004;;2004-03-31;March 2012;2012-03-31;March 2017;Anticipated;2017-03-31;March 2012;Actual;2012-03-31;;Interventional;;;Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents;Multicenter Therapy-Optimization Trial AML-BFM 2004 for the Treatment of Acute Myeloid Leukemias in Children and Adolescents;Unknown status;;Phase 2/Phase 3;550;Actual;University Hospital Muenster;;4;;;FALSE;;;;TRUE;;;;;;;;;;;;;2020-06-01T21:26:55Z;2020-06-01T21:26:55Z;Hannover Münster;3753858;Principal Investigator;Ursula Creutzig, Prof. Dr. med.;Medical School Hannover;Anthracyclines | liposomal daunorubicin | 2-CDA | AI;63772521;1;;;2005;2020-05-29;97;FALSE;;FALSE;TRUE;;18;;Years;2;1;
NCT00074230;ClinicalTrials.gov processed this data on May 29, 2020;2003-12-10;;;2015-05-11;2003-12-10;2003-12-11;Estimate;;;;;;;2015-05-11;2015-05-12;Estimate;July 2003;;2003-07-31;May 2015;2015-05-31;March 2014;Actual;2014-03-31;March 2014;Actual;2014-03-31;;Interventional;;;Vaccine Therapy in Treating Patients With Stage IV Cutaneous Melanoma;Vaccination of Stage IV Cutaneous Melanoma Patients With Mature, Autologous Monocyte-Derived Dendritic Cells Transfected With RNAs Encoding for Mage-3, MelanA, and Survivin Antigens;Completed;;Phase 1/Phase 2;82;Actual;University Hospital Erlangen;;;;;FALSE;;;;;;;;;;;;;;;;;2020-06-01T21:41:19Z;2020-06-01T21:41:19Z;Erlangen;3757954;Principal Investigator;Gerold Schuler;Dermatologische Klinik MIT Poliklinik-Universitaetsklinikum Erlangen;Autologous Dendritic Cells loaded with MAGE-A3, MelanA and Survivin;63776553;1;;;2003;2020-05-29;129;FALSE;;FALSE;TRUE;18;;Years;;2;4;
NCT00055874;ClinicalTrials.gov processed this data on May 29, 2020;2003-03-06;;;2018-05-02;2003-03-06;2003-03-07;Estimate;;;;;;;2018-05-02;2018-05-03;Actual;June 2002;;2002-06-30;November 2011;2011-11-30;March 31, 2017;Actual;2017-03-31;March 31, 2012;Actual;2012-03-31;;Interventional;;;Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia;Treatment Optimization Trial in Chronic Myeloid Leukemia (CML) - Randomized Controlled Comparison of Imatinib vs. Imatinib/Interferon-alpha vs. Imatinib/Low-Dose AraC vs. Interferon-alpha Standard Therapy and Determination of the Role of Allografting in Newly Diagnosed Chronic Phase;Completed;;Phase 3;1551;Actual;Heidelberg University;;;;;FALSE;;;;;FALSE;FALSE;;;;;;;;;;;2020-06-01T21:46:20Z;2020-06-01T21:46:20Z;Heidelberg Mannheim;3759571;Study Chair;Ruediger Hehlmann, MD;III. Medizinische Klinik Mannheim;recombinant interferon alfa | cytarabine | hydroxyurea | imatinib mesylate | allogeneic bone marrow transplantation | autologous bone marrow transplantation | peripheral blood stem cell transplantation;63778214;66;;;2003;2020-05-29;118;FALSE;;FALSE;FALSE;18;120;Years;Years;4;2;
